data_2n02_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n02 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.5 t . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 88.6 Cg_exo -55.28 -22.91 34.96 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.218 1.279 . . . . 0.0 112.794 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.31 62.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.4 t -64.31 -42.69 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.15 -34.61 90.4 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.012 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.57 -44.23 76.66 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.795 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 t -78.83 -33.43 46.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.241 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.39 -35.44 80.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.794 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 t -54.35 -57.27 19.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.54 -33.21 97.04 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 120.843 1.029 . . . . 0.0 112.767 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -59.31 -38.05 79.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.941 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.04 -38.52 91.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.579 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.97 -53.88 27.87 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.882 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.92 90.68 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CZ ' ' NH1' ' A' ' 27' ' ' ARG . 54.3 t80 -59.13 -43.47 91.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.296 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtt -61.06 -40.78 94.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.072 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.15 -42.46 91.48 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.64 -27.74 65.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.22 0.533 . . . . 0.0 110.302 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -35.39 76.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.669 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 40.7 t80 -61.05 -49.94 75.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.91 -34.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.693 0.759 . . . . 0.0 109.645 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.48 ' NH1' ' CZ ' ' A' ' 20' ' ' PHE . 7.9 ttt180 -61.81 -40.91 96.9 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.779 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.14 -123.47 3.16 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.149 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.1 -29.54 60.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.204 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -33.43 17.93 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -50.37 -43.18 54.25 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -61.41 -43.07 99.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.58 . . . . 0.0 109.834 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.94 -39.17 93.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.85 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.617 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 16.5 m-85 -63.88 -23.26 67.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.29 -40.19 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.796 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.98 -31.96 72.92 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 34' ' ' TYR . 51.1 mt -90.62 148.55 22.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.869 0.366 . . . . 0.0 110.976 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -98.43 127.04 44.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.598 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.711 ' HZ2' ' NH1' ' A' ' 46' ' ' ARG . 11.0 mtpt -105.21 138.3 19.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -55.65 141.47 83.78 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.669 0.913 . . . . 0.0 111.888 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.8 p -62.76 -30.04 71.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.335 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -78.39 0.18 26.7 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.884 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 19.7 t-80 -59.61 127.64 85.16 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 98.4 Cg_endo -81.68 167.06 17.1 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.181 1.254 . . . . 0.0 111.803 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -52.01 140.66 49.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.731 1.621 . . . . 0.0 111.482 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.711 ' NH1' ' HZ2' ' A' ' 39' ' ' LYS . 62.5 mtt-85 -59.74 -36.37 76.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.519 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -73.94 -13.54 60.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.948 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 m -75.91 -69.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.421 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.549 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 63.4 mt -66.01 -34.78 78.87 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.476 -0.49 . . . . 0.0 112.031 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -42.03 -41.03 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.324 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 51.0 Cg_exo -67.2 -7.11 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 123.123 2.549 . . . . 0.0 113.983 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 24.4 pt -42.8 -40.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.465 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 99.3 m95 -53.44 -32.95 52.16 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.578 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.75 97.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -68.39 -51.04 48.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.924 0.393 . . . . 0.0 111.403 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.95 -33.39 74.58 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.248 0.547 . . . . 0.0 110.111 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 17.1 t80 -51.15 -57.16 9.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.125 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -64.97 -38.74 91.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.871 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.24 99.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.214 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.5 mtt -61.34 -37.89 84.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.43 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -55.81 16.12 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -62.15 -38.46 89.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.503 0.192 . . . . 0.0 111.257 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.46 -42.62 93.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.822 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 99.2 p -62.58 -30.74 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.27 -43.27 92.52 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.48 -43.87 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.873 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.04 -40.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.287 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.72 -33.23 75.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 29.0 mtpt -62.17 -44.04 97.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.44 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 80.1 mt-10 -70.89 -45.75 63.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.734 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.41 -27.81 60.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.792 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.7 67.96 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.663 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.55 -161.29 28.76 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.94 108.51 20.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.641 0.734 . . . . 0.0 109.904 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . 11.8 t -133.53 167.6 20.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.209 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' THR . 77.6 mm-40 -43.98 -35.57 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.321 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.95 -41.99 97.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.613 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.7 69.52 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.678 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 78.9 mmm -61.21 -34.78 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.534 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.56 -48.36 95.75 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -73.35 -62.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.272 1.315 . . . . 0.0 113.387 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.82 -41.32 97.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.034 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.55 97.92 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.28 -40.32 90.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.666 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -59.82 -44.54 93.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.769 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.7 m -65.69 -42.41 91.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.98 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.84 -55.91 6.21 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -57.87 -41.27 82.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.412 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.22 -38.87 84.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.113 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.29 84.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.107 0.48 . . . . 0.0 111.414 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.65 -41.8 82.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.039 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.48 HD21 ' CA ' ' A' ' 117' ' ' GLY . 50.4 t-20 -65.93 -36.0 82.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.758 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.572 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m95 -53.06 -30.84 38.27 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.38 62.9 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.198 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.55 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 40.0 t-105 -64.03 -56.75 22.05 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.572 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 46.1 Cg_endo -54.83 131.83 48.37 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.742 1.628 . . . . 0.0 113.035 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.461 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 42.5 Cg_endo -107.56 -26.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.435 1.423 . . . . 0.0 110.556 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.461 ' H ' ' CD ' ' A' ' 97' ' ' PRO . 27.1 pt -60.69 -25.59 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.069 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 35.3 p90 -51.69 -42.74 62.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.29 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.499 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.8 t80 -64.53 -49.55 70.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.874 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 102' ' ' ALA . . . -113.49 -68.65 0.51 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.369 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.587 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 75.53 -3.66 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -54.74 -34.07 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -86.4 155.88 20.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 111.194 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.706 ' C ' ' H ' ' A' ' 107' ' ' TRP . 20.8 ttm -57.39 -14.26 4.52 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.811 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -44.69 2.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.155 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.706 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -47.42 -21.84 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.472 0.636 . . . . 0.0 111.374 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -55.14 -27.86 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.61 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.23 -33.18 73.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.009 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.73 79.89 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.543 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 56.1 t0 -61.75 -45.02 95.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.347 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.53 -47.77 71.84 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.715 -0.394 . . . . 0.0 112.005 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.522 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.0 tt -67.0 -41.18 87.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.381 0.61 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.0 tp -53.22 -60.88 2.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.404 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.82 -63.21 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.452 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.0 t -65.39 -38.8 91.08 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.48 ' CA ' HD21 ' A' ' 92' ' ' ASN . . . -61.61 -56.55 22.46 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.714 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.1 -38.26 77.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.972 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -75.88 -47.47 25.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 32.0 m -58.98 -43.39 91.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.02 -50.99 43.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.558 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.2 m -65.08 -40.99 95.41 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 71.1 m -60.56 -46.55 89.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.2 mt -66.25 -35.99 81.84 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.67 -64.14 1.23 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.403 ' O ' ' N ' ' A' ' 130' ' ' SER . 38.6 m0 -66.4 -41.17 89.72 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 33.5 t-80 -58.49 -49.03 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.922 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -65.61 -46.07 80.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.486 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 99.0 t -78.27 -46.5 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 126' ' ' TRP . 20.1 p -129.4 82.42 67.84 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.591 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.474 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 36.5 Cg_exo -53.14 -43.34 57.95 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.795 1.663 . . . . 0.0 112.257 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 23.7 Cg_exo -58.02 -32.47 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.474 0.783 . . . . 0.0 112.208 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.46 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.522 . . . . 0.0 110.379 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.72 77.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.098 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.501 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 42.7 mtm105 -62.95 -38.59 91.69 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.296 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.15 -38.53 62.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.16 0.505 . . . . 0.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.519 ' O ' ' C ' ' A' ' 138' ' ' TYR . 83.7 mt -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -2.81 -67.33 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.794 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.475 ' N ' ' O ' ' A' ' 137' ' ' LEU . 10.9 Cg_endo -54.31 -30.06 60.66 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 120.799 0.999 . . . . 0.0 112.992 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -56.77 -40.69 76.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.2 tm? -63.61 -42.85 98.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.84 75.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.269 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.639 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -61.7 -50.34 72.83 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.483 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.84 -33.73 76.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.839 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.58 96.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.201 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -61.47 -41.65 97.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.345 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.639 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 53.8 p -60.81 -38.64 86.08 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.1 m -59.49 -50.59 73.34 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.948 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 91.8 t -71.32 -43.88 73.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.864 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.97 -41.59 83.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.184 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 147' ' ' THR . 47.3 m-80 -63.04 -40.14 96.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.492 ' O ' ' CB ' ' A' ' 156' ' ' ARG . 37.1 m-85 -62.19 -39.57 93.15 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.697 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.441 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 47.4 t80 -59.9 -46.59 88.84 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.175 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -71.4 -51.32 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.9 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.427 ' O ' ' OG ' ' A' ' 159' ' ' SER . 1.0 OUTLIER -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.771 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 152' ' ' TYR . 28.4 ttp180 -59.57 -38.32 80.81 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.162 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 92.6 m-20 -59.37 -42.46 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.905 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -87.44 -54.64 4.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.345 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 79.7 p . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.913 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -53.58 -22.66 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 120.656 0.904 . . . . 0.0 111.8 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.34 -33.92 55.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.36 -42.22 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.83 -35.25 91.68 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 11' ' ' LEU . 9.8 mp -56.46 -41.62 76.82 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 122.728 -0.277 . . . . 0.0 110.962 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 t -79.71 -34.89 39.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.511 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.08 -36.22 79.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.1 t -48.0 -56.41 13.82 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.22 -34.16 98.18 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.719 0.946 . . . . 0.0 112.933 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.4 m -59.04 -40.47 85.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.271 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.09 -37.89 88.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.001 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.29 -40.22 98.3 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.89 -44.22 98.36 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.881 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.4 m-85 -63.88 -43.38 96.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.3 mtt -61.83 -40.91 96.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.81 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.44 -45.82 10.72 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.15 -25.15 64.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.33 0.586 . . . . 0.0 110.014 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -52.95 -36.55 60.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.358 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 89.7 t80 -60.24 -47.12 87.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.61 -32.81 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.448 ' CA ' ' HE ' ' A' ' 46' ' ' ARG . 20.5 ttt-85 -62.42 -42.77 99.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.029 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.94 -132.07 1.18 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.687 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.0 -26.05 59.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.796 0.331 . . . . 0.0 110.69 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.49 8.94 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.25 -41.64 62.97 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.67 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -62.87 -42.17 99.66 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.365 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -61.27 -39.89 92.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.592 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 29.3 m-85 -64.55 -22.82 67.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.021 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.7 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.338 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.86 82.25 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 72.8 mt -91.54 150.02 21.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.408 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.72 126.91 41.32 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.222 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -102.47 141.69 23.03 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -57.99 144.15 94.96 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.112 1.208 . . . . 0.0 112.32 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.7 p -64.08 -30.24 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.039 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -78.66 3.76 15.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.927 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 32.8 t-80 -60.1 139.52 91.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.598 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 79.7 Cg_endo -95.67 169.3 1.32 Allowed 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.035 1.157 . . . . 0.0 112.759 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.578 ' CG ' ' HG1' ' A' ' 48' ' ' THR . 43.3 Cg_exo -54.36 148.46 41.9 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.876 2.384 . . . . 0.0 112.167 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HE ' ' CA ' ' A' ' 27' ' ' ARG . 22.7 tpt85 -57.21 -39.39 75.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -79.89 -5.94 56.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.578 ' HG1' ' CG ' ' A' ' 45' ' ' PRO . 20.4 m -76.79 -76.4 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.9 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 69.9 mt -66.38 -32.29 73.58 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.889 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -41.52 -42.73 5.11 Favored Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.374 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 61.7 Cg_exo -64.31 -6.94 12.68 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.083 2.522 . . . . 0.0 113.789 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 18.4 pt -42.32 -44.03 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.731 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.3 m95 -54.8 -31.99 59.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.606 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.68 -39.89 98.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -68.77 -51.79 37.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.092 0.472 . . . . 0.0 111.036 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.81 -32.63 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.87 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 8.8 t80 -51.79 -49.39 62.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.734 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.0 p -70.88 -36.04 72.6 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.456 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.76 89.07 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.06 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.5 mtt -62.25 -38.77 90.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.427 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.52 -56.68 10.78 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.92 -38.41 88.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.93 92.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 94.1 p -63.5 -28.89 70.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.939 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -58.88 -43.81 91.0 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.22 -46.43 88.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.26 -41.05 85.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.522 0.677 . . . . 0.0 109.198 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.505 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.35 -34.19 77.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.206 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -63.23 -43.18 98.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 82.7 mt-10 -67.49 -37.06 82.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.25 -4.39 58.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.18 46.67 15.18 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.721 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.443 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.39 -159.53 23.34 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.677 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -85.18 111.62 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.719 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 t -130.27 161.21 31.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -47.07 -39.75 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.482 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -63.33 -39.62 95.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.719 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.8 71.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.212 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 87.4 mmm -58.72 -34.54 71.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.112 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.15 -59.23 13.97 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.22 -53.84 1.33 Allowed 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 120.828 1.019 . . . . 0.0 112.767 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.0 -43.01 96.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.448 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.55 -41.99 97.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.84 -39.33 77.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.921 0.391 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 73.2 t80 -60.42 -44.17 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.561 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.0 m -64.85 -43.1 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 112.072 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.23 -58.25 4.39 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.76 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -57.8 -40.91 81.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.681 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.77 -41.21 99.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.633 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 111.416 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.36 -37.76 78.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.734 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 45.3 t-20 -61.73 -42.46 98.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.169 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -57.57 -31.42 66.13 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.775 0.322 . . . . 0.0 111.193 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.1 -28.81 69.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.666 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -55.05 -55.45 38.89 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -38.49 81.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.814 1.676 . . . . 0.0 113.18 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' A' ' 95' ' ' TRP . 65.1 Cg_endo -63.71 -23.69 69.44 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 120.498 0.799 . . . . 0.0 111.704 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 38.1 pt -62.21 -30.0 47.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.65 -48.26 66.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.779 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.489 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 68.5 t80 -64.95 -46.78 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.633 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.571 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -109.38 -65.04 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 59.79 -1.32 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 110.838 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.571 ' H ' ' C ' ' A' ' 101' ' ' GLY . 24.0 ttp-105 -52.59 -33.55 46.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -91.52 151.77 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.263 0.554 . . . . 0.0 111.688 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.631 ' C ' ' H ' ' A' ' 107' ' ' TRP . 3.0 ttp -62.93 -14.63 49.34 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.193 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.75 32.65 0.01 OUTLIER Glycine 0 CA--C 1.543 1.824 0 C-N-CA 121.821 -0.228 . . . . 0.0 113.018 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.631 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -63.58 -19.61 64.97 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -179.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.528 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -42.97 -21.89 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.859 0.361 . . . . 0.0 111.924 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 107' ' ' TRP . 75.3 mt -58.73 -34.79 71.76 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.9 t0 -63.84 -48.06 78.28 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.5 tp -61.54 -49.39 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.399 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.516 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.6 tt -67.16 -41.27 86.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.289 0.566 . . . . 0.0 110.11 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.42 -59.89 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.678 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.8 t -71.13 -63.07 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.588 -1.187 . . . . 0.0 113.2 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.487 ' O ' ' OG1' ' A' ' 120' ' ' THR . 43.7 t -66.93 -39.29 87.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.22 -56.12 23.88 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.355 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.25 -37.3 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.317 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.03 -52.81 8.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.9 m -54.58 -42.58 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -60.37 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.913 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.608 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 21.6 m -66.02 -41.19 91.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.6 m -58.27 -47.22 84.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.165 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.1 -34.17 77.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.11 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.608 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 39.0 m0 -65.06 -45.3 85.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.662 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -59.84 -43.89 94.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.148 -177.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.56 -43.45 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.221 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.492 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 84.7 t -81.02 -50.83 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 126' ' ' TRP . 76.1 p -128.58 88.88 51.0 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.046 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.5 Cg_exo -52.06 -40.14 68.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 121.651 1.567 . . . . 0.0 113.019 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.7 Cg_exo -57.42 -27.0 74.03 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.532 0.821 . . . . 0.0 112.905 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.77 74.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.639 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.62 -38.83 86.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.202 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 59.8 ttt180 -60.39 -38.76 84.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.14 -39.13 74.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.176 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.0 mt -56.79 -33.14 66.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.852 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.522 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER 9.91 -72.62 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -53.4 -26.43 35.48 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 120.617 0.878 . . . . 0.0 113.675 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -57.5 -41.33 80.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.357 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -64.96 -41.15 95.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.09 0.472 . . . . 0.0 109.943 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.74 -42.4 95.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.633 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -67.2 -53.11 33.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.398 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.39 -33.41 73.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.674 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.36 96.96 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.555 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -60.55 -41.11 93.87 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.129 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.633 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 69.4 p -61.82 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.452 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.438 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 59.3 m -61.21 -53.06 61.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.445 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.4 -42.84 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.9 tp -57.39 -41.92 81.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.425 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.03 -41.8 97.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 148' ' ' THR . 50.1 m-85 -64.85 -36.75 85.36 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.659 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 62.2 t80 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.426 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.43 -49.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.135 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.471 ' O ' ' OG ' ' A' ' 159' ' ' SER . 3.0 m0 -61.72 -43.91 97.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.555 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 152' ' ' TYR . 82.2 mmt-85 -62.87 -34.77 78.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.381 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 91.0 m-20 -56.56 -41.27 76.58 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.795 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -94.22 -48.13 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.443 . . . . 0.0 110.573 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 80.6 p . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.788 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.19 -19.83 35.75 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 119.368 0.81 . . . . 0.0 112.514 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.35 -34.73 61.7 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.85 -39.97 81.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -36.47 92.74 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.7 -41.99 87.55 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 122.824 -0.221 . . . . 0.0 111.565 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 t -75.41 -37.33 60.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.189 -0.604 . . . . 0.0 112.072 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' OG ' ' A' ' 16' ' ' SER . 86.5 mt -61.56 -36.71 81.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 t -51.6 -43.07 86.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.48 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -58.39 -36.45 97.55 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.15 1.233 . . . . 0.0 112.902 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 82.7 p -63.46 -37.52 87.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.602 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.68 -40.03 80.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.455 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.99 76.34 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.7 -40.85 97.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.59 -48.65 80.85 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.171 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 65.0 mtt -63.93 -39.47 94.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.409 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.84 -45.47 74.25 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.799 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.31 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 111.64 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -57.61 -30.94 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 90.6 t80 -61.0 -48.6 81.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.73 -32.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.747 0.785 . . . . 0.0 109.631 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -63.06 -41.18 99.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.575 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.86 -128.58 4.78 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.025 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' CG ' HH21 ' A' ' 32' ' ' ARG . 84.2 tt0 -49.97 -30.51 10.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.253 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.97 -33.12 20.48 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.8 mt -50.59 -44.63 56.97 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.522 HH21 ' CG ' ' A' ' 29' ' ' GLU . 67.9 mtm180 -62.18 -43.45 98.8 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.0 110.071 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.06 -39.74 91.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.954 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' LEU . 17.8 m-85 -65.27 -23.14 66.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.2 -41.11 49.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.155 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.18 -32.62 84.53 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' TYR . 67.5 mt -92.51 150.63 20.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -101.54 127.83 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.917 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.744 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 14.0 mtpt -107.42 140.69 21.75 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.595 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 37.1 Cg_endo -58.03 130.23 37.12 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 120.713 0.942 . . . . 0.0 111.431 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.6 p -75.64 -13.44 60.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.884 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 2.7 p90 -77.29 -15.49 59.41 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.488 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -76.04 147.35 80.14 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.49 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -72.83 162.05 42.15 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.803 1.002 . . . . 0.0 111.297 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.9 Cg_endo -50.73 150.6 12.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.217 1.945 . . . . 0.0 111.848 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.744 ' HE ' ' HZ3' ' A' ' 39' ' ' LYS . 51.7 mtt85 -57.11 -36.85 71.13 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.447 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 5.1 p90 -65.02 -22.09 66.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.864 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.7 m -78.45 -63.07 1.49 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.431 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.544 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 85.8 mt -63.24 -36.98 85.46 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -45.49 -41.38 16.72 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.742 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 75.3 Cg_exo -64.92 -7.56 15.48 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 123.376 2.718 . . . . 0.0 114.081 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.547 ' CD1' ' CE2' ' A' ' 143' ' ' TRP . 27.9 pt -41.99 -41.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.291 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' TYR . 97.2 m95 -51.2 -34.09 30.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.946 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.19 -39.99 96.66 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.0 m -68.68 -51.44 41.83 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.99 0.424 . . . . 0.0 110.936 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.98 -32.42 73.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' TRP . 3.5 t80 -52.28 -48.97 65.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.463 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -68.37 -36.92 79.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.23 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.91 76.54 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.672 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.512 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 62.9 mtt -61.84 -37.23 83.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -63.93 -61.75 5.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -61.61 -36.05 79.62 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.753 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.61 -42.91 58.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 84.1 p -66.65 -27.29 67.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -55.5 -49.86 71.45 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.445 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.7 mt -66.25 -37.33 79.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.668 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.7 t -53.88 -48.03 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.448 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.6 p90 -73.23 -30.74 63.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.235 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 65.6 mmtt -58.36 -38.56 77.48 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.204 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.26 -40.91 94.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.27 -25.77 60.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.772 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 104.77 39.12 2.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.15 -166.55 28.52 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.662 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.13 112.05 19.47 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.16 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 78' ' ' ALA . 4.2 t -129.94 165.77 21.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.589 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.85 -37.87 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.471 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -64.28 -38.92 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.868 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.402 ' H ' HG22 ' A' ' 75' ' ' THR . . . -67.4 -32.29 73.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.662 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 81.6 mmm -59.74 -33.74 72.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.974 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.4 -57.6 23.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.66 -50.85 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 120.61 0.874 . . . . 0.0 112.335 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.0 mp -65.06 -41.16 95.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.109 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.66 -39.23 97.65 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.94 -38.38 78.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.112 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.512 ' OH ' ' SD ' ' A' ' 60' ' ' MET . 86.8 t80 -59.36 -45.17 92.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.144 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.7 m -69.15 -41.89 76.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.45 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.19 -54.41 6.96 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.548 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -57.98 -41.41 82.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.299 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.54 -37.29 85.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.835 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.79 81.72 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.711 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.36 -36.53 84.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -57.85 -40.96 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -66.01 -32.68 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.76 78.17 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.583 ' O ' ' N ' ' A' ' 97' ' ' PRO . 3.8 t-105 -57.84 -50.68 86.73 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -42.79 82.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.403 1.402 . . . . 0.0 112.549 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 95' ' ' TRP . 72.3 Cg_endo -62.35 -25.45 76.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 120.574 0.849 . . . . 0.0 111.601 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 102' ' ' ALA . 29.0 pt -59.91 -33.73 53.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -46.61 64.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.89 -50.48 66.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.826 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.33 -53.1 0.47 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 57.14 3.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 0.0 110.797 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' A' ' 101' ' ' GLY . 12.6 tpt180 -53.12 -34.96 59.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -92.0 145.33 24.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.329 0.585 . . . . 0.0 111.503 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.637 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.3 ttp -65.31 -14.36 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.343 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.03 38.56 0.01 OUTLIER Glycine 0 CA--C 1.54 1.628 0 O-C-N 123.077 0.236 . . . . 0.0 112.952 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.637 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -65.16 -18.94 65.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.499 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -41.5 -21.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.756 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 107' ' ' TRP . 89.2 mt -57.2 -39.47 75.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.503 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -67.81 -39.04 84.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 109.942 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 49.6 t0 -60.92 -45.18 95.67 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.71 -48.99 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.46 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 117' ' ' GLY . 85.0 mt -69.08 -40.34 78.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.417 0.627 . . . . 0.0 110.459 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.442 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 15.1 tp -51.75 -60.25 3.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.154 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.11 -63.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.754 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -71.63 -40.32 69.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -61.36 -51.29 58.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.534 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.43 ' O ' ' OG1' ' A' ' 122' ' ' THR . 3.7 p -65.83 -37.04 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.174 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -78.78 -51.43 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.8 m -59.49 -45.28 92.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.28 68.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.37 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.476 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.3 m -64.33 -39.07 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.156 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 89.9 m -59.62 -52.96 63.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 0.0 112.296 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.597 ' O ' ' NE ' ' A' ' 128' ' ' ARG . 65.9 mt -59.34 -31.2 68.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.991 0.425 . . . . 0.0 110.362 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.87 -63.17 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.493 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 33.8 m0 -86.5 -52.21 5.71 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.47 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -52.63 -47.15 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.597 ' NE ' ' O ' ' A' ' 124' ' ' LEU . 68.2 mtm180 -63.5 -40.83 98.1 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.3 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.36 -43.41 49.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.8 p -140.33 94.87 8.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.875 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.457 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.3 Cg_exo -54.08 -39.94 83.59 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.948 1.765 . . . . 0.0 113.775 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.5 Cg_exo -55.7 -26.21 54.98 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.338 0.692 . . . . 0.0 112.87 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.54 -31.24 71.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.668 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.15 93.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.441 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.537 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 51.9 ttp180 -59.77 -38.16 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.3 tp -58.7 -38.83 79.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.203 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 139' ' ' PRO . 22.0 mt -56.04 -29.62 60.7 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.065 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.9 OUTLIER 9.28 -74.41 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.6 Cg_endo -52.32 -29.12 37.37 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 120.436 0.758 . . . . 0.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -57.92 -42.34 84.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.987 0.423 . . . . 0.0 109.977 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 42.7 tp -63.34 -39.56 94.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.63 96.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.006 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.614 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 0.9 OUTLIER -67.09 -47.93 69.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.234 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 44.5 mt -65.25 -33.74 76.71 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.801 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.89 77.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -63.32 -42.02 98.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.646 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.614 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 3.0 m -57.6 -43.74 84.89 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.516 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.7 m -60.18 -49.61 76.94 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.705 0.288 . . . . 0.0 111.604 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.44 -40.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.54 0.686 . . . . 0.0 109.757 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 63.8 tp -57.79 -42.98 85.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.729 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 147' ' ' THR . 17.1 m120 -63.48 -41.24 98.58 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -66.04 -40.32 90.9 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -61.52 -40.9 96.32 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.811 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.6 -47.66 79.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.509 ' O ' ' O ' ' A' ' 159' ' ' SER . 5.3 m0 -62.15 -39.23 91.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -54.81 -31.1 58.75 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.215 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.49 -40.86 68.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.651 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -103.8 -60.91 1.5 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.675 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 155' ' ' TRP . 49.2 m . . . . . 0 N--CA 1.461 0.111 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.875 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.87 -21.35 25.77 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.445 1.43 . . . . 0.0 112.617 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.09 -40.94 59.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.797 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.37 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.74 -34.44 89.91 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.277 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 11' ' ' LEU . 10.1 mp -56.55 -42.63 78.85 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.871 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 t -76.03 -36.55 59.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.822 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.98 -38.17 90.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -53.87 -42.23 91.85 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -56.47 -36.36 97.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 120.953 1.102 . . . . 0.0 112.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -61.25 -37.88 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 mt -62.35 -39.11 92.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.252 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.82 -52.58 28.22 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.76 -38.27 95.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -57.33 -44.78 84.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.279 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.08 -38.92 90.66 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.375 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.72 -46.27 76.93 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.99 -24.08 62.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 110.826 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -34.92 70.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 54.3 t80 -60.71 -49.05 79.06 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.62 -33.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.156 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -61.01 -40.79 94.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.817 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.06 -125.83 2.67 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.032 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.87 -28.8 62.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 111.209 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.4 -33.97 12.58 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 94.1 mt -48.78 -44.33 38.82 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.663 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.09 -42.45 99.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.976 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -62.31 -38.14 88.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.843 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.607 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.1 m-85 -63.78 -22.75 67.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.224 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.19 -41.41 27.06 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.973 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.99 -32.25 76.73 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.8 mt -88.93 149.51 23.28 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.451 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.0 mt-30 -101.96 130.17 48.41 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.079 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 16.1 mtpt -108.99 141.5 23.51 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 27.6 Cg_endo -58.98 135.93 69.95 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.387 1.391 . . . . 0.0 111.944 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.9 p -71.94 -21.29 61.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.312 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.525 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 4.5 p90 -77.95 -14.8 59.41 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.66 148.49 92.74 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.948 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -80.14 162.34 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.202 1.935 . . . . 0.0 111.424 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.2 Cg_endo -52.47 149.49 23.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.768 1.645 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.604 ' HE ' ' HZ3' ' A' ' 39' ' ' LYS . 39.2 mtt85 -57.19 -37.96 72.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 48' ' ' THR . 5.0 p90 -63.98 -28.21 69.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.941 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 25.0 m -66.12 -61.21 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.534 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 91.2 mt -72.22 -34.78 68.61 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -38.33 -49.35 3.44 Favored Pre-proline 0 C--N 1.321 -0.634 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.938 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 18.4 Cg_endo -73.19 4.67 3.61 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 122.113 1.875 . . . . 0.0 114.134 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 11.5 pt -42.07 -40.17 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.637 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.441 ' O ' ' N ' ' A' ' 57' ' ' TYR . 98.6 m95 -50.7 -32.32 19.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.333 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.1 -40.69 95.95 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 m -67.98 -50.97 52.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 111.352 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.61 -33.12 74.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.238 0.542 . . . . 0.0 109.897 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 53' ' ' TRP . 3.3 t80 -52.67 -49.43 65.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.2 p -70.41 -36.55 74.1 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.684 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.33 -40.88 85.96 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.781 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.48 -39.37 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.095 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.99 -49.3 76.81 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -64.05 -39.16 93.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.82 -42.09 85.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.472 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.9 p -64.27 -29.27 70.37 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.76 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.553 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 50.6 t80 -58.78 -40.13 83.05 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.218 0.532 . . . . 0.0 110.169 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.38 -39.55 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.539 0.685 . . . . 0.0 109.865 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.42 -54.08 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.55 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.441 ' NE1' ' HG2' ' A' ' 69' ' ' LYS . 0.7 OUTLIER -66.37 -35.75 81.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.553 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 22.0 mmtp -61.4 -39.49 90.92 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.495 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -63.32 -40.07 96.3 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.334 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.73 -25.49 59.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.74 49.26 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.449 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.39 -158.64 24.64 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.633 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -92.18 109.13 20.49 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.482 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.548 ' CG2' ' OD1' ' A' ' 77' ' ' ASP . 6.3 t -131.68 167.37 19.58 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -49.91 -38.36 35.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 35.6 p30 -66.45 -32.87 74.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.974 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.664 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -76.61 -30.69 57.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.633 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 88.1 mmm -59.04 -34.9 72.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.23 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -64.08 -58.13 15.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.37 -56.5 1.28 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 121.461 1.441 . . . . 0.0 113.117 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.14 -43.07 96.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.947 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.85 97.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.868 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -57.33 -39.8 76.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.083 0.468 . . . . 0.0 110.203 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -61.12 -43.98 98.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.042 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.3 m -68.42 -42.93 78.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -61.2 2.97 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -55.6 -41.09 72.93 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.22 -38.82 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.43 69.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.1 -38.54 86.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.918 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 42.8 t-20 -60.65 -42.13 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -58.14 -31.71 67.46 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.619 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.5 70.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.374 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -54.3 -54.3 49.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -40.37 79.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.678 1.586 . . . . 0.0 113.28 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.601 ' N ' ' O ' ' A' ' 95' ' ' TRP . 57.3 Cg_endo -61.0 -21.3 71.06 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 120.818 1.012 . . . . 0.0 110.525 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 29.0 pt -62.41 -23.96 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.175 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -54.49 -46.88 73.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.027 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 69.3 t80 -64.33 -50.2 68.72 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.17 0.42 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.676 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.595 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 60.98 -2.3 0.2 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.567 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.0 ttt180 -53.92 -35.08 61.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.58 157.02 19.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.244 0.545 . . . . 0.0 111.455 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.696 ' O ' ' N ' ' A' ' 107' ' ' TRP . 21.7 ttm -56.26 -14.07 2.58 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.584 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.31 -1.37 0.01 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.368 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.696 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.92 -20.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.081 -0.658 . . . . 0.0 111.08 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.555 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.49 -27.45 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.739 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.98 -33.88 73.92 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -62.18 -37.14 84.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.544 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.9 t0 -63.11 -50.43 70.53 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.59 -46.38 86.08 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.498 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -67.6 -42.16 82.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.359 0.599 . . . . 0.0 110.35 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 15.6 tp -50.02 -59.51 3.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.489 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.69 -63.19 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.04 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.492 ' O ' ' OG1' ' A' ' 120' ' ' THR . 42.3 t -66.1 -38.97 89.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.4 -55.87 26.63 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.963 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -65.21 -39.07 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.741 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.486 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.72 -45.18 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 116' ' ' SER . 62.3 m -60.56 -42.27 96.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.7 -53.82 16.76 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.155 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.422 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 49.0 m -64.36 -41.18 96.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 65.5 m -59.2 -45.68 90.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.7 -37.22 85.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.01 -64.22 1.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.422 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.1 m0 -66.54 -42.16 87.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 123' ' ' THR . 50.6 t-80 -58.33 -48.08 81.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.698 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -62.43 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.33 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -72.57 -43.57 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 0.0 111.448 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.3 p -145.84 106.23 4.25 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.666 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.493 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.0 Cg_exo -56.58 -38.2 95.98 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.371 1.38 . . . . 0.0 112.985 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.8 Cg_exo -55.16 -27.46 56.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 120.484 0.789 . . . . 0.0 112.446 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.84 -24.48 65.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.516 0.674 . . . . 0.0 109.296 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.67 -43.64 92.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.37 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.439 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.6 mtt85 -66.28 -37.44 85.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.548 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.556 ' CD1' ' C ' ' A' ' 136' ' ' LEU . 1.1 tm? -49.23 -43.16 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.401 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.503 ' O ' ' C ' ' A' ' 138' ' ' TYR . 60.2 mt -60.84 -29.02 69.25 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.503 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 2.82 -76.2 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -53.08 -25.57 29.42 Favored 'Trans proline' 0 N--CA 1.509 2.423 0 CA-C-N 119.384 0.816 . . . . 0.0 113.278 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -56.61 -38.41 72.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -178.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 34.0 tp -65.17 -40.36 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.79 94.09 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.608 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -65.3 -50.81 64.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.114 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.51 -34.1 77.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.079 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 150' ' ' LEU . 21.4 t80 -62.72 -42.2 99.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.624 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.608 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 53.2 p -60.28 -38.0 82.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.5 m -59.6 -50.99 71.75 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.1 t -69.94 -44.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.215 0.531 . . . . 0.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 62.2 tp -58.09 -40.68 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 147' ' ' THR . 43.2 m-80 -63.96 -40.03 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -61.94 -44.29 97.08 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.325 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -64.22 -40.04 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.076 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.82 -48.99 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -40.23 96.26 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.65 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 159' ' ' SER . 39.1 mtm180 -60.03 -23.58 63.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.291 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 88.1 m-20 -53.63 -42.38 67.71 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.142 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -102.41 -41.4 6.33 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 156' ' ' ARG . 50.4 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.112 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -58.05 -28.06 81.96 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 CA-C-N 119.01 0.682 . . . . 0.0 111.052 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 -30.92 63.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.11 -42.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.25 -36.26 93.18 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.685 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mp -56.27 -44.21 79.54 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.609 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.401 ' OG1' ' SD ' ' A' ' 60' ' ' MET . 13.2 t -79.33 -30.51 42.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.107 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.07 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 t -52.32 -56.6 20.8 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.95 -33.36 98.68 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 CA-C-N 119.076 0.706 . . . . 0.0 112.72 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -60.23 -39.41 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.303 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.3 -37.66 88.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.232 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -64.49 -53.37 35.99 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.94 95.23 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.0 -45.9 89.52 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.567 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.3 mtm -62.91 -37.22 86.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.281 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.94 98.77 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.124 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.07 64.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.93 -34.22 69.64 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.98 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 86.8 t80 -62.53 -46.75 86.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.216 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.09 -33.2 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.83 0.824 . . . . 0.0 109.766 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -59.35 -40.39 86.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.019 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.8 -130.6 4.64 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.808 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -51.55 -28.05 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.071 0.462 . . . . 0.0 110.85 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.99 15.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.3 mt -51.35 -43.21 61.74 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.848 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.391 0.615 . . . . 0.0 110.618 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -59.79 -40.44 88.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.662 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' NZ ' ' A' ' 39' ' ' LYS . 44.3 m-85 -66.08 -22.64 66.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.745 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.95 -41.65 16.47 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.443 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.74 -32.2 83.36 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.4 mt -93.63 149.16 21.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.286 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.585 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.8 mt-30 -99.21 122.21 42.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.87 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.699 ' NZ ' ' CD1' ' A' ' 34' ' ' TYR . 22.4 mttp -94.5 141.0 22.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -57.25 144.85 89.71 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.557 1.504 . . . . 0.0 113.069 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 m -61.58 -32.42 72.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.918 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.2 p90 -76.87 2.08 15.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.583 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.699 ' CE1' ' NH1' ' A' ' 46' ' ' ARG . 8.4 t-80 -62.7 140.16 97.06 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 71.7 Cg_endo -101.14 169.86 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.111 1.207 . . . . 0.0 112.461 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.3 147.97 26.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.653 2.235 . . . . 0.0 112.209 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.699 ' NH1' ' CE1' ' A' ' 43' ' ' HIS . 80.0 mmt-85 -58.33 -37.58 75.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -81.21 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.1 m -74.3 -76.18 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.599 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.546 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 77.6 mt -66.09 -32.73 74.36 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.653 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -41.0 -43.45 4.57 Favored Pre-proline 0 C--N 1.324 -0.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.63 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 53.8 Cg_exo -63.61 -7.2 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.929 2.419 . . . . 0.0 113.714 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 22.5 pt -42.44 -41.46 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.437 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 97.9 m95 -53.91 -33.79 57.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.442 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.64 94.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -69.38 -52.8 23.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.754 0.311 . . . . 0.0 111.44 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.48 -33.68 76.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.179 0.514 . . . . 0.0 110.423 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 23.8 t80 -49.37 -59.55 3.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.287 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 m -65.01 -38.05 89.66 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.81 95.38 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.701 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.401 ' SD ' ' OG1' ' A' ' 12' ' ' THR . 63.3 mtt -63.16 -37.73 88.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.687 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -66.24 -58.66 8.39 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -61.67 -37.44 84.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.491 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.86 -41.45 67.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 85.3 p -66.64 -27.95 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.37 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -55.82 -45.92 78.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.14 -44.19 97.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.75 -37.04 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.739 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.612 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 58.4 mttt -65.2 -41.71 94.27 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.465 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 87.3 mt-10 -70.15 -37.93 75.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.7 mt -92.2 -0.54 57.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.6 5.21 67.07 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 90.52 -167.18 32.24 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -59.3 82.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.212 0.53 . . . . 0.0 111.065 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.0 t -133.12 160.84 36.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.664 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -41.95 -40.48 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.323 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 75' ' ' THR . 87.1 m-20 -66.88 -44.12 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.539 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 73' ' ' GLY . . . -77.67 -33.24 53.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 83' ' ' GLY . 87.8 mtp -57.87 -33.7 68.96 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.156 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.01 -50.17 89.56 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.305 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.7 -52.31 1.05 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 120.495 0.797 . . . . 0.0 111.948 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.44 -42.48 99.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.319 0.581 . . . . 0.0 109.507 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.86 -38.66 96.91 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -58.38 -38.03 76.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.149 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 88.5 t80 -60.4 -44.45 95.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.1 m -65.88 -41.29 91.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.507 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.86 -54.22 19.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.819 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -59.79 -39.88 86.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.635 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.7 tp -58.79 -37.99 77.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.178 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.42 88.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 0.0 111.199 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -58.66 -39.95 82.1 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.478 HD21 ' CA ' ' A' ' 117' ' ' GLY . 50.8 t-20 -64.48 -35.96 82.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.693 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.557 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.7 m95 -56.17 -31.86 63.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.316 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.01 -16.39 62.06 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.6 t-105 -70.32 -52.81 11.29 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 27.4 Cg_endo -55.86 131.11 44.05 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.864 1.709 . . . . 0.0 113.309 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.445 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 41.3 Cg_endo -107.97 -28.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 120.841 1.028 . . . . 0.0 111.382 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 102' ' ' ALA . 28.8 pt -56.58 -30.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.367 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 15.6 p90 -54.12 -42.29 69.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.526 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.9 t80 -63.53 -51.29 66.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.315 . . . . 0.0 111.532 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -114.11 -54.53 0.42 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 60.86 -1.0 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 101' ' ' GLY . 25.7 tpt180 -54.36 -33.72 59.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.847 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.77 151.36 27.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.318 0.58 . . . . 0.0 111.958 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.619 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ppp? -65.58 -14.41 61.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.741 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.37 32.74 0.02 OUTLIER Glycine 0 CA--C 1.538 1.496 0 O-C-N 123.131 0.269 . . . . 0.0 112.924 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.619 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.49 -21.26 62.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.596 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -50.1 -23.73 2.29 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.773 0.32 . . . . 0.0 111.813 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.11 -32.14 70.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.379 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.61 -45.52 93.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.495 . . . . 0.0 109.948 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.565 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 37.3 t0 -63.44 -44.03 95.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.903 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -60.73 -40.05 90.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.148 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.502 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -66.63 -48.25 70.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 pp -75.31 -34.05 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.796 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.416 ' CG2' ' OD1' ' A' ' 111' ' ' ASP . 45.3 t -63.63 -45.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.777 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 t -85.8 -41.45 15.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.478 ' CA ' HD21 ' A' ' 92' ' ' ASN . . . -56.56 -47.1 86.66 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.573 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.2 -46.22 45.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.568 0.223 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -71.71 -57.97 3.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 38.1 m -58.04 -43.12 86.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -59.42 2.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.011 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 34.4 m -64.64 -41.59 96.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 55.8 m -59.46 -47.73 84.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.09 -34.55 78.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.44 -63.7 1.36 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.477 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.2 m0 -66.78 -43.95 82.59 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -177.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.475 ' HE2' ' CD1' ' A' ' 137' ' ' LEU . 22.3 m170 -59.87 -45.32 92.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.931 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -61.96 -44.4 96.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.354 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.497 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 77.1 t -76.85 -47.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.418 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.0 p -134.58 91.26 21.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.073 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.461 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.7 Cg_exo -52.4 -40.53 70.86 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.607 1.538 . . . . 0.0 112.975 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.6 Cg_exo -57.63 -29.18 84.38 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.591 0.861 . . . . 0.0 112.857 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.44 -32.3 71.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.202 0.525 . . . . 0.0 110.5 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.55 77.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.368 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.64 -39.23 83.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.366 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 tp -57.7 -39.76 77.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.007 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 140' ' ' TYR . 82.7 mt -59.52 -27.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.973 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -6.2 -64.32 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.453 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -54.05 -30.2 58.64 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 CA-C-N 119.523 0.865 . . . . 0.0 112.898 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.45 -47.02 80.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 41.2 tp -60.58 -39.76 89.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.21 96.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.581 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -70.0 -50.22 43.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.893 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.38 -34.06 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.523 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.11 -47.54 84.14 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -64.18 -43.69 94.34 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.345 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.579 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.2 m -56.14 -43.99 78.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.951 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 48.9 m -64.79 -48.37 74.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.775 0.322 . . . . 0.0 111.564 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.26 -41.74 86.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.6 tp -57.9 -41.15 81.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.974 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.565 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.5 m120 -62.09 -41.35 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -64.14 -42.37 96.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.818 0.674 . . . . 0.0 112.818 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -58.63 -45.21 89.75 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.062 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.97 -46.01 82.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.442 ' O ' ' N ' ' A' ' 159' ' ' SER . 1.6 m0 -61.78 -40.03 93.73 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.78 -29.98 65.29 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.229 -0.589 . . . . 0.0 111.471 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 86.9 m-20 -50.71 -39.8 52.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -103.11 -58.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.228 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 155' ' ' TRP . 87.0 p . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.224 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.91 -21.7 21.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 120.841 1.027 . . . . 0.0 111.921 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.17 -35.96 62.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.933 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.8 t -62.48 -43.32 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.64 -33.37 85.96 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.378 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.8 mp -56.13 -43.2 77.98 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.136 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -37.95 35.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.836 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' OG ' ' A' ' 16' ' ' SER . 83.1 mt -62.3 -37.61 86.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -52.67 -43.43 92.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.819 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -57.17 -33.26 95.58 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.167 1.245 . . . . 0.0 113.176 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 83.6 p -62.19 -35.46 78.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.93 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.078 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -42.1 97.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.1 97.63 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.91 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 55.5 m-85 -61.99 -41.21 97.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.539 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.68 -40.29 96.62 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.765 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.42 -47.87 11.81 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.31 -23.37 63.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.209 0.528 . . . . 0.0 110.441 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -51.62 -38.95 57.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.032 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 58.1 t80 -62.69 -48.79 77.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -32.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.55 0.69 . . . . 0.0 109.967 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.459 ' CB ' ' HE ' ' A' ' 46' ' ' ARG . 13.9 ttt-85 -62.4 -41.44 98.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.023 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -131.22 2.64 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.132 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -26.99 48.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.618 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.6 -35.49 11.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -49.14 -44.64 42.75 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.962 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -61.0 -39.34 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.938 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -58.68 -37.07 75.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.349 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 37' ' ' LEU . 55.8 m-85 -61.02 -22.8 64.9 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.7 -40.57 6.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.059 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.47 -31.8 71.28 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 34' ' ' TYR . 56.9 mt -92.79 148.16 22.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 110.887 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -96.49 123.79 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.85 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -94.85 139.61 22.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 74.4 Cg_endo -58.84 147.06 90.73 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.501 1.467 . . . . 0.0 112.601 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -64.45 -29.42 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.09 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.436 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 39.4 p90 -78.32 2.7 17.66 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.492 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 57.8 t-80 -62.16 142.71 95.59 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 87.1 Cg_endo -107.74 172.55 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.336 1.357 . . . . 0.0 112.282 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -54.41 148.14 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.87 2.38 . . . . 0.0 112.335 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HE ' ' CB ' ' A' ' 27' ' ' ARG . 28.6 tpt85 -56.61 -39.28 73.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 26.4 p90 -77.15 -9.12 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -75.57 -73.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.573 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.549 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 92.1 mt -66.94 -32.72 74.16 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.694 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -41.38 -42.71 4.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.156 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . 76.1 Cg_exo -63.79 -6.27 10.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.914 2.409 . . . . 0.0 113.387 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 11.1 pt -41.24 -44.84 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.084 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.492 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.1 m95 -58.08 -34.0 69.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.089 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.26 -40.35 98.48 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -66.99 -53.26 33.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 0.0 111.325 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.82 -32.16 72.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.0 t80 -52.34 -50.14 62.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.875 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -69.89 -36.62 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.29 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.57 -43.46 80.58 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.046 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.5 mtt -60.63 -38.9 86.31 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.87 -52.64 40.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -61.4 -35.48 77.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.572 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.64 -46.02 59.54 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p -63.26 -30.13 71.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.456 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 46.7 t80 -55.01 -40.3 70.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 109.797 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.0 mt -69.51 -44.39 79.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.68 -51.89 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -64.27 -33.07 74.97 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.838 -178.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -60.64 -40.79 93.27 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.783 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -67.68 -34.05 76.14 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.143 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -85.5 -0.54 55.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.092 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.76 44.08 8.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.43 -154.43 23.43 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -87.25 110.71 20.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.517 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 77' ' ' ASP . 6.1 t -133.95 168.63 18.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.893 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -52.27 -37.96 56.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.385 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' H ' HG22 ' A' ' 75' ' ' THR . 84.8 m-20 -62.22 -40.02 94.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.339 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.49 -28.28 67.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.851 0.358 . . . . 0.0 111.377 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 mtt -58.82 -35.25 72.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.306 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.18 -47.65 98.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -77.75 -63.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 120.735 0.957 . . . . 0.0 112.538 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.7 mt -59.49 -41.71 90.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.19 98.78 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.773 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.55 -38.11 74.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 109.916 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -57.92 -43.94 86.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.588 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.98 -60.72 3.76 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.396 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.59 -40.06 74.63 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.56 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.63 -40.39 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.224 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.96 78.52 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.48 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.11 87.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.226 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.436 HD21 ' HA3' ' A' ' 117' ' ' GLY . 41.3 t-20 -62.23 -39.91 94.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.568 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.8 m95 -59.46 -28.45 67.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.07 63.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 97' ' ' PRO . 8.7 t-105 -71.12 -55.7 6.14 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.5 Cg_endo -40.96 82.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.034 1.156 . . . . 0.0 112.317 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -59.33 -23.82 71.7 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.739 1.626 . . . . 0.0 112.459 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.419 ' H ' ' CD ' ' A' ' 97' ' ' PRO . 35.5 pt -59.62 -30.02 43.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.402 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.3 p90 -44.85 -42.27 7.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.493 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 57.7 t80 -66.62 -52.01 49.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.79 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.27 -68.69 0.48 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.737 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.532 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 65.58 5.07 3.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -54.92 -35.55 64.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 109.913 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -85.74 152.86 22.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.245 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.661 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.4 ttm -61.14 -14.97 28.55 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.975 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.7 21.59 0.01 OUTLIER Glycine 0 CA--C 1.543 1.79 0 C-N-CA 121.724 -0.274 . . . . 0.0 113.239 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.661 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.6 -19.82 41.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.409 0.605 . . . . 0.0 112.248 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.571 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -42.58 -22.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.446 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 107' ' ' TRP . 77.8 mt -59.63 -36.45 76.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.6 -40.25 88.77 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.33 0.586 . . . . 0.0 109.858 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.489 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 48.6 t0 -60.57 -57.15 13.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.664 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.97 -37.9 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.673 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.518 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.1 tt -64.46 -49.94 69.45 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.58 -35.21 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.065 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 ' CG2' ' HG1' ' A' ' 147' ' ' THR . 55.7 t -66.6 -59.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 111.595 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -72.47 -40.48 66.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' HD21 ' A' ' 92' ' ' ASN . . . -58.54 -54.43 37.84 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.598 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.71 -35.69 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.504 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.517 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -75.46 -52.96 9.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.0 m -57.45 -43.04 83.65 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.66 -54.62 13.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.545 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.2 m -66.79 -40.01 87.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 91.2 m -59.36 -47.09 86.76 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.2 mt -72.83 -34.25 66.7 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.68 -64.16 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -64.56 -43.61 93.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -59.38 -44.7 92.72 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.022 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -61.58 -43.61 98.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.586 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.6 t -79.95 -46.68 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.557 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 96.0 p -133.58 88.53 33.76 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.48 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 34.7 Cg_exo -53.94 -41.01 78.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.766 1.644 . . . . 0.0 112.858 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 33.4 Cg_exo -56.44 -30.59 82.48 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 120.597 0.864 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.79 68.81 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.261 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.25 76.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.421 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.508 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 93.2 mtt180 -63.28 -37.4 87.12 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.001 0.429 . . . . 0.0 110.533 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.0 tp -54.28 -37.69 65.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 138' ' ' TYR . 85.1 mt -67.56 -3.16 7.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.147 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -26.97 -59.99 0.2 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.89 -23.96 78.18 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.079 1.186 . . . . 0.0 113.802 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -55.47 -41.21 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.179 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 37.2 tp -63.47 -39.51 94.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.17 93.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.669 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.59 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -66.44 -53.97 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.614 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.446 ' O ' ' OG1' ' A' ' 147' ' ' THR . 50.1 mt -63.85 -33.51 75.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -41.02 95.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 49' ' ' LEU . 28.2 t80 -61.69 -40.27 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.59 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 81.4 p -59.93 -37.94 80.94 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.404 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.6 p -68.33 -47.2 68.14 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.087 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.84 -41.16 79.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.373 0.606 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.9 tp -60.3 -42.95 96.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.353 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.489 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.3 m120 -66.51 -36.65 83.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.23 0.538 . . . . 0.0 110.947 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.553 ' CE1' ' NE ' ' A' ' 156' ' ' ARG . 1.4 t80 -56.42 -48.17 77.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.104 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -67.28 -45.01 77.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.82 -47.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.467 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 1.2 m0 -61.1 -40.73 94.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.553 ' NE ' ' CE1' ' A' ' 152' ' ' TYR . 86.2 mtt-85 -59.39 -28.07 66.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.526 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -51.71 -40.63 60.49 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.202 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -105.28 -60.34 1.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.449 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.767 -179.402 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 17.1 t . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.29 -18.25 29.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 120.44 0.76 . . . . 0.0 112.288 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.26 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.3 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.93 -40.31 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.64 -36.9 93.36 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.52 -42.22 87.25 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.17 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 t -74.95 -35.46 62.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.581 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.481 ' O ' ' OG ' ' A' ' 16' ' ' SER . 96.0 mt -67.48 -34.9 78.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 t -47.91 -56.6 12.9 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.58 -34.44 98.84 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 120.797 0.998 . . . . 0.0 112.958 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 84.5 p -62.14 -37.56 85.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.403 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.17 -38.71 85.9 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.479 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' C ' ' CZ3' ' A' ' 93' ' ' TRP . . . -67.76 -54.23 19.66 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.815 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.671 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -59.86 -36.17 89.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.814 -0.515 . . . . 0.0 111.814 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.48 -45.03 89.52 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.435 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.5 mtt -63.45 -39.23 93.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.8 0.333 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.95 -43.52 91.1 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.66 -26.07 64.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 110.816 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.78 -36.61 72.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.711 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 69.5 t80 -59.94 -49.67 76.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -73.6 -34.15 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.725 0.774 . . . . 0.0 109.929 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -61.79 -42.0 98.45 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.783 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.45 -127.51 1.57 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.854 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.93 -27.61 61.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.708 0.29 . . . . 0.0 110.682 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.24 -34.81 13.37 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -50.79 -41.48 57.17 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.488 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -61.06 -43.46 98.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.366 0.603 . . . . 0.0 109.458 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.17 -40.2 95.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.518 ' O ' ' O ' ' A' ' 37' ' ' LEU . 15.4 m-85 -62.4 -22.74 66.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.11 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.6 -41.5 31.04 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.209 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.0 79.02 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.1 mt -90.87 148.57 22.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.587 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -100.82 128.88 46.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.887 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.655 ' HZ1' ' NH2' ' A' ' 46' ' ' ARG . 11.1 mtpt -106.5 145.56 31.27 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.946 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.41 137.13 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.135 1.223 . . . . 0.0 111.691 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -66.03 -26.73 67.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.089 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -78.32 -4.19 46.75 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.685 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 3.4 t-80 -60.09 134.09 90.31 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.362 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 51.4 Cg_exo -75.03 167.23 27.48 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.092 1.195 . . . . 0.0 111.678 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -53.88 149.22 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.948 1.765 . . . . 0.0 111.242 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.655 ' NH2' ' HZ1' ' A' ' 39' ' ' LYS . 25.9 mmt180 -57.24 -36.08 70.48 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.208 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -76.81 -11.54 59.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -77.02 -72.43 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.799 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.558 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 91.9 mt -62.77 -35.59 80.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.158 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.619 ' O ' ' CE3' ' A' ' 53' ' ' TRP . . . -42.58 -41.28 5.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.002 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 66.1 Cg_exo -67.06 -2.21 7.55 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.917 2.411 . . . . 0.0 113.73 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.558 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 20.1 pt -46.51 -34.57 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.732 0.301 . . . . 0.0 111.512 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.619 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 4.7 m-90 -54.07 -27.36 32.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.7 94.83 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -72.99 -45.85 55.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.853 0.358 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 143' ' ' TRP . 6.8 mt -66.03 -33.61 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.228 0.537 . . . . 0.0 109.877 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 25.2 t80 -60.14 -50.05 75.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.913 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.7 p -74.79 -33.32 62.22 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.971 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.69 -46.18 83.48 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.638 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.8 mtt -63.93 -38.2 90.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.657 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.85 -61.41 5.58 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.13 -37.3 86.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.603 0.239 . . . . 0.0 111.256 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.22 -43.33 74.54 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.8 p -67.44 -26.0 66.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.475 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -56.45 -50.16 72.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.163 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.58 -41.72 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.8 t -53.64 -48.32 59.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.424 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.4 p90 -70.58 -31.52 68.56 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.966 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 67.8 mmtt -59.71 -37.92 80.21 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.761 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 81.0 mt-10 -68.15 -35.66 78.43 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.87 3.68 47.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.931 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 36.0 11.62 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.32 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 89.21 -174.85 42.42 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.61 84.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.6 m -93.42 146.69 23.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.212 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -50.88 -37.96 46.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.596 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.25 -39.52 92.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.17 0.51 . . . . 0.0 109.671 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.5 71.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.601 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.4 mtp -58.49 -33.05 69.37 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.612 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -55.98 -57.9 19.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.791 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.7 -47.9 10.21 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 119.023 0.687 . . . . 0.0 112.428 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.221 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.0 -37.44 94.96 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.6 tp -57.03 -41.65 78.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.42 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 77.6 t80 -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.3 m -65.42 -42.72 92.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.674 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.51 -58.41 3.88 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.635 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -57.15 -41.67 79.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.577 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 36.2 tp -63.25 -38.1 89.84 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.135 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.76 75.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.9 -39.13 88.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -60.78 -38.3 84.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.475 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.671 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 50.2 m95 -62.07 -31.33 71.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.632 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -31.8 73.14 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.597 ' O ' ' N ' ' A' ' 97' ' ' PRO . 4.0 t-105 -55.38 -50.69 85.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -41.05 80.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.684 1.589 . . . . 0.0 113.107 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.597 ' N ' ' O ' ' A' ' 95' ' ' TRP . 67.5 Cg_endo -63.04 -26.25 73.65 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 120.616 0.878 . . . . 0.0 111.143 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.501 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 42.4 pt -63.82 -33.96 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -44.88 -41.09 6.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.808 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 64.8 t80 -67.18 -51.76 49.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.323 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.38 -65.83 0.44 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.572 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.512 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 64.84 5.19 2.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.441 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -54.24 -34.26 60.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.953 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -90.12 153.61 20.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.477 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.687 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.8 ttm -61.95 -15.16 41.4 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.18 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.7 20.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.638 0 C-N-CA 121.526 -0.369 . . . . 0.0 113.345 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.687 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -60.05 -19.38 52.59 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.564 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -42.82 -20.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' TRP . 83.8 mt -59.23 -38.91 81.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.03 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -66.12 -38.44 88.21 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.372 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.456 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 59.4 t0 -60.66 -45.88 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.96 -47.49 65.51 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.732 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.78 -38.9 83.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.421 0.629 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 19.7 tp -52.93 -61.51 2.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.282 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.78 -63.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.765 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' OG1' ' A' ' 120' ' ' THR . 36.4 t -69.71 -40.78 76.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.02 -51.52 56.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.702 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.2 -37.36 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.386 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.516 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -78.47 -49.71 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 116' ' ' SER . 38.1 m -55.44 -42.23 73.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.58 -54.37 12.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.623 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.5 m -65.78 -39.22 90.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.17 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 85.9 m -58.96 -47.47 84.99 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.91 -34.63 77.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.37 1.43 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.623 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.2 m0 -67.65 -44.01 78.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -57.72 -45.46 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.534 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -63.07 -43.04 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.454 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.513 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 76.5 t -79.21 -53.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.936 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 43.8 p -128.39 91.38 44.13 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.319 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 45.2 Cg_exo -51.39 -42.28 55.61 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.915 1.743 . . . . 0.0 113.158 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.4 Cg_exo -56.47 -28.02 71.36 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.211 0.607 . . . . 0.0 112.311 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.38 71.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.77 -41.44 95.5 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -61.45 -36.06 79.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.49 . . . . 0.0 110.744 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.38 -38.19 76.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.6 mt -59.22 -30.76 68.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.521 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 0.17 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.3 Cg_endo -50.73 -29.96 27.63 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.513 0.809 . . . . 0.0 112.331 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -60.65 -36.49 78.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -67.8 -44.35 77.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.025 0.441 . . . . 0.0 110.104 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.58 -49.8 37.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.094 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.569 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 1.7 t-105 -59.94 -49.01 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 147' ' ' THR . 74.7 mt -66.07 -32.4 73.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.301 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.39 90.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' A' ' 49' ' ' LEU . 23.1 t80 -63.25 -42.03 99.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.264 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.569 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 74.3 p -60.84 -38.36 85.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.604 -0.438 . . . . 0.0 112.049 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.8 m -62.34 -49.31 76.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.695 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.22 -40.68 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.45 0.643 . . . . 0.0 111.01 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.5 tp -55.91 -47.02 78.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.54 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 147' ' ' THR . 14.9 m120 -66.95 -37.59 84.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.389 0.614 . . . . 0.0 110.449 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -58.88 -44.31 91.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.903 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.97 -46.12 86.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.999 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.06 -47.74 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.57 ' O ' ' N ' ' A' ' 159' ' ' SER . 1.7 m95 -61.27 -43.65 98.52 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.493 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.4 mmt-85 -59.7 -35.65 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.842 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -59.46 -41.05 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -96.63 -59.62 1.78 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TRP . 34.4 m . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.524 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.31 -24.49 51.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.002 1.135 . . . . 0.0 111.733 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.22 -34.12 21.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.141 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.52 -41.93 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.29 92.6 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.447 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.38 -39.56 83.73 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.375 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -81.23 -36.57 29.83 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.93 -36.63 81.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 t -54.9 -43.73 99.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.601 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.41 -32.61 94.48 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.397 1.398 . . . . 0.0 113.49 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.9 m -59.34 -38.0 79.23 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.716 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.5 mt -60.67 -38.08 83.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.165 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.91 99.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.599 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.61 -42.4 99.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.128 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.404 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.0 m-85 -62.98 -45.37 92.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.0 mtm -62.57 -40.31 96.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 -48.26 23.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.21 -18.68 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.478 . . . . 0.0 110.969 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -54.25 -36.98 64.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.26 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 48.5 t80 -61.05 -50.75 72.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.04 -35.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.63 0.729 . . . . 0.0 110.216 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -60.95 -41.12 95.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.786 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.17 -125.21 2.27 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.031 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -56.99 -27.98 62.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.473 -0.364 . . . . 0.0 111.052 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.71 -32.78 17.87 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -51.33 -41.54 60.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.344 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -63.15 -42.87 99.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -62.12 -37.27 84.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.652 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' LEU . 6.0 m-85 -61.29 -23.2 65.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.955 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.86 -43.44 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.456 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.9 -32.21 81.99 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 34' ' ' TYR . 45.5 mt -93.07 149.23 21.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.831 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -100.94 129.92 46.86 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.004 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.589 ' HZ3' HH21 ' A' ' 46' ' ' ARG . 11.9 mtpt -107.74 139.42 20.59 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.424 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 60.6 Cg_endo -61.47 134.05 49.32 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 120.668 0.912 . . . . 0.0 111.6 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.9 p -81.78 -9.81 59.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.781 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.478 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 3.8 p90 -77.88 -15.34 59.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.661 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.59 ' ND1' ' C ' ' A' ' 43' ' ' HIS . 0.7 OUTLIER -76.69 149.81 81.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.915 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -76.38 163.99 31.48 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.573 1.515 . . . . 0.0 111.136 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.7 Cg_endo -51.38 149.45 17.25 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.803 1.669 . . . . 0.0 111.951 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.589 HH21 ' HZ3' ' A' ' 39' ' ' LYS . 42.0 mtt85 -57.0 -35.51 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 4.5 p90 -64.19 -20.27 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.118 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.87 -62.77 1.48 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.426 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.551 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 88.4 mt -67.46 -36.14 80.58 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -43.09 -41.0 6.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.983 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 54' ' ' GLY . 53.0 Cg_exo -66.33 -7.39 17.4 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.181 2.587 . . . . 0.0 113.745 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 19.0 pt -42.03 -43.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.357 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.472 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 95.0 m95 -54.28 -32.45 56.33 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.722 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.19 -39.2 96.82 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.1 m -69.62 -51.21 37.09 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.12 0.486 . . . . 0.0 111.04 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.55 -31.77 72.09 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.431 0.634 . . . . 0.0 109.771 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -51.23 -55.87 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.633 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.6 m -64.03 -40.09 95.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.341 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.92 -44.5 89.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.993 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.52 -38.05 88.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.831 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -70.53 -54.81 9.56 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.32 -37.6 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.13 -40.72 91.98 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.6 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 96.5 p -63.27 -31.71 72.93 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.188 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.33 -42.41 86.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.913 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 -41.22 84.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.7 t -58.7 -40.72 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.943 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.41 -51.16 70.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.464 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 71.4 mttt -53.36 -35.1 59.91 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.424 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.51 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 88.8 mt-10 -75.75 -43.82 44.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.767 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.29 -26.65 58.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.86 -5.42 42.9 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.681 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.58 -167.46 29.2 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.874 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -90.86 87.05 6.49 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' ALA . 11.2 p -124.04 167.64 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.205 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -42.88 -36.96 1.67 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.261 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 89.2 m-20 -62.54 -41.01 98.61 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.75 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -84.89 -40.27 17.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' GLY . 86.7 mtp -59.95 -35.17 74.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.27 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.9 -57.25 25.19 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.49 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.423 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 13.0 Cg_endo -61.95 -53.45 2.09 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.011 1.141 . . . . 0.0 112.01 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.52 -41.27 98.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.242 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.97 -39.76 97.99 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.41 -38.72 77.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.039 0.447 . . . . 0.0 110.241 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -59.79 -44.4 93.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.11 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.9 m -65.82 -45.4 82.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.472 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.83 5.97 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.42 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.72 -41.66 86.91 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.493 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.08 -36.96 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.82 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.59 66.74 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.63 -37.32 81.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 21.2 t-20 -60.04 -43.89 95.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.951 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.547 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 60.0 m95 -57.45 -30.47 65.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.041 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 -23.57 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 97' ' ' PRO . 55.9 t-105 -54.15 -67.56 0.61 Allowed Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 22.8 Cg_endo -43.35 80.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.832 1.688 . . . . 0.0 112.007 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.609 ' N ' ' O ' ' A' ' 95' ' ' TRP . 69.2 Cg_endo -57.54 -22.04 49.25 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.294 1.996 . . . . 0.0 113.293 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 pt -57.11 -23.27 18.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 8.4 p90 -45.06 -41.59 7.77 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.718 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.532 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 75.7 t80 -66.51 -52.13 49.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.8 -68.89 0.5 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.791 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.557 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 63.79 3.21 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 0.0 110.749 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -53.8 -35.04 60.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -89.57 155.22 19.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.674 ' C ' ' H ' ' A' ' 107' ' ' TRP . 21.9 ttm -58.75 -15.17 10.88 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.039 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.59 15.06 0.01 OUTLIER Glycine 0 CA--C 1.544 1.846 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.351 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.674 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -56.15 -19.25 12.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.359 0.58 . . . . 0.0 112.257 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -43.09 -21.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 111.742 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.6 mt -61.08 -36.17 78.92 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.654 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -64.34 -39.29 93.6 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.731 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.492 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.0 t0 -62.95 -46.79 86.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.51 -49.11 76.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.904 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.542 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.5 tt -67.99 -42.54 80.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.544 0.688 . . . . 0.0 109.768 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 18.1 tp -50.67 -60.2 3.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.05 -63.58 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.495 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.477 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.8 t -68.91 -40.36 79.15 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.39 -51.01 60.71 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.795 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.83 -38.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.27 -47.88 22.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 116' ' ' SER . 56.7 m -57.89 -42.48 84.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.88 -57.58 3.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.675 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.636 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 16.9 m -62.3 -41.18 98.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.283 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 85.9 m -61.61 -45.47 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.11 -37.45 87.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.5 -63.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.636 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.7 m0 -65.98 -41.02 91.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.451 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.3 t-80 -57.4 -47.14 82.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.079 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.28 -43.74 90.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.73 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.51 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 86.4 t -78.6 -48.7 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.5 p -127.9 85.34 60.89 Favored Pre-proline 0 N--CA 1.465 0.297 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.726 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.463 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.05 -44.95 42.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.628 1.552 . . . . 0.0 112.258 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 17.0 Cg_exo -58.44 -31.76 94.85 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.361 0.708 . . . . 0.0 111.913 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.68 72.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.538 . . . . 0.0 110.078 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.3 84.75 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.704 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.57 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 73.7 ttt180 -60.51 -41.03 93.52 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 110.109 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.2 tp -53.29 -35.68 60.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.23 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.531 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 43.3 mt -69.64 12.42 0.19 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.331 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -44.88 -41.96 14.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.531 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 10.3 Cg_endo -64.24 -22.59 66.71 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.95 1.375 . . . . 0.0 112.5 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.24 -39.61 90.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.024 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.0 tm? -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.318 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.89 -43.59 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 111.593 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 1.4 t-105 -66.0 -51.35 59.16 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.467 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.439 ' O ' ' OG1' ' A' ' 147' ' ' THR . 54.0 mt -64.12 -34.09 77.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.179 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.89 95.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.241 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -62.31 -40.76 97.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.405 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.455 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 66.9 p -58.28 -38.32 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.259 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.5 m -63.56 -51.15 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.346 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.48 -41.67 80.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.749 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.89 -40.8 81.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.406 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.519 ' N ' HD21 ' A' ' 151' ' ' ASN . 2.2 m120 -65.53 -41.12 93.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.49 -40.21 96.47 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.85 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -60.42 -45.85 92.14 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.866 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.56 -48.22 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 159' ' ' SER . 1.2 m0 -63.85 -48.68 75.8 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.887 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -56.35 -32.38 64.67 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.198 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -56.73 -40.0 74.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -99.61 -61.12 1.41 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.825 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 155' ' ' TRP . 22.9 t . . . . . 0 CA--C 1.529 0.143 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.22 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.0 t . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 37.2 Cg_exo -53.74 -23.34 26.18 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 CA-C-N 119.232 0.761 . . . . 0.0 112.236 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.42 47.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.5 t -60.99 -41.71 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.12 -36.32 92.77 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.443 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mp -58.32 -40.9 83.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.013 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -77.78 -34.5 52.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.676 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.2 mt -66.78 -34.95 78.96 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 t -50.99 -58.06 11.61 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.33 -31.51 93.99 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 120.577 0.852 . . . . 0.0 112.556 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -59.31 -38.12 79.47 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt -64.36 -37.99 89.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.262 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -66.39 -53.27 29.83 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.052 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.14 94.41 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -59.63 -48.95 79.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.018 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.16 -39.42 92.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.064 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.7 90.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.91 65.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.099 0.476 . . . . 0.0 110.279 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -56.6 -34.11 66.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.483 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 81.3 t80 -60.27 -47.85 84.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -74.15 -32.51 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.784 0.802 . . . . 0.0 109.936 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -61.32 -41.46 97.05 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.939 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.23 -124.84 2.53 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.133 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.562 ' OE1' ' NE ' ' A' ' 32' ' ' ARG . 78.1 mm-40 -56.88 -28.24 61.56 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.964 0.412 . . . . 0.0 110.857 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.13 -32.74 13.27 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.5 mt -51.33 -42.19 61.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' OE1' ' A' ' 29' ' ' GLU . 72.7 mtm180 -61.53 -42.71 99.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.401 0.62 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.76 -41.76 98.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.603 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 46.8 m-85 -66.32 -22.98 66.29 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.518 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.15 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.169 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.69 84.65 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 34' ' ' TYR . 69.5 mt -90.13 151.07 21.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.744 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.424 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 90.2 mt-30 -97.32 128.27 44.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.058 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HZ3' HH21 ' A' ' 46' ' ' ARG . 55.7 mttt -103.04 143.94 27.62 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -57.03 140.25 92.1 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 120.677 0.918 . . . . 0.0 111.829 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.8 p -64.2 -30.31 71.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.346 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -78.53 -1.58 34.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.462 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.2 t-80 -60.37 126.4 84.3 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.316 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 74.1 Cg_endo -79.73 164.24 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.347 1.365 . . . . 0.0 111.28 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.448 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 16.1 Cg_exo -50.78 139.85 39.11 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.341 1.361 . . . . 0.0 111.322 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.588 HH21 ' HZ3' ' A' ' 39' ' ' LYS . 50.2 mtt85 -58.86 -36.13 74.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.981 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.448 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 5.0 p90 -66.98 -24.0 66.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.413 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 52.7 m -67.88 -63.35 1.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.965 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.548 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 71.6 mt -72.19 -34.24 68.26 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.31 -49.56 3.42 Favored Pre-proline 0 C--N 1.321 -0.635 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.671 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' A' ' 47' ' ' TRP . 12.1 Cg_endo -71.43 6.11 2.05 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.034 1.823 . . . . 0.0 114.117 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 22.9 pt -50.09 -25.39 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.158 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 5.0 m-90 -55.03 -34.41 63.49 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.421 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -44.47 97.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.0 m -65.21 -47.57 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.129 0.49 . . . . 0.0 110.557 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -67.71 -34.21 76.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.587 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' TRP . 15.2 t80 -58.88 -50.87 72.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.762 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.1 p -71.03 -33.06 69.96 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.83 -43.14 97.09 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.696 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -64.28 -37.12 86.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.194 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.18 -64.19 3.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -59.94 -39.26 84.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.707 0.289 . . . . 0.0 111.312 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.48 -43.19 85.34 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.8 p -63.95 -27.98 69.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.908 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -57.59 -43.51 84.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.84 -43.41 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.44 -38.63 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.957 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.05 -36.57 79.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.17 -45.68 83.93 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.048 0.452 . . . . 0.0 110.82 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.83 -39.52 76.41 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.07 -2.6 57.59 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.94 7.08 66.45 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.269 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.21 -163.55 29.1 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.14 80.0 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.918 0.866 . . . . 0.0 110.365 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.3 m -119.82 147.4 44.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.556 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -41.11 -37.45 0.87 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.163 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.1 -42.77 96.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.833 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -71.33 -29.41 64.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 83' ' ' GLY . 92.6 mmm -57.21 -34.4 68.49 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.784 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.87 -54.35 57.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.828 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -65.21 -55.65 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 120.439 0.759 . . . . 0.0 112.713 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.57 -42.49 98.93 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.684 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.36 -38.07 95.65 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.7 tp -58.1 -40.28 80.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 110.166 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -61.13 -43.45 98.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.424 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 m -64.84 -41.38 95.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -53.56 5.81 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.261 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.02 -41.87 84.09 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.227 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.2 tp -62.59 -37.64 87.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.117 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -46.25 80.81 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.75 -39.06 87.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.458 HD21 ' CA ' ' A' ' 117' ' ' GLY . 49.0 t-20 -63.52 -37.1 86.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.355 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.415 ' CZ2' ' CA ' ' A' ' 18' ' ' GLY . 1.7 m95 -56.24 -32.4 64.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.359 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.1 75.0 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.439 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 21.0 t-105 -54.78 -56.31 28.88 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 19.9 Cg_endo -57.95 128.61 29.58 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.469 1.446 . . . . 0.0 113.209 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -108.04 -28.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.112 1.875 . . . . 0.0 110.745 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.562 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 22.7 pt -54.21 -30.31 20.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.23 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 21.3 p90 -54.61 -44.64 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.512 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.574 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 78.6 t80 -64.17 -48.35 76.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.13 -58.07 0.42 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 57.97 -0.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.589 ' H ' ' C ' ' A' ' 101' ' ' GLY . 14.7 tpt180 -53.56 -33.27 54.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.081 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -84.5 152.95 23.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.288 0.566 . . . . 0.0 111.603 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.615 ' O ' ' N ' ' A' ' 107' ' ' TRP . 2.8 ttp -62.06 -14.7 38.73 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.098 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.39 33.71 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.826 -0.226 . . . . 0.0 113.27 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.7 -20.89 62.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.575 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.06 -23.97 15.61 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.441 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 109' ' ' LEU . 5.8 mp -59.66 -33.86 72.1 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.898 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.0 -37.01 83.24 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 30.0 t0 -61.53 -41.11 96.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.015 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.3 tp -60.51 -57.09 14.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.548 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 2.7 tt -61.85 -41.2 97.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.523 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.03 -64.91 0.67 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.744 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.04 -56.61 11.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.598 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.7 t -69.38 -44.01 72.37 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.458 ' CA ' HD21 ' A' ' 92' ' ' ASN . . . -56.61 -49.41 70.0 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -45.4 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.658 0.266 . . . . 0.0 111.297 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.494 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.68 -56.12 5.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.7 m -58.59 -43.57 89.57 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.99 -58.0 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.054 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.654 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.3 m -63.87 -41.87 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.6 m -61.47 -45.51 93.93 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.74 -36.03 82.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.72 -63.2 1.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.654 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 37.0 m0 -65.75 -42.06 91.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.0 t-80 -59.2 -48.33 82.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.684 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -64.66 -45.21 87.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.865 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.4 t -76.18 -45.43 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.2 p -133.65 86.76 38.47 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.193 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 40.2 Cg_exo -52.7 -42.25 63.94 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.755 1.637 . . . . 0.0 112.873 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -57.09 -31.27 89.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.359 0.706 . . . . 0.0 112.344 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.48 71.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.72 80.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.888 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -59.27 -39.35 82.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.17 -39.43 75.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.2 mt -58.79 -29.79 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.423 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.524 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER 1.83 -63.77 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.7 Cg_endo -51.09 -31.01 33.72 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 120.798 0.999 . . . . 0.0 112.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -59.43 -40.97 88.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.938 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -68.55 -41.98 79.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.649 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.8 34.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.023 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.695 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 1.3 t-105 -63.02 -51.79 65.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.5 mt -62.47 -32.78 73.73 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.704 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.34 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.854 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -61.87 -42.77 99.45 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.661 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.695 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 71.3 p -60.06 -37.26 79.34 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.402 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 55.3 m -60.79 -50.86 71.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.385 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.99 -43.47 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.214 0.53 . . . . 0.0 110.432 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.82 -40.58 84.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.483 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.5 m120 -62.6 -41.39 98.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 148' ' ' THR . 54.5 m-85 -65.08 -39.52 93.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.435 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -58.94 -47.14 86.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.59 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.14 -46.17 67.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.447 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 1.3 m0 -62.15 -42.66 99.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -60.08 -29.85 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.582 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 84.2 m-20 -51.7 -40.6 60.43 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.895 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -104.46 -61.84 1.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.094 -178.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 15.1 t . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 7.6 Cg_endo -57.27 -20.59 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.105 0.716 . . . . 0.0 112.037 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.53 59.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.95 -39.95 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.148 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.17 -36.54 93.57 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.19 -42.63 95.47 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 57' ' ' TYR . 3.9 t -79.64 -46.12 17.79 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 12' ' ' THR . 93.1 mt -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -50.18 -41.97 69.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.776 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.26 -33.0 89.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.172 . . . . 0.0 113.246 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.53 -39.06 86.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.48 -37.91 89.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.15 -55.63 17.92 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.802 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.42 91.39 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.094 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.11 -47.84 80.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.348 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.1 mtm -64.33 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.798 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.31 -45.19 88.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.654 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.22 64.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.203 0.525 . . . . 0.0 110.929 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -30.99 65.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.036 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 85.4 t80 -63.46 -47.7 80.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -69.45 -32.1 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.87 0.843 . . . . 0.0 109.256 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -64.38 -40.79 96.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.191 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.51 -116.94 2.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.791 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.23 -30.23 62.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 111.123 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.51 -33.13 24.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.5 mt -50.94 -44.44 60.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.365 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -63.35 -41.98 98.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 0.0 111.048 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -59.26 -38.69 80.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.96 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.552 ' O ' ' O ' ' A' ' 37' ' ' LEU . 66.5 m-85 -63.61 -22.73 67.05 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.733 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.85 17.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.677 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.89 -34.23 65.74 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.552 ' O ' ' O ' ' A' ' 34' ' ' TYR . 66.2 mt -92.31 152.35 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 89.8 mt-30 -92.65 128.38 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -106.47 144.22 28.56 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.62 0.248 . . . . 0.0 110.766 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.522 ' CG ' ' CE1' ' A' ' 43' ' ' HIS . 96.2 Cg_endo -62.68 138.64 70.74 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.299 1.999 . . . . 0.0 111.949 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.0 m -84.19 0.54 48.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -101.18 12.04 38.3 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.102 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.77 ' HE2' ' CD1' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -85.3 137.66 36.85 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.759 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.4 171.48 18.0 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.63 1.554 . . . . 0.0 110.796 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB2' ' CE2' ' A' ' 47' ' ' TRP . 3.0 Cg_exo -49.46 145.19 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 120.289 0.659 . . . . 0.0 110.659 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.565 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 36.7 mtt180 -58.62 -33.69 70.32 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.311 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CE2' ' HB2' ' A' ' 45' ' ' PRO . 11.9 p90 -71.83 -11.94 61.04 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -74.77 -68.06 0.58 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.551 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 94.2 mt -67.76 -35.68 79.15 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.322 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.605 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -41.24 -39.65 2.17 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 38.4 Cg_exo -71.03 1.29 5.43 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.892 2.395 . . . . 0.0 113.562 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 15.9 pt -46.21 -37.23 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.726 0.298 . . . . 0.0 111.568 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.605 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.0 m-90 -53.8 -29.52 40.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.921 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 57' ' ' TYR . . . -53.44 -40.87 62.48 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -81.25 -39.61 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 mt -64.73 -38.94 92.68 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 58' ' ' SER . 2.0 p90 -67.68 -44.02 78.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.293 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.525 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 49.6 m -60.67 -42.39 96.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.633 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.57 -43.72 88.91 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.886 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.7 mtt -63.08 -37.51 87.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.779 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.57 -59.14 9.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 47.9 t80 -64.65 -36.96 85.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.863 0.363 . . . . 0.0 110.792 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.81 -42.44 68.91 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.6 p -68.72 -26.26 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.637 0.256 . . . . 0.0 110.669 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 42.7 t80 -55.34 -49.27 72.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.229 0.538 . . . . 0.0 110.225 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.94 -40.92 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.507 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.37 -45.9 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 69' ' ' LYS . 1.2 p90 -69.48 -31.95 70.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.279 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 73.9 mttt -59.66 -37.66 79.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.047 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 83.9 mt-10 -67.12 -35.17 79.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.44 2.3 48.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.41 37.44 10.87 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.013 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.08 -161.09 27.68 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -87.45 109.52 19.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -133.35 168.78 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.176 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.85 -38.68 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.093 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.406 ' H ' HG22 ' A' ' 75' ' ' THR . 85.0 m-20 -63.11 -39.75 95.62 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.626 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.99 66.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.851 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 83' ' ' GLY . 8.8 mtt -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.806 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -58.25 -51.78 79.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.721 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.11 -56.91 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 120.701 0.934 . . . . 0.0 112.428 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.9 mp -63.46 -41.62 98.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.634 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.51 -38.24 95.47 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.1 tp -56.8 -40.24 75.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 110.186 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.6 -44.19 96.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -66.12 -41.59 90.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.152 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.5 -55.04 5.73 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.089 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -59.06 -41.31 87.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 37.8 tp -61.8 -38.89 89.8 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.238 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -46.25 90.53 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.293 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.11 -36.2 83.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.113 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -58.6 -43.18 89.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.948 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -64.42 -32.9 74.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.01 -31.62 72.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 95' ' ' TRP . 8.3 t-105 -54.82 -54.86 44.82 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.15 87.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.034 0 CA-C-N 119.304 0.787 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.58 -18.75 41.51 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.176 1.251 . . . . 0.0 111.843 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.2 pt -58.62 -23.98 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.845 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 5.4 p90 -45.94 -41.31 11.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.555 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 52.7 t80 -67.37 -57.45 6.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.932 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.67 -68.77 0.47 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.84 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' HB3' ' CG ' ' A' ' 25' ' ' PHE . . . 72.73 11.89 5.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.256 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -52.2 -35.56 49.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.333 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -87.17 149.63 24.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.659 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.623 ' C ' ' H ' ' A' ' 107' ' ' TRP . 13.5 ptm -62.56 -16.01 53.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.557 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -44.79 -4.01 0.01 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.565 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.623 ' H ' ' C ' ' A' ' 105' ' ' MET . 1.7 p90 -44.49 -18.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.474 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.29 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.803 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 107' ' ' TRP . 70.8 mt -61.93 -35.6 78.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -62.09 -40.68 96.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 62.3 t0 -61.46 -49.82 75.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.295 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 tp -66.06 -44.11 85.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.02 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 113' ' ' LEU . 1.2 mm? -72.16 -38.78 69.08 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.869 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 17.8 tp -53.02 -62.12 1.86 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.388 0.613 . . . . 0.0 110.816 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.61 -62.87 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.814 -1.084 . . . . 0.0 113.252 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 120' ' ' THR . 44.1 t -69.49 -39.04 77.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.73 -55.86 27.49 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.942 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.75 -37.22 79.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.634 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.486 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.5 -49.19 15.27 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 116' ' ' SER . 37.0 m -56.67 -41.83 77.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -58.14 3.8 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.733 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.532 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 31.8 m -64.72 -40.76 95.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 77.4 m -59.93 -45.62 92.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.88 -63.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.532 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 45.7 m0 -65.41 -41.3 93.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.1 t-80 -58.02 -48.0 81.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.003 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -64.9 -42.99 94.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 70.7 t -78.19 -53.11 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.428 ' HG ' ' CB ' ' A' ' 133' ' ' ALA . 58.6 p -127.31 90.81 47.91 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.3 Cg_exo -52.69 -42.22 64.07 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.866 1.711 . . . . 0.0 113.0 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 26.5 Cg_exo -56.78 -30.45 84.75 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 120.269 0.646 . . . . 0.0 112.258 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.428 ' CB ' ' HG ' ' A' ' 130' ' ' SER . . . -62.77 -28.8 70.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.5 91.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.668 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -59.82 -38.26 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 0.0 110.432 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.6 -35.34 70.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 138' ' ' TYR . 82.9 mt -64.95 -5.05 5.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.204 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -24.55 -53.57 0.15 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.5 -27.8 77.98 Favored 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 121.513 1.475 . . . . 0.0 113.523 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -58.21 -43.34 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.514 -178.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.5 tp -72.01 -41.58 67.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.24 73.54 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.527 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.532 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 2.5 t-105 -64.92 -49.92 68.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.945 0.402 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.9 mt -66.47 -34.38 77.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.849 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.93 79.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.403 ' CZ ' HD23 ' A' ' 150' ' ' LEU . 20.4 t80 -66.41 -45.04 81.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.532 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 68.9 p -58.23 -40.21 81.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.607 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.9 m -60.53 -46.88 88.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.204 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.9 t -68.59 -43.81 83.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 111.721 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.77 ' CD1' ' HE2' ' A' ' 43' ' ' HIS . 0.4 OUTLIER -65.06 -41.9 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.834 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 147' ' ' THR . 19.4 m120 -60.47 -39.84 89.1 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.046 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -64.69 -39.19 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.75 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.18 -46.09 83.12 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.431 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.0 t -72.25 -46.21 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.474 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 3.5 m95 -61.4 -37.19 82.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 159' ' ' SER . 24.1 mmt85 -56.32 -26.16 51.38 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.889 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.478 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 92.6 m-20 -53.48 -41.86 66.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.754 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -111.01 4.13 19.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.029 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 156' ' ' ARG . 48.2 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.564 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -54.54 -23.74 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.311 1.341 . . . . 0.0 112.497 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.98 60.37 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.624 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.41 -42.45 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.9 -34.52 88.81 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.147 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -54.9 -44.43 74.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.886 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 t -78.7 -35.71 44.57 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.885 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.16 -37.7 88.22 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -51.57 -41.93 80.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.679 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -57.58 -27.59 77.53 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.411 1.407 . . . . 0.0 113.674 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.432 ' HG ' ' N ' ' A' ' 17' ' ' LEU . 86.2 p -61.17 -32.75 72.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.432 ' N ' ' HG ' ' A' ' 16' ' ' SER . 82.5 mt -61.59 -38.32 87.14 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.522 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.76 92.37 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.169 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.3 -59.29 3.94 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.775 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -58.79 -46.15 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.3 mmm -62.88 -40.0 96.18 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 -43.2 10.9 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.182 -0.533 . . . . 0.0 111.997 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.72 -21.66 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -53.35 -32.89 51.32 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.279 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 52.3 t80 -59.53 -47.49 85.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -72.94 -34.08 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.647 0.737 . . . . 0.0 109.713 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -61.09 -40.58 94.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.886 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.38 -132.57 2.02 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.987 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.61 -26.34 55.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.168 0.508 . . . . 0.0 110.669 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.41 8.84 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -52.45 -43.96 65.22 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.963 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -60.77 -40.65 93.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.022 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -59.32 -40.49 86.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.216 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' LEU . 57.3 m-85 -63.83 -22.93 67.15 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.974 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.19 10.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.852 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.55 81.59 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 34' ' ' TYR . 32.2 mt -91.23 151.15 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.853 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -98.85 130.76 45.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.032 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.699 ' HZ1' HH21 ' A' ' 46' ' ' ARG . 61.0 mttt -102.93 140.57 21.19 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 31.1 Cg_endo -59.81 132.72 46.77 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.144 1.229 . . . . 0.0 112.414 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.1 m -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.117 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.486 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 5.8 p90 -76.1 -11.96 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.99 147.95 98.42 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.289 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.96 171.63 7.97 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.916 1.744 . . . . 0.0 111.521 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.23 143.64 51.7 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.976 1.784 . . . . 0.0 111.793 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.699 HH21 ' HZ1' ' A' ' 39' ' ' LYS . 38.8 mtt85 -58.9 -37.91 77.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.446 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 10.6 p90 -69.2 -26.89 65.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.497 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.2 m -64.75 -55.12 21.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.521 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 87.0 mt -75.19 -32.49 61.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -38.79 -48.28 3.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.517 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.6 Cg_endo -71.85 1.78 5.44 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.299 2.0 . . . . 0.0 114.063 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 22.7 pt -44.85 -40.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.82 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' TYR . 98.4 m95 -53.25 -33.39 52.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.607 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.39 -41.6 98.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 m -67.09 -49.52 64.71 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.797 0.332 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -67.73 -33.08 74.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' TRP . 4.4 t80 -52.38 -49.72 63.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.823 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.7 p -69.57 -36.63 76.47 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.18 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.4 -44.99 77.49 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.2 mtt -61.98 -37.5 85.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.105 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.68 -53.11 25.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -62.52 -38.38 89.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.931 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.55 -43.38 78.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 86.9 p -62.83 -30.4 71.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -56.76 -46.9 81.14 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.911 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.08 -42.95 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.0 t -61.9 -40.51 87.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.715 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.528 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -62.63 -37.38 86.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -61.06 -41.55 96.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -63.94 -40.38 96.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.978 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.163 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 10.53 61.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.21 -162.14 27.88 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.08 111.32 23.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 78' ' ' ALA . 14.5 t -135.27 166.63 22.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -46.78 -33.73 4.65 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -36.57 72.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -63.06 -27.36 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.38 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.1 mmt -55.5 -35.95 66.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.87 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.66 -42.34 91.04 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.589 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -89.64 -71.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 120.826 1.017 . . . . 0.0 112.594 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.05 -43.41 98.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.604 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.77 -43.03 98.24 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.16 -39.13 88.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.232 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.6 -43.24 89.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.1 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.2 m -68.03 -42.9 79.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.139 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.15 -58.8 3.29 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -56.13 -40.91 74.51 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.323 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 13.3 tp -64.18 -40.34 95.91 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.011 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.6 -48.1 76.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.534 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.9 mt -61.21 -39.21 89.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.335 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -61.76 -41.45 97.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.479 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 52.9 m95 -58.96 -29.26 67.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.249 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.5 64.39 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.543 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.9 t-105 -61.59 -66.15 1.72 Allowed Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 85.0 Cg_endo -45.21 85.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.957 1.771 . . . . 0.0 112.543 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' TRP . 83.9 Cg_endo -59.52 -16.54 36.46 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.542 1.495 . . . . 0.0 112.31 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.5 pt -58.57 -26.56 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.581 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.97 -41.89 16.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.022 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.52 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.9 t80 -69.28 -51.99 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.201 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.87 -68.52 0.49 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.185 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 65.43 8.77 5.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 110.447 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -52.43 -35.17 51.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -94.17 154.41 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.259 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.645 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.7 ttm -58.44 -19.03 33.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.255 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -40.98 -8.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.263 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.67 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.645 ' N ' ' O ' ' A' ' 105' ' ' MET . 1.7 p90 -45.31 -16.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.469 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.46 -23.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.098 -178.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.4 mp -60.74 -35.52 76.57 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.738 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.15 96.79 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.459 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 56.3 t0 -63.27 -55.27 26.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.561 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 tp -64.93 -40.21 94.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.847 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.542 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.7 tt -69.56 -46.83 65.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER -72.74 -36.66 67.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.632 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.418 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 42.5 t -70.58 -62.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.532 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -69.55 -39.85 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.12 -52.52 52.88 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.512 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.8 p -64.7 -36.34 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.689 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.519 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.95 -53.52 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -56.91 -41.56 78.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.52 8.92 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.778 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.595 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.8 m -66.07 -41.93 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.2 m -58.9 -46.31 88.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.58 -33.37 71.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.46 -63.91 1.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.595 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 33.9 m0 -64.57 -43.71 93.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.664 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -58.2 -41.73 84.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.391 -177.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -60.64 -43.75 97.18 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.2 t -79.97 -46.79 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.416 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 p -135.64 93.55 15.92 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.483 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 53.2 Cg_exo -54.7 -39.13 90.69 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.84 1.694 . . . . 0.0 113.101 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 44.7 Cg_exo -55.67 -27.97 63.66 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.536 0.824 . . . . 0.0 112.652 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.66 71.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.14 87.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.123 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.436 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 75.1 ttt180 -60.76 -39.68 89.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 138' ' ' TYR . 18.2 tp -54.5 -37.41 65.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.207 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.506 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 76.0 mt -65.06 13.25 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.456 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -46.09 -42.53 27.42 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.506 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 17.9 Cg_endo -67.14 -19.84 50.58 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.985 1.388 . . . . 0.0 112.885 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.45 -38.46 87.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 24.9 tp -65.94 -38.85 89.69 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.668 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.73 76.28 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.764 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.604 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -68.45 -52.02 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.366 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -33.85 76.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.417 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 141' ' ' LEU . . . -60.72 -46.56 89.95 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.608 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -64.07 -40.09 95.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.551 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.7 m -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.375 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.9 m -63.95 -48.21 77.4 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.392 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.84 -40.48 78.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.172 0.511 . . . . 0.0 110.564 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.6 tp -55.04 -54.32 44.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.558 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.459 ' OD1' ' CG ' ' A' ' 111' ' ' ASP . 9.4 m120 -63.36 -36.65 84.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.602 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.487 ' CE2' ' NH1' ' A' ' 156' ' ' ARG . 20.8 t80 -58.4 -42.27 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.592 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -63.36 -47.0 83.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.386 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.03 -48.5 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.469 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 2.2 m95 -63.5 -39.35 94.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.662 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.487 ' NH1' ' CE2' ' A' ' 152' ' ' TYR . 29.8 ttp-105 -57.88 -37.79 74.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.358 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.97 -43.06 95.31 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.3 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -89.9 -49.48 6.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 155' ' ' TRP . 70.0 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.0 Cg_endo -57.05 -20.17 36.2 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 CA-C-N 119.231 0.761 . . . . 0.0 112.513 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -33.78 54.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.124 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.42 -40.74 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.03 92.83 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.36 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.85 -41.67 82.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.863 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -78.83 -35.97 43.21 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.105 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.34 -37.03 84.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 t -52.35 -55.93 27.14 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.98 -34.5 99.18 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 120.697 0.931 . . . . 0.0 113.124 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.14 -37.16 79.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.146 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.0 -39.5 94.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.48 -48.35 69.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.784 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.76 96.8 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.248 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -58.65 -45.63 88.92 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.607 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -61.78 -38.77 89.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.135 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.93 93.85 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.22 -26.61 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.975 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -35.52 69.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.081 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 65.0 t80 -61.34 -46.0 92.06 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.271 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.38 -33.14 39.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.0 109.568 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -62.5 -40.67 97.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.531 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.87 -128.92 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.915 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.98 -27.72 61.7 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.698 0.285 . . . . 0.0 110.934 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.24 -32.27 6.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.6 ' CD2' ' HE ' ' A' ' 46' ' ' ARG . 94.9 mt -51.55 -45.06 62.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -65.39 -40.9 94.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 111.563 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -57.83 -37.48 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.23 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 78.6 m-85 -63.89 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.979 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -43.97 -41.91 5.62 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.353 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.5 -32.19 71.36 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 34' ' ' TYR . 34.4 mt -92.52 154.55 18.38 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.311 -0.444 . . . . 0.0 111.069 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 93.5 mm-40 -103.19 129.13 50.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mttp -103.23 145.15 30.05 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -57.08 136.1 74.59 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 120.881 1.054 . . . . 0.0 111.122 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.8 p -64.54 -25.92 68.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.005 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -79.45 -4.86 53.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.574 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.607 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.8 t-80 -53.85 130.06 56.65 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.637 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.607 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.8 Cg_endo -87.12 170.94 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.073 1.849 . . . . 0.0 111.219 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -49.92 138.39 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 120.42 0.746 . . . . 0.0 110.911 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HE ' ' CD2' ' A' ' 31' ' ' LEU . 38.1 mtt-85 -59.61 -36.49 76.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 8.0 p90 -72.6 -19.55 61.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.742 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -66.46 -63.35 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.871 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.53 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 85.4 mt -71.9 -33.07 68.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -37.38 -50.11 2.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.814 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 10.2 Cg_endo -70.77 2.19 4.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.342 2.028 . . . . 0.0 114.286 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CD1' ' CE2' ' A' ' 143' ' ' TRP . 23.8 pt -45.22 -38.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.199 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' TYR . 99.8 m95 -52.18 -29.11 20.8 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.718 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.01 -44.33 92.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.567 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -74.04 -44.76 53.18 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.199 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.74 -33.07 75.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.179 0.514 . . . . 0.0 109.664 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' TRP . 2.1 t80 -55.41 -57.55 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.841 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -66.0 -38.72 89.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.812 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.44 90.76 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.6 mtt -61.14 -37.86 84.34 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.33 -54.0 22.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -63.11 -39.32 94.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.962 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.7 -41.36 74.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 90.8 p -66.28 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.429 ' CZ ' ' CE ' ' A' ' 69' ' ' LYS . 56.0 t80 -56.44 -48.69 76.49 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.46 -39.71 86.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.201 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.5 t -57.4 -49.02 81.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.3 p90 -73.64 -26.13 60.62 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.084 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CE ' ' CZ ' ' A' ' 65' ' ' TYR . 70.2 mmtt -59.87 -37.64 79.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.324 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 77.2 mt-10 -67.67 -41.03 84.39 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.374 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.3 mt -72.83 -25.81 61.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.754 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 103.42 45.9 1.5 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.98 -168.03 35.17 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.627 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.54 109.98 17.23 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.709 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.1 t -128.74 164.55 22.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.611 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -52.43 -37.88 57.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.414 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' H ' HG23 ' A' ' 75' ' ' THR . 85.2 m-20 -63.65 -38.96 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.714 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.45 71.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.627 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 82.0 mmm -59.22 -33.01 70.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.476 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.36 -56.96 26.11 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.957 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -65.14 -52.78 1.03 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.654 0.903 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.29 -42.37 99.08 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.411 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.45 -38.33 95.58 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.7 tp -57.86 -40.0 79.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.727 0.299 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -60.67 -45.99 92.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.549 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.5 m -67.74 -41.57 83.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.076 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.52 -55.15 5.66 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.431 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -57.9 -41.37 82.49 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.23 -37.97 84.95 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.061 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.95 86.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.472 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.26 -39.14 85.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.456 ' ND2' ' CA ' ' A' ' 117' ' ' GLY . 39.3 t-20 -64.44 -37.79 88.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.325 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -53.99 -32.18 53.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.19 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.22 70.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -55.84 -56.81 26.24 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.37 130.26 39.65 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 120.721 0.947 . . . . 0.0 112.969 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 41.5 Cg_endo -107.63 -24.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.568 1.512 . . . . 0.0 110.372 177.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.541 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 34.7 pt -60.54 -28.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.884 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 24.3 p90 -55.8 -44.34 77.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.2 t80 -65.42 -50.29 66.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.677 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.75 -57.11 0.4 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 61.19 -1.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.566 0.222 . . . . 0.0 110.908 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 101' ' ' GLY . 61.6 ttt180 -54.58 -34.5 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.061 0.458 . . . . 0.0 110.376 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -86.15 157.9 19.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.222 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.707 ' C ' ' H ' ' A' ' 107' ' ' TRP . 4.1 tpp -57.4 -13.74 3.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.471 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.07 -1.58 0.01 OUTLIER Glycine 0 CA--C 1.539 1.539 0 C-N-CA 121.703 -0.284 . . . . 0.0 112.418 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.707 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.83 -22.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.411 -0.464 . . . . 0.0 111.079 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.591 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.8 -28.13 68.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.202 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.58 -30.34 68.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.42 -37.46 78.1 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.474 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 t0 -63.01 -44.21 96.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.0 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.01 -53.32 55.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 117' ' ' GLY . 3.0 tt -64.1 -40.37 96.07 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.824 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.9 tp -51.03 -63.8 1.01 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.938 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.53 -55.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.942 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 t -67.63 -44.9 76.87 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.456 ' CA ' ' ND2' ' A' ' 92' ' ' ASN . . . -56.72 -48.35 78.4 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.499 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.21 -46.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.392 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -54.23 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.2 m -59.91 -44.18 94.42 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.32 -58.27 3.94 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.149 -0.621 . . . . 0.0 112.183 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.613 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.2 m -64.79 -40.95 96.07 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 76.7 m -60.01 -45.92 91.17 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.49 -37.32 87.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.83 -63.52 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.613 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.94 -42.3 97.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.419 ' CB ' ' O ' ' A' ' 123' ' ' THR . 29.0 t-80 -59.61 -48.21 82.54 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.322 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.72 -43.4 93.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.894 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.483 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 93.4 t -78.51 -47.8 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.1 p -133.42 90.42 29.48 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.5 Cg_exo -55.32 -42.65 66.3 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.712 1.608 . . . . 0.0 112.541 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 21.7 Cg_exo -57.23 -28.48 79.72 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 120.323 0.682 . . . . 0.0 111.987 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -31.41 71.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.101 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.17 81.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.277 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -58.03 -39.24 77.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 110.206 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.05 -36.76 78.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.897 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 71.7 mt -67.47 -5.19 13.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.086 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -25.3 -58.75 0.16 Allowed Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.27 -28.99 79.49 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 120.643 0.895 . . . . 0.0 113.273 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -57.43 -45.09 85.05 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.473 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 22.8 tp -65.39 -39.75 92.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.01 82.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.133 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.659 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.7 t-105 -64.06 -45.6 88.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.571 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.4 mt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.33 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.28 97.01 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.321 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 150' ' ' LEU . 67.6 t80 -63.64 -44.53 93.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.116 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.659 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 2.1 m -62.74 -42.4 99.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.737 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.1 m -57.37 -49.83 74.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.399 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.19 -41.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.325 0.583 . . . . 0.0 110.75 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.451 HD13 ' CZ ' ' A' ' 146' ' ' PHE . 9.6 tt -60.33 -44.12 95.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.322 -0.853 . . . . 0.0 112.028 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 147' ' ' THR . 18.0 m120 -64.28 -41.0 97.1 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.38 -36.82 85.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.041 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -57.03 -44.8 83.25 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.546 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.76 -47.12 80.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.667 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' SER . 0.5 OUTLIER -64.32 -45.43 87.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.521 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -61.04 -32.53 72.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.079 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 92.6 m-20 -52.95 -40.12 63.43 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -97.46 -56.75 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.288 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 155' ' ' TRP . 88.7 p . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.904 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -54.35 -22.46 26.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 120.72 0.946 . . . . 0.0 112.153 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.18 -32.01 45.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.695 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.93 -41.84 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.68 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.56 -35.92 92.47 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.44 -42.02 86.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.682 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 t -76.71 -34.35 58.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.845 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.497 ' O ' ' OG ' ' A' ' 16' ' ' SER . 95.7 mt -67.47 -34.69 77.67 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.0 t -46.95 -56.2 12.67 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.85 -29.19 87.66 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 120.826 1.017 . . . . 0.0 113.347 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 79.7 p -61.17 -36.74 80.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.612 -0.435 . . . . 0.0 112.061 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.7 -39.22 93.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.288 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.12 -40.14 98.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.55 99.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.236 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE1' ' CZ3' ' A' ' 53' ' ' TRP . 57.9 m-85 -61.86 -49.09 77.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.916 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.6 mtm -64.88 -40.35 94.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.438 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.55 60.9 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.837 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.45 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.158 0.504 . . . . 0.0 111.015 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -35.35 69.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.764 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 58.8 t80 -60.7 -48.15 83.09 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.1 -31.48 29.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -60.6 -42.55 97.02 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.323 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -129.35 5.41 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.996 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.56 -29.65 3.0 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.588 0.233 . . . . 0.0 110.442 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.39 -35.24 27.89 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.5 mt -50.5 -45.19 56.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -62.71 -38.55 90.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -58.62 -38.02 77.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.298 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' LEU . 86.9 m-85 -62.05 -22.36 65.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.742 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.83 -32.36 1.54 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.079 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.18 -32.3 20.61 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 34' ' ' TYR . 56.0 mt -93.35 150.52 20.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.992 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -98.3 132.61 43.64 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.72 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 42.1 mttt -105.82 145.54 31.08 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -60.91 143.36 99.34 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.454 1.436 . . . . 0.0 112.212 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.1 p -64.27 -29.93 71.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.526 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.6 p90 -78.32 3.24 16.06 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.106 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.031 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.75 167.7 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.181 1.254 . . . . 0.0 111.842 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -52.44 140.87 52.94 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.65 1.567 . . . . 0.0 111.533 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.72 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 39.4 mtt85 -61.77 -35.63 78.7 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.611 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -72.25 -14.58 61.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -76.94 -67.18 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.002 0.429 . . . . 0.0 110.663 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.554 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 81.2 mt -67.52 -33.07 74.34 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.744 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' O ' ' CE3' ' A' ' 53' ' ' TRP . . . -42.72 -41.12 5.49 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.789 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 71.0 Cg_exo -64.21 -9.53 20.09 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 123.239 2.626 . . . . 0.0 113.953 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 32.1 pt -45.11 -32.5 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.773 0.32 . . . . 0.0 111.252 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.599 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 6.2 m0 -53.61 -31.27 46.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.34 -43.81 95.46 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.9 p -71.75 -44.87 63.32 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.611 -0.347 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.94 -33.69 76.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.865 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -61.18 -50.98 70.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.376 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -73.36 -33.71 65.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.82 89.13 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.845 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtt -64.25 -36.94 85.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.567 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.41 -64.5 3.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.53 -37.32 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.125 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.89 -42.7 60.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 86.9 p -67.14 -26.75 66.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.59 0.233 . . . . 0.0 110.544 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.75 -49.69 72.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 110.356 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.31 -35.02 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.77 -46.75 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.001 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.441 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.6 p90 -74.22 -31.54 62.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.145 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 68.3 mmtt -59.76 -39.08 83.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.215 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.82 -38.4 88.83 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.85 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.14 -13.18 56.11 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.945 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 98.07 1.6 58.31 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.61 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 136.09 -166.5 24.65 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.716 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.92 102.09 11.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.369 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 p -124.33 164.92 18.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.21 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.43 -37.03 10.79 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.341 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.31 -45.0 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.245 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.64 -35.14 62.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 111.392 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.716 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.3 mmm -58.7 -34.03 70.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -60.21 -60.73 9.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.65 -50.29 11.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.997 1.131 . . . . 0.0 112.151 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.89 -40.85 91.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.852 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.92 96.73 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.53 -40.01 85.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 68.5 t80 -60.93 -45.58 94.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.742 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 m -65.23 -42.93 92.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.0 -57.55 3.69 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.37 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -57.19 -41.98 80.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.419 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 41.4 tp -62.93 -39.22 93.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.91 65.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.153 0.502 . . . . 0.0 110.338 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.45 -38.61 84.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -61.49 -40.67 95.43 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.272 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.546 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 33.0 m95 -58.11 -27.93 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.77 -23.0 65.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.019 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.497 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 20.0 t-105 -54.13 -64.43 1.88 Allowed Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.546 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 86.2 Cg_endo -55.46 130.36 40.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.992 1.795 . . . . 0.0 112.584 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -100.81 -15.55 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.34 1.36 . . . . 0.0 111.105 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 29.7 pt -59.37 -30.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.29 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.548 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 30.7 p90 -55.63 -44.76 77.42 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.913 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.548 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 71.6 t80 -64.86 -48.94 72.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.542 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.08 -59.62 0.42 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 60.09 -1.92 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.691 0.281 . . . . 0.0 110.836 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.4 ttt180 -52.91 -35.71 58.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.957 0.408 . . . . 0.0 110.44 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -87.83 157.46 19.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.365 0.602 . . . . 0.0 111.797 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.716 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.0 ttm -56.32 -13.56 2.26 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.684 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.08 -2.59 0.01 OUTLIER Glycine 0 CA--C 1.541 1.673 0 C-N-CA 121.493 -0.384 . . . . 0.0 112.637 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.716 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.36 -20.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.475 -0.427 . . . . 0.0 111.273 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.02 -28.51 67.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.89 -30.92 70.45 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.269 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.11 -35.89 76.23 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.485 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.5 t0 -64.65 -46.09 83.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 tp -63.99 -48.39 76.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.528 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.5 tt -64.95 -40.3 94.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.493 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.2 tp -55.02 -63.75 1.05 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.311 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.04 -53.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -75.32 -41.74 56.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.87 85.64 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.675 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 t -71.44 -45.46 68.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.039 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.518 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.83 -57.35 4.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 m -57.23 -44.67 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -55.35 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.96 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.647 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.3 m -65.18 -41.5 94.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 83.8 m -59.67 -46.8 87.94 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.16 -35.64 80.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.79 -63.01 1.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.647 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.96 -43.98 94.14 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -59.67 -45.61 91.53 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.621 -0.831 . . . . 0.0 111.616 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.35 -41.37 96.94 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.339 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.8 t -80.78 -49.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.8 p -132.01 89.64 37.7 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.255 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.9 Cg_exo -53.85 -41.89 70.99 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.943 1.762 . . . . 0.0 113.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.9 Cg_exo -55.72 -31.52 80.43 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.613 0.875 . . . . 0.0 112.721 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.32 67.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.462 . . . . 0.0 110.652 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.6 87.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.871 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.529 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 71.5 mtm180 -63.61 -37.98 89.39 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.913 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -51.63 -38.55 55.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.498 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 70.6 mt -57.65 -31.3 66.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.171 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER 4.42 -65.43 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.9 Cg_endo -51.56 -28.5 28.91 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 120.867 1.044 . . . . 0.0 112.847 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -61.9 -35.38 78.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.002 0.43 . . . . 0.0 110.319 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.2 tm? -67.12 -45.49 77.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.064 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.46 41.04 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.609 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 3.6 t-105 -61.4 -50.81 71.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.453 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.6 mt -64.3 -31.83 73.18 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.36 93.9 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.711 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 150' ' ' LEU . 19.0 t80 -66.99 -44.74 79.65 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.483 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.609 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 4.1 m -56.91 -42.07 79.26 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.427 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.6 m -60.65 -50.48 73.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.935 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.4 -40.98 85.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.345 0.593 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 17.6 tp -55.61 -46.07 77.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.739 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 147' ' ' THR . 69.1 m-80 -62.65 -38.89 92.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -64.11 -39.94 95.13 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.422 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -60.09 -45.89 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.939 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.49 -47.14 78.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.93 -41.45 82.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -57.67 -41.88 82.46 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.885 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -63.49 -49.57 73.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.112 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.55 -43.04 67.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.324 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.435 -179.05 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.41 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.6 t . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 111.184 0.068 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 14.3 Cg_endo -59.62 -23.61 71.98 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 120.316 0.678 . . . . 0.0 111.443 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.2 -34.62 66.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.197 0.522 . . . . 0.0 110.384 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.43 -41.07 86.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.86 -35.68 91.68 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.1 -44.87 87.9 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 t -79.11 -37.19 39.29 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.21 -31.83 73.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 t -47.14 -56.47 12.1 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -60.45 -28.79 87.38 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.073 1.182 . . . . 0.0 113.25 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.0 m -57.29 -39.26 75.38 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.249 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.79 -40.17 91.69 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.006 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.25 -49.27 47.22 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.98 93.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.39 -43.51 88.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.92 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.9 mtt -60.75 -40.05 91.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.263 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.64 83.32 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.19 -29.16 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.295 0.569 . . . . 0.0 109.935 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -36.15 73.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.468 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 62.0 t80 -61.15 -47.55 85.72 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' O ' ' NH1' ' A' ' 46' ' ' ARG . 1.2 m -71.26 -31.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.839 0.828 . . . . 0.0 109.337 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -67.47 -41.03 85.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.781 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.91 -120.37 0.66 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.343 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.77 -28.51 61.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.899 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.93 -32.81 19.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.6 mt -49.93 -46.98 52.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.326 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -62.98 -39.89 96.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.55 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -59.64 -39.92 85.95 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.108 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 37' ' ' LEU . 76.2 m-85 -63.93 -23.07 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.08 -42.76 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.6 75.15 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 34' ' ' TYR . 38.8 mt -91.55 152.19 20.41 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.064 0.459 . . . . 0.0 111.454 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.545 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.9 mt-30 -101.16 129.09 47.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.657 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 31.7 mttt -100.14 142.86 25.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.38 135.59 66.2 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.206 1.271 . . . . 0.0 111.702 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.3 p -68.59 -23.32 64.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.307 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 10.4 p90 -78.55 -10.19 59.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.579 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.596 ' NE2' ' O ' ' A' ' 44' ' ' PRO . 1.5 t-80 -69.99 133.49 88.0 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.46 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.596 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 18.2 Cg_endo -75.97 163.2 33.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.243 1.295 . . . . 0.0 110.675 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.13 146.7 17.05 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 120.48 0.786 . . . . 0.0 111.094 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.657 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 62.8 mtt180 -57.52 -37.08 72.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 48' ' ' THR . 4.5 p90 -63.34 -31.05 72.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.654 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 16.1 m -63.18 -55.67 23.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.557 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 96.4 mt -73.24 -35.6 66.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.41 -50.18 3.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.441 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 17.9 Cg_endo -71.01 6.54 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.979 1.786 . . . . 0.0 113.822 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.557 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 13.8 pt -44.21 -33.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.257 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.611 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.1 m-90 -53.54 -28.24 30.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.875 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 57' ' ' TYR . . . -52.52 -38.59 51.78 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.7 t -87.1 -41.74 13.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.684 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.458 ' N ' ' CG2' ' A' ' 55' ' ' THR . 9.8 mt -61.25 -38.97 88.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 58' ' ' SER . 1.4 p90 -64.6 -43.64 93.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.906 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 26.9 m -61.2 -39.75 91.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.34 99.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.492 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mtt -63.08 -36.15 82.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.67 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -66.08 -65.22 2.95 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.36 -38.46 87.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.84 -43.12 81.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 87.5 p -64.88 -27.54 68.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.851 0.358 . . . . 0.0 110.041 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -57.98 -44.49 87.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.48 -42.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.9 -37.94 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.592 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.7 -37.8 85.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.931 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -64.59 -45.23 87.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -68.92 -39.56 79.56 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.4 mt -91.48 -0.51 57.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.39 5.99 66.7 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.24 -165.79 30.42 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.466 -0.397 . . . . 0.0 112.301 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.08 80.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.292 0.568 . . . . 0.0 111.511 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.9 p -125.59 162.04 25.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.764 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -44.32 -38.87 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.99 -46.33 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.738 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 73' ' ' GLY . . . -76.33 -32.79 58.88 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.3 mtp -56.53 -32.8 65.46 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.235 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.28 -47.2 94.83 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.725 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -66.16 -56.72 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.617 0.878 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.7 mp -60.04 -41.35 92.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.94 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.86 93.52 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.0 -39.58 78.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.877 0.37 . . . . 0.0 110.049 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 81.0 t80 -60.07 -44.8 94.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 48.8 m -68.51 -41.35 80.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.56 -64.21 2.54 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.653 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -57.16 -40.61 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.853 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 30.2 tp -63.01 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -49.92 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.57 -38.71 85.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 63.7 t30 -62.14 -41.15 97.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.351 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.473 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 35.5 m95 -56.75 -30.58 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.747 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.94 -24.38 66.06 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' PRO . 14.5 t-105 -54.99 -70.92 0.26 Allowed Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 53.0 Cg_endo -43.32 82.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.949 1.766 . . . . 0.0 112.641 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.558 ' N ' ' O ' ' A' ' 95' ' ' TRP . 90.3 Cg_endo -58.91 -16.84 33.96 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.108 1.872 . . . . 0.0 112.57 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.6 pt -59.01 -25.03 28.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.049 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.36 -44.63 17.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.492 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 67.3 t80 -66.95 -50.39 62.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.76 -68.99 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.271 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 62.12 7.22 2.07 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -50.5 -35.94 31.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.251 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -90.36 153.43 20.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.678 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.677 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ttp -59.02 -16.45 18.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.03 13.84 0.01 OUTLIER Glycine 0 CA--C 1.539 1.568 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.194 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.677 ' H ' ' C ' ' A' ' 105' ' ' MET . 1.8 p90 -60.5 -18.7 53.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.923 0.862 . . . . 0.0 112.02 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.39 -19.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.3 mp -62.46 -35.13 78.34 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.814 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.69 89.31 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.2 t0 -62.24 -45.13 94.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.409 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 tp -63.29 -47.64 81.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.625 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.4 tt -68.92 -40.96 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.518 0.675 . . . . 0.0 109.965 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.2 tp -52.21 -60.31 3.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.095 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.4 t -69.83 -57.11 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.737 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 120' ' ' THR . 25.4 t -67.92 -41.74 82.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -56.55 -48.12 79.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.457 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.2 t -71.09 -46.61 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.096 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -74.46 -54.96 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 116' ' ' SER . 26.6 m -57.41 -44.3 84.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.96 3.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.825 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.652 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 26.8 m -62.13 -40.28 95.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.51 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 82.2 m -61.65 -44.74 96.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.98 -36.69 84.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.26 -63.6 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.652 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.5 m0 -66.92 -42.33 85.58 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 52.0 t-80 -58.03 -47.28 83.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.241 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.53 -44.4 94.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.61 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.63 -49.96 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -132.49 89.94 34.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.464 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 41.1 Cg_exo -52.54 -41.21 69.5 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.447 1.431 . . . . 0.0 112.786 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.1 Cg_exo -57.45 -28.27 79.81 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 120.348 0.699 . . . . 0.0 112.713 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.58 71.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.142 0.496 . . . . 0.0 110.281 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.16 90.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.3 ttt-85 -59.11 -39.85 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.5 tp -57.33 -38.07 73.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.088 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.617 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.7 mt -57.91 -31.28 66.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.385 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 8.56 -68.74 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' A' ' 137' ' ' LEU . 4.8 Cg_endo -49.74 -27.37 15.18 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 120.727 0.951 . . . . 0.0 113.072 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -61.77 -40.72 96.13 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.103 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -66.57 -41.98 87.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.734 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.58 -51.74 26.31 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.524 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 2.7 t-105 -61.54 -49.61 75.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.05 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.2 mt -64.44 -34.16 77.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.1 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.06 95.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.883 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -60.86 -42.06 97.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.568 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.524 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 79.7 p -61.49 -35.59 78.09 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.537 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.3 m -63.95 -52.38 59.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.042 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.0 -42.64 82.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.113 0.483 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.26 -41.48 75.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.234 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.43 -42.32 96.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -64.56 -40.5 95.68 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.472 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -59.97 -46.93 87.83 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.632 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.9 -45.5 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.443 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 3.5 m95 -59.82 -40.36 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.07 -30.04 68.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.578 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 95.1 m-20 -50.37 -39.97 48.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.15 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -102.13 -60.5 1.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.278 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.848 -179.447 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 87.2 Cg_exo -53.62 -22.33 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.137 1.224 . . . . 0.0 112.346 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.48 62.86 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.932 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.64 -44.02 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.5 89.93 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.334 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.409 HD11 ' N ' ' A' ' 11' ' ' LEU . 9.7 mp -56.53 -40.9 75.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 111.265 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 t -79.0 -32.9 45.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.72 -37.45 84.24 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 t -53.75 -42.78 94.33 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.416 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.46 -37.44 71.16 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.392 1.395 . . . . 0.0 113.348 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.9 m -60.05 -38.58 83.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.92 -38.94 87.53 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.417 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.36 99.88 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.106 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.79 -42.18 97.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.963 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 24' ' ' TYR . 58.7 m-85 -61.89 -39.66 92.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -60.76 -39.34 88.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.675 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.54 -46.48 25.12 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.53 -22.85 62.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.231 0.538 . . . . 0.0 110.209 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -55.68 -33.47 64.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 29.8 t80 -64.6 -49.88 69.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.394 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.49 -37.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.791 0.805 . . . . 0.0 109.65 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -59.27 -39.83 84.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.351 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -129.12 2.23 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.695 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.87 -27.03 62.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 110.981 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -32.39 10.07 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -50.76 -45.25 58.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.835 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -60.57 -41.91 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.23 -41.46 98.42 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 23.0 m-85 -64.02 -22.89 67.12 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.689 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.44 -41.46 52.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.003 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.36 -29.86 74.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 34' ' ' TYR . 50.2 mt -91.14 150.11 21.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.544 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -100.9 128.63 46.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 18.8 mtpp -109.9 139.22 21.09 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 39.2 Cg_endo -60.41 130.71 34.93 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.172 1.248 . . . . 0.0 112.515 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.4 m -66.67 -23.1 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.206 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.51 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 3.7 p90 -75.91 -15.5 60.18 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.606 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 1.2 p80 -72.62 143.29 84.75 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.429 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -69.42 161.97 43.78 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.808 1.005 . . . . 0.0 110.849 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.27 152.76 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.144 1.23 . . . . 0.0 110.931 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -55.57 -36.24 66.63 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 9.2 p90 -71.88 -14.67 62.01 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.886 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -80.06 -68.4 0.68 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.29 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.538 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 91.8 mt -62.11 -34.61 76.65 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.556 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -44.97 -41.8 13.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.724 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 85.4 Cg_exo -63.62 -8.64 15.79 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 123.217 2.611 . . . . 0.0 113.958 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CD1' ' CE2' ' A' ' 143' ' ' TRP . 25.3 pt -40.99 -40.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.369 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' TYR . 99.9 m95 -53.21 -33.7 53.93 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.172 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.0 -38.88 96.24 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.0 m -68.52 -51.74 39.76 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.067 0.46 . . . . 0.0 110.616 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.25 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.923 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' TRP . 20.9 t80 -50.86 -53.32 33.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.022 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.8 p -67.9 -34.99 77.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.981 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.58 93.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.521 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.57 -38.14 90.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.56 -57.86 9.44 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.46 -0.876 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -62.43 -36.5 82.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.639 0.257 . . . . 0.0 111.287 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -42.8 84.31 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.427 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -65.36 -30.12 70.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.394 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -58.92 -43.84 91.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.416 . . . . 0.0 110.006 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.07 -40.11 82.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 109.967 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.02 -40.48 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.963 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -62.42 -49.56 74.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.517 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.595 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 75.2 mttt -54.44 -37.15 64.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.421 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -71.54 -43.61 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.495 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -77.89 -26.11 48.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.54 -3.6 46.54 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.76 -169.3 26.12 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.05 95.74 8.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.56 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -122.99 174.29 7.28 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.968 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.45 -35.37 39.3 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 87.7 m-20 -63.97 -39.88 95.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.73 -40.33 17.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.785 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.68 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.2 mmm -59.1 -36.17 74.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.531 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.94 -56.82 25.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.409 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 18.2 Cg_endo -62.94 -53.69 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.071 1.181 . . . . 0.0 112.234 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.53 -41.37 98.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.802 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.9 96.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.29 -38.97 78.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -59.56 -44.88 93.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.484 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.8 m -69.67 -41.33 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.71 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.96 -61.93 2.76 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.982 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -55.92 -41.77 75.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.544 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.44 -39.14 93.69 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.332 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.015 0.436 . . . . 0.0 110.646 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.51 -38.42 84.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 60.8 t30 -61.86 -41.66 98.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.562 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.534 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 30.5 m95 -57.41 -31.16 65.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.632 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.87 -23.53 66.02 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 97' ' ' PRO . 45.6 t-105 -58.46 -67.95 0.82 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 29.5 Cg_endo -38.68 81.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.25 1.967 . . . . 0.0 113.046 -177.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.585 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.4 Cg_endo -62.84 -21.84 73.4 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.141 1.894 . . . . 0.0 112.544 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 46.0 pt -59.83 -25.89 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.488 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.51 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.3 p90 -44.86 -41.81 7.42 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.279 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 72.5 t80 -66.76 -51.83 51.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.73 -69.05 0.5 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.813 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.557 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 63.12 8.01 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.589 0.233 . . . . 0.0 110.722 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.505 ' CZ ' ' NE2' ' A' ' 104' ' ' GLN . 68.5 ttp85 -53.59 -33.9 56.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.505 ' NE2' ' CZ ' ' A' ' 103' ' ' ARG . 90.1 mm-40 -88.45 149.08 23.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.598 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.697 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.1 ttm -60.43 -18.97 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -49.73 8.96 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.217 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.697 ' H ' ' C ' ' A' ' 105' ' ' MET . 23.1 p-90 -49.36 -15.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.418 0.609 . . . . 0.0 112.018 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.449 ' HA ' ' CE3' ' A' ' 107' ' ' TRP . . . -36.39 -17.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.9 mp -66.34 -32.5 73.93 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.104 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.73 -56.68 15.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.618 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.468 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 21.2 t70 -58.16 -44.48 87.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.53 -40.19 93.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.599 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 5.5 tt -73.37 -45.76 53.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -74.08 -38.35 63.93 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.087 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.5 t -67.83 -44.6 85.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.58 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 120' ' ' THR . 42.3 t -84.72 -41.19 16.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.15 -43.58 83.68 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.172 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.11 -48.65 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.655 0.264 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.511 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -72.64 -57.25 4.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 116' ' ' SER . 37.4 m -59.82 -43.61 94.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.87 -56.64 5.35 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.095 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.642 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.5 m -63.3 -41.99 99.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 87.7 m -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.55 -38.12 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.186 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.68 -63.91 1.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.642 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 43.0 m0 -65.74 -41.33 92.33 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.9 t-80 -59.51 -48.7 80.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.914 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -65.7 -45.21 83.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.798 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.3 t -76.6 -46.76 30.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' TRP . 25.6 p -130.9 83.76 60.29 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.288 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.455 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.2 Cg_exo -51.3 -43.94 46.17 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.497 1.465 . . . . 0.0 112.433 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 20.8 Cg_exo -59.15 -32.19 96.75 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.565 0.843 . . . . 0.0 112.364 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.65 -29.02 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.54 91.4 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 79.6 mtt180 -62.57 -38.87 91.8 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.437 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.7 tp -52.53 -37.31 57.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.091 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 138' ' ' TYR . 54.0 mt -58.93 -27.55 65.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.291 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -2.92 -69.9 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.811 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 138' ' ' TYR . 11.8 Cg_endo -50.97 -26.51 18.61 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 120.653 0.902 . . . . 0.0 112.951 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -57.61 -43.71 84.95 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 31.2 tp -59.45 -39.91 85.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.352 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.91 92.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.059 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.577 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -67.36 -50.73 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.434 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.6 mt -65.26 -32.34 73.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.029 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 141' ' ' LEU . . . -61.49 -49.02 78.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.724 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 150' ' ' LEU . 30.7 t80 -64.43 -40.48 95.83 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.613 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 1.4 m -55.12 -43.79 74.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.503 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 60.8 p -67.98 -44.47 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.974 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.42 -42.05 92.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.52 0.676 . . . . 0.0 109.797 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 53.2 tp -59.91 -38.23 81.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 147' ' ' THR . 3.2 m120 -61.67 -41.91 98.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 73.2 m-85 -65.82 -39.52 90.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.0 t80 -61.68 -45.08 95.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.761 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.96 -52.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 159' ' ' SER . 5.1 m0 -63.56 -42.32 98.37 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CG ' ' O ' ' A' ' 152' ' ' TYR . 24.5 mmt85 -60.81 -35.85 77.56 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.117 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 88.0 m-20 -59.33 -40.94 87.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.577 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -92.34 -55.89 3.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.717 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 155' ' ' TRP . 85.3 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.313 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.31 -20.79 20.9 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 120.764 0.976 . . . . 0.0 111.806 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.36 -36.28 53.26 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.9 -42.01 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.19 -34.81 90.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.261 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 11' ' ' LEU . 10.6 mp -57.52 -41.33 80.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.036 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -76.8 -31.77 57.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.212 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 57' ' ' TYR . 96.7 mt -67.44 -32.83 73.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.823 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -44.44 -57.42 6.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.68 -32.77 97.55 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 121.013 1.142 . . . . 0.0 113.029 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -58.46 -39.14 79.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.422 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.07 -36.35 82.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.539 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.7 -58.16 7.26 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.006 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -36.29 82.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -57.71 -47.04 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.67 0.271 . . . . 0.0 110.979 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -64.48 -38.49 91.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.572 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.53 -42.24 97.56 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.627 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.45 -26.07 65.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.917 0.389 . . . . 0.0 111.701 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -32.6 65.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 51.4 t80 -60.51 -48.71 80.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -72.81 -31.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -63.21 -41.86 99.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.076 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.36 -126.26 4.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.91 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.22 -30.18 11.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.683 0.278 . . . . 0.0 111.037 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.77 -31.58 23.89 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.2 mt -51.74 -46.1 63.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.907 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -63.55 -37.6 87.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.83 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -56.22 -37.91 70.34 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.942 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CZ3' ' A' ' 107' ' ' TRP . 84.9 m-85 -63.31 -21.92 66.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.23 -35.05 2.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.659 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.69 -30.17 27.49 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 49.8 mt -95.69 151.45 19.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.499 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.1 mt-30 -97.76 133.18 42.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -111.34 142.15 25.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.304 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 58.2 Cg_endo -61.31 134.42 51.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.382 1.388 . . . . 0.0 111.341 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 p -78.94 -12.13 60.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.51 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 3.8 p90 -81.12 -15.17 56.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.6 148.96 95.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.814 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -83.29 175.66 8.06 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.878 1.719 . . . . 0.0 111.82 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CB ' ' NE1' ' A' ' 47' ' ' TRP . 39.7 Cg_exo -51.44 144.77 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.115 1.877 . . . . 0.0 112.057 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 49.9 mtt85 -59.84 -36.32 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.495 ' NE1' ' CB ' ' A' ' 45' ' ' PRO . 61.6 p-90 -70.95 -26.92 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.073 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -62.92 -57.86 9.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.923 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.532 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 86.2 mt -73.91 -34.21 64.28 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -36.89 -51.21 2.08 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.012 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' CD ' ' O ' ' A' ' 47' ' ' TRP . 18.7 Cg_endo -68.81 0.61 4.72 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.455 2.103 . . . . 0.0 114.17 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 14.1 pt -43.81 -42.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' TYR . 96.9 m95 -51.69 -32.82 31.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.96 96.18 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.8 m -68.54 -50.99 47.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.065 0.46 . . . . 0.0 111.206 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.33 -34.27 76.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.94 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 53' ' ' TRP . 5.5 t80 -48.76 -60.62 2.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -63.47 -38.21 90.26 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.536 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.199 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.0 mtt -64.61 -38.55 91.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -62.29 -48.06 85.23 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.259 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -61.18 -38.68 87.38 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.48 -43.0 66.54 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.235 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 92.2 p -61.25 -31.67 71.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -58.61 -47.65 83.64 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.196 -0.601 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.07 -41.53 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 109.558 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.0 -38.46 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -65.16 -36.56 84.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.907 178.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -63.81 -43.25 96.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.683 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.79 -44.38 85.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.492 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt -76.68 -26.4 54.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.115 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.24 -4.15 62.25 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.437 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 156.64 -167.41 33.6 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.389 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.582 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 1.2 t80 -85.57 99.17 11.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' ALA . 5.7 t -133.48 165.71 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.62 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -41.69 -35.5 0.79 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.598 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -60.69 -40.89 93.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.959 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -74.86 -32.22 61.83 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.012 0.434 . . . . 0.0 111.94 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.582 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 55.7 mmm -62.29 -35.12 78.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -59.66 -40.69 81.29 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.538 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -85.56 -65.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.056 1.171 . . . . 0.0 112.231 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.78 -44.16 94.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.27 96.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.23 -36.62 78.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -56.58 -43.48 80.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.131 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.1 m -63.82 -43.65 95.61 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.16 -57.43 3.68 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.744 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.91 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.93 -39.67 95.29 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.68 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.37 75.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.043 0.449 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.35 -39.72 88.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.007 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.451 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 58.5 t30 -62.29 -40.75 97.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -57.44 -29.99 64.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.925 0.393 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.93 67.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.544 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.634 ' O ' ' N ' ' A' ' 97' ' ' PRO . 36.7 t-105 -59.71 -68.51 0.73 Allowed Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -40.2 78.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.263 0 C-N-CA 121.699 1.599 . . . . 0.0 112.662 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' TRP . 97.1 Cg_endo -57.28 -19.78 36.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.947 1.765 . . . . 0.0 112.076 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 33.3 pt -58.7 -23.36 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.042 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.1 p90 -56.54 -47.07 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.606 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.7 t80 -64.81 -49.59 70.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.51 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.6 0.42 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.626 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.534 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 60.94 -2.24 0.2 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.636 0.255 . . . . 0.0 110.705 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 101' ' ' GLY . 60.8 ttt85 -54.34 -35.44 62.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.63 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -85.8 158.65 19.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.522 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 107' ' ' TRP . 15.4 ttm -56.46 -13.9 2.64 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.255 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.95 -3.33 0.01 OUTLIER Glycine 0 CA--C 1.538 1.503 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.503 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.715 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.12 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.252 -0.558 . . . . 0.0 110.995 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.32 -27.93 67.72 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.832 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.09 -31.3 68.78 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.131 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -61.68 -38.72 88.84 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.547 ' CG ' HD21 ' A' ' 151' ' ' ASN . 54.7 t0 -63.94 -45.95 86.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.8 tp -64.71 -49.54 70.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.051 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 117' ' ' GLY . 3.7 tt -67.17 -40.96 86.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.414 0.626 . . . . 0.0 110.078 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 18.9 tp -50.82 -59.01 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.711 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.98 -60.74 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.647 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.497 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -66.98 -42.74 84.57 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -60.38 -56.04 26.72 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.446 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.09 -38.62 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.671 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.48 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.32 -48.06 18.36 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.5 m -59.29 -41.68 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.55 -54.96 10.07 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.97 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.57 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 17.7 m -66.1 -42.3 89.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 53.4 m -59.4 -46.63 88.16 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.67 -34.7 78.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.055 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.23 -64.5 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.5 m0 -70.09 -42.0 73.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 40.8 t-80 -56.41 -45.59 80.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.277 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -63.1 -44.23 96.24 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.849 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.52 -47.47 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.587 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.4 p -133.79 87.28 36.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.472 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.7 Cg_exo -52.03 -40.86 67.03 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.767 1.645 . . . . 0.0 112.932 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.0 Cg_exo -58.27 -27.62 81.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 120.49 0.794 . . . . 0.0 112.81 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.18 -33.48 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.187 0.518 . . . . 0.0 110.783 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.18 -36.42 77.56 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.989 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -60.59 -34.84 74.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.151 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -62.07 -40.06 94.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.902 0.858 . . . . 0.0 110.013 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.487 ' O ' ' C ' ' A' ' 138' ' ' TYR . 38.4 mt -62.6 -26.72 68.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.964 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -1.74 -67.86 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 19.4 Cg_endo -51.27 -24.38 15.36 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 CA-C-N 119.711 0.933 . . . . 0.0 112.91 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -59.34 -39.37 82.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.818 0.342 . . . . 0.0 110.446 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -62.77 -41.39 99.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.897 0.38 . . . . 0.0 110.244 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.98 73.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.628 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.643 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 2.5 t-105 -61.27 -44.63 96.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.0 mt -69.67 -36.66 76.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.634 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.273 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 150' ' ' LEU . 64.7 t80 -62.85 -46.92 85.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.094 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.643 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 2.4 m -62.48 -41.75 99.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.09 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.1 m -58.93 -50.41 74.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.807 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 -40.35 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 110.491 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.45 HD11 ' CZ ' ' A' ' 146' ' ' PHE . 9.5 tt -56.81 -46.36 81.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.692 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 147' ' ' THR . 79.7 m-20 -65.37 -41.55 93.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -64.58 -38.99 92.91 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.772 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -58.26 -43.66 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.104 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.76 -42.96 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.374 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -60.87 -25.1 66.43 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -50.38 -36.57 33.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.562 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 91.2 m-20 -59.76 -43.77 94.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.085 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -87.62 -51.23 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 p . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.568 -179.719 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -55.29 -22.93 35.16 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 120.738 0.959 . . . . 0.0 112.769 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.65 63.99 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -44.07 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.77 90.79 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.533 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.4 ' N ' HD11 ' A' ' 11' ' ' LEU . 9.7 mp -56.6 -41.53 77.2 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.293 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 t -79.4 -32.28 42.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.854 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.44 -37.09 86.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.8 t -50.85 -43.57 83.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.026 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.66 -36.8 91.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.357 1.372 . . . . 0.0 112.835 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.4 m -60.6 -39.16 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.812 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.44 -37.98 87.99 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.225 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.33 -55.0 17.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.576 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -62.67 -37.3 94.55 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.268 -0.491 . . . . 0.0 111.954 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.0 -46.97 86.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.8 mtm -63.47 -39.85 95.57 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.44 97.44 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.11 -28.37 63.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 0.0 110.648 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -35.88 74.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.05 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 69.5 t80 -60.75 -48.67 80.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.58 -36.01 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.933 0.873 . . . . 0.0 109.627 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -60.2 -41.08 92.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.097 -1.41 . . . . 0.0 112.357 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.72 -129.88 1.4 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.714 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.05 -26.67 60.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.91 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.08 -33.52 10.61 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.53 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.6 mt -50.87 -41.31 57.96 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -61.63 -43.53 98.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.506 0.669 . . . . 0.0 109.594 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -62.72 -40.1 96.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.146 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.6 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.9 m-85 -63.87 -22.94 67.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.328 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.59 -40.81 28.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.123 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -31.98 78.87 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.0 mt -91.1 148.81 22.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.977 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.32 127.92 46.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.654 ' HZ2' ' CZ ' ' A' ' 46' ' ' ARG . 12.1 mtpt -100.67 136.06 19.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 59.2 Cg_endo -56.06 143.79 82.17 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.139 1.226 . . . . 0.0 112.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 t -60.84 -31.22 70.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.998 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.402 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 18.4 p90 -76.99 0.39 21.36 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.309 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.6 t-80 -61.86 124.38 81.41 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.587 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.2 Cg_endo -80.86 166.01 19.42 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.462 1.442 . . . . 0.0 111.295 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.25 140.75 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.133 1.222 . . . . 0.0 111.364 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.654 ' CZ ' ' HZ2' ' A' ' 39' ' ' LYS . 36.8 mtt-85 -58.74 -37.38 76.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.006 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.437 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 8.5 p90 -74.8 -21.5 59.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.928 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -65.25 -59.91 3.56 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.008 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.539 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 71.2 mt -72.85 -33.31 66.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -37.4 -50.69 2.54 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.951 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLY . 16.6 Cg_endo -69.59 0.8 5.0 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.433 2.088 . . . . 0.0 114.05 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 13.3 pt -42.34 -41.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.228 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 57' ' ' TYR . 99.4 m95 -53.86 -33.15 55.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.322 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.15 -40.11 98.09 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -67.83 -51.84 43.82 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.235 0.541 . . . . 0.0 110.82 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -66.55 -32.85 74.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.934 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' TRP . 22.8 t80 -51.63 -53.53 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.374 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 59' ' ' ALA . 39.8 p -68.04 -36.85 80.59 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.326 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.538 ' N ' ' HG ' ' A' ' 58' ' ' SER . . . -65.43 -44.09 88.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.091 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.3 mtt -62.86 -37.47 87.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.68 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -69.16 -57.94 7.14 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.524 -0.846 . . . . 0.0 110.987 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.64 -39.35 87.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.595 0.236 . . . . 0.0 110.825 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.78 -42.02 84.57 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 89.0 p -62.35 -29.4 70.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.85 -44.47 91.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.807 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.13 -42.49 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.89 -40.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.522 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.65 -33.27 75.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.153 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 31.5 mtpt -65.49 -44.89 85.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.151 0.5 . . . . 0.0 111.091 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.95 -37.94 85.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.774 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.6 mt -91.36 -3.75 56.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.44 35.9 40.49 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.479 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.37 -161.71 24.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.4 OUTLIER -78.64 109.91 13.29 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 121.56 0.695 . . . . 0.0 110.741 -178.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.423 HG21 ' H ' ' A' ' 78' ' ' ALA . 4.9 t -133.94 164.45 27.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -43.93 -38.24 3.32 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.023 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.5 -41.94 92.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.912 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.423 ' H ' HG21 ' A' ' 75' ' ' THR . . . -71.97 -33.24 68.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.632 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.1 mmm -59.06 -35.17 72.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.561 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.48 -59.68 12.77 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.2 -54.09 2.03 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.415 1.41 . . . . 0.0 113.051 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.57 -41.61 99.03 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.127 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.51 98.27 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp -58.29 -39.28 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -59.0 -44.42 91.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 65.4 m -68.22 -39.92 82.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.42 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.18 -58.98 3.5 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.894 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -56.96 -42.04 79.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.331 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.826 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.76 78.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.04 -40.4 89.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.826 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -62.66 -39.78 94.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.512 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.554 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.0 m95 -57.97 -27.46 63.46 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.12 62.63 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 26.4 t-105 -71.51 -56.36 5.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 76.4 Cg_endo -44.08 86.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.099 1.199 . . . . 0.0 112.549 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.3 Cg_endo -57.05 -26.71 70.16 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 120.845 1.03 . . . . 0.0 111.321 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.439 ' H ' ' CD ' ' A' ' 97' ' ' PRO . 39.5 pt -62.44 -28.19 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.702 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.35 -44.47 65.22 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.895 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 70.5 t80 -64.43 -49.35 71.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.876 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 102' ' ' ALA . . . -113.38 -68.6 0.51 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.308 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.484 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 80.15 -5.26 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -54.4 -36.56 64.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -80.72 146.43 31.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.125 0.488 . . . . 0.0 111.257 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.615 ' C ' ' H ' ' A' ' 107' ' ' TRP . 3.3 ttp -64.22 -15.69 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.214 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.13 33.95 0.02 OUTLIER Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -61.41 -19.74 62.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -46.88 -24.47 0.6 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 111.594 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.1 -31.16 69.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.365 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.91 -52.74 58.46 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.662 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.535 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 24.0 t0 -62.2 -45.71 92.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.64 -38.52 85.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 110.379 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 6.4 tt -71.15 -48.99 48.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.22 -31.46 62.62 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.49 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.405 ' CG2' ' OD1' ' A' ' 111' ' ' ASP . 48.3 t -67.18 -61.58 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.722 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.9 t -72.54 -42.13 65.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.25 60.3 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.339 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -67.38 -35.93 75.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.649 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.33 -57.4 3.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -60.08 -42.7 95.16 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.81 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.94 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.438 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 27.2 m -63.62 -39.39 94.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.935 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 77.7 m -59.34 -48.79 80.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 128' ' ' ARG . 74.3 mt -63.87 -32.31 73.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.68 -63.39 1.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 39.7 m0 -76.12 -45.28 34.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 123' ' ' THR . 16.4 t-80 -57.67 -43.42 85.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.949 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.481 ' CG ' ' O ' ' A' ' 124' ' ' LEU . 37.0 mmm-85 -64.63 -46.08 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.273 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.24 -48.65 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' TRP . 37.4 p -128.64 84.77 62.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.138 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.7 Cg_exo -53.41 -41.81 70.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.178 1.919 . . . . 0.0 112.925 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 24.3 Cg_exo -57.36 -30.15 86.78 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 120.323 0.682 . . . . 0.0 112.378 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.46 71.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.074 0.464 . . . . 0.0 110.316 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.74 76.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.811 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 50.4 ttt85 -59.59 -40.9 88.98 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.433 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 138' ' ' TYR . 16.0 tp -54.55 -36.04 63.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.305 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.516 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 55.6 mt -70.73 16.87 0.08 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.423 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -48.04 -41.06 38.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.231 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.516 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 18.2 Cg_endo -67.9 -18.67 46.84 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 CA-C-N 120.633 1.262 . . . . 0.0 112.876 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -58.98 -41.33 87.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.915 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 36.4 tp -63.79 -38.39 90.91 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.424 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.92 -43.95 91.11 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.596 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.606 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.3 t-105 -69.86 -50.46 42.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.449 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.83 -32.87 74.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.404 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.13 -50.2 74.15 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.733 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -64.15 -42.28 96.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.905 0.383 . . . . 0.0 111.605 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.606 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.8 m -55.73 -43.66 76.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.1 m -64.36 -49.63 70.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.512 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.51 -40.23 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.193 0.521 . . . . 0.0 110.667 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 63.9 tp -56.06 -42.4 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.249 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.535 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.4 m120 -64.55 -41.0 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -62.69 -40.89 98.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.415 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -61.03 -46.41 90.85 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.227 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.87 -45.18 81.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.037 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.449 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -59.72 -39.21 83.89 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.647 -178.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 159' ' ' SER . 66.5 mtp180 -58.66 -25.96 63.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.65 -39.4 58.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.702 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -113.77 -2.39 13.71 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.145 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 156' ' ' ARG . 69.8 m . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.641 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.8 Cg_endo -58.01 -20.53 45.68 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.554 0.836 . . . . 0.0 112.222 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.589 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.24 -40.5 83.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.017 0.437 . . . . 0.0 109.863 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.65 -36.86 93.3 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.33 -42.19 90.87 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 57' ' ' TYR . 2.9 t -78.15 -41.4 34.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.514 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.25 -35.33 80.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 t -50.07 -43.9 78.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.354 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.07 -34.58 98.92 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.3 1.333 . . . . 0.0 112.895 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 m -59.61 -39.56 84.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 0.0 112.009 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.03 -37.72 83.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.365 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.46 -40.88 99.28 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.925 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -44.59 97.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.489 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -61.92 -40.87 96.98 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.65 -39.85 92.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.717 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -43.99 9.56 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.041 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.01 -24.57 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.432 . . . . 0.0 110.89 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.26 -35.42 64.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.55 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 64.1 t80 -60.92 -48.02 83.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.34 -32.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.721 0.772 . . . . 0.0 109.451 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -63.6 -41.26 98.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.523 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.41 -129.63 2.21 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.855 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.19 -27.93 62.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.853 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.21 -31.5 6.24 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.7 mt -51.9 -45.89 64.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.814 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -62.48 -39.0 92.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -57.34 -39.91 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.891 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.541 ' O ' ' O ' ' A' ' 37' ' ' LEU . 74.9 m-85 -64.76 -22.43 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.41 -40.23 5.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.74 -34.61 72.51 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 34' ' ' TYR . 31.6 mt -93.29 152.87 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.52 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.6 mt-30 -98.55 132.48 43.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.501 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 48.6 mttt -99.39 148.57 34.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -57.49 140.02 91.95 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.62 1.546 . . . . 0.0 111.908 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 m -61.53 -33.22 73.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.762 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.434 ' NE1' ' CE1' ' A' ' 146' ' ' PHE . 13.3 p90 -85.79 6.43 28.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.496 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -54.86 124.55 51.85 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.136 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.93 168.45 6.75 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.172 1.248 . . . . 0.0 111.581 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -51.21 139.28 44.14 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.427 1.418 . . . . 0.0 111.924 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.501 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 39.7 mtt85 -61.9 -37.09 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.2 p90 -73.88 -13.38 60.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.622 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -77.5 -65.92 0.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.967 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.561 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 77.7 mt -65.79 -35.63 81.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.498 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -42.12 -40.42 3.87 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.033 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 54' ' ' GLY . 63.6 Cg_exo -66.81 -8.95 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.913 2.409 . . . . 0.0 113.746 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 26.3 pt -41.84 -42.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.412 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.428 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.3 m95 -53.54 -32.05 48.99 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.264 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -52.6 -37.08 49.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.5 p -87.54 -45.85 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.97 -40.32 96.13 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.523 ' O ' ' OG1' ' A' ' 12' ' ' THR . 0.2 OUTLIER -62.62 -44.65 95.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.639 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 57' ' ' TYR . 28.4 m -60.15 -40.79 91.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.61 91.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.439 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 63.9 mtt -62.42 -37.88 87.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -65.6 -55.53 19.83 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -61.78 -33.76 74.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.118 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.35 -44.18 58.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 95.4 p -64.13 -31.52 72.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -56.61 -46.04 81.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.412 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.6 mt -61.59 -39.4 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.18 -38.78 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.13 -51.41 69.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.943 0.401 . . . . 0.0 111.2 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 73.5 mttt -54.96 -36.57 65.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.367 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -72.77 -41.17 65.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.89 -8.22 40.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.82 -6.28 58.58 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.515 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 124.8 -168.19 16.97 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.431 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -59.5 79.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.789 0.804 . . . . 0.0 108.873 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.1 m -116.09 152.77 32.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.595 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' THR . 97.0 mt-10 -42.59 -36.52 1.4 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.184 -0.607 . . . . 0.0 109.894 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.58 -41.33 98.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.114 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -74.97 -33.03 61.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.46 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.452 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 89.3 mmm -61.2 -35.76 78.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.652 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -56.42 -45.06 99.97 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.585 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.18 -61.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 120.929 1.086 . . . . 0.0 111.985 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 mt -57.81 -43.75 85.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.91 0.386 . . . . 0.0 110.927 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.83 -43.85 98.66 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -59.07 -38.45 79.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.269 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.439 ' OH ' ' SD ' ' A' ' 60' ' ' MET . 79.2 t80 -56.85 -42.98 80.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.612 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 m -65.66 -42.35 91.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.33 3.08 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.897 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -55.78 -41.59 74.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.522 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.21 -37.91 89.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.03 -49.84 73.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 111.004 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.8 -37.01 82.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -59.51 -41.34 89.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.559 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.483 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 62.0 m95 -62.1 -30.42 70.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.652 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.24 -28.95 66.79 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.557 ' O ' ' N ' ' A' ' 97' ' ' PRO . 18.9 t-105 -55.74 -64.52 2.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_endo -46.2 82.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.457 1.438 . . . . 0.0 112.148 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.557 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.5 Cg_endo -57.82 -19.21 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.351 1.368 . . . . 0.0 111.477 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.6 pt -60.23 -26.18 35.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.032 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.7 p90 -46.82 -44.64 19.48 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.386 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 73.6 t80 -70.05 -49.4 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.99 -66.24 0.48 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.947 -0.645 . . . . 0.0 113.131 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 66.16 8.57 5.63 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.608 0.242 . . . . 0.0 111.015 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.498 HH11 ' NE2' ' A' ' 104' ' ' GLN . 79.7 ttt-85 -55.07 -36.31 65.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.498 ' NE2' HH11 ' A' ' 103' ' ' ARG . 96.5 mm-40 -88.66 149.77 23.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.286 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 107' ' ' TRP . 1.7 ttp -59.98 -19.41 52.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.298 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.02 -8.06 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.88 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' MET . 1.5 p90 -44.67 -18.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.19 -20.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.0 mt -60.87 -35.76 77.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.8 93.04 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.479 0.657 . . . . 0.0 109.345 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 111' ' ' ASP . 56.7 t0 -66.73 -43.38 84.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.785 -1.098 . . . . 0.0 113.57 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.21 -49.26 65.19 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 117' ' ' GLY . 21.8 mt -67.87 -38.85 83.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.02 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.0 tp -51.6 -55.81 17.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.286 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.1 -63.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.662 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -67.82 -41.86 82.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -63.48 -52.9 42.81 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.965 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 p -65.93 -36.83 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.582 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.494 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -80.9 -56.0 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.3 m -56.34 -42.34 77.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.97 -53.96 15.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.397 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.499 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.8 m -65.03 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 86.9 m -59.16 -48.2 82.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.96 -35.1 79.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.319 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.66 -55.25 6.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.499 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 38.6 m0 -84.86 -49.96 7.96 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.658 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -52.25 -41.87 63.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.206 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -61.44 -43.57 98.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.316 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.3 t -78.6 -48.98 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.589 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 87.8 p -132.47 88.06 40.41 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.786 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.8 Cg_exo -53.31 -39.58 80.7 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.931 1.754 . . . . 0.0 113.147 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 34.1 Cg_exo -56.27 -29.74 77.49 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.35 0.7 . . . . 0.0 112.76 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -32.65 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.63 . . . . 0.0 110.392 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 127' ' ' HIS . . . -59.48 -38.4 80.74 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 45.5 ttp180 -61.28 -38.65 87.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.625 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.58 -39.74 71.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.8 mt -56.85 -28.82 62.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.314 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.51 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 5.86 -69.45 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 9.6 Cg_endo -52.1 -31.36 44.6 Favored 'Trans proline' 0 N--CA 1.505 2.158 0 C-N-CA 120.435 0.756 . . . . 0.0 113.275 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -59.07 -38.3 79.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.809 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.1 tm? -59.58 -44.24 93.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.303 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.42 72.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.8 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.615 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.8 t-105 -61.26 -44.04 97.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.3 mt -65.8 -34.25 77.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.823 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.42 89.39 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.727 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.434 ' CE1' ' NE1' ' A' ' 42' ' ' TRP . 15.7 t80 -65.27 -43.21 91.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.615 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.6 m -57.31 -42.73 82.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.612 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -61.26 -47.29 86.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.163 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.81 -42.7 82.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.688 0.756 . . . . 0.0 109.995 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 14.1 tp -53.44 -60.86 2.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.118 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -63.02 -38.81 92.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.272 0.558 . . . . 0.0 110.518 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.35 -43.09 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.19 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.88 -44.46 96.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.47 -42.7 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 111.209 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.477 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 4.9 m95 -57.65 -36.23 71.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.37 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -57.35 -30.41 64.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 89.5 m-20 -53.13 -40.31 64.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.564 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -109.06 -60.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.4 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.793 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -54.52 -21.22 23.41 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 120.916 1.077 . . . . 0.0 112.177 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.29 -36.81 53.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.04 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.38 -42.81 96.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.47 -34.79 90.17 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.482 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' N ' HD11 ' A' ' 11' ' ' LEU . 10.1 mp -55.82 -43.75 77.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.105 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 t -75.99 -27.01 57.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.19 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.97 -32.42 67.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 40.9 t -45.51 -57.69 7.22 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 16' ' ' SER . 6.6 Cg_endo -57.88 -31.52 92.76 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.086 1.191 . . . . 0.0 112.902 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 15' ' ' PRO . 23.2 t -60.2 -39.47 86.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.56 -39.27 87.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.275 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.56 15.37 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.2 94.05 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.08 -45.37 87.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.907 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.88 -39.42 94.41 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.51 -42.84 97.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.07 -26.28 62.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.386 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -62.94 -34.9 78.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.913 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 74.8 t80 -61.25 -49.45 77.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.64 -35.79 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.477 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -34.16 74.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.654 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.9 -136.88 2.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.505 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.1 -24.73 59.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.121 0.486 . . . . 0.0 110.759 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.86 -32.69 4.64 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -52.18 -43.42 64.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.074 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.23 -42.84 99.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 110.238 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -60.05 -39.15 84.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.589 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 45.1 m-85 -64.89 -23.06 67.11 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.751 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.15 -41.62 27.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.543 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.04 84.48 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 73.3 mt -91.0 149.18 21.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.789 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -98.0 122.56 41.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.791 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.665 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 54.7 mttt -91.35 140.94 25.67 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 30.4 Cg_endo -56.44 140.73 89.6 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.122 1.215 . . . . 0.0 112.398 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.4 m -61.17 -34.04 74.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.207 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.403 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 39.0 p90 -77.43 4.45 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.619 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.586 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.3 t-80 -64.5 132.0 95.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 57.6 Cg_endo -89.81 169.65 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.697 1.598 . . . . 0.0 111.284 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -50.92 138.73 42.32 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.84 1.027 . . . . 0.0 111.501 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.665 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 43.0 mtt85 -60.43 -38.69 84.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.9 p90 -72.21 -25.66 61.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.901 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -64.24 -57.45 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 50.1 mt -73.28 -33.78 65.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.445 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -37.36 -48.64 2.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.882 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 18.2 Cg_endo -72.34 3.77 3.88 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.364 2.043 . . . . 0.0 114.189 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.575 ' CD1' ' CE2' ' A' ' 143' ' ' TRP . 19.4 pt -47.21 -38.24 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.263 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.448 ' O ' ' N ' ' A' ' 57' ' ' TYR . 98.7 m95 -51.76 -33.59 35.76 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.079 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.23 97.86 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.7 m -66.39 -51.17 59.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 110.834 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.28 -33.09 74.58 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.205 0.526 . . . . 0.0 109.966 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' TRP . 31.1 t80 -53.12 -52.8 57.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.618 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.5 p -69.42 -35.39 75.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.618 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.74 90.13 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.455 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.2 mtt -62.29 -37.41 85.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.269 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.29 -56.25 14.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.95 -40.13 96.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 111.102 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.85 -43.41 92.37 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.7 p -63.5 -28.14 69.76 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.954 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -58.3 -44.85 88.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.95 -44.71 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.914 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.32 -41.64 84.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.21 -37.17 86.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.511 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -62.46 -40.94 98.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.064 0.459 . . . . 0.0 111.113 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.63 -37.59 88.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.07 -5.31 56.7 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.47 17.19 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.972 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.435 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 104.24 -166.35 15.33 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.96 110.11 21.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.461 0.648 . . . . 0.0 109.332 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.7 t -131.32 163.47 27.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.981 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -43.51 -37.85 2.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.309 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.45 -41.02 98.64 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.879 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.4 -29.18 65.74 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.689 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 86.1 mmm -60.15 -33.64 72.45 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.781 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.3 t -60.33 -50.22 86.84 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.22 -61.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.935 1.09 . . . . 0.0 113.038 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.87 -39.26 91.3 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.077 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.18 96.26 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.82 -39.27 80.72 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.407 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 84.0 t80 -60.62 -45.71 93.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.034 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.0 m -67.95 -40.28 83.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.856 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.93 -60.33 3.17 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.022 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -56.96 -40.63 76.83 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.17 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 44.9 tp -61.96 -40.23 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.174 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.0 79.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.98 0.419 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.02 85.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t30 -61.64 -42.44 98.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.679 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -58.42 -29.62 66.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.831 0.348 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -31.12 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.279 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.0 t-105 -56.94 -44.25 99.71 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -53.05 127.37 24.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.521 1.48 . . . . 0.0 113.125 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.486 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 37.5 Cg_endo -108.67 -27.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.194 1.263 . . . . 0.0 110.793 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 26.5 pt -59.59 -27.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.953 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 20.8 p90 -56.7 -44.51 81.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.608 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.568 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 60.5 t80 -64.95 -49.08 71.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.908 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.32 -59.16 0.41 Allowed Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 60.52 -1.27 0.22 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.649 0.262 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 101' ' ' GLY . 71.0 ttp85 -52.89 -33.28 49.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 110.34 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.505 ' NE2' ' CZ ' ' A' ' 103' ' ' ARG . 97.2 mm-40 -86.62 151.82 23.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.784 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.7 ' C ' ' H ' ' A' ' 107' ' ' TRP . 2.7 ttp -62.16 -13.41 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.109 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.07 27.43 0.01 OUTLIER Glycine 0 CA--C 1.541 1.683 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.869 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.7 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.47 -19.17 34.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.559 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -55.07 -24.22 24.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.33 -33.1 65.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.431 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -63.76 -38.01 89.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.54 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 56.6 t0 -65.21 -48.43 73.39 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.29 -47.39 86.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.872 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 117' ' ' GLY . 4.3 tt -69.11 -40.43 78.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.379 0.609 . . . . 0.0 110.356 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 14.4 tp -54.07 -57.47 10.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.309 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.9 t -69.7 -56.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.883 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -68.7 -42.35 77.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -58.04 -45.2 94.14 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.661 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.38 -45.53 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.677 0.275 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.48 -55.59 9.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.1 m -59.72 -42.81 93.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.38 -60.37 2.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.459 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.6 m -62.48 -41.05 98.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 76.3 m -59.3 -46.47 88.49 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.5 -35.01 79.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.41 -63.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 39.8 m0 -64.47 -43.76 93.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -56.87 -43.38 81.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.634 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.12 -44.32 96.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.587 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.9 -42.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.815 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.55 103.65 3.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.262 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.529 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.3 Cg_exo -60.76 -38.98 66.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.699 1.599 . . . . 0.0 113.236 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 28.1 Cg_exo -56.45 -29.59 78.5 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.93 1.086 . . . . 0.0 112.96 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 -33.53 73.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.018 0.437 . . . . 0.0 110.765 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.29 77.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.902 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 44.1 ttt180 -59.45 -40.77 87.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.396 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.6 -36.84 67.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.307 0.575 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.524 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 60.8 mt -70.66 15.39 0.1 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.543 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -46.27 -40.64 19.01 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.072 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 9.2 Cg_endo -66.92 -22.9 47.94 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.809 1.325 . . . . 0.0 112.417 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.56 -34.02 74.86 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.0 tm? -67.93 -41.55 82.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.927 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.71 -52.15 33.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.619 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.1 t-105 -61.31 -46.34 90.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.756 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.8 mt -67.6 -33.83 75.79 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.843 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.03 89.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.993 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 150' ' ' LEU . 16.1 t80 -64.69 -43.33 93.88 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.426 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.619 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.6 m -57.66 -43.48 85.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.39 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 54.4 m -60.29 -49.73 76.45 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.557 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.39 -41.81 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.366 0.603 . . . . 0.0 110.331 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 23.9 tp -56.76 -47.88 79.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.139 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 147' ' ' THR . 72.4 m-80 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -65.28 -40.52 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.342 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.74 -45.98 88.43 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.304 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.68 -45.62 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.406 ' O ' ' N ' ' A' ' 159' ' ' SER . 1.0 OUTLIER -62.66 -44.08 97.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.669 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -60.44 -32.12 71.07 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.306 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -54.71 -40.85 69.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.948 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -99.73 -59.97 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.5 m . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.108 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.3 t . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.0 Cg_endo -55.31 -19.4 21.71 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 CA-C-N 119.147 0.731 . . . . 0.0 111.451 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.12 -32.01 53.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.17 -41.15 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.86 93.07 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.312 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.27 -41.69 84.86 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 t -75.81 -34.52 60.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.652 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.15 -34.74 78.21 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.8 t -49.26 -55.84 19.32 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.92 -32.6 97.7 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 120.539 0.826 . . . . 0.0 112.963 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.8 m -59.97 -40.04 87.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.746 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.98 -38.09 87.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.42 -59.04 8.24 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.191 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -60.1 -36.34 90.21 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.284 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.15 -46.48 85.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.497 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.08 -38.21 87.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.554 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.83 -39.51 97.48 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.646 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.66 -28.42 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.337 . . . . 0.0 111.763 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.72 -34.82 67.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.724 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 88.6 t80 -60.89 -47.59 85.71 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -71.79 -33.9 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.702 0.763 . . . . 0.0 109.333 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -61.75 -40.77 96.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.028 -1.442 . . . . 0.0 112.674 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.14 -126.08 1.83 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.047 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.39 -28.11 62.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.777 0.322 . . . . 0.0 111.317 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.96 -32.88 12.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.25 -41.23 62.64 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.025 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.2 mtp85 -61.48 -45.86 92.45 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.677 0.751 . . . . 0.0 109.334 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -62.46 -40.67 97.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.595 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 21.4 m-85 -65.16 -23.0 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.647 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.86 -39.72 54.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.56 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -33.21 85.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 60.5 mt -91.47 149.42 21.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.59 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -99.62 130.71 45.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.639 -0.425 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -111.67 141.35 24.49 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.852 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 62.3 Cg_endo -58.61 133.29 53.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.972 1.114 . . . . 0.0 111.971 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.3 p -82.47 -9.19 59.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.05 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 3.3 p90 -77.79 -15.4 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.818 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -74.2 151.97 88.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.407 -178.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.68 173.13 14.07 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 112.455 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 19.5 Cg_exo -51.72 151.38 15.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.984 2.456 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -58.09 -35.69 71.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 14.7 p90 -74.51 -12.3 60.44 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.672 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -76.96 -66.91 0.76 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 110.956 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.572 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 19.5 mt -66.52 -35.82 81.2 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.581 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -40.76 -42.49 3.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 54' ' ' GLY . 51.3 Cg_exo -65.51 -5.39 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.87 2.38 . . . . 0.0 112.98 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.572 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 5.9 pt -41.22 -42.54 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 120.658 0.266 . . . . 0.0 111.709 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.449 ' O ' ' N ' ' A' ' 57' ' ' TYR . 95.0 m95 -56.31 -34.06 66.17 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.105 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.49 -39.09 95.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -66.73 -52.28 46.25 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.19 0.519 . . . . 0.0 111.049 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.511 ' CD2' ' CE3' ' A' ' 143' ' ' TRP . 6.8 mp -68.22 -31.47 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.076 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' TRP . 19.8 t80 -52.2 -49.12 64.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.131 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -74.09 -34.79 64.09 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.651 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.94 -45.02 87.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.858 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.78 -37.18 85.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.75 -60.84 6.46 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.152 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -62.15 -36.48 81.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.637 0.256 . . . . 0.0 111.02 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.81 85.0 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.115 -1.04 . . . . 0.0 110.738 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.2 p -65.07 -30.11 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.566 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -58.49 -44.01 89.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.43 -38.48 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.949 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.1 t -62.15 -41.6 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.636 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.33 -50.03 75.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.308 -178.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 74.9 mttt -54.4 -36.24 63.75 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.978 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -72.94 -44.73 60.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.658 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.6 mt -77.41 -26.06 51.36 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.07 -6.85 40.42 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.269 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.85 -161.61 25.49 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.113 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.686 ' CD2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -89.23 82.68 6.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.35 0.595 . . . . 0.0 110.083 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' ALA . 13.4 p -123.16 166.0 15.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.46 -36.87 3.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.82 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.76 -42.82 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.952 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -82.27 -36.64 26.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.983 0.42 . . . . 0.0 111.657 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.686 ' SD ' ' CD2' ' A' ' 74' ' ' PHE . 98.7 mmm -59.08 -34.47 72.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.052 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.3 t -60.14 -52.39 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.929 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -68.88 -58.78 0.1 Allowed 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.155 1.237 . . . . 0.0 112.775 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.84 -42.0 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.194 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.19 95.38 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.34 -39.79 76.66 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.441 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 75.0 t80 -59.13 -43.99 92.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.1 m -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.134 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.89 -60.07 3.26 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.595 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -56.97 -41.17 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.329 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 33.0 tp -61.94 -38.86 90.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.632 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.78 76.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.981 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.4 -39.09 86.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -61.46 -41.07 96.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.666 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.572 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 48.3 m95 -60.42 -28.76 68.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.71 -17.86 62.82 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.587 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.3 t-105 -72.43 -55.92 4.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 71.8 Cg_endo -42.62 87.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.182 1.255 . . . . 0.0 112.508 -177.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.6 Cg_endo -59.53 -27.1 84.13 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 120.606 0.871 . . . . 0.0 111.762 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.43 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 40.0 pt -61.71 -33.99 60.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.5 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -46.68 -43.78 18.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.534 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -67.53 -52.16 42.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.68 -55.11 0.39 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.847 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 61.04 10.81 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 0.0 110.356 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -55.66 -35.6 66.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.546 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -87.22 149.38 24.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.501 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.602 ' C ' ' H ' ' A' ' 107' ' ' TRP . 3.4 ttp -62.62 -14.93 48.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.28 35.44 0.02 OUTLIER Glycine 0 CA--C 1.54 1.598 0 C-N-CA 121.679 -0.296 . . . . 0.0 112.743 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.602 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -64.03 -19.67 65.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -47.46 -22.7 0.49 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.91 0.386 . . . . 0.0 111.258 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt -57.77 -31.48 66.57 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.563 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.02 -53.72 45.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.576 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 31.1 t70 -63.13 -46.7 86.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.61 -38.09 83.57 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.529 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.6 tt -67.26 -48.78 66.71 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pp -76.15 -32.99 59.37 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.977 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 70.6 t -64.82 -45.91 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.89 -38.75 17.72 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.55 -42.22 89.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.213 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.86 -48.38 29.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.776 0.322 . . . . 0.0 111.033 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.513 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.24 -56.79 10.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.7 m -61.9 -45.17 94.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.79 -59.11 3.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.423 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 28.3 m -63.11 -41.71 99.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 88.8 m -58.84 -45.22 90.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.393 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.45 -37.48 87.44 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.215 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.28 -64.3 1.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.423 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.6 m0 -66.1 -43.01 88.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -59.29 -50.12 75.2 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.691 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.11 -43.53 95.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.798 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.02 -48.04 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 p -134.1 87.87 32.97 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.446 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.46 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.53 -42.41 61.91 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.391 1.394 . . . . 0.0 112.433 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.5 Cg_exo -56.79 -30.46 84.91 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 120.328 0.685 . . . . 0.0 111.994 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -30.79 70.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.094 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.91 97.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.114 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -59.98 -38.4 82.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.07 0.462 . . . . 0.0 110.352 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.53 -37.71 73.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.198 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.3 mt -57.86 -31.54 66.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.499 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 5.88 -72.37 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.4 Cg_endo -50.8 -22.32 9.67 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 CA-C-N 119.23 0.761 . . . . 0.0 112.79 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 p90 -57.73 -41.95 82.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -61.34 -44.39 97.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.053 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.21 83.57 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.234 0.54 . . . . 0.0 110.344 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TRP . . . . . 0.511 ' CE3' ' CD2' ' A' ' 56' ' ' LEU . 26.7 t90 -60.47 -50.59 72.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.486 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.444 ' CD2' ' CE3' ' A' ' 143' ' ' TRP . 57.8 mt -74.78 -29.69 61.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.32 -54.92 39.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.841 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -65.36 -44.93 86.1 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.786 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.559 ' CG2' ' OD1' ' A' ' 111' ' ' ASP . 9.6 m -56.56 -42.33 78.42 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.672 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.5 m -68.18 -50.17 56.08 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 111.604 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.06 -39.57 86.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.258 0.551 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 66.1 tp -55.45 -41.73 73.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.119 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 6.2 m120 -63.18 -42.62 99.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -63.58 -35.9 82.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.664 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -58.57 -47.02 85.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.549 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.42 -47.44 52.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.756 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TRP . . . . . 0.437 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 3.1 m0 -61.58 -43.91 97.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -60.86 -33.66 73.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.269 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.6 -41.08 76.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.126 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -96.75 -59.97 1.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 111.482 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.069 -178.743 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 mtp . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -57.31 -22.23 48.27 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.695 1.597 . . . . 0.0 112.373 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.93 -27.83 61.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.178 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -56.33 -42.67 78.05 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.403 ' NE1' ' HB2' ' A' ' 74' ' ' PHE . 10.5 m-90 -79.24 -30.61 43.23 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.5 t -41.43 -39.45 2.26 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.577 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 88.6 Cg_exo -55.28 -22.91 34.96 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.218 1.279 . . . . 0.0 112.794 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.31 62.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.4 t -64.31 -42.69 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.15 -34.61 90.4 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.012 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.57 -44.23 76.66 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.795 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 t -78.83 -33.43 46.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.241 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.39 -35.44 80.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.794 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 t -54.35 -57.27 19.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.54 -33.21 97.04 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 120.843 1.029 . . . . 0.0 112.767 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -59.31 -38.05 79.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.941 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.04 -38.52 91.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.579 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.97 -53.88 27.87 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.882 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.92 90.68 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CZ ' ' NH1' ' A' ' 27' ' ' ARG . 54.3 t80 -59.13 -43.47 91.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.296 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtt -61.06 -40.78 94.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.072 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.15 -42.46 91.48 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.488 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -69.64 -27.74 65.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.22 0.533 . . . . 0.0 110.302 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -35.39 76.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.669 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 40.7 t80 -61.05 -49.94 75.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.91 -34.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.693 0.759 . . . . 0.0 109.645 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.48 ' NH1' ' CZ ' ' A' ' 20' ' ' PHE . 7.9 ttt180 -61.81 -40.91 96.9 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.779 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.14 -123.47 3.16 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.149 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.1 -29.54 60.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.204 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -33.43 17.93 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.1 mt -50.37 -43.18 54.25 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -61.41 -43.07 99.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.58 . . . . 0.0 109.834 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.94 -39.17 93.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.85 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.617 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 16.5 m-85 -63.88 -23.26 67.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.29 -40.19 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.796 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.98 -31.96 72.92 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 34' ' ' TYR . 51.1 mt -90.62 148.55 22.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.869 0.366 . . . . 0.0 110.976 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -98.43 127.04 44.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.598 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.711 ' HZ2' ' NH1' ' A' ' 46' ' ' ARG . 11.0 mtpt -105.21 138.3 19.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -55.65 141.47 83.78 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.669 0.913 . . . . 0.0 111.888 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.8 p -62.76 -30.04 71.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.335 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -78.39 0.18 26.7 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.884 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 19.7 t-80 -59.61 127.64 85.16 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 98.4 Cg_endo -81.68 167.06 17.1 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.181 1.254 . . . . 0.0 111.803 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -52.01 140.66 49.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.731 1.621 . . . . 0.0 111.482 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.711 ' NH1' ' HZ2' ' A' ' 39' ' ' LYS . 62.5 mtt-85 -59.74 -36.37 76.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.519 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -73.94 -13.54 60.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.948 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 m -75.91 -69.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.421 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.549 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 63.4 mt -66.01 -34.78 78.87 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.476 -0.49 . . . . 0.0 112.031 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -42.03 -41.03 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.324 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 51.0 Cg_exo -67.2 -7.11 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 123.123 2.549 . . . . 0.0 113.983 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 24.4 pt -42.8 -40.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.546 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 99.3 m95 -53.44 -32.95 52.16 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.578 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.75 97.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -68.39 -51.04 48.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.924 0.393 . . . . 0.0 111.403 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.95 -33.39 74.58 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.248 0.547 . . . . 0.0 110.111 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 17.1 t80 -51.15 -57.16 9.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.125 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -64.97 -38.74 91.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.871 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.24 99.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.214 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.5 mtt -61.34 -37.89 84.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.43 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -55.81 16.12 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -62.15 -38.46 89.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.503 0.192 . . . . 0.0 111.257 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.46 -42.62 93.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.822 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 99.2 p -62.58 -30.74 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.27 -43.27 92.52 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.48 -43.87 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.873 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.04 -40.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.287 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.72 -33.23 75.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 29.0 mtpt -62.17 -44.04 97.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.44 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 80.1 mt-10 -70.89 -45.75 63.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.734 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.41 -27.81 60.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.792 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.7 67.96 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.663 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.55 -161.29 28.76 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.94 108.51 20.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.641 0.734 . . . . 0.0 109.904 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . 11.8 t -133.53 167.6 20.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.209 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' THR . 77.6 mm-40 -43.98 -35.57 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.321 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.95 -41.99 97.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.613 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.7 69.52 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.678 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 78.9 mmm -61.21 -34.78 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.534 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.56 -48.36 95.75 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -73.35 -62.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.272 1.315 . . . . 0.0 113.387 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.82 -41.32 97.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.034 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.55 97.92 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.28 -40.32 90.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.666 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -59.82 -44.54 93.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.769 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.7 m -65.69 -42.41 91.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.98 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.84 -55.91 6.21 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -57.87 -41.27 82.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.412 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.22 -38.87 84.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.113 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.29 84.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.107 0.48 . . . . 0.0 111.414 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.65 -41.8 82.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.039 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.48 HD21 ' CA ' ' A' ' 117' ' ' GLY . 50.4 t-20 -65.93 -36.0 82.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.758 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.572 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m95 -53.06 -30.84 38.27 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.38 62.9 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.198 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.55 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 40.0 t-105 -64.03 -56.75 22.05 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.572 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 46.1 Cg_endo -54.83 131.83 48.37 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.742 1.628 . . . . 0.0 113.035 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.461 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 42.5 Cg_endo -107.56 -26.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.435 1.423 . . . . 0.0 110.556 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.461 ' H ' ' CD ' ' A' ' 97' ' ' PRO . 27.1 pt -60.69 -25.59 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.069 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 35.3 p90 -51.69 -42.74 62.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.29 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.499 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.8 t80 -64.53 -49.55 70.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.874 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 102' ' ' ALA . . . -113.49 -68.65 0.51 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.369 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.587 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 75.53 -3.66 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -54.74 -34.07 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -86.4 155.88 20.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 111.194 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.706 ' C ' ' H ' ' A' ' 107' ' ' TRP . 20.8 ttm -57.39 -14.26 4.52 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.811 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -44.69 2.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.155 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.706 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -47.42 -21.84 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.472 0.636 . . . . 0.0 111.374 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -55.14 -27.86 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.61 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.23 -33.18 73.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.009 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.73 79.89 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.543 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 56.1 t0 -61.75 -45.02 95.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.347 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.53 -47.77 71.84 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.715 -0.394 . . . . 0.0 112.005 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.0 tt -67.0 -41.18 87.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.381 0.61 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.0 tp -53.22 -60.88 2.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.404 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.82 -63.21 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.452 -176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.0 t -65.39 -38.8 91.08 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.48 ' CA ' HD21 ' A' ' 92' ' ' ASN . . . -61.61 -56.55 22.46 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.714 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.1 -38.26 77.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.972 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -75.88 -47.47 25.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 32.0 m -58.98 -43.39 91.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.02 -50.99 43.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.558 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.2 m -65.08 -40.99 95.41 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 71.1 m -60.56 -46.55 89.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.2 mt -66.25 -35.99 81.84 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.67 -64.14 1.23 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.403 ' O ' ' N ' ' A' ' 130' ' ' SER . 38.6 m0 -66.4 -41.17 89.72 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 33.5 t-80 -58.49 -49.03 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.922 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -65.61 -46.07 80.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.486 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 99.0 t -78.27 -46.5 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 126' ' ' TRP . 20.1 p -129.4 82.42 67.84 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.591 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.474 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 36.5 Cg_exo -53.14 -43.34 57.95 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.795 1.663 . . . . 0.0 112.257 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 23.7 Cg_exo -58.02 -32.47 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.474 0.783 . . . . 0.0 112.208 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.46 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.522 . . . . 0.0 110.379 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.72 77.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.098 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.501 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 42.7 mtm105 -62.95 -38.59 91.69 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.296 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.15 -38.53 62.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.16 0.505 . . . . 0.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.519 ' O ' ' C ' ' A' ' 138' ' ' TYR . 83.7 mt -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -2.81 -67.33 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.794 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.475 ' N ' ' O ' ' A' ' 137' ' ' LEU . 10.9 Cg_endo -54.31 -30.06 60.66 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 120.799 0.999 . . . . 0.0 112.992 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -56.77 -40.69 76.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.2 tm? -63.61 -42.85 98.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.84 75.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.269 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.639 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -61.7 -50.34 72.83 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.483 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.1 mt -63.84 -33.73 76.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.839 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.58 96.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.201 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -61.47 -41.65 97.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.345 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.639 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 53.8 p -60.81 -38.64 86.08 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.1 m -59.49 -50.59 73.34 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.948 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 91.8 t -71.32 -43.88 73.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.864 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.97 -41.59 83.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.184 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 147' ' ' THR . 47.3 m-80 -63.04 -40.14 96.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.492 ' O ' ' CB ' ' A' ' 156' ' ' ARG . 37.1 m-85 -62.19 -39.57 93.15 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.697 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.441 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 47.4 t80 -59.9 -46.59 88.84 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.175 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -71.4 -51.32 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.9 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.427 ' O ' ' OG ' ' A' ' 159' ' ' SER . 1.0 OUTLIER -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.771 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 152' ' ' TYR . 28.4 ttp180 -59.57 -38.32 80.81 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.162 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 92.6 m-20 -59.37 -42.46 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.905 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -87.44 -54.64 4.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.345 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 79.7 p -61.46 -24.69 66.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.913 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -52.94 -30.95 38.5 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -57.28 -31.9 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 110.43 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -117.57 146.88 43.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.343 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.02 14.26 67.39 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -52.97 -35.18 47.74 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.3 p -61.64 -26.63 68.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 110.304 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -56.14 -32.79 64.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.274 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.22 146.75 25.19 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.311 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -102.32 150.19 23.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.638 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 168' ' ' ALA . 95.3 mt-10 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.936 -1.03 . . . . 0.0 111.498 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.606 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.637 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.731 0.3 . . . . 0.0 110.504 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.407 ' HD3' ' H1 ' ' A' ' 1' ' ' MET . 71.7 Cg_endo -56.54 -22.91 45.34 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.036 1.824 . . . . 0.0 112.192 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.1 -35.12 74.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.0 m -63.12 -39.8 95.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.953 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.639 ' CD1' ' CE3' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -71.66 -35.12 70.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.74 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -42.27 -42.18 6.04 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.29 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -53.58 -22.66 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 120.656 0.904 . . . . 0.0 111.8 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.34 -33.92 55.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.36 -42.22 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.83 -35.25 91.68 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 11' ' ' LEU . 9.8 mp -56.46 -41.62 76.82 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 122.728 -0.277 . . . . 0.0 110.962 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 t -79.71 -34.89 39.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.511 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.08 -36.22 79.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.1 t -48.0 -56.41 13.82 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.22 -34.16 98.18 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.719 0.946 . . . . 0.0 112.933 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.4 m -59.04 -40.47 85.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.271 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.09 -37.89 88.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.001 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.29 -40.22 98.3 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.89 -44.22 98.36 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.881 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.4 m-85 -63.88 -43.38 96.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.3 mtt -61.83 -40.91 96.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.81 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.44 -45.82 10.72 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.15 -25.15 64.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.33 0.586 . . . . 0.0 110.014 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -52.95 -36.55 60.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.358 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 89.7 t80 -60.24 -47.12 87.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.61 -32.81 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.448 ' CA ' ' HE ' ' A' ' 46' ' ' ARG . 20.5 ttt-85 -62.42 -42.77 99.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.029 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.94 -132.07 1.18 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.687 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.0 -26.05 59.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.796 0.331 . . . . 0.0 110.69 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.49 8.94 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.25 -41.64 62.97 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.67 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -62.87 -42.17 99.66 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.365 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -61.27 -39.89 92.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.592 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 29.3 m-85 -64.55 -22.82 67.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.021 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.7 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.338 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.86 82.25 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 72.8 mt -91.54 150.02 21.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.408 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.72 126.91 41.32 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.222 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -102.47 141.69 23.03 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -57.99 144.15 94.96 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.112 1.208 . . . . 0.0 112.32 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.7 p -64.08 -30.24 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.039 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 35.6 p90 -78.66 3.76 15.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.927 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 32.8 t-80 -60.1 139.52 91.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.598 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 79.7 Cg_endo -95.67 169.3 1.32 Allowed 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.035 1.157 . . . . 0.0 112.759 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.578 ' CG ' ' HG1' ' A' ' 48' ' ' THR . 43.3 Cg_exo -54.36 148.46 41.9 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.876 2.384 . . . . 0.0 112.167 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HE ' ' CA ' ' A' ' 27' ' ' ARG . 22.7 tpt85 -57.21 -39.39 75.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -79.89 -5.94 56.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.578 ' HG1' ' CG ' ' A' ' 45' ' ' PRO . 20.4 m -76.79 -76.4 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.9 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.543 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 69.9 mt -66.38 -32.29 73.58 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.889 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -41.52 -42.73 5.11 Favored Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.374 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 61.7 Cg_exo -64.31 -6.94 12.68 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.083 2.522 . . . . 0.0 113.789 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 18.4 pt -42.32 -44.03 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.731 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.526 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 98.3 m95 -54.8 -31.99 59.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.606 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.68 -39.89 98.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -68.77 -51.79 37.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.092 0.472 . . . . 0.0 111.036 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.81 -32.63 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.87 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 8.8 t80 -51.79 -49.39 62.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.734 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.0 p -70.88 -36.04 72.6 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.456 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.76 89.07 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.06 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.5 mtt -62.25 -38.77 90.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.427 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.434 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.52 -56.68 10.78 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.92 -38.41 88.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.93 92.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 94.1 p -63.5 -28.89 70.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.939 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -58.88 -43.81 91.0 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.22 -46.43 88.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.26 -41.05 85.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.522 0.677 . . . . 0.0 109.198 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.639 ' CE3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -63.35 -34.19 77.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.206 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -63.23 -43.18 98.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 82.7 mt-10 -67.49 -37.06 82.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.25 -4.39 58.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.18 46.67 15.18 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.721 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.443 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.39 -159.53 23.34 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.677 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -85.18 111.62 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.719 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 t -130.27 161.21 31.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -47.07 -39.75 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.482 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -63.33 -39.62 95.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.719 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.8 71.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.212 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 87.4 mmm -58.72 -34.54 71.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.112 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.15 -59.23 13.97 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.22 -53.84 1.33 Allowed 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 120.828 1.019 . . . . 0.0 112.767 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.0 -43.01 96.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.448 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.55 -41.99 97.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.84 -39.33 77.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.921 0.391 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 73.2 t80 -60.42 -44.17 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.561 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.0 m -64.85 -43.1 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 112.072 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.23 -58.25 4.39 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.76 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -57.8 -40.91 81.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.681 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.77 -41.21 99.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.633 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 111.416 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.36 -37.76 78.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.734 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 45.3 t-20 -61.73 -42.46 98.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.169 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -57.57 -31.42 66.13 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.775 0.322 . . . . 0.0 111.193 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.1 -28.81 69.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.666 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -55.05 -55.45 38.89 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -38.49 81.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.814 1.676 . . . . 0.0 113.18 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' A' ' 95' ' ' TRP . 65.1 Cg_endo -63.71 -23.69 69.44 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 120.498 0.799 . . . . 0.0 111.704 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 38.1 pt -62.21 -30.0 47.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.65 -48.26 66.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.779 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.489 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 68.5 t80 -64.95 -46.78 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.633 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.571 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -109.38 -65.04 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 59.79 -1.32 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 110.838 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.571 ' H ' ' C ' ' A' ' 101' ' ' GLY . 24.0 ttp-105 -52.59 -33.55 46.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -91.52 151.77 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.263 0.554 . . . . 0.0 111.688 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.631 ' C ' ' H ' ' A' ' 107' ' ' TRP . 3.0 ttp -62.93 -14.63 49.34 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.193 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.75 32.65 0.01 OUTLIER Glycine 0 CA--C 1.543 1.824 0 C-N-CA 121.821 -0.228 . . . . 0.0 113.018 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.631 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -63.58 -19.61 64.97 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -179.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.528 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -42.97 -21.89 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.859 0.361 . . . . 0.0 111.924 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 107' ' ' TRP . 75.3 mt -58.73 -34.79 71.76 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.9 t0 -63.84 -48.06 78.28 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.5 tp -61.54 -49.39 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.399 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.516 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.6 tt -67.16 -41.27 86.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.289 0.566 . . . . 0.0 110.11 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.42 -59.89 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.678 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.8 t -71.13 -63.07 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.588 -1.187 . . . . 0.0 113.2 -177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.487 ' O ' ' OG1' ' A' ' 120' ' ' THR . 43.7 t -66.93 -39.29 87.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.22 -56.12 23.88 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.355 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.25 -37.3 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.317 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.03 -52.81 8.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.9 m -54.58 -42.58 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -60.37 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.913 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.608 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 21.6 m -66.02 -41.19 91.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.6 m -58.27 -47.22 84.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.165 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.1 -34.17 77.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.11 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.608 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 39.0 m0 -65.06 -45.3 85.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.662 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -59.84 -43.89 94.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.148 -177.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.56 -43.45 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.221 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.492 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 84.7 t -81.02 -50.83 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 126' ' ' TRP . 76.1 p -128.58 88.88 51.0 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.046 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.5 Cg_exo -52.06 -40.14 68.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 121.651 1.567 . . . . 0.0 113.019 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.7 Cg_exo -57.42 -27.0 74.03 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.532 0.821 . . . . 0.0 112.905 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.77 74.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.639 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.62 -38.83 86.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.202 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 59.8 ttt180 -60.39 -38.76 84.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.14 -39.13 74.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.176 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.0 mt -56.79 -33.14 66.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.852 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.522 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER 9.91 -72.62 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -53.4 -26.43 35.48 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 120.617 0.878 . . . . 0.0 113.675 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -57.5 -41.33 80.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.357 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -64.96 -41.15 95.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.09 0.472 . . . . 0.0 109.943 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.74 -42.4 95.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.633 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -67.2 -53.11 33.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.398 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.39 -33.41 73.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.674 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.36 96.96 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.555 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -60.55 -41.11 93.87 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.129 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.633 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 69.4 p -61.82 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.452 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.438 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 59.3 m -61.21 -53.06 61.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.445 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.4 -42.84 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 54.9 tp -57.39 -41.92 81.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.425 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.03 -41.8 97.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 148' ' ' THR . 50.1 m-85 -64.85 -36.75 85.36 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.659 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 62.2 t80 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.426 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.43 -49.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.135 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.471 ' O ' ' OG ' ' A' ' 159' ' ' SER . 3.0 m0 -61.72 -43.91 97.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.555 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 160' ' ' GLY . 82.2 mmt-85 -62.87 -34.77 78.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.381 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 91.0 m-20 -56.56 -41.27 76.58 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.795 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -94.22 -48.13 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.443 . . . . 0.0 110.573 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 80.6 p -69.12 -22.69 63.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.788 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -80.6 177.43 54.36 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.791 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -69.52 146.1 52.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.891 0.377 . . . . 0.0 110.833 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -59.36 -32.83 70.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.57 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -54.71 -32.91 54.81 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -54.25 -32.84 51.61 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.4 p -60.99 -25.85 67.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.732 0.301 . . . . 0.0 110.724 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -53.68 -37.58 63.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.563 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.403 HD11 ' N ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -63.84 -33.62 76.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.928 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.47 162.43 28.83 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.415 0.626 . . . . 0.0 111.136 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 C--N 1.322 -0.621 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.609 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.56 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.818 0.342 . . . . 0.0 110.543 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.37 -18.99 20.61 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.578 2.185 . . . . 0.0 112.136 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.25 -31.63 67.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.83 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -60.68 -43.22 97.95 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.744 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -75.67 -32.76 60.29 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.72 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t -41.34 -49.51 8.94 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.19 -19.83 35.75 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 119.368 0.81 . . . . 0.0 112.514 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.35 -34.73 61.7 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.85 -39.97 81.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -36.47 92.74 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.7 -41.99 87.55 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 122.824 -0.221 . . . . 0.0 111.565 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 t -75.41 -37.33 60.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.189 -0.604 . . . . 0.0 112.072 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' O ' ' OG ' ' A' ' 16' ' ' SER . 86.5 mt -61.56 -36.71 81.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 t -51.6 -43.07 86.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.48 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -58.39 -36.45 97.55 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.15 1.233 . . . . 0.0 112.902 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 82.7 p -63.46 -37.52 87.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.602 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.68 -40.03 80.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.455 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.99 76.34 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.7 -40.85 97.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.59 -48.65 80.85 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.171 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 65.0 mtt -63.93 -39.47 94.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.409 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.84 -45.47 74.25 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.799 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.448 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.31 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 111.64 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -57.61 -30.94 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 90.6 t80 -61.0 -48.6 81.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.73 -32.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.747 0.785 . . . . 0.0 109.631 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -63.06 -41.18 99.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.575 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.86 -128.58 4.78 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.025 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' CG ' HH21 ' A' ' 32' ' ' ARG . 84.2 tt0 -49.97 -30.51 10.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.253 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.97 -33.12 20.48 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.8 mt -50.59 -44.63 56.97 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.522 HH21 ' CG ' ' A' ' 29' ' ' GLU . 67.9 mtm180 -62.18 -43.45 98.8 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.0 110.071 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.06 -39.74 91.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.954 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' LEU . 17.8 m-85 -65.27 -23.14 66.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.2 -41.11 49.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.155 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.18 -32.62 84.53 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' TYR . 67.5 mt -92.51 150.63 20.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -101.54 127.83 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.917 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.744 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 14.0 mtpt -107.42 140.69 21.75 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 37.1 Cg_endo -58.03 130.23 37.12 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 120.713 0.942 . . . . 0.0 111.431 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.6 p -75.64 -13.44 60.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.884 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.508 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 2.7 p90 -77.29 -15.49 59.41 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.488 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -76.04 147.35 80.14 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.49 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -72.83 162.05 42.15 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.803 1.002 . . . . 0.0 111.297 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.9 Cg_endo -50.73 150.6 12.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.217 1.945 . . . . 0.0 111.848 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.744 ' HE ' ' HZ3' ' A' ' 39' ' ' LYS . 51.7 mtt85 -57.11 -36.85 71.13 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.447 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 5.1 p90 -65.02 -22.09 66.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.864 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.7 m -78.45 -63.07 1.49 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.431 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.544 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 85.8 mt -63.24 -36.98 85.46 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -45.49 -41.38 16.72 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.742 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 75.3 Cg_exo -64.92 -7.56 15.48 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 123.376 2.718 . . . . 0.0 114.081 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.547 ' CD1' ' CE2' ' A' ' 143' ' ' TRP . 27.9 pt -41.99 -41.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.291 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.44 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 97.2 m95 -51.2 -34.09 30.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.946 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.19 -39.99 96.66 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.0 m -68.68 -51.44 41.83 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.99 0.424 . . . . 0.0 110.936 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.98 -32.42 73.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.43 ' N ' ' O ' ' A' ' 53' ' ' TRP . 3.5 t80 -52.28 -48.97 65.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.463 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -68.37 -36.92 79.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.23 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.91 76.54 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.672 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.512 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 62.9 mtt -61.84 -37.23 83.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -63.93 -61.75 5.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -61.61 -36.05 79.62 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.753 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.61 -42.91 58.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 84.1 p -66.65 -27.29 67.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -55.5 -49.86 71.45 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.445 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.7 mt -66.25 -37.33 79.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.668 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.7 t -53.88 -48.03 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.448 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.6 p90 -73.23 -30.74 63.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.235 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 65.6 mmtt -58.36 -38.56 77.48 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.204 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.26 -40.91 94.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.27 -25.77 60.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.772 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 104.77 39.12 2.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.15 -166.55 28.52 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.662 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.13 112.05 19.47 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.16 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 78' ' ' ALA . 4.2 t -129.94 165.77 21.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.589 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.85 -37.87 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.471 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -64.28 -38.92 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.868 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.402 ' H ' HG22 ' A' ' 75' ' ' THR . . . -67.4 -32.29 73.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.662 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 81.6 mmm -59.74 -33.74 72.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.974 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.4 -57.6 23.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.66 -50.85 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 120.61 0.874 . . . . 0.0 112.335 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.0 mp -65.06 -41.16 95.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.109 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.66 -39.23 97.65 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.94 -38.38 78.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.112 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.512 ' OH ' ' SD ' ' A' ' 60' ' ' MET . 86.8 t80 -59.36 -45.17 92.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.144 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.7 m -69.15 -41.89 76.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.45 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.19 -54.41 6.96 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.548 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -57.98 -41.41 82.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.299 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.54 -37.29 85.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.835 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.79 81.72 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.711 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.36 -36.53 84.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -57.85 -40.96 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -66.01 -32.68 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.76 78.17 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.583 ' O ' ' N ' ' A' ' 97' ' ' PRO . 3.8 t-105 -57.84 -50.68 86.73 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -42.79 82.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.403 1.402 . . . . 0.0 112.549 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 95' ' ' TRP . 72.3 Cg_endo -62.35 -25.45 76.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 120.574 0.849 . . . . 0.0 111.601 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.538 ' O ' ' N ' ' A' ' 102' ' ' ALA . 29.0 pt -59.91 -33.73 53.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -46.61 64.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.89 -50.48 66.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.826 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.33 -53.1 0.47 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 57.14 3.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 0.0 110.797 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' A' ' 101' ' ' GLY . 12.6 tpt180 -53.12 -34.96 59.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -92.0 145.33 24.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.329 0.585 . . . . 0.0 111.503 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.637 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.3 ttp -65.31 -14.36 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.343 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.03 38.56 0.01 OUTLIER Glycine 0 CA--C 1.54 1.628 0 O-C-N 123.077 0.236 . . . . 0.0 112.952 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.637 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -65.16 -18.94 65.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.499 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -41.5 -21.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.756 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 107' ' ' TRP . 89.2 mt -57.2 -39.47 75.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.503 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -67.81 -39.04 84.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 109.942 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 49.6 t0 -60.92 -45.18 95.67 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.71 -48.99 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.46 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 117' ' ' GLY . 85.0 mt -69.08 -40.34 78.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.417 0.627 . . . . 0.0 110.459 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.442 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 15.1 tp -51.75 -60.25 3.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.154 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.11 -63.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.754 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -71.63 -40.32 69.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -61.36 -51.29 58.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.534 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.43 ' O ' ' OG1' ' A' ' 122' ' ' THR . 3.7 p -65.83 -37.04 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.174 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -78.78 -51.43 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.8 m -59.49 -45.28 92.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.28 68.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.37 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.476 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.3 m -64.33 -39.07 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.156 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 89.9 m -59.62 -52.96 63.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 0.0 112.296 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.597 ' O ' ' NE ' ' A' ' 128' ' ' ARG . 65.9 mt -59.34 -31.2 68.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.991 0.425 . . . . 0.0 110.362 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.87 -63.17 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.493 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 33.8 m0 -86.5 -52.21 5.71 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.47 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -52.63 -47.15 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.597 ' NE ' ' O ' ' A' ' 124' ' ' LEU . 68.2 mtm180 -63.5 -40.83 98.1 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.3 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.36 -43.41 49.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.8 p -140.33 94.87 8.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.875 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.457 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.3 Cg_exo -54.08 -39.94 83.59 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.948 1.765 . . . . 0.0 113.775 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.5 Cg_exo -55.7 -26.21 54.98 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.338 0.692 . . . . 0.0 112.87 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.54 -31.24 71.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.668 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.38 -40.15 93.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.441 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.537 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 51.9 ttp180 -59.77 -38.16 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.3 tp -58.7 -38.83 79.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.203 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 139' ' ' PRO . 22.0 mt -56.04 -29.62 60.7 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.065 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.9 OUTLIER 9.28 -74.41 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.6 Cg_endo -52.32 -29.12 37.37 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 120.436 0.758 . . . . 0.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -57.92 -42.34 84.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.987 0.423 . . . . 0.0 109.977 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 42.7 tp -63.34 -39.56 94.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.63 96.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.006 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.614 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 0.9 OUTLIER -67.09 -47.93 69.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.234 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 44.5 mt -65.25 -33.74 76.71 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.801 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.89 77.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -63.32 -42.02 98.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.646 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.614 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 3.0 m -57.6 -43.74 84.89 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.516 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.7 m -60.18 -49.61 76.94 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.705 0.288 . . . . 0.0 111.604 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.44 -40.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.54 0.686 . . . . 0.0 109.757 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 63.8 tp -57.79 -42.98 85.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.729 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 147' ' ' THR . 17.1 m120 -63.48 -41.24 98.58 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.475 ' CD1' ' NH1' ' A' ' 161' ' ' ARG . 57.5 m-85 -66.04 -40.32 90.9 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -61.52 -40.9 96.32 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.811 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.6 -47.66 79.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.509 ' O ' ' O ' ' A' ' 159' ' ' SER . 5.3 m0 -62.15 -39.23 91.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -54.81 -31.1 58.75 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.215 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.49 -40.86 68.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.651 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -103.8 -60.91 1.5 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.675 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 155' ' ' TRP . 49.2 m -120.78 143.46 48.82 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.875 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.04 -174.31 50.29 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.475 ' NH1' ' CD1' ' A' ' 152' ' ' TYR . 95.4 mtt-85 -59.99 148.28 35.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 111.035 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -57.61 -33.85 68.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.571 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -54.95 -33.49 56.96 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.65 28.94 56.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.7 p -60.5 -28.21 68.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.699 0.285 . . . . 0.0 110.671 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -54.92 -37.48 66.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.005 0.431 . . . . 0.0 110.64 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.19 -34.19 74.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.554 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 -49.17 74.55 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.155 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 . . . . . 0 N--CA 1.445 -0.72 0 CA-C-O 117.93 -1.034 . . . . 0.0 111.065 178.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.669 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 120.56 0.219 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -56.82 -16.94 21.57 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.653 1.569 . . . . 0.0 111.863 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' CD ' ' A' ' 7' ' ' PRO . 84.8 tt0 -51.23 -27.67 9.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.018 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 m -58.59 -39.47 80.45 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' HE1' ' N ' ' A' ' 74' ' ' PHE . 5.0 m-90 -74.54 -36.98 63.14 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -42.45 -41.97 6.14 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' A' ' 3' ' ' GLU . 76.6 Cg_exo -54.87 -21.35 25.77 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.445 1.43 . . . . 0.0 112.617 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.09 -40.94 59.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.797 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.37 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.74 -34.44 89.91 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.277 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 11' ' ' LEU . 10.1 mp -56.55 -42.63 78.85 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.871 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 t -76.03 -36.55 59.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.822 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.98 -38.17 90.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -53.87 -42.23 91.85 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -56.47 -36.36 97.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 120.953 1.102 . . . . 0.0 112.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -61.25 -37.88 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 mt -62.35 -39.11 92.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.252 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.82 -52.58 28.22 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.76 -38.27 95.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -57.33 -44.78 84.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.279 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.08 -38.92 90.66 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.375 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.72 -46.27 76.93 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.469 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.99 -24.08 62.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 110.826 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -34.92 70.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 54.3 t80 -60.71 -49.05 79.06 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.62 -33.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.156 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -61.01 -40.79 94.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.817 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.06 -125.83 2.67 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.032 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.87 -28.8 62.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 111.209 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.4 -33.97 12.58 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 94.1 mt -48.78 -44.33 38.82 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.663 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.09 -42.45 99.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.976 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -62.31 -38.14 88.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.843 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.607 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.1 m-85 -63.78 -22.75 67.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.224 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.19 -41.41 27.06 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.973 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.99 -32.25 76.73 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.8 mt -88.93 149.51 23.28 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.451 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.0 mt-30 -101.96 130.17 48.41 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.079 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' HZ3' ' HE ' ' A' ' 46' ' ' ARG . 16.1 mtpt -108.99 141.5 23.51 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 27.6 Cg_endo -58.98 135.93 69.95 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.387 1.391 . . . . 0.0 111.944 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.9 p -71.94 -21.29 61.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.312 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.525 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 4.5 p90 -77.95 -14.8 59.41 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.66 148.49 92.74 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.948 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -80.14 162.34 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.202 1.935 . . . . 0.0 111.424 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.2 Cg_endo -52.47 149.49 23.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.768 1.645 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.604 ' HE ' ' HZ3' ' A' ' 39' ' ' LYS . 39.2 mtt85 -57.19 -37.96 72.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 48' ' ' THR . 5.0 p90 -63.98 -28.21 69.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.941 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 25.0 m -66.12 -61.21 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.534 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 91.2 mt -72.22 -34.78 68.61 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -38.33 -49.35 3.44 Favored Pre-proline 0 C--N 1.321 -0.634 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.938 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 18.4 Cg_endo -73.19 4.67 3.61 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 122.113 1.875 . . . . 0.0 114.134 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 11.5 pt -42.07 -40.17 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.637 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.516 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 98.6 m95 -50.7 -32.32 19.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.333 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.1 -40.69 95.95 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 m -67.98 -50.97 52.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 111.352 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.61 -33.12 74.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.238 0.542 . . . . 0.0 109.897 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 53' ' ' TRP . 3.3 t80 -52.67 -49.43 65.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.2 p -70.41 -36.55 74.1 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.684 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.33 -40.88 85.96 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.781 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.48 -39.37 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.095 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.99 -49.3 76.81 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -64.05 -39.16 93.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.82 -42.09 85.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.472 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.9 p -64.27 -29.27 70.37 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.76 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.553 ' OH ' ' NZ ' ' A' ' 69' ' ' LYS . 50.6 t80 -58.78 -40.13 83.05 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.218 0.532 . . . . 0.0 110.169 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.38 -39.55 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.539 0.685 . . . . 0.0 109.865 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.42 -54.08 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.55 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.441 ' NE1' ' HG2' ' A' ' 69' ' ' LYS . 0.7 OUTLIER -66.37 -35.75 81.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.553 ' NZ ' ' OH ' ' A' ' 65' ' ' TYR . 22.0 mmtp -61.4 -39.49 90.92 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.495 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -63.32 -40.07 96.3 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.334 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.73 -25.49 59.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.74 49.26 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.449 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.39 -158.64 24.64 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.633 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -92.18 109.13 20.49 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.482 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.548 ' CG2' ' OD1' ' A' ' 77' ' ' ASP . 6.3 t -131.68 167.37 19.58 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -49.91 -38.36 35.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 35.6 p30 -66.45 -32.87 74.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.974 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.664 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -76.61 -30.69 57.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.633 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 88.1 mmm -59.04 -34.9 72.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.23 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -64.08 -58.13 15.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.37 -56.5 1.28 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 121.461 1.441 . . . . 0.0 113.117 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.3 mp -64.14 -43.07 96.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.947 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.85 97.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.868 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -57.33 -39.8 76.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.083 0.468 . . . . 0.0 110.203 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -61.12 -43.98 98.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.042 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.3 m -68.42 -42.93 78.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -61.2 2.97 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -55.6 -41.09 72.93 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.22 -38.82 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.43 69.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.1 -38.54 86.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.918 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 42.8 t-20 -60.65 -42.13 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -58.14 -31.71 67.46 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.619 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.5 70.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.374 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -54.3 -54.3 49.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -40.37 79.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.678 1.586 . . . . 0.0 113.28 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.601 ' N ' ' O ' ' A' ' 95' ' ' TRP . 57.3 Cg_endo -61.0 -21.3 71.06 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 120.818 1.012 . . . . 0.0 110.525 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 29.0 pt -62.41 -23.96 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.175 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -54.49 -46.88 73.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.027 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 69.3 t80 -64.33 -50.2 68.72 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.561 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.17 0.42 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.676 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.595 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 60.98 -2.3 0.2 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.567 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.0 ttt180 -53.92 -35.08 61.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.58 157.02 19.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.244 0.545 . . . . 0.0 111.455 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.696 ' O ' ' N ' ' A' ' 107' ' ' TRP . 21.7 ttm -56.26 -14.07 2.58 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.584 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.31 -1.37 0.01 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.368 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.696 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.92 -20.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.081 -0.658 . . . . 0.0 111.08 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.555 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.49 -27.45 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.739 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.98 -33.88 73.92 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -62.18 -37.14 84.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.544 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.9 t0 -63.11 -50.43 70.53 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.59 -46.38 86.08 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.498 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -67.6 -42.16 82.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.359 0.599 . . . . 0.0 110.35 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 15.6 tp -50.02 -59.51 3.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.489 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.69 -63.19 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.04 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.492 ' O ' ' OG1' ' A' ' 120' ' ' THR . 42.3 t -66.1 -38.97 89.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.4 -55.87 26.63 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.963 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -65.21 -39.07 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.741 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.486 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.72 -45.18 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 116' ' ' SER . 62.3 m -60.56 -42.27 96.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.7 -53.82 16.76 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.155 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.422 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 49.0 m -64.36 -41.18 96.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 65.5 m -59.2 -45.68 90.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.7 -37.22 85.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.01 -64.22 1.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.422 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.1 m0 -66.54 -42.16 87.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.408 ' CB ' ' O ' ' A' ' 123' ' ' THR . 50.6 t-80 -58.33 -48.08 81.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.698 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -62.43 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.33 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -72.57 -43.57 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 0.0 111.448 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.3 p -145.84 106.23 4.25 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.666 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.493 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.0 Cg_exo -56.58 -38.2 95.98 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.371 1.38 . . . . 0.0 112.985 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.8 Cg_exo -55.16 -27.46 56.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 120.484 0.789 . . . . 0.0 112.446 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.84 -24.48 65.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.516 0.674 . . . . 0.0 109.296 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.67 -43.64 92.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.37 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.439 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.6 mtt85 -66.28 -37.44 85.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.548 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.556 ' CD1' ' C ' ' A' ' 136' ' ' LEU . 1.1 tm? -49.23 -43.16 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.401 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.503 ' O ' ' C ' ' A' ' 138' ' ' TYR . 60.2 mt -60.84 -29.02 69.25 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.503 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 2.82 -76.2 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -53.08 -25.57 29.42 Favored 'Trans proline' 0 N--CA 1.509 2.423 0 CA-C-N 119.384 0.816 . . . . 0.0 113.278 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -56.61 -38.41 72.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -178.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 34.0 tp -65.17 -40.36 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.79 94.09 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.608 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -65.3 -50.81 64.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.114 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.8 mt -64.51 -34.1 77.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.079 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 150' ' ' LEU . 21.4 t80 -62.72 -42.2 99.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.624 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.608 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 53.2 p -60.28 -38.0 82.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.5 m -59.6 -50.99 71.75 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.1 t -69.94 -44.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.215 0.531 . . . . 0.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 62.2 tp -58.09 -40.68 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 147' ' ' THR . 43.2 m-80 -63.96 -40.03 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -61.94 -44.29 97.08 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.325 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -64.22 -40.04 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.076 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.82 -48.99 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -40.23 96.26 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.65 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 159' ' ' SER . 39.1 mtm180 -60.03 -23.58 63.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.291 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 88.1 m-20 -53.63 -42.38 67.71 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.142 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -102.41 -41.4 6.33 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 156' ' ' ARG . 50.4 p -84.59 172.63 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.112 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.02 2.87 62.22 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -55.69 -32.98 63.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.366 . . . . 0.0 110.358 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -55.01 -33.38 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.187 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.43 -31.81 44.05 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -54.11 -28.97 43.25 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.2 p -58.94 -25.29 63.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.754 0.311 . . . . 0.0 110.407 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -54.02 -38.35 65.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.403 HD11 ' N ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -64.07 -33.43 75.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.994 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' O ' ' OXT' ' A' ' 169' ' ' GLU . . . -74.33 157.91 34.92 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.194 0.521 . . . . 0.0 110.635 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' OXT' ' O ' ' A' ' 168' ' ' ALA . 95.4 mt-10 . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.606 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.612 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 mtp . . . . . 0 C--O 1.233 0.188 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -55.61 -16.88 15.74 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.982 1.788 . . . . 0.0 111.915 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.22 -34.21 31.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.61 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -61.89 -40.41 95.33 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.609 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 8' ' ' ALA . 14.5 m0 -73.64 -31.14 63.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.739 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t -40.64 -52.52 6.27 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.543 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -58.05 -28.06 81.96 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 CA-C-N 119.01 0.682 . . . . 0.0 111.052 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 5' ' ' TRP . . . -56.44 -30.92 63.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.11 -42.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.25 -36.26 93.18 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.685 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mp -56.27 -44.21 79.54 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.609 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.401 ' OG1' ' SD ' ' A' ' 60' ' ' MET . 13.2 t -79.33 -30.51 42.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.107 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.07 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 t -52.32 -56.6 20.8 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.95 -33.36 98.68 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 CA-C-N 119.076 0.706 . . . . 0.0 112.72 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -60.23 -39.41 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.303 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.3 -37.66 88.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.232 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -64.49 -53.37 35.99 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.94 95.23 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.0 -45.9 89.52 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.567 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.3 mtm -62.91 -37.22 86.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.281 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.94 98.77 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.124 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.467 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.24 -28.07 64.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.93 -34.22 69.64 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.98 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 86.8 t80 -62.53 -46.75 86.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.216 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.09 -33.2 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.83 0.824 . . . . 0.0 109.766 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -59.35 -40.39 86.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.019 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.8 -130.6 4.64 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.808 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -51.55 -28.05 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.071 0.462 . . . . 0.0 110.85 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.99 15.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.3 mt -51.35 -43.21 61.74 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.848 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.391 0.615 . . . . 0.0 110.618 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -59.79 -40.44 88.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.662 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' NZ ' ' A' ' 39' ' ' LYS . 44.3 m-85 -66.08 -22.64 66.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.745 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.95 -41.65 16.47 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.443 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.74 -32.2 83.36 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.4 mt -93.63 149.16 21.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.286 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.585 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.8 mt-30 -99.21 122.21 42.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.87 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.699 ' NZ ' ' CD1' ' A' ' 34' ' ' TYR . 22.4 mttp -94.5 141.0 22.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -57.25 144.85 89.71 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.557 1.504 . . . . 0.0 113.069 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 m -61.58 -32.42 72.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.918 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.2 p90 -76.87 2.08 15.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.583 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.699 ' CE1' ' NH1' ' A' ' 46' ' ' ARG . 8.4 t-80 -62.7 140.16 97.06 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 71.7 Cg_endo -101.14 169.86 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.111 1.207 . . . . 0.0 112.461 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.3 147.97 26.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.653 2.235 . . . . 0.0 112.209 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.699 ' NH1' ' CE1' ' A' ' 43' ' ' HIS . 80.0 mmt-85 -58.33 -37.58 75.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -81.21 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.1 m -74.3 -76.18 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.599 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.546 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 77.6 mt -66.09 -32.73 74.36 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.653 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -41.0 -43.45 4.57 Favored Pre-proline 0 C--N 1.324 -0.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.63 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 53.8 Cg_exo -63.61 -7.2 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.929 2.419 . . . . 0.0 113.714 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 22.5 pt -42.44 -41.46 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.437 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 97.9 m95 -53.91 -33.79 57.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.442 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.64 94.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -69.38 -52.8 23.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.754 0.311 . . . . 0.0 111.44 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.48 -33.68 76.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.179 0.514 . . . . 0.0 110.423 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 23.8 t80 -49.37 -59.55 3.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.287 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 m -65.01 -38.05 89.66 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.81 95.38 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.701 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.401 ' SD ' ' OG1' ' A' ' 12' ' ' THR . 63.3 mtt -63.16 -37.73 88.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.687 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -66.24 -58.66 8.39 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -61.67 -37.44 84.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.491 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.86 -41.45 67.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 85.3 p -66.64 -27.95 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.37 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -55.82 -45.92 78.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.14 -44.19 97.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.75 -37.04 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.739 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.612 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 58.4 mttt -65.2 -41.71 94.27 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.465 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 87.3 mt-10 -70.15 -37.93 75.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.7 mt -92.2 -0.54 57.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.6 5.21 67.07 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 90.52 -167.18 32.24 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -59.3 82.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.212 0.53 . . . . 0.0 111.065 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.0 t -133.12 160.84 36.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.664 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -41.95 -40.48 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.323 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 75' ' ' THR . 87.1 m-20 -66.88 -44.12 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.539 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 73' ' ' GLY . . . -77.67 -33.24 53.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.469 ' O ' ' N ' ' A' ' 83' ' ' GLY . 87.8 mtp -57.87 -33.7 68.96 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.156 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.01 -50.17 89.56 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.305 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.7 -52.31 1.05 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 120.495 0.797 . . . . 0.0 111.948 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.44 -42.48 99.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.319 0.581 . . . . 0.0 109.507 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.86 -38.66 96.91 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -58.38 -38.03 76.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.149 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 88.5 t80 -60.4 -44.45 95.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.1 m -65.88 -41.29 91.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.507 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.86 -54.22 19.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.819 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -59.79 -39.88 86.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.635 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.7 tp -58.79 -37.99 77.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.178 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.42 88.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 0.0 111.199 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -58.66 -39.95 82.1 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.478 HD21 ' CA ' ' A' ' 117' ' ' GLY . 50.8 t-20 -64.48 -35.96 82.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.693 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.557 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.7 m95 -56.17 -31.86 63.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.316 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.01 -16.39 62.06 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.6 t-105 -70.32 -52.81 11.29 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 27.4 Cg_endo -55.86 131.11 44.05 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.864 1.709 . . . . 0.0 113.309 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.445 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 41.3 Cg_endo -107.97 -28.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 120.841 1.028 . . . . 0.0 111.382 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 102' ' ' ALA . 28.8 pt -56.58 -30.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.367 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 15.6 p90 -54.12 -42.29 69.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.526 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.9 t80 -63.53 -51.29 66.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.315 . . . . 0.0 111.532 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -114.11 -54.53 0.42 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 98' ' ' ILE . . . 60.86 -1.0 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.539 ' H ' ' C ' ' A' ' 101' ' ' GLY . 25.7 tpt180 -54.36 -33.72 59.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.847 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.77 151.36 27.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.318 0.58 . . . . 0.0 111.958 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.619 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ppp? -65.58 -14.41 61.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.741 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.37 32.74 0.02 OUTLIER Glycine 0 CA--C 1.538 1.496 0 O-C-N 123.131 0.269 . . . . 0.0 112.924 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.619 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.49 -21.26 62.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.596 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -50.1 -23.73 2.29 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.773 0.32 . . . . 0.0 111.813 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.11 -32.14 70.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.379 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.61 -45.52 93.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.495 . . . . 0.0 109.948 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.565 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 37.3 t0 -63.44 -44.03 95.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.903 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -60.73 -40.05 90.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.148 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.502 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -66.63 -48.25 70.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 pp -75.31 -34.05 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.796 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.416 ' CG2' ' OD1' ' A' ' 111' ' ' ASP . 45.3 t -63.63 -45.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.777 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 t -85.8 -41.45 15.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.478 ' CA ' HD21 ' A' ' 92' ' ' ASN . . . -56.56 -47.1 86.66 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.573 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.2 -46.22 45.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.568 0.223 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -71.71 -57.97 3.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 38.1 m -58.04 -43.12 86.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -59.42 2.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.011 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 34.4 m -64.64 -41.59 96.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 55.8 m -59.46 -47.73 84.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.09 -34.55 78.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.44 -63.7 1.36 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.477 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.2 m0 -66.78 -43.95 82.59 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -177.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.475 ' HE2' ' CD1' ' A' ' 137' ' ' LEU . 22.3 m170 -59.87 -45.32 92.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.931 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -61.96 -44.4 96.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.354 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.497 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 77.1 t -76.85 -47.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.418 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.0 p -134.58 91.26 21.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.073 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.461 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.7 Cg_exo -52.4 -40.53 70.86 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.607 1.538 . . . . 0.0 112.975 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.6 Cg_exo -57.63 -29.18 84.38 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.591 0.861 . . . . 0.0 112.857 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.44 -32.3 71.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.202 0.525 . . . . 0.0 110.5 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.55 77.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.368 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.64 -39.23 83.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.366 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 tp -57.7 -39.76 77.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.007 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 140' ' ' TYR . 82.7 mt -59.52 -27.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.973 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -6.2 -64.32 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.453 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -54.05 -30.2 58.64 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 CA-C-N 119.523 0.865 . . . . 0.0 112.898 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.45 -47.02 80.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 41.2 tp -60.58 -39.76 89.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.21 96.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.581 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -70.0 -50.22 43.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.893 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.0 mt -65.38 -34.06 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.523 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.11 -47.54 84.14 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -64.18 -43.69 94.34 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.345 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.579 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.2 m -56.14 -43.99 78.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.951 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 48.9 m -64.79 -48.37 74.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.775 0.322 . . . . 0.0 111.564 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.26 -41.74 86.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.6 tp -57.9 -41.15 81.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.974 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.565 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.5 m120 -62.09 -41.35 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -64.14 -42.37 96.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.818 0.674 . . . . 0.0 112.818 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -58.63 -45.21 89.75 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.062 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.97 -46.01 82.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.442 ' O ' ' N ' ' A' ' 159' ' ' SER . 1.6 m0 -61.78 -40.03 93.73 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.78 -29.98 65.29 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.229 -0.589 . . . . 0.0 111.471 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 86.9 m-20 -50.71 -39.8 52.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -103.11 -58.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.228 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 155' ' ' TRP . 87.0 p -62.66 -27.92 69.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.224 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.83 -30.26 36.0 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -55.51 -34.84 64.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.813 0.339 . . . . 0.0 110.397 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -57.29 -31.79 65.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.668 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.01 -32.41 42.18 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -84.65 -177.44 51.14 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.3 m -118.81 147.77 43.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 110.627 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 168' ' ' ALA . 91.8 mtt180 -124.45 137.37 54.45 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.196 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 166' ' ' ARG . 13.3 mt 33.02 -81.5 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.91 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 166' ' ' ARG . . . -143.09 149.63 38.42 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 110.142 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.645 179.91 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.563 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.52 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 1' ' ' MET . 48.2 Cg_endo -55.61 -22.84 37.37 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.366 2.044 . . . . 0.0 111.962 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.22 -33.94 71.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.606 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.2 m -62.82 -40.31 97.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.039 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.66 ' CD1' ' CE3' ' A' ' 68' ' ' TRP . 1.4 t90 -72.59 -33.96 67.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.69 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 t -41.5 -41.54 3.95 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.692 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.91 -21.7 21.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 120.841 1.027 . . . . 0.0 111.921 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.17 -35.96 62.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.933 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.8 t -62.48 -43.32 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.64 -33.37 85.96 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.378 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.8 mp -56.13 -43.2 77.98 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.136 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -37.95 35.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.836 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' O ' ' OG ' ' A' ' 16' ' ' SER . 83.1 mt -62.3 -37.61 86.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -52.67 -43.43 92.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.819 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -57.17 -33.26 95.58 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.167 1.245 . . . . 0.0 113.176 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 83.6 p -62.19 -35.46 78.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.93 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.078 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -42.1 97.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.1 97.63 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.91 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 55.5 m-85 -61.99 -41.21 97.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.539 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.68 -40.29 96.62 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.765 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.42 -47.87 11.81 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.31 -23.37 63.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.209 0.528 . . . . 0.0 110.441 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -51.62 -38.95 57.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.032 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 58.1 t80 -62.69 -48.79 77.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -32.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.55 0.69 . . . . 0.0 109.967 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.459 ' CB ' ' HE ' ' A' ' 46' ' ' ARG . 13.9 ttt-85 -62.4 -41.44 98.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.023 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -131.22 2.64 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.132 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -26.99 48.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.618 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.6 -35.49 11.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -49.14 -44.64 42.75 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.962 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -61.0 -39.34 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.938 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -58.68 -37.07 75.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.349 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 37' ' ' LEU . 55.8 m-85 -61.02 -22.8 64.9 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.7 -40.57 6.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.059 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.47 -31.8 71.28 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 34' ' ' TYR . 56.9 mt -92.79 148.16 22.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 110.887 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -96.49 123.79 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.85 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -94.85 139.61 22.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 74.4 Cg_endo -58.84 147.06 90.73 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.501 1.467 . . . . 0.0 112.601 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -64.45 -29.42 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.09 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.436 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 39.4 p90 -78.32 2.7 17.66 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.492 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 57.8 t-80 -62.16 142.71 95.59 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 87.1 Cg_endo -107.74 172.55 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.336 1.357 . . . . 0.0 112.282 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -54.41 148.14 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.87 2.38 . . . . 0.0 112.335 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HE ' ' CB ' ' A' ' 27' ' ' ARG . 28.6 tpt85 -56.61 -39.28 73.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 26.4 p90 -77.15 -9.12 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -75.57 -73.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.573 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.549 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 92.1 mt -66.94 -32.72 74.16 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.694 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -41.38 -42.71 4.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.156 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . 76.1 Cg_exo -63.79 -6.27 10.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.914 2.409 . . . . 0.0 113.387 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 11.1 pt -41.24 -44.84 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.084 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.492 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.1 m95 -58.08 -34.0 69.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.089 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.26 -40.35 98.48 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -66.99 -53.26 33.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 0.0 111.325 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.82 -32.16 72.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.0 t80 -52.34 -50.14 62.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.875 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -69.89 -36.62 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.29 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.57 -43.46 80.58 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.046 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.5 mtt -60.63 -38.9 86.31 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.87 -52.64 40.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -61.4 -35.48 77.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.572 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.64 -46.02 59.54 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p -63.26 -30.13 71.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.456 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 46.7 t80 -55.01 -40.3 70.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 109.797 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.0 mt -69.51 -44.39 79.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.68 -51.89 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.66 ' CE3' ' CD1' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -64.27 -33.07 74.97 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.838 -178.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -60.64 -40.79 93.27 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.783 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -67.68 -34.05 76.14 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.143 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -85.5 -0.54 55.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.092 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.76 44.08 8.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.43 -154.43 23.43 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -87.25 110.71 20.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.517 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 77' ' ' ASP . 6.1 t -133.95 168.63 18.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.893 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -52.27 -37.96 56.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.385 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' H ' HG22 ' A' ' 75' ' ' THR . 84.8 m-20 -62.22 -40.02 94.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.339 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.49 -28.28 67.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.851 0.358 . . . . 0.0 111.377 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 mtt -58.82 -35.25 72.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.306 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.18 -47.65 98.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -77.75 -63.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 120.735 0.957 . . . . 0.0 112.538 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.7 mt -59.49 -41.71 90.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.19 98.78 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.773 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.55 -38.11 74.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 109.916 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -57.92 -43.94 86.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.588 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.98 -60.72 3.76 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.396 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.59 -40.06 74.63 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.56 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.63 -40.39 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.224 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.96 78.52 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.48 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.11 87.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.226 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.436 HD21 ' HA3' ' A' ' 117' ' ' GLY . 41.3 t-20 -62.23 -39.91 94.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.568 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.8 m95 -59.46 -28.45 67.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.07 63.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 97' ' ' PRO . 8.7 t-105 -71.12 -55.7 6.14 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.5 Cg_endo -40.96 82.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.034 1.156 . . . . 0.0 112.317 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -59.33 -23.82 71.7 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.739 1.626 . . . . 0.0 112.459 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.419 ' H ' ' CD ' ' A' ' 97' ' ' PRO . 35.5 pt -59.62 -30.02 43.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.402 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.3 p90 -44.85 -42.27 7.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.493 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 57.7 t80 -66.62 -52.01 49.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.79 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.27 -68.69 0.48 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.737 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.532 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 65.58 5.07 3.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -54.92 -35.55 64.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 109.913 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -85.74 152.86 22.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.245 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.661 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.4 ttm -61.14 -14.97 28.55 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.975 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.7 21.59 0.01 OUTLIER Glycine 0 CA--C 1.543 1.79 0 C-N-CA 121.724 -0.274 . . . . 0.0 113.239 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.661 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.6 -19.82 41.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.409 0.605 . . . . 0.0 112.248 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.571 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -42.58 -22.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.446 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 107' ' ' TRP . 77.8 mt -59.63 -36.45 76.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.6 -40.25 88.77 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.33 0.586 . . . . 0.0 109.858 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.489 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 48.6 t0 -60.57 -57.15 13.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.664 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.97 -37.9 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.673 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.518 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.1 tt -64.46 -49.94 69.45 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.58 -35.21 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.065 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 ' CG2' ' HG1' ' A' ' 147' ' ' THR . 55.7 t -66.6 -59.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 111.595 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -72.47 -40.48 66.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA3' HD21 ' A' ' 92' ' ' ASN . . . -58.54 -54.43 37.84 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.598 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.71 -35.69 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.504 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.517 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -75.46 -52.96 9.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.0 m -57.45 -43.04 83.65 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.66 -54.62 13.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.545 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.2 m -66.79 -40.01 87.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 91.2 m -59.36 -47.09 86.76 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.2 mt -72.83 -34.25 66.7 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.68 -64.16 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -64.56 -43.61 93.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -59.38 -44.7 92.72 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.022 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -61.58 -43.61 98.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.586 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.6 t -79.95 -46.68 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.557 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 96.0 p -133.58 88.53 33.76 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.48 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 34.7 Cg_exo -53.94 -41.01 78.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.766 1.644 . . . . 0.0 112.858 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 33.4 Cg_exo -56.44 -30.59 82.48 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 120.597 0.864 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.79 68.81 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.261 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.25 76.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.421 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.508 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 93.2 mtt180 -63.28 -37.4 87.12 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.001 0.429 . . . . 0.0 110.533 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.0 tp -54.28 -37.69 65.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 138' ' ' TYR . 85.1 mt -67.56 -3.16 7.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.147 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -26.97 -59.99 0.2 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.89 -23.96 78.18 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.079 1.186 . . . . 0.0 113.802 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -55.47 -41.21 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.179 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 37.2 tp -63.47 -39.51 94.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.17 93.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.669 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.59 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -66.44 -53.97 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.614 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.446 ' O ' ' OG1' ' A' ' 147' ' ' THR . 50.1 mt -63.85 -33.51 75.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -41.02 95.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 49' ' ' LEU . 28.2 t80 -61.69 -40.27 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.59 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 81.4 p -59.93 -37.94 80.94 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.404 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.6 p -68.33 -47.2 68.14 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.087 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.84 -41.16 79.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.373 0.606 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 36.9 tp -60.3 -42.95 96.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.353 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.489 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.3 m120 -66.51 -36.65 83.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.23 0.538 . . . . 0.0 110.947 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.553 ' CE1' ' NE ' ' A' ' 156' ' ' ARG . 1.4 t80 -56.42 -48.17 77.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.104 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -67.28 -45.01 77.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.82 -47.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.467 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 1.2 m0 -61.1 -40.73 94.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.553 ' NE ' ' CE1' ' A' ' 152' ' ' TYR . 86.2 mtt-85 -59.39 -28.07 66.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.526 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -51.71 -40.63 60.49 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.202 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.47 ' OD1' ' NH2' ' A' ' 161' ' ' ARG . 41.0 t30 -105.28 -60.34 1.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.449 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.7 m -59.44 -35.05 73.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.767 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.69 -29.6 33.3 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.47 ' NH2' ' OD1' ' A' ' 158' ' ' ASN . 74.4 mtm180 -55.28 -34.18 63.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.296 . . . . 0.0 110.793 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -56.11 -36.91 68.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.52 -127.14 19.74 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.17 -164.08 38.24 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 168' ' ' ALA . 92.5 p -118.9 154.9 32.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.956 0.407 . . . . 0.0 110.661 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -58.28 -33.98 70.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.401 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.44 -36.51 80.56 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.481 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -149.36 145.69 27.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.917 0.389 . . . . 0.0 110.834 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.544 179.636 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.552 ' C23' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 1' ' ' MET . 7.0 mmm . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -56.28 -21.17 35.06 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.606 1.538 . . . . 0.0 111.616 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.51 -31.14 69.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.869 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 t -60.87 -43.21 98.73 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.351 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -75.08 -32.15 61.4 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 17.1 t -41.35 -50.34 8.78 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.29 -18.25 29.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 120.44 0.76 . . . . 0.0 112.288 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.26 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.3 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.93 -40.31 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.64 -36.9 93.36 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -58.52 -42.22 87.25 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.17 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 t -74.95 -35.46 62.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.581 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.481 ' O ' ' OG ' ' A' ' 16' ' ' SER . 96.0 mt -67.48 -34.9 78.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 t -47.91 -56.6 12.9 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.58 -34.44 98.84 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 120.797 0.998 . . . . 0.0 112.958 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 84.5 p -62.14 -37.56 85.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.403 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.17 -38.71 85.9 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.479 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' C ' ' CZ3' ' A' ' 93' ' ' TRP . . . -67.76 -54.23 19.66 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.815 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.671 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -59.86 -36.17 89.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.814 -0.515 . . . . 0.0 111.814 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.48 -45.03 89.52 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.435 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.5 mtt -63.45 -39.23 93.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.8 0.333 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.95 -43.52 91.1 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -69.66 -26.07 64.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 110.816 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.78 -36.61 72.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.711 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 69.5 t80 -59.94 -49.67 76.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -73.6 -34.15 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.725 0.774 . . . . 0.0 109.929 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -61.79 -42.0 98.45 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.783 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.45 -127.51 1.57 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.854 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.93 -27.61 61.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.708 0.29 . . . . 0.0 110.682 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.24 -34.81 13.37 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -50.79 -41.48 57.17 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.488 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -61.06 -43.46 98.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.366 0.603 . . . . 0.0 109.458 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.17 -40.2 95.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.518 ' O ' ' O ' ' A' ' 37' ' ' LEU . 15.4 m-85 -62.4 -22.74 66.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.11 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.6 -41.5 31.04 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.209 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.0 79.02 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.1 mt -90.87 148.57 22.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.587 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -100.82 128.88 46.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.887 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.655 ' HZ1' ' NH2' ' A' ' 46' ' ' ARG . 11.1 mtpt -106.5 145.56 31.27 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.946 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -58.41 137.13 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.135 1.223 . . . . 0.0 111.691 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -66.03 -26.73 67.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.089 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -78.32 -4.19 46.75 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.685 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 3.4 t-80 -60.09 134.09 90.31 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.362 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 51.4 Cg_exo -75.03 167.23 27.48 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.092 1.195 . . . . 0.0 111.678 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -53.88 149.22 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.948 1.765 . . . . 0.0 111.242 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.655 ' NH2' ' HZ1' ' A' ' 39' ' ' LYS . 25.9 mmt180 -57.24 -36.08 70.48 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.208 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -76.81 -11.54 59.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -77.02 -72.43 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.799 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.558 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 91.9 mt -62.77 -35.59 80.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.158 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.619 ' O ' ' CE3' ' A' ' 53' ' ' TRP . . . -42.58 -41.28 5.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.002 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 66.1 Cg_exo -67.06 -2.21 7.55 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.917 2.411 . . . . 0.0 113.73 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.558 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 20.1 pt -46.51 -34.57 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.732 0.301 . . . . 0.0 111.512 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.619 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 4.7 m-90 -54.07 -27.36 32.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.7 94.83 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -72.99 -45.85 55.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.853 0.358 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 143' ' ' TRP . 6.8 mt -66.03 -33.61 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.228 0.537 . . . . 0.0 109.877 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 25.2 t80 -60.14 -50.05 75.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.913 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.7 p -74.79 -33.32 62.22 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.971 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.69 -46.18 83.48 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.638 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.8 mtt -63.93 -38.2 90.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.657 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.85 -61.41 5.58 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.13 -37.3 86.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.603 0.239 . . . . 0.0 111.256 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.22 -43.33 74.54 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.8 p -67.44 -26.0 66.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.475 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -56.45 -50.16 72.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.163 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.58 -41.72 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.8 t -53.64 -48.32 59.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.424 ' O ' ' N ' ' A' ' 73' ' ' GLY . 1.4 p90 -70.58 -31.52 68.56 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.966 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 67.8 mmtt -59.71 -37.92 80.21 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.761 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 81.0 mt-10 -68.15 -35.66 78.43 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.87 3.68 47.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.931 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 36.0 11.62 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.32 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 89.21 -174.85 42.42 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.61 84.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.6 m -93.42 146.69 23.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.212 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -50.88 -37.96 46.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.596 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.25 -39.52 92.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.17 0.51 . . . . 0.0 109.671 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.5 71.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.601 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.4 mtp -58.49 -33.05 69.37 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.612 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -55.98 -57.9 19.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.791 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.7 -47.9 10.21 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 119.023 0.687 . . . . 0.0 112.428 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.221 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.0 -37.44 94.96 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.6 tp -57.03 -41.65 78.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.42 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 77.6 t80 -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.3 m -65.42 -42.72 92.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.674 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.51 -58.41 3.88 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.635 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -57.15 -41.67 79.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.577 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 36.2 tp -63.25 -38.1 89.84 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.135 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.76 75.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.9 -39.13 88.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -60.78 -38.3 84.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.475 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.671 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 50.2 m95 -62.07 -31.33 71.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.632 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -31.8 73.14 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.597 ' O ' ' N ' ' A' ' 97' ' ' PRO . 4.0 t-105 -55.38 -50.69 85.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -41.05 80.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.684 1.589 . . . . 0.0 113.107 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.597 ' N ' ' O ' ' A' ' 95' ' ' TRP . 67.5 Cg_endo -63.04 -26.25 73.65 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 120.616 0.878 . . . . 0.0 111.143 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.501 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 42.4 pt -63.82 -33.96 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -44.88 -41.09 6.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.808 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 64.8 t80 -67.18 -51.76 49.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.323 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.38 -65.83 0.44 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.572 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.512 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 64.84 5.19 2.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.441 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -54.24 -34.26 60.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.953 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -90.12 153.61 20.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.477 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.687 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.8 ttm -61.95 -15.16 41.4 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.18 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.7 20.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.638 0 C-N-CA 121.526 -0.369 . . . . 0.0 113.345 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.687 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -60.05 -19.38 52.59 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.564 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -42.82 -20.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' TRP . 83.8 mt -59.23 -38.91 81.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.03 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -66.12 -38.44 88.21 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.372 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.456 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 59.4 t0 -60.66 -45.88 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.96 -47.49 65.51 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.732 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.78 -38.9 83.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.421 0.629 . . . . 0.0 109.909 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 19.7 tp -52.93 -61.51 2.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.282 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.78 -63.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.765 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' OG1' ' A' ' 120' ' ' THR . 36.4 t -69.71 -40.78 76.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.02 -51.52 56.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.702 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.6 p -66.2 -37.36 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.386 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.516 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -78.47 -49.71 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 116' ' ' SER . 38.1 m -55.44 -42.23 73.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.58 -54.37 12.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.623 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.5 m -65.78 -39.22 90.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.17 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 85.9 m -58.96 -47.47 84.99 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.91 -34.63 77.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.37 1.43 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.623 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.2 m0 -67.65 -44.01 78.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -57.72 -45.46 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.534 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -63.07 -43.04 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.454 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.513 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 76.5 t -79.21 -53.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.936 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 43.8 p -128.39 91.38 44.13 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.319 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.441 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 45.2 Cg_exo -51.39 -42.28 55.61 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.915 1.743 . . . . 0.0 113.158 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.4 Cg_exo -56.47 -28.02 71.36 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.211 0.607 . . . . 0.0 112.311 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.38 71.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.77 -41.44 95.5 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.768 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -61.45 -36.06 79.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.49 . . . . 0.0 110.744 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.38 -38.19 76.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.6 mt -59.22 -30.76 68.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.521 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 0.17 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.3 Cg_endo -50.73 -29.96 27.63 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.513 0.809 . . . . 0.0 112.331 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -60.65 -36.49 78.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -67.8 -44.35 77.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.025 0.441 . . . . 0.0 110.104 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.58 -49.8 37.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.094 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.569 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 1.7 t-105 -59.94 -49.01 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 147' ' ' THR . 74.7 mt -66.07 -32.4 73.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.301 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.39 90.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' A' ' 49' ' ' LEU . 23.1 t80 -63.25 -42.03 99.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.264 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.569 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 74.3 p -60.84 -38.36 85.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.604 -0.438 . . . . 0.0 112.049 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.8 m -62.34 -49.31 76.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.695 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.22 -40.68 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.45 0.643 . . . . 0.0 111.01 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 53.5 tp -55.91 -47.02 78.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.54 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.587 HD22 ' C21' ' A' ' 201' ' ' PKA . 14.9 m120 -66.95 -37.59 84.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.389 0.614 . . . . 0.0 110.449 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -58.88 -44.31 91.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.903 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.97 -46.12 86.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.999 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.06 -47.74 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.57 ' O ' ' N ' ' A' ' 159' ' ' SER . 1.7 m95 -61.27 -43.65 98.52 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.493 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.4 mmt-85 -59.7 -35.65 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.842 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -59.46 -41.05 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -96.63 -59.62 1.78 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TRP . 34.4 m -57.13 -32.3 66.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.524 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.11 161.09 44.93 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -56.85 -36.5 70.09 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.955 0.407 . . . . 0.0 110.45 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -56.38 -35.4 67.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.291 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.52 -31.17 43.65 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -80.32 174.09 54.94 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.4 p -78.79 160.58 27.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 111.065 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.0 ttp85 -57.97 -32.71 68.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.555 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.14 146.14 26.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.904 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.438 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -84.07 126.3 32.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.001 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 92.5 mt-10 . . . . . 0 C--O 1.218 -0.56 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.371 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.625 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.643 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 1.3 mpp? . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.954 0.407 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 1' ' ' MET . 18.5 Cg_endo -55.71 -22.47 36.58 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.389 2.059 . . . . 0.0 111.572 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.15 -31.83 70.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.938 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -62.19 -41.84 98.73 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.298 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.401 ' CZ2' ' CD2' ' A' ' 68' ' ' TRP . 10.9 m0 -73.83 -31.48 63.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.833 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -42.28 -43.07 7.13 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.46 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.31 -24.49 51.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.002 1.135 . . . . 0.0 111.733 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.22 -34.12 21.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.141 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.52 -41.93 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.29 92.6 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.447 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.38 -39.56 83.73 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.375 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -81.23 -36.57 29.83 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -61.93 -36.63 81.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 t -54.9 -43.73 99.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.601 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.41 -32.61 94.48 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.397 1.398 . . . . 0.0 113.49 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.9 m -59.34 -38.0 79.23 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.716 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.5 mt -60.67 -38.08 83.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.165 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.91 99.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.599 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.61 -42.4 99.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.128 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.0 m-85 -62.98 -45.37 92.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.0 mtm -62.57 -40.31 96.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 -48.26 23.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.21 -18.68 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.478 . . . . 0.0 110.969 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -54.25 -36.98 64.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.26 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 48.5 t80 -61.05 -50.75 72.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.04 -35.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.63 0.729 . . . . 0.0 110.216 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -60.95 -41.12 95.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.786 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.17 -125.21 2.27 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.031 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -56.99 -27.98 62.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.473 -0.364 . . . . 0.0 111.052 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.71 -32.78 17.87 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -51.33 -41.54 60.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.344 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -63.15 -42.87 99.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -62.12 -37.27 84.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.652 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' LEU . 6.0 m-85 -61.29 -23.2 65.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.955 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.86 -43.44 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.456 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.9 -32.21 81.99 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 34' ' ' TYR . 45.5 mt -93.07 149.23 21.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.831 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -100.94 129.92 46.86 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.004 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.589 ' HZ3' HH21 ' A' ' 46' ' ' ARG . 11.9 mtpt -107.74 139.42 20.59 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.424 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 60.6 Cg_endo -61.47 134.05 49.32 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 120.668 0.912 . . . . 0.0 111.6 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.9 p -81.78 -9.81 59.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.781 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.478 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 3.8 p90 -77.88 -15.34 59.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.661 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' ND1' ' C ' ' A' ' 43' ' ' HIS . 0.7 OUTLIER -76.69 149.81 81.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.915 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -76.38 163.99 31.48 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.573 1.515 . . . . 0.0 111.136 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.7 Cg_endo -51.38 149.45 17.25 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.803 1.669 . . . . 0.0 111.951 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.589 HH21 ' HZ3' ' A' ' 39' ' ' LYS . 42.0 mtt85 -57.0 -35.51 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.415 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 4.5 p90 -64.19 -20.27 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.118 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.87 -62.77 1.48 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.426 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.551 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 88.4 mt -67.46 -36.14 80.58 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -43.09 -41.0 6.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.983 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 54' ' ' GLY . 53.0 Cg_exo -66.33 -7.39 17.4 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.181 2.587 . . . . 0.0 113.745 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 19.0 pt -42.03 -43.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.357 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.515 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 95.0 m95 -54.28 -32.45 56.33 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.722 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.19 -39.2 96.82 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.1 m -69.62 -51.21 37.09 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.12 0.486 . . . . 0.0 111.04 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.55 -31.77 72.09 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.431 0.634 . . . . 0.0 109.771 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -51.23 -55.87 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.633 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.6 m -64.03 -40.09 95.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.341 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.92 -44.5 89.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.993 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.52 -38.05 88.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.831 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -70.53 -54.81 9.56 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.32 -37.6 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.13 -40.72 91.98 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.6 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 96.5 p -63.27 -31.71 72.93 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.188 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.33 -42.41 86.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.913 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 -41.22 84.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.7 t -58.7 -40.72 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.943 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.41 -51.16 70.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.464 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 71.4 mttt -53.36 -35.1 59.91 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.424 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.51 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 88.8 mt-10 -75.75 -43.82 44.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.767 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.29 -26.65 58.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.86 -5.42 42.9 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.681 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.58 -167.46 29.2 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.874 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -90.86 87.05 6.49 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' ALA . 11.2 p -124.04 167.64 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.205 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -42.88 -36.96 1.67 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.261 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 89.2 m-20 -62.54 -41.01 98.61 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.75 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -84.89 -40.27 17.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' GLY . 86.7 mtp -59.95 -35.17 74.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.27 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.9 -57.25 25.19 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.49 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.423 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 13.0 Cg_endo -61.95 -53.45 2.09 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.011 1.141 . . . . 0.0 112.01 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.52 -41.27 98.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.242 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.97 -39.76 97.99 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.41 -38.72 77.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.039 0.447 . . . . 0.0 110.241 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -59.79 -44.4 93.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.11 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.9 m -65.82 -45.4 82.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.472 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.83 5.97 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.42 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.72 -41.66 86.91 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.493 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.08 -36.96 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.82 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.59 66.74 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.63 -37.32 81.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 21.2 t-20 -60.04 -43.89 95.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.951 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.547 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 60.0 m95 -57.45 -30.47 65.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.041 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 -23.57 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 97' ' ' PRO . 55.9 t-105 -54.15 -67.56 0.61 Allowed Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 22.8 Cg_endo -43.35 80.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.832 1.688 . . . . 0.0 112.007 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.609 ' N ' ' O ' ' A' ' 95' ' ' TRP . 69.2 Cg_endo -57.54 -22.04 49.25 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.294 1.996 . . . . 0.0 113.293 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 pt -57.11 -23.27 18.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 8.4 p90 -45.06 -41.59 7.77 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.718 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.532 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 75.7 t80 -66.51 -52.13 49.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.8 -68.89 0.5 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.791 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.557 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 63.79 3.21 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 0.0 110.749 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -53.8 -35.04 60.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -89.57 155.22 19.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.674 ' C ' ' H ' ' A' ' 107' ' ' TRP . 21.9 ttm -58.75 -15.17 10.88 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.039 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.59 15.06 0.01 OUTLIER Glycine 0 CA--C 1.544 1.846 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.351 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.674 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -56.15 -19.25 12.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.359 0.58 . . . . 0.0 112.257 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.574 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -43.09 -21.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 111.742 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.6 mt -61.08 -36.17 78.92 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.654 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.43 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -64.34 -39.29 93.6 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.731 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.492 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.0 t0 -62.95 -46.79 86.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.51 -49.11 76.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.904 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.542 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.5 tt -67.99 -42.54 80.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.544 0.688 . . . . 0.0 109.768 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.43 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 18.1 tp -50.67 -60.2 3.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.7 t -71.05 -63.58 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.495 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.477 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.8 t -68.91 -40.36 79.15 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.39 -51.01 60.71 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.795 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.83 -38.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.27 -47.88 22.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 116' ' ' SER . 56.7 m -57.89 -42.48 84.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.88 -57.58 3.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.675 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.636 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 16.9 m -62.3 -41.18 98.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.283 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 85.9 m -61.61 -45.47 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.11 -37.45 87.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.5 -63.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.636 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.7 m0 -65.98 -41.02 91.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.451 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.3 t-80 -57.4 -47.14 82.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.079 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.28 -43.74 90.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.73 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.51 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 86.4 t -78.6 -48.7 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.5 p -127.9 85.34 60.89 Favored Pre-proline 0 N--CA 1.465 0.297 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.726 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.463 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.05 -44.95 42.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.628 1.552 . . . . 0.0 112.258 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 17.0 Cg_exo -58.44 -31.76 94.85 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.361 0.708 . . . . 0.0 111.913 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.68 72.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.538 . . . . 0.0 110.078 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.3 84.75 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.704 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.57 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 73.7 ttt180 -60.51 -41.03 93.52 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 110.109 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.2 tp -53.29 -35.68 60.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.23 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.531 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 43.3 mt -69.64 12.42 0.19 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.331 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -44.88 -41.96 14.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.531 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 10.3 Cg_endo -64.24 -22.59 66.71 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.95 1.375 . . . . 0.0 112.5 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.24 -39.61 90.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.024 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.0 tm? -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.318 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.89 -43.59 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 111.593 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 1.4 t-105 -66.0 -51.35 59.16 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.467 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.439 ' O ' ' OG1' ' A' ' 147' ' ' THR . 54.0 mt -64.12 -34.09 77.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.179 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.89 95.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.241 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -62.31 -40.76 97.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.405 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.455 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 66.9 p -58.28 -38.32 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.259 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.5 m -63.56 -51.15 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.346 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.48 -41.67 80.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.749 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 64.9 tp -57.89 -40.8 81.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.406 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.519 ' N ' HD21 ' A' ' 151' ' ' ASN . 2.2 m120 -65.53 -41.12 93.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.49 -40.21 96.47 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.85 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -60.42 -45.85 92.14 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.866 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.56 -48.22 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 159' ' ' SER . 1.2 m0 -63.85 -48.68 75.8 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.887 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.675 ' NH2' HH22 ' A' ' 166' ' ' ARG . 90.0 mtt-85 -56.35 -32.38 64.67 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.198 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -56.73 -40.0 74.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -99.61 -61.12 1.41 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.825 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 155' ' ' TRP . 22.9 t -127.87 135.64 50.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.22 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -154.27 177.66 31.54 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.554 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -129.44 150.62 50.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.372 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 166' ' ' ARG . 98.2 mtt180 -121.3 145.73 47.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.188 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.23 158.52 23.65 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -59.47 -34.33 80.58 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 168' ' ' ALA . 86.9 p -60.9 -28.69 69.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.57 0.224 . . . . 0.0 111.215 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.675 HH22 ' NH2' ' A' ' 156' ' ' ARG . 92.5 mtt-85 -57.47 -36.88 72.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.63 -36.62 84.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.276 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -151.36 147.1 26.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.005 0.431 . . . . 0.0 110.927 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.469 179.613 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.585 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 mmt . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -54.93 142.89 74.63 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.55 1.5 . . . . 0.0 112.318 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.35 -34.12 77.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.055 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -62.53 -42.28 99.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.418 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -76.0 -32.51 59.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 0.0 111.817 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.0 t -40.58 -41.66 2.82 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.337 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 37.2 Cg_exo -53.74 -23.34 26.18 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 CA-C-N 119.232 0.761 . . . . 0.0 112.236 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.42 47.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.5 t -60.99 -41.71 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.12 -36.32 92.77 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.443 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mp -58.32 -40.9 83.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.013 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -77.78 -34.5 52.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.676 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.2 mt -66.78 -34.95 78.96 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 t -50.99 -58.06 11.61 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.33 -31.51 93.99 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 120.577 0.852 . . . . 0.0 112.556 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -59.31 -38.12 79.47 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt -64.36 -37.99 89.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.262 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -66.39 -53.27 29.83 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.052 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.14 94.41 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -59.63 -48.95 79.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.018 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.16 -39.42 92.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.064 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.7 90.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.454 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -69.94 -28.91 65.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.099 0.476 . . . . 0.0 110.279 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -56.6 -34.11 66.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.483 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 81.3 t80 -60.27 -47.85 84.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -74.15 -32.51 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.784 0.802 . . . . 0.0 109.936 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -61.32 -41.46 97.05 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.939 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.23 -124.84 2.53 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.133 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.562 ' OE1' ' NE ' ' A' ' 32' ' ' ARG . 78.1 mm-40 -56.88 -28.24 61.56 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.964 0.412 . . . . 0.0 110.857 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.13 -32.74 13.27 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.5 mt -51.33 -42.19 61.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' OE1' ' A' ' 29' ' ' GLU . 72.7 mtm180 -61.53 -42.71 99.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.401 0.62 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.76 -41.76 98.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.603 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 46.8 m-85 -66.32 -22.98 66.29 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.518 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.15 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.169 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.69 84.65 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 34' ' ' TYR . 69.5 mt -90.13 151.07 21.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.744 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.424 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 90.2 mt-30 -97.32 128.27 44.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.058 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HZ3' HH21 ' A' ' 46' ' ' ARG . 55.7 mttt -103.04 143.94 27.62 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -57.03 140.25 92.1 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 120.677 0.918 . . . . 0.0 111.829 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.8 p -64.2 -30.31 71.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.346 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -78.53 -1.58 34.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.462 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.2 t-80 -60.37 126.4 84.3 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.316 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 74.1 Cg_endo -79.73 164.24 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.347 1.365 . . . . 0.0 111.28 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 16.1 Cg_exo -50.78 139.85 39.11 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.341 1.361 . . . . 0.0 111.322 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.588 HH21 ' HZ3' ' A' ' 39' ' ' LYS . 50.2 mtt85 -58.86 -36.13 74.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.981 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.448 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 5.0 p90 -66.98 -24.0 66.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.413 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 52.7 m -67.88 -63.35 1.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.965 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.548 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 71.6 mt -72.19 -34.24 68.26 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.31 -49.56 3.42 Favored Pre-proline 0 C--N 1.321 -0.635 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.671 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' A' ' 47' ' ' TRP . 12.1 Cg_endo -71.43 6.11 2.05 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.034 1.823 . . . . 0.0 114.117 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 22.9 pt -50.09 -25.39 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.158 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 5.0 m-90 -55.03 -34.41 63.49 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.421 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -44.47 97.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.0 m -65.21 -47.57 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.129 0.49 . . . . 0.0 110.557 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -67.71 -34.21 76.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.587 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' TRP . 15.2 t80 -58.88 -50.87 72.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.762 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.1 p -71.03 -33.06 69.96 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.83 -43.14 97.09 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.696 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -64.28 -37.12 86.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.194 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.18 -64.19 3.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -59.94 -39.26 84.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.707 0.289 . . . . 0.0 111.312 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.48 -43.19 85.34 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.8 p -63.95 -27.98 69.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.908 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -57.59 -43.51 84.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.84 -43.41 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.44 -38.63 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.957 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.05 -36.57 79.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.17 -45.68 83.93 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.048 0.452 . . . . 0.0 110.82 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.83 -39.52 76.41 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.07 -2.6 57.59 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.94 7.08 66.45 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.269 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.21 -163.55 29.1 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.14 80.0 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.918 0.866 . . . . 0.0 110.365 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.3 m -119.82 147.4 44.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.556 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -41.11 -37.45 0.87 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.163 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.1 -42.77 96.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.833 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -71.33 -29.41 64.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 83' ' ' GLY . 92.6 mmm -57.21 -34.4 68.49 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.784 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.87 -54.35 57.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.828 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -65.21 -55.65 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 120.439 0.759 . . . . 0.0 112.713 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.57 -42.49 98.93 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.684 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.36 -38.07 95.65 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.7 tp -58.1 -40.28 80.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 110.166 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -61.13 -43.45 98.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.424 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 m -64.84 -41.38 95.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -53.56 5.81 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.261 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.02 -41.87 84.09 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.227 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.2 tp -62.59 -37.64 87.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.117 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -46.25 80.81 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.75 -39.06 87.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.458 HD21 ' CA ' ' A' ' 117' ' ' GLY . 49.0 t-20 -63.52 -37.1 86.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.355 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.415 ' CZ2' ' CA ' ' A' ' 18' ' ' GLY . 1.7 m95 -56.24 -32.4 64.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.359 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.1 75.0 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.439 ' N ' ' HD2' ' A' ' 96' ' ' PRO . 21.0 t-105 -54.78 -56.31 28.88 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 19.9 Cg_endo -57.95 128.61 29.58 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.469 1.446 . . . . 0.0 113.209 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -108.04 -28.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.112 1.875 . . . . 0.0 110.745 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.562 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 22.7 pt -54.21 -30.31 20.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.23 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 21.3 p90 -54.61 -44.64 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.512 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.574 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 78.6 t80 -64.17 -48.35 76.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.589 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.13 -58.07 0.42 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.562 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 57.97 -0.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.589 ' H ' ' C ' ' A' ' 101' ' ' GLY . 14.7 tpt180 -53.56 -33.27 54.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.081 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -84.5 152.95 23.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.288 0.566 . . . . 0.0 111.603 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.615 ' O ' ' N ' ' A' ' 107' ' ' TRP . 2.8 ttp -62.06 -14.7 38.73 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.098 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.39 33.71 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.826 -0.226 . . . . 0.0 113.27 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.7 -20.89 62.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.575 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.06 -23.97 15.61 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.441 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 109' ' ' LEU . 5.8 mp -59.66 -33.86 72.1 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.898 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.0 -37.01 83.24 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 30.0 t0 -61.53 -41.11 96.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.015 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.3 tp -60.51 -57.09 14.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.548 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 2.7 tt -61.85 -41.2 97.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.523 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.7 tp -53.03 -64.91 0.67 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.744 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 95.5 t -69.04 -56.61 11.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.598 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.7 t -69.38 -44.01 72.37 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.458 ' CA ' HD21 ' A' ' 92' ' ' ASN . . . -56.61 -49.41 70.0 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -45.4 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.658 0.266 . . . . 0.0 111.297 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.494 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.68 -56.12 5.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.7 m -58.59 -43.57 89.57 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.99 -58.0 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.054 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.654 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.3 m -63.87 -41.87 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.6 m -61.47 -45.51 93.93 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.74 -36.03 82.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.72 -63.2 1.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.654 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 37.0 m0 -65.75 -42.06 91.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.0 t-80 -59.2 -48.33 82.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.684 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -64.66 -45.21 87.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.865 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.4 t -76.18 -45.43 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.2 p -133.65 86.76 38.47 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.193 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 40.2 Cg_exo -52.7 -42.25 63.94 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.755 1.637 . . . . 0.0 112.873 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -57.09 -31.27 89.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.359 0.706 . . . . 0.0 112.344 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.48 71.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.72 80.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.888 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -59.27 -39.35 82.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.17 -39.43 75.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.2 mt -58.79 -29.79 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.423 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.524 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER 1.83 -63.77 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.7 Cg_endo -51.09 -31.01 33.72 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 120.798 0.999 . . . . 0.0 112.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -59.43 -40.97 88.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.938 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.4 OUTLIER -68.55 -41.98 79.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.649 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.8 34.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.023 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.695 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 1.3 t-105 -63.02 -51.79 65.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.5 mt -62.47 -32.78 73.73 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.704 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.34 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.854 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -61.87 -42.77 99.45 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.661 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.695 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 71.3 p -60.06 -37.26 79.34 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.402 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 55.3 m -60.79 -50.86 71.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.385 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.99 -43.47 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.214 0.53 . . . . 0.0 110.432 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.9 tp -58.82 -40.58 84.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.378 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.483 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.5 m120 -62.6 -41.39 98.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 148' ' ' THR . 54.5 m-85 -65.08 -39.52 93.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.435 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -58.94 -47.14 86.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.59 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.14 -46.17 67.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.447 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 1.3 m0 -62.15 -42.66 99.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -60.08 -29.85 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.582 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 84.2 m-20 -51.7 -40.6 60.43 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.895 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -104.46 -61.84 1.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p -65.81 -29.37 69.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.094 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -55.67 -33.59 59.66 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.275 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -58.29 -34.25 70.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.23 146.08 52.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.682 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.78 -177.3 37.26 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.47 8.8 70.29 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.3 m -57.23 -34.05 68.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.668 0.27 . . . . 0.0 110.682 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -56.0 -37.29 68.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.197 0.522 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.83 150.97 22.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.306 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 169' ' ' GLU . . . -137.33 149.21 46.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.005 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 168' ' ' ALA . 77.2 mm-40 . . . . . 0 C--N 1.322 -0.596 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.524 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.582 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.659 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.305 0.098 . . . . 0.0 111.039 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 1' ' ' MET . 35.0 Cg_exo -55.37 -19.29 21.67 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.355 1.37 . . . . 0.0 111.632 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.78 -31.89 50.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 m -60.53 -42.08 95.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.189 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -77.02 -30.68 55.89 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.836 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 15.1 t -40.56 -48.68 6.99 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 7.6 Cg_endo -57.27 -20.59 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.105 0.716 . . . . 0.0 112.037 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.53 59.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.95 -39.95 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.148 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.17 -36.54 93.57 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.1 mp -60.19 -42.63 95.47 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 57' ' ' TYR . 3.9 t -79.64 -46.12 17.79 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 12' ' ' THR . 93.1 mt -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -50.18 -41.97 69.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.776 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.26 -33.0 89.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.172 . . . . 0.0 113.246 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.53 -39.06 86.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.48 -37.91 89.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.15 -55.63 17.92 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.802 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.42 91.39 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.094 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.11 -47.84 80.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.348 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.1 mtm -64.33 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.798 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.31 -45.19 88.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.654 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.22 64.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.203 0.525 . . . . 0.0 110.929 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -30.99 65.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.036 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 85.4 t80 -63.46 -47.7 80.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -69.45 -32.1 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.87 0.843 . . . . 0.0 109.256 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -64.38 -40.79 96.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.191 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.51 -116.94 2.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.791 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.23 -30.23 62.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 111.123 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.51 -33.13 24.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.5 mt -50.94 -44.44 60.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.365 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -63.35 -41.98 98.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 0.0 111.048 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -59.26 -38.69 80.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.96 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.552 ' O ' ' O ' ' A' ' 37' ' ' LEU . 66.5 m-85 -63.61 -22.73 67.05 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.733 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.85 17.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.677 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.89 -34.23 65.74 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.552 ' O ' ' O ' ' A' ' 34' ' ' TYR . 66.2 mt -92.31 152.35 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 89.8 mt-30 -92.65 128.38 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -106.47 144.22 28.56 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.62 0.248 . . . . 0.0 110.766 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.522 ' CG ' ' CE1' ' A' ' 43' ' ' HIS . 96.2 Cg_endo -62.68 138.64 70.74 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.299 1.999 . . . . 0.0 111.949 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.0 m -84.19 0.54 48.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -101.18 12.04 38.3 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.102 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.77 ' HE2' ' CD1' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -85.3 137.66 36.85 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.759 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.4 171.48 18.0 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.63 1.554 . . . . 0.0 110.796 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB2' ' CE2' ' A' ' 47' ' ' TRP . 3.0 Cg_exo -49.46 145.19 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 120.289 0.659 . . . . 0.0 110.659 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.565 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 36.7 mtt180 -58.62 -33.69 70.32 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.311 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CE2' ' HB2' ' A' ' 45' ' ' PRO . 11.9 p90 -71.83 -11.94 61.04 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -74.77 -68.06 0.58 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.551 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 94.2 mt -67.76 -35.68 79.15 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.322 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.605 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -41.24 -39.65 2.17 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 38.4 Cg_exo -71.03 1.29 5.43 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.892 2.395 . . . . 0.0 113.562 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 15.9 pt -46.21 -37.23 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.726 0.298 . . . . 0.0 111.568 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.605 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.0 m-90 -53.8 -29.52 40.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.921 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 57' ' ' TYR . . . -53.44 -40.87 62.48 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -81.25 -39.61 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 mt -64.73 -38.94 92.68 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 58' ' ' SER . 2.0 p90 -67.68 -44.02 78.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.293 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.525 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 49.6 m -60.67 -42.39 96.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.633 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.57 -43.72 88.91 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.886 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.7 mtt -63.08 -37.51 87.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.779 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.57 -59.14 9.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 47.9 t80 -64.65 -36.96 85.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.863 0.363 . . . . 0.0 110.792 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.81 -42.44 68.91 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.6 p -68.72 -26.26 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.637 0.256 . . . . 0.0 110.669 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 42.7 t80 -55.34 -49.27 72.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.229 0.538 . . . . 0.0 110.225 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.94 -40.92 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.507 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.37 -45.9 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 69' ' ' LYS . 1.2 p90 -69.48 -31.95 70.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.279 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 73.9 mttt -59.66 -37.66 79.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.047 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 83.9 mt-10 -67.12 -35.17 79.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.44 2.3 48.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.41 37.44 10.87 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.013 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.08 -161.09 27.68 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -87.45 109.52 19.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -133.35 168.78 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.176 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.85 -38.68 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.093 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.406 ' H ' HG22 ' A' ' 75' ' ' THR . 85.0 m-20 -63.11 -39.75 95.62 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.626 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.99 66.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.851 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 83' ' ' GLY . 8.8 mtt -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.806 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -58.25 -51.78 79.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.721 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.11 -56.91 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 120.701 0.934 . . . . 0.0 112.428 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.9 mp -63.46 -41.62 98.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.634 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.51 -38.24 95.47 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.1 tp -56.8 -40.24 75.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 110.186 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.6 -44.19 96.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -66.12 -41.59 90.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.152 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.5 -55.04 5.73 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.089 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -59.06 -41.31 87.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 37.8 tp -61.8 -38.89 89.8 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.238 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -46.25 90.53 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.293 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.11 -36.2 83.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.113 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -58.6 -43.18 89.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.948 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -64.42 -32.9 74.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.01 -31.62 72.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 95' ' ' TRP . 8.3 t-105 -54.82 -54.86 44.82 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.15 87.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.034 0 CA-C-N 119.304 0.787 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.58 -18.75 41.51 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.176 1.251 . . . . 0.0 111.843 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.2 pt -58.62 -23.98 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.845 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 5.4 p90 -45.94 -41.31 11.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.555 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 52.7 t80 -67.37 -57.45 6.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.932 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.67 -68.77 0.47 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.84 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' HB3' ' CG ' ' A' ' 25' ' ' PHE . . . 72.73 11.89 5.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.256 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -52.2 -35.56 49.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.333 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -87.17 149.63 24.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.659 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.623 ' C ' ' H ' ' A' ' 107' ' ' TRP . 13.5 ptm -62.56 -16.01 53.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.557 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -44.79 -4.01 0.01 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.565 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.623 ' H ' ' C ' ' A' ' 105' ' ' MET . 1.7 p90 -44.49 -18.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.474 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.29 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.803 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 107' ' ' TRP . 70.8 mt -61.93 -35.6 78.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -62.09 -40.68 96.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 62.3 t0 -61.46 -49.82 75.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.295 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 tp -66.06 -44.11 85.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.02 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 113' ' ' LEU . 1.2 mm? -72.16 -38.78 69.08 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.869 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 17.8 tp -53.02 -62.12 1.86 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.388 0.613 . . . . 0.0 110.816 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.61 -62.87 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.814 -1.084 . . . . 0.0 113.252 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 120' ' ' THR . 44.1 t -69.49 -39.04 77.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.73 -55.86 27.49 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.942 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.75 -37.22 79.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.634 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.486 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.5 -49.19 15.27 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 116' ' ' SER . 37.0 m -56.67 -41.83 77.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -58.14 3.8 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.733 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.532 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 31.8 m -64.72 -40.76 95.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 77.4 m -59.93 -45.62 92.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 99.0 mt -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.88 -63.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.532 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 45.7 m0 -65.41 -41.3 93.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.1 t-80 -58.02 -48.0 81.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.003 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -64.9 -42.99 94.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 70.7 t -78.19 -53.11 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.428 ' HG ' ' CB ' ' A' ' 133' ' ' ALA . 58.6 p -127.31 90.81 47.91 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.3 Cg_exo -52.69 -42.22 64.07 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.866 1.711 . . . . 0.0 113.0 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 26.5 Cg_exo -56.78 -30.45 84.75 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 120.269 0.646 . . . . 0.0 112.258 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.428 ' CB ' ' HG ' ' A' ' 130' ' ' SER . . . -62.77 -28.8 70.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.5 91.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.668 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -59.82 -38.26 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 0.0 110.432 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.6 -35.34 70.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 138' ' ' TYR . 82.9 mt -64.95 -5.05 5.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.204 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -24.55 -53.57 0.15 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.5 -27.8 77.98 Favored 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 121.513 1.475 . . . . 0.0 113.523 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -58.21 -43.34 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.514 -178.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.5 tp -72.01 -41.58 67.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.24 73.54 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.527 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.532 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 2.5 t-105 -64.92 -49.92 68.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.945 0.402 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.9 mt -66.47 -34.38 77.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.849 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.93 79.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.403 ' CZ ' HD23 ' A' ' 150' ' ' LEU . 20.4 t80 -66.41 -45.04 81.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.532 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 68.9 p -58.23 -40.21 81.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.607 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.9 m -60.53 -46.88 88.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.204 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.9 t -68.59 -43.81 83.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 111.721 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.77 ' CD1' ' HE2' ' A' ' 43' ' ' HIS . 0.4 OUTLIER -65.06 -41.9 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.834 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.674 HD22 ' C21' ' A' ' 201' ' ' PKA . 19.4 m120 -60.47 -39.84 89.1 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.046 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -64.69 -39.19 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.75 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.18 -46.09 83.12 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.431 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.0 t -72.25 -46.21 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.474 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 3.5 m95 -61.4 -37.19 82.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 159' ' ' SER . 24.1 mmt85 -56.32 -26.16 51.38 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.889 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.478 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 92.6 m-20 -53.48 -41.86 66.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.754 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -111.01 4.13 19.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.029 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 156' ' ' ARG . 48.2 t -128.65 149.61 50.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.564 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 167.61 -175.75 42.5 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -57.57 -36.74 72.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 110.244 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -56.32 -35.67 67.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.771 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -51.68 -31.14 29.65 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -54.53 -30.72 51.0 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.9 p -59.57 -25.9 64.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.687 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -56.75 -30.92 64.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.746 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.52 146.13 24.34 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -67.03 132.0 46.99 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.146 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 88.9 mt-10 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.674 ' C21' HD22 ' A' ' 151' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.877 0.37 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -55.92 -16.92 17.3 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.801 2.334 . . . . 0.0 112.075 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -51.19 -36.22 40.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.63 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.0 m -64.44 -38.71 91.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.302 0.572 . . . . 0.0 110.288 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.615 ' NE1' ' CE3' ' A' ' 68' ' ' TRP . 1.3 t90 -67.72 -37.16 81.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.739 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 t -44.12 -42.28 11.97 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.415 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -54.54 -23.74 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.311 1.341 . . . . 0.0 112.497 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.98 60.37 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.624 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.41 -42.45 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.9 -34.52 88.81 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.147 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -54.9 -44.43 74.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.886 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 t -78.7 -35.71 44.57 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.885 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.16 -37.7 88.22 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -51.57 -41.93 80.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.679 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -57.58 -27.59 77.53 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.411 1.407 . . . . 0.0 113.674 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.432 ' HG ' ' N ' ' A' ' 17' ' ' LEU . 86.2 p -61.17 -32.75 72.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.432 ' N ' ' HG ' ' A' ' 16' ' ' SER . 82.5 mt -61.59 -38.32 87.14 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.522 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.76 92.37 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.169 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.3 -59.29 3.94 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.775 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -58.79 -46.15 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.3 mmm -62.88 -40.0 96.18 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 -43.2 10.9 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.182 -0.533 . . . . 0.0 111.997 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.473 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -66.72 -21.66 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -53.35 -32.89 51.32 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.279 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 52.3 t80 -59.53 -47.49 85.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -72.94 -34.08 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.647 0.737 . . . . 0.0 109.713 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -61.09 -40.58 94.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.886 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.38 -132.57 2.02 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.987 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.61 -26.34 55.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.168 0.508 . . . . 0.0 110.669 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.41 8.84 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -52.45 -43.96 65.22 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.963 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -60.77 -40.65 93.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.022 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -59.32 -40.49 86.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.216 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' LEU . 57.3 m-85 -63.83 -22.93 67.15 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.974 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.19 10.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.852 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.55 81.59 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 34' ' ' TYR . 32.2 mt -91.23 151.15 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.853 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -98.85 130.76 45.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.032 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.699 ' HZ1' HH21 ' A' ' 46' ' ' ARG . 61.0 mttt -102.93 140.57 21.19 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 31.1 Cg_endo -59.81 132.72 46.77 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.144 1.229 . . . . 0.0 112.414 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.1 m -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.117 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.486 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 5.8 p90 -76.1 -11.96 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.99 147.95 98.42 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.289 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.96 171.63 7.97 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.916 1.744 . . . . 0.0 111.521 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.23 143.64 51.7 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.976 1.784 . . . . 0.0 111.793 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.699 HH21 ' HZ1' ' A' ' 39' ' ' LYS . 38.8 mtt85 -58.9 -37.91 77.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.446 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 10.6 p90 -69.2 -26.89 65.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.497 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.2 m -64.75 -55.12 21.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.521 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 87.0 mt -75.19 -32.49 61.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -38.79 -48.28 3.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.517 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 54' ' ' GLY . 15.6 Cg_endo -71.85 1.78 5.44 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.299 2.0 . . . . 0.0 114.063 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 22.7 pt -44.85 -40.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.82 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.438 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 98.4 m95 -53.25 -33.39 52.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.607 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.39 -41.6 98.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 m -67.09 -49.52 64.71 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.797 0.332 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -67.73 -33.08 74.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' TRP . 4.4 t80 -52.38 -49.72 63.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.823 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.7 p -69.57 -36.63 76.47 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.18 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.4 -44.99 77.49 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.2 mtt -61.98 -37.5 85.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.105 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.68 -53.11 25.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -62.52 -38.38 89.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.931 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.55 -43.38 78.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 86.9 p -62.83 -30.4 71.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -56.76 -46.9 81.14 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.911 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.08 -42.95 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.0 t -61.9 -40.51 87.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.715 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.615 ' CE3' ' NE1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -62.63 -37.38 86.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -61.06 -41.55 96.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -63.94 -40.38 96.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.978 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.163 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 10.53 61.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.21 -162.14 27.88 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.08 111.32 23.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 78' ' ' ALA . 14.5 t -135.27 166.63 22.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -46.78 -33.73 4.65 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -36.57 72.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -63.06 -27.36 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.38 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.1 mmt -55.5 -35.95 66.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.87 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.66 -42.34 91.04 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.589 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -89.64 -71.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 120.826 1.017 . . . . 0.0 112.594 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.05 -43.41 98.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.604 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.77 -43.03 98.24 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.16 -39.13 88.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.232 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.6 -43.24 89.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.1 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.2 m -68.03 -42.9 79.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.139 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.15 -58.8 3.29 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -56.13 -40.91 74.51 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.323 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 13.3 tp -64.18 -40.34 95.91 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.011 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.6 -48.1 76.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.534 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.9 mt -61.21 -39.21 89.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.335 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -61.76 -41.45 97.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.479 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 52.9 m95 -58.96 -29.26 67.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.249 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.5 64.39 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.543 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.9 t-105 -61.59 -66.15 1.72 Allowed Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 85.0 Cg_endo -45.21 85.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.957 1.771 . . . . 0.0 112.543 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' TRP . 83.9 Cg_endo -59.52 -16.54 36.46 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.542 1.495 . . . . 0.0 112.31 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.5 pt -58.57 -26.56 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.581 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.97 -41.89 16.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.022 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.52 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.9 t80 -69.28 -51.99 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.201 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.87 -68.52 0.49 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.185 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 65.43 8.77 5.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 110.447 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -52.43 -35.17 51.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -94.17 154.41 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.259 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.645 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.7 ttm -58.44 -19.03 33.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.255 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -40.98 -8.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.263 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.67 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.645 ' N ' ' O ' ' A' ' 105' ' ' MET . 1.7 p90 -45.31 -16.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.469 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.46 -23.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.098 -178.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.4 mp -60.74 -35.52 76.57 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.738 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.15 96.79 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.459 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 56.3 t0 -63.27 -55.27 26.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.561 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 tp -64.93 -40.21 94.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.847 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.542 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.7 tt -69.56 -46.83 65.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HG ' ' N ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER -72.74 -36.66 67.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.632 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.418 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 42.5 t -70.58 -62.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.532 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -69.55 -39.85 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.12 -52.52 52.88 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.512 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.8 p -64.7 -36.34 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.689 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.519 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.95 -53.52 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -56.91 -41.56 78.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.52 8.92 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.778 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.595 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.8 m -66.07 -41.93 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.2 m -58.9 -46.31 88.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.58 -33.37 71.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.46 -63.91 1.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.595 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 33.9 m0 -64.57 -43.71 93.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.664 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -58.2 -41.73 84.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.391 -177.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -60.64 -43.75 97.18 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.2 t -79.97 -46.79 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.416 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 p -135.64 93.55 15.92 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.483 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 53.2 Cg_exo -54.7 -39.13 90.69 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.84 1.694 . . . . 0.0 113.101 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 44.7 Cg_exo -55.67 -27.97 63.66 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.536 0.824 . . . . 0.0 112.652 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.66 71.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.14 87.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.123 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.436 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 75.1 ttt180 -60.76 -39.68 89.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 138' ' ' TYR . 18.2 tp -54.5 -37.41 65.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.207 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.506 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 76.0 mt -65.06 13.25 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.456 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -46.09 -42.53 27.42 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.506 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 17.9 Cg_endo -67.14 -19.84 50.58 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.985 1.388 . . . . 0.0 112.885 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.45 -38.46 87.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 24.9 tp -65.94 -38.85 89.69 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.668 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.73 76.28 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.764 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.604 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -68.45 -52.02 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.366 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -33.85 76.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.417 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 141' ' ' LEU . . . -60.72 -46.56 89.95 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.608 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -64.07 -40.09 95.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.551 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.7 m -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.375 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.9 m -63.95 -48.21 77.4 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.392 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.84 -40.48 78.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.172 0.511 . . . . 0.0 110.564 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 58.6 tp -55.04 -54.32 44.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.558 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.459 ' OD1' ' CG ' ' A' ' 111' ' ' ASP . 9.4 m120 -63.36 -36.65 84.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.602 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.487 ' CE2' ' NH1' ' A' ' 156' ' ' ARG . 20.8 t80 -58.4 -42.27 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.592 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -63.36 -47.0 83.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.386 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.03 -48.5 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.469 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 2.2 m95 -63.5 -39.35 94.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.662 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.487 ' NH1' ' CE2' ' A' ' 152' ' ' TYR . 29.8 ttp-105 -57.88 -37.79 74.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.358 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.97 -43.06 95.31 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.3 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -89.9 -49.48 6.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 155' ' ' TRP . 70.0 p -63.31 -24.53 67.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -53.16 -29.29 36.21 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -54.8 -33.88 62.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.753 0.311 . . . . 0.0 110.328 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -57.9 -33.38 68.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.55 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -84.12 -175.2 50.75 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.23 -179.57 17.28 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.6 m -117.58 148.85 41.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.55 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -57.42 -33.02 67.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.176 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -93.53 143.48 26.26 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.689 -0.404 . . . . 0.0 109.922 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -87.87 119.2 27.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.98 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.512 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.613 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.643 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.788 0.328 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -56.87 -20.35 35.63 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.28 1.986 . . . . 0.0 112.386 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.31 -31.34 32.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.465 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.0 t -61.0 -41.56 96.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.396 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -73.65 -33.92 64.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.934 0.397 . . . . 0.0 111.955 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t -41.03 -49.85 7.9 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.0 Cg_endo -57.05 -20.17 36.2 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 CA-C-N 119.231 0.761 . . . . 0.0 112.513 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -33.78 54.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.124 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.42 -40.74 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.03 92.83 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.36 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.85 -41.67 82.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.863 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -78.83 -35.97 43.21 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.105 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.34 -37.03 84.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 t -52.35 -55.93 27.14 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.98 -34.5 99.18 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 120.697 0.931 . . . . 0.0 113.124 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.14 -37.16 79.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.146 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.0 -39.5 94.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.48 -48.35 69.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.784 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.76 96.8 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.248 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -58.65 -45.63 88.92 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.607 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -61.78 -38.77 89.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.135 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.93 93.85 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.495 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.22 -26.61 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.975 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -35.52 69.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.081 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 65.0 t80 -61.34 -46.0 92.06 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.271 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.38 -33.14 39.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.0 109.568 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -62.5 -40.67 97.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.531 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.87 -128.92 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.915 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.98 -27.72 61.7 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.698 0.285 . . . . 0.0 110.934 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.24 -32.27 6.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.6 ' CD2' ' HE ' ' A' ' 46' ' ' ARG . 94.9 mt -51.55 -45.06 62.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -65.39 -40.9 94.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 111.563 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -57.83 -37.48 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.23 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 78.6 m-85 -63.89 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.979 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -43.97 -41.91 5.62 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.353 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.5 -32.19 71.36 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 34' ' ' TYR . 34.4 mt -92.52 154.55 18.38 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.311 -0.444 . . . . 0.0 111.069 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 93.5 mm-40 -103.19 129.13 50.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mttp -103.23 145.15 30.05 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -57.08 136.1 74.59 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 120.881 1.054 . . . . 0.0 111.122 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.8 p -64.54 -25.92 68.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.005 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -79.45 -4.86 53.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.574 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.607 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.8 t-80 -53.85 130.06 56.65 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.637 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.607 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.8 Cg_endo -87.12 170.94 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.073 1.849 . . . . 0.0 111.219 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -49.92 138.39 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 120.42 0.746 . . . . 0.0 110.911 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HE ' ' CD2' ' A' ' 31' ' ' LEU . 38.1 mtt-85 -59.61 -36.49 76.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 8.0 p90 -72.6 -19.55 61.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.742 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -66.46 -63.35 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.871 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.53 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 85.4 mt -71.9 -33.07 68.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -37.38 -50.11 2.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.814 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 10.2 Cg_endo -70.77 2.19 4.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.342 2.028 . . . . 0.0 114.286 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CD1' ' CE2' ' A' ' 143' ' ' TRP . 23.8 pt -45.22 -38.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.199 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.481 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 99.8 m95 -52.18 -29.11 20.8 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.718 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.01 -44.33 92.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.567 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -74.04 -44.76 53.18 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.199 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.74 -33.07 75.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.179 0.514 . . . . 0.0 109.664 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' TRP . 2.1 t80 -55.41 -57.55 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.841 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -66.0 -38.72 89.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.812 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.44 90.76 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.6 mtt -61.14 -37.86 84.34 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.33 -54.0 22.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -63.11 -39.32 94.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.962 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.7 -41.36 74.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 90.8 p -66.28 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' CZ ' ' CE ' ' A' ' 69' ' ' LYS . 56.0 t80 -56.44 -48.69 76.49 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.46 -39.71 86.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.201 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.5 t -57.4 -49.02 81.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.3 p90 -73.64 -26.13 60.62 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.084 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CE ' ' CZ ' ' A' ' 65' ' ' TYR . 70.2 mmtt -59.87 -37.64 79.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.324 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 77.2 mt-10 -67.67 -41.03 84.39 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.374 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.3 mt -72.83 -25.81 61.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.754 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 103.42 45.9 1.5 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.98 -168.03 35.17 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.627 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.54 109.98 17.23 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.709 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.1 t -128.74 164.55 22.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.611 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -52.43 -37.88 57.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.414 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' H ' HG23 ' A' ' 75' ' ' THR . 85.2 m-20 -63.65 -38.96 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.714 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.45 71.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.627 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 82.0 mmm -59.22 -33.01 70.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.476 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.36 -56.96 26.11 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.957 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -65.14 -52.78 1.03 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.654 0.903 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.29 -42.37 99.08 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.411 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.45 -38.33 95.58 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.7 tp -57.86 -40.0 79.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.727 0.299 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -60.67 -45.99 92.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.549 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.5 m -67.74 -41.57 83.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.076 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.52 -55.15 5.66 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.431 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -57.9 -41.37 82.49 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.23 -37.97 84.95 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.061 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.95 86.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.472 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.26 -39.14 85.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.456 ' ND2' ' CA ' ' A' ' 117' ' ' GLY . 39.3 t-20 -64.44 -37.79 88.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.325 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -53.99 -32.18 53.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.19 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.22 70.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -55.84 -56.81 26.24 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.37 130.26 39.65 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 120.721 0.947 . . . . 0.0 112.969 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.447 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 41.5 Cg_endo -107.63 -24.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.568 1.512 . . . . 0.0 110.372 177.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.541 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 34.7 pt -60.54 -28.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.884 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 24.3 p90 -55.8 -44.34 77.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.2 t80 -65.42 -50.29 66.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.677 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.531 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.75 -57.11 0.4 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 61.19 -1.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.566 0.222 . . . . 0.0 110.908 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 101' ' ' GLY . 61.6 ttt180 -54.58 -34.5 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.061 0.458 . . . . 0.0 110.376 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -86.15 157.9 19.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.222 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.707 ' C ' ' H ' ' A' ' 107' ' ' TRP . 4.1 tpp -57.4 -13.74 3.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.471 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.07 -1.58 0.01 OUTLIER Glycine 0 CA--C 1.539 1.539 0 C-N-CA 121.703 -0.284 . . . . 0.0 112.418 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.707 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.83 -22.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.411 -0.464 . . . . 0.0 111.079 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.591 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.8 -28.13 68.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.202 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.58 -30.34 68.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.42 -37.46 78.1 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.474 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 t0 -63.01 -44.21 96.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.0 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.01 -53.32 55.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 117' ' ' GLY . 3.0 tt -64.1 -40.37 96.07 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.824 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.9 tp -51.03 -63.8 1.01 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.938 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.1 t -69.53 -55.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.942 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 t -67.63 -44.9 76.87 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.456 ' CA ' ' ND2' ' A' ' 92' ' ' ASN . . . -56.72 -48.35 78.4 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.499 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.21 -46.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.392 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -54.23 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.2 m -59.91 -44.18 94.42 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.32 -58.27 3.94 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.149 -0.621 . . . . 0.0 112.183 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.613 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.2 m -64.79 -40.95 96.07 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 76.7 m -60.01 -45.92 91.17 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.49 -37.32 87.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.83 -63.52 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.613 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.94 -42.3 97.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.419 ' CB ' ' O ' ' A' ' 123' ' ' THR . 29.0 t-80 -59.61 -48.21 82.54 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.322 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.72 -43.4 93.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.894 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.483 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 93.4 t -78.51 -47.8 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.1 p -133.42 90.42 29.48 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.5 Cg_exo -55.32 -42.65 66.3 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.712 1.608 . . . . 0.0 112.541 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 21.7 Cg_exo -57.23 -28.48 79.72 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 120.323 0.682 . . . . 0.0 111.987 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -31.41 71.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.101 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.17 81.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.277 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -58.03 -39.24 77.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 110.206 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.05 -36.76 78.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.897 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 71.7 mt -67.47 -5.19 13.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.086 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -25.3 -58.75 0.16 Allowed Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.27 -28.99 79.49 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 120.643 0.895 . . . . 0.0 113.273 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -57.43 -45.09 85.05 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.473 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 22.8 tp -65.39 -39.75 92.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.01 82.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.133 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.659 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.7 t-105 -64.06 -45.6 88.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.571 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 40.4 mt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.33 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.28 97.01 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.321 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 150' ' ' LEU . 67.6 t80 -63.64 -44.53 93.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.116 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.659 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 2.1 m -62.74 -42.4 99.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.737 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.1 m -57.37 -49.83 74.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.399 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.19 -41.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.325 0.583 . . . . 0.0 110.75 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.451 HD13 ' CZ ' ' A' ' 146' ' ' PHE . 9.6 tt -60.33 -44.12 95.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.322 -0.853 . . . . 0.0 112.028 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 147' ' ' THR . 18.0 m120 -64.28 -41.0 97.1 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.38 -36.82 85.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.041 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -57.03 -44.8 83.25 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.546 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.76 -47.12 80.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.667 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.412 ' O ' ' N ' ' A' ' 159' ' ' SER . 0.5 OUTLIER -64.32 -45.43 87.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.521 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 160' ' ' GLY . 70.7 mtm180 -61.04 -32.53 72.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.079 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 92.6 m-20 -52.95 -40.12 63.43 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -97.46 -56.75 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.288 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 155' ' ' TRP . 88.7 p -63.08 -22.71 67.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.904 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -49.33 -27.88 8.44 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -56.11 -30.77 62.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.937 0.399 . . . . 0.0 110.268 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -117.08 146.71 42.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -130.74 58.0 0.71 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -79.61 -176.33 48.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.2 p -68.97 162.35 26.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -56.78 -34.18 67.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.068 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.65 146.42 23.84 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 110.075 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -137.31 147.46 45.65 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 168' ' ' ALA . 96.2 mt-10 . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.533 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.644 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.651 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.3 mmm . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -56.37 -23.85 48.85 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.546 1.497 . . . . 0.0 111.676 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.26 -32.34 72.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.201 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -61.5 -42.92 99.53 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.456 ' CD1' ' CE3' ' A' ' 68' ' ' TRP . 7.4 m0 -72.9 -33.14 65.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 111.964 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 t -42.73 -44.25 9.81 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -54.35 -22.46 26.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 120.72 0.946 . . . . 0.0 112.153 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.18 -32.01 45.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.695 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.1 t -59.93 -41.84 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.68 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.56 -35.92 92.47 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.44 -42.02 86.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.682 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 t -76.71 -34.35 58.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.845 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.497 ' O ' ' OG ' ' A' ' 16' ' ' SER . 95.7 mt -67.47 -34.69 77.67 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.0 t -46.95 -56.2 12.67 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.85 -29.19 87.66 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 120.826 1.017 . . . . 0.0 113.347 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 79.7 p -61.17 -36.74 80.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.612 -0.435 . . . . 0.0 112.061 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.7 -39.22 93.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.288 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.12 -40.14 98.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.55 99.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.236 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE1' ' CZ3' ' A' ' 53' ' ' TRP . 57.9 m-85 -61.86 -49.09 77.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.916 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.6 mtm -64.88 -40.35 94.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.438 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.55 60.9 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.837 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.522 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -75.05 -22.45 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.158 0.504 . . . . 0.0 111.015 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -35.35 69.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.764 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 58.8 t80 -60.7 -48.15 83.09 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.1 -31.48 29.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.3 ttt-85 -60.6 -42.55 97.02 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.323 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -129.35 5.41 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.996 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.56 -29.65 3.0 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.588 0.233 . . . . 0.0 110.442 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.39 -35.24 27.89 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.5 mt -50.5 -45.19 56.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -62.71 -38.55 90.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -58.62 -38.02 77.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.298 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' LEU . 86.9 m-85 -62.05 -22.36 65.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.742 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.83 -32.36 1.54 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.079 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.18 -32.3 20.61 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 34' ' ' TYR . 56.0 mt -93.35 150.52 20.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.992 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -98.3 132.61 43.64 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.72 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 42.1 mttt -105.82 145.54 31.08 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -60.91 143.36 99.34 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.454 1.436 . . . . 0.0 112.212 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.1 p -64.27 -29.93 71.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.526 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 41.6 p90 -78.32 3.24 16.06 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.106 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.476 ' HE2' ' C2 ' ' A' ' 201' ' ' PKA . 41.4 t-80 -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.031 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.75 167.7 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.181 1.254 . . . . 0.0 111.842 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -52.44 140.87 52.94 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.65 1.567 . . . . 0.0 111.533 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.72 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 39.4 mtt85 -61.77 -35.63 78.7 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.611 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -72.25 -14.58 61.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -76.94 -67.18 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.002 0.429 . . . . 0.0 110.663 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.554 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 81.2 mt -67.52 -33.07 74.34 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.744 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' O ' ' CE3' ' A' ' 53' ' ' TRP . . . -42.72 -41.12 5.49 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.789 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 71.0 Cg_exo -64.21 -9.53 20.09 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 123.239 2.626 . . . . 0.0 113.953 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 32.1 pt -45.11 -32.5 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.773 0.32 . . . . 0.0 111.252 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.599 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 6.2 m0 -53.61 -31.27 46.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.34 -43.81 95.46 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.9 p -71.75 -44.87 63.32 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.611 -0.347 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.94 -33.69 76.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.865 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -61.18 -50.98 70.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.376 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -73.36 -33.71 65.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.82 89.13 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.845 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtt -64.25 -36.94 85.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.567 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.41 -64.5 3.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.53 -37.32 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.125 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.89 -42.7 60.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 86.9 p -67.14 -26.75 66.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.59 0.233 . . . . 0.0 110.544 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.75 -49.69 72.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 110.356 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.31 -35.02 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.77 -46.75 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.001 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.456 ' CE3' ' CD1' ' A' ' 5' ' ' TRP . 1.6 p90 -74.22 -31.54 62.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.145 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 68.3 mmtt -59.76 -39.08 83.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.215 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.82 -38.4 88.83 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.85 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.14 -13.18 56.11 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.945 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 98.07 1.6 58.31 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.61 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 136.09 -166.5 24.65 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.716 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.92 102.09 11.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.369 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 p -124.33 164.92 18.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.21 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.43 -37.03 10.79 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.341 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.31 -45.0 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.245 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.64 -35.14 62.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 111.392 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.716 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.3 mmm -58.7 -34.03 70.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -60.21 -60.73 9.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.65 -50.29 11.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.997 1.131 . . . . 0.0 112.151 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.89 -40.85 91.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.852 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.92 96.73 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.53 -40.01 85.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 68.5 t80 -60.93 -45.58 94.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.742 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 m -65.23 -42.93 92.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.0 -57.55 3.69 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.37 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -57.19 -41.98 80.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.419 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 41.4 tp -62.93 -39.22 93.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.91 65.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.153 0.502 . . . . 0.0 110.338 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.45 -38.61 84.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -61.49 -40.67 95.43 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.272 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.546 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 33.0 m95 -58.11 -27.93 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.77 -23.0 65.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.019 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.497 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 20.0 t-105 -54.13 -64.43 1.88 Allowed Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.546 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 86.2 Cg_endo -55.46 130.36 40.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.992 1.795 . . . . 0.0 112.584 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -100.81 -15.55 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.34 1.36 . . . . 0.0 111.105 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 29.7 pt -59.37 -30.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.29 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.548 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 30.7 p90 -55.63 -44.76 77.42 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.913 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.548 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 71.6 t80 -64.86 -48.94 72.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.542 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.08 -59.62 0.42 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 60.09 -1.92 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.691 0.281 . . . . 0.0 110.836 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.542 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.4 ttt180 -52.91 -35.71 58.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.957 0.408 . . . . 0.0 110.44 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -87.83 157.46 19.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.365 0.602 . . . . 0.0 111.797 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.716 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.0 ttm -56.32 -13.56 2.26 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.684 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.08 -2.59 0.01 OUTLIER Glycine 0 CA--C 1.541 1.673 0 C-N-CA 121.493 -0.384 . . . . 0.0 112.637 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.716 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.36 -20.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.475 -0.427 . . . . 0.0 111.273 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.02 -28.51 67.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.89 -30.92 70.45 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.269 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.11 -35.89 76.23 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.485 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.5 t0 -64.65 -46.09 83.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 tp -63.99 -48.39 76.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.528 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 4.5 tt -64.95 -40.3 94.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.493 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.2 tp -55.02 -63.75 1.05 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.311 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.9 t -67.04 -53.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -75.32 -41.74 56.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.87 85.64 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.675 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 t -71.44 -45.46 68.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.039 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.518 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.83 -57.35 4.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 m -57.23 -44.67 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -55.35 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.96 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.647 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.3 m -65.18 -41.5 94.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 83.8 m -59.67 -46.8 87.94 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.16 -35.64 80.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.79 -63.01 1.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.647 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.96 -43.98 94.14 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -59.67 -45.61 91.53 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.621 -0.831 . . . . 0.0 111.616 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.35 -41.37 96.94 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.339 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.8 t -80.78 -49.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.8 p -132.01 89.64 37.7 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.255 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.9 Cg_exo -53.85 -41.89 70.99 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.943 1.762 . . . . 0.0 113.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.9 Cg_exo -55.72 -31.52 80.43 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.613 0.875 . . . . 0.0 112.721 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.32 67.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.462 . . . . 0.0 110.652 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.6 87.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.871 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.529 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 71.5 mtm180 -63.61 -37.98 89.39 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.913 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -51.63 -38.55 55.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.498 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 70.6 mt -57.65 -31.3 66.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.171 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER 4.42 -65.43 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.9 Cg_endo -51.56 -28.5 28.91 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 120.867 1.044 . . . . 0.0 112.847 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -61.9 -35.38 78.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.002 0.43 . . . . 0.0 110.319 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.2 tm? -67.12 -45.49 77.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.064 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.46 41.04 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.609 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 3.6 t-105 -61.4 -50.81 71.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.453 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.6 mt -64.3 -31.83 73.18 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.36 93.9 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.711 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 150' ' ' LEU . 19.0 t80 -66.99 -44.74 79.65 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.483 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.609 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 4.1 m -56.91 -42.07 79.26 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.427 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.6 m -60.65 -50.48 73.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.935 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.4 -40.98 85.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.345 0.593 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 17.6 tp -55.61 -46.07 77.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.739 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.602 ' ND2' ' O ' ' A' ' 147' ' ' THR . 69.1 m-80 -62.65 -38.89 92.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -64.11 -39.94 95.13 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.422 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -60.09 -45.89 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.939 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.49 -47.14 78.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.93 -41.45 82.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -57.67 -41.88 82.46 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.885 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -63.49 -49.57 73.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.112 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.55 -43.04 67.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.324 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.5 p -66.87 -26.84 67.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.435 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -55.21 -33.26 57.78 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -56.87 -31.95 65.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.72 0.295 . . . . 0.0 111.26 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -53.76 -35.32 61.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.088 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -52.6 -34.85 44.07 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -56.11 -31.39 58.92 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 88.3 p -60.27 -26.42 66.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.555 0.217 . . . . 0.0 110.862 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -53.49 -37.59 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.732 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.52 -33.33 75.35 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.427 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -76.01 126.68 31.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.536 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 92.4 mt-10 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.546 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.709 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.657 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 1' ' ' MET . 40.1 Cg_endo -55.8 -19.55 25.35 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.426 2.084 . . . . 0.0 112.066 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.91 -33.28 68.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.997 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.6 p -63.4 -38.62 91.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.397 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 8' ' ' ALA . 11.2 m0 -75.13 -32.42 61.35 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.698 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.41 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.6 t -40.79 -54.57 5.19 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.184 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 14.3 Cg_endo -59.62 -23.61 71.98 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 120.316 0.678 . . . . 0.0 111.443 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 5' ' ' TRP . . . -56.2 -34.62 66.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.197 0.522 . . . . 0.0 110.384 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.43 -41.07 86.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.86 -35.68 91.68 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.1 -44.87 87.9 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 t -79.11 -37.19 39.29 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.21 -31.83 73.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 t -47.14 -56.47 12.1 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -60.45 -28.79 87.38 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.073 1.182 . . . . 0.0 113.25 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.0 m -57.29 -39.26 75.38 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.249 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.79 -40.17 91.69 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.006 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.25 -49.27 47.22 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.98 93.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.39 -43.51 88.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.92 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.9 mtt -60.75 -40.05 91.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.263 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.64 83.32 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.429 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.19 -29.16 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.295 0.569 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -36.15 73.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.468 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 62.0 t80 -61.15 -47.55 85.72 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' O ' ' NH1' ' A' ' 46' ' ' ARG . 1.2 m -71.26 -31.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.839 0.828 . . . . 0.0 109.337 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -67.47 -41.03 85.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.781 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.91 -120.37 0.66 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.343 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.77 -28.51 61.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.899 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.93 -32.81 19.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.6 mt -49.93 -46.98 52.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.326 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -62.98 -39.89 96.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.55 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -59.64 -39.92 85.95 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.108 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 37' ' ' LEU . 76.2 m-85 -63.93 -23.07 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.08 -42.76 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.6 75.15 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 34' ' ' TYR . 38.8 mt -91.55 152.19 20.41 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.064 0.459 . . . . 0.0 111.454 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.545 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.9 mt-30 -101.16 129.09 47.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.657 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 31.7 mttt -100.14 142.86 25.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -59.38 135.59 66.2 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.206 1.271 . . . . 0.0 111.702 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.3 p -68.59 -23.32 64.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.307 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 10.4 p90 -78.55 -10.19 59.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.579 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.596 ' NE2' ' O ' ' A' ' 44' ' ' PRO . 1.5 t-80 -69.99 133.49 88.0 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.46 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.596 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 18.2 Cg_endo -75.97 163.2 33.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.243 1.295 . . . . 0.0 110.675 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -50.13 146.7 17.05 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 120.48 0.786 . . . . 0.0 111.094 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.657 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 62.8 mtt180 -57.52 -37.08 72.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 48' ' ' THR . 4.5 p90 -63.34 -31.05 72.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.654 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 16.1 m -63.18 -55.67 23.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.557 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 96.4 mt -73.24 -35.6 66.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.41 -50.18 3.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.441 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 17.9 Cg_endo -71.01 6.54 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.979 1.786 . . . . 0.0 113.822 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.557 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 13.8 pt -44.21 -33.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.257 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.611 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.1 m-90 -53.54 -28.24 30.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.875 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 57' ' ' TYR . . . -52.52 -38.59 51.78 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.7 t -87.1 -41.74 13.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.684 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.458 ' N ' ' CG2' ' A' ' 55' ' ' THR . 9.8 mt -61.25 -38.97 88.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 58' ' ' SER . 1.4 p90 -64.6 -43.64 93.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.906 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 26.9 m -61.2 -39.75 91.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.34 99.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.492 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mtt -63.08 -36.15 82.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.67 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -66.08 -65.22 2.95 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.36 -38.46 87.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.84 -43.12 81.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 87.5 p -64.88 -27.54 68.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.851 0.358 . . . . 0.0 110.041 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' CE2' ' CZ2' ' A' ' 5' ' ' TRP . 30.6 t80 -57.98 -44.49 87.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.48 -42.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.9 -37.94 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.592 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.7 -37.8 85.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.931 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -64.59 -45.23 87.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -68.92 -39.56 79.56 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.4 mt -91.48 -0.51 57.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.39 5.99 66.7 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.24 -165.79 30.42 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.466 -0.397 . . . . 0.0 112.301 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.08 80.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.292 0.568 . . . . 0.0 111.511 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.9 p -125.59 162.04 25.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.764 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -44.32 -38.87 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.99 -46.33 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.738 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 73' ' ' GLY . . . -76.33 -32.79 58.88 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.3 mtp -56.53 -32.8 65.46 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.235 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.28 -47.2 94.83 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.725 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -66.16 -56.72 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.617 0.878 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.7 mp -60.04 -41.35 92.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.94 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.86 93.52 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.0 -39.58 78.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.877 0.37 . . . . 0.0 110.049 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 81.0 t80 -60.07 -44.8 94.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 48.8 m -68.51 -41.35 80.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.56 -64.21 2.54 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.653 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -57.16 -40.61 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.853 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.422 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 30.2 tp -63.01 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -49.92 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.57 -38.71 85.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 63.7 t30 -62.14 -41.15 97.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.351 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.473 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 35.5 m95 -56.75 -30.58 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.747 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.94 -24.38 66.06 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' PRO . 14.5 t-105 -54.99 -70.92 0.26 Allowed Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 53.0 Cg_endo -43.32 82.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.949 1.766 . . . . 0.0 112.641 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' N ' ' O ' ' A' ' 95' ' ' TRP . 90.3 Cg_endo -58.91 -16.84 33.96 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.108 1.872 . . . . 0.0 112.57 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.6 pt -59.01 -25.03 28.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.049 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.36 -44.63 17.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.492 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 67.3 t80 -66.95 -50.39 62.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.76 -68.99 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.271 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 62.12 7.22 2.07 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -50.5 -35.94 31.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.251 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -90.36 153.43 20.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.678 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.677 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ttp -59.02 -16.45 18.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.03 13.84 0.01 OUTLIER Glycine 0 CA--C 1.539 1.568 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.194 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.677 ' H ' ' C ' ' A' ' 105' ' ' MET . 1.8 p90 -60.5 -18.7 53.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.923 0.862 . . . . 0.0 112.02 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.39 -19.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.3 mp -62.46 -35.13 78.34 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.814 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.69 89.31 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.2 t0 -62.24 -45.13 94.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.409 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 tp -63.29 -47.64 81.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.625 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.4 tt -68.92 -40.96 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.518 0.675 . . . . 0.0 109.965 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.2 tp -52.21 -60.31 3.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.095 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.4 t -69.83 -57.11 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.737 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 120' ' ' THR . 25.4 t -67.92 -41.74 82.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -56.55 -48.12 79.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.457 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.2 t -71.09 -46.61 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.096 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.523 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -74.46 -54.96 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 116' ' ' SER . 26.6 m -57.41 -44.3 84.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.96 3.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.825 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.652 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 26.8 m -62.13 -40.28 95.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.51 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 82.2 m -61.65 -44.74 96.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.98 -36.69 84.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.26 -63.6 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.652 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.5 m0 -66.92 -42.33 85.58 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 52.0 t-80 -58.03 -47.28 83.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.241 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.53 -44.4 94.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.61 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.63 -49.96 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -132.49 89.94 34.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.464 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 41.1 Cg_exo -52.54 -41.21 69.5 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.447 1.431 . . . . 0.0 112.786 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.1 Cg_exo -57.45 -28.27 79.81 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 120.348 0.699 . . . . 0.0 112.713 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.58 71.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.142 0.496 . . . . 0.0 110.281 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.16 90.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.3 ttt-85 -59.11 -39.85 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.5 tp -57.33 -38.07 73.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.088 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.617 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.7 mt -57.91 -31.28 66.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.385 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 8.56 -68.74 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' A' ' 137' ' ' LEU . 4.8 Cg_endo -49.74 -27.37 15.18 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 120.727 0.951 . . . . 0.0 113.072 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -61.77 -40.72 96.13 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.103 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -66.57 -41.98 87.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.734 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.58 -51.74 26.31 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.524 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 2.7 t-105 -61.54 -49.61 75.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.05 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 52.2 mt -64.44 -34.16 77.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.1 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.06 95.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.883 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -60.86 -42.06 97.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.568 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.524 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 79.7 p -61.49 -35.59 78.09 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.537 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.3 m -63.95 -52.38 59.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.042 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.0 -42.64 82.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.113 0.483 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.26 -41.48 75.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.234 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.43 -42.32 96.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -64.56 -40.5 95.68 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.472 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -59.97 -46.93 87.83 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.632 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.9 -45.5 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.443 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 3.5 m95 -59.82 -40.36 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.07 -30.04 68.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.578 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 95.1 m-20 -50.37 -39.97 48.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.15 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -102.13 -60.5 1.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.278 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.518 ' OG ' ' NH2' ' A' ' 162' ' ' ARG . 22.8 t -60.45 -36.13 77.49 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.848 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.78 -31.92 39.39 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -54.75 -34.81 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.38 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.518 ' NH2' ' OG ' ' A' ' 159' ' ' SER . 78.4 mtm180 -55.56 -34.52 64.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.482 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.87 -177.81 50.14 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.47 -159.58 38.86 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.0 t -85.13 145.23 27.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.901 0.381 . . . . 0.0 110.71 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -57.21 -32.03 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.935 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.3 145.6 26.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.966 0.412 . . . . 0.0 110.0 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -83.4 124.79 31.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.672 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 91.4 mt-10 . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.558 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.607 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 mmt . . . . . 0 C--O 1.232 0.163 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -56.11 -24.57 50.22 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.394 1.396 . . . . 0.0 111.426 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -59.87 -31.07 69.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.199 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -61.49 -40.64 95.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.373 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -73.57 -34.88 65.35 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t -41.15 -41.14 3.02 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 87.2 Cg_exo -53.62 -22.33 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.137 1.224 . . . . 0.0 112.346 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.48 62.86 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.932 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.64 -44.02 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.5 89.93 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.334 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.409 HD11 ' N ' ' A' ' 11' ' ' LEU . 9.7 mp -56.53 -40.9 75.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 111.265 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 t -79.0 -32.9 45.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -61.72 -37.45 84.24 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 t -53.75 -42.78 94.33 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.416 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.46 -37.44 71.16 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.392 1.395 . . . . 0.0 113.348 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.9 m -60.05 -38.58 83.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.92 -38.94 87.53 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.417 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.36 99.88 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.106 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.79 -42.18 97.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.963 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 24' ' ' TYR . 58.7 m-85 -61.89 -39.66 92.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -60.76 -39.34 88.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.675 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.54 -46.48 25.12 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.526 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.53 -22.85 62.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.231 0.538 . . . . 0.0 110.209 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -55.68 -33.47 64.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 29.8 t80 -64.6 -49.88 69.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.394 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.49 -37.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.791 0.805 . . . . 0.0 109.65 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -59.27 -39.83 84.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.351 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -129.12 2.23 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.695 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.87 -27.03 62.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 110.981 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -32.39 10.07 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -50.76 -45.25 58.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.835 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -60.57 -41.91 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.23 -41.46 98.42 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 23.0 m-85 -64.02 -22.89 67.12 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.689 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.44 -41.46 52.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.003 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.36 -29.86 74.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 34' ' ' TYR . 50.2 mt -91.14 150.11 21.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.544 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -100.9 128.63 46.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 18.8 mtpp -109.9 139.22 21.09 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 39.2 Cg_endo -60.41 130.71 34.93 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.172 1.248 . . . . 0.0 112.515 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.4 m -66.67 -23.1 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.206 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.51 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 3.7 p90 -75.91 -15.5 60.18 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.606 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 1.2 p80 -72.62 143.29 84.75 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.429 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -69.42 161.97 43.78 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.808 1.005 . . . . 0.0 110.849 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.27 152.76 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.144 1.23 . . . . 0.0 110.931 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -55.57 -36.24 66.63 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 9.2 p90 -71.88 -14.67 62.01 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.886 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -80.06 -68.4 0.68 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.29 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.538 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 91.8 mt -62.11 -34.61 76.65 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.556 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' CB ' ' CD ' ' A' ' 51' ' ' PRO . . . -44.97 -41.8 13.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.724 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 50' ' ' ALA . 85.4 Cg_exo -63.62 -8.64 15.79 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 123.217 2.611 . . . . 0.0 113.958 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CD1' ' CE2' ' A' ' 143' ' ' TRP . 25.3 pt -40.99 -40.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.369 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' TYR . 99.9 m95 -53.21 -33.7 53.93 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.172 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.0 -38.88 96.24 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.0 m -68.52 -51.74 39.76 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.067 0.46 . . . . 0.0 110.616 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.25 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.923 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' TRP . 20.9 t80 -50.86 -53.32 33.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.022 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.8 p -67.9 -34.99 77.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.981 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.58 93.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.521 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.57 -38.14 90.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.56 -57.86 9.44 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.46 -0.876 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -62.43 -36.5 82.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.639 0.257 . . . . 0.0 111.287 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -42.8 84.31 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.427 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -65.36 -30.12 70.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.394 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -58.92 -43.84 91.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.416 . . . . 0.0 110.006 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.07 -40.11 82.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 109.967 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.02 -40.48 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.963 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -62.42 -49.56 74.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.517 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.595 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 75.2 mttt -54.44 -37.15 64.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.421 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -71.54 -43.61 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.495 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -77.89 -26.11 48.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.54 -3.6 46.54 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.76 -169.3 26.12 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.05 95.74 8.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.56 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -122.99 174.29 7.28 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.968 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.45 -35.37 39.3 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 87.7 m-20 -63.97 -39.88 95.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.73 -40.33 17.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.785 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.68 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.2 mmm -59.1 -36.17 74.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.531 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.94 -56.82 25.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.409 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 18.2 Cg_endo -62.94 -53.69 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.071 1.181 . . . . 0.0 112.234 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.53 -41.37 98.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.802 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.9 96.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.29 -38.97 78.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -59.56 -44.88 93.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.484 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.8 m -69.67 -41.33 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.71 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.96 -61.93 2.76 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.982 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -55.92 -41.77 75.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.544 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.44 -39.14 93.69 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.332 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.015 0.436 . . . . 0.0 110.646 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.51 -38.42 84.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 60.8 t30 -61.86 -41.66 98.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.562 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.534 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 30.5 m95 -57.41 -31.16 65.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.632 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.87 -23.53 66.02 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 97' ' ' PRO . 45.6 t-105 -58.46 -67.95 0.82 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 29.5 Cg_endo -38.68 81.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.25 1.967 . . . . 0.0 113.046 -177.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.585 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.4 Cg_endo -62.84 -21.84 73.4 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.141 1.894 . . . . 0.0 112.544 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 46.0 pt -59.83 -25.89 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.488 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.51 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.3 p90 -44.86 -41.81 7.42 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.279 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 72.5 t80 -66.76 -51.83 51.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.73 -69.05 0.5 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.813 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.557 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 63.12 8.01 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.589 0.233 . . . . 0.0 110.722 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.505 ' CZ ' ' NE2' ' A' ' 104' ' ' GLN . 68.5 ttp85 -53.59 -33.9 56.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.505 ' NE2' ' CZ ' ' A' ' 103' ' ' ARG . 90.1 mm-40 -88.45 149.08 23.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.598 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.697 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.1 ttm -60.43 -18.97 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -49.73 8.96 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.217 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.697 ' H ' ' C ' ' A' ' 105' ' ' MET . 23.1 p-90 -49.36 -15.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.418 0.609 . . . . 0.0 112.018 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.449 ' HA ' ' CE3' ' A' ' 107' ' ' TRP . . . -36.39 -17.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.9 mp -66.34 -32.5 73.93 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.104 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.73 -56.68 15.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.618 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.468 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 21.2 t70 -58.16 -44.48 87.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.53 -40.19 93.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.599 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 5.5 tt -73.37 -45.76 53.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -74.08 -38.35 63.93 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.087 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.5 t -67.83 -44.6 85.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.58 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 120' ' ' THR . 42.3 t -84.72 -41.19 16.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -55.15 -43.58 83.68 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.172 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.11 -48.65 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.655 0.264 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.511 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -72.64 -57.25 4.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 116' ' ' SER . 37.4 m -59.82 -43.61 94.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.87 -56.64 5.35 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.095 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.642 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.5 m -63.3 -41.99 99.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 87.7 m -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.55 -38.12 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.186 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.68 -63.91 1.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.642 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 43.0 m0 -65.74 -41.33 92.33 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.9 t-80 -59.51 -48.7 80.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.914 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -65.7 -45.21 83.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.798 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.3 t -76.6 -46.76 30.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 126' ' ' TRP . 25.6 p -130.9 83.76 60.29 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.288 -178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.455 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.2 Cg_exo -51.3 -43.94 46.17 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.497 1.465 . . . . 0.0 112.433 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 20.8 Cg_exo -59.15 -32.19 96.75 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.565 0.843 . . . . 0.0 112.364 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.65 -29.02 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.54 91.4 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 79.6 mtt180 -62.57 -38.87 91.8 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.437 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.7 tp -52.53 -37.31 57.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.091 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 138' ' ' TYR . 54.0 mt -58.93 -27.55 65.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.291 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -2.92 -69.9 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.811 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 138' ' ' TYR . 11.8 Cg_endo -50.97 -26.51 18.61 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 120.653 0.902 . . . . 0.0 112.951 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -57.61 -43.71 84.95 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 31.2 tp -59.45 -39.91 85.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.352 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.91 92.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.059 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.577 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -67.36 -50.73 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.434 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 28.6 mt -65.26 -32.34 73.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.029 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 141' ' ' LEU . . . -61.49 -49.02 78.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.724 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 150' ' ' LEU . 30.7 t80 -64.43 -40.48 95.83 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.613 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 1.4 m -55.12 -43.79 74.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.503 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 60.8 p -67.98 -44.47 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.974 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.42 -42.05 92.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.52 0.676 . . . . 0.0 109.797 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 53.2 tp -59.91 -38.23 81.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 147' ' ' THR . 3.2 m120 -61.67 -41.91 98.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 73.2 m-85 -65.82 -39.52 90.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.0 t80 -61.68 -45.08 95.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.761 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.96 -52.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 159' ' ' SER . 5.1 m0 -63.56 -42.32 98.37 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CG ' ' O ' ' A' ' 152' ' ' TYR . 24.5 mmt85 -60.81 -35.85 77.56 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.117 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 88.0 m-20 -59.33 -40.94 87.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.577 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -92.34 -55.89 3.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.717 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 155' ' ' TRP . 85.3 p -59.88 -25.26 64.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.313 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.13 -34.03 38.84 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -69.49 150.65 46.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -55.97 -34.14 65.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.799 0.333 . . . . 0.0 110.604 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.79 8.28 70.0 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -53.67 -32.44 46.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.1 p -62.33 -25.75 68.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.541 0.21 . . . . 0.0 111.016 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -55.16 -36.49 65.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.016 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.18 -36.86 80.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.5 -32.23 73.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.816 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.604 -179.821 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.725 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.022 0.439 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.84 145.92 70.11 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.514 2.143 . . . . 0.0 112.013 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.45 -36.39 80.27 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.181 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.2 m -64.91 -41.16 95.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.439 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.08 -31.56 61.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.821 0.343 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 t -41.98 -41.7 4.96 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.535 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.31 -20.79 20.9 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 120.764 0.976 . . . . 0.0 111.806 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.36 -36.28 53.26 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.9 -42.01 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.19 -34.81 90.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.261 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 11' ' ' LEU . 10.6 mp -57.52 -41.33 80.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.036 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -76.8 -31.77 57.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.212 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 57' ' ' TYR . 96.7 mt -67.44 -32.83 73.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.823 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -44.44 -57.42 6.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.68 -32.77 97.55 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 121.013 1.142 . . . . 0.0 113.029 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -58.46 -39.14 79.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.422 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.07 -36.35 82.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.539 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.7 -58.16 7.26 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.006 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -36.29 82.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -57.71 -47.04 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.67 0.271 . . . . 0.0 110.979 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -64.48 -38.49 91.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.572 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.53 -42.24 97.56 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.627 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.464 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -68.45 -26.07 65.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.917 0.389 . . . . 0.0 111.701 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -32.6 65.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 51.4 t80 -60.51 -48.71 80.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.446 HG11 'CL ' ' A' ' 201' ' ' PKA . 1.3 m -72.81 -31.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -63.21 -41.86 99.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.076 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.36 -126.26 4.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.91 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.22 -30.18 11.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.683 0.278 . . . . 0.0 111.037 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.77 -31.58 23.89 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.2 mt -51.74 -46.1 63.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.907 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -63.55 -37.6 87.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.83 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -56.22 -37.91 70.34 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.942 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CZ3' ' A' ' 107' ' ' TRP . 84.9 m-85 -63.31 -21.92 66.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.23 -35.05 2.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.659 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.69 -30.17 27.49 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 49.8 mt -95.69 151.45 19.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.499 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.1 mt-30 -97.76 133.18 42.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.635 ' HZ1' ' C1 ' ' A' ' 201' ' ' PKA . 6.1 mttm -111.34 142.15 25.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.304 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 58.2 Cg_endo -61.31 134.42 51.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.382 1.388 . . . . 0.0 111.341 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 p -78.94 -12.13 60.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.51 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 3.8 p90 -81.12 -15.17 56.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.6 148.96 95.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.814 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -83.29 175.66 8.06 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.878 1.719 . . . . 0.0 111.82 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CB ' ' NE1' ' A' ' 47' ' ' TRP . 39.7 Cg_exo -51.44 144.77 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.115 1.877 . . . . 0.0 112.057 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 49.9 mtt85 -59.84 -36.32 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.495 ' NE1' ' CB ' ' A' ' 45' ' ' PRO . 61.6 p-90 -70.95 -26.92 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.073 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -62.92 -57.86 9.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.923 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.532 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 86.2 mt -73.91 -34.21 64.28 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -36.89 -51.21 2.08 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.012 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' CD ' ' O ' ' A' ' 47' ' ' TRP . 18.7 Cg_endo -68.81 0.61 4.72 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.455 2.103 . . . . 0.0 114.17 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 14.1 pt -43.81 -42.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.587 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 96.9 m95 -51.69 -32.82 31.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.96 96.18 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.8 m -68.54 -50.99 47.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.065 0.46 . . . . 0.0 111.206 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.33 -34.27 76.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.94 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' A' ' 53' ' ' TRP . 5.5 t80 -48.76 -60.62 2.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -63.47 -38.21 90.26 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.536 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.199 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.0 mtt -64.61 -38.55 91.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -62.29 -48.06 85.23 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.259 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -61.18 -38.68 87.38 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.48 -43.0 66.54 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.235 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 92.2 p -61.25 -31.67 71.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -58.61 -47.65 83.64 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.196 -0.601 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.07 -41.53 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 109.558 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.0 -38.46 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -65.16 -36.56 84.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.907 178.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -63.81 -43.25 96.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.683 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.79 -44.38 85.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.492 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt -76.68 -26.4 54.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.115 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.24 -4.15 62.25 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.437 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 156.64 -167.41 33.6 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.389 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.582 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 1.2 t80 -85.57 99.17 11.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' ALA . 5.7 t -133.48 165.71 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.62 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -41.69 -35.5 0.79 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.598 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -60.69 -40.89 93.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.959 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -74.86 -32.22 61.83 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.012 0.434 . . . . 0.0 111.94 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.582 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 55.7 mmm -62.29 -35.12 78.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -59.66 -40.69 81.29 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.538 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -85.56 -65.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.056 1.171 . . . . 0.0 112.231 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.78 -44.16 94.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.27 96.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.23 -36.62 78.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -56.58 -43.48 80.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.131 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.1 m -63.82 -43.65 95.61 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.16 -57.43 3.68 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.744 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.91 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.93 -39.67 95.29 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.68 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.37 75.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.043 0.449 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.35 -39.72 88.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.007 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.451 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 58.5 t30 -62.29 -40.75 97.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -57.44 -29.99 64.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.925 0.393 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.93 67.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.544 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.634 ' O ' ' N ' ' A' ' 97' ' ' PRO . 36.7 t-105 -59.71 -68.51 0.73 Allowed Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -40.2 78.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.263 0 C-N-CA 121.699 1.599 . . . . 0.0 112.662 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' TRP . 97.1 Cg_endo -57.28 -19.78 36.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.947 1.765 . . . . 0.0 112.076 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.526 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 33.3 pt -58.7 -23.36 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.042 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.1 p90 -56.54 -47.07 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.606 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.7 t80 -64.81 -49.59 70.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.51 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.6 0.42 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.626 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.534 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 60.94 -2.24 0.2 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.636 0.255 . . . . 0.0 110.705 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 101' ' ' GLY . 60.8 ttt85 -54.34 -35.44 62.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.63 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -85.8 158.65 19.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.522 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 107' ' ' TRP . 15.4 ttm -56.46 -13.9 2.64 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.255 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.95 -3.33 0.01 OUTLIER Glycine 0 CA--C 1.538 1.503 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.503 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.715 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.12 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.252 -0.558 . . . . 0.0 110.995 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.32 -27.93 67.72 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.832 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.6 mt -59.09 -31.3 68.78 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.131 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -61.68 -38.72 88.84 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.547 ' CG ' HD21 ' A' ' 151' ' ' ASN . 54.7 t0 -63.94 -45.95 86.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.8 tp -64.71 -49.54 70.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.051 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 117' ' ' GLY . 3.7 tt -67.17 -40.96 86.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.414 0.626 . . . . 0.0 110.078 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.427 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 18.9 tp -50.82 -59.01 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.711 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.98 -60.74 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.647 -178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.497 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -66.98 -42.74 84.57 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -60.38 -56.04 26.72 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.446 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.09 -38.62 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.671 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.48 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.32 -48.06 18.36 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.5 m -59.29 -41.68 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.55 -54.96 10.07 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.97 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.57 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 17.7 m -66.1 -42.3 89.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 53.4 m -59.4 -46.63 88.16 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.67 -34.7 78.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.055 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.23 -64.5 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.5 m0 -70.09 -42.0 73.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 40.8 t-80 -56.41 -45.59 80.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.277 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -63.1 -44.23 96.24 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.849 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.52 -47.47 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.587 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.4 p -133.79 87.28 36.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.472 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.7 Cg_exo -52.03 -40.86 67.03 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.767 1.645 . . . . 0.0 112.932 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.0 Cg_exo -58.27 -27.62 81.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 120.49 0.794 . . . . 0.0 112.81 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.18 -33.48 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.187 0.518 . . . . 0.0 110.783 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.18 -36.42 77.56 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.989 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -60.59 -34.84 74.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.151 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -62.07 -40.06 94.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.902 0.858 . . . . 0.0 110.013 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.487 ' O ' ' C ' ' A' ' 138' ' ' TYR . 38.4 mt -62.6 -26.72 68.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.964 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -1.74 -67.86 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 19.4 Cg_endo -51.27 -24.38 15.36 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 CA-C-N 119.711 0.933 . . . . 0.0 112.91 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -59.34 -39.37 82.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.818 0.342 . . . . 0.0 110.446 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -62.77 -41.39 99.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.897 0.38 . . . . 0.0 110.244 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.98 73.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.628 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.643 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 2.5 t-105 -61.27 -44.63 96.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.0 mt -69.67 -36.66 76.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.634 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.273 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.45 ' CZ ' HD11 ' A' ' 150' ' ' LEU . 64.7 t80 -62.85 -46.92 85.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.094 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.643 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 2.4 m -62.48 -41.75 99.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.09 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.1 m -58.93 -50.41 74.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.807 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 -40.35 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 110.491 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.45 HD11 ' CZ ' ' A' ' 146' ' ' PHE . 9.5 tt -56.81 -46.36 81.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.692 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 147' ' ' THR . 79.7 m-20 -65.37 -41.55 93.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -64.58 -38.99 92.91 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.772 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -58.26 -43.66 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.104 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.76 -42.96 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.374 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -60.87 -25.1 66.43 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -50.38 -36.57 33.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.562 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 91.2 m-20 -59.76 -43.77 94.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.085 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -87.62 -51.23 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 162' ' ' ARG . 62.5 p -62.67 -23.75 67.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.568 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.54 -31.93 37.61 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -57.16 -33.97 67.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.74 0.305 . . . . 0.0 110.711 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 159' ' ' SER . 80.4 mtm180 -118.7 148.36 42.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.428 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 82.66 18.97 64.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.02 -177.08 51.63 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.3 m -57.59 -36.44 71.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.722 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 -57.32 -37.25 72.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.591 ' CD1' ' N ' ' A' ' 167' ' ' LEU . 0.7 OUTLIER -94.72 145.39 24.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.272 179.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -138.36 149.05 45.19 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.066 0.46 . . . . 0.0 110.417 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 168' ' ' ALA . 95.9 mt-10 . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.79 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.635 ' C1 ' ' HZ1' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.603 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.976 0.417 . . . . 0.0 110.569 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 1' ' ' MET . 18.5 Cg_endo -55.72 -18.7 21.86 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.799 2.333 . . . . 0.0 112.062 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.3 -35.54 60.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.355 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 t -61.62 -41.57 97.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.928 0.394 . . . . 0.0 110.691 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.86 -30.45 62.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.139 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t -40.16 -39.28 1.33 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.862 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -55.29 -22.93 35.16 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 120.738 0.959 . . . . 0.0 112.769 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.65 63.99 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -44.07 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.77 90.79 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.533 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.4 ' N ' HD11 ' A' ' 11' ' ' LEU . 9.7 mp -56.6 -41.53 77.2 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.293 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 t -79.4 -32.28 42.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.854 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.44 -37.09 86.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.8 t -50.85 -43.57 83.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.026 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.66 -36.8 91.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.357 1.372 . . . . 0.0 112.835 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.4 m -60.6 -39.16 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.812 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.44 -37.98 87.99 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.225 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.33 -55.0 17.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.576 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -62.67 -37.3 94.55 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.268 -0.491 . . . . 0.0 111.954 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.0 -46.97 86.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.8 mtm -63.47 -39.85 95.57 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.44 97.44 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.459 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -72.11 -28.37 63.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 0.0 110.648 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -35.88 74.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.05 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 69.5 t80 -60.75 -48.67 80.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.58 -36.01 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.933 0.873 . . . . 0.0 109.627 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -60.2 -41.08 92.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.097 -1.41 . . . . 0.0 112.357 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.72 -129.88 1.4 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.714 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.05 -26.67 60.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.91 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.08 -33.52 10.61 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.53 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.6 mt -50.87 -41.31 57.96 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -61.63 -43.53 98.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.506 0.669 . . . . 0.0 109.594 178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -62.72 -40.1 96.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.146 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.6 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.9 m-85 -63.87 -22.94 67.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.328 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.59 -40.81 28.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.123 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -31.98 78.87 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.0 mt -91.1 148.81 22.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.977 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.32 127.92 46.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' HZ2' ' CZ ' ' A' ' 46' ' ' ARG . 12.1 mtpt -100.67 136.06 19.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 59.2 Cg_endo -56.06 143.79 82.17 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.139 1.226 . . . . 0.0 112.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 t -60.84 -31.22 70.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.998 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.402 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 18.4 p90 -76.99 0.39 21.36 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.309 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.6 t-80 -61.86 124.38 81.41 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.587 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.2 Cg_endo -80.86 166.01 19.42 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.462 1.442 . . . . 0.0 111.295 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -49.25 140.75 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.133 1.222 . . . . 0.0 111.364 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.654 ' CZ ' ' HZ2' ' A' ' 39' ' ' LYS . 36.8 mtt-85 -58.74 -37.38 76.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.006 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.437 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 8.5 p90 -74.8 -21.5 59.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.928 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -65.25 -59.91 3.56 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.008 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.539 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 71.2 mt -72.85 -33.31 66.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -37.4 -50.69 2.54 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.951 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLY . 16.6 Cg_endo -69.59 0.8 5.0 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.433 2.088 . . . . 0.0 114.05 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 13.3 pt -42.34 -41.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.228 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.444 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 99.4 m95 -53.86 -33.15 55.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.322 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.15 -40.11 98.09 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -67.83 -51.84 43.82 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.235 0.541 . . . . 0.0 110.82 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 mp -66.55 -32.85 74.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.934 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' TRP . 22.8 t80 -51.63 -53.53 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.374 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 59' ' ' ALA . 39.8 p -68.04 -36.85 80.59 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.326 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.538 ' N ' ' HG ' ' A' ' 58' ' ' SER . . . -65.43 -44.09 88.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.091 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.3 mtt -62.86 -37.47 87.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.68 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -69.16 -57.94 7.14 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.524 -0.846 . . . . 0.0 110.987 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.64 -39.35 87.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.595 0.236 . . . . 0.0 110.825 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.78 -42.02 84.57 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 89.0 p -62.35 -29.4 70.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.85 -44.47 91.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.807 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.13 -42.49 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.89 -40.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.522 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.65 -33.27 75.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.153 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 31.5 mtpt -65.49 -44.89 85.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.151 0.5 . . . . 0.0 111.091 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.95 -37.94 85.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.774 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.6 mt -91.36 -3.75 56.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.44 35.9 40.49 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.479 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.37 -161.71 24.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.4 OUTLIER -78.64 109.91 13.29 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 121.56 0.695 . . . . 0.0 110.741 -178.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.423 HG21 ' H ' ' A' ' 78' ' ' ALA . 4.9 t -133.94 164.45 27.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -43.93 -38.24 3.32 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.023 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.5 -41.94 92.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.912 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.423 ' H ' HG21 ' A' ' 75' ' ' THR . . . -71.97 -33.24 68.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.632 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.1 mmm -59.06 -35.17 72.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.561 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.48 -59.68 12.77 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.2 -54.09 2.03 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.415 1.41 . . . . 0.0 113.051 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.57 -41.61 99.03 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.127 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.51 98.27 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp -58.29 -39.28 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -59.0 -44.42 91.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 65.4 m -68.22 -39.92 82.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.42 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.18 -58.98 3.5 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.894 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -56.96 -42.04 79.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.331 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.826 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.76 78.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.04 -40.4 89.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.826 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -62.66 -39.78 94.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.512 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.554 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.0 m95 -57.97 -27.46 63.46 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.12 62.63 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 26.4 t-105 -71.51 -56.36 5.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 76.4 Cg_endo -44.08 86.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.099 1.199 . . . . 0.0 112.549 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.3 Cg_endo -57.05 -26.71 70.16 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 120.845 1.03 . . . . 0.0 111.321 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.439 ' H ' ' CD ' ' A' ' 97' ' ' PRO . 39.5 pt -62.44 -28.19 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.702 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.35 -44.47 65.22 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.895 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 70.5 t80 -64.43 -49.35 71.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.876 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 102' ' ' ALA . . . -113.38 -68.6 0.51 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.308 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 80.15 -5.26 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -54.4 -36.56 64.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -80.72 146.43 31.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.125 0.488 . . . . 0.0 111.257 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.615 ' C ' ' H ' ' A' ' 107' ' ' TRP . 3.3 ttp -64.22 -15.69 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.214 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.13 33.95 0.02 OUTLIER Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -61.41 -19.74 62.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -46.88 -24.47 0.6 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 111.594 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.1 -31.16 69.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.365 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.91 -52.74 58.46 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.662 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.535 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 24.0 t0 -62.2 -45.71 92.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.64 -38.52 85.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 110.379 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 6.4 tt -71.15 -48.99 48.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.22 -31.46 62.62 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.49 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.405 ' CG2' ' OD1' ' A' ' 111' ' ' ASP . 48.3 t -67.18 -61.58 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.722 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.9 t -72.54 -42.13 65.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.25 60.3 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.339 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -67.38 -35.93 75.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.649 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.33 -57.4 3.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -60.08 -42.7 95.16 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.81 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.94 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.438 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 27.2 m -63.62 -39.39 94.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.935 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 77.7 m -59.34 -48.79 80.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 128' ' ' ARG . 74.3 mt -63.87 -32.31 73.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.68 -63.39 1.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 39.7 m0 -76.12 -45.28 34.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 123' ' ' THR . 16.4 t-80 -57.67 -43.42 85.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.949 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.481 ' CG ' ' O ' ' A' ' 124' ' ' LEU . 37.0 mmm-85 -64.63 -46.08 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.273 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.24 -48.65 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 126' ' ' TRP . 37.4 p -128.64 84.77 62.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.138 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.7 Cg_exo -53.41 -41.81 70.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.178 1.919 . . . . 0.0 112.925 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 24.3 Cg_exo -57.36 -30.15 86.78 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 120.323 0.682 . . . . 0.0 112.378 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.46 71.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.074 0.464 . . . . 0.0 110.316 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.74 76.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.811 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 50.4 ttt85 -59.59 -40.9 88.98 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.433 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 138' ' ' TYR . 16.0 tp -54.55 -36.04 63.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.305 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.516 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 55.6 mt -70.73 16.87 0.08 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.423 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -48.04 -41.06 38.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.231 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.516 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 18.2 Cg_endo -67.9 -18.67 46.84 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 CA-C-N 120.633 1.262 . . . . 0.0 112.876 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -58.98 -41.33 87.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.915 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 36.4 tp -63.79 -38.39 90.91 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.424 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.92 -43.95 91.11 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.596 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.606 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.3 t-105 -69.86 -50.46 42.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.449 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.83 -32.87 74.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.404 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.13 -50.2 74.15 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.733 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -64.15 -42.28 96.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.905 0.383 . . . . 0.0 111.605 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.606 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.8 m -55.73 -43.66 76.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.1 m -64.36 -49.63 70.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.512 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.51 -40.23 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.193 0.521 . . . . 0.0 110.667 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 63.9 tp -56.06 -42.4 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.249 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.535 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.4 m120 -64.55 -41.0 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -62.69 -40.89 98.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.415 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -61.03 -46.41 90.85 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.227 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.87 -45.18 81.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.037 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.449 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -59.72 -39.21 83.89 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.647 -178.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 159' ' ' SER . 66.5 mtp180 -58.66 -25.96 63.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.65 -39.4 58.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.702 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -113.77 -2.39 13.71 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.145 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 156' ' ' ARG . 69.8 m -121.99 155.91 34.56 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.641 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.73 2.23 63.17 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -55.46 -35.18 65.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.874 0.368 . . . . 0.0 110.606 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -54.5 -32.92 58.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.859 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -51.91 -33.76 36.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 86.86 12.05 69.37 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.7 p -60.6 -27.42 67.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.939 0.4 . . . . 0.0 110.516 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -55.01 -36.93 65.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.014 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.16 -33.56 73.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.07 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.52 158.06 36.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.304 0.573 . . . . 0.0 110.509 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 C--N 1.318 -0.784 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.473 -179.675 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.564 ' C22' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.881 0.372 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -54.66 148.26 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.554 2.17 . . . . 0.0 112.611 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.84 -31.93 70.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.493 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m -62.14 -47.98 82.14 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -77.45 -29.97 53.06 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 111.503 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t -40.04 -50.41 6.0 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.947 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.8 Cg_endo -58.01 -20.53 45.68 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.554 0.836 . . . . 0.0 112.222 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.589 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.24 -40.5 83.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.017 0.437 . . . . 0.0 109.863 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.65 -36.86 93.3 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.33 -42.19 90.87 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 57' ' ' TYR . 2.9 t -78.15 -41.4 34.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.514 -178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.25 -35.33 80.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 t -50.07 -43.9 78.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.354 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.07 -34.58 98.92 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.3 1.333 . . . . 0.0 112.895 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 m -59.61 -39.56 84.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 0.0 112.009 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.03 -37.72 83.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.365 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.46 -40.88 99.28 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.925 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -44.59 97.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.489 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -61.92 -40.87 96.98 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.65 -39.85 92.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.717 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -43.99 9.56 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.041 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -68.01 -24.57 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.432 . . . . 0.0 110.89 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.26 -35.42 64.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.55 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 64.1 t80 -60.92 -48.02 83.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.34 -32.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.721 0.772 . . . . 0.0 109.451 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -63.6 -41.26 98.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.523 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.41 -129.63 2.21 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.855 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.19 -27.93 62.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.853 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.21 -31.5 6.24 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.7 mt -51.9 -45.89 64.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.814 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -62.48 -39.0 92.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -57.34 -39.91 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.891 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.541 ' O ' ' O ' ' A' ' 37' ' ' LEU . 74.9 m-85 -64.76 -22.43 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.41 -40.23 5.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.74 -34.61 72.51 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 34' ' ' TYR . 31.6 mt -93.29 152.87 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.52 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.6 mt-30 -98.55 132.48 43.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.501 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 48.6 mttt -99.39 148.57 34.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -57.49 140.02 91.95 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.62 1.546 . . . . 0.0 111.908 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 m -61.53 -33.22 73.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.762 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.434 ' NE1' ' CE1' ' A' ' 146' ' ' PHE . 13.3 p90 -85.79 6.43 28.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.496 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' HE2' ' H6B' ' A' ' 201' ' ' PKA . 37.3 t-80 -54.86 124.55 51.85 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.136 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.93 168.45 6.75 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.172 1.248 . . . . 0.0 111.581 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -51.21 139.28 44.14 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.427 1.418 . . . . 0.0 111.924 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.501 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 39.7 mtt85 -61.9 -37.09 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.2 p90 -73.88 -13.38 60.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.622 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -77.5 -65.92 0.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.967 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.561 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 77.7 mt -65.79 -35.63 81.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.498 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -42.12 -40.42 3.87 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.033 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 54' ' ' GLY . 63.6 Cg_exo -66.81 -8.95 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.913 2.409 . . . . 0.0 113.746 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 26.3 pt -41.84 -42.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.412 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.473 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 99.3 m95 -53.54 -32.05 48.99 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.264 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -52.6 -37.08 49.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.5 p -87.54 -45.85 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.97 -40.32 96.13 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.523 ' O ' ' OG1' ' A' ' 12' ' ' THR . 0.2 OUTLIER -62.62 -44.65 95.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.639 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 57' ' ' TYR . 28.4 m -60.15 -40.79 91.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.61 91.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.439 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 63.9 mtt -62.42 -37.88 87.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -65.6 -55.53 19.83 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -61.78 -33.76 74.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.118 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.35 -44.18 58.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 95.4 p -64.13 -31.52 72.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -56.61 -46.04 81.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.412 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.6 mt -61.59 -39.4 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.18 -38.78 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.13 -51.41 69.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.943 0.401 . . . . 0.0 111.2 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 73.5 mttt -54.96 -36.57 65.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.367 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -72.77 -41.17 65.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.89 -8.22 40.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.82 -6.28 58.58 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.515 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 124.8 -168.19 16.97 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.431 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -59.5 79.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.789 0.804 . . . . 0.0 108.873 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.1 m -116.09 152.77 32.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.595 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' THR . 97.0 mt-10 -42.59 -36.52 1.4 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.184 -0.607 . . . . 0.0 109.894 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.58 -41.33 98.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.114 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -74.97 -33.03 61.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.46 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.452 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 89.3 mmm -61.2 -35.76 78.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.652 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -56.42 -45.06 99.97 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.585 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -78.18 -61.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 120.929 1.086 . . . . 0.0 111.985 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 mt -57.81 -43.75 85.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.91 0.386 . . . . 0.0 110.927 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.83 -43.85 98.66 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -59.07 -38.45 79.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.269 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.439 ' OH ' ' SD ' ' A' ' 60' ' ' MET . 79.2 t80 -56.85 -42.98 80.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.612 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 m -65.66 -42.35 91.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.33 3.08 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.897 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -55.78 -41.59 74.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.522 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.21 -37.91 89.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.03 -49.84 73.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 111.004 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.8 -37.01 82.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -59.51 -41.34 89.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.559 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.483 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 62.0 m95 -62.1 -30.42 70.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.652 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.24 -28.95 66.79 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.557 ' O ' ' N ' ' A' ' 97' ' ' PRO . 18.9 t-105 -55.74 -64.52 2.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_endo -46.2 82.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.457 1.438 . . . . 0.0 112.148 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.557 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.5 Cg_endo -57.82 -19.21 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.351 1.368 . . . . 0.0 111.477 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 39.6 pt -60.23 -26.18 35.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.032 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.7 p90 -46.82 -44.64 19.48 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.386 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 73.6 t80 -70.05 -49.4 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.99 -66.24 0.48 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.947 -0.645 . . . . 0.0 113.131 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 66.16 8.57 5.63 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.608 0.242 . . . . 0.0 111.015 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.498 HH11 ' NE2' ' A' ' 104' ' ' GLN . 79.7 ttt-85 -55.07 -36.31 65.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.498 ' NE2' HH11 ' A' ' 103' ' ' ARG . 96.5 mm-40 -88.66 149.77 23.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.286 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 107' ' ' TRP . 1.7 ttp -59.98 -19.41 52.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.298 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.02 -8.06 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.88 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.643 ' N ' ' O ' ' A' ' 105' ' ' MET . 1.5 p90 -44.67 -18.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' CB ' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.19 -20.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.0 mt -60.87 -35.76 77.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.8 93.04 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.479 0.657 . . . . 0.0 109.345 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 111' ' ' ASP . 56.7 t0 -66.73 -43.38 84.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.785 -1.098 . . . . 0.0 113.57 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.21 -49.26 65.19 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 117' ' ' GLY . 21.8 mt -67.87 -38.85 83.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.02 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 15.0 tp -51.6 -55.81 17.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.286 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.1 -63.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.662 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -67.82 -41.86 82.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -63.48 -52.9 42.81 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.965 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 p -65.93 -36.83 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.582 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.494 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -80.9 -56.0 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.3 m -56.34 -42.34 77.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.97 -53.96 15.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.397 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.499 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.8 m -65.03 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 86.9 m -59.16 -48.2 82.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.96 -35.1 79.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.319 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.66 -55.25 6.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.499 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 38.6 m0 -84.86 -49.96 7.96 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.658 ' N ' ' HD1' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -52.25 -41.87 63.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.206 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -61.44 -43.57 98.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.316 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.3 t -78.6 -48.98 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.589 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 87.8 p -132.47 88.06 40.41 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.786 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.8 Cg_exo -53.31 -39.58 80.7 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.931 1.754 . . . . 0.0 113.147 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 34.1 Cg_exo -56.27 -29.74 77.49 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.35 0.7 . . . . 0.0 112.76 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -32.65 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.63 . . . . 0.0 110.392 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 127' ' ' HIS . . . -59.48 -38.4 80.74 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 45.5 ttp180 -61.28 -38.65 87.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.625 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.58 -39.74 71.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.8 mt -56.85 -28.82 62.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.314 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.51 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 5.86 -69.45 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 9.6 Cg_endo -52.1 -31.36 44.6 Favored 'Trans proline' 0 N--CA 1.505 2.158 0 C-N-CA 120.435 0.756 . . . . 0.0 113.275 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -59.07 -38.3 79.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.809 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.1 tm? -59.58 -44.24 93.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.303 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.42 72.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.8 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.615 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.8 t-105 -61.26 -44.04 97.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 43.3 mt -65.8 -34.25 77.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.823 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.42 89.39 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.727 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.434 ' CE1' ' NE1' ' A' ' 42' ' ' TRP . 15.7 t80 -65.27 -43.21 91.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.615 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.6 m -57.31 -42.73 82.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.612 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -61.26 -47.29 86.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.163 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.81 -42.7 82.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.688 0.756 . . . . 0.0 109.995 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 14.1 tp -53.44 -60.86 2.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.118 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -63.02 -38.81 92.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.272 0.558 . . . . 0.0 110.518 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.35 -43.09 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.19 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.88 -44.46 96.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.47 -42.7 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 111.209 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.477 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 4.9 m95 -57.65 -36.23 71.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.37 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -57.35 -30.41 64.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 89.5 m-20 -53.13 -40.31 64.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.564 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -109.06 -60.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.4 m -60.56 -32.57 71.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.793 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.38 -32.99 38.69 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -121.87 149.47 43.34 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 110.976 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -118.5 149.08 41.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.95 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.59 -179.33 50.39 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -85.26 -174.9 50.36 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 53.8 p -67.92 160.31 28.8 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.19 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -58.36 -35.1 71.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.759 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.401 ' N ' HD13 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -62.47 -33.45 74.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.747 179.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.7 34.32 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.994 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.563 179.834 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.787 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 mmt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.946 0.403 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -56.64 -19.19 29.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.883 2.389 . . . . 0.0 112.144 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.07 -33.39 70.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.095 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.1 m -61.16 -40.86 95.46 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.22 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -31.18 57.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.864 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -41.17 -40.89 2.86 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.252 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -54.52 -21.22 23.41 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 120.916 1.077 . . . . 0.0 112.177 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.29 -36.81 53.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.04 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.8 t -62.38 -42.81 96.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.47 -34.79 90.17 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.482 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' N ' HD11 ' A' ' 11' ' ' LEU . 10.1 mp -55.82 -43.75 77.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.105 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 t -75.99 -27.01 57.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.19 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.97 -32.42 67.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 40.9 t -45.51 -57.69 7.22 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 16' ' ' SER . 6.6 Cg_endo -57.88 -31.52 92.76 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.086 1.191 . . . . 0.0 112.902 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.459 ' H ' ' HD2' ' A' ' 15' ' ' PRO . 23.2 t -60.2 -39.47 86.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.56 -39.27 87.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.275 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.56 15.37 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.2 94.05 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.08 -45.37 87.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.907 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.88 -39.42 94.41 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.51 -42.84 97.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.549 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -71.07 -26.28 62.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.386 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -62.94 -34.9 78.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.913 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 74.8 t80 -61.25 -49.45 77.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.64 -35.79 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.477 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -34.16 74.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.654 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.9 -136.88 2.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.505 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.1 -24.73 59.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.121 0.486 . . . . 0.0 110.759 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.86 -32.69 4.64 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.1 mt -52.18 -43.42 64.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.074 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.23 -42.84 99.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 110.238 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -60.05 -39.15 84.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.589 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 45.1 m-85 -64.89 -23.06 67.11 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.751 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.15 -41.62 27.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.543 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.04 84.48 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 73.3 mt -91.0 149.18 21.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.789 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -98.0 122.56 41.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.791 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.665 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 54.7 mttt -91.35 140.94 25.67 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 30.4 Cg_endo -56.44 140.73 89.6 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.122 1.215 . . . . 0.0 112.398 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.4 m -61.17 -34.04 74.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.207 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.403 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 39.0 p90 -77.43 4.45 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.619 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.586 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.3 t-80 -64.5 132.0 95.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 57.6 Cg_endo -89.81 169.65 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.697 1.598 . . . . 0.0 111.284 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -50.92 138.73 42.32 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.84 1.027 . . . . 0.0 111.501 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.665 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 43.0 mtt85 -60.43 -38.69 84.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.9 p90 -72.21 -25.66 61.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.901 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -64.24 -57.45 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 50.1 mt -73.28 -33.78 65.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.445 ' N ' ' HD2' ' A' ' 51' ' ' PRO . . . -37.36 -48.64 2.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.882 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 50' ' ' ALA . 18.2 Cg_endo -72.34 3.77 3.88 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.364 2.043 . . . . 0.0 114.189 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.575 ' CD1' ' CE2' ' A' ' 143' ' ' TRP . 19.4 pt -47.21 -38.24 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.263 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.526 ' HE1' ' H13' ' A' ' 201' ' ' PKA . 98.7 m95 -51.76 -33.59 35.76 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.079 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.23 97.86 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.7 m -66.39 -51.17 59.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 110.834 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.28 -33.09 74.58 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.205 0.526 . . . . 0.0 109.966 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' TRP . 31.1 t80 -53.12 -52.8 57.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.618 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.5 p -69.42 -35.39 75.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.618 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.74 90.13 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.455 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.2 mtt -62.29 -37.41 85.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.269 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.29 -56.25 14.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.95 -40.13 96.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 111.102 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.85 -43.41 92.37 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.7 p -63.5 -28.14 69.76 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.954 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -58.3 -44.85 88.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.95 -44.71 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.914 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.32 -41.64 84.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.21 -37.17 86.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.511 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -62.46 -40.94 98.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.064 0.459 . . . . 0.0 111.113 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.63 -37.59 88.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.07 -5.31 56.7 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.47 17.19 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.972 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.435 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 104.24 -166.35 15.33 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.96 110.11 21.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.461 0.648 . . . . 0.0 109.332 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.7 t -131.32 163.47 27.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.981 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -43.51 -37.85 2.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.309 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.45 -41.02 98.64 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.879 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.4 -29.18 65.74 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.689 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 86.1 mmm -60.15 -33.64 72.45 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.781 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.3 t -60.33 -50.22 86.84 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.22 -61.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.935 1.09 . . . . 0.0 113.038 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.87 -39.26 91.3 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.077 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.18 96.26 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.82 -39.27 80.72 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 84.0 t80 -60.62 -45.71 93.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.034 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.0 m -67.95 -40.28 83.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.856 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.93 -60.33 3.17 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.022 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -56.96 -40.63 76.83 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.17 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 44.9 tp -61.96 -40.23 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.174 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.0 79.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.98 0.419 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.02 85.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t30 -61.64 -42.44 98.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.679 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -58.42 -29.62 66.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.831 0.348 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -31.12 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.279 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.0 t-105 -56.94 -44.25 99.71 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -53.05 127.37 24.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.521 1.48 . . . . 0.0 113.125 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.486 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 37.5 Cg_endo -108.67 -27.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.194 1.263 . . . . 0.0 110.793 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 26.5 pt -59.59 -27.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.953 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 20.8 p90 -56.7 -44.51 81.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.608 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.568 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 60.5 t80 -64.95 -49.08 71.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.908 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.32 -59.16 0.41 Allowed Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 98' ' ' ILE . . . 60.52 -1.27 0.22 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.649 0.262 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 101' ' ' GLY . 71.0 ttp85 -52.89 -33.28 49.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 110.34 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.505 ' NE2' ' CZ ' ' A' ' 103' ' ' ARG . 97.2 mm-40 -86.62 151.82 23.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.784 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.7 ' C ' ' H ' ' A' ' 107' ' ' TRP . 2.7 ttp -62.16 -13.41 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.109 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.07 27.43 0.01 OUTLIER Glycine 0 CA--C 1.541 1.683 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.869 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.7 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.47 -19.17 34.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.559 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -55.07 -24.22 24.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.33 -33.1 65.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.431 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -63.76 -38.01 89.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.54 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 56.6 t0 -65.21 -48.43 73.39 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.29 -47.39 86.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.872 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 117' ' ' GLY . 4.3 tt -69.11 -40.43 78.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.379 0.609 . . . . 0.0 110.356 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 110' ' ' ALA . 14.4 tp -54.07 -57.47 10.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.309 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.9 t -69.7 -56.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.883 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -68.7 -42.35 77.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -58.04 -45.2 94.14 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.661 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.38 -45.53 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.677 0.275 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.48 -55.59 9.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.1 m -59.72 -42.81 93.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.38 -60.37 2.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.459 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.6 m -62.48 -41.05 98.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 76.3 m -59.3 -46.47 88.49 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.5 -35.01 79.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.41 -63.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 126' ' ' TRP . 39.8 m0 -64.47 -43.76 93.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -56.87 -43.38 81.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.634 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.12 -44.32 96.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.587 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.9 -42.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.815 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.55 103.65 3.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.262 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.529 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.3 Cg_exo -60.76 -38.98 66.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.699 1.599 . . . . 0.0 113.236 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 28.1 Cg_exo -56.45 -29.59 78.5 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.93 1.086 . . . . 0.0 112.96 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 -33.53 73.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.018 0.437 . . . . 0.0 110.765 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.44 -37.29 77.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.902 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 44.1 ttt180 -59.45 -40.77 87.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.396 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.6 -36.84 67.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.307 0.575 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.524 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 60.8 mt -70.66 15.39 0.1 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.543 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -46.27 -40.64 19.01 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.072 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 9.2 Cg_endo -66.92 -22.9 47.94 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.809 1.325 . . . . 0.0 112.417 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.56 -34.02 74.86 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 3.0 tm? -67.93 -41.55 82.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.927 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.71 -52.15 33.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.619 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.1 t-105 -61.31 -46.34 90.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.756 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.8 mt -67.6 -33.83 75.79 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.843 178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.93 -46.03 89.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.993 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 150' ' ' LEU . 16.1 t80 -64.69 -43.33 93.88 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.426 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.619 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.6 m -57.66 -43.48 85.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.39 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 54.4 m -60.29 -49.73 76.45 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.557 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.39 -41.81 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.366 0.603 . . . . 0.0 110.331 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . 23.9 tp -56.76 -47.88 79.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.139 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 147' ' ' THR . 72.4 m-80 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -65.28 -40.52 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.342 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.74 -45.98 88.43 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.304 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.68 -45.62 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.406 ' O ' ' N ' ' A' ' 159' ' ' SER . 1.0 OUTLIER -62.66 -44.08 97.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.669 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -60.44 -32.12 71.07 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.306 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -54.71 -40.85 69.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.948 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -99.73 -59.97 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.5 m -58.78 -33.24 70.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.108 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.55 -178.91 52.48 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -116.55 149.81 39.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -108.54 149.23 29.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.288 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.6 -177.8 52.0 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.55 -176.88 51.38 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 56.2 p -69.03 163.66 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 110.573 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -56.36 -33.0 65.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.85 -34.53 76.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.288 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -75.23 157.55 34.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.305 0.574 . . . . 0.0 110.741 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 168' ' ' ALA . 94.6 mt-10 . . . . . 0 C--N 1.319 -0.756 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.276 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.67 ' N18' ' H3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtp . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.53 -16.81 19.8 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.501 1.468 . . . . 0.0 112.013 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.47 -33.15 53.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.309 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.9 m -60.19 -40.64 90.74 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.522 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.467 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 8.1 m0 -76.23 -31.55 58.43 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.3 t -41.44 -51.69 8.41 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.0 Cg_endo -55.31 -19.4 21.71 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 CA-C-N 119.147 0.731 . . . . 0.0 111.451 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 5' ' ' TRP . . . -54.12 -32.01 53.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -61.17 -41.15 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.86 93.07 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.312 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.27 -41.69 84.86 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 t -75.81 -34.52 60.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.652 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.15 -34.74 78.21 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.8 t -49.26 -55.84 19.32 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.92 -32.6 97.7 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 120.539 0.826 . . . . 0.0 112.963 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.8 m -59.97 -40.04 87.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.746 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.98 -38.09 87.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.42 -59.04 8.24 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.191 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -60.1 -36.34 90.21 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.284 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.15 -46.48 85.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.497 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.08 -38.21 87.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.554 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.83 -39.51 97.48 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.646 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.44 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -67.66 -28.42 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.337 . . . . 0.0 111.763 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.72 -34.82 67.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.724 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 88.6 t80 -60.89 -47.59 85.71 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -71.79 -33.9 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.702 0.763 . . . . 0.0 109.333 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -61.75 -40.77 96.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.028 -1.442 . . . . 0.0 112.674 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.14 -126.08 1.83 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.047 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.39 -28.11 62.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.777 0.322 . . . . 0.0 111.317 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.96 -32.88 12.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.25 -41.23 62.64 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.025 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.2 mtp85 -61.48 -45.86 92.45 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.677 0.751 . . . . 0.0 109.334 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -62.46 -40.67 97.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.595 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 21.4 m-85 -65.16 -23.0 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.647 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.86 -39.72 54.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.56 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -33.21 85.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 60.5 mt -91.47 149.42 21.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.59 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -99.62 130.71 45.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.639 -0.425 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' NZ ' ' C1 ' ' A' ' 201' ' ' PKA . 1.3 mtpt -111.67 141.35 24.49 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.852 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 62.3 Cg_endo -58.61 133.29 53.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.972 1.114 . . . . 0.0 111.971 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.3 p -82.47 -9.19 59.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.05 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.523 ' CD1' ' C ' ' A' ' 42' ' ' TRP . 3.3 p90 -77.79 -15.4 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.818 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -74.2 151.97 88.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.407 -178.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.68 173.13 14.07 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 112.455 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 19.5 Cg_exo -51.72 151.38 15.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.984 2.456 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -58.09 -35.69 71.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 14.7 p90 -74.51 -12.3 60.44 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.672 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -76.96 -66.91 0.76 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 110.956 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.572 ' O ' ' CG2' ' A' ' 52' ' ' ILE . 19.5 mt -66.52 -35.82 81.2 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.581 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 49' ' ' LEU . . . -40.76 -42.49 3.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 54' ' ' GLY . 51.3 Cg_exo -65.51 -5.39 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.87 2.38 . . . . 0.0 112.98 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.572 ' CG2' ' O ' ' A' ' 49' ' ' LEU . 5.9 pt -41.22 -42.54 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 120.658 0.266 . . . . 0.0 111.709 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.449 ' O ' ' N ' ' A' ' 57' ' ' TYR . 95.0 m95 -56.31 -34.06 66.17 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.105 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.49 -39.09 95.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -66.73 -52.28 46.25 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.19 0.519 . . . . 0.0 111.049 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.511 ' CD2' ' CE3' ' A' ' 143' ' ' TRP . 6.8 mp -68.22 -31.47 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.076 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' TRP . 19.8 t80 -52.2 -49.12 64.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.131 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -74.09 -34.79 64.09 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.651 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.94 -45.02 87.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.858 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.78 -37.18 85.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.75 -60.84 6.46 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.152 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -62.15 -36.48 81.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.637 0.256 . . . . 0.0 111.02 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.81 85.0 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.115 -1.04 . . . . 0.0 110.738 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.2 p -65.07 -30.11 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.566 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -58.49 -44.01 89.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.43 -38.48 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.949 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.1 t -62.15 -41.6 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.636 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.33 -50.03 75.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.308 -178.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 74.9 mttt -54.4 -36.24 63.75 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.978 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -72.94 -44.73 60.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.658 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.6 mt -77.41 -26.06 51.36 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.07 -6.85 40.42 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.269 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.85 -161.61 25.49 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.113 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.686 ' CD2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -89.23 82.68 6.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.35 0.595 . . . . 0.0 110.083 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' ALA . 13.4 p -123.16 166.0 15.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.46 -36.87 3.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.82 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.76 -42.82 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.952 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -82.27 -36.64 26.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.983 0.42 . . . . 0.0 111.657 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.686 ' SD ' ' CD2' ' A' ' 74' ' ' PHE . 98.7 mmm -59.08 -34.47 72.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.052 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.3 t -60.14 -52.39 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.929 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -68.88 -58.78 0.1 Allowed 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.155 1.237 . . . . 0.0 112.775 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.84 -42.0 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.194 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.19 95.38 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.34 -39.79 76.66 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.441 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 75.0 t80 -59.13 -43.99 92.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.1 m -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.134 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.89 -60.07 3.26 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.595 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -56.97 -41.17 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.329 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.441 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 33.0 tp -61.94 -38.86 90.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.632 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.78 76.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.981 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.4 -39.09 86.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -61.46 -41.07 96.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.666 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.572 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 48.3 m95 -60.42 -28.76 68.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.71 -17.86 62.82 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.587 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.3 t-105 -72.43 -55.92 4.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 71.8 Cg_endo -42.62 87.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.182 1.255 . . . . 0.0 112.508 -177.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.6 Cg_endo -59.53 -27.1 84.13 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 120.606 0.871 . . . . 0.0 111.762 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.43 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 40.0 pt -61.71 -33.99 60.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.5 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -46.68 -43.78 18.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.534 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -67.53 -52.16 42.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.68 -55.11 0.39 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.847 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 61.04 10.81 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 0.0 110.356 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -55.66 -35.6 66.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.546 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -87.22 149.38 24.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.501 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.602 ' C ' ' H ' ' A' ' 107' ' ' TRP . 3.4 ttp -62.62 -14.93 48.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.28 35.44 0.02 OUTLIER Glycine 0 CA--C 1.54 1.598 0 C-N-CA 121.679 -0.296 . . . . 0.0 112.743 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.602 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -64.03 -19.67 65.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -47.46 -22.7 0.49 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.91 0.386 . . . . 0.0 111.258 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt -57.77 -31.48 66.57 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.563 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.02 -53.72 45.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.576 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 31.1 t70 -63.13 -46.7 86.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.61 -38.09 83.57 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.529 ' CD2' ' C ' ' A' ' 113' ' ' LEU . 5.6 tt -67.26 -48.78 66.71 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 pp -76.15 -32.99 59.37 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.977 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 70.6 t -64.82 -45.91 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.89 -38.75 17.72 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.55 -42.22 89.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.213 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.86 -48.38 29.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.776 0.322 . . . . 0.0 111.033 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.513 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.24 -56.79 10.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.7 m -61.9 -45.17 94.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.79 -59.11 3.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.423 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 28.3 m -63.11 -41.71 99.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 88.8 m -58.84 -45.22 90.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.393 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.45 -37.48 87.44 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.215 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.28 -64.3 1.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.423 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.6 m0 -66.1 -43.01 88.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -59.29 -50.12 75.2 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.691 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.11 -43.53 95.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.798 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.02 -48.04 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 p -134.1 87.87 32.97 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.446 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.46 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.53 -42.41 61.91 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.391 1.394 . . . . 0.0 112.433 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.5 Cg_exo -56.79 -30.46 84.91 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 120.328 0.685 . . . . 0.0 111.994 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -30.79 70.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.094 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.91 97.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.114 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -59.98 -38.4 82.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.07 0.462 . . . . 0.0 110.352 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.53 -37.71 73.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.198 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.3 mt -57.86 -31.54 66.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.499 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 5.88 -72.37 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.4 Cg_endo -50.8 -22.32 9.67 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 CA-C-N 119.23 0.761 . . . . 0.0 112.79 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 p90 -57.73 -41.95 82.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -61.34 -44.39 97.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.053 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.21 83.57 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.234 0.54 . . . . 0.0 110.344 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TRP . . . . . 0.511 ' CE3' ' CD2' ' A' ' 56' ' ' LEU . 26.7 t90 -60.47 -50.59 72.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.486 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.444 ' CD2' ' CE3' ' A' ' 143' ' ' TRP . 57.8 mt -74.78 -29.69 61.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.32 -54.92 39.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.841 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -65.36 -44.93 86.1 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.786 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.559 ' CG2' ' OD1' ' A' ' 111' ' ' ASP . 9.6 m -56.56 -42.33 78.42 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.672 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.5 m -68.18 -50.17 56.08 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 111.604 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.06 -39.57 86.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.258 0.551 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 66.1 tp -55.45 -41.73 73.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.119 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 6.2 m120 -63.18 -42.62 99.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -63.58 -35.9 82.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.664 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -58.57 -47.02 85.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.549 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.42 -47.44 52.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.756 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TRP . . . . . 0.437 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 3.1 m0 -61.58 -43.91 97.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -60.86 -33.66 73.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.269 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.6 -41.08 76.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.126 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -96.75 -59.97 1.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 111.482 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p -62.09 -25.94 68.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.069 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.5 155.58 53.3 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.149 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -122.52 156.39 34.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.747 0.308 . . . . 0.0 110.569 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -53.8 -37.03 63.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.433 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -55.9 -30.6 57.26 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -52.93 -33.06 42.96 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.4 m -56.53 -33.41 66.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.895 0.379 . . . . 0.0 110.397 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -55.41 -35.09 64.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.33 144.88 24.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.85 0.357 . . . . 0.0 110.283 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -85.02 124.62 31.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.494 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 92.4 mt-10 . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.53 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PKA . . . . . 0.491 ' C15' 'CL ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.5 t . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.56 ' O ' HD13 ' A' ' 11' ' ' LEU . 88.6 Cg_exo -55.28 -22.91 34.96 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.218 1.279 . . . . 0.0 112.794 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.31 62.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.4 t -64.31 -42.69 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.15 -34.61 90.4 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.012 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.1 mp -55.57 -44.23 76.66 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.795 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 t -78.83 -33.43 46.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.241 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.408 HD21 ' CE1' ' A' ' 57' ' ' TYR . 87.1 mt -65.39 -35.44 80.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.794 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 t -54.35 -57.27 19.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.54 -33.21 97.04 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 120.843 1.029 . . . . 0.0 112.767 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -59.31 -38.05 79.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.941 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.04 -38.52 91.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.579 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.97 -53.88 27.87 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.882 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.92 90.68 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CZ ' ' NH1' ' A' ' 27' ' ' ARG . 54.3 t80 -59.13 -43.47 91.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.296 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtt -61.06 -40.78 94.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.072 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.15 -42.46 91.48 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.64 -27.74 65.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.22 0.533 . . . . 0.0 110.302 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -35.39 76.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.669 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 40.7 t80 -61.05 -49.94 75.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.91 -34.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.693 0.759 . . . . 0.0 109.645 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.48 ' NH1' ' CZ ' ' A' ' 20' ' ' PHE . 7.9 ttt180 -61.81 -40.91 96.9 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.779 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.14 -123.47 3.16 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.149 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.1 -29.54 60.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.204 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -33.43 17.93 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD21 ' NE ' ' A' ' 46' ' ' ARG . 96.1 mt -50.37 -43.18 54.25 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -61.41 -43.07 99.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.58 . . . . 0.0 109.834 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.94 -39.17 93.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.85 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.617 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 16.5 m-85 -63.88 -23.26 67.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.29 -40.19 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.796 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.98 -31.96 72.92 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 34' ' ' TYR . 51.1 mt -90.62 148.55 22.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.869 0.366 . . . . 0.0 110.976 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -98.43 127.04 44.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.598 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.773 ' HZ1' ' NH1' ' A' ' 46' ' ' ARG . 11.0 mtpt -105.21 138.3 19.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 37.2 Cg_endo -55.65 141.47 83.78 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.669 0.913 . . . . 0.0 111.888 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.8 p -62.76 -30.04 71.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.335 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.42 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 24.8 p90 -78.39 0.18 26.7 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.884 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 19.7 t-80 -59.61 127.64 85.16 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 98.4 Cg_endo -81.68 167.06 17.1 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.181 1.254 . . . . 0.0 111.803 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 33.0 Cg_exo -52.01 140.66 49.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.731 1.621 . . . . 0.0 111.482 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.773 ' NH1' ' HZ1' ' A' ' 39' ' ' LYS . 62.5 mtt-85 -59.74 -36.37 76.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.519 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.412 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 7.7 p90 -73.94 -13.54 60.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.948 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 m -75.91 -69.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.421 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.008 ' O ' HG23 ' A' ' 52' ' ' ILE . 63.4 mt -66.01 -34.78 78.87 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.476 -0.49 . . . . 0.0 112.031 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.03 -41.03 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.324 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 51.0 Cg_exo -67.2 -7.11 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 123.123 2.549 . . . . 0.0 113.983 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.008 HG23 ' O ' ' A' ' 49' ' ' LEU . 24.4 pt -42.8 -40.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.465 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 99.3 m95 -53.44 -32.95 52.16 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.578 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.75 97.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -68.39 -51.04 48.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.924 0.393 . . . . 0.0 111.403 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.2 mp -67.95 -33.39 74.58 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.248 0.547 . . . . 0.0 110.111 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 17.1 t80 -51.15 -57.16 9.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.125 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -64.97 -38.74 91.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.871 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.24 99.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.214 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.5 mtt -61.34 -37.89 84.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.43 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -55.81 16.12 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -62.15 -38.46 89.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.503 0.192 . . . . 0.0 111.257 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.46 -42.62 93.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.822 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 82' ' ' LEU . 99.2 p -62.58 -30.74 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.27 -43.27 92.52 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.48 -43.87 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.873 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.446 HG13 HG11 ' A' ' 129' ' ' VAL . 77.8 t -61.04 -40.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.287 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.72 -33.23 75.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 29.0 mtpt -62.17 -44.04 97.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.44 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 80.1 mt-10 -70.89 -45.75 63.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.734 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.41 -27.81 60.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.792 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.7 67.96 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.663 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.414 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 149.55 -161.29 28.76 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.94 108.51 20.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.641 0.734 . . . . 0.0 109.904 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . 11.8 t -133.53 167.6 20.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.209 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' THR . 77.6 mm-40 -43.98 -35.57 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.321 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.95 -41.99 97.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.613 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.7 69.52 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.678 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 78.9 mmm -61.21 -34.78 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.534 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.56 -48.36 95.75 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -73.35 -62.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.272 1.315 . . . . 0.0 113.387 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 64' ' ' SER . 8.3 mp -61.82 -41.32 97.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.034 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.55 97.92 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.28 -40.32 90.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.666 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -59.82 -44.54 93.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.769 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.7 m -65.69 -42.41 91.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.98 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.84 -55.91 6.21 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -57.87 -41.27 82.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.412 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.22 -38.87 84.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.113 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.29 84.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.107 0.48 . . . . 0.0 111.414 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.65 -41.8 82.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.039 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -36.0 82.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.758 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.572 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m95 -53.06 -30.84 38.27 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.38 62.9 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.198 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.55 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 40.0 t-105 -64.03 -56.75 22.05 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.572 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 46.1 Cg_endo -54.83 131.83 48.37 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.742 1.628 . . . . 0.0 113.035 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.418 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 42.5 Cg_endo -107.56 -26.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.435 1.423 . . . . 0.0 110.556 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 110' ' ' ALA . 27.1 pt -60.69 -25.59 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.069 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 35.3 p90 -51.69 -42.74 62.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.29 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.499 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.8 t80 -64.53 -49.55 70.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.874 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -113.49 -68.65 0.51 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.369 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 75.53 -3.66 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -54.74 -34.07 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -86.4 155.88 20.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 111.194 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.704 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.8 ttm -57.39 -14.26 4.52 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.811 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -44.69 2.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.155 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.704 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -47.42 -21.84 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.472 0.636 . . . . 0.0 111.374 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 155' ' ' TRP . . . -55.14 -27.86 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.61 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.23 -33.18 73.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.009 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.86 -36.73 79.89 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -61.75 -45.02 95.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.347 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.53 -47.77 71.84 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.715 -0.394 . . . . 0.0 112.005 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.796 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.0 tt -67.0 -41.18 87.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.381 0.61 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.696 ' CD2' HG21 ' A' ' 147' ' ' THR . 17.0 tp -53.22 -60.88 2.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.404 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.505 ' HA ' HD13 ' A' ' 144' ' ' LEU . 65.3 t -70.82 -63.21 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.452 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.0 t -65.39 -38.8 91.08 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.61 -56.55 22.46 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.714 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.1 -38.26 77.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.972 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.88 -47.47 25.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 32.0 m -58.98 -43.39 91.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.02 -50.99 43.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.558 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.403 HG23 ' CD2' ' A' ' 126' ' ' TRP . 34.2 m -65.08 -40.99 95.41 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 71.1 m -60.56 -46.55 89.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 124' ' ' LEU . 83.2 mt -66.25 -35.99 81.84 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.67 -64.14 1.23 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.403 ' CD2' HG23 ' A' ' 122' ' ' THR . 38.6 m0 -66.4 -41.17 89.72 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 33.5 t-80 -58.49 -49.03 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.922 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -65.61 -46.07 80.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.486 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 99.0 t -78.27 -46.5 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.414 ' OG ' HG22 ' A' ' 67' ' ' VAL . 20.1 p -129.4 82.42 67.84 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.591 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.474 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 36.5 Cg_exo -53.14 -43.34 57.95 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.795 1.663 . . . . 0.0 112.257 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 23.7 Cg_exo -58.02 -32.47 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.474 0.783 . . . . 0.0 112.208 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.46 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.522 . . . . 0.0 110.379 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.72 77.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.098 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.501 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 42.7 mtm105 -62.95 -38.59 91.69 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.296 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.15 -38.53 62.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.16 0.505 . . . . 0.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 140' ' ' TYR . 83.7 mt -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -2.81 -67.33 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.794 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.475 ' N ' ' O ' ' A' ' 137' ' ' LEU . 10.9 Cg_endo -54.31 -30.06 60.66 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 120.799 0.999 . . . . 0.0 112.992 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -56.77 -40.69 76.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.733 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.2 tm? -63.61 -42.85 98.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.84 75.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.269 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.639 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -61.7 -50.34 72.83 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.483 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 115' ' ' VAL . 41.1 mt -63.84 -33.73 76.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.839 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.58 96.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.201 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.709 ' CE2' HD22 ' A' ' 150' ' ' LEU . 21.3 t80 -61.47 -41.65 97.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.345 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.696 HG21 ' CD2' ' A' ' 114' ' ' LEU . 53.8 p -60.81 -38.64 86.08 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.1 m -59.49 -50.59 73.34 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.948 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 91.8 t -71.32 -43.88 73.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.864 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.709 HD22 ' CE2' ' A' ' 146' ' ' PHE . 62.2 tp -57.97 -41.59 83.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.184 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 147' ' ' THR . 14.5 m120 -63.04 -40.14 96.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.492 ' O ' ' CB ' ' A' ' 156' ' ' ARG . 37.1 m-85 -62.19 -39.57 93.15 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.697 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.441 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 47.4 t80 -59.9 -46.59 88.84 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.175 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -71.4 -51.32 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.9 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.595 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.771 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 152' ' ' TYR . 28.4 ttp180 -59.57 -38.32 80.81 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.162 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 92.6 m-20 -59.37 -42.46 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.905 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -87.44 -54.64 4.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.345 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 79.7 p . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.913 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.447 ' O ' HD13 ' A' ' 11' ' ' LEU . 75.5 Cg_exo -53.58 -22.66 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 120.656 0.904 . . . . 0.0 111.8 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.34 -33.92 55.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.36 -42.22 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -64.83 -35.25 91.68 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.8 mp -56.46 -41.62 76.82 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 122.728 -0.277 . . . . 0.0 110.962 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 t -79.71 -34.89 39.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.511 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.08 -36.22 79.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.1 t -48.0 -56.41 13.82 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HB3' HD21 ' A' ' 89' ' ' LEU . 20.6 Cg_endo -59.22 -34.16 98.18 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.719 0.946 . . . . 0.0 112.933 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.4 m -59.04 -40.47 85.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.271 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.09 -37.89 88.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.001 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.29 -40.22 98.3 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.89 -44.22 98.36 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.881 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.4 m-85 -63.88 -43.38 96.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.3 mtt -61.83 -40.91 96.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.81 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.44 -45.82 10.72 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB1' ' NH2' ' A' ' 46' ' ' ARG . . . -69.15 -25.15 64.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.33 0.586 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -52.95 -36.55 60.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.358 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 89.7 t80 -60.24 -47.12 87.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.61 -32.81 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' CA ' ' HE ' ' A' ' 46' ' ' ARG . 20.5 ttt-85 -62.42 -42.77 99.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.029 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.94 -132.07 1.18 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.687 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.0 -26.05 59.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.796 0.331 . . . . 0.0 110.69 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.49 8.94 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.25 -41.64 62.97 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.67 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -62.87 -42.17 99.66 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.365 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -61.27 -39.89 92.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.592 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 29.3 m-85 -64.55 -22.82 67.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.021 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.7 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.338 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.86 82.25 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 72.8 mt -91.54 150.02 21.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.408 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.72 126.91 41.32 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.222 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -102.47 141.69 23.03 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 69.3 Cg_endo -57.99 144.15 94.96 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.112 1.208 . . . . 0.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.7 p -64.08 -30.24 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.039 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 35.6 p90 -78.66 3.76 15.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.927 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -60.1 139.52 91.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -95.67 169.3 1.32 Allowed 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.035 1.157 . . . . 0.0 112.759 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.36 148.46 41.9 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.876 2.384 . . . . 0.0 112.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' NH2' ' HB1' ' A' ' 23' ' ' ALA . 22.7 tpt85 -57.21 -39.39 75.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -79.89 -5.94 56.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.4 m -76.79 -76.4 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.9 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.004 ' O ' HG23 ' A' ' 52' ' ' ILE . 69.9 mt -66.38 -32.29 73.58 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.889 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.52 -42.73 5.11 Favored Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.374 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 61.7 Cg_exo -64.31 -6.94 12.68 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.083 2.522 . . . . 0.0 113.789 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.004 HG23 ' O ' ' A' ' 49' ' ' LEU . 18.4 pt -42.32 -44.03 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.731 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.3 m95 -54.8 -31.99 59.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.606 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.68 -39.89 98.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -68.77 -51.79 37.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.092 0.472 . . . . 0.0 111.036 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.1 mp -66.81 -32.63 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.87 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 8.8 t80 -51.79 -49.39 62.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.734 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.0 p -70.88 -36.04 72.6 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.456 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.76 89.07 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.06 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.5 mtt -62.25 -38.77 90.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.427 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.52 -56.68 10.78 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.92 -38.41 88.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.93 92.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 94.1 p -63.5 -28.89 70.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -58.88 -43.81 91.0 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.22 -46.43 88.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.411 HG22 ' OG ' ' A' ' 130' ' ' SER . 78.1 t -60.26 -41.05 85.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.522 0.677 . . . . 0.0 109.198 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.505 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.35 -34.19 77.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.206 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -63.23 -43.18 98.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 82.7 mt-10 -67.49 -37.06 82.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.25 -4.39 58.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.18 46.67 15.18 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.721 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.463 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.39 -159.53 23.34 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.677 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -85.18 111.62 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.719 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.473 HG23 ' H ' ' A' ' 77' ' ' ASP . 3.6 t -130.27 161.21 31.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -47.07 -39.75 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.482 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.473 ' H ' HG23 ' A' ' 75' ' ' THR . 86.2 m-20 -63.33 -39.62 95.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.719 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.8 71.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.212 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 87.4 mmm -58.72 -34.54 71.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.112 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.15 -59.23 13.97 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.22 -53.84 1.33 Allowed 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 120.828 1.019 . . . . 0.0 112.767 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.2 mp -64.0 -43.01 96.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.448 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.55 -41.99 97.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.84 -39.33 77.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.921 0.391 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 73.2 t80 -60.42 -44.17 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.561 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.0 m -64.85 -43.1 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 112.072 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.23 -58.25 4.39 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.76 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -57.8 -40.91 81.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.681 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 15' ' ' PRO . 25.4 tp -62.77 -41.21 99.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.633 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 111.416 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.36 -37.76 78.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.734 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 45.3 t-20 -61.73 -42.46 98.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.169 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -57.57 -31.42 66.13 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.775 0.322 . . . . 0.0 111.193 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.1 -28.81 69.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.666 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -55.05 -55.45 38.89 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.406 ' CD ' HD13 ' A' ' 113' ' ' LEU . 73.4 Cg_exo -38.49 81.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.814 1.676 . . . . 0.0 113.18 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' A' ' 95' ' ' TRP . 65.1 Cg_endo -63.71 -23.69 69.44 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 120.498 0.799 . . . . 0.0 111.704 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 38.1 pt -62.21 -30.0 47.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.65 -48.26 66.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.779 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.489 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 68.5 t80 -64.95 -46.78 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.633 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -109.38 -65.04 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 59.79 -1.32 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 110.838 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 101' ' ' GLY . 24.0 ttp-105 -52.59 -33.55 46.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -91.52 151.77 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.263 0.554 . . . . 0.0 111.688 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.648 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.0 ttp -62.93 -14.63 49.34 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.193 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.75 32.65 0.01 OUTLIER Glycine 0 CA--C 1.543 1.824 0 C-N-CA 121.821 -0.228 . . . . 0.0 113.018 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -63.58 -19.61 64.97 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -179.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.681 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.97 -21.89 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.859 0.361 . . . . 0.0 111.924 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 107' ' ' TRP . 75.3 mt -58.73 -34.79 71.76 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.9 t0 -63.84 -48.06 78.28 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.5 tp -61.54 -49.39 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.399 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.6 tt -67.16 -41.27 86.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.289 0.566 . . . . 0.0 110.11 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.629 ' CD2' HG21 ' A' ' 147' ' ' THR . 13.3 tp -51.42 -59.89 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.678 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.529 ' HA ' HD13 ' A' ' 144' ' ' LEU . 59.8 t -71.13 -63.07 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.588 -1.187 . . . . 0.0 113.2 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.486 ' O ' ' OG1' ' A' ' 120' ' ' THR . 43.7 t -66.93 -39.29 87.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.22 -56.12 23.88 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.355 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 114' ' ' LEU . 4.1 p -65.25 -37.3 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.317 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.03 -52.81 8.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.9 m -54.58 -42.58 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -60.37 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.913 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.608 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 21.6 m -66.02 -41.19 91.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.765 HG23 ' CD2' ' A' ' 127' ' ' HIS . 47.6 m -58.27 -47.22 84.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.165 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.1 -34.17 77.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.11 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.608 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 39.0 m0 -65.06 -45.3 85.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.765 ' CD2' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -59.84 -43.89 94.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.148 -177.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.56 -43.45 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.221 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.492 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 84.7 t -81.02 -50.83 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 67' ' ' VAL . 76.1 p -128.58 88.88 51.0 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.046 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.5 Cg_exo -52.06 -40.14 68.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 121.651 1.567 . . . . 0.0 113.019 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.7 Cg_exo -57.42 -27.0 74.03 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.532 0.821 . . . . 0.0 112.905 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.77 74.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.639 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.62 -38.83 86.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.202 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 59.8 ttt180 -60.39 -38.76 84.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.14 -39.13 74.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.176 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.0 mt -56.79 -33.14 66.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.852 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.522 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER 9.91 -72.62 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -53.4 -26.43 35.48 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 120.617 0.878 . . . . 0.0 113.675 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -57.5 -41.33 80.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.357 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.678 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -64.96 -41.15 95.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.09 0.472 . . . . 0.0 109.943 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.74 -42.4 95.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.647 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -67.2 -53.11 33.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.398 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 115' ' ' VAL . 43.7 mt -61.39 -33.41 73.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.674 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.36 96.96 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.555 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 21.5 t80 -60.55 -41.11 93.87 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.633 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 69.4 p -61.82 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.452 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.438 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 59.3 m -61.21 -53.06 61.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.445 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.4 -42.84 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 54.9 tp -57.39 -41.92 81.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.03 -41.8 97.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 148' ' ' THR . 50.1 m-85 -64.85 -36.75 85.36 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.659 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 62.2 t80 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.426 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.43 -49.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.135 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.681 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.0 m0 -61.72 -43.91 97.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.555 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 152' ' ' TYR . 82.2 mmt-85 -62.87 -34.77 78.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.381 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 91.0 m-20 -56.56 -41.27 76.58 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.795 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -94.22 -48.13 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.443 . . . . 0.0 110.573 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 80.6 p . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.788 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.19 -19.83 35.75 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 119.368 0.81 . . . . 0.0 112.514 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.35 -34.73 61.7 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' THR . 70.1 t -59.85 -39.97 81.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -36.47 92.74 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.7 -41.99 87.55 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 122.824 -0.221 . . . . 0.0 111.565 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 9' ' ' VAL . 3.8 t -75.41 -37.33 60.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.189 -0.604 . . . . 0.0 112.072 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.56 -36.71 81.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 t -51.6 -43.07 86.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.48 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -58.39 -36.45 97.55 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.15 1.233 . . . . 0.0 112.902 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -63.46 -37.52 87.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.602 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.68 -40.03 80.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.455 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.99 76.34 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.7 -40.85 97.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.59 -48.65 80.85 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.171 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 65.0 mtt -63.93 -39.47 94.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.409 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.84 -45.47 74.25 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.799 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.31 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 111.64 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -57.61 -30.94 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 90.6 t80 -61.0 -48.6 81.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.73 -32.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.747 0.785 . . . . 0.0 109.631 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -63.06 -41.18 99.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.575 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.86 -128.58 4.78 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.025 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CG ' HH21 ' A' ' 32' ' ' ARG . 84.2 tt0 -49.97 -30.51 10.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.253 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.97 -33.12 20.48 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.8 mt -50.59 -44.63 56.97 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.543 HH21 ' CG ' ' A' ' 29' ' ' GLU . 67.9 mtm180 -62.18 -43.45 98.8 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.0 110.071 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.06 -39.74 91.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.954 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' LEU . 17.8 m-85 -65.27 -23.14 66.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.2 -41.11 49.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.155 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.18 -32.62 84.53 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' TYR . 67.5 mt -92.51 150.63 20.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -101.54 127.83 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.917 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.792 ' HZ2' ' HE ' ' A' ' 46' ' ' ARG . 14.0 mtpt -107.42 140.69 21.75 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.595 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 37.1 Cg_endo -58.03 130.23 37.12 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 120.713 0.942 . . . . 0.0 111.431 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.6 p -75.64 -13.44 60.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.884 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.508 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 2.7 p90 -77.29 -15.49 59.41 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.488 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -76.04 147.35 80.14 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.49 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HG2' HD21 ' A' ' 49' ' ' LEU . 1.3 Cg_endo -72.83 162.05 42.15 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.803 1.002 . . . . 0.0 111.297 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.9 Cg_endo -50.73 150.6 12.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.217 1.945 . . . . 0.0 111.848 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.792 ' HE ' ' HZ2' ' A' ' 39' ' ' LYS . 51.7 mtt85 -57.11 -36.85 71.13 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.447 ' C ' ' CD1' ' A' ' 47' ' ' TRP . 5.1 p90 -65.02 -22.09 66.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.864 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.7 m -78.45 -63.07 1.49 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.431 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.007 ' O ' HG23 ' A' ' 52' ' ' ILE . 85.8 mt -63.24 -36.98 85.46 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -45.49 -41.38 16.72 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.742 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 75.3 Cg_exo -64.92 -7.56 15.48 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 123.376 2.718 . . . . 0.0 114.081 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.007 HG23 ' O ' ' A' ' 49' ' ' LEU . 27.9 pt -41.99 -41.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.291 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' TYR . 97.2 m95 -51.2 -34.09 30.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.946 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.19 -39.99 96.66 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.0 m -68.68 -51.44 41.83 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.99 0.424 . . . . 0.0 110.936 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -65.98 -32.42 73.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 53' ' ' TRP . 3.5 t80 -52.28 -48.97 65.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.463 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -68.37 -36.92 79.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.23 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.91 76.54 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.672 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.503 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 62.9 mtt -61.84 -37.23 83.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.93 -61.75 5.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 39.4 t80 -61.61 -36.05 79.62 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.753 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.61 -42.91 58.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.1 p -66.65 -27.29 67.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 49.9 t80 -55.5 -49.86 71.45 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.445 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.7 mt -66.25 -37.33 79.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.668 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.7 t -53.88 -48.03 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.448 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.6 p90 -73.23 -30.74 63.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.235 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 65.6 mmtt -58.36 -38.56 77.48 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.204 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.26 -40.91 94.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.27 -25.77 60.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.772 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 104.77 39.12 2.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.15 -166.55 28.52 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.662 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.13 112.05 19.47 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.16 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.2 t -129.94 165.77 21.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.589 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.85 -37.87 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.471 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 75' ' ' THR . 85.3 m-20 -64.28 -38.92 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.868 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.29 73.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.662 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 81.6 mmm -59.74 -33.74 72.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.974 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.4 -57.6 23.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.66 -50.85 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 120.61 0.874 . . . . 0.0 112.335 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.0 mp -65.06 -41.16 95.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.109 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.66 -39.23 97.65 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.94 -38.38 78.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.112 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' OH ' ' SD ' ' A' ' 60' ' ' MET . 86.8 t80 -59.36 -45.17 92.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.144 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.7 m -69.15 -41.89 76.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.45 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.19 -54.41 6.96 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.548 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -57.98 -41.41 82.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.299 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.54 -37.29 85.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.835 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.79 81.72 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.711 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.36 -36.53 84.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -57.85 -40.96 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -66.01 -32.68 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.76 78.17 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.594 ' CD1' HD11 ' A' ' 113' ' ' LEU . 3.8 t-105 -57.84 -50.68 86.73 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 47.9 Cg_exo -42.79 82.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.403 1.402 . . . . 0.0 112.549 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 95' ' ' TRP . 72.3 Cg_endo -62.35 -25.45 76.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 120.574 0.849 . . . . 0.0 111.601 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.801 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.0 pt -59.91 -33.73 53.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -46.61 64.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.89 -50.48 66.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.826 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.33 -53.1 0.47 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.801 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 57.14 3.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 0.0 110.797 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 101' ' ' GLY . 12.6 tpt180 -53.12 -34.96 59.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -92.0 145.33 24.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.329 0.585 . . . . 0.0 111.503 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.637 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.3 ttp -65.31 -14.36 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.343 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.03 38.56 0.01 OUTLIER Glycine 0 CA--C 1.54 1.628 0 O-C-N 123.077 0.236 . . . . 0.0 112.952 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.694 ' HA ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.16 -18.94 65.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.672 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -41.5 -21.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.756 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 107' ' ' TRP . 89.2 mt -57.2 -39.47 75.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.503 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -67.81 -39.04 84.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 109.942 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 49.6 t0 -60.92 -45.18 95.67 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.71 -48.99 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.46 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.594 HD11 ' CD1' ' A' ' 95' ' ' TRP . 85.0 mt -69.08 -40.34 78.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.417 0.627 . . . . 0.0 110.459 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.793 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.1 tp -51.75 -60.25 3.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.154 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.514 ' HA ' HD13 ' A' ' 144' ' ' LEU . 97.5 t -69.11 -63.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.754 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -71.63 -40.32 69.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -61.36 -51.29 58.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.534 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 114' ' ' LEU . 3.7 p -65.83 -37.04 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.174 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.78 -51.43 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.8 m -59.49 -45.28 92.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.28 68.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.37 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.476 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.3 m -64.33 -39.07 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.156 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 89.9 m -59.62 -52.96 63.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 0.0 112.296 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.597 ' O ' ' NE ' ' A' ' 128' ' ' ARG . 65.9 mt -59.34 -31.2 68.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.991 0.425 . . . . 0.0 110.362 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.87 -63.17 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.493 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 33.8 m0 -86.5 -52.21 5.71 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.603 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 0.5 OUTLIER -52.63 -47.15 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.597 ' NE ' ' O ' ' A' ' 124' ' ' LEU . 68.2 mtm180 -63.5 -40.83 98.1 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.3 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.36 -43.41 49.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.8 p -140.33 94.87 8.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.875 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.457 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.3 Cg_exo -54.08 -39.94 83.59 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.948 1.765 . . . . 0.0 113.775 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.5 Cg_exo -55.7 -26.21 54.98 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.338 0.692 . . . . 0.0 112.87 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.54 -31.24 71.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.668 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.603 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -61.38 -40.15 93.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.441 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.537 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 51.9 ttp180 -59.77 -38.16 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.3 tp -58.7 -38.83 79.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.203 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 139' ' ' PRO . 22.0 mt -56.04 -29.62 60.7 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.065 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.9 OUTLIER 9.28 -74.41 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.6 Cg_endo -52.32 -29.12 37.37 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 120.436 0.758 . . . . 0.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -57.92 -42.34 84.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.987 0.423 . . . . 0.0 109.977 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 42.7 tp -63.34 -39.56 94.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.63 96.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.006 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.663 ' CD1' HD12 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -67.09 -47.93 69.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.234 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 115' ' ' VAL . 44.5 mt -65.25 -33.74 76.71 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.801 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.89 77.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.795 ' CE2' HD22 ' A' ' 150' ' ' LEU . 16.0 t80 -63.32 -42.02 98.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.646 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.793 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.0 m -57.6 -43.74 84.89 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.516 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.7 m -60.18 -49.61 76.94 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.705 0.288 . . . . 0.0 111.604 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.44 -40.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.54 0.686 . . . . 0.0 109.757 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.795 HD22 ' CE2' ' A' ' 146' ' ' PHE . 63.8 tp -57.79 -42.98 85.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.729 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 147' ' ' THR . 17.1 m120 -63.48 -41.24 98.58 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -66.04 -40.32 90.9 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -61.52 -40.9 96.32 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.811 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.6 -47.66 79.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 5.3 m0 -62.15 -39.23 91.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -54.81 -31.1 58.75 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.215 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.49 -40.86 68.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.651 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -103.8 -60.91 1.5 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.675 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 155' ' ' TRP . 49.2 m . . . . . 0 N--CA 1.461 0.111 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.875 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.486 ' O ' HD13 ' A' ' 11' ' ' LEU . 76.6 Cg_exo -54.87 -21.35 25.77 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.445 1.43 . . . . 0.0 112.617 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.09 -40.94 59.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.797 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 12' ' ' THR . 93.9 t -63.37 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.74 -34.44 89.91 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.277 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.1 mp -56.55 -42.63 78.85 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.871 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 9' ' ' VAL . 4.0 t -76.03 -36.55 59.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.822 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.98 -38.17 90.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -53.87 -42.23 91.85 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -56.47 -36.36 97.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 120.953 1.102 . . . . 0.0 112.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -61.25 -37.88 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 mt -62.35 -39.11 92.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.252 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.82 -52.58 28.22 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.76 -38.27 95.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -57.33 -44.78 84.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.279 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.08 -38.92 90.66 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.375 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.72 -46.27 76.93 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.99 -24.08 62.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 110.826 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -34.92 70.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 54.3 t80 -60.71 -49.05 79.06 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.62 -33.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.156 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -61.01 -40.79 94.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.817 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.06 -125.83 2.67 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.032 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.87 -28.8 62.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 111.209 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.4 -33.97 12.58 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 94.1 mt -48.78 -44.33 38.82 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.663 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.09 -42.45 99.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.976 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -62.31 -38.14 88.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.843 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.607 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.1 m-85 -63.78 -22.75 67.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.224 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.19 -41.41 27.06 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.973 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.99 -32.25 76.73 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.8 mt -88.93 149.51 23.28 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.451 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.0 mt-30 -101.96 130.17 48.41 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.079 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HZ1' ' HE ' ' A' ' 46' ' ' ARG . 16.1 mtpt -108.99 141.5 23.51 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 27.6 Cg_endo -58.98 135.93 69.95 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.387 1.391 . . . . 0.0 111.944 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.9 p -71.94 -21.29 61.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.312 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.525 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 4.5 p90 -77.95 -14.8 59.41 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.66 148.49 92.74 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.948 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -80.14 162.34 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.202 1.935 . . . . 0.0 111.424 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.2 Cg_endo -52.47 149.49 23.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.768 1.645 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HE ' ' HZ1' ' A' ' 39' ' ' LYS . 39.2 mtt85 -57.19 -37.96 72.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 48' ' ' THR . 5.0 p90 -63.98 -28.21 69.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.941 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 25.0 m -66.12 -61.21 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.993 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.2 mt -72.22 -34.78 68.61 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -38.33 -49.35 3.44 Favored Pre-proline 0 C--N 1.321 -0.634 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.938 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.4 Cg_endo -73.19 4.67 3.61 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 122.113 1.875 . . . . 0.0 114.134 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.993 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.5 pt -42.07 -40.17 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.637 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.6 m95 -50.7 -32.32 19.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.333 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.1 -40.69 95.95 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 m -67.98 -50.97 52.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 111.352 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -67.61 -33.12 74.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.238 0.542 . . . . 0.0 109.897 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.3 t80 -52.67 -49.43 65.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.2 p -70.41 -36.55 74.1 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.684 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.403 ' C ' HD11 ' A' ' 136' ' ' LEU . . . -67.33 -40.88 85.96 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.48 -39.37 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.095 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.99 -49.3 76.81 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -64.05 -39.16 93.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -55.82 -42.09 85.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.472 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.9 p -64.27 -29.27 70.37 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.76 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 50.6 t80 -58.78 -40.13 83.05 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.218 0.532 . . . . 0.0 110.169 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.38 -39.55 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.539 0.685 . . . . 0.0 109.865 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.567 HG22 ' OG ' ' A' ' 130' ' ' SER . 61.4 t -65.42 -54.08 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.55 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.46 ' NE1' ' HG2' ' A' ' 69' ' ' LYS . 0.7 OUTLIER -66.37 -35.75 81.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG2' ' NE1' ' A' ' 68' ' ' TRP . 22.0 mmtp -61.4 -39.49 90.92 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.495 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -63.32 -40.07 96.3 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.334 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 71' ' ' LEU . 77.3 mt -74.73 -25.49 59.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.74 49.26 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.449 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.39 -158.64 24.64 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.633 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -92.18 109.13 20.49 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.482 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.548 ' CG2' ' OD1' ' A' ' 77' ' ' ASP . 6.3 t -131.68 167.37 19.58 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -49.91 -38.36 35.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 35.6 p30 -66.45 -32.87 74.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.974 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.664 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -76.61 -30.69 57.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.633 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 88.1 mmm -59.04 -34.9 72.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.23 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -64.08 -58.13 15.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.406 ' CA ' ' HB1' ' A' ' 125' ' ' ALA . 13.3 Cg_endo -59.37 -56.5 1.28 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 121.461 1.441 . . . . 0.0 113.117 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.3 mp -64.14 -43.07 96.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.947 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.85 97.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.868 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -57.33 -39.8 76.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.083 0.468 . . . . 0.0 110.203 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -61.12 -43.98 98.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.042 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.3 m -68.42 -42.93 78.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -61.2 2.97 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -55.6 -41.09 72.93 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.22 -38.82 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.43 69.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.1 -38.54 86.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.918 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.436 ' OD1' HD12 ' A' ' 113' ' ' LEU . 42.8 t-20 -60.65 -42.13 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -58.14 -31.71 67.46 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.619 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.5 70.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.374 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -54.3 -54.3 49.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.401 ' CD ' HD13 ' A' ' 113' ' ' LEU . 86.8 Cg_exo -40.37 79.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.678 1.586 . . . . 0.0 113.28 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.601 ' N ' ' O ' ' A' ' 95' ' ' TRP . 57.3 Cg_endo -61.0 -21.3 71.06 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 120.818 1.012 . . . . 0.0 110.525 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.871 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.0 pt -62.41 -23.96 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.175 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -54.49 -46.88 73.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.027 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 69.3 t80 -64.33 -50.2 68.72 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.17 0.42 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.676 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.98 -2.3 0.2 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.567 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.0 ttt180 -53.92 -35.08 61.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.58 157.02 19.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.244 0.545 . . . . 0.0 111.455 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.696 ' O ' ' N ' ' A' ' 107' ' ' TRP . 21.7 ttm -56.26 -14.07 2.58 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.584 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.31 -1.37 0.01 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.368 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.696 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.92 -20.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.081 -0.658 . . . . 0.0 111.08 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.555 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.49 -27.45 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.739 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.98 -33.88 73.92 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.546 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.18 -37.14 84.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.4 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 60.9 t0 -63.11 -50.43 70.53 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.59 -46.38 86.08 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.498 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.764 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -67.6 -42.16 82.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.359 0.599 . . . . 0.0 110.35 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.684 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.6 tp -50.02 -59.51 3.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.489 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 144' ' ' LEU . 60.3 t -70.69 -63.19 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.04 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.411 ' O ' ' OG1' ' A' ' 120' ' ' THR . 42.3 t -66.1 -38.97 89.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.4 -55.87 26.63 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.963 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -65.21 -39.07 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.741 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.72 -45.18 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 116' ' ' SER . 62.3 m -60.56 -42.27 96.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.7 -53.82 16.76 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.155 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.457 HG23 ' CE3' ' A' ' 126' ' ' TRP . 49.0 m -64.36 -41.18 96.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 65.5 m -59.2 -45.68 90.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.7 -37.22 85.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB1' ' CA ' ' A' ' 81' ' ' PRO . . . -83.01 -64.22 1.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.457 ' CE3' HG23 ' A' ' 122' ' ' THR . 41.1 m0 -66.54 -42.16 87.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 50.6 t-80 -58.33 -48.08 81.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.698 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -62.43 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.33 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -72.57 -43.57 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 0.0 111.448 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 67' ' ' VAL . 1.3 p -145.84 106.23 4.25 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.666 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.493 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.0 Cg_exo -56.58 -38.2 95.98 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.371 1.38 . . . . 0.0 112.985 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.8 Cg_exo -55.16 -27.46 56.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 120.484 0.789 . . . . 0.0 112.446 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' LEU . . . -60.84 -24.48 65.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.516 0.674 . . . . 0.0 109.296 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.49 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -64.67 -43.64 92.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.37 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.439 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.6 mtt85 -66.28 -37.44 85.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.548 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.834 ' C ' HD13 ' A' ' 136' ' ' LEU . 1.1 tm? -49.23 -43.16 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.401 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.503 ' O ' ' C ' ' A' ' 138' ' ' TYR . 60.2 mt -60.84 -29.02 69.25 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.503 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 2.82 -76.2 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -53.08 -25.57 29.42 Favored 'Trans proline' 0 N--CA 1.509 2.423 0 CA-C-N 119.384 0.816 . . . . 0.0 113.278 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -56.61 -38.41 72.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -178.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 34.0 tp -65.17 -40.36 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.79 94.09 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.647 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -65.3 -50.81 64.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.114 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.519 HD13 ' HA ' ' A' ' 115' ' ' VAL . 43.8 mt -64.51 -34.1 77.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.079 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.723 ' CE2' HD22 ' A' ' 150' ' ' LEU . 21.4 t80 -62.72 -42.2 99.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.624 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.684 HG21 ' CD2' ' A' ' 114' ' ' LEU . 53.2 p -60.28 -38.0 82.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.5 m -59.6 -50.99 71.75 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.1 t -69.94 -44.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.215 0.531 . . . . 0.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.723 HD22 ' CE2' ' A' ' 146' ' ' PHE . 62.2 tp -58.09 -40.68 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 147' ' ' THR . 13.0 m120 -63.96 -40.03 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -61.94 -44.29 97.08 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.325 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -64.22 -40.04 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.076 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.82 -48.99 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.516 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -62.59 -40.23 96.26 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.65 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 159' ' ' SER . 39.1 mtm180 -60.03 -23.58 63.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.291 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 88.1 m-20 -53.63 -42.38 67.71 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.142 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -102.41 -41.4 6.33 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 156' ' ' ARG . 50.4 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.112 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.41 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -58.05 -28.06 81.96 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 CA-C-N 119.01 0.682 . . . . 0.0 111.052 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 -30.92 63.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.11 -42.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.25 -36.26 93.18 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.685 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mp -56.27 -44.21 79.54 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.609 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -79.33 -30.51 42.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.107 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.07 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 t -52.32 -56.6 20.8 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.2 Cg_endo -58.95 -33.36 98.68 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 CA-C-N 119.076 0.706 . . . . 0.0 112.72 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -60.23 -39.41 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.303 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.3 -37.66 88.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.232 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -64.49 -53.37 35.99 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.94 95.23 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.0 -45.9 89.52 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.567 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.3 mtm -62.91 -37.22 86.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.281 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.94 98.77 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.124 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.07 64.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.93 -34.22 69.64 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.98 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 86.8 t80 -62.53 -46.75 86.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.216 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -74.09 -33.2 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.83 0.824 . . . . 0.0 109.766 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -59.35 -40.39 86.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.019 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.8 -130.6 4.64 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.808 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -51.55 -28.05 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.071 0.462 . . . . 0.0 110.85 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.99 15.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD21 ' HE ' ' A' ' 46' ' ' ARG . 95.3 mt -51.35 -43.21 61.74 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.848 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.391 0.615 . . . . 0.0 110.618 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -59.79 -40.44 88.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.662 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' NZ ' ' A' ' 39' ' ' LYS . 44.3 m-85 -66.08 -22.64 66.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.745 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.95 -41.65 16.47 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.443 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.74 -32.2 83.36 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.4 mt -93.63 149.16 21.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.286 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.585 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.8 mt-30 -99.21 122.21 42.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.87 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.699 ' NZ ' ' CD1' ' A' ' 34' ' ' TYR . 22.4 mttp -94.5 141.0 22.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HG3' HD12 ' A' ' 150' ' ' LEU . 55.2 Cg_endo -57.25 144.85 89.71 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.557 1.504 . . . . 0.0 113.069 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 m -61.58 -32.42 72.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.918 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 20.2 p90 -76.87 2.08 15.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.583 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.699 ' CE1' ' NH1' ' A' ' 46' ' ' ARG . 8.4 t-80 -62.7 140.16 97.06 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 71.7 Cg_endo -101.14 169.86 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.111 1.207 . . . . 0.0 112.461 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 50.4 Cg_exo -52.3 147.97 26.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.653 2.235 . . . . 0.0 112.209 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.699 ' NH1' ' CE1' ' A' ' 43' ' ' HIS . 80.0 mmt-85 -58.33 -37.58 75.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.402 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 25.7 p90 -81.21 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 49' ' ' LEU . 16.1 m -74.3 -76.18 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.599 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.99 ' O ' HG23 ' A' ' 52' ' ' ILE . 77.6 mt -66.09 -32.73 74.36 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.653 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.0 -43.45 4.57 Favored Pre-proline 0 C--N 1.324 -0.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.63 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 53.8 Cg_exo -63.61 -7.2 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.929 2.419 . . . . 0.0 113.714 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.99 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.5 pt -42.44 -41.46 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.444 ' N ' HG13 ' A' ' 52' ' ' ILE . 97.9 m95 -53.91 -33.79 57.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.442 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.64 94.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -69.38 -52.8 23.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.754 0.311 . . . . 0.0 111.44 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.1 mp -66.48 -33.68 76.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.179 0.514 . . . . 0.0 110.423 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 23.8 t80 -49.37 -59.55 3.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.287 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 m -65.01 -38.05 89.66 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.81 95.38 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.701 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -63.16 -37.73 88.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.687 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.24 -58.66 8.39 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -61.67 -37.44 84.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.491 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.86 -41.45 67.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 85.3 p -66.64 -27.95 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.37 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -55.82 -45.92 78.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.14 -44.19 97.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.75 -37.04 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.739 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.612 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 58.4 mttt -65.2 -41.71 94.27 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.465 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 87.3 mt-10 -70.15 -37.93 75.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . 58.7 mt -92.2 -0.54 57.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.6 5.21 67.07 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 90.52 -167.18 32.24 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -59.3 82.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.212 0.53 . . . . 0.0 111.065 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.0 t -133.12 160.84 36.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.664 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -41.95 -40.48 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.323 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 75' ' ' THR . 87.1 m-20 -66.88 -44.12 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.539 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 73' ' ' GLY . . . -77.67 -33.24 53.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 83' ' ' GLY . 87.8 mtp -57.87 -33.7 68.96 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.156 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.01 -50.17 89.56 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.305 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.7 -52.31 1.05 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 120.495 0.797 . . . . 0.0 111.948 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.4 mp -62.44 -42.48 99.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.319 0.581 . . . . 0.0 109.507 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.86 -38.66 96.91 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -58.38 -38.03 76.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.149 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 88.5 t80 -60.4 -44.45 95.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.1 m -65.88 -41.29 91.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.507 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.86 -54.22 19.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.819 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -59.79 -39.88 86.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.635 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' A' ' 15' ' ' PRO . 22.7 tp -58.79 -37.99 77.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.178 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.42 88.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 0.0 111.199 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -58.66 -39.95 82.1 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.417 ' ND2' ' HG ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -64.48 -35.96 82.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.693 178.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.557 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.7 m95 -56.17 -31.86 63.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.316 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.01 -16.39 62.06 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.6 t-105 -70.32 -52.81 11.29 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 27.4 Cg_endo -55.86 131.11 44.05 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.864 1.709 . . . . 0.0 113.309 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.412 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 41.3 Cg_endo -107.97 -28.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 120.841 1.028 . . . . 0.0 111.382 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.754 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 28.8 pt -56.58 -30.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.367 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 15.6 p90 -54.12 -42.29 69.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.526 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.9 t80 -63.53 -51.29 66.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.315 . . . . 0.0 111.532 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -114.11 -54.53 0.42 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.86 -1.0 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 101' ' ' GLY . 25.7 tpt180 -54.36 -33.72 59.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.847 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.77 151.36 27.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.318 0.58 . . . . 0.0 111.958 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.598 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ppp? -65.58 -14.41 61.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.741 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.37 32.74 0.02 OUTLIER Glycine 0 CA--C 1.538 1.496 0 O-C-N 123.131 0.269 . . . . 0.0 112.924 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.598 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.49 -21.26 62.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.596 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -50.1 -23.73 2.29 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.773 0.32 . . . . 0.0 111.813 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.11 -32.14 70.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.379 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.669 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.61 -45.52 93.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.495 . . . . 0.0 109.948 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.565 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 37.3 t0 -63.44 -44.03 95.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.903 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -60.73 -40.05 90.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.148 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.756 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -66.63 -48.25 70.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 113' ' ' LEU . 2.6 pp -75.31 -34.05 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.796 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 111' ' ' ASP . 45.3 t -63.63 -45.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.777 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 t -85.8 -41.45 15.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.56 -47.1 86.66 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.573 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.2 -46.22 45.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.568 0.223 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -71.71 -57.97 3.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 38.1 m -58.04 -43.12 86.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -59.42 2.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.011 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 34.4 m -64.64 -41.59 96.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.796 HG23 ' ND1' ' A' ' 127' ' ' HIS . 55.8 m -59.46 -47.73 84.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.412 HD22 HH21 ' A' ' 128' ' ' ARG . 88.9 mt -66.09 -34.55 78.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.44 -63.7 1.36 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.477 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.2 m0 -66.78 -43.95 82.59 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -177.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.796 ' ND1' HG23 ' A' ' 123' ' ' THR . 22.3 m170 -59.87 -45.32 92.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.931 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.412 HH21 HD22 ' A' ' 124' ' ' LEU . 96.7 mtt-85 -61.96 -44.4 96.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.354 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.497 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 77.1 t -76.85 -47.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.418 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.0 p -134.58 91.26 21.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.073 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.461 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.7 Cg_exo -52.4 -40.53 70.86 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.607 1.538 . . . . 0.0 112.975 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.6 Cg_exo -57.63 -29.18 84.38 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.591 0.861 . . . . 0.0 112.857 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.44 -32.3 71.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.202 0.525 . . . . 0.0 110.5 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.15 -36.55 77.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.64 -39.23 83.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.366 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 tp -57.7 -39.76 77.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.007 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 140' ' ' TYR . 82.7 mt -59.52 -27.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.973 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -6.2 -64.32 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.453 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -54.05 -30.2 58.64 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 CA-C-N 119.523 0.865 . . . . 0.0 112.898 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.45 -47.02 80.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 41.2 tp -60.58 -39.76 89.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.21 96.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.581 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -70.0 -50.22 43.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.893 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 115' ' ' VAL . 24.0 mt -65.38 -34.06 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.523 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.11 -47.54 84.14 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CE2' HD22 ' A' ' 150' ' ' LEU . 32.1 t80 -64.18 -43.69 94.34 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.345 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.568 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.2 m -56.14 -43.99 78.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.951 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 48.9 m -64.79 -48.37 74.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.775 0.322 . . . . 0.0 111.564 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.26 -41.74 86.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.836 HD22 ' CE2' ' A' ' 146' ' ' PHE . 56.6 tp -57.9 -41.15 81.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.974 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.565 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.5 m120 -62.09 -41.35 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -64.14 -42.37 96.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.818 0.674 . . . . 0.0 112.818 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -58.63 -45.21 89.75 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.062 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.97 -46.01 82.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.6 m0 -61.78 -40.03 93.73 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.78 -29.98 65.29 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.229 -0.589 . . . . 0.0 111.471 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 86.9 m-20 -50.71 -39.8 52.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -103.11 -58.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.228 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.224 -179.189 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 11' ' ' LEU . 86.0 Cg_exo -53.91 -21.7 21.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 120.841 1.027 . . . . 0.0 111.921 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.17 -35.96 62.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.933 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.8 t -62.48 -43.32 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.64 -33.37 85.96 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.378 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.8 mp -56.13 -43.2 77.98 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.136 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -37.95 35.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.836 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 57' ' ' TYR . 83.1 mt -62.3 -37.61 86.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -52.67 -43.43 92.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.819 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -57.17 -33.26 95.58 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.167 1.245 . . . . 0.0 113.176 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.6 p -62.19 -35.46 78.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.93 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.078 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -42.1 97.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.1 97.63 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.91 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 55.5 m-85 -61.99 -41.21 97.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.539 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.68 -40.29 96.62 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.765 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.42 -47.87 11.81 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.586 ' HB1' ' NH2' ' A' ' 46' ' ' ARG . . . -69.31 -23.37 63.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.209 0.528 . . . . 0.0 110.441 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -51.62 -38.95 57.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.032 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.558 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 58.1 t80 -62.69 -48.79 77.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -32.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.55 0.69 . . . . 0.0 109.967 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.494 ' CB ' ' HE ' ' A' ' 46' ' ' ARG . 13.9 ttt-85 -62.4 -41.44 98.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.023 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -131.22 2.64 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.132 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -26.99 48.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.618 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.6 -35.49 11.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -49.14 -44.64 42.75 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.962 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -61.0 -39.34 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.938 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -58.68 -37.07 75.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.349 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 37' ' ' LEU . 55.8 m-85 -61.02 -22.8 64.9 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.7 -40.57 6.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.059 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.47 -31.8 71.28 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 34' ' ' TYR . 56.9 mt -92.79 148.16 22.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 110.887 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -96.49 123.79 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.85 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -94.85 139.61 22.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 74.4 Cg_endo -58.84 147.06 90.73 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.501 1.467 . . . . 0.0 112.601 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -64.45 -29.42 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.09 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 39.4 p90 -78.32 2.7 17.66 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.492 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 57.8 t-80 -62.16 142.71 95.59 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 87.1 Cg_endo -107.74 172.55 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.336 1.357 . . . . 0.0 112.282 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 27.6 Cg_exo -54.41 148.14 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.87 2.38 . . . . 0.0 112.335 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.586 ' NH2' ' HB1' ' A' ' 23' ' ' ALA . 28.6 tpt85 -56.61 -39.28 73.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.406 ' CZ2' ' HB3' ' A' ' 45' ' ' PRO . 26.4 p90 -77.15 -9.12 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -75.57 -73.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.573 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.994 ' O ' HG23 ' A' ' 52' ' ' ILE . 92.1 mt -66.94 -32.72 74.16 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.694 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.38 -42.71 4.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.156 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 76.1 Cg_exo -63.79 -6.27 10.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.914 2.409 . . . . 0.0 113.387 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.1 pt -41.24 -44.84 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.084 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.492 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.1 m95 -58.08 -34.0 69.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.089 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.26 -40.35 98.48 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -66.99 -53.26 33.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 0.0 111.325 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.8 mp -67.82 -32.16 72.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.0 t80 -52.34 -50.14 62.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.875 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -69.89 -36.62 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.29 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' HD21 ' A' ' 136' ' ' LEU . . . -67.57 -43.46 80.58 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.046 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.5 mtt -60.63 -38.9 86.31 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.87 -52.64 40.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -61.4 -35.48 77.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.572 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.64 -46.02 59.54 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.435 ' CB ' HD21 ' A' ' 82' ' ' LEU . 97.4 p -63.26 -30.13 71.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.456 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 46.7 t80 -55.01 -40.3 70.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 109.797 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.0 mt -69.51 -44.39 79.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG13 HG11 ' A' ' 129' ' ' VAL . 53.8 t -63.68 -51.89 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -64.27 -33.07 74.97 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.838 -178.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 67.0 mmtt -60.64 -40.79 93.27 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.783 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -67.68 -34.05 76.14 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.143 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 78' ' ' ALA . 54.6 mt -85.5 -0.54 55.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.092 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.76 44.08 8.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 90.43 -154.43 23.43 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -87.25 110.71 20.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.517 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.1 t -133.95 168.63 18.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.893 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -52.27 -37.96 56.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.385 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' H ' HG23 ' A' ' 75' ' ' THR . 84.8 m-20 -62.22 -40.02 94.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.339 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 71' ' ' LEU . . . -67.49 -28.28 67.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.851 0.358 . . . . 0.0 111.377 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 mtt -58.82 -35.25 72.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.306 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.18 -47.65 98.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.457 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 16.2 Cg_endo -77.75 -63.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 120.735 0.957 . . . . 0.0 112.538 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' A' ' 64' ' ' SER . 20.7 mt -59.49 -41.71 90.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.19 98.78 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.773 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.55 -38.11 74.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 109.916 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -57.92 -43.94 86.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.588 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.98 -60.72 3.76 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.396 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.59 -40.06 74.63 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.56 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.63 -40.39 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.224 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.96 78.52 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.48 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.11 87.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.226 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.546 ' O ' HD11 ' A' ' 113' ' ' LEU . 41.3 t-20 -62.23 -39.91 94.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.568 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.8 m95 -59.46 -28.45 67.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.07 63.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 97' ' ' PRO . 8.7 t-105 -71.12 -55.7 6.14 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.5 Cg_endo -40.96 82.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.034 1.156 . . . . 0.0 112.317 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -59.33 -23.82 71.7 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.739 1.626 . . . . 0.0 112.459 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.645 HD11 ' HB2' ' A' ' 110' ' ' ALA . 35.5 pt -59.62 -30.02 43.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.402 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.3 p90 -44.85 -42.27 7.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.493 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 57.7 t80 -66.62 -52.01 49.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.79 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.27 -68.69 0.48 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.737 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.558 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 65.58 5.07 3.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -54.92 -35.55 64.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 109.913 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -85.74 152.86 22.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.245 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.634 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.4 ttm -61.14 -14.97 28.55 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.975 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.7 21.59 0.01 OUTLIER Glycine 0 CA--C 1.543 1.79 0 C-N-CA 121.724 -0.274 . . . . 0.0 113.239 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.634 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.6 -19.82 41.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.409 0.605 . . . . 0.0 112.248 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.58 -22.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.446 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 107' ' ' TRP . 77.8 mt -59.63 -36.45 76.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.645 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -66.6 -40.25 88.77 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.33 0.586 . . . . 0.0 109.858 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.489 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 48.6 t0 -60.57 -57.15 13.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.664 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.97 -37.9 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.673 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.1 tt -64.46 -49.94 69.45 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 113' ' ' LEU . 3.2 pp -75.58 -35.21 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.065 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.516 ' HA ' HD22 ' A' ' 144' ' ' LEU . 55.7 t -66.6 -59.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 111.595 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -72.47 -40.48 66.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.474 ' HA3' HD22 ' A' ' 92' ' ' ASN . . . -58.54 -54.43 37.84 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.598 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.71 -35.69 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.504 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -75.46 -52.96 9.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.0 m -57.45 -43.04 83.65 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.66 -54.62 13.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.545 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.2 m -66.79 -40.01 87.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 91.2 m -59.36 -47.09 86.76 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 HH21 ' A' ' 128' ' ' ARG . 70.2 mt -72.83 -34.25 66.7 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.457 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -78.68 -64.16 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -64.56 -43.61 93.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.685 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 51.2 m170 -59.38 -44.7 92.72 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.022 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.489 HH21 HD22 ' A' ' 124' ' ' LEU . 98.5 mtt180 -61.58 -43.61 98.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.586 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.54 HG11 HG13 ' A' ' 67' ' ' VAL . 95.6 t -79.95 -46.68 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.557 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 96.0 p -133.58 88.53 33.76 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.48 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 34.7 Cg_exo -53.94 -41.01 78.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.766 1.644 . . . . 0.0 112.858 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 33.4 Cg_exo -56.44 -30.59 82.48 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 120.597 0.864 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.79 68.81 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.261 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.685 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -57.74 -39.25 76.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.421 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.508 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 93.2 mtt180 -63.28 -37.4 87.12 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.001 0.429 . . . . 0.0 110.533 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 59' ' ' ALA . 17.0 tp -54.28 -37.69 65.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 138' ' ' TYR . 85.1 mt -67.56 -3.16 7.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.147 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -26.97 -59.99 0.2 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.89 -23.96 78.18 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.079 1.186 . . . . 0.0 113.802 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -55.47 -41.21 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.179 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 37.2 tp -63.47 -39.51 94.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.17 93.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.669 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.708 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -66.44 -53.97 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.614 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 115' ' ' VAL . 50.1 mt -63.85 -33.51 75.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -41.02 95.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.799 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 28.2 t80 -61.69 -40.27 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.59 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 81.4 p -59.93 -37.94 80.94 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.404 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.6 p -68.33 -47.2 68.14 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.087 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.84 -41.16 79.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.373 0.606 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.799 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 36.9 tp -60.3 -42.95 96.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.489 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.3 m120 -66.51 -36.65 83.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.23 0.538 . . . . 0.0 110.947 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.553 ' CE1' ' NE ' ' A' ' 156' ' ' ARG . 1.4 t80 -56.42 -48.17 77.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.104 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -67.28 -45.01 77.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.82 -47.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.2 m0 -61.1 -40.73 94.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.553 ' NE ' ' CE1' ' A' ' 152' ' ' TYR . 86.2 mtt-85 -59.39 -28.07 66.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.526 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -51.71 -40.63 60.49 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.202 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -105.28 -60.34 1.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.449 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.767 -179.402 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 17.1 t . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.29 -18.25 29.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 120.44 0.76 . . . . 0.0 112.288 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.26 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.3 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 12' ' ' THR . 60.8 t -59.93 -40.31 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.64 -36.9 93.36 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.8 mp -58.52 -42.22 87.25 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 9' ' ' VAL . 6.6 t -74.95 -35.46 62.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.581 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.48 -34.9 78.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 10' ' ' GLY . 16.9 t -47.91 -56.6 12.9 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.0 Cg_endo -58.58 -34.44 98.84 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 120.797 0.998 . . . . 0.0 112.958 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p -62.14 -37.56 85.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.403 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.17 -38.71 85.9 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.479 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' C ' ' CZ3' ' A' ' 93' ' ' TRP . . . -67.76 -54.23 19.66 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.815 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.671 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -59.86 -36.17 89.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.814 -0.515 . . . . 0.0 111.814 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.48 -45.03 89.52 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.435 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.5 mtt -63.45 -39.23 93.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.8 0.333 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.95 -43.52 91.1 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.66 -26.07 64.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 110.816 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.78 -36.61 72.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.711 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 69.5 t80 -59.94 -49.67 76.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.4 m -73.6 -34.15 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.725 0.774 . . . . 0.0 109.929 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -61.79 -42.0 98.45 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.783 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.45 -127.51 1.57 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.854 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.93 -27.61 61.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.708 0.29 . . . . 0.0 110.682 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.24 -34.81 13.37 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -50.79 -41.48 57.17 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.488 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -61.06 -43.46 98.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.366 0.603 . . . . 0.0 109.458 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.17 -40.2 95.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.518 ' O ' ' O ' ' A' ' 37' ' ' LEU . 15.4 m-85 -62.4 -22.74 66.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.11 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.6 -41.5 31.04 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.209 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.0 79.02 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.1 mt -90.87 148.57 22.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.587 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -100.82 128.88 46.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.887 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.5 145.56 31.27 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.946 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 24.0 Cg_endo -58.41 137.13 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.135 1.223 . . . . 0.0 111.691 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -66.03 -26.73 67.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.089 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.411 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 13.0 p90 -78.32 -4.19 46.75 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.685 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 3.4 t-80 -60.09 134.09 90.31 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.362 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 51.4 Cg_exo -75.03 167.23 27.48 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.092 1.195 . . . . 0.0 111.678 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 26.9 Cg_exo -53.88 149.22 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.948 1.765 . . . . 0.0 111.242 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -57.24 -36.08 70.48 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.208 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CZ2' ' HB3' ' A' ' 45' ' ' PRO . 22.5 p90 -76.81 -11.54 59.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -77.02 -72.43 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.799 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.03 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.9 mt -62.77 -35.59 80.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.158 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.58 -41.28 5.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.002 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 66.1 Cg_exo -67.06 -2.21 7.55 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.917 2.411 . . . . 0.0 113.73 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.03 HG23 ' O ' ' A' ' 49' ' ' LEU . 20.1 pt -46.51 -34.57 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.732 0.301 . . . . 0.0 111.512 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.619 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 4.7 m-90 -54.07 -27.36 32.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.7 94.83 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -72.99 -45.85 55.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.853 0.358 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.682 HD11 ' CD1' ' A' ' 143' ' ' TRP . 6.8 mt -66.03 -33.61 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.228 0.537 . . . . 0.0 109.877 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 25.2 t80 -60.14 -50.05 75.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.913 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.7 p -74.79 -33.32 62.22 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.971 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.69 -46.18 83.48 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.638 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.8 mtt -63.93 -38.2 90.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.657 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.85 -61.41 5.58 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.13 -37.3 86.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.603 0.239 . . . . 0.0 111.256 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.22 -43.33 74.54 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.8 p -67.44 -26.0 66.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.475 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 43.7 t80 -56.45 -50.16 72.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.163 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.58 -41.72 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.583 HG22 ' OG ' ' A' ' 130' ' ' SER . 62.8 t -53.64 -48.32 59.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 65' ' ' TYR . 1.4 p90 -70.58 -31.52 68.56 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.966 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 67.8 mmtt -59.71 -37.92 80.21 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.761 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 81.0 mt-10 -68.15 -35.66 78.43 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.87 3.68 47.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.931 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 36.0 11.62 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.32 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 89.21 -174.85 42.42 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.61 84.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.6 m -93.42 146.69 23.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.212 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -50.88 -37.96 46.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.596 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.25 -39.52 92.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.17 0.51 . . . . 0.0 109.671 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.5 71.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.601 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.4 mtp -58.49 -33.05 69.37 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.612 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -55.98 -57.9 19.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.791 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.7 -47.9 10.21 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 119.023 0.687 . . . . 0.0 112.428 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.221 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.0 -37.44 94.96 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.6 tp -57.03 -41.65 78.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 77.6 t80 -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.3 m -65.42 -42.72 92.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.674 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.51 -58.41 3.88 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.635 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -57.15 -41.67 79.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.577 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 15' ' ' PRO . 36.2 tp -63.25 -38.1 89.84 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.135 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.76 75.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.9 -39.13 88.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.589 ' OD1' HD13 ' A' ' 113' ' ' LEU . 43.6 t-20 -60.78 -38.3 84.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.475 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.671 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 50.2 m95 -62.07 -31.33 71.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.632 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -31.8 73.14 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.686 ' CD1' HD11 ' A' ' 113' ' ' LEU . 4.0 t-105 -55.38 -50.69 85.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -41.05 80.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.684 1.589 . . . . 0.0 113.107 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.597 ' N ' ' O ' ' A' ' 95' ' ' TRP . 67.5 Cg_endo -63.04 -26.25 73.65 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 120.616 0.878 . . . . 0.0 111.143 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 107' ' ' TRP . 42.4 pt -63.82 -33.96 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -44.88 -41.09 6.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.808 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 64.8 t80 -67.18 -51.76 49.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.323 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.38 -65.83 0.44 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.572 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.512 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 64.84 5.19 2.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.441 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -54.24 -34.26 60.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.953 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -90.12 153.61 20.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.477 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.662 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.8 ttm -61.95 -15.16 41.4 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.18 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.7 20.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.638 0 C-N-CA 121.526 -0.369 . . . . 0.0 113.345 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.662 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -60.05 -19.38 52.59 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.74 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.82 -20.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' TRP . 83.8 mt -59.23 -38.91 81.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.03 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -66.12 -38.44 88.21 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.372 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.456 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 59.4 t0 -60.66 -45.88 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.96 -47.49 65.51 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.732 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 95' ' ' TRP . 76.8 mt -67.78 -38.9 83.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.421 0.629 . . . . 0.0 109.909 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.707 HD21 HG21 ' A' ' 147' ' ' THR . 19.7 tp -52.93 -61.51 2.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.282 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 144' ' ' LEU . 74.0 t -69.78 -63.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.765 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' ' 120' ' ' THR . 36.4 t -69.71 -40.78 76.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.02 -51.52 56.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.702 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 114' ' ' LEU . 3.6 p -66.2 -37.36 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.386 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.504 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -78.47 -49.71 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 116' ' ' SER . 38.1 m -55.44 -42.23 73.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.58 -54.37 12.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.623 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.5 m -65.78 -39.22 90.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.17 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.745 HG23 ' ND1' ' A' ' 127' ' ' HIS . 85.9 m -58.96 -47.47 84.99 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.91 -34.63 77.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.37 1.43 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.623 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.2 m0 -67.65 -44.01 78.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.745 ' ND1' HG23 ' A' ' 123' ' ' THR . 30.5 m170 -57.72 -45.46 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.534 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -63.07 -43.04 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.454 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.513 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 76.5 t -79.21 -53.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.936 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.583 ' OG ' HG22 ' A' ' 67' ' ' VAL . 43.8 p -128.39 91.38 44.13 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.319 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 45.2 Cg_exo -51.39 -42.28 55.61 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.915 1.743 . . . . 0.0 113.158 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.4 Cg_exo -56.47 -28.02 71.36 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.211 0.607 . . . . 0.0 112.311 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.38 71.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.77 -41.44 95.5 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.768 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -61.45 -36.06 79.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.49 . . . . 0.0 110.744 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.38 -38.19 76.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.6 mt -59.22 -30.76 68.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.521 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 0.17 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.3 Cg_endo -50.73 -29.96 27.63 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.513 0.809 . . . . 0.0 112.331 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -60.65 -36.49 78.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.633 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -67.8 -44.35 77.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.025 0.441 . . . . 0.0 110.104 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.58 -49.8 37.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.094 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.682 ' CD1' HD11 ' A' ' 56' ' ' LEU . 1.7 t-105 -59.94 -49.01 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 115' ' ' VAL . 74.7 mt -66.07 -32.4 73.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.301 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.39 90.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.825 ' CE2' HD22 ' A' ' 150' ' ' LEU . 23.1 t80 -63.25 -42.03 99.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.264 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.707 HG21 HD21 ' A' ' 114' ' ' LEU . 74.3 p -60.84 -38.36 85.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.604 -0.438 . . . . 0.0 112.049 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.8 m -62.34 -49.31 76.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.695 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.22 -40.68 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.45 0.643 . . . . 0.0 111.01 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 146' ' ' PHE . 53.5 tp -55.91 -47.02 78.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.54 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 147' ' ' THR . 14.9 m120 -66.95 -37.59 84.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.389 0.614 . . . . 0.0 110.449 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -58.88 -44.31 91.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.903 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.97 -46.12 86.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.999 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.06 -47.74 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.7 m95 -61.27 -43.65 98.52 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.493 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.4 mmt-85 -59.7 -35.65 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.842 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -59.46 -41.05 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -96.63 -59.62 1.78 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TRP . 34.4 m . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.524 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.31 -24.49 51.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.002 1.135 . . . . 0.0 111.733 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.22 -34.12 21.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.141 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.52 -41.93 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.29 92.6 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.447 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.38 -39.56 83.73 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.375 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -81.23 -36.57 29.83 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' CZ ' ' A' ' 57' ' ' TYR . 96.4 mt -61.93 -36.63 81.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 t -54.9 -43.73 99.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.601 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.41 -32.61 94.48 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.397 1.398 . . . . 0.0 113.49 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.9 m -59.34 -38.0 79.23 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.716 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.5 mt -60.67 -38.08 83.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.165 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.91 99.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.599 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.61 -42.4 99.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.128 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.404 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.0 m-85 -62.98 -45.37 92.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.0 mtm -62.57 -40.31 96.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 -48.26 23.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.21 -18.68 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.478 . . . . 0.0 110.969 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -54.25 -36.98 64.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.26 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 48.5 t80 -61.05 -50.75 72.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.04 -35.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.63 0.729 . . . . 0.0 110.216 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -60.95 -41.12 95.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.786 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.17 -125.21 2.27 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.031 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -56.99 -27.98 62.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.473 -0.364 . . . . 0.0 111.052 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.71 -32.78 17.87 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -51.33 -41.54 60.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.344 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -63.15 -42.87 99.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -62.12 -37.27 84.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.652 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' LEU . 6.0 m-85 -61.29 -23.2 65.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.955 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.86 -43.44 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.456 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.9 -32.21 81.99 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 34' ' ' TYR . 45.5 mt -93.07 149.23 21.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.831 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -100.94 129.92 46.86 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.004 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.579 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 11.9 mtpt -107.74 139.42 20.59 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.424 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 60.6 Cg_endo -61.47 134.05 49.32 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 120.668 0.912 . . . . 0.0 111.6 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.9 p -81.78 -9.81 59.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.781 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.478 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.8 p90 -77.88 -15.34 59.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.661 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' ND1' ' A' ' 43' ' ' HIS . 0.7 OUTLIER -76.69 149.81 81.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.915 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -76.38 163.99 31.48 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.573 1.515 . . . . 0.0 111.136 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.7 Cg_endo -51.38 149.45 17.25 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.803 1.669 . . . . 0.0 111.951 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.579 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 42.0 mtt85 -57.0 -35.51 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.426 ' CD2' ' HB2' ' A' ' 45' ' ' PRO . 4.5 p90 -64.19 -20.27 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.118 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.87 -62.77 1.48 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.426 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.979 ' O ' HG23 ' A' ' 52' ' ' ILE . 88.4 mt -67.46 -36.14 80.58 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.652 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -43.09 -41.0 6.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.983 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 53.0 Cg_exo -66.33 -7.39 17.4 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.181 2.587 . . . . 0.0 113.745 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.979 HG23 ' O ' ' A' ' 49' ' ' LEU . 19.0 pt -42.03 -43.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.357 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.472 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 95.0 m95 -54.28 -32.45 56.33 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.722 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.19 -39.2 96.82 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.1 m -69.62 -51.21 37.09 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.12 0.486 . . . . 0.0 111.04 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.8 mp -67.55 -31.77 72.09 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.431 0.634 . . . . 0.0 109.771 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.489 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -51.23 -55.87 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.633 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.6 m -64.03 -40.09 95.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.341 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.92 -44.5 89.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.993 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.52 -38.05 88.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.831 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -54.81 9.56 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.32 -37.6 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.13 -40.72 91.98 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.6 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -63.27 -31.71 72.93 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.188 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.33 -42.41 86.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.913 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 -41.22 84.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG13 HG11 ' A' ' 129' ' ' VAL . 46.7 t -58.7 -40.72 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.943 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.41 -51.16 70.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.464 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 71.4 mttt -53.36 -35.1 59.91 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.424 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.51 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 88.8 mt-10 -75.75 -43.82 44.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.767 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.29 -26.65 58.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.86 -5.42 42.9 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.681 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.58 -167.46 29.2 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.874 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 79' ' ' MET . 7.6 t80 -90.86 87.05 6.49 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' ALA . 11.2 p -124.04 167.64 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.205 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -42.88 -36.96 1.67 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.261 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 89.2 m-20 -62.54 -41.01 98.61 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.75 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -84.89 -40.27 17.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' GLY . 86.7 mtp -59.95 -35.17 74.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.27 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.9 -57.25 25.19 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.49 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.423 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 13.0 Cg_endo -61.95 -53.45 2.09 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.011 1.141 . . . . 0.0 112.01 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -63.52 -41.27 98.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.242 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.97 -39.76 97.99 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.41 -38.72 77.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.039 0.447 . . . . 0.0 110.241 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -59.79 -44.4 93.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.11 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.9 m -65.82 -45.4 82.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.472 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.83 5.97 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.42 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.72 -41.66 86.91 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.493 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.08 -36.96 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.82 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.59 66.74 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.63 -37.32 81.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.564 ' OD1' HD11 ' A' ' 113' ' ' LEU . 21.2 t-20 -60.04 -43.89 95.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.951 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.547 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 60.0 m95 -57.45 -30.47 65.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.041 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 -23.57 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 97' ' ' PRO . 55.9 t-105 -54.15 -67.56 0.61 Allowed Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 22.8 Cg_endo -43.35 80.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.832 1.688 . . . . 0.0 112.007 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.609 ' N ' ' O ' ' A' ' 95' ' ' TRP . 69.2 Cg_endo -57.54 -22.04 49.25 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.294 1.996 . . . . 0.0 113.293 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 107' ' ' TRP . 37.3 pt -57.11 -23.27 18.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 8.4 p90 -45.06 -41.59 7.77 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.718 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.532 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 75.7 t80 -66.51 -52.13 49.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.8 -68.89 0.5 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.791 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 63.79 3.21 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 0.0 110.749 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -53.8 -35.04 60.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -89.57 155.22 19.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.672 ' C ' ' H ' ' A' ' 107' ' ' TRP . 21.9 ttm -58.75 -15.17 10.88 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.039 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.59 15.06 0.01 OUTLIER Glycine 0 CA--C 1.544 1.846 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.351 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.672 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -56.15 -19.25 12.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.359 0.58 . . . . 0.0 112.257 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.662 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -43.09 -21.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 111.742 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.6 mt -61.08 -36.17 78.92 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.654 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.34 -39.29 93.6 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.731 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.642 ' OD2' ' ND2' ' A' ' 151' ' ' ASN . 47.0 t0 -62.95 -46.79 86.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.51 -49.11 76.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.904 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.5 tt -67.99 -42.54 80.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.544 0.688 . . . . 0.0 109.768 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 147' ' ' THR . 18.1 tp -50.67 -60.2 3.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.582 ' HA ' HD22 ' A' ' 144' ' ' LEU . 71.7 t -71.05 -63.58 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.495 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.8 t -68.91 -40.36 79.15 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.39 -51.01 60.71 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.795 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.83 -38.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.27 -47.88 22.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 116' ' ' SER . 56.7 m -57.89 -42.48 84.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.88 -57.58 3.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.675 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.636 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 16.9 m -62.3 -41.18 98.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.283 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 85.9 m -61.61 -45.47 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 124' ' ' LEU . 95.9 mt -63.11 -37.45 87.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.5 -63.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.636 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.7 m0 -65.98 -41.02 91.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.451 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.3 t-80 -57.4 -47.14 82.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.079 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.28 -43.74 90.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.73 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.63 HG11 HG13 ' A' ' 67' ' ' VAL . 86.4 t -78.6 -48.7 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.5 p -127.9 85.34 60.89 Favored Pre-proline 0 N--CA 1.465 0.297 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.726 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.463 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.05 -44.95 42.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.628 1.552 . . . . 0.0 112.258 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 17.0 Cg_exo -58.44 -31.76 94.85 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.361 0.708 . . . . 0.0 111.913 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.68 72.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.538 . . . . 0.0 110.078 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.3 84.75 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.704 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.57 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 73.7 ttt180 -60.51 -41.03 93.52 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 110.109 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.2 tp -53.29 -35.68 60.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.23 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.531 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 43.3 mt -69.64 12.42 0.19 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.331 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -44.88 -41.96 14.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.531 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 10.3 Cg_endo -64.24 -22.59 66.71 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.95 1.375 . . . . 0.0 112.5 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.24 -39.61 90.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.024 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.769 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.0 tm? -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.318 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.89 -43.59 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 111.593 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.714 ' CE2' HD12 ' A' ' 52' ' ' ILE . 1.4 t-105 -66.0 -51.35 59.16 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.467 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 115' ' ' VAL . 54.0 mt -64.12 -34.09 77.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.179 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.89 95.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.241 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.738 ' CE2' HD22 ' A' ' 150' ' ' LEU . 22.0 t80 -62.31 -40.76 97.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.405 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.758 HG21 HD21 ' A' ' 114' ' ' LEU . 66.9 p -58.28 -38.32 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.259 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.5 m -63.56 -51.15 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.346 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.48 -41.67 80.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.749 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.738 HD22 ' CE2' ' A' ' 146' ' ' PHE . 64.9 tp -57.89 -40.8 81.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.406 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.642 ' ND2' ' OD2' ' A' ' 111' ' ' ASP . 24.8 m-20 -65.53 -41.12 93.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.49 -40.21 96.47 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.85 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -60.42 -45.85 92.14 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.866 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.56 -48.22 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.662 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.2 m0 -63.85 -48.68 75.8 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.887 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -56.35 -32.38 64.67 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.198 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -56.73 -40.0 74.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -99.61 -61.12 1.41 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.825 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 155' ' ' TRP . 22.9 t . . . . . 0 CA--C 1.529 0.143 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.22 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.0 t . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 37.2 Cg_exo -53.74 -23.34 26.18 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 CA-C-N 119.232 0.761 . . . . 0.0 112.236 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.42 47.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 12' ' ' THR . 88.5 t -60.99 -41.71 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.12 -36.32 92.77 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.443 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mp -58.32 -40.9 83.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.013 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.1 t -77.78 -34.5 52.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.676 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.2 mt -66.78 -34.95 78.96 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 t -50.99 -58.06 11.61 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.3 Cg_endo -58.33 -31.51 93.99 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 120.577 0.852 . . . . 0.0 112.556 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -59.31 -38.12 79.47 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt -64.36 -37.99 89.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.262 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -66.39 -53.27 29.83 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.052 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.14 94.41 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -59.63 -48.95 79.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.018 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.16 -39.42 92.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.064 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.7 90.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.91 65.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.099 0.476 . . . . 0.0 110.279 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -56.6 -34.11 66.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.483 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 81.3 t80 -60.27 -47.85 84.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.1 m -74.15 -32.51 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.784 0.802 . . . . 0.0 109.936 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' O ' HD11 ' A' ' 31' ' ' LEU . 14.4 ttt85 -61.32 -41.46 97.05 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.939 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.23 -124.84 2.53 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.133 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.562 ' OE1' ' NE ' ' A' ' 32' ' ' ARG . 78.1 mm-40 -56.88 -28.24 61.56 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.964 0.412 . . . . 0.0 110.857 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.13 -32.74 13.27 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.5 mt -51.33 -42.19 61.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' OE1' ' A' ' 29' ' ' GLU . 72.7 mtm180 -61.53 -42.71 99.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.401 0.62 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.76 -41.76 98.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.59 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 46.8 m-85 -66.32 -22.98 66.29 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.518 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.15 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.169 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.69 84.65 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 34' ' ' TYR . 69.5 mt -90.13 151.07 21.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.744 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.424 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 90.2 mt-30 -97.32 128.27 44.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.058 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 55.7 mttt -103.04 143.94 27.62 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 20.9 Cg_endo -57.03 140.25 92.1 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 120.677 0.918 . . . . 0.0 111.829 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.8 p -64.2 -30.31 71.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.346 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.409 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 20.7 p90 -78.53 -1.58 34.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.462 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.403 ' NE2' ' O ' ' A' ' 44' ' ' PRO . 36.3 t60 -60.37 126.4 84.3 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.316 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.403 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 74.1 Cg_endo -79.73 164.24 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.347 1.365 . . . . 0.0 111.28 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.448 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 16.1 Cg_exo -50.78 139.85 39.11 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.341 1.361 . . . . 0.0 111.322 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.602 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 50.2 mtt85 -58.86 -36.13 74.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.981 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.448 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 5.0 p90 -66.98 -24.0 66.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.413 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 52.7 m -67.88 -63.35 1.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.965 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.007 ' O ' HG23 ' A' ' 52' ' ' ILE . 71.6 mt -72.19 -34.24 68.26 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.31 -49.56 3.42 Favored Pre-proline 0 C--N 1.321 -0.635 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.671 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 12.1 Cg_endo -71.43 6.11 2.05 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.034 1.823 . . . . 0.0 114.117 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.007 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.9 pt -50.09 -25.39 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.158 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 5.0 m-90 -55.03 -34.41 63.49 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.421 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -44.47 97.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.0 m -65.21 -47.57 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.129 0.49 . . . . 0.0 110.557 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 143' ' ' TRP . 6.1 mt -67.71 -34.21 76.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.587 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' TRP . 15.2 t80 -58.88 -50.87 72.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.762 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.1 p -71.03 -33.06 69.96 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.83 -43.14 97.09 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.696 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -64.28 -37.12 86.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.194 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.18 -64.19 3.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -59.94 -39.26 84.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.707 0.289 . . . . 0.0 111.312 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.48 -43.19 85.34 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.8 p -63.95 -27.98 69.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.908 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -57.59 -43.51 84.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.84 -43.41 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.44 -38.63 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.957 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.05 -36.57 79.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.17 -45.68 83.93 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.048 0.452 . . . . 0.0 110.82 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.83 -39.52 76.41 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.07 -2.6 57.59 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.94 7.08 66.45 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.269 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.21 -163.55 29.1 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.14 80.0 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.918 0.866 . . . . 0.0 110.365 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.3 m -119.82 147.4 44.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.556 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -41.11 -37.45 0.87 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.163 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.1 -42.77 96.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.833 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -71.33 -29.41 64.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.6 mmm -57.21 -34.4 68.49 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.784 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.87 -54.35 57.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.828 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -65.21 -55.65 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 120.439 0.759 . . . . 0.0 112.713 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -61.57 -42.49 98.93 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.684 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.07 95.65 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.7 tp -58.1 -40.28 80.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 110.166 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -61.13 -43.45 98.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.424 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 m -64.84 -41.38 95.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -53.56 5.81 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.261 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.02 -41.87 84.09 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.227 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 15' ' ' PRO . 25.2 tp -62.59 -37.64 87.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.117 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -46.25 80.81 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.75 -39.06 87.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.441 ' O ' HD12 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -63.52 -37.1 86.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.355 178.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.415 ' CZ2' ' CA ' ' A' ' 18' ' ' GLY . 1.7 m95 -56.24 -32.4 64.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.359 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.1 75.0 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.563 ' NE1' HD23 ' A' ' 112' ' ' LEU . 21.0 t-105 -54.78 -56.31 28.88 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 19.9 Cg_endo -57.95 128.61 29.58 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.469 1.446 . . . . 0.0 113.209 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 109' ' ' LEU . 98.5 Cg_endo -108.04 -28.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.112 1.875 . . . . 0.0 110.745 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.84 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 22.7 pt -54.21 -30.31 20.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.23 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 21.3 p90 -54.61 -44.64 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.512 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.574 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 78.6 t80 -64.17 -48.35 76.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.13 -58.07 0.42 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.84 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 57.97 -0.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 101' ' ' GLY . 14.7 tpt180 -53.56 -33.27 54.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.081 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -84.5 152.95 23.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.288 0.566 . . . . 0.0 111.603 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.65 ' O ' ' N ' ' A' ' 107' ' ' TRP . 2.8 ttp -62.06 -14.7 38.73 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.098 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.39 33.71 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.826 -0.226 . . . . 0.0 113.27 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.65 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.7 -20.89 62.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.575 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.06 -23.97 15.61 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.441 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 109' ' ' LEU . 5.8 mp -59.66 -33.86 72.1 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.898 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.0 -37.01 83.24 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 30.0 t0 -61.53 -41.11 96.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.015 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.563 HD23 ' NE1' ' A' ' 95' ' ' TRP . 45.3 tp -60.51 -57.09 14.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 113' ' ' LEU . 2.7 tt -61.85 -41.2 97.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.523 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.601 HD21 ' CZ2' ' A' ' 143' ' ' TRP . 13.7 tp -53.03 -64.91 0.67 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.744 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.635 ' HA ' HD13 ' A' ' 144' ' ' LEU . 95.5 t -69.04 -56.61 11.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.598 -176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.7 t -69.38 -44.01 72.37 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.61 -49.41 70.0 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -45.4 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.658 0.266 . . . . 0.0 111.297 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.475 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.68 -56.12 5.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.7 m -58.59 -43.57 89.57 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.99 -58.0 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.054 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.654 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.3 m -63.87 -41.87 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.6 m -61.47 -45.51 93.93 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.74 -36.03 82.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.72 -63.2 1.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.654 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 37.0 m0 -65.75 -42.06 91.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.0 t-80 -59.2 -48.33 82.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.684 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -64.66 -45.21 87.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.865 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.4 t -76.18 -45.43 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.2 p -133.65 86.76 38.47 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.193 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 40.2 Cg_exo -52.7 -42.25 63.94 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.755 1.637 . . . . 0.0 112.873 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -57.09 -31.27 89.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.359 0.706 . . . . 0.0 112.344 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.48 71.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.72 80.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.888 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -59.27 -39.35 82.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.17 -39.43 75.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.2 mt -58.79 -29.79 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.423 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.524 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER 1.83 -63.77 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.7 Cg_endo -51.09 -31.01 33.72 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 120.798 0.999 . . . . 0.0 112.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -59.43 -40.97 88.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.938 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.705 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -68.55 -41.98 79.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.649 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.8 34.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.023 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.695 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 1.3 t-105 -63.02 -51.79 65.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 115' ' ' VAL . 55.5 mt -62.47 -32.78 73.73 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.52 -39.34 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.684 ' CE2' HD22 ' A' ' 150' ' ' LEU . 23.0 t80 -61.87 -42.77 99.45 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.695 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 71.3 p -60.06 -37.26 79.34 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.402 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 55.3 m -60.79 -50.86 71.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.385 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.99 -43.47 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.214 0.53 . . . . 0.0 110.432 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.684 HD22 ' CE2' ' A' ' 146' ' ' PHE . 60.9 tp -58.82 -40.58 84.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.378 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.483 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.5 m120 -62.6 -41.39 98.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 148' ' ' THR . 54.5 m-85 -65.08 -39.52 93.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.435 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -58.94 -47.14 86.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.59 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.14 -46.17 67.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.539 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.3 m0 -62.15 -42.66 99.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -60.08 -29.85 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.582 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 84.2 m-20 -51.7 -40.6 60.43 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.895 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -104.46 -61.84 1.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.094 -178.886 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 15.1 t . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 7.6 Cg_endo -57.27 -20.59 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.105 0.716 . . . . 0.0 112.037 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.53 59.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.95 -39.95 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.148 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -63.17 -36.54 93.57 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 11' ' ' LEU . 11.1 mp -60.19 -42.63 95.47 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 57' ' ' TYR . 3.9 t -79.64 -46.12 17.79 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 12' ' ' THR . 93.1 mt -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 t -50.18 -41.97 69.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.776 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.26 -33.0 89.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.172 . . . . 0.0 113.246 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.53 -39.06 86.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.48 -37.91 89.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.15 -55.63 17.92 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.802 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.42 91.39 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.094 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.11 -47.84 80.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.348 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.1 mtm -64.33 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.798 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.31 -45.19 88.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.654 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.22 64.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.203 0.525 . . . . 0.0 110.929 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -30.99 65.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.036 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 102' ' ' ALA . 85.4 t80 -63.46 -47.7 80.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.2 m -69.45 -32.1 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.87 0.843 . . . . 0.0 109.256 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -64.38 -40.79 96.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.191 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.51 -116.94 2.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.791 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.23 -30.23 62.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 111.123 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.51 -33.13 24.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.5 mt -50.94 -44.44 60.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.365 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -63.35 -41.98 98.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 0.0 111.048 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -59.26 -38.69 80.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.96 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.552 ' O ' ' O ' ' A' ' 37' ' ' LEU . 66.5 m-85 -63.61 -22.73 67.05 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.733 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.85 17.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.677 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.89 -34.23 65.74 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.552 ' O ' ' O ' ' A' ' 34' ' ' TYR . 66.2 mt -92.31 152.35 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 89.8 mt-30 -92.65 128.38 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -106.47 144.22 28.56 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.62 0.248 . . . . 0.0 110.766 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.522 ' CG ' ' CE1' ' A' ' 43' ' ' HIS . 96.2 Cg_endo -62.68 138.64 70.74 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.299 1.999 . . . . 0.0 111.949 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.0 m -84.19 0.54 48.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.417 ' CZ3' ' HB3' ' A' ' 40' ' ' PRO . 13.0 p90 -101.18 12.04 38.3 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.102 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.863 ' NE2' HD13 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -85.3 137.66 36.85 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.759 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.4 171.48 18.0 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.63 1.554 . . . . 0.0 110.796 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HB2' ' CE2' ' A' ' 47' ' ' TRP . 3.0 Cg_exo -49.46 145.19 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 120.289 0.659 . . . . 0.0 110.659 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.565 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 36.7 mtt180 -58.62 -33.69 70.32 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.311 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.43 ' CE2' ' HB2' ' A' ' 45' ' ' PRO . 11.9 p90 -71.83 -11.94 61.04 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -74.77 -68.06 0.58 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.021 ' O ' HG23 ' A' ' 52' ' ' ILE . 94.2 mt -67.76 -35.68 79.15 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.322 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.24 -39.65 2.17 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 38.4 Cg_exo -71.03 1.29 5.43 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.892 2.395 . . . . 0.0 113.562 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.021 HG23 ' O ' ' A' ' 49' ' ' LEU . 15.9 pt -46.21 -37.23 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.726 0.298 . . . . 0.0 111.568 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.605 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.0 m-90 -53.8 -29.52 40.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.921 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 57' ' ' TYR . . . -53.44 -40.87 62.48 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -81.25 -39.61 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 143' ' ' TRP . 4.7 mt -64.73 -38.94 92.68 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 58' ' ' SER . 2.0 p90 -67.68 -44.02 78.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.293 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.525 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 49.6 m -60.67 -42.39 96.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.633 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.57 -43.72 88.91 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.886 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.7 mtt -63.08 -37.51 87.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.779 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.57 -59.14 9.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 47.9 t80 -64.65 -36.96 85.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.863 0.363 . . . . 0.0 110.792 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.81 -42.44 68.91 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.6 p -68.72 -26.26 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.637 0.256 . . . . 0.0 110.669 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 42.7 t80 -55.34 -49.27 72.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.229 0.538 . . . . 0.0 110.225 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.94 -40.92 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.507 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.37 -45.9 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 69' ' ' LYS . 1.2 p90 -69.48 -31.95 70.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.279 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 73.9 mttt -59.66 -37.66 79.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.047 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 83.9 mt-10 -67.12 -35.17 79.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.44 2.3 48.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.41 37.44 10.87 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.013 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.08 -161.09 27.68 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -87.45 109.52 19.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -133.35 168.78 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.176 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.85 -38.68 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.093 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 75' ' ' THR . 85.0 m-20 -63.11 -39.75 95.62 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.626 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.99 66.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.851 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 83' ' ' GLY . 8.8 mtt -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.806 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -58.25 -51.78 79.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.721 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.11 -56.91 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 120.701 0.934 . . . . 0.0 112.428 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.9 mp -63.46 -41.62 98.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.634 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.51 -38.24 95.47 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.1 tp -56.8 -40.24 75.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 110.186 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.6 -44.19 96.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -66.12 -41.59 90.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.152 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.5 -55.04 5.73 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.089 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -59.06 -41.31 87.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.404 ' HG ' ' NE1' ' A' ' 93' ' ' TRP . 37.8 tp -61.8 -38.89 89.8 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.238 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -46.25 90.53 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.293 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.11 -36.2 83.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.113 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -58.6 -43.18 89.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.948 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.404 ' NE1' ' HG ' ' A' ' 89' ' ' LEU . 74.5 m95 -64.42 -32.9 74.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.01 -31.62 72.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.53 ' C ' ' CD1' ' A' ' 95' ' ' TRP . 8.3 t-105 -54.82 -54.86 44.82 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.15 87.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.034 0 CA-C-N 119.304 0.787 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.58 -18.75 41.51 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.176 1.251 . . . . 0.0 111.843 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.752 HG21 ' HA ' ' A' ' 107' ' ' TRP . 47.2 pt -58.62 -23.98 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 5.4 p90 -45.94 -41.31 11.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.555 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 52.7 t80 -67.37 -57.45 6.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.932 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -114.67 -68.77 0.47 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.84 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 101' ' ' GLY . . . 72.73 11.89 5.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.256 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -52.2 -35.56 49.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.333 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -87.17 149.63 24.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.659 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.615 ' O ' ' N ' ' A' ' 107' ' ' TRP . 13.5 ptm -62.56 -16.01 53.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.557 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -44.79 -4.01 0.01 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.565 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.752 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.7 p90 -44.49 -18.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.791 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.29 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.803 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 107' ' ' TRP . 70.8 mt -61.93 -35.6 78.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.09 -40.68 96.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 62.3 t0 -61.46 -49.82 75.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.295 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 tp -66.06 -44.11 85.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.02 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 113' ' ' LEU . 1.2 mm? -72.16 -38.78 69.08 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.869 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.58 HD21 HG21 ' A' ' 147' ' ' THR . 17.8 tp -53.02 -62.12 1.86 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.388 0.613 . . . . 0.0 110.816 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.555 ' HA ' HD13 ' A' ' 144' ' ' LEU . 97.0 t -66.61 -62.87 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.814 -1.084 . . . . 0.0 113.252 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 120' ' ' THR . 44.1 t -69.49 -39.04 77.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.73 -55.86 27.49 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.942 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 114' ' ' LEU . 6.1 p -65.75 -37.22 79.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.634 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.5 -49.19 15.27 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 116' ' ' SER . 37.0 m -56.67 -41.83 77.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -58.14 3.8 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.733 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.532 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 31.8 m -64.72 -40.76 95.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 77.4 m -59.93 -45.62 92.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.452 HD22 HH21 ' A' ' 128' ' ' ARG . 99.0 mt -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.88 -63.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.532 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 45.7 m0 -65.41 -41.3 93.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.1 t-80 -58.02 -48.0 81.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.003 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.452 HH21 HD22 ' A' ' 124' ' ' LEU . 85.0 mtt180 -64.9 -42.99 94.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 70.7 t -78.19 -53.11 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.6 p -127.31 90.81 47.91 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.3 Cg_exo -52.69 -42.22 64.07 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.866 1.711 . . . . 0.0 113.0 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 26.5 Cg_exo -56.78 -30.45 84.75 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 120.269 0.646 . . . . 0.0 112.258 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.8 70.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.5 91.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.668 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -59.82 -38.26 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 0.0 110.432 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.6 -35.34 70.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 138' ' ' TYR . 82.9 mt -64.95 -5.05 5.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.204 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -24.55 -53.57 0.15 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.5 -27.8 77.98 Favored 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 121.513 1.475 . . . . 0.0 113.523 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -58.21 -43.34 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.514 -178.295 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.5 tp -72.01 -41.58 67.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.24 73.54 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.527 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.557 ' CE2' HD12 ' A' ' 52' ' ' ILE . 2.5 t-105 -64.92 -49.92 68.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.945 0.402 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.555 HD13 ' HA ' ' A' ' 115' ' ' VAL . 78.9 mt -66.47 -34.38 77.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.849 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -59.51 -37.93 79.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.297 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.41 -45.04 81.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.58 HG21 HD21 ' A' ' 114' ' ' LEU . 68.9 p -58.23 -40.21 81.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.607 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.9 m -60.53 -46.88 88.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.204 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.9 t -68.59 -43.81 83.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 111.721 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.978 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -65.06 -41.9 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.834 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 147' ' ' THR . 19.4 m120 -60.47 -39.84 89.1 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.046 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -64.69 -39.19 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.75 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.18 -46.09 83.12 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.431 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.0 t -72.25 -46.21 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.791 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.5 m95 -61.4 -37.19 82.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 159' ' ' SER . 24.1 mmt85 -56.32 -26.16 51.38 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.889 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.478 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 92.6 m-20 -53.48 -41.86 66.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.754 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.546 ' ND2' HD21 ' A' ' 37' ' ' LEU . 86.0 m-20 -111.01 4.13 19.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.029 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 156' ' ' ARG . 48.2 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.564 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.53 ' O ' HD13 ' A' ' 11' ' ' LEU . 87.4 Cg_exo -54.54 -23.74 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.311 1.341 . . . . 0.0 112.497 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.98 60.37 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.624 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.41 -42.45 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.9 -34.52 88.81 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.147 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.6 mp -54.9 -44.43 74.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.886 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 t -78.7 -35.71 44.57 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.885 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.16 -37.7 88.22 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -51.57 -41.93 80.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.679 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -57.58 -27.59 77.53 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.411 1.407 . . . . 0.0 113.674 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.2 p -61.17 -32.75 72.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.59 -38.32 87.14 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.522 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.76 92.37 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.169 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.3 -59.29 3.94 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.775 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -58.79 -46.15 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.3 mmm -62.88 -40.0 96.18 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 -43.2 10.9 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.182 -0.533 . . . . 0.0 111.997 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.72 -21.66 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -53.35 -32.89 51.32 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.279 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 52.3 t80 -59.53 -47.49 85.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -72.94 -34.08 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.647 0.737 . . . . 0.0 109.713 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -61.09 -40.58 94.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.886 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.38 -132.57 2.02 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.987 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.61 -26.34 55.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.168 0.508 . . . . 0.0 110.669 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.41 8.84 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -52.45 -43.96 65.22 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.963 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -60.77 -40.65 93.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.022 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -59.32 -40.49 86.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.216 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' LEU . 57.3 m-85 -63.83 -22.93 67.15 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.974 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.19 10.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.852 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.55 81.59 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 34' ' ' TYR . 32.2 mt -91.23 151.15 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.853 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -98.85 130.76 45.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.032 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.623 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 61.0 mttt -102.93 140.57 21.19 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 31.1 Cg_endo -59.81 132.72 46.77 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.144 1.229 . . . . 0.0 112.414 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.1 m -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.117 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.486 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 5.8 p90 -76.1 -11.96 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.99 147.95 98.42 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.289 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.96 171.63 7.97 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.916 1.744 . . . . 0.0 111.521 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 24.0 Cg_exo -53.23 143.64 51.7 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.976 1.784 . . . . 0.0 111.793 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.623 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 38.8 mtt85 -58.9 -37.91 77.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.446 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 10.6 p90 -69.2 -26.89 65.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.497 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.2 m -64.75 -55.12 21.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.973 ' O ' HG23 ' A' ' 52' ' ' ILE . 87.0 mt -75.19 -32.49 61.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -38.79 -48.28 3.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.517 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 15.6 Cg_endo -71.85 1.78 5.44 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.299 2.0 . . . . 0.0 114.063 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.973 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.7 pt -44.85 -40.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.82 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' TYR . 98.4 m95 -53.25 -33.39 52.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.607 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.39 -41.6 98.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 m -67.09 -49.52 64.71 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.797 0.332 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -67.73 -33.08 74.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' TRP . 4.4 t80 -52.38 -49.72 63.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.823 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.7 p -69.57 -36.63 76.47 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.18 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.4 -44.99 77.49 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.2 mtt -61.98 -37.5 85.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.105 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.11 25.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -62.52 -38.38 89.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.931 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.55 -43.38 78.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.449 ' CB ' HD21 ' A' ' 82' ' ' LEU . 86.9 p -62.83 -30.4 71.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -56.76 -46.9 81.14 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.911 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.08 -42.95 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.45 HG22 ' OG ' ' A' ' 130' ' ' SER . 71.0 t -61.9 -40.51 87.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.715 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.528 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -62.63 -37.38 86.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -61.06 -41.55 96.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -63.94 -40.38 96.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.978 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.163 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 10.53 61.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.21 -162.14 27.88 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.08 111.32 23.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 78' ' ' ALA . 14.5 t -135.27 166.63 22.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -46.78 -33.73 4.65 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -36.57 72.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -63.06 -27.36 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.38 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.1 mmt -55.5 -35.95 66.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.87 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.66 -42.34 91.04 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.589 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 14.5 Cg_endo -89.64 -71.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 120.826 1.017 . . . . 0.0 112.594 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.449 HD21 ' CB ' ' A' ' 64' ' ' SER . 19.0 mt -62.05 -43.41 98.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.604 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.77 -43.03 98.24 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.16 -39.13 88.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.232 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.6 -43.24 89.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.1 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.2 m -68.03 -42.9 79.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.139 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.15 -58.8 3.29 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -56.13 -40.91 74.51 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.323 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 13.3 tp -64.18 -40.34 95.91 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.011 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.6 -48.1 76.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.534 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.9 mt -61.21 -39.21 89.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.335 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' HD11 ' A' ' 113' ' ' LEU . 41.6 t-20 -61.76 -41.45 97.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.479 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 52.9 m95 -58.96 -29.26 67.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.249 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.5 64.39 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.543 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.9 t-105 -61.59 -66.15 1.72 Allowed Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 85.0 Cg_endo -45.21 85.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.957 1.771 . . . . 0.0 112.543 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' TRP . 83.9 Cg_endo -59.52 -16.54 36.46 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.542 1.495 . . . . 0.0 112.31 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.792 HG21 ' HA ' ' A' ' 107' ' ' TRP . 33.5 pt -58.57 -26.56 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.581 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.97 -41.89 16.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.022 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.52 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.9 t80 -69.28 -51.99 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.201 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.87 -68.52 0.49 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.185 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 65.43 8.77 5.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 110.447 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -52.43 -35.17 51.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -94.17 154.41 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.259 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.645 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.7 ttm -58.44 -19.03 33.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.255 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -40.98 -8.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.263 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.67 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.792 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.7 p90 -45.31 -16.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.818 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.46 -23.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.098 -178.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.4 mp -60.74 -35.52 76.57 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.738 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.47 -41.15 96.79 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.459 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 56.3 t0 -63.27 -55.27 26.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.561 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 tp -64.93 -40.21 94.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.847 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.7 tt -69.56 -46.83 65.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.74 -36.66 67.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.632 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.443 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 42.5 t -70.58 -62.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.532 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -69.55 -39.85 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.12 -52.52 52.88 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.512 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 114' ' ' LEU . 6.8 p -64.7 -36.34 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.689 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.95 -53.52 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -56.91 -41.56 78.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.52 8.92 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.778 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.595 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.8 m -66.07 -41.93 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.551 HG23 ' CD2' ' A' ' 127' ' ' HIS . 47.2 m -58.9 -46.31 88.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.58 -33.37 71.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 81' ' ' PRO . . . -78.46 -63.91 1.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.595 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 33.9 m0 -64.57 -43.71 93.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.564 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -58.2 -41.73 84.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.391 -177.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -60.64 -43.75 97.18 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.2 t -79.97 -46.79 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.416 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 67' ' ' VAL . 22.9 p -135.64 93.55 15.92 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.483 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 53.2 Cg_exo -54.7 -39.13 90.69 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.84 1.694 . . . . 0.0 113.101 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 44.7 Cg_exo -55.67 -27.97 63.66 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.536 0.824 . . . . 0.0 112.652 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.66 71.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.81 -40.14 87.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.123 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.436 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 75.1 ttt180 -60.76 -39.68 89.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.5 -37.41 65.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.506 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 76.0 mt -65.06 13.25 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -46.09 -42.53 27.42 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.506 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 17.9 Cg_endo -67.14 -19.84 50.58 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.985 1.388 . . . . 0.0 112.885 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.45 -38.46 87.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 24.9 tp -65.94 -38.85 89.69 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.668 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.73 76.28 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.764 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.604 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -68.45 -52.02 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.366 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' A' ' 140' ' ' TYR . 34.1 mt -64.35 -33.85 76.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -60.72 -46.56 89.95 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.608 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.775 ' CE2' HD22 ' A' ' 150' ' ' LEU . 24.0 t80 -64.07 -40.09 95.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.522 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.7 m -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.375 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.9 m -63.95 -48.21 77.4 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.392 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.84 -40.48 78.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.172 0.511 . . . . 0.0 110.564 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.775 HD22 ' CE2' ' A' ' 146' ' ' PHE . 58.6 tp -55.04 -54.32 44.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.558 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.459 ' OD1' ' CG ' ' A' ' 111' ' ' ASP . 9.4 m120 -63.36 -36.65 84.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.602 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.487 ' CE2' ' NH1' ' A' ' 156' ' ' ARG . 20.8 t80 -58.4 -42.27 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.592 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.427 ' HA ' HH12 ' A' ' 156' ' ' ARG . 61.5 t80 -63.36 -47.0 83.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.03 -48.5 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.818 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 2.2 m95 -63.5 -39.35 94.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.662 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.487 ' NH1' ' CE2' ' A' ' 152' ' ' TYR . 29.8 ttp-105 -57.88 -37.79 74.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.358 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.97 -43.06 95.31 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.3 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -89.9 -49.48 6.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 155' ' ' TRP . 70.0 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.0 Cg_endo -57.05 -20.17 36.2 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 CA-C-N 119.231 0.761 . . . . 0.0 112.513 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -33.78 54.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.124 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.509 ' O ' HG22 ' A' ' 12' ' ' THR . 74.4 t -60.42 -40.74 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.03 92.83 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.36 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.85 -41.67 82.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.863 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.1 t -78.83 -35.97 43.21 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.105 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.34 -37.03 84.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.401 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.5 t -52.35 -55.93 27.14 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 14.9 Cg_endo -58.98 -34.5 99.18 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 120.697 0.931 . . . . 0.0 113.124 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.14 -37.16 79.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.146 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.0 -39.5 94.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.48 -48.35 69.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.784 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.76 96.8 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.248 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -58.65 -45.63 88.92 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.607 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -61.78 -38.77 89.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.135 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.93 93.85 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.22 -26.61 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.975 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -35.52 69.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.081 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 65.0 t80 -61.34 -46.0 92.06 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.271 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.408 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -73.38 -33.14 39.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.0 109.568 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -62.5 -40.67 97.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.531 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.87 -128.92 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.915 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.98 -27.72 61.7 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.698 0.285 . . . . 0.0 110.934 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.24 -32.27 6.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.624 ' CD2' ' HE ' ' A' ' 46' ' ' ARG . 94.9 mt -51.55 -45.06 62.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -65.39 -40.9 94.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 111.563 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -57.83 -37.48 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.23 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 78.6 m-85 -63.89 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.979 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -43.97 -41.91 5.62 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.353 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.5 -32.19 71.36 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 34' ' ' TYR . 34.4 mt -92.52 154.55 18.38 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.311 -0.444 . . . . 0.0 111.069 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 93.5 mm-40 -103.19 129.13 50.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mttp -103.23 145.15 30.05 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -57.08 136.1 74.59 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 120.881 1.054 . . . . 0.0 111.122 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.8 p -64.54 -25.92 68.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.005 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -79.45 -4.86 53.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.574 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.607 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.8 t-80 -53.85 130.06 56.65 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.637 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.607 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.8 Cg_endo -87.12 170.94 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.073 1.849 . . . . 0.0 111.219 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 28.6 Cg_exo -49.92 138.39 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 120.42 0.746 . . . . 0.0 110.911 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.624 ' HE ' ' CD2' ' A' ' 31' ' ' LEU . 38.1 mtt-85 -59.61 -36.49 76.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 8.0 p90 -72.6 -19.55 61.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.742 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -66.46 -63.35 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.871 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.997 ' O ' HG23 ' A' ' 52' ' ' ILE . 85.4 mt -71.9 -33.07 68.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.63 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.38 -50.11 2.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.814 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 10.2 Cg_endo -70.77 2.19 4.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.342 2.028 . . . . 0.0 114.286 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' O ' ' A' ' 49' ' ' LEU . 23.8 pt -45.22 -38.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.199 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.406 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.8 m95 -52.18 -29.11 20.8 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.718 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.01 -44.33 92.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.567 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -74.04 -44.76 53.18 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.199 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.74 -33.07 75.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.179 0.514 . . . . 0.0 109.664 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.41 -57.55 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.841 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -66.0 -38.72 89.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.812 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.44 90.76 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.6 mtt -61.14 -37.86 84.34 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.33 -54.0 22.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 88.8 t80 -63.11 -39.32 94.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.962 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.7 -41.36 74.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 90.8 p -66.28 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.431 ' HA ' ' CE2' ' A' ' 68' ' ' TRP . 56.0 t80 -56.44 -48.69 76.49 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.46 -39.71 86.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.201 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG22 ' OG ' ' A' ' 130' ' ' SER . 52.5 t -57.4 -49.02 81.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.3 p90 -73.64 -26.13 60.62 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.084 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CE ' ' CZ ' ' A' ' 65' ' ' TYR . 70.2 mmtt -59.87 -37.64 79.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.324 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 77.2 mt-10 -67.67 -41.03 84.39 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.374 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.3 mt -72.83 -25.81 61.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.754 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 103.42 45.9 1.5 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.98 -168.03 35.17 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.627 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.54 109.98 17.23 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.709 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.1 t -128.74 164.55 22.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.611 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -52.43 -37.88 57.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.414 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' H ' HG23 ' A' ' 75' ' ' THR . 85.2 m-20 -63.65 -38.96 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.714 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.45 71.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.627 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 82.0 mmm -59.22 -33.01 70.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.476 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.36 -56.96 26.11 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.957 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -65.14 -52.78 1.03 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.654 0.903 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.6 mp -63.29 -42.37 99.08 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.411 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.45 -38.33 95.58 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.7 tp -57.86 -40.0 79.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.727 0.299 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -60.67 -45.99 92.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.549 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.5 m -67.74 -41.57 83.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.076 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.52 -55.15 5.66 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.431 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -57.9 -41.37 82.49 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.23 -37.97 84.95 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.061 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.95 86.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.472 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.26 -39.14 85.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.456 ' ND2' ' CA ' ' A' ' 117' ' ' GLY . 39.3 t-20 -64.44 -37.79 88.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.325 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -53.99 -32.18 53.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.19 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.22 70.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -55.84 -56.81 26.24 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.37 130.26 39.65 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 120.721 0.947 . . . . 0.0 112.969 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -107.63 -24.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.568 1.512 . . . . 0.0 110.372 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.861 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 34.7 pt -60.54 -28.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.884 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 24.3 p90 -55.8 -44.34 77.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.2 t80 -65.42 -50.29 66.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.677 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.75 -57.11 0.4 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.861 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 61.19 -1.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.566 0.222 . . . . 0.0 110.908 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 101' ' ' GLY . 61.6 ttt180 -54.58 -34.5 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.061 0.458 . . . . 0.0 110.376 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -86.15 157.9 19.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.222 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.1 tpp -57.4 -13.74 3.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.471 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.07 -1.58 0.01 OUTLIER Glycine 0 CA--C 1.539 1.539 0 C-N-CA 121.703 -0.284 . . . . 0.0 112.418 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.702 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.83 -22.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.411 -0.464 . . . . 0.0 111.079 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.591 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.8 -28.13 68.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.202 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.58 -30.34 68.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.59 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -59.42 -37.46 78.1 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.474 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 t0 -63.01 -44.21 96.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.0 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.01 -53.32 55.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.1 -40.37 96.07 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.77 ' CD2' HG21 ' A' ' 147' ' ' THR . 19.9 tp -51.03 -63.8 1.01 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.938 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.613 ' HA ' HD13 ' A' ' 144' ' ' LEU . 88.1 t -69.53 -55.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.942 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 t -67.63 -44.9 76.87 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.456 ' CA ' ' ND2' ' A' ' 92' ' ' ASN . . . -56.72 -48.35 78.4 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.499 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -74.21 -46.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.392 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -54.23 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.2 m -59.91 -44.18 94.42 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.32 -58.27 3.94 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.149 -0.621 . . . . 0.0 112.183 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.613 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.2 m -64.79 -40.95 96.07 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 76.7 m -60.01 -45.92 91.17 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.49 -37.32 87.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.83 -63.52 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.613 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.94 -42.3 97.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.419 ' CB ' ' O ' ' A' ' 123' ' ' THR . 29.0 t-80 -59.61 -48.21 82.54 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.322 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.72 -43.4 93.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.894 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.483 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 93.4 t -78.51 -47.8 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 67' ' ' VAL . 51.1 p -133.42 90.42 29.48 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.5 Cg_exo -55.32 -42.65 66.3 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.712 1.608 . . . . 0.0 112.541 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 21.7 Cg_exo -57.23 -28.48 79.72 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 120.323 0.682 . . . . 0.0 111.987 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -31.41 71.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.101 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.17 81.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.277 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -58.03 -39.24 77.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 110.206 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.05 -36.76 78.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.897 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 71.7 mt -67.47 -5.19 13.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.086 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -25.3 -58.75 0.16 Allowed Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.27 -28.99 79.49 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 120.643 0.895 . . . . 0.0 113.273 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -57.43 -45.09 85.05 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.473 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 22.8 tp -65.39 -39.75 92.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.01 82.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.133 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.659 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.7 t-105 -64.06 -45.6 88.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.571 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.613 HD13 ' HA ' ' A' ' 115' ' ' VAL . 40.4 mt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.33 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.28 97.01 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.321 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 67.6 t80 -63.64 -44.53 93.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.116 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.77 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.1 m -62.74 -42.4 99.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.737 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.1 m -57.37 -49.83 74.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.399 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.19 -41.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.325 0.583 . . . . 0.0 110.75 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.604 HD12 ' CZ ' ' A' ' 146' ' ' PHE . 9.6 tt -60.33 -44.12 95.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.322 -0.853 . . . . 0.0 112.028 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.71 ' OD1' HG22 ' A' ' 147' ' ' THR . 18.0 m120 -64.28 -41.0 97.1 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.38 -36.82 85.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.041 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -57.03 -44.8 83.25 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.546 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.76 -47.12 80.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.667 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.566 ' NE1' ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -64.32 -45.43 87.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.521 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.456 ' HA ' ' HG ' ' A' ' 159' ' ' SER . 70.7 mtm180 -61.04 -32.53 72.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.079 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 92.6 m-20 -52.95 -40.12 63.43 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -97.46 -56.75 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.288 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.456 ' HG ' ' HA ' ' A' ' 156' ' ' ARG . 88.7 p . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.904 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.406 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.2 t . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 29.6 Cg_exo -54.35 -22.46 26.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 120.72 0.946 . . . . 0.0 112.153 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.18 -32.01 45.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.695 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' THR . 72.1 t -59.93 -41.84 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.68 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -62.56 -35.92 92.47 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.8 mp -58.44 -42.02 86.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.682 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.7 t -76.71 -34.35 58.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.845 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' OG ' ' A' ' 16' ' ' SER . 95.7 mt -67.47 -34.69 77.67 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 10' ' ' GLY . 13.0 t -46.95 -56.2 12.67 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.85 -29.19 87.66 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 120.826 1.017 . . . . 0.0 113.347 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 79.7 p -61.17 -36.74 80.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.612 -0.435 . . . . 0.0 112.061 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.7 -39.22 93.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.288 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.12 -40.14 98.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.55 99.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.236 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE1' ' CZ3' ' A' ' 53' ' ' TRP . 57.9 m-85 -61.86 -49.09 77.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.916 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.6 mtm -64.88 -40.35 94.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.438 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.55 60.9 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.837 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.45 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.158 0.504 . . . . 0.0 111.015 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -35.35 69.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.764 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 58.8 t80 -60.7 -48.15 83.09 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.1 -31.48 29.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' HD11 ' A' ' 31' ' ' LEU . 28.3 ttt-85 -60.6 -42.55 97.02 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.323 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -129.35 5.41 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.996 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.56 -29.65 3.0 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.588 0.233 . . . . 0.0 110.442 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.39 -35.24 27.89 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.5 mt -50.5 -45.19 56.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -62.71 -38.55 90.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -58.62 -38.02 77.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.298 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' LEU . 86.9 m-85 -62.05 -22.36 65.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.742 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.83 -32.36 1.54 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.079 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.18 -32.3 20.61 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 34' ' ' TYR . 56.0 mt -93.35 150.52 20.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.992 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -98.3 132.61 43.64 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.865 ' HZ1' HH21 ' A' ' 46' ' ' ARG . 42.1 mttt -105.82 145.54 31.08 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 38.7 Cg_endo -60.91 143.36 99.34 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.454 1.436 . . . . 0.0 112.212 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.1 p -64.27 -29.93 71.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.526 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 41.6 p90 -78.32 3.24 16.06 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.106 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.031 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.75 167.7 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.181 1.254 . . . . 0.0 111.842 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 34.9 Cg_exo -52.44 140.87 52.94 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.65 1.567 . . . . 0.0 111.533 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.865 HH21 ' HZ1' ' A' ' 39' ' ' LYS . 39.4 mtt85 -61.77 -35.63 78.7 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.611 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 8.0 p90 -72.25 -14.58 61.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -76.94 -67.18 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.002 0.429 . . . . 0.0 110.663 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.028 ' O ' HG23 ' A' ' 52' ' ' ILE . 81.2 mt -67.52 -33.07 74.34 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.744 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.72 -41.12 5.49 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.789 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 71.0 Cg_exo -64.21 -9.53 20.09 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 123.239 2.626 . . . . 0.0 113.953 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.028 HG23 ' O ' ' A' ' 49' ' ' LEU . 32.1 pt -45.11 -32.5 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.773 0.32 . . . . 0.0 111.252 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.599 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 6.2 m0 -53.61 -31.27 46.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.34 -43.81 95.46 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.9 p -71.75 -44.87 63.32 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.611 -0.347 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.94 -33.69 76.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.865 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -61.18 -50.98 70.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.376 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -73.36 -33.71 65.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.82 89.13 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.845 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtt -64.25 -36.94 85.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.567 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.41 -64.5 3.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.53 -37.32 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.125 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.89 -42.7 60.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 86.9 p -67.14 -26.75 66.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.59 0.233 . . . . 0.0 110.544 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.75 -49.69 72.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 110.356 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.31 -35.02 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.641 HG22 ' OG ' ' A' ' 130' ' ' SER . 74.2 t -55.77 -46.75 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.001 -177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.441 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.6 p90 -74.22 -31.54 62.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.145 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 68.3 mmtt -59.76 -39.08 83.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.215 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.82 -38.4 88.83 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.85 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.14 -13.18 56.11 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.945 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 98.07 1.6 58.31 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.61 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 136.09 -166.5 24.65 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.716 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.92 102.09 11.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.369 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.508 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 1.4 p -124.33 164.92 18.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.21 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.43 -37.03 10.79 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.341 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.31 -45.0 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.245 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.508 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -74.64 -35.14 62.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 111.392 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.716 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.3 mmm -58.7 -34.03 70.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -60.21 -60.73 9.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.65 -50.29 11.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.997 1.131 . . . . 0.0 112.151 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.8 mp -65.89 -40.85 91.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.852 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.92 96.73 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.53 -40.01 85.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 68.5 t80 -60.93 -45.58 94.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.742 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 m -65.23 -42.93 92.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.0 -57.55 3.69 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.37 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -57.19 -41.98 80.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.419 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 41.4 tp -62.93 -39.22 93.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.91 65.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.153 0.502 . . . . 0.0 110.338 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.45 -38.61 84.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 113' ' ' LEU . 50.3 t-20 -61.49 -40.67 95.43 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.272 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.546 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 33.0 m95 -58.11 -27.93 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.77 -23.0 65.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.019 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.497 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 20.0 t-105 -54.13 -64.43 1.88 Allowed Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.546 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 86.2 Cg_endo -55.46 130.36 40.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.992 1.795 . . . . 0.0 112.584 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -100.81 -15.55 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.34 1.36 . . . . 0.0 111.105 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.858 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.7 pt -59.37 -30.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.29 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.548 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 30.7 p90 -55.63 -44.76 77.42 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.913 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.548 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 71.6 t80 -64.86 -48.94 72.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.08 -59.62 0.42 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.09 -1.92 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.691 0.281 . . . . 0.0 110.836 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.4 ttt180 -52.91 -35.71 58.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.957 0.408 . . . . 0.0 110.44 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -87.83 157.46 19.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.365 0.602 . . . . 0.0 111.797 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.716 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.0 ttm -56.32 -13.56 2.26 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.684 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.08 -2.59 0.01 OUTLIER Glycine 0 CA--C 1.541 1.673 0 C-N-CA 121.493 -0.384 . . . . 0.0 112.637 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.716 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.36 -20.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.475 -0.427 . . . . 0.0 111.273 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.02 -28.51 67.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.89 -30.92 70.45 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.269 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.571 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.11 -35.89 76.23 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -64.65 -46.09 83.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 tp -63.99 -48.39 76.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.8 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.5 tt -64.95 -40.3 94.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.493 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.764 ' CD2' HG21 ' A' ' 147' ' ' THR . 21.2 tp -55.02 -63.75 1.05 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.311 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.579 ' HA ' HD13 ' A' ' 144' ' ' LEU . 96.9 t -67.04 -53.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -75.32 -41.74 56.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.87 85.64 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.675 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 t -71.44 -45.46 68.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.039 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.83 -57.35 4.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 m -57.23 -44.67 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -55.35 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.96 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.647 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.3 m -65.18 -41.5 94.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.832 HG23 ' CE1' ' A' ' 127' ' ' HIS . 83.8 m -59.67 -46.8 87.94 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.16 -35.64 80.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.79 -63.01 1.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.647 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.96 -43.98 94.14 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.832 ' CE1' HG23 ' A' ' 123' ' ' THR . 25.2 m170 -59.67 -45.61 91.53 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.621 -0.831 . . . . 0.0 111.616 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.35 -41.37 96.94 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.339 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.8 t -80.78 -49.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.641 ' OG ' HG22 ' A' ' 67' ' ' VAL . 3.8 p -132.01 89.64 37.7 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.255 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.9 Cg_exo -53.85 -41.89 70.99 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.943 1.762 . . . . 0.0 113.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.9 Cg_exo -55.72 -31.52 80.43 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.613 0.875 . . . . 0.0 112.721 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.32 67.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.462 . . . . 0.0 110.652 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.6 87.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.871 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.529 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 71.5 mtm180 -63.61 -37.98 89.39 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.913 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -51.63 -38.55 55.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.498 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 70.6 mt -57.65 -31.3 66.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.171 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER 4.42 -65.43 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.9 Cg_endo -51.56 -28.5 28.91 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 120.867 1.044 . . . . 0.0 112.847 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -61.9 -35.38 78.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.002 0.43 . . . . 0.0 110.319 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.701 ' O ' HD13 ' A' ' 141' ' ' LEU . 3.2 tm? -67.12 -45.49 77.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.064 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.46 41.04 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.604 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 3.6 t-105 -61.4 -50.81 71.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.453 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 115' ' ' VAL . 52.6 mt -64.3 -31.83 73.18 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.03 -45.36 93.9 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.711 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.732 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 19.0 t80 -66.99 -44.74 79.65 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.483 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.764 HG21 ' CD2' ' A' ' 114' ' ' LEU . 4.1 m -56.91 -42.07 79.26 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.427 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.6 m -60.65 -50.48 73.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.935 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.4 -40.98 85.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.345 0.593 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.732 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 17.6 tp -55.61 -46.07 77.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.739 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 147' ' ' THR . 28.4 m120 -62.65 -38.89 92.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -64.11 -39.94 95.13 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.422 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -60.09 -45.89 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.939 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.49 -47.14 78.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.576 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -67.93 -41.45 82.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.349 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -57.67 -41.88 82.46 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.885 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -63.49 -49.57 73.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.112 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.55 -43.04 67.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.324 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.435 -179.05 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.6 t . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 111.184 0.068 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 14.3 Cg_endo -59.62 -23.61 71.98 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 120.316 0.678 . . . . 0.0 111.443 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.2 -34.62 66.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.197 0.522 . . . . 0.0 110.384 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.43 -41.07 86.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.86 -35.68 91.68 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.1 -44.87 87.9 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 t -79.11 -37.19 39.29 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.21 -31.83 73.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.5 t -47.14 -56.47 12.1 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.68 ' HB3' HD21 ' A' ' 89' ' ' LEU . 7.7 Cg_endo -60.45 -28.79 87.38 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.073 1.182 . . . . 0.0 113.25 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.0 m -57.29 -39.26 75.38 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.249 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.79 -40.17 91.69 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.006 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.25 -49.27 47.22 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.98 93.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.39 -43.51 88.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.92 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.9 mtt -60.75 -40.05 91.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.263 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.64 83.32 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.19 -29.16 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.295 0.569 . . . . 0.0 109.935 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -36.15 73.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.468 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 62.0 t80 -61.15 -47.55 85.72 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.2 m -71.26 -31.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.839 0.828 . . . . 0.0 109.337 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -67.47 -41.03 85.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.781 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.91 -120.37 0.66 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.343 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.77 -28.51 61.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.899 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.93 -32.81 19.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.6 mt -49.93 -46.98 52.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.326 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -62.98 -39.89 96.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.55 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -59.64 -39.92 85.95 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.108 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 37' ' ' LEU . 76.2 m-85 -63.93 -23.07 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.08 -42.76 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.6 75.15 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 34' ' ' TYR . 38.8 mt -91.55 152.19 20.41 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.064 0.459 . . . . 0.0 111.454 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.545 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.9 mt-30 -101.16 129.09 47.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.657 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 31.7 mttt -100.14 142.86 25.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 56.1 Cg_endo -59.38 135.59 66.2 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.206 1.271 . . . . 0.0 111.702 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.3 p -68.59 -23.32 64.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.307 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 10.4 p90 -78.55 -10.19 59.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.579 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.596 ' NE2' ' O ' ' A' ' 44' ' ' PRO . 1.5 t-80 -69.99 133.49 88.0 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.46 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.596 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 18.2 Cg_endo -75.97 163.2 33.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.243 1.295 . . . . 0.0 110.675 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.0 Cg_endo -50.13 146.7 17.05 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 120.48 0.786 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.657 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 62.8 mtt180 -57.52 -37.08 72.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 48' ' ' THR . 4.5 p90 -63.34 -31.05 72.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.654 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 16.1 m -63.18 -55.67 23.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 96.4 mt -73.24 -35.6 66.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.41 -50.18 3.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.441 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 17.9 Cg_endo -71.01 6.54 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.979 1.786 . . . . 0.0 113.822 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.996 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.8 pt -44.21 -33.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.257 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.611 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.1 m-90 -53.54 -28.24 30.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.875 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 57' ' ' TYR . . . -52.52 -38.59 51.78 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.7 t -87.1 -41.74 13.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.684 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.634 HD11 ' CD1' ' A' ' 143' ' ' TRP . 9.8 mt -61.25 -38.97 88.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 58' ' ' SER . 1.4 p90 -64.6 -43.64 93.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.906 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 26.9 m -61.2 -39.75 91.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.34 99.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.492 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mtt -63.08 -36.15 82.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.67 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.08 -65.22 2.95 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.36 -38.46 87.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.84 -43.12 81.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.5 p -64.88 -27.54 68.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.851 0.358 . . . . 0.0 110.041 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -57.98 -44.49 87.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.48 -42.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.9 -37.94 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.592 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.7 -37.8 85.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.931 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -64.59 -45.23 87.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -68.92 -39.56 79.56 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . 49.4 mt -91.48 -0.51 57.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.39 5.99 66.7 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.24 -165.79 30.42 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.466 -0.397 . . . . 0.0 112.301 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.08 80.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.292 0.568 . . . . 0.0 111.511 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.485 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 6.9 p -125.59 162.04 25.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.764 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -44.32 -38.87 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.99 -46.33 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.738 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 73' ' ' GLY . . . -76.33 -32.79 58.88 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.3 mtp -56.53 -32.8 65.46 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.235 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.28 -47.2 94.83 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.725 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -66.16 -56.72 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.617 0.878 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.7 mp -60.04 -41.35 92.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.94 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.86 93.52 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.0 -39.58 78.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.877 0.37 . . . . 0.0 110.049 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.462 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 81.0 t80 -60.07 -44.8 94.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 48.8 m -68.51 -41.35 80.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.56 -64.21 2.54 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.653 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -57.16 -40.61 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.853 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 15' ' ' PRO . 30.2 tp -63.01 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -49.92 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.57 -38.71 85.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 63.7 t30 -62.14 -41.15 97.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.351 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.473 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 35.5 m95 -56.75 -30.58 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.747 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.94 -24.38 66.06 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' PRO . 14.5 t-105 -54.99 -70.92 0.26 Allowed Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 53.0 Cg_endo -43.32 82.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.949 1.766 . . . . 0.0 112.641 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.558 ' N ' ' O ' ' A' ' 95' ' ' TRP . 90.3 Cg_endo -58.91 -16.84 33.96 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.108 1.872 . . . . 0.0 112.57 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.721 HG21 ' HA ' ' A' ' 107' ' ' TRP . 33.6 pt -59.01 -25.03 28.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.049 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.36 -44.63 17.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.492 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 67.3 t80 -66.95 -50.39 62.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.76 -68.99 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.271 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 62.12 7.22 2.07 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -50.5 -35.94 31.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.251 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -90.36 153.43 20.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.678 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.647 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ttp -59.02 -16.45 18.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.03 13.84 0.01 OUTLIER Glycine 0 CA--C 1.539 1.568 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.194 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.721 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.8 p90 -60.5 -18.7 53.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.923 0.862 . . . . 0.0 112.02 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.39 -19.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.3 mp -62.46 -35.13 78.34 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.814 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.63 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.9 -38.69 89.31 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.2 t0 -62.24 -45.13 94.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.409 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 tp -63.29 -47.64 81.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.625 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.4 tt -68.92 -40.96 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.518 0.675 . . . . 0.0 109.965 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.7 HD21 HG21 ' A' ' 147' ' ' THR . 18.2 tp -52.21 -60.31 3.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.095 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 144' ' ' LEU . 67.4 t -69.83 -57.11 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.737 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 120' ' ' THR . 25.4 t -67.92 -41.74 82.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -56.55 -48.12 79.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.457 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 119' ' ' ALA . 1.2 t -71.09 -46.61 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.511 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -74.46 -54.96 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' SER . 26.6 m -57.41 -44.3 84.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.96 3.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.825 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.652 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 26.8 m -62.13 -40.28 95.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.51 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 82.2 m -61.65 -44.74 96.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.98 -36.69 84.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.26 -63.6 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.652 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.5 m0 -66.92 -42.33 85.58 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 52.0 t-80 -58.03 -47.28 83.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.241 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.53 -44.4 94.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.61 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.63 -49.96 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -132.49 89.94 34.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.464 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 41.1 Cg_exo -52.54 -41.21 69.5 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.447 1.431 . . . . 0.0 112.786 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.1 Cg_exo -57.45 -28.27 79.81 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 120.348 0.699 . . . . 0.0 112.713 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.58 71.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.142 0.496 . . . . 0.0 110.281 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.16 90.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.3 ttt-85 -59.11 -39.85 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.5 tp -57.33 -38.07 73.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.088 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.617 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.7 mt -57.91 -31.28 66.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.385 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 8.56 -68.74 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' A' ' 137' ' ' LEU . 4.8 Cg_endo -49.74 -27.37 15.18 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 120.727 0.951 . . . . 0.0 113.072 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -61.77 -40.72 96.13 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.103 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -66.57 -41.98 87.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.734 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.58 -51.74 26.31 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.634 ' CD1' HD11 ' A' ' 56' ' ' LEU . 2.7 t-105 -61.54 -49.61 75.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.05 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 115' ' ' VAL . 52.2 mt -64.44 -34.16 77.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.66 -40.06 95.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.883 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.76 ' CE2' HD22 ' A' ' 150' ' ' LEU . 24.3 t80 -60.86 -42.06 97.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.568 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.7 HG21 HD21 ' A' ' 114' ' ' LEU . 79.7 p -61.49 -35.59 78.09 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.537 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.3 m -63.95 -52.38 59.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.042 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.0 -42.64 82.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.113 0.483 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.76 HD22 ' CE2' ' A' ' 146' ' ' PHE . 61.6 tp -56.26 -41.48 75.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.234 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.43 -42.32 96.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -64.56 -40.5 95.68 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.472 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -59.97 -46.93 87.83 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.632 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.9 -45.5 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.693 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.5 m95 -59.82 -40.36 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.07 -30.04 68.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.578 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 95.1 m-20 -50.37 -39.97 48.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.15 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -102.13 -60.5 1.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.278 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.848 -179.447 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.409 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.562 ' O ' HD13 ' A' ' 11' ' ' LEU . 87.2 Cg_exo -53.62 -22.33 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.137 1.224 . . . . 0.0 112.346 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.48 62.86 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.932 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 12' ' ' THR . 73.3 t -62.64 -44.02 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.5 89.93 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.334 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.7 mp -56.53 -40.9 75.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 111.265 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.5 t -79.0 -32.9 45.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 13' ' ' LEU . 96.7 mt -61.72 -37.45 84.24 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 t -53.75 -42.78 94.33 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.416 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.46 -37.44 71.16 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.392 1.395 . . . . 0.0 113.348 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.9 m -60.05 -38.58 83.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.92 -38.94 87.53 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.417 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.36 99.88 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.106 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.79 -42.18 97.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.963 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -61.89 -39.66 92.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -60.76 -39.34 88.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.675 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.54 -46.48 25.12 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.53 -22.85 62.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.231 0.538 . . . . 0.0 110.209 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -55.68 -33.47 64.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 29.8 t80 -64.6 -49.88 69.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.394 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.49 -37.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.791 0.805 . . . . 0.0 109.65 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -59.27 -39.83 84.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.351 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -129.12 2.23 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.695 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.87 -27.03 62.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 110.981 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -32.39 10.07 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -50.76 -45.25 58.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.835 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -60.57 -41.91 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.23 -41.46 98.42 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 23.0 m-85 -64.02 -22.89 67.12 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.689 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.44 -41.46 52.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.003 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.36 -29.86 74.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 34' ' ' TYR . 50.2 mt -91.14 150.11 21.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.544 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -100.9 128.63 46.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 18.8 mtpp -109.9 139.22 21.09 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 39.2 Cg_endo -60.41 130.71 34.93 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.172 1.248 . . . . 0.0 112.515 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.4 m -66.67 -23.1 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.206 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.51 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.7 p90 -75.91 -15.5 60.18 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.606 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 1.2 p80 -72.62 143.29 84.75 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.429 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -69.42 161.97 43.78 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.808 1.005 . . . . 0.0 110.849 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.27 152.76 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.144 1.23 . . . . 0.0 110.931 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -55.57 -36.24 66.63 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 9.2 p90 -71.88 -14.67 62.01 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.886 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -80.06 -68.4 0.68 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.29 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.8 mt -62.11 -34.61 76.65 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.556 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.655 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -44.97 -41.8 13.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.724 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 85.4 Cg_exo -63.62 -8.64 15.79 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 123.217 2.611 . . . . 0.0 113.958 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.996 HG23 ' O ' ' A' ' 49' ' ' LEU . 25.3 pt -40.99 -40.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.369 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.455 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.9 m95 -53.21 -33.7 53.93 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.172 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.0 -38.88 96.24 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.0 m -68.52 -51.74 39.76 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.067 0.46 . . . . 0.0 110.616 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -66.25 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.923 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' TRP . 20.9 t80 -50.86 -53.32 33.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.022 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.8 p -67.9 -34.99 77.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.981 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.58 93.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.521 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.57 -38.14 90.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.56 -57.86 9.44 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.46 -0.876 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -62.43 -36.5 82.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.639 0.257 . . . . 0.0 111.287 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -42.8 84.31 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.427 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -65.36 -30.12 70.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.394 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -58.92 -43.84 91.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.416 . . . . 0.0 110.006 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.07 -40.11 82.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 109.967 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.534 HG13 HG11 ' A' ' 129' ' ' VAL . 55.1 t -61.02 -40.48 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.963 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -62.42 -49.56 74.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.517 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.595 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 75.2 mttt -54.44 -37.15 64.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.421 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -71.54 -43.61 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.495 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -77.89 -26.11 48.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.54 -3.6 46.54 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.76 -169.3 26.12 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.05 95.74 8.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.56 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 16.8 p -122.99 174.29 7.28 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.968 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.45 -35.37 39.3 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 87.7 m-20 -63.97 -39.88 95.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.411 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -84.73 -40.33 17.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.785 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.68 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.2 mmm -59.1 -36.17 74.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.531 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.94 -56.82 25.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.409 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 18.2 Cg_endo -62.94 -53.69 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.071 1.181 . . . . 0.0 112.234 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -63.53 -41.37 98.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.802 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.9 96.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.29 -38.97 78.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -59.56 -44.88 93.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.484 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.8 m -69.67 -41.33 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.71 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.96 -61.93 2.76 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.982 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -55.92 -41.77 75.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.544 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.44 -39.14 93.69 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.332 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.015 0.436 . . . . 0.0 110.646 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.51 -38.42 84.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.554 ' O ' HD11 ' A' ' 113' ' ' LEU . 60.8 t30 -61.86 -41.66 98.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.562 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.534 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 30.5 m95 -57.41 -31.16 65.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.632 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.87 -23.53 66.02 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 97' ' ' PRO . 45.6 t-105 -58.46 -67.95 0.82 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 29.5 Cg_endo -38.68 81.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.25 1.967 . . . . 0.0 113.046 -177.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.585 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.4 Cg_endo -62.84 -21.84 73.4 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.141 1.894 . . . . 0.0 112.544 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.692 HG21 ' HA ' ' A' ' 107' ' ' TRP . 46.0 pt -59.83 -25.89 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.488 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.51 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.3 p90 -44.86 -41.81 7.42 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.279 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 72.5 t80 -66.76 -51.83 51.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.73 -69.05 0.5 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.813 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 63.12 8.01 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.589 0.233 . . . . 0.0 110.722 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -53.59 -33.9 56.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -88.45 149.08 23.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.598 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.668 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.1 ttm -60.43 -18.97 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -49.73 8.96 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.217 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.692 ' HA ' HG21 ' A' ' 98' ' ' ILE . 23.1 p-90 -49.36 -15.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.418 0.609 . . . . 0.0 112.018 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.728 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -36.39 -17.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.9 mp -66.34 -32.5 73.93 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.104 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.495 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.73 -56.68 15.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.472 ' OD1' HG22 ' A' ' 147' ' ' THR . 21.2 t70 -58.16 -44.48 87.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.53 -40.19 93.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.599 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 92' ' ' ASN . 5.5 tt -73.37 -45.76 53.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 113' ' ' LEU . 1.9 pp -74.08 -38.35 63.93 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.087 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.524 ' HA ' HD22 ' A' ' 144' ' ' LEU . 65.5 t -67.83 -44.6 85.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.58 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 120' ' ' THR . 42.3 t -84.72 -41.19 16.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 121' ' ' ALA . . . -55.15 -43.58 83.68 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.172 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 119' ' ' ALA . 0.9 OUTLIER -74.11 -48.65 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.655 0.264 . . . . 0.0 110.923 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -72.64 -57.25 4.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 116' ' ' SER . 37.4 m -59.82 -43.61 94.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 117' ' ' GLY . . . -71.87 -56.64 5.35 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.095 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.642 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.5 m -63.3 -41.99 99.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 87.7 m -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.55 -38.12 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.186 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.68 -63.91 1.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.642 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 43.0 m0 -65.74 -41.33 92.33 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.9 t-80 -59.51 -48.7 80.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.914 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -65.7 -45.21 83.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.798 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.534 HG11 HG13 ' A' ' 67' ' ' VAL . 86.3 t -76.6 -46.76 30.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.6 p -130.9 83.76 60.29 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.288 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.455 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.2 Cg_exo -51.3 -43.94 46.17 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.497 1.465 . . . . 0.0 112.433 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 20.8 Cg_exo -59.15 -32.19 96.75 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.565 0.843 . . . . 0.0 112.364 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.65 -29.02 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.54 91.4 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 79.6 mtt180 -62.57 -38.87 91.8 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.437 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.7 tp -52.53 -37.31 57.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.091 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 138' ' ' TYR . 54.0 mt -58.93 -27.55 65.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.291 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -2.92 -69.9 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.811 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 138' ' ' TYR . 11.8 Cg_endo -50.97 -26.51 18.61 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 120.653 0.902 . . . . 0.0 112.951 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -57.61 -43.71 84.95 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 31.2 tp -59.45 -39.91 85.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.352 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.91 92.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.059 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.586 ' NE1' HD12 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -67.36 -50.73 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.434 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 115' ' ' VAL . 28.6 mt -65.26 -32.34 73.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.029 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.49 -49.02 78.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.724 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.749 ' CZ ' HD13 ' A' ' 150' ' ' LEU . 30.7 t80 -64.43 -40.48 95.83 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.613 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 1.4 m -55.12 -43.79 74.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.503 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 60.8 p -67.98 -44.47 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.974 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.42 -42.05 92.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.52 0.676 . . . . 0.0 109.797 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.749 HD13 ' CZ ' ' A' ' 146' ' ' PHE . 53.2 tp -59.91 -38.23 81.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 147' ' ' THR . 3.2 m120 -61.67 -41.91 98.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 73.2 m-85 -65.82 -39.52 90.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.0 t80 -61.68 -45.08 95.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.761 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.96 -52.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.728 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 5.1 m0 -63.56 -42.32 98.37 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CG ' ' O ' ' A' ' 152' ' ' TYR . 24.5 mmt85 -60.81 -35.85 77.56 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.117 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 88.0 m-20 -59.33 -40.94 87.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.577 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -92.34 -55.89 3.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.717 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 155' ' ' TRP . 85.3 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.313 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' O ' HD13 ' A' ' 11' ' ' LEU . 77.5 Cg_exo -54.31 -20.79 20.9 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 120.764 0.976 . . . . 0.0 111.806 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.36 -36.28 53.26 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 12' ' ' THR . 89.9 t -62.9 -42.01 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.19 -34.81 90.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.261 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.6 mp -57.52 -41.33 80.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.036 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 9' ' ' VAL . 6.9 t -76.8 -31.77 57.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.212 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.44 -32.83 73.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.823 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -44.44 -57.42 6.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 89' ' ' LEU . 17.9 Cg_endo -58.68 -32.77 97.55 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 121.013 1.142 . . . . 0.0 113.029 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -58.46 -39.14 79.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.422 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.07 -36.35 82.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.539 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.7 -58.16 7.26 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.006 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -36.29 82.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -57.71 -47.04 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.67 0.271 . . . . 0.0 110.979 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -64.48 -38.49 91.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.572 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.53 -42.24 97.56 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.627 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.45 -26.07 65.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.917 0.389 . . . . 0.0 111.701 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -32.6 65.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 51.4 t80 -60.51 -48.71 80.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -72.81 -31.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -63.21 -41.86 99.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.076 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.36 -126.26 4.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.91 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.22 -30.18 11.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.683 0.278 . . . . 0.0 111.037 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.77 -31.58 23.89 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.2 mt -51.74 -46.1 63.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.907 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -63.55 -37.6 87.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.83 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -56.22 -37.91 70.34 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.942 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CZ3' ' A' ' 107' ' ' TRP . 84.9 m-85 -63.31 -21.92 66.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.23 -35.05 2.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.659 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.69 -30.17 27.49 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 49.8 mt -95.69 151.45 19.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.499 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.1 mt-30 -97.76 133.18 42.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -111.34 142.15 25.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.304 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 58.2 Cg_endo -61.31 134.42 51.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.382 1.388 . . . . 0.0 111.341 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 p -78.94 -12.13 60.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.51 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.8 p90 -81.12 -15.17 56.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.6 148.96 95.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.814 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -83.29 175.66 8.06 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.878 1.719 . . . . 0.0 111.82 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CB ' ' NE1' ' A' ' 47' ' ' TRP . 39.7 Cg_exo -51.44 144.77 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.115 1.877 . . . . 0.0 112.057 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 49.9 mtt85 -59.84 -36.32 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.495 ' NE1' ' CB ' ' A' ' 45' ' ' PRO . 61.6 p-90 -70.95 -26.92 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.073 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -62.92 -57.86 9.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.923 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.982 ' O ' HG23 ' A' ' 52' ' ' ILE . 86.2 mt -73.91 -34.21 64.28 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -36.89 -51.21 2.08 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.012 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.7 Cg_endo -68.81 0.61 4.72 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.455 2.103 . . . . 0.0 114.17 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 49' ' ' LEU . 14.1 pt -43.81 -42.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 96.9 m95 -51.69 -32.82 31.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.96 96.18 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.8 m -68.54 -50.99 47.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.065 0.46 . . . . 0.0 111.206 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.3 mp -67.33 -34.27 76.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.94 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.446 ' CD1' HG23 ' A' ' 12' ' ' THR . 5.5 t80 -48.76 -60.62 2.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -63.47 -38.21 90.26 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.536 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.199 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.0 mtt -64.61 -38.55 91.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.29 -48.06 85.23 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.259 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -61.18 -38.68 87.38 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.48 -43.0 66.54 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.235 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -61.25 -31.67 71.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -58.61 -47.65 83.64 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.196 -0.601 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.07 -41.53 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 109.558 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG22 ' OG ' ' A' ' 130' ' ' SER . 97.3 t -61.0 -38.46 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -65.16 -36.56 84.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.907 178.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -63.81 -43.25 96.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.683 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.79 -44.38 85.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.492 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 78' ' ' ALA . 65.1 mt -76.68 -26.4 54.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.24 -4.15 62.25 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 156.64 -167.41 33.6 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.389 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.582 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 1.2 t80 -85.57 99.17 11.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 77' ' ' ASP . 5.7 t -133.48 165.71 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.62 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -41.69 -35.5 0.79 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.598 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.722 ' H ' HG23 ' A' ' 75' ' ' THR . 88.0 m-20 -60.69 -40.89 93.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.959 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.464 ' HB2' HD12 ' A' ' 71' ' ' LEU . . . -74.86 -32.22 61.83 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.012 0.434 . . . . 0.0 111.94 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.582 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 55.7 mmm -62.29 -35.12 78.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -59.66 -40.69 81.29 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.538 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.493 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 13.1 Cg_endo -85.56 -65.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.056 1.171 . . . . 0.0 112.231 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.78 -44.16 94.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.27 96.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.23 -36.62 78.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.469 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 89.6 t80 -56.58 -43.48 80.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.1 m -63.82 -43.65 95.61 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.16 -57.43 3.68 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.744 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.91 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.469 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 42.3 tp -62.93 -39.67 95.29 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.37 75.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.043 0.449 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.35 -39.72 88.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.007 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.451 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 58.5 t30 -62.29 -40.75 97.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -57.44 -29.99 64.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.925 0.393 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.93 67.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.544 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.634 ' O ' ' N ' ' A' ' 97' ' ' PRO . 36.7 t-105 -59.71 -68.51 0.73 Allowed Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 113' ' ' LEU . 10.4 Cg_endo -40.2 78.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.263 0 C-N-CA 121.699 1.599 . . . . 0.0 112.662 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' TRP . 97.1 Cg_endo -57.28 -19.78 36.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.947 1.765 . . . . 0.0 112.076 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.909 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 33.3 pt -58.7 -23.36 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.042 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.1 p90 -56.54 -47.07 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.606 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.7 t80 -64.81 -49.59 70.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.51 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.6 0.42 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.626 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.94 -2.24 0.2 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.636 0.255 . . . . 0.0 110.705 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.515 ' H ' ' C ' ' A' ' 101' ' ' GLY . 60.8 ttt85 -54.34 -35.44 62.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.63 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -85.8 158.65 19.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.522 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 107' ' ' TRP . 15.4 ttm -56.46 -13.9 2.64 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.255 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.95 -3.33 0.01 OUTLIER Glycine 0 CA--C 1.538 1.503 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.503 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.715 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.12 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.252 -0.558 . . . . 0.0 110.995 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.32 -27.93 67.72 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.832 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 109' ' ' LEU . 82.6 mt -59.09 -31.3 68.78 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.131 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.68 -38.72 88.84 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.94 -45.95 86.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.8 tp -64.71 -49.54 70.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.051 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.462 HD13 ' HD3' ' A' ' 96' ' ' PRO . 3.7 tt -67.17 -40.96 86.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.414 0.626 . . . . 0.0 110.078 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.785 ' CD2' HG21 ' A' ' 147' ' ' THR . 18.9 tp -50.82 -59.01 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.711 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 144' ' ' LEU . 61.0 t -69.98 -60.74 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.647 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.497 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -66.98 -42.74 84.57 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -60.38 -56.04 26.72 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.446 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.09 -38.62 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.671 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.32 -48.06 18.36 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.5 m -59.29 -41.68 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.55 -54.96 10.07 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.97 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.57 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 17.7 m -66.1 -42.3 89.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.443 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 53.4 m -59.4 -46.63 88.16 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.67 -34.7 78.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.055 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -82.23 -64.5 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.5 m0 -70.09 -42.0 73.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 40.8 t-80 -56.41 -45.59 80.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.277 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -63.1 -44.23 96.24 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.849 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.52 -47.47 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.587 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.578 ' OG ' HG22 ' A' ' 67' ' ' VAL . 59.4 p -133.79 87.28 36.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.472 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.7 Cg_exo -52.03 -40.86 67.03 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.767 1.645 . . . . 0.0 112.932 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.0 Cg_exo -58.27 -27.62 81.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 120.49 0.794 . . . . 0.0 112.81 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.18 -33.48 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.187 0.518 . . . . 0.0 110.783 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 137' ' ' LEU . . . -60.18 -36.42 77.56 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.989 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -60.59 -34.84 74.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.151 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -62.07 -40.06 94.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.902 0.858 . . . . 0.0 110.013 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 134' ' ' ALA . 38.4 mt -62.6 -26.72 68.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.964 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -1.74 -67.86 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 19.4 Cg_endo -51.27 -24.38 15.36 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 CA-C-N 119.711 0.933 . . . . 0.0 112.91 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -59.34 -39.37 82.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.818 0.342 . . . . 0.0 110.446 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.624 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -62.77 -41.39 99.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.897 0.38 . . . . 0.0 110.244 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.98 73.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.628 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.691 ' CE2' HD12 ' A' ' 52' ' ' ILE . 2.5 t-105 -61.27 -44.63 96.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 115' ' ' VAL . 50.0 mt -69.67 -36.66 76.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.634 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.273 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.644 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 64.7 t80 -62.85 -46.92 85.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.094 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.785 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.4 m -62.48 -41.75 99.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.09 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.1 m -58.93 -50.41 74.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.807 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 -40.35 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 110.491 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.644 HD12 ' CZ ' ' A' ' 146' ' ' PHE . 9.5 tt -56.81 -46.36 81.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.692 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.527 ' OD1' HG22 ' A' ' 147' ' ' THR . 32.5 m120 -65.37 -41.55 93.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -64.58 -38.99 92.91 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.772 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -58.26 -43.66 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.104 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.76 -42.96 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.374 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 1.6 m95 -60.87 -25.1 66.43 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -50.38 -36.57 33.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.562 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 91.2 m-20 -59.76 -43.77 94.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.085 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -87.62 -51.23 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 p . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.568 -179.719 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.529 ' O ' HD13 ' A' ' 11' ' ' LEU . 86.0 Cg_exo -55.29 -22.93 35.16 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 120.738 0.959 . . . . 0.0 112.769 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.65 63.99 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -44.07 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.77 90.79 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.533 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.7 mp -56.6 -41.53 77.2 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.293 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.409 HG23 ' CD1' ' A' ' 57' ' ' TYR . 3.2 t -79.4 -32.28 42.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.854 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 13' ' ' LEU . 96.3 mt -64.44 -37.09 86.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.8 t -50.85 -43.57 83.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.026 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.66 -36.8 91.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.357 1.372 . . . . 0.0 112.835 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.4 m -60.6 -39.16 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.812 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.44 -37.98 87.99 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.225 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.33 -55.0 17.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.576 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -62.67 -37.3 94.55 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.268 -0.491 . . . . 0.0 111.954 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.0 -46.97 86.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.8 mtm -63.47 -39.85 95.57 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.44 97.44 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.11 -28.37 63.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 0.0 110.648 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -35.88 74.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.05 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.62 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 69.5 t80 -60.75 -48.67 80.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.58 -36.01 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.933 0.873 . . . . 0.0 109.627 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -60.2 -41.08 92.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.097 -1.41 . . . . 0.0 112.357 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.72 -129.88 1.4 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.714 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.403 ' HB3' HH21 ' A' ' 32' ' ' ARG . 96.9 mt-10 -57.05 -26.67 60.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.91 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.08 -33.52 10.61 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.53 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.6 mt -50.87 -41.31 57.96 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.403 HH21 ' HB3' ' A' ' 29' ' ' GLU . 49.5 mtm180 -61.63 -43.53 98.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.506 0.669 . . . . 0.0 109.594 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -62.72 -40.1 96.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.146 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.6 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.9 m-85 -63.87 -22.94 67.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.328 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.59 -40.81 28.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.123 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -31.98 78.87 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.0 mt -91.1 148.81 22.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.977 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.32 127.92 46.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 12.1 mtpt -100.67 136.06 19.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 59.2 Cg_endo -56.06 143.79 82.17 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.139 1.226 . . . . 0.0 112.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 t -60.84 -31.22 70.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.998 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.425 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 18.4 p90 -76.99 0.39 21.36 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.309 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.6 t-80 -61.86 124.38 81.41 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.587 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.2 Cg_endo -80.86 166.01 19.42 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.462 1.442 . . . . 0.0 111.295 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 31.5 Cg_exo -49.25 140.75 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.133 1.222 . . . . 0.0 111.364 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.616 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 36.8 mtt-85 -58.74 -37.38 76.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.006 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.437 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 8.5 p90 -74.8 -21.5 59.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.928 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -65.25 -59.91 3.56 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.008 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.977 ' O ' HG23 ' A' ' 52' ' ' ILE . 71.2 mt -72.85 -33.31 66.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.4 -50.69 2.54 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.951 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 16.6 Cg_endo -69.59 0.8 5.0 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.433 2.088 . . . . 0.0 114.05 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.977 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.3 pt -42.34 -41.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.228 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 57' ' ' TYR . 99.4 m95 -53.86 -33.15 55.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.322 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.15 -40.11 98.09 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -67.83 -51.84 43.82 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.235 0.541 . . . . 0.0 110.82 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.7 mp -66.55 -32.85 74.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.934 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' TRP . 22.8 t80 -51.63 -53.53 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.374 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 p -68.04 -36.85 80.59 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.326 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.09 88.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.3 mtt -62.86 -37.47 87.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.68 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.16 -57.94 7.14 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.524 -0.846 . . . . 0.0 110.987 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.64 -39.35 87.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.595 0.236 . . . . 0.0 110.825 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.78 -42.02 84.57 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.0 p -62.35 -29.4 70.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.85 -44.47 91.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.807 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.13 -42.49 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.533 HG22 ' OG ' ' A' ' 130' ' ' SER . 90.5 t -60.89 -40.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.522 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.65 -33.27 75.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.153 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 31.5 mtpt -65.49 -44.89 85.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.151 0.5 . . . . 0.0 111.091 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.95 -37.94 85.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.774 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.6 mt -91.36 -3.75 56.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.44 35.9 40.49 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.518 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.37 -161.71 24.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.4 OUTLIER -78.64 109.91 13.29 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 121.56 0.695 . . . . 0.0 110.741 -178.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.9 t -133.94 164.45 27.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -43.93 -38.24 3.32 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.023 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.626 ' H ' HG23 ' A' ' 75' ' ' THR . 86.7 m-20 -65.5 -41.94 92.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.912 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -71.97 -33.24 68.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.632 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.1 mmm -59.06 -35.17 72.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.561 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.48 -59.68 12.77 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.2 -54.09 2.03 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.415 1.41 . . . . 0.0 113.051 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -62.57 -41.61 99.03 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.127 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.51 98.27 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp -58.29 -39.28 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -59.0 -44.42 91.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 65.4 m -68.22 -39.92 82.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.42 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.18 -58.98 3.5 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.894 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -56.96 -42.04 79.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.331 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.826 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.76 78.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.04 -40.4 89.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.826 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.515 ' O ' HD11 ' A' ' 113' ' ' LEU . 43.0 t-20 -62.66 -39.78 94.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.512 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.554 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.0 m95 -57.97 -27.46 63.46 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.12 62.63 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 26.4 t-105 -71.51 -56.36 5.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 76.4 Cg_endo -44.08 86.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.099 1.199 . . . . 0.0 112.549 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.3 Cg_endo -57.05 -26.71 70.16 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 120.845 1.03 . . . . 0.0 111.321 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.628 HD11 ' HB2' ' A' ' 110' ' ' ALA . 39.5 pt -62.44 -28.19 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.702 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.35 -44.47 65.22 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.895 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 70.5 t80 -64.43 -49.35 71.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.876 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -113.38 -68.6 0.51 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.308 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 101' ' ' GLY . . . 80.15 -5.26 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -54.4 -36.56 64.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -80.72 146.43 31.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.125 0.488 . . . . 0.0 111.257 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.629 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.3 ttp -64.22 -15.69 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.214 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.13 33.95 0.02 OUTLIER Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.629 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -61.41 -19.74 62.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -46.88 -24.47 0.6 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 111.594 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.1 -31.16 69.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.365 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.91 -52.74 58.46 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.662 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.0 t0 -62.2 -45.71 92.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.64 -38.52 85.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 110.379 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.792 HD23 ' C ' ' A' ' 113' ' ' LEU . 6.4 tt -71.15 -48.99 48.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 113' ' ' LEU . 2.8 pp -74.22 -31.46 62.62 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.49 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 111' ' ' ASP . 48.3 t -67.18 -61.58 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.722 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.9 t -72.54 -42.13 65.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 92' ' ' ASN . . . -59.18 -51.25 60.3 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.339 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 114' ' ' LEU . 2.4 p -67.38 -35.93 75.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.649 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.33 -57.4 3.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -60.08 -42.7 95.16 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.81 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.94 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.438 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 27.2 m -63.62 -39.39 94.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.935 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.432 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 77.7 m -59.34 -48.79 80.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 128' ' ' ARG . 74.3 mt -63.87 -32.31 73.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.68 -63.39 1.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.7 m0 -76.12 -45.28 34.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 123' ' ' THR . 2.0 t60 -57.67 -43.42 85.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.949 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.481 ' CG ' ' O ' ' A' ' 124' ' ' LEU . 37.0 mmm-85 -64.63 -46.08 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.273 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.24 -48.65 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.533 ' OG ' HG22 ' A' ' 67' ' ' VAL . 37.4 p -128.64 84.77 62.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.138 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.7 Cg_exo -53.41 -41.81 70.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.178 1.919 . . . . 0.0 112.925 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 24.3 Cg_exo -57.36 -30.15 86.78 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 120.323 0.682 . . . . 0.0 112.378 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.46 71.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.074 0.464 . . . . 0.0 110.316 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.74 76.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.811 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 50.4 ttt85 -59.59 -40.9 88.98 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.433 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.55 -36.04 63.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.305 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.516 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 55.6 mt -70.73 16.87 0.08 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.423 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -48.04 -41.06 38.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.231 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.516 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 18.2 Cg_endo -67.9 -18.67 46.84 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 CA-C-N 120.633 1.262 . . . . 0.0 112.876 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -58.98 -41.33 87.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.915 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 36.4 tp -63.79 -38.39 90.91 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.424 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.92 -43.95 91.11 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.596 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.59 ' CE2' HD12 ' A' ' 52' ' ' ILE . 1.3 t-105 -69.86 -50.46 42.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.449 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 115' ' ' VAL . 30.2 mt -65.83 -32.87 74.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.404 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -50.2 74.15 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.733 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.843 ' CE2' HD22 ' A' ' 150' ' ' LEU . 29.7 t80 -64.15 -42.28 96.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.905 0.383 . . . . 0.0 111.605 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.582 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.8 m -55.73 -43.66 76.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.1 m -64.36 -49.63 70.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.512 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.51 -40.23 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.193 0.521 . . . . 0.0 110.667 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.843 HD22 ' CE2' ' A' ' 146' ' ' PHE . 63.9 tp -56.06 -42.4 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.249 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.535 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.4 m120 -64.55 -41.0 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -62.69 -40.89 98.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.415 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -61.03 -46.41 90.85 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.227 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.87 -45.18 81.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.037 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.449 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -59.72 -39.21 83.89 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.647 -178.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 159' ' ' SER . 66.5 mtp180 -58.66 -25.96 63.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.65 -39.4 58.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.702 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -113.77 -2.39 13.71 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.145 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 156' ' ' ARG . 69.8 m . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.641 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.8 Cg_endo -58.01 -20.53 45.68 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.554 0.836 . . . . 0.0 112.222 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.589 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 13' ' ' LEU . 68.0 t -60.24 -40.5 83.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.017 0.437 . . . . 0.0 109.863 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.65 -36.86 93.3 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.33 -42.19 90.87 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 t -78.15 -41.4 34.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.514 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 HG12 ' A' ' 9' ' ' VAL . 85.8 mt -65.25 -35.33 80.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 10' ' ' GLY . 13.7 t -50.07 -43.9 78.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.354 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.07 -34.58 98.92 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.3 1.333 . . . . 0.0 112.895 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 m -59.61 -39.56 84.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 0.0 112.009 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.03 -37.72 83.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.365 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.46 -40.88 99.28 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.925 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -44.59 97.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.489 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -61.92 -40.87 96.98 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.65 -39.85 92.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.717 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -43.99 9.56 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.041 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.01 -24.57 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.432 . . . . 0.0 110.89 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.26 -35.42 64.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.55 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 64.1 t80 -60.92 -48.02 83.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.34 -32.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.721 0.772 . . . . 0.0 109.451 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -63.6 -41.26 98.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.523 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.41 -129.63 2.21 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.855 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.19 -27.93 62.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.853 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.21 -31.5 6.24 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.7 mt -51.9 -45.89 64.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.814 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -62.48 -39.0 92.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -57.34 -39.91 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.891 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.541 ' O ' ' O ' ' A' ' 37' ' ' LEU . 74.9 m-85 -64.76 -22.43 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.41 -40.23 5.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.74 -34.61 72.51 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 34' ' ' TYR . 31.6 mt -93.29 152.87 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.496 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.6 mt-30 -98.55 132.48 43.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 48.6 mttt -99.39 148.57 34.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 9.8 Cg_endo -57.49 140.02 91.95 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.62 1.546 . . . . 0.0 111.908 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 m -61.53 -33.22 73.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.762 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.434 ' NE1' ' CE1' ' A' ' 146' ' ' PHE . 13.3 p90 -85.79 6.43 28.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.496 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -54.86 124.55 51.85 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.136 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.93 168.45 6.75 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.172 1.248 . . . . 0.0 111.581 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 48.7 Cg_exo -51.21 139.28 44.14 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.427 1.418 . . . . 0.0 111.924 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.518 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 39.7 mtt85 -61.9 -37.09 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.2 p90 -73.88 -13.38 60.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.622 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -77.5 -65.92 0.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.967 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.994 ' O ' HG23 ' A' ' 52' ' ' ILE . 77.7 mt -65.79 -35.63 81.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.498 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.652 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.12 -40.42 3.87 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.033 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 63.6 Cg_exo -66.81 -8.95 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.913 2.409 . . . . 0.0 113.746 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' O ' ' A' ' 49' ' ' LEU . 26.3 pt -41.84 -42.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.412 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.45 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.3 m95 -53.54 -32.05 48.99 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.264 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -52.6 -37.08 49.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.5 p -87.54 -45.85 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.97 -40.32 96.13 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CE1' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -62.62 -44.65 95.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.639 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 57' ' ' TYR . 28.4 m -60.15 -40.79 91.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.61 91.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.42 -37.88 87.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.6 -55.53 19.83 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -61.78 -33.76 74.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.118 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.35 -44.18 58.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.48 ' CB ' HD21 ' A' ' 82' ' ' LEU . 95.4 p -64.13 -31.52 72.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -56.61 -46.04 81.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.412 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.6 mt -61.59 -39.4 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 129' ' ' VAL . 75.7 t -63.18 -38.78 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.91 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.13 -51.41 69.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.943 0.401 . . . . 0.0 111.2 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 73.5 mttt -54.96 -36.57 65.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.367 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -72.77 -41.17 65.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.89 -8.22 40.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.82 -6.28 58.58 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.515 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 124.8 -168.19 16.97 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.431 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -59.5 79.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.789 0.804 . . . . 0.0 108.873 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.1 m -116.09 152.77 32.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.595 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' THR . 97.0 mt-10 -42.59 -36.52 1.4 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.184 -0.607 . . . . 0.0 109.894 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.58 -41.33 98.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.114 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -74.97 -33.03 61.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.46 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.452 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 89.3 mmm -61.2 -35.76 78.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.652 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -56.42 -45.06 99.97 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.585 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 9.5 Cg_endo -78.18 -61.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 120.929 1.086 . . . . 0.0 111.985 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.48 HD21 ' CB ' ' A' ' 64' ' ' SER . 27.9 mt -57.81 -43.75 85.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.91 0.386 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.83 -43.85 98.66 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -59.07 -38.45 79.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.269 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.85 -42.98 80.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 m -65.66 -42.35 91.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.33 3.08 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.897 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -55.78 -41.59 74.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.522 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.21 -37.91 89.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.03 -49.84 73.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 111.004 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.8 -37.01 82.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.461 HD21 HD22 ' A' ' 113' ' ' LEU . 19.8 t-20 -59.51 -41.34 89.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.559 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.483 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 62.0 m95 -62.1 -30.42 70.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.652 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.24 -28.95 66.79 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.685 ' CD1' HD11 ' A' ' 113' ' ' LEU . 18.9 t-105 -55.74 -64.52 2.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_endo -46.2 82.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.457 1.438 . . . . 0.0 112.148 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.557 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.5 Cg_endo -57.82 -19.21 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.351 1.368 . . . . 0.0 111.477 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.746 HG21 ' HA ' ' A' ' 107' ' ' TRP . 39.6 pt -60.23 -26.18 35.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.032 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.7 p90 -46.82 -44.64 19.48 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.386 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 73.6 t80 -70.05 -49.4 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.99 -66.24 0.48 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.947 -0.645 . . . . 0.0 113.131 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 66.16 8.57 5.63 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.608 0.242 . . . . 0.0 111.015 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -55.07 -36.31 65.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -88.66 149.77 23.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.286 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 107' ' ' TRP . 1.7 ttp -59.98 -19.41 52.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.298 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.02 -8.06 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.88 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.746 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.5 p90 -44.67 -18.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.19 -20.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.0 mt -60.87 -35.76 77.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.82 -39.8 93.04 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.479 0.657 . . . . 0.0 109.345 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 111' ' ' ASP . 56.7 t0 -66.73 -43.38 84.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.785 -1.098 . . . . 0.0 113.57 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.21 -49.26 65.19 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.685 HD11 ' CD1' ' A' ' 95' ' ' TRP . 21.8 mt -67.87 -38.85 83.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.02 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.765 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.0 tp -51.6 -55.81 17.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.286 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' HD22 ' A' ' 144' ' ' LEU . 57.3 t -73.1 -63.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.662 -178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -67.82 -41.86 82.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -63.48 -52.9 42.81 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.965 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 114' ' ' LEU . 1.8 p -65.93 -36.83 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.582 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.9 -56.0 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.3 m -56.34 -42.34 77.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.97 -53.96 15.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.397 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.499 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.8 m -65.03 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.874 HG23 ' CD2' ' A' ' 127' ' ' HIS . 86.9 m -59.16 -48.2 82.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.508 HD22 HH21 ' A' ' 128' ' ' ARG . 78.9 mt -65.96 -35.1 79.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.319 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -73.66 -55.25 6.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.499 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 38.6 m0 -84.86 -49.96 7.96 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.874 ' CD2' HG23 ' A' ' 123' ' ' THR . 0.2 OUTLIER -52.25 -41.87 63.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.206 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.508 HH21 HD22 ' A' ' 124' ' ' LEU . 96.9 mtt-85 -61.44 -43.57 98.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.316 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.408 HG11 HG13 ' A' ' 67' ' ' VAL . 79.3 t -78.6 -48.98 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.589 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 87.8 p -132.47 88.06 40.41 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.786 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.8 Cg_exo -53.31 -39.58 80.7 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.931 1.754 . . . . 0.0 113.147 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 34.1 Cg_exo -56.27 -29.74 77.49 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.35 0.7 . . . . 0.0 112.76 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -32.65 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.63 . . . . 0.0 110.392 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.542 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.48 -38.4 80.74 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 45.5 ttp180 -61.28 -38.65 87.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.625 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.58 -39.74 71.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.8 mt -56.85 -28.82 62.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.314 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.51 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 5.86 -69.45 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 9.6 Cg_endo -52.1 -31.36 44.6 Favored 'Trans proline' 0 N--CA 1.505 2.158 0 C-N-CA 120.435 0.756 . . . . 0.0 113.275 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -59.07 -38.3 79.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.809 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.754 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.1 tm? -59.58 -44.24 93.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.303 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.42 72.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.8 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.6 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 1.8 t-105 -61.26 -44.04 97.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 115' ' ' VAL . 43.3 mt -65.8 -34.25 77.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.823 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.42 89.39 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.727 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.675 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 15.7 t80 -65.27 -43.21 91.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.765 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.6 m -57.31 -42.73 82.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.612 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -61.26 -47.29 86.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.163 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.81 -42.7 82.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.688 0.756 . . . . 0.0 109.995 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.675 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 14.1 tp -53.44 -60.86 2.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.118 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.572 ' OD1' HG22 ' A' ' 147' ' ' THR . 31.7 m120 -63.02 -38.81 92.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.272 0.558 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.35 -43.09 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.19 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.88 -44.46 96.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.47 -42.7 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 111.209 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 4.9 m95 -57.65 -36.23 71.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.37 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -57.35 -30.41 64.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 89.5 m-20 -53.13 -40.31 64.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.564 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -109.06 -60.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.4 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.793 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.3 t . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.5 ' O ' HD13 ' A' ' 11' ' ' LEU . 79.5 Cg_exo -54.52 -21.22 23.41 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 120.916 1.077 . . . . 0.0 112.177 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.29 -36.81 53.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.04 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 12' ' ' THR . 96.8 t -62.38 -42.81 96.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.47 -34.79 90.17 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.482 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.1 mp -55.82 -43.75 77.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.105 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.451 HG23 ' CD1' ' A' ' 57' ' ' TYR . 7.5 t -75.99 -27.01 57.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.19 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.97 -32.42 67.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 40.9 t -45.51 -57.69 7.22 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB3' HD21 ' A' ' 89' ' ' LEU . 6.6 Cg_endo -57.88 -31.52 92.76 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.086 1.191 . . . . 0.0 112.902 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.422 ' H ' ' HD2' ' A' ' 15' ' ' PRO . 23.2 t -60.2 -39.47 86.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.56 -39.27 87.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.275 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.56 15.37 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.2 94.05 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.08 -45.37 87.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.907 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.88 -39.42 94.41 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.51 -42.84 97.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.07 -26.28 62.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.386 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -62.94 -34.9 78.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.913 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 74.8 t80 -61.25 -49.45 77.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.64 -35.79 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.477 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -34.16 74.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.654 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.9 -136.88 2.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.505 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.1 -24.73 59.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.121 0.486 . . . . 0.0 110.759 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.86 -32.69 4.64 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.468 HD22 ' CZ ' ' A' ' 46' ' ' ARG . 92.1 mt -52.18 -43.42 64.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.074 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.23 -42.84 99.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 110.238 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -60.05 -39.15 84.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 45.1 m-85 -64.89 -23.06 67.11 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.751 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.15 -41.62 27.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.543 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.04 84.48 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 73.3 mt -91.0 149.18 21.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.789 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -98.0 122.56 41.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.791 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.696 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 54.7 mttt -91.35 140.94 25.67 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 30.4 Cg_endo -56.44 140.73 89.6 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.122 1.215 . . . . 0.0 112.398 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.4 m -61.17 -34.04 74.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.207 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 39.0 p90 -77.43 4.45 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.619 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.586 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.3 t-80 -64.5 132.0 95.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 57.6 Cg_endo -89.81 169.65 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.697 1.598 . . . . 0.0 111.284 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 41.0 Cg_exo -50.92 138.73 42.32 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.84 1.027 . . . . 0.0 111.501 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.696 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 43.0 mtt85 -60.43 -38.69 84.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.9 p90 -72.21 -25.66 61.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.901 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -64.24 -57.45 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.983 ' O ' HG23 ' A' ' 52' ' ' ILE . 50.1 mt -73.28 -33.78 65.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.36 -48.64 2.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.882 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.2 Cg_endo -72.34 3.77 3.88 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.364 2.043 . . . . 0.0 114.189 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 49' ' ' LEU . 19.4 pt -47.21 -38.24 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.263 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -51.76 -33.59 35.76 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.079 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.23 97.86 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.7 m -66.39 -51.17 59.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 110.834 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.28 -33.09 74.58 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.205 0.526 . . . . 0.0 109.966 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.451 ' CD1' HG23 ' A' ' 12' ' ' THR . 31.1 t80 -53.12 -52.8 57.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.618 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.5 p -69.42 -35.39 75.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.618 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.74 90.13 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.455 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.2 mtt -62.29 -37.41 85.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.269 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.29 -56.25 14.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.95 -40.13 96.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 111.102 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.85 -43.41 92.37 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.482 ' HB2' HD21 ' A' ' 82' ' ' LEU . 92.7 p -63.5 -28.14 69.76 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.954 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -58.3 -44.85 88.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.95 -44.71 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.914 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 HG11 ' A' ' 129' ' ' VAL . 55.4 t -59.32 -41.64 84.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.21 -37.17 86.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.511 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -62.46 -40.94 98.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.064 0.459 . . . . 0.0 111.113 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.63 -37.59 88.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.07 -5.31 56.7 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.47 17.19 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.972 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.451 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 104.24 -166.35 15.33 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.96 110.11 21.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.461 0.648 . . . . 0.0 109.332 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 77' ' ' ASP . 5.7 t -131.32 163.47 27.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.981 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -43.51 -37.85 2.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.309 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' H ' HG23 ' A' ' 75' ' ' THR . 83.9 m-20 -63.45 -41.02 98.64 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.879 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.4 -29.18 65.74 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.689 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 86.1 mmm -60.15 -33.64 72.45 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.781 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.3 t -60.33 -50.22 86.84 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.22 -61.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.935 1.09 . . . . 0.0 113.038 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 64' ' ' SER . 7.3 mp -61.87 -39.26 91.3 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.077 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.18 96.26 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.82 -39.27 80.72 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.407 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 84.0 t80 -60.62 -45.71 93.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.034 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.0 m -67.95 -40.28 83.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.856 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.93 -60.33 3.17 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.022 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -56.96 -40.63 76.83 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.17 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 15' ' ' PRO . 44.9 tp -61.96 -40.23 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.174 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.0 79.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.98 0.419 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.02 85.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t30 -61.64 -42.44 98.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.679 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -58.42 -29.62 66.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.831 0.348 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -31.12 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.279 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.0 t-105 -56.94 -44.25 99.71 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -53.05 127.37 24.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.521 1.48 . . . . 0.0 113.125 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.454 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 37.5 Cg_endo -108.67 -27.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.194 1.263 . . . . 0.0 110.793 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 26.5 pt -59.59 -27.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.953 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 20.8 p90 -56.7 -44.51 81.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.608 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.568 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 60.5 t80 -64.95 -49.08 71.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.908 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.32 -59.16 0.41 Allowed Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.52 -1.27 0.22 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.649 0.262 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 101' ' ' GLY . 71.0 ttp85 -52.89 -33.28 49.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 110.34 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -86.62 151.82 23.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.784 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.683 ' C ' ' H ' ' A' ' 107' ' ' TRP . 2.7 ttp -62.16 -13.41 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.109 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.07 27.43 0.01 OUTLIER Glycine 0 CA--C 1.541 1.683 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.869 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.683 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.47 -19.17 34.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.559 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -55.07 -24.22 24.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.33 -33.1 65.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.431 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.537 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.76 -38.01 89.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -65.21 -48.43 73.39 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.29 -47.39 86.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.872 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.3 tt -69.11 -40.43 78.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.379 0.609 . . . . 0.0 110.356 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.737 ' CD2' HG21 ' A' ' 147' ' ' THR . 14.4 tp -54.07 -57.47 10.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.309 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.554 ' HA ' HD13 ' A' ' 144' ' ' LEU . 98.9 t -69.7 -56.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.883 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -68.7 -42.35 77.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -58.04 -45.2 94.14 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.661 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.38 -45.53 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.677 0.275 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.48 -55.59 9.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.1 m -59.72 -42.81 93.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.38 -60.37 2.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.459 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.6 m -62.48 -41.05 98.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.859 HG23 ' CE1' ' A' ' 127' ' ' HIS . 76.3 m -59.3 -46.47 88.49 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.5 -35.01 79.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.41 -63.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.8 m0 -64.47 -43.76 93.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.859 ' CE1' HG23 ' A' ' 123' ' ' THR . 24.9 m170 -56.87 -43.38 81.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.634 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.12 -44.32 96.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.587 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.509 HG11 HG13 ' A' ' 67' ' ' VAL . 98.5 t -75.9 -42.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.815 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.55 103.65 3.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.262 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.529 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.3 Cg_exo -60.76 -38.98 66.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.699 1.599 . . . . 0.0 113.236 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 28.1 Cg_exo -56.45 -29.59 78.5 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.93 1.086 . . . . 0.0 112.96 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 -33.53 73.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.018 0.437 . . . . 0.0 110.765 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.55 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.44 -37.29 77.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.902 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 44.1 ttt180 -59.45 -40.77 87.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.396 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.6 -36.84 67.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.307 0.575 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.524 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 60.8 mt -70.66 15.39 0.1 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.543 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -46.27 -40.64 19.01 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.072 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 9.2 Cg_endo -66.92 -22.9 47.94 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.809 1.325 . . . . 0.0 112.417 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.56 -34.02 74.86 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.751 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.0 tm? -67.93 -41.55 82.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.927 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.71 -52.15 33.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 0.661 ' CD1' HD12 ' A' ' 52' ' ' ILE . 1.1 t-105 -61.31 -46.34 90.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.756 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 115' ' ' VAL . 34.8 mt -67.6 -33.83 75.79 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.843 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.93 -46.03 89.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.993 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.694 ' CE2' HD22 ' A' ' 150' ' ' LEU . 16.1 t80 -64.69 -43.33 93.88 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.426 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.737 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.6 m -57.66 -43.48 85.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.39 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 54.4 m -60.29 -49.73 76.45 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.557 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.39 -41.81 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.366 0.603 . . . . 0.0 110.331 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 146' ' ' PHE . 23.9 tp -56.76 -47.88 79.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.139 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 147' ' ' THR . 32.5 m120 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -65.28 -40.52 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.342 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.74 -45.98 88.43 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.304 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.68 -45.62 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -62.66 -44.08 97.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.669 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -60.44 -32.12 71.07 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.306 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -54.71 -40.85 69.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.948 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -99.73 -59.97 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.5 m . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.108 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.3 t . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.0 Cg_endo -55.31 -19.4 21.71 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 CA-C-N 119.147 0.731 . . . . 0.0 111.451 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.12 -32.01 53.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 12' ' ' THR . 79.2 t -61.17 -41.15 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.25 -36.86 93.07 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.312 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.27 -41.69 84.86 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 9' ' ' VAL . 9.2 t -75.81 -34.52 60.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.652 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.15 -34.74 78.21 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 10' ' ' GLY . 26.8 t -49.26 -55.84 19.32 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.2 Cg_endo -58.92 -32.6 97.7 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 120.539 0.826 . . . . 0.0 112.963 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.8 m -59.97 -40.04 87.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.746 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.98 -38.09 87.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.42 -59.04 8.24 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.191 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -60.1 -36.34 90.21 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.284 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.15 -46.48 85.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.497 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.08 -38.21 87.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.554 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.83 -39.51 97.48 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.646 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.66 -28.42 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.337 . . . . 0.0 111.763 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.72 -34.82 67.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.724 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 88.6 t80 -60.89 -47.59 85.71 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.435 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.1 m -71.79 -33.9 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.702 0.763 . . . . 0.0 109.333 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -61.75 -40.77 96.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.028 -1.442 . . . . 0.0 112.674 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.14 -126.08 1.83 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.047 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.39 -28.11 62.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.777 0.322 . . . . 0.0 111.317 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.96 -32.88 12.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.25 -41.23 62.64 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.025 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.2 mtp85 -61.48 -45.86 92.45 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.677 0.751 . . . . 0.0 109.334 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -62.46 -40.67 97.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.595 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 21.4 m-85 -65.16 -23.0 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.647 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.86 -39.72 54.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.56 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -33.21 85.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 60.5 mt -91.47 149.42 21.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.59 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -99.62 130.71 45.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.639 -0.425 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -111.67 141.35 24.49 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.852 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 62.3 Cg_endo -58.61 133.29 53.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.972 1.114 . . . . 0.0 111.971 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.3 p -82.47 -9.19 59.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.05 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.3 p90 -77.79 -15.4 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.818 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -74.2 151.97 88.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.407 -178.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.68 173.13 14.07 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 112.455 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 19.5 Cg_exo -51.72 151.38 15.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.984 2.456 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -58.09 -35.69 71.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 14.7 p90 -74.51 -12.3 60.44 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.672 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -76.96 -66.91 0.76 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 110.956 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 19.5 mt -66.52 -35.82 81.2 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.581 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.656 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -40.76 -42.49 3.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 51.3 Cg_exo -65.51 -5.39 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.87 2.38 . . . . 0.0 112.98 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.035 HD12 ' HE1' ' A' ' 143' ' ' TRP . 5.9 pt -41.22 -42.54 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 120.658 0.266 . . . . 0.0 111.709 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.449 ' O ' ' N ' ' A' ' 57' ' ' TYR . 95.0 m95 -56.31 -34.06 66.17 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.105 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.49 -39.09 95.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -66.73 -52.28 46.25 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.19 0.519 . . . . 0.0 111.049 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.722 HD21 ' CE3' ' A' ' 143' ' ' TRP . 6.8 mp -68.22 -31.47 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.076 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' TRP . 19.8 t80 -52.2 -49.12 64.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.131 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -74.09 -34.79 64.09 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.651 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.94 -45.02 87.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.858 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.78 -37.18 85.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.75 -60.84 6.46 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.152 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -62.15 -36.48 81.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.637 0.256 . . . . 0.0 111.02 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.81 85.0 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.115 -1.04 . . . . 0.0 110.738 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.2 p -65.07 -30.11 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.566 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -58.49 -44.01 89.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.43 -38.48 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.949 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 129' ' ' VAL . 63.1 t -62.15 -41.6 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.636 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.33 -50.03 75.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.308 -178.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 74.9 mttt -54.4 -36.24 63.75 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.978 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -72.94 -44.73 60.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.658 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 78' ' ' ALA . 70.6 mt -77.41 -26.06 51.36 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.07 -6.85 40.42 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.269 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.85 -161.61 25.49 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.113 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.686 ' CD2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -89.23 82.68 6.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.35 0.595 . . . . 0.0 110.083 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 13.4 p -123.16 166.0 15.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.46 -36.87 3.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.82 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.76 -42.82 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.952 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -82.27 -36.64 26.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.983 0.42 . . . . 0.0 111.657 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.686 ' SD ' ' CD2' ' A' ' 74' ' ' PHE . 98.7 mmm -59.08 -34.47 72.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.052 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.3 t -60.14 -52.39 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.929 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -68.88 -58.78 0.1 Allowed 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.155 1.237 . . . . 0.0 112.775 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 82' ' ' LEU . 11.0 mp -60.84 -42.0 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.194 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.19 95.38 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.34 -39.79 76.66 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.449 ' CE2' HD22 ' A' ' 89' ' ' LEU . 75.0 t80 -59.13 -43.99 92.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.1 m -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.134 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.89 -60.07 3.26 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.595 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -56.97 -41.17 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.329 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 15' ' ' PRO . 33.0 tp -61.94 -38.86 90.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.632 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.78 76.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.981 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.4 -39.09 86.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.555 ' O ' HD11 ' A' ' 113' ' ' LEU . 57.5 t30 -61.46 -41.07 96.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.666 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.572 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 48.3 m95 -60.42 -28.76 68.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.71 -17.86 62.82 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.587 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.3 t-105 -72.43 -55.92 4.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 71.8 Cg_endo -42.62 87.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.182 1.255 . . . . 0.0 112.508 -177.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.6 Cg_endo -59.53 -27.1 84.13 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 120.606 0.871 . . . . 0.0 111.762 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.655 HD11 ' HB2' ' A' ' 110' ' ' ALA . 40.0 pt -61.71 -33.99 60.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.5 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -46.68 -43.78 18.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.534 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -67.53 -52.16 42.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.68 -55.11 0.39 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.847 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 61.04 10.81 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 0.0 110.356 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -55.66 -35.6 66.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.546 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -87.22 149.38 24.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.501 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.633 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.4 ttp -62.62 -14.93 48.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.28 35.44 0.02 OUTLIER Glycine 0 CA--C 1.54 1.598 0 C-N-CA 121.679 -0.296 . . . . 0.0 112.743 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.633 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -64.03 -19.67 65.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.605 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -47.46 -22.7 0.49 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.91 0.386 . . . . 0.0 111.258 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt -57.77 -31.48 66.57 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.563 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.02 -53.72 45.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.678 ' OD1' HG22 ' A' ' 147' ' ' THR . 31.1 t70 -63.13 -46.7 86.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.61 -38.09 83.57 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.781 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.6 tt -67.26 -48.78 66.71 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.616 ' N ' HD23 ' A' ' 113' ' ' LEU . 1.6 pp -76.15 -32.99 59.37 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.977 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 111' ' ' ASP . 70.6 t -64.82 -45.91 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.89 -38.75 17.72 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.55 -42.22 89.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.213 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 119' ' ' ALA . 0.9 OUTLIER -75.86 -48.38 29.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.776 0.322 . . . . 0.0 111.033 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.24 -56.79 10.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.7 m -61.9 -45.17 94.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.79 -59.11 3.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.423 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 28.3 m -63.11 -41.71 99.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 88.8 m -58.84 -45.22 90.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.393 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 124' ' ' LEU . 96.4 mt -63.45 -37.48 87.44 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.215 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.28 -64.3 1.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.423 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.6 m0 -66.1 -43.01 88.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -59.29 -50.12 75.2 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.691 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.11 -43.53 95.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.798 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 67' ' ' VAL . 97.7 t -76.02 -48.04 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 p -134.1 87.87 32.97 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.446 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.46 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.53 -42.41 61.91 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.391 1.394 . . . . 0.0 112.433 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.5 Cg_exo -56.79 -30.46 84.91 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 120.328 0.685 . . . . 0.0 111.994 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -30.79 70.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.094 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.91 97.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.114 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -59.98 -38.4 82.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.07 0.462 . . . . 0.0 110.352 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.53 -37.71 73.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.198 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.3 mt -57.86 -31.54 66.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.499 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 5.88 -72.37 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.4 Cg_endo -50.8 -22.32 9.67 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 CA-C-N 119.23 0.761 . . . . 0.0 112.79 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 p90 -57.73 -41.95 82.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.696 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -61.34 -44.39 97.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.053 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.21 83.57 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.234 0.54 . . . . 0.0 110.344 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TRP . . . . . 1.035 ' HE1' HD12 ' A' ' 52' ' ' ILE . 26.7 t90 -60.47 -50.59 72.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.486 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.736 HD21 ' CZ3' ' A' ' 143' ' ' TRP . 57.8 mt -74.78 -29.69 61.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.32 -54.92 39.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.841 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 150' ' ' LEU . 40.8 t80 -65.36 -44.93 86.1 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.786 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.678 HG22 ' OD1' ' A' ' 111' ' ' ASP . 9.6 m -56.56 -42.33 78.42 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.672 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.5 m -68.18 -50.17 56.08 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 111.604 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.06 -39.57 86.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.258 0.551 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 146' ' ' PHE . 66.1 tp -55.45 -41.73 73.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 6.2 m120 -63.18 -42.62 99.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -63.58 -35.9 82.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.664 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -58.57 -47.02 85.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.549 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.42 -47.44 52.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.756 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 3.1 m0 -61.58 -43.91 97.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -60.86 -33.66 73.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.269 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.6 -41.08 76.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.126 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -96.75 -59.97 1.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 111.482 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.069 -178.743 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 mtp . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -57.31 -22.23 48.27 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.695 1.597 . . . . 0.0 112.373 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.93 -27.83 61.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.178 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -56.33 -42.67 78.05 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.403 ' NE1' ' HB2' ' A' ' 74' ' ' PHE . 10.5 m-90 -79.24 -30.61 43.23 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.5 t -41.43 -39.45 2.26 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.577 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.56 ' O ' HD13 ' A' ' 11' ' ' LEU . 88.6 Cg_exo -55.28 -22.91 34.96 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.218 1.279 . . . . 0.0 112.794 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.31 62.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.4 t -64.31 -42.69 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.15 -34.61 90.4 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.012 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.1 mp -55.57 -44.23 76.66 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.795 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 t -78.83 -33.43 46.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.241 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.408 HD21 ' CE1' ' A' ' 57' ' ' TYR . 87.1 mt -65.39 -35.44 80.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.794 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 t -54.35 -57.27 19.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.54 -33.21 97.04 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 120.843 1.029 . . . . 0.0 112.767 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -59.31 -38.05 79.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.941 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.04 -38.52 91.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.579 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.97 -53.88 27.87 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.882 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.92 90.68 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CZ ' ' NH1' ' A' ' 27' ' ' ARG . 54.3 t80 -59.13 -43.47 91.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.296 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtt -61.06 -40.78 94.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.072 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.15 -42.46 91.48 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -69.64 -27.74 65.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.22 0.533 . . . . 0.0 110.302 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -35.39 76.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.669 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 40.7 t80 -61.05 -49.94 75.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.91 -34.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.693 0.759 . . . . 0.0 109.645 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.48 ' NH1' ' CZ ' ' A' ' 20' ' ' PHE . 7.9 ttt180 -61.81 -40.91 96.9 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.779 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.14 -123.47 3.16 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.149 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.1 -29.54 60.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.204 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -33.43 17.93 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD21 ' NE ' ' A' ' 46' ' ' ARG . 96.1 mt -50.37 -43.18 54.25 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -61.41 -43.07 99.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.58 . . . . 0.0 109.834 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.94 -39.17 93.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.85 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.617 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 16.5 m-85 -63.88 -23.26 67.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.29 -40.19 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.796 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.98 -31.96 72.92 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 34' ' ' TYR . 51.1 mt -90.62 148.55 22.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.869 0.366 . . . . 0.0 110.976 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -98.43 127.04 44.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.598 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.773 ' HZ1' ' NH1' ' A' ' 46' ' ' ARG . 11.0 mtpt -105.21 138.3 19.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 37.2 Cg_endo -55.65 141.47 83.78 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.669 0.913 . . . . 0.0 111.888 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.8 p -62.76 -30.04 71.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.335 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.42 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 24.8 p90 -78.39 0.18 26.7 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.884 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 19.7 t-80 -59.61 127.64 85.16 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 98.4 Cg_endo -81.68 167.06 17.1 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.181 1.254 . . . . 0.0 111.803 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 33.0 Cg_exo -52.01 140.66 49.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.731 1.621 . . . . 0.0 111.482 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.773 ' NH1' ' HZ1' ' A' ' 39' ' ' LYS . 62.5 mtt-85 -59.74 -36.37 76.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.519 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.412 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 7.7 p90 -73.94 -13.54 60.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.948 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 m -75.91 -69.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.421 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.008 ' O ' HG23 ' A' ' 52' ' ' ILE . 63.4 mt -66.01 -34.78 78.87 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.476 -0.49 . . . . 0.0 112.031 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.03 -41.03 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.324 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 51.0 Cg_exo -67.2 -7.11 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 123.123 2.549 . . . . 0.0 113.983 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.008 HG23 ' O ' ' A' ' 49' ' ' LEU . 24.4 pt -42.8 -40.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.465 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 99.3 m95 -53.44 -32.95 52.16 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.578 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.75 97.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -68.39 -51.04 48.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.924 0.393 . . . . 0.0 111.403 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.2 mp -67.95 -33.39 74.58 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.248 0.547 . . . . 0.0 110.111 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 17.1 t80 -51.15 -57.16 9.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.125 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -64.97 -38.74 91.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.871 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.24 99.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.214 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.5 mtt -61.34 -37.89 84.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.43 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -55.81 16.12 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -62.15 -38.46 89.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.503 0.192 . . . . 0.0 111.257 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.46 -42.62 93.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.822 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 82' ' ' LEU . 99.2 p -62.58 -30.74 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.27 -43.27 92.52 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.48 -43.87 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.873 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.446 HG13 HG11 ' A' ' 129' ' ' VAL . 77.8 t -61.04 -40.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.287 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.72 -33.23 75.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 29.0 mtpt -62.17 -44.04 97.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.44 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 80.1 mt-10 -70.89 -45.75 63.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.734 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.41 -27.81 60.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.792 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.7 67.96 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.663 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.414 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 149.55 -161.29 28.76 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.94 108.51 20.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.641 0.734 . . . . 0.0 109.904 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . 11.8 t -133.53 167.6 20.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.209 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' THR . 77.6 mm-40 -43.98 -35.57 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.321 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.95 -41.99 97.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.613 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.7 69.52 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.678 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 78.9 mmm -61.21 -34.78 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.534 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.56 -48.36 95.75 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -73.35 -62.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.272 1.315 . . . . 0.0 113.387 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 64' ' ' SER . 8.3 mp -61.82 -41.32 97.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.034 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.55 97.92 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.28 -40.32 90.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.666 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -59.82 -44.54 93.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.769 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.7 m -65.69 -42.41 91.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.98 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.84 -55.91 6.21 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -57.87 -41.27 82.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.412 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.22 -38.87 84.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.113 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.29 84.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.107 0.48 . . . . 0.0 111.414 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.65 -41.8 82.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.039 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -36.0 82.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.758 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.572 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m95 -53.06 -30.84 38.27 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.38 62.9 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.198 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.55 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 40.0 t-105 -64.03 -56.75 22.05 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.572 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 46.1 Cg_endo -54.83 131.83 48.37 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.742 1.628 . . . . 0.0 113.035 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.418 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 42.5 Cg_endo -107.56 -26.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.435 1.423 . . . . 0.0 110.556 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 110' ' ' ALA . 27.1 pt -60.69 -25.59 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.069 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 35.3 p90 -51.69 -42.74 62.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.29 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.499 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.8 t80 -64.53 -49.55 70.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.874 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -113.49 -68.65 0.51 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.369 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 75.53 -3.66 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -54.74 -34.07 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -86.4 155.88 20.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 111.194 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.704 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.8 ttm -57.39 -14.26 4.52 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.811 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -44.69 2.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.155 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.704 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -47.42 -21.84 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.472 0.636 . . . . 0.0 111.374 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 155' ' ' TRP . . . -55.14 -27.86 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.61 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.23 -33.18 73.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.009 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.86 -36.73 79.89 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.543 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 56.1 t0 -61.75 -45.02 95.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.347 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.53 -47.77 71.84 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.715 -0.394 . . . . 0.0 112.005 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.796 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.0 tt -67.0 -41.18 87.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.381 0.61 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.696 ' CD2' HG21 ' A' ' 147' ' ' THR . 17.0 tp -53.22 -60.88 2.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.404 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.505 ' HA ' HD13 ' A' ' 144' ' ' LEU . 65.3 t -70.82 -63.21 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.452 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.0 t -65.39 -38.8 91.08 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.61 -56.55 22.46 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.714 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.1 -38.26 77.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.972 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.88 -47.47 25.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 32.0 m -58.98 -43.39 91.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.02 -50.99 43.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.558 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.403 HG23 ' CD2' ' A' ' 126' ' ' TRP . 34.2 m -65.08 -40.99 95.41 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 71.1 m -60.56 -46.55 89.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 124' ' ' LEU . 83.2 mt -66.25 -35.99 81.84 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.67 -64.14 1.23 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.403 ' CD2' HG23 ' A' ' 122' ' ' THR . 38.6 m0 -66.4 -41.17 89.72 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 33.5 t-80 -58.49 -49.03 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.922 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -65.61 -46.07 80.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.486 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 99.0 t -78.27 -46.5 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.414 ' OG ' HG22 ' A' ' 67' ' ' VAL . 20.1 p -129.4 82.42 67.84 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.591 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.474 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 36.5 Cg_exo -53.14 -43.34 57.95 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.795 1.663 . . . . 0.0 112.257 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 23.7 Cg_exo -58.02 -32.47 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.474 0.783 . . . . 0.0 112.208 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.46 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.522 . . . . 0.0 110.379 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.72 77.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.098 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.501 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 42.7 mtm105 -62.95 -38.59 91.69 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.296 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.15 -38.53 62.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.16 0.505 . . . . 0.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 140' ' ' TYR . 83.7 mt -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -2.81 -67.33 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.794 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.475 ' N ' ' O ' ' A' ' 137' ' ' LEU . 10.9 Cg_endo -54.31 -30.06 60.66 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 120.799 0.999 . . . . 0.0 112.992 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -56.77 -40.69 76.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.733 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.2 tm? -63.61 -42.85 98.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.84 75.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.269 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.639 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -61.7 -50.34 72.83 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.483 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 115' ' ' VAL . 41.1 mt -63.84 -33.73 76.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.839 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.58 96.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.201 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.709 ' CE2' HD22 ' A' ' 150' ' ' LEU . 21.3 t80 -61.47 -41.65 97.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.345 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.696 HG21 ' CD2' ' A' ' 114' ' ' LEU . 53.8 p -60.81 -38.64 86.08 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.1 m -59.49 -50.59 73.34 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.948 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 91.8 t -71.32 -43.88 73.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.864 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.709 HD22 ' CE2' ' A' ' 146' ' ' PHE . 62.2 tp -57.97 -41.59 83.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.184 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 147' ' ' THR . 47.3 m-80 -63.04 -40.14 96.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.492 ' O ' ' CB ' ' A' ' 156' ' ' ARG . 37.1 m-85 -62.19 -39.57 93.15 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.697 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.441 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 47.4 t80 -59.9 -46.59 88.84 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.175 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -71.4 -51.32 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.9 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.595 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.771 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 152' ' ' TYR . 28.4 ttp180 -59.57 -38.32 80.81 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.162 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 92.6 m-20 -59.37 -42.46 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.905 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -87.44 -54.64 4.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.345 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 79.7 p -61.46 -24.69 66.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.913 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -52.94 -30.95 38.5 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -57.28 -31.9 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 110.43 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -117.57 146.88 43.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.343 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.02 14.26 67.39 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -52.97 -35.18 47.74 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.3 p -61.64 -26.63 68.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 110.304 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -56.14 -32.79 64.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.274 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.501 ' H ' HD22 ' A' ' 167' ' ' LEU . 1.0 OUTLIER -88.22 146.75 25.19 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.311 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -102.32 150.19 23.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.638 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 168' ' ' ALA . 95.3 mt-10 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.936 -1.03 . . . . 0.0 111.498 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.523 ' C23' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.628 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.731 0.3 . . . . 0.0 110.504 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -56.54 -22.91 45.34 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.036 1.824 . . . . 0.0 112.192 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.1 -35.12 74.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.0 m -63.12 -39.8 95.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.953 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.639 ' CD1' ' CE3' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -71.66 -35.12 70.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.74 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -42.27 -42.18 6.04 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.29 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.447 ' O ' HD13 ' A' ' 11' ' ' LEU . 75.5 Cg_exo -53.58 -22.66 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 120.656 0.904 . . . . 0.0 111.8 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.34 -33.92 55.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.36 -42.22 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -64.83 -35.25 91.68 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.8 mp -56.46 -41.62 76.82 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 122.728 -0.277 . . . . 0.0 110.962 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 t -79.71 -34.89 39.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.511 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.08 -36.22 79.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.1 t -48.0 -56.41 13.82 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HB3' HD21 ' A' ' 89' ' ' LEU . 20.6 Cg_endo -59.22 -34.16 98.18 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.719 0.946 . . . . 0.0 112.933 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.4 m -59.04 -40.47 85.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.271 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.09 -37.89 88.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.001 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.29 -40.22 98.3 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.89 -44.22 98.36 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.881 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.4 m-85 -63.88 -43.38 96.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.3 mtt -61.83 -40.91 96.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.81 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.44 -45.82 10.72 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB1' ' NH2' ' A' ' 46' ' ' ARG . . . -69.15 -25.15 64.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.33 0.586 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -52.95 -36.55 60.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.358 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 89.7 t80 -60.24 -47.12 87.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.61 -32.81 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' CA ' ' HE ' ' A' ' 46' ' ' ARG . 20.5 ttt-85 -62.42 -42.77 99.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.029 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.94 -132.07 1.18 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.687 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.0 -26.05 59.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.796 0.331 . . . . 0.0 110.69 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.49 8.94 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.25 -41.64 62.97 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.67 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -62.87 -42.17 99.66 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.365 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -61.27 -39.89 92.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.592 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 29.3 m-85 -64.55 -22.82 67.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.021 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.7 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.338 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.86 82.25 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 72.8 mt -91.54 150.02 21.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.408 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.72 126.91 41.32 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.222 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -102.47 141.69 23.03 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 69.3 Cg_endo -57.99 144.15 94.96 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.112 1.208 . . . . 0.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.7 p -64.08 -30.24 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.039 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 35.6 p90 -78.66 3.76 15.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.927 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 32.8 t-80 -60.1 139.52 91.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.598 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 79.7 Cg_endo -95.67 169.3 1.32 Allowed 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.035 1.157 . . . . 0.0 112.759 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.36 148.46 41.9 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.876 2.384 . . . . 0.0 112.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' NH2' ' HB1' ' A' ' 23' ' ' ALA . 22.7 tpt85 -57.21 -39.39 75.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -79.89 -5.94 56.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.4 m -76.79 -76.4 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.9 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.004 ' O ' HG23 ' A' ' 52' ' ' ILE . 69.9 mt -66.38 -32.29 73.58 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.889 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.52 -42.73 5.11 Favored Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.374 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 61.7 Cg_exo -64.31 -6.94 12.68 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.083 2.522 . . . . 0.0 113.789 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.004 HG23 ' O ' ' A' ' 49' ' ' LEU . 18.4 pt -42.32 -44.03 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.731 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.3 m95 -54.8 -31.99 59.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.606 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.68 -39.89 98.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -68.77 -51.79 37.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.092 0.472 . . . . 0.0 111.036 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.1 mp -66.81 -32.63 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.87 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 8.8 t80 -51.79 -49.39 62.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.734 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.0 p -70.88 -36.04 72.6 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.456 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.76 89.07 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.06 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.5 mtt -62.25 -38.77 90.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.427 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.52 -56.68 10.78 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.92 -38.41 88.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.93 92.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 94.1 p -63.5 -28.89 70.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -58.88 -43.81 91.0 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.22 -46.43 88.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.411 HG22 ' OG ' ' A' ' 130' ' ' SER . 78.1 t -60.26 -41.05 85.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.522 0.677 . . . . 0.0 109.198 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.639 ' CE3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -63.35 -34.19 77.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.206 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -63.23 -43.18 98.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 82.7 mt-10 -67.49 -37.06 82.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.25 -4.39 58.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.18 46.67 15.18 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.721 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.463 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.39 -159.53 23.34 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.677 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -85.18 111.62 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.719 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.473 HG23 ' H ' ' A' ' 77' ' ' ASP . 3.6 t -130.27 161.21 31.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -47.07 -39.75 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.482 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.473 ' H ' HG23 ' A' ' 75' ' ' THR . 86.2 m-20 -63.33 -39.62 95.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.719 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.8 71.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.212 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 87.4 mmm -58.72 -34.54 71.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.112 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.15 -59.23 13.97 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.22 -53.84 1.33 Allowed 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 120.828 1.019 . . . . 0.0 112.767 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.2 mp -64.0 -43.01 96.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.448 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.55 -41.99 97.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.84 -39.33 77.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.921 0.391 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 73.2 t80 -60.42 -44.17 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.561 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.0 m -64.85 -43.1 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 112.072 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.23 -58.25 4.39 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.76 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -57.8 -40.91 81.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.681 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 15' ' ' PRO . 25.4 tp -62.77 -41.21 99.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.633 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 111.416 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.36 -37.76 78.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.734 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 45.3 t-20 -61.73 -42.46 98.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.169 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -57.57 -31.42 66.13 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.775 0.322 . . . . 0.0 111.193 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.1 -28.81 69.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.666 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -55.05 -55.45 38.89 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.406 ' CD ' HD13 ' A' ' 113' ' ' LEU . 73.4 Cg_exo -38.49 81.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.814 1.676 . . . . 0.0 113.18 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' A' ' 95' ' ' TRP . 65.1 Cg_endo -63.71 -23.69 69.44 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 120.498 0.799 . . . . 0.0 111.704 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 38.1 pt -62.21 -30.0 47.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.65 -48.26 66.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.779 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.489 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 68.5 t80 -64.95 -46.78 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.633 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -109.38 -65.04 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 59.79 -1.32 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 110.838 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 101' ' ' GLY . 24.0 ttp-105 -52.59 -33.55 46.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -91.52 151.77 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.263 0.554 . . . . 0.0 111.688 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.648 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.0 ttp -62.93 -14.63 49.34 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.193 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.75 32.65 0.01 OUTLIER Glycine 0 CA--C 1.543 1.824 0 C-N-CA 121.821 -0.228 . . . . 0.0 113.018 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -63.58 -19.61 64.97 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -179.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.681 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.97 -21.89 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.859 0.361 . . . . 0.0 111.924 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 107' ' ' TRP . 75.3 mt -58.73 -34.79 71.76 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.9 t0 -63.84 -48.06 78.28 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.5 tp -61.54 -49.39 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.399 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.6 tt -67.16 -41.27 86.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.289 0.566 . . . . 0.0 110.11 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.629 ' CD2' HG21 ' A' ' 147' ' ' THR . 13.3 tp -51.42 -59.89 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.678 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.529 ' HA ' HD13 ' A' ' 144' ' ' LEU . 59.8 t -71.13 -63.07 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.588 -1.187 . . . . 0.0 113.2 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.486 ' O ' ' OG1' ' A' ' 120' ' ' THR . 43.7 t -66.93 -39.29 87.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.22 -56.12 23.88 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.355 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 114' ' ' LEU . 4.1 p -65.25 -37.3 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.317 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.03 -52.81 8.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.9 m -54.58 -42.58 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -60.37 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.913 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.608 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 21.6 m -66.02 -41.19 91.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.765 HG23 ' CD2' ' A' ' 127' ' ' HIS . 47.6 m -58.27 -47.22 84.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.165 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.1 -34.17 77.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.11 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.608 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 39.0 m0 -65.06 -45.3 85.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.765 ' CD2' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -59.84 -43.89 94.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.148 -177.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.56 -43.45 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.221 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.492 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 84.7 t -81.02 -50.83 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 67' ' ' VAL . 76.1 p -128.58 88.88 51.0 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.046 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.5 Cg_exo -52.06 -40.14 68.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 121.651 1.567 . . . . 0.0 113.019 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.7 Cg_exo -57.42 -27.0 74.03 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.532 0.821 . . . . 0.0 112.905 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.77 74.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.639 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.62 -38.83 86.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.202 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 59.8 ttt180 -60.39 -38.76 84.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.14 -39.13 74.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.176 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.0 mt -56.79 -33.14 66.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.852 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.522 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER 9.91 -72.62 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -53.4 -26.43 35.48 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 120.617 0.878 . . . . 0.0 113.675 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -57.5 -41.33 80.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.357 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.678 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -64.96 -41.15 95.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.09 0.472 . . . . 0.0 109.943 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.74 -42.4 95.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.647 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -67.2 -53.11 33.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.398 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 115' ' ' VAL . 43.7 mt -61.39 -33.41 73.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.674 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.36 96.96 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.555 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 21.5 t80 -60.55 -41.11 93.87 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.633 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 69.4 p -61.82 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.452 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.438 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 59.3 m -61.21 -53.06 61.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.445 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.4 -42.84 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 54.9 tp -57.39 -41.92 81.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.03 -41.8 97.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 148' ' ' THR . 50.1 m-85 -64.85 -36.75 85.36 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.659 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 62.2 t80 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.426 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.43 -49.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.135 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.681 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.0 m0 -61.72 -43.91 97.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.555 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 160' ' ' GLY . 82.2 mmt-85 -62.87 -34.77 78.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.381 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 91.0 m-20 -56.56 -41.27 76.58 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.795 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -94.22 -48.13 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.443 . . . . 0.0 110.573 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 80.6 p -69.12 -22.69 63.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.788 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -80.6 177.43 54.36 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.791 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -69.52 146.1 52.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.891 0.377 . . . . 0.0 110.833 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -59.36 -32.83 70.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.57 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -54.71 -32.91 54.81 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.454 ' O ' HD22 ' A' ' 167' ' ' LEU . . . -54.25 -32.84 51.61 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.4 p -60.99 -25.85 67.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.732 0.301 . . . . 0.0 110.724 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -53.68 -37.58 63.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.563 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -63.84 -33.62 76.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.928 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.47 162.43 28.83 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.415 0.626 . . . . 0.0 111.136 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 C--N 1.322 -0.621 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.609 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.428 ' C10' ' CH2' ' A' ' 143' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.818 0.342 . . . . 0.0 110.543 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.37 -18.99 20.61 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.578 2.185 . . . . 0.0 112.136 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.25 -31.63 67.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.83 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -60.68 -43.22 97.95 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.744 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -75.67 -32.76 60.29 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.72 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t -41.34 -49.51 8.94 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.19 -19.83 35.75 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 119.368 0.81 . . . . 0.0 112.514 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.35 -34.73 61.7 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' THR . 70.1 t -59.85 -39.97 81.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -36.47 92.74 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.7 -41.99 87.55 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 122.824 -0.221 . . . . 0.0 111.565 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 9' ' ' VAL . 3.8 t -75.41 -37.33 60.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.189 -0.604 . . . . 0.0 112.072 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.56 -36.71 81.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 t -51.6 -43.07 86.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.48 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -58.39 -36.45 97.55 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.15 1.233 . . . . 0.0 112.902 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -63.46 -37.52 87.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.602 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.68 -40.03 80.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.455 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.99 76.34 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.7 -40.85 97.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.59 -48.65 80.85 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.171 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 65.0 mtt -63.93 -39.47 94.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.409 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.84 -45.47 74.25 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.799 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.31 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 111.64 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -57.61 -30.94 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 90.6 t80 -61.0 -48.6 81.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.73 -32.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.747 0.785 . . . . 0.0 109.631 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -63.06 -41.18 99.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.575 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.86 -128.58 4.78 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.025 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CG ' HH21 ' A' ' 32' ' ' ARG . 84.2 tt0 -49.97 -30.51 10.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.253 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.97 -33.12 20.48 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.8 mt -50.59 -44.63 56.97 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.543 HH21 ' CG ' ' A' ' 29' ' ' GLU . 67.9 mtm180 -62.18 -43.45 98.8 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.0 110.071 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.06 -39.74 91.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.954 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' LEU . 17.8 m-85 -65.27 -23.14 66.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.2 -41.11 49.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.155 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.18 -32.62 84.53 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' TYR . 67.5 mt -92.51 150.63 20.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -101.54 127.83 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.917 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.792 ' HZ2' ' HE ' ' A' ' 46' ' ' ARG . 14.0 mtpt -107.42 140.69 21.75 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 37.1 Cg_endo -58.03 130.23 37.12 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 120.713 0.942 . . . . 0.0 111.431 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.6 p -75.64 -13.44 60.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.884 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.508 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 2.7 p90 -77.29 -15.49 59.41 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.488 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -76.04 147.35 80.14 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.49 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HG2' HD21 ' A' ' 49' ' ' LEU . 1.3 Cg_endo -72.83 162.05 42.15 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.803 1.002 . . . . 0.0 111.297 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.9 Cg_endo -50.73 150.6 12.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.217 1.945 . . . . 0.0 111.848 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.792 ' HE ' ' HZ2' ' A' ' 39' ' ' LYS . 51.7 mtt85 -57.11 -36.85 71.13 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.447 ' C ' ' CD1' ' A' ' 47' ' ' TRP . 5.1 p90 -65.02 -22.09 66.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.864 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.7 m -78.45 -63.07 1.49 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.431 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.007 ' O ' HG23 ' A' ' 52' ' ' ILE . 85.8 mt -63.24 -36.98 85.46 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -45.49 -41.38 16.72 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.742 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 75.3 Cg_exo -64.92 -7.56 15.48 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 123.376 2.718 . . . . 0.0 114.081 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.007 HG23 ' O ' ' A' ' 49' ' ' LEU . 27.9 pt -41.99 -41.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.291 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' TYR . 97.2 m95 -51.2 -34.09 30.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.946 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.19 -39.99 96.66 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.0 m -68.68 -51.44 41.83 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.99 0.424 . . . . 0.0 110.936 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -65.98 -32.42 73.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 53' ' ' TRP . 3.5 t80 -52.28 -48.97 65.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.463 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -68.37 -36.92 79.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.23 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.91 76.54 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.672 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.503 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 62.9 mtt -61.84 -37.23 83.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.93 -61.75 5.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 39.4 t80 -61.61 -36.05 79.62 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.753 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.61 -42.91 58.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.1 p -66.65 -27.29 67.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 49.9 t80 -55.5 -49.86 71.45 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.445 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.7 mt -66.25 -37.33 79.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.668 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.7 t -53.88 -48.03 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.448 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.6 p90 -73.23 -30.74 63.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.235 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 65.6 mmtt -58.36 -38.56 77.48 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.204 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.26 -40.91 94.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.27 -25.77 60.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.772 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 104.77 39.12 2.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.15 -166.55 28.52 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.662 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.13 112.05 19.47 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.16 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.2 t -129.94 165.77 21.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.589 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.85 -37.87 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.471 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 75' ' ' THR . 85.3 m-20 -64.28 -38.92 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.868 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.29 73.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.662 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 81.6 mmm -59.74 -33.74 72.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.974 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.4 -57.6 23.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.66 -50.85 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 120.61 0.874 . . . . 0.0 112.335 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.0 mp -65.06 -41.16 95.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.109 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.66 -39.23 97.65 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.94 -38.38 78.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.112 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' OH ' ' SD ' ' A' ' 60' ' ' MET . 86.8 t80 -59.36 -45.17 92.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.144 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.7 m -69.15 -41.89 76.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.45 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.19 -54.41 6.96 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.548 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -57.98 -41.41 82.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.299 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.54 -37.29 85.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.835 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.79 81.72 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.711 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.36 -36.53 84.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -57.85 -40.96 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -66.01 -32.68 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.76 78.17 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.594 ' CD1' HD11 ' A' ' 113' ' ' LEU . 3.8 t-105 -57.84 -50.68 86.73 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 47.9 Cg_exo -42.79 82.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.403 1.402 . . . . 0.0 112.549 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 95' ' ' TRP . 72.3 Cg_endo -62.35 -25.45 76.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 120.574 0.849 . . . . 0.0 111.601 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.801 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.0 pt -59.91 -33.73 53.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -46.61 64.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.89 -50.48 66.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.826 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.33 -53.1 0.47 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.801 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 57.14 3.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 0.0 110.797 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 101' ' ' GLY . 12.6 tpt180 -53.12 -34.96 59.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -92.0 145.33 24.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.329 0.585 . . . . 0.0 111.503 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.637 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.3 ttp -65.31 -14.36 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.343 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.03 38.56 0.01 OUTLIER Glycine 0 CA--C 1.54 1.628 0 O-C-N 123.077 0.236 . . . . 0.0 112.952 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.694 ' HA ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.16 -18.94 65.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.672 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -41.5 -21.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.756 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 107' ' ' TRP . 89.2 mt -57.2 -39.47 75.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.503 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -67.81 -39.04 84.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 109.942 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 49.6 t0 -60.92 -45.18 95.67 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.71 -48.99 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.46 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.594 HD11 ' CD1' ' A' ' 95' ' ' TRP . 85.0 mt -69.08 -40.34 78.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.417 0.627 . . . . 0.0 110.459 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.793 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.1 tp -51.75 -60.25 3.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.154 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.514 ' HA ' HD13 ' A' ' 144' ' ' LEU . 97.5 t -69.11 -63.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.754 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -71.63 -40.32 69.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -61.36 -51.29 58.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.534 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 114' ' ' LEU . 3.7 p -65.83 -37.04 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.174 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.78 -51.43 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.8 m -59.49 -45.28 92.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.28 68.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.37 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.476 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.3 m -64.33 -39.07 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.156 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 89.9 m -59.62 -52.96 63.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 0.0 112.296 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.597 ' O ' ' NE ' ' A' ' 128' ' ' ARG . 65.9 mt -59.34 -31.2 68.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.991 0.425 . . . . 0.0 110.362 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.87 -63.17 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.493 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 33.8 m0 -86.5 -52.21 5.71 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.603 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 0.5 OUTLIER -52.63 -47.15 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.597 ' NE ' ' O ' ' A' ' 124' ' ' LEU . 68.2 mtm180 -63.5 -40.83 98.1 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.3 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.36 -43.41 49.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.8 p -140.33 94.87 8.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.875 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.457 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.3 Cg_exo -54.08 -39.94 83.59 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.948 1.765 . . . . 0.0 113.775 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.5 Cg_exo -55.7 -26.21 54.98 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.338 0.692 . . . . 0.0 112.87 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.54 -31.24 71.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.668 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.603 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -61.38 -40.15 93.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.441 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.537 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 51.9 ttp180 -59.77 -38.16 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.3 tp -58.7 -38.83 79.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.203 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 139' ' ' PRO . 22.0 mt -56.04 -29.62 60.7 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.065 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.9 OUTLIER 9.28 -74.41 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.6 Cg_endo -52.32 -29.12 37.37 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 120.436 0.758 . . . . 0.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -57.92 -42.34 84.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.987 0.423 . . . . 0.0 109.977 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 42.7 tp -63.34 -39.56 94.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.63 96.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.006 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.663 ' CD1' HD12 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -67.09 -47.93 69.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.234 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 115' ' ' VAL . 44.5 mt -65.25 -33.74 76.71 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.801 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.89 77.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.795 ' CE2' HD22 ' A' ' 150' ' ' LEU . 16.0 t80 -63.32 -42.02 98.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.646 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.793 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.0 m -57.6 -43.74 84.89 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.516 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.7 m -60.18 -49.61 76.94 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.705 0.288 . . . . 0.0 111.604 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.44 -40.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.54 0.686 . . . . 0.0 109.757 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.795 HD22 ' CE2' ' A' ' 146' ' ' PHE . 63.8 tp -57.79 -42.98 85.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.729 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 147' ' ' THR . 17.1 m120 -63.48 -41.24 98.58 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.475 ' CD1' ' NH1' ' A' ' 161' ' ' ARG . 57.5 m-85 -66.04 -40.32 90.9 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -61.52 -40.9 96.32 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.811 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.6 -47.66 79.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 5.3 m0 -62.15 -39.23 91.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -54.81 -31.1 58.75 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.215 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.49 -40.86 68.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.651 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -103.8 -60.91 1.5 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.675 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 155' ' ' TRP . 49.2 m -120.78 143.46 48.82 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.875 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.04 -174.31 50.29 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.475 ' NH1' ' CD1' ' A' ' 152' ' ' TYR . 95.4 mtt-85 -59.99 148.28 35.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 111.035 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -57.61 -33.85 68.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.571 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -54.95 -33.49 56.96 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.451 ' O ' HD22 ' A' ' 167' ' ' LEU . . . 77.65 28.94 56.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.7 p -60.5 -28.21 68.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.699 0.285 . . . . 0.0 110.671 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -54.92 -37.48 66.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.005 0.431 . . . . 0.0 110.64 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -61.19 -34.19 74.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.554 179.536 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 -49.17 74.55 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.155 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 . . . . . 0 N--CA 1.445 -0.72 0 CA-C-O 117.93 -1.034 . . . . 0.0 111.065 178.973 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.589 ' C22' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 120.56 0.219 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -56.82 -16.94 21.57 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.653 1.569 . . . . 0.0 111.863 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' CD ' ' A' ' 7' ' ' PRO . 84.8 tt0 -51.23 -27.67 9.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.018 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 m -58.59 -39.47 80.45 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' HE1' ' N ' ' A' ' 74' ' ' PHE . 5.0 m-90 -74.54 -36.98 63.14 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -42.45 -41.97 6.14 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.486 ' O ' HD13 ' A' ' 11' ' ' LEU . 76.6 Cg_exo -54.87 -21.35 25.77 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.445 1.43 . . . . 0.0 112.617 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.09 -40.94 59.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.797 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 12' ' ' THR . 93.9 t -63.37 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.74 -34.44 89.91 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.277 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.1 mp -56.55 -42.63 78.85 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.871 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 9' ' ' VAL . 4.0 t -76.03 -36.55 59.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.822 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.98 -38.17 90.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -53.87 -42.23 91.85 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -56.47 -36.36 97.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 120.953 1.102 . . . . 0.0 112.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -61.25 -37.88 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 mt -62.35 -39.11 92.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.252 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.82 -52.58 28.22 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.76 -38.27 95.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -57.33 -44.78 84.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.279 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.08 -38.92 90.66 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.375 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.72 -46.27 76.93 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.476 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.99 -24.08 62.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 110.826 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -34.92 70.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 54.3 t80 -60.71 -49.05 79.06 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.62 -33.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.156 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -61.01 -40.79 94.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.817 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.06 -125.83 2.67 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.032 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.87 -28.8 62.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 111.209 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.4 -33.97 12.58 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 94.1 mt -48.78 -44.33 38.82 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.663 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.09 -42.45 99.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.976 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -62.31 -38.14 88.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.843 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.607 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.1 m-85 -63.78 -22.75 67.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.224 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.19 -41.41 27.06 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.973 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.99 -32.25 76.73 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.8 mt -88.93 149.51 23.28 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.451 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.0 mt-30 -101.96 130.17 48.41 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.079 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HZ1' ' HE ' ' A' ' 46' ' ' ARG . 16.1 mtpt -108.99 141.5 23.51 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 27.6 Cg_endo -58.98 135.93 69.95 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.387 1.391 . . . . 0.0 111.944 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.9 p -71.94 -21.29 61.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.312 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.525 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 4.5 p90 -77.95 -14.8 59.41 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.66 148.49 92.74 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.948 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -80.14 162.34 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.202 1.935 . . . . 0.0 111.424 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.2 Cg_endo -52.47 149.49 23.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.768 1.645 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HE ' ' HZ1' ' A' ' 39' ' ' LYS . 39.2 mtt85 -57.19 -37.96 72.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 48' ' ' THR . 5.0 p90 -63.98 -28.21 69.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.941 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 25.0 m -66.12 -61.21 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.993 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.2 mt -72.22 -34.78 68.61 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -38.33 -49.35 3.44 Favored Pre-proline 0 C--N 1.321 -0.634 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.938 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.4 Cg_endo -73.19 4.67 3.61 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 122.113 1.875 . . . . 0.0 114.134 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.993 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.5 pt -42.07 -40.17 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.637 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.6 m95 -50.7 -32.32 19.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.333 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.1 -40.69 95.95 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 m -67.98 -50.97 52.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 111.352 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -67.61 -33.12 74.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.238 0.542 . . . . 0.0 109.897 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.3 t80 -52.67 -49.43 65.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.2 p -70.41 -36.55 74.1 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.684 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.403 ' C ' HD11 ' A' ' 136' ' ' LEU . . . -67.33 -40.88 85.96 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.48 -39.37 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.095 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.99 -49.3 76.81 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -64.05 -39.16 93.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -55.82 -42.09 85.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.472 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.9 p -64.27 -29.27 70.37 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.76 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 50.6 t80 -58.78 -40.13 83.05 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.218 0.532 . . . . 0.0 110.169 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.38 -39.55 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.539 0.685 . . . . 0.0 109.865 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.567 HG22 ' OG ' ' A' ' 130' ' ' SER . 61.4 t -65.42 -54.08 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.55 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.46 ' NE1' ' HG2' ' A' ' 69' ' ' LYS . 0.7 OUTLIER -66.37 -35.75 81.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG2' ' NE1' ' A' ' 68' ' ' TRP . 22.0 mmtp -61.4 -39.49 90.92 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.495 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -63.32 -40.07 96.3 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.334 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 71' ' ' LEU . 77.3 mt -74.73 -25.49 59.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.74 49.26 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.449 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.39 -158.64 24.64 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.633 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -92.18 109.13 20.49 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.482 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.548 ' CG2' ' OD1' ' A' ' 77' ' ' ASP . 6.3 t -131.68 167.37 19.58 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -49.91 -38.36 35.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 35.6 p30 -66.45 -32.87 74.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.974 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.664 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -76.61 -30.69 57.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.633 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 88.1 mmm -59.04 -34.9 72.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.23 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -64.08 -58.13 15.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.406 ' CA ' ' HB1' ' A' ' 125' ' ' ALA . 13.3 Cg_endo -59.37 -56.5 1.28 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 121.461 1.441 . . . . 0.0 113.117 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.3 mp -64.14 -43.07 96.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.947 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.85 97.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.868 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -57.33 -39.8 76.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.083 0.468 . . . . 0.0 110.203 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -61.12 -43.98 98.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.042 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.3 m -68.42 -42.93 78.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -61.2 2.97 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -55.6 -41.09 72.93 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.22 -38.82 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.43 69.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.1 -38.54 86.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.918 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.436 ' OD1' HD12 ' A' ' 113' ' ' LEU . 42.8 t-20 -60.65 -42.13 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -58.14 -31.71 67.46 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.619 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.5 70.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.374 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -54.3 -54.3 49.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' CD ' HD13 ' A' ' 113' ' ' LEU . 86.8 Cg_exo -40.37 79.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.678 1.586 . . . . 0.0 113.28 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.601 ' N ' ' O ' ' A' ' 95' ' ' TRP . 57.3 Cg_endo -61.0 -21.3 71.06 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 120.818 1.012 . . . . 0.0 110.525 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.871 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.0 pt -62.41 -23.96 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.175 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -54.49 -46.88 73.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.027 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 69.3 t80 -64.33 -50.2 68.72 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.17 0.42 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.676 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.98 -2.3 0.2 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.567 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.0 ttt180 -53.92 -35.08 61.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.58 157.02 19.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.244 0.545 . . . . 0.0 111.455 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.696 ' O ' ' N ' ' A' ' 107' ' ' TRP . 21.7 ttm -56.26 -14.07 2.58 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.584 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.31 -1.37 0.01 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.368 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.696 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.92 -20.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.081 -0.658 . . . . 0.0 111.08 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.555 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.49 -27.45 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.739 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.98 -33.88 73.92 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.546 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.18 -37.14 84.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.544 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.9 t0 -63.11 -50.43 70.53 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.59 -46.38 86.08 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.498 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.764 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -67.6 -42.16 82.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.359 0.599 . . . . 0.0 110.35 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.684 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.6 tp -50.02 -59.51 3.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.489 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 144' ' ' LEU . 60.3 t -70.69 -63.19 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.04 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.411 ' O ' ' OG1' ' A' ' 120' ' ' THR . 42.3 t -66.1 -38.97 89.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.4 -55.87 26.63 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.963 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -65.21 -39.07 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.741 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.72 -45.18 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 116' ' ' SER . 62.3 m -60.56 -42.27 96.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.7 -53.82 16.76 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.155 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.457 HG23 ' CE3' ' A' ' 126' ' ' TRP . 49.0 m -64.36 -41.18 96.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 65.5 m -59.2 -45.68 90.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.7 -37.22 85.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB1' ' CA ' ' A' ' 81' ' ' PRO . . . -83.01 -64.22 1.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.457 ' CE3' HG23 ' A' ' 122' ' ' THR . 41.1 m0 -66.54 -42.16 87.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 50.6 t-80 -58.33 -48.08 81.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.698 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -62.43 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.33 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -72.57 -43.57 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 0.0 111.448 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 67' ' ' VAL . 1.3 p -145.84 106.23 4.25 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.666 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.493 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.0 Cg_exo -56.58 -38.2 95.98 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.371 1.38 . . . . 0.0 112.985 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.8 Cg_exo -55.16 -27.46 56.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 120.484 0.789 . . . . 0.0 112.446 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' LEU . . . -60.84 -24.48 65.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.516 0.674 . . . . 0.0 109.296 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.49 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -64.67 -43.64 92.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.37 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.439 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.6 mtt85 -66.28 -37.44 85.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.548 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.834 ' C ' HD13 ' A' ' 136' ' ' LEU . 1.1 tm? -49.23 -43.16 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.401 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.503 ' O ' ' C ' ' A' ' 138' ' ' TYR . 60.2 mt -60.84 -29.02 69.25 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.503 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 2.82 -76.2 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -53.08 -25.57 29.42 Favored 'Trans proline' 0 N--CA 1.509 2.423 0 CA-C-N 119.384 0.816 . . . . 0.0 113.278 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -56.61 -38.41 72.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -178.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 34.0 tp -65.17 -40.36 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.79 94.09 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.647 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -65.3 -50.81 64.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.114 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.519 HD13 ' HA ' ' A' ' 115' ' ' VAL . 43.8 mt -64.51 -34.1 77.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.079 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.723 ' CE2' HD22 ' A' ' 150' ' ' LEU . 21.4 t80 -62.72 -42.2 99.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.624 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.684 HG21 ' CD2' ' A' ' 114' ' ' LEU . 53.2 p -60.28 -38.0 82.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.5 m -59.6 -50.99 71.75 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.1 t -69.94 -44.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.215 0.531 . . . . 0.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.723 HD22 ' CE2' ' A' ' 146' ' ' PHE . 62.2 tp -58.09 -40.68 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 147' ' ' THR . 43.2 m-80 -63.96 -40.03 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -61.94 -44.29 97.08 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.325 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -64.22 -40.04 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.076 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.82 -48.99 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.516 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -62.59 -40.23 96.26 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.65 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 159' ' ' SER . 39.1 mtm180 -60.03 -23.58 63.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.291 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 88.1 m-20 -53.63 -42.38 67.71 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.142 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -102.41 -41.4 6.33 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 156' ' ' ARG . 50.4 p -84.59 172.63 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.112 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.02 2.87 62.22 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -55.69 -32.98 63.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.366 . . . . 0.0 110.358 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -55.01 -33.38 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.187 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.43 -31.81 44.05 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' O ' HD22 ' A' ' 167' ' ' LEU . . . -54.11 -28.97 43.25 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.2 p -58.94 -25.29 63.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.754 0.311 . . . . 0.0 110.407 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -54.02 -38.35 65.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -64.07 -33.43 75.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.994 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' O ' ' OXT' ' A' ' 169' ' ' GLU . . . -74.33 157.91 34.92 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.194 0.521 . . . . 0.0 110.635 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' OXT' ' O ' ' A' ' 168' ' ' ALA . 95.4 mt-10 . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.606 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.588 ' C23' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 mtp . . . . . 0 C--O 1.233 0.188 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -55.61 -16.88 15.74 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.982 1.788 . . . . 0.0 111.915 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.22 -34.21 31.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.61 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -61.89 -40.41 95.33 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.609 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.588 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 14.5 m0 -73.64 -31.14 63.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.739 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.41 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t -40.64 -52.52 6.27 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.543 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -58.05 -28.06 81.96 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 CA-C-N 119.01 0.682 . . . . 0.0 111.052 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 5' ' ' TRP . . . -56.44 -30.92 63.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.11 -42.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.25 -36.26 93.18 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.685 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mp -56.27 -44.21 79.54 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.609 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -79.33 -30.51 42.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.107 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.07 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 t -52.32 -56.6 20.8 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.2 Cg_endo -58.95 -33.36 98.68 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 CA-C-N 119.076 0.706 . . . . 0.0 112.72 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -60.23 -39.41 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.303 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.3 -37.66 88.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.232 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -64.49 -53.37 35.99 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.94 95.23 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.0 -45.9 89.52 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.567 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.3 mtm -62.91 -37.22 86.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.281 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.94 98.77 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.124 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.24 -28.07 64.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.93 -34.22 69.64 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.98 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 86.8 t80 -62.53 -46.75 86.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.216 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -74.09 -33.2 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.83 0.824 . . . . 0.0 109.766 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -59.35 -40.39 86.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.019 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.8 -130.6 4.64 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.808 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -51.55 -28.05 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.071 0.462 . . . . 0.0 110.85 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.99 15.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD21 ' HE ' ' A' ' 46' ' ' ARG . 95.3 mt -51.35 -43.21 61.74 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.848 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.391 0.615 . . . . 0.0 110.618 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -59.79 -40.44 88.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.662 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' NZ ' ' A' ' 39' ' ' LYS . 44.3 m-85 -66.08 -22.64 66.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.745 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.95 -41.65 16.47 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.443 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.74 -32.2 83.36 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.4 mt -93.63 149.16 21.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.286 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.585 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.8 mt-30 -99.21 122.21 42.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.87 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.699 ' NZ ' ' CD1' ' A' ' 34' ' ' TYR . 22.4 mttp -94.5 141.0 22.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HG3' HD12 ' A' ' 150' ' ' LEU . 55.2 Cg_endo -57.25 144.85 89.71 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.557 1.504 . . . . 0.0 113.069 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 m -61.58 -32.42 72.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.918 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 20.2 p90 -76.87 2.08 15.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.583 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.699 ' CE1' ' NH1' ' A' ' 46' ' ' ARG . 8.4 t-80 -62.7 140.16 97.06 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 71.7 Cg_endo -101.14 169.86 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.111 1.207 . . . . 0.0 112.461 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 50.4 Cg_exo -52.3 147.97 26.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.653 2.235 . . . . 0.0 112.209 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.699 ' NH1' ' CE1' ' A' ' 43' ' ' HIS . 80.0 mmt-85 -58.33 -37.58 75.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.402 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 25.7 p90 -81.21 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 49' ' ' LEU . 16.1 m -74.3 -76.18 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.599 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.99 ' O ' HG23 ' A' ' 52' ' ' ILE . 77.6 mt -66.09 -32.73 74.36 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.653 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.0 -43.45 4.57 Favored Pre-proline 0 C--N 1.324 -0.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.63 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 53.8 Cg_exo -63.61 -7.2 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.929 2.419 . . . . 0.0 113.714 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.99 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.5 pt -42.44 -41.46 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.444 ' N ' HG13 ' A' ' 52' ' ' ILE . 97.9 m95 -53.91 -33.79 57.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.442 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.64 94.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -69.38 -52.8 23.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.754 0.311 . . . . 0.0 111.44 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.1 mp -66.48 -33.68 76.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.179 0.514 . . . . 0.0 110.423 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 23.8 t80 -49.37 -59.55 3.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.287 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 m -65.01 -38.05 89.66 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.81 95.38 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.701 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -63.16 -37.73 88.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.687 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.24 -58.66 8.39 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -61.67 -37.44 84.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.491 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.86 -41.45 67.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 85.3 p -66.64 -27.95 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.37 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -55.82 -45.92 78.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.14 -44.19 97.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.75 -37.04 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.739 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.612 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 58.4 mttt -65.2 -41.71 94.27 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.465 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 87.3 mt-10 -70.15 -37.93 75.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . 58.7 mt -92.2 -0.54 57.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.6 5.21 67.07 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 90.52 -167.18 32.24 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -59.3 82.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.212 0.53 . . . . 0.0 111.065 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.0 t -133.12 160.84 36.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.664 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -41.95 -40.48 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.323 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 75' ' ' THR . 87.1 m-20 -66.88 -44.12 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.539 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 73' ' ' GLY . . . -77.67 -33.24 53.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 83' ' ' GLY . 87.8 mtp -57.87 -33.7 68.96 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.156 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.01 -50.17 89.56 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.305 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.7 -52.31 1.05 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 120.495 0.797 . . . . 0.0 111.948 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.4 mp -62.44 -42.48 99.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.319 0.581 . . . . 0.0 109.507 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.86 -38.66 96.91 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -58.38 -38.03 76.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.149 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 88.5 t80 -60.4 -44.45 95.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.1 m -65.88 -41.29 91.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.507 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.86 -54.22 19.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.819 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -59.79 -39.88 86.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.635 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' A' ' 15' ' ' PRO . 22.7 tp -58.79 -37.99 77.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.178 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.42 88.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 0.0 111.199 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -58.66 -39.95 82.1 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.417 ' ND2' ' HG ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -64.48 -35.96 82.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.693 178.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.557 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.7 m95 -56.17 -31.86 63.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.316 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.01 -16.39 62.06 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.6 t-105 -70.32 -52.81 11.29 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 27.4 Cg_endo -55.86 131.11 44.05 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.864 1.709 . . . . 0.0 113.309 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 41.3 Cg_endo -107.97 -28.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 120.841 1.028 . . . . 0.0 111.382 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.754 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 28.8 pt -56.58 -30.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.367 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 15.6 p90 -54.12 -42.29 69.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.526 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.9 t80 -63.53 -51.29 66.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.315 . . . . 0.0 111.532 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -114.11 -54.53 0.42 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.86 -1.0 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 101' ' ' GLY . 25.7 tpt180 -54.36 -33.72 59.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.847 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.77 151.36 27.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.318 0.58 . . . . 0.0 111.958 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.598 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ppp? -65.58 -14.41 61.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.741 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.37 32.74 0.02 OUTLIER Glycine 0 CA--C 1.538 1.496 0 O-C-N 123.131 0.269 . . . . 0.0 112.924 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.598 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.49 -21.26 62.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.596 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -50.1 -23.73 2.29 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.773 0.32 . . . . 0.0 111.813 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.11 -32.14 70.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.379 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.669 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.61 -45.52 93.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.495 . . . . 0.0 109.948 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.565 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 37.3 t0 -63.44 -44.03 95.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.903 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -60.73 -40.05 90.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.148 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.756 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -66.63 -48.25 70.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 113' ' ' LEU . 2.6 pp -75.31 -34.05 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.796 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 111' ' ' ASP . 45.3 t -63.63 -45.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.777 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 t -85.8 -41.45 15.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.56 -47.1 86.66 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.573 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.2 -46.22 45.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.568 0.223 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -71.71 -57.97 3.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 38.1 m -58.04 -43.12 86.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -59.42 2.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.011 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 34.4 m -64.64 -41.59 96.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.796 HG23 ' ND1' ' A' ' 127' ' ' HIS . 55.8 m -59.46 -47.73 84.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.412 HD22 HH21 ' A' ' 128' ' ' ARG . 88.9 mt -66.09 -34.55 78.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.44 -63.7 1.36 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.477 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.2 m0 -66.78 -43.95 82.59 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -177.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.796 ' ND1' HG23 ' A' ' 123' ' ' THR . 22.3 m170 -59.87 -45.32 92.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.931 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.412 HH21 HD22 ' A' ' 124' ' ' LEU . 96.7 mtt-85 -61.96 -44.4 96.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.354 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.497 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 77.1 t -76.85 -47.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.418 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.0 p -134.58 91.26 21.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.073 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.461 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.7 Cg_exo -52.4 -40.53 70.86 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.607 1.538 . . . . 0.0 112.975 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.6 Cg_exo -57.63 -29.18 84.38 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.591 0.861 . . . . 0.0 112.857 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.44 -32.3 71.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.202 0.525 . . . . 0.0 110.5 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.15 -36.55 77.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.64 -39.23 83.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.366 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 tp -57.7 -39.76 77.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.007 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 140' ' ' TYR . 82.7 mt -59.52 -27.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.973 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -6.2 -64.32 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.453 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -54.05 -30.2 58.64 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 CA-C-N 119.523 0.865 . . . . 0.0 112.898 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.45 -47.02 80.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 41.2 tp -60.58 -39.76 89.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.21 96.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.581 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -70.0 -50.22 43.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.893 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 115' ' ' VAL . 24.0 mt -65.38 -34.06 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.523 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.11 -47.54 84.14 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CE2' HD22 ' A' ' 150' ' ' LEU . 32.1 t80 -64.18 -43.69 94.34 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.345 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.568 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.2 m -56.14 -43.99 78.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.951 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 48.9 m -64.79 -48.37 74.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.775 0.322 . . . . 0.0 111.564 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.26 -41.74 86.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.836 HD22 ' CE2' ' A' ' 146' ' ' PHE . 56.6 tp -57.9 -41.15 81.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.974 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.565 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.5 m120 -62.09 -41.35 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -64.14 -42.37 96.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.818 0.674 . . . . 0.0 112.818 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -58.63 -45.21 89.75 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.062 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.97 -46.01 82.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.6 m0 -61.78 -40.03 93.73 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.78 -29.98 65.29 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.229 -0.589 . . . . 0.0 111.471 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 86.9 m-20 -50.71 -39.8 52.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -103.11 -58.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.228 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.0 p -62.66 -27.92 69.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.224 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.83 -30.26 36.0 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -55.51 -34.84 64.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.813 0.339 . . . . 0.0 110.397 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -57.29 -31.79 65.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.668 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.01 -32.41 42.18 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -84.65 -177.44 51.14 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.3 m -118.81 147.77 43.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 110.627 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 168' ' ' ALA . 91.8 mtt180 -124.45 137.37 54.45 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.196 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 166' ' ' ARG . 13.3 mt 33.02 -81.5 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.91 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 166' ' ' ARG . . . -143.09 149.63 38.42 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 110.142 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.645 179.91 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.548 ' C22' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.52 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 1' ' ' MET . 48.2 Cg_endo -55.61 -22.84 37.37 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.366 2.044 . . . . 0.0 111.962 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.22 -33.94 71.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.606 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.2 m -62.82 -40.31 97.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.039 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.66 ' CD1' ' CE3' ' A' ' 68' ' ' TRP . 1.4 t90 -72.59 -33.96 67.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.69 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 t -41.5 -41.54 3.95 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.692 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 11' ' ' LEU . 86.0 Cg_exo -53.91 -21.7 21.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 120.841 1.027 . . . . 0.0 111.921 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.17 -35.96 62.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.933 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.8 t -62.48 -43.32 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.64 -33.37 85.96 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.378 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.8 mp -56.13 -43.2 77.98 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.136 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -37.95 35.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.836 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 57' ' ' TYR . 83.1 mt -62.3 -37.61 86.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -52.67 -43.43 92.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.819 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -57.17 -33.26 95.58 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.167 1.245 . . . . 0.0 113.176 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.6 p -62.19 -35.46 78.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.93 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.078 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -42.1 97.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.1 97.63 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.91 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 55.5 m-85 -61.99 -41.21 97.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.539 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.68 -40.29 96.62 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.765 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.42 -47.87 11.81 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.586 ' HB1' ' NH2' ' A' ' 46' ' ' ARG . . . -69.31 -23.37 63.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.209 0.528 . . . . 0.0 110.441 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -51.62 -38.95 57.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.032 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.558 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 58.1 t80 -62.69 -48.79 77.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -32.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.55 0.69 . . . . 0.0 109.967 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.494 ' CB ' ' HE ' ' A' ' 46' ' ' ARG . 13.9 ttt-85 -62.4 -41.44 98.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.023 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -131.22 2.64 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.132 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -26.99 48.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.618 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.6 -35.49 11.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -49.14 -44.64 42.75 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.962 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -61.0 -39.34 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.938 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -58.68 -37.07 75.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.349 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 37' ' ' LEU . 55.8 m-85 -61.02 -22.8 64.9 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.7 -40.57 6.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.059 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.47 -31.8 71.28 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 34' ' ' TYR . 56.9 mt -92.79 148.16 22.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 110.887 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -96.49 123.79 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.85 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -94.85 139.61 22.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 74.4 Cg_endo -58.84 147.06 90.73 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.501 1.467 . . . . 0.0 112.601 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -64.45 -29.42 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.09 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 39.4 p90 -78.32 2.7 17.66 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.492 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 57.8 t-80 -62.16 142.71 95.59 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 87.1 Cg_endo -107.74 172.55 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.336 1.357 . . . . 0.0 112.282 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 27.6 Cg_exo -54.41 148.14 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.87 2.38 . . . . 0.0 112.335 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.586 ' NH2' ' HB1' ' A' ' 23' ' ' ALA . 28.6 tpt85 -56.61 -39.28 73.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.406 ' CZ2' ' HB3' ' A' ' 45' ' ' PRO . 26.4 p90 -77.15 -9.12 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -75.57 -73.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.573 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.994 ' O ' HG23 ' A' ' 52' ' ' ILE . 92.1 mt -66.94 -32.72 74.16 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.694 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.38 -42.71 4.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.156 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 76.1 Cg_exo -63.79 -6.27 10.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.914 2.409 . . . . 0.0 113.387 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.1 pt -41.24 -44.84 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.084 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.492 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.1 m95 -58.08 -34.0 69.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.089 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.26 -40.35 98.48 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -66.99 -53.26 33.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 0.0 111.325 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.8 mp -67.82 -32.16 72.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.0 t80 -52.34 -50.14 62.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.875 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -69.89 -36.62 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.29 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' HD21 ' A' ' 136' ' ' LEU . . . -67.57 -43.46 80.58 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.046 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.5 mtt -60.63 -38.9 86.31 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.87 -52.64 40.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -61.4 -35.48 77.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.572 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.64 -46.02 59.54 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.435 ' CB ' HD21 ' A' ' 82' ' ' LEU . 97.4 p -63.26 -30.13 71.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.456 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 46.7 t80 -55.01 -40.3 70.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 109.797 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.0 mt -69.51 -44.39 79.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG13 HG11 ' A' ' 129' ' ' VAL . 53.8 t -63.68 -51.89 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.66 ' CE3' ' CD1' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -64.27 -33.07 74.97 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.838 -178.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 67.0 mmtt -60.64 -40.79 93.27 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.783 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -67.68 -34.05 76.14 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.143 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 78' ' ' ALA . 54.6 mt -85.5 -0.54 55.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.092 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.76 44.08 8.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 90.43 -154.43 23.43 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -87.25 110.71 20.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.517 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.1 t -133.95 168.63 18.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.893 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -52.27 -37.96 56.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.385 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' H ' HG23 ' A' ' 75' ' ' THR . 84.8 m-20 -62.22 -40.02 94.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.339 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 71' ' ' LEU . . . -67.49 -28.28 67.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.851 0.358 . . . . 0.0 111.377 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 mtt -58.82 -35.25 72.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.306 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.18 -47.65 98.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.457 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 16.2 Cg_endo -77.75 -63.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 120.735 0.957 . . . . 0.0 112.538 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' A' ' 64' ' ' SER . 20.7 mt -59.49 -41.71 90.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.19 98.78 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.773 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.55 -38.11 74.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 109.916 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -57.92 -43.94 86.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.588 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.98 -60.72 3.76 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.396 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.59 -40.06 74.63 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.56 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.63 -40.39 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.224 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.96 78.52 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.48 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.11 87.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.226 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.546 ' O ' HD11 ' A' ' 113' ' ' LEU . 41.3 t-20 -62.23 -39.91 94.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.568 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.8 m95 -59.46 -28.45 67.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.07 63.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 97' ' ' PRO . 8.7 t-105 -71.12 -55.7 6.14 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.5 Cg_endo -40.96 82.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.034 1.156 . . . . 0.0 112.317 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -59.33 -23.82 71.7 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.739 1.626 . . . . 0.0 112.459 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.645 HD11 ' HB2' ' A' ' 110' ' ' ALA . 35.5 pt -59.62 -30.02 43.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.402 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.3 p90 -44.85 -42.27 7.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.493 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 57.7 t80 -66.62 -52.01 49.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.79 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.27 -68.69 0.48 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.737 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.558 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 65.58 5.07 3.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -54.92 -35.55 64.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 109.913 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -85.74 152.86 22.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.245 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.634 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.4 ttm -61.14 -14.97 28.55 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.975 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.7 21.59 0.01 OUTLIER Glycine 0 CA--C 1.543 1.79 0 C-N-CA 121.724 -0.274 . . . . 0.0 113.239 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.634 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.6 -19.82 41.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.409 0.605 . . . . 0.0 112.248 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.58 -22.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.446 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 107' ' ' TRP . 77.8 mt -59.63 -36.45 76.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.645 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -66.6 -40.25 88.77 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.33 0.586 . . . . 0.0 109.858 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.489 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 48.6 t0 -60.57 -57.15 13.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.664 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.97 -37.9 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.673 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.1 tt -64.46 -49.94 69.45 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 113' ' ' LEU . 3.2 pp -75.58 -35.21 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.065 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.516 ' HA ' HD22 ' A' ' 144' ' ' LEU . 55.7 t -66.6 -59.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 111.595 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -72.47 -40.48 66.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.474 ' HA3' HD22 ' A' ' 92' ' ' ASN . . . -58.54 -54.43 37.84 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.598 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.71 -35.69 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.504 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -75.46 -52.96 9.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.0 m -57.45 -43.04 83.65 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.66 -54.62 13.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.545 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.2 m -66.79 -40.01 87.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 91.2 m -59.36 -47.09 86.76 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 HH21 ' A' ' 128' ' ' ARG . 70.2 mt -72.83 -34.25 66.7 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.457 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -78.68 -64.16 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -64.56 -43.61 93.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.685 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 51.2 m170 -59.38 -44.7 92.72 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.022 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.489 HH21 HD22 ' A' ' 124' ' ' LEU . 98.5 mtt180 -61.58 -43.61 98.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.586 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.54 HG11 HG13 ' A' ' 67' ' ' VAL . 95.6 t -79.95 -46.68 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.557 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 96.0 p -133.58 88.53 33.76 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.48 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 34.7 Cg_exo -53.94 -41.01 78.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.766 1.644 . . . . 0.0 112.858 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 33.4 Cg_exo -56.44 -30.59 82.48 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 120.597 0.864 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.79 68.81 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.261 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.685 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -57.74 -39.25 76.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.421 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.508 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 93.2 mtt180 -63.28 -37.4 87.12 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.001 0.429 . . . . 0.0 110.533 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 59' ' ' ALA . 17.0 tp -54.28 -37.69 65.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 138' ' ' TYR . 85.1 mt -67.56 -3.16 7.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.147 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -26.97 -59.99 0.2 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.89 -23.96 78.18 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.079 1.186 . . . . 0.0 113.802 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -55.47 -41.21 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.179 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 37.2 tp -63.47 -39.51 94.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.17 93.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.669 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.708 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -66.44 -53.97 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.614 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 115' ' ' VAL . 50.1 mt -63.85 -33.51 75.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -41.02 95.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.799 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 28.2 t80 -61.69 -40.27 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.59 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 81.4 p -59.93 -37.94 80.94 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.404 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.6 p -68.33 -47.2 68.14 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.087 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.84 -41.16 79.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.373 0.606 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.799 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 36.9 tp -60.3 -42.95 96.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.489 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.3 m120 -66.51 -36.65 83.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.23 0.538 . . . . 0.0 110.947 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.553 ' CE1' ' NE ' ' A' ' 156' ' ' ARG . 1.4 t80 -56.42 -48.17 77.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.104 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -67.28 -45.01 77.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.82 -47.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.2 m0 -61.1 -40.73 94.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.553 ' NE ' ' CE1' ' A' ' 152' ' ' TYR . 86.2 mtt-85 -59.39 -28.07 66.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.526 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -51.71 -40.63 60.49 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.202 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.47 ' OD1' ' NH2' ' A' ' 161' ' ' ARG . 41.0 t30 -105.28 -60.34 1.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.449 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.7 m -59.44 -35.05 73.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.767 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' A' ' 156' ' ' ARG . . . -52.69 -29.6 33.3 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.47 ' NH2' ' OD1' ' A' ' 158' ' ' ASN . 74.4 mtm180 -55.28 -34.18 63.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.296 . . . . 0.0 110.793 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -56.11 -36.91 68.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.52 -127.14 19.74 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.17 -164.08 38.24 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 168' ' ' ALA . 92.5 p -118.9 154.9 32.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.956 0.407 . . . . 0.0 110.661 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -58.28 -33.98 70.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.401 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.611 ' H ' HD22 ' A' ' 167' ' ' LEU . 1.0 OUTLIER -61.44 -36.51 80.56 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.481 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -149.36 145.69 27.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.917 0.389 . . . . 0.0 110.834 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.544 179.636 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.552 ' C23' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 1' ' ' MET . 7.0 mmm . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -56.28 -21.17 35.06 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.606 1.538 . . . . 0.0 111.616 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.51 -31.14 69.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.869 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 t -60.87 -43.21 98.73 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.351 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -75.08 -32.15 61.4 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 17.1 t -41.35 -50.34 8.78 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.29 -18.25 29.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 120.44 0.76 . . . . 0.0 112.288 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.26 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.3 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 12' ' ' THR . 60.8 t -59.93 -40.31 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.64 -36.9 93.36 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.8 mp -58.52 -42.22 87.25 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 9' ' ' VAL . 6.6 t -74.95 -35.46 62.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.581 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.48 -34.9 78.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 10' ' ' GLY . 16.9 t -47.91 -56.6 12.9 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.0 Cg_endo -58.58 -34.44 98.84 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 120.797 0.998 . . . . 0.0 112.958 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p -62.14 -37.56 85.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.403 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.17 -38.71 85.9 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.479 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' C ' ' CZ3' ' A' ' 93' ' ' TRP . . . -67.76 -54.23 19.66 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.815 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.671 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -59.86 -36.17 89.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.814 -0.515 . . . . 0.0 111.814 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.48 -45.03 89.52 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.435 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.5 mtt -63.45 -39.23 93.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.8 0.333 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.95 -43.52 91.1 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -69.66 -26.07 64.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 110.816 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.78 -36.61 72.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.711 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 69.5 t80 -59.94 -49.67 76.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.4 m -73.6 -34.15 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.725 0.774 . . . . 0.0 109.929 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -61.79 -42.0 98.45 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.783 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.45 -127.51 1.57 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.854 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.93 -27.61 61.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.708 0.29 . . . . 0.0 110.682 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.24 -34.81 13.37 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -50.79 -41.48 57.17 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.488 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -61.06 -43.46 98.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.366 0.603 . . . . 0.0 109.458 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.17 -40.2 95.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.518 ' O ' ' O ' ' A' ' 37' ' ' LEU . 15.4 m-85 -62.4 -22.74 66.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.11 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.6 -41.5 31.04 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.209 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.0 79.02 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.1 mt -90.87 148.57 22.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.587 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -100.82 128.88 46.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.887 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.5 145.56 31.27 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.946 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 24.0 Cg_endo -58.41 137.13 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.135 1.223 . . . . 0.0 111.691 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -66.03 -26.73 67.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.089 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.411 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 13.0 p90 -78.32 -4.19 46.75 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.685 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 3.4 t-80 -60.09 134.09 90.31 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.362 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 51.4 Cg_exo -75.03 167.23 27.48 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.092 1.195 . . . . 0.0 111.678 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 26.9 Cg_exo -53.88 149.22 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.948 1.765 . . . . 0.0 111.242 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -57.24 -36.08 70.48 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.208 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CZ2' ' HB3' ' A' ' 45' ' ' PRO . 22.5 p90 -76.81 -11.54 59.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -77.02 -72.43 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.799 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.03 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.9 mt -62.77 -35.59 80.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.158 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.58 -41.28 5.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.002 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 66.1 Cg_exo -67.06 -2.21 7.55 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.917 2.411 . . . . 0.0 113.73 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.03 HG23 ' O ' ' A' ' 49' ' ' LEU . 20.1 pt -46.51 -34.57 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.732 0.301 . . . . 0.0 111.512 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.619 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 4.7 m-90 -54.07 -27.36 32.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.7 94.83 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -72.99 -45.85 55.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.853 0.358 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.682 HD11 ' CD1' ' A' ' 143' ' ' TRP . 6.8 mt -66.03 -33.61 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.228 0.537 . . . . 0.0 109.877 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 25.2 t80 -60.14 -50.05 75.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.913 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.7 p -74.79 -33.32 62.22 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.971 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.69 -46.18 83.48 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.638 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.8 mtt -63.93 -38.2 90.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.657 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.85 -61.41 5.58 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.13 -37.3 86.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.603 0.239 . . . . 0.0 111.256 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.22 -43.33 74.54 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.8 p -67.44 -26.0 66.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.475 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 43.7 t80 -56.45 -50.16 72.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.163 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.58 -41.72 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.583 HG22 ' OG ' ' A' ' 130' ' ' SER . 62.8 t -53.64 -48.32 59.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 65' ' ' TYR . 1.4 p90 -70.58 -31.52 68.56 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.966 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 67.8 mmtt -59.71 -37.92 80.21 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.761 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 81.0 mt-10 -68.15 -35.66 78.43 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.87 3.68 47.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.931 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 36.0 11.62 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.32 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 89.21 -174.85 42.42 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.61 84.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.6 m -93.42 146.69 23.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.212 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -50.88 -37.96 46.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.596 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.25 -39.52 92.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.17 0.51 . . . . 0.0 109.671 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.5 71.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.601 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.4 mtp -58.49 -33.05 69.37 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.612 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -55.98 -57.9 19.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.791 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.7 -47.9 10.21 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 119.023 0.687 . . . . 0.0 112.428 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.221 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.0 -37.44 94.96 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.6 tp -57.03 -41.65 78.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 77.6 t80 -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.3 m -65.42 -42.72 92.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.674 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.51 -58.41 3.88 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.635 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -57.15 -41.67 79.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.577 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 15' ' ' PRO . 36.2 tp -63.25 -38.1 89.84 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.135 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.76 75.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.9 -39.13 88.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.589 ' OD1' HD13 ' A' ' 113' ' ' LEU . 43.6 t-20 -60.78 -38.3 84.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.475 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.671 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 50.2 m95 -62.07 -31.33 71.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.632 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -31.8 73.14 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.686 ' CD1' HD11 ' A' ' 113' ' ' LEU . 4.0 t-105 -55.38 -50.69 85.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -41.05 80.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.684 1.589 . . . . 0.0 113.107 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.597 ' N ' ' O ' ' A' ' 95' ' ' TRP . 67.5 Cg_endo -63.04 -26.25 73.65 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 120.616 0.878 . . . . 0.0 111.143 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 107' ' ' TRP . 42.4 pt -63.82 -33.96 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -44.88 -41.09 6.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.808 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 64.8 t80 -67.18 -51.76 49.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.323 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.38 -65.83 0.44 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.572 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.512 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 64.84 5.19 2.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.441 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -54.24 -34.26 60.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.953 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -90.12 153.61 20.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.477 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.662 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.8 ttm -61.95 -15.16 41.4 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.18 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.7 20.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.638 0 C-N-CA 121.526 -0.369 . . . . 0.0 113.345 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.662 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -60.05 -19.38 52.59 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.74 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.82 -20.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' TRP . 83.8 mt -59.23 -38.91 81.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.03 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -66.12 -38.44 88.21 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.372 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.606 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 59.4 t0 -60.66 -45.88 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.96 -47.49 65.51 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.732 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 95' ' ' TRP . 76.8 mt -67.78 -38.9 83.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.421 0.629 . . . . 0.0 109.909 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.707 HD21 HG21 ' A' ' 147' ' ' THR . 19.7 tp -52.93 -61.51 2.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.282 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 144' ' ' LEU . 74.0 t -69.78 -63.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.765 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' ' 120' ' ' THR . 36.4 t -69.71 -40.78 76.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.02 -51.52 56.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.702 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 114' ' ' LEU . 3.6 p -66.2 -37.36 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.386 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.504 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -78.47 -49.71 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 116' ' ' SER . 38.1 m -55.44 -42.23 73.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.58 -54.37 12.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.623 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.5 m -65.78 -39.22 90.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.17 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.745 HG23 ' ND1' ' A' ' 127' ' ' HIS . 85.9 m -58.96 -47.47 84.99 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.91 -34.63 77.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.37 1.43 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.623 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.2 m0 -67.65 -44.01 78.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.745 ' ND1' HG23 ' A' ' 123' ' ' THR . 30.5 m170 -57.72 -45.46 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.534 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -63.07 -43.04 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.454 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.513 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 76.5 t -79.21 -53.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.936 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.583 ' OG ' HG22 ' A' ' 67' ' ' VAL . 43.8 p -128.39 91.38 44.13 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.319 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.441 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 45.2 Cg_exo -51.39 -42.28 55.61 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.915 1.743 . . . . 0.0 113.158 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.4 Cg_exo -56.47 -28.02 71.36 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.211 0.607 . . . . 0.0 112.311 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.38 71.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.77 -41.44 95.5 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.768 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -61.45 -36.06 79.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.49 . . . . 0.0 110.744 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.38 -38.19 76.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.6 mt -59.22 -30.76 68.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.521 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 0.17 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.3 Cg_endo -50.73 -29.96 27.63 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.513 0.809 . . . . 0.0 112.331 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -60.65 -36.49 78.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.633 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -67.8 -44.35 77.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.025 0.441 . . . . 0.0 110.104 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.58 -49.8 37.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.094 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.682 ' CD1' HD11 ' A' ' 56' ' ' LEU . 1.7 t-105 -59.94 -49.01 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 115' ' ' VAL . 74.7 mt -66.07 -32.4 73.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.301 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.39 90.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.825 ' CE2' HD22 ' A' ' 150' ' ' LEU . 23.1 t80 -63.25 -42.03 99.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.264 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.707 HG21 HD21 ' A' ' 114' ' ' LEU . 74.3 p -60.84 -38.36 85.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.604 -0.438 . . . . 0.0 112.049 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.8 m -62.34 -49.31 76.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.695 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.22 -40.68 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.45 0.643 . . . . 0.0 111.01 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 146' ' ' PHE . 53.5 tp -55.91 -47.02 78.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.54 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.646 ' ND2' ' O ' ' A' ' 147' ' ' THR . 65.0 m-20 -66.95 -37.59 84.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.389 0.614 . . . . 0.0 110.449 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -58.88 -44.31 91.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.903 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.97 -46.12 86.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.999 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.06 -47.74 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.7 m95 -61.27 -43.65 98.52 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.493 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.4 mmt-85 -59.7 -35.65 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.842 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -59.46 -41.05 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -96.63 -59.62 1.78 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TRP . 34.4 m -57.13 -32.3 66.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.524 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.11 161.09 44.93 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -56.85 -36.5 70.09 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.955 0.407 . . . . 0.0 110.45 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -56.38 -35.4 67.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.291 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.52 -31.17 43.65 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -80.32 174.09 54.94 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.4 p -78.79 160.58 27.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 111.065 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.0 ttp85 -57.97 -32.71 68.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.555 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.51 ' H ' HD22 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -87.14 146.14 26.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.904 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.438 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -84.07 126.3 32.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.001 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 92.5 mt-10 . . . . . 0 C--O 1.218 -0.56 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.371 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.545 ' C12' HD11 ' A' ' 52' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.82 ' H2 ' ' CD ' ' A' ' 2' ' ' PRO . 1.3 mpp? . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.954 0.407 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.82 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 18.5 Cg_endo -55.71 -22.47 36.58 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.389 2.059 . . . . 0.0 111.572 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.15 -31.83 70.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.938 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -62.19 -41.84 98.73 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.298 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.401 ' CZ2' ' CD2' ' A' ' 68' ' ' TRP . 10.9 m0 -73.83 -31.48 63.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.833 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -42.28 -43.07 7.13 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.46 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.31 -24.49 51.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.002 1.135 . . . . 0.0 111.733 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.22 -34.12 21.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.141 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.52 -41.93 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.29 92.6 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.447 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.38 -39.56 83.73 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.375 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -81.23 -36.57 29.83 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' CZ ' ' A' ' 57' ' ' TYR . 96.4 mt -61.93 -36.63 81.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 t -54.9 -43.73 99.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.601 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.41 -32.61 94.48 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.397 1.398 . . . . 0.0 113.49 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.9 m -59.34 -38.0 79.23 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.716 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.5 mt -60.67 -38.08 83.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.165 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.91 99.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.599 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.61 -42.4 99.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.128 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.0 m-85 -62.98 -45.37 92.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.0 mtm -62.57 -40.31 96.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 -48.26 23.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.21 -18.68 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.478 . . . . 0.0 110.969 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -54.25 -36.98 64.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.26 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 48.5 t80 -61.05 -50.75 72.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.04 -35.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.63 0.729 . . . . 0.0 110.216 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -60.95 -41.12 95.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.786 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.17 -125.21 2.27 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.031 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -56.99 -27.98 62.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.473 -0.364 . . . . 0.0 111.052 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.71 -32.78 17.87 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -51.33 -41.54 60.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.344 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -63.15 -42.87 99.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -62.12 -37.27 84.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.652 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' LEU . 6.0 m-85 -61.29 -23.2 65.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.955 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.86 -43.44 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.456 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.9 -32.21 81.99 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 34' ' ' TYR . 45.5 mt -93.07 149.23 21.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.831 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -100.94 129.92 46.86 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.004 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.579 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 11.9 mtpt -107.74 139.42 20.59 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.424 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 60.6 Cg_endo -61.47 134.05 49.32 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 120.668 0.912 . . . . 0.0 111.6 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.9 p -81.78 -9.81 59.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.781 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.478 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.8 p90 -77.88 -15.34 59.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.661 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' ND1' ' A' ' 43' ' ' HIS . 0.7 OUTLIER -76.69 149.81 81.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.915 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -76.38 163.99 31.48 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.573 1.515 . . . . 0.0 111.136 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.7 Cg_endo -51.38 149.45 17.25 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.803 1.669 . . . . 0.0 111.951 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.579 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 42.0 mtt85 -57.0 -35.51 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.426 ' CD2' ' HB2' ' A' ' 45' ' ' PRO . 4.5 p90 -64.19 -20.27 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.118 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.87 -62.77 1.48 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.426 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.979 ' O ' HG23 ' A' ' 52' ' ' ILE . 88.4 mt -67.46 -36.14 80.58 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.652 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -43.09 -41.0 6.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.983 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 53.0 Cg_exo -66.33 -7.39 17.4 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.181 2.587 . . . . 0.0 113.745 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.979 HG23 ' O ' ' A' ' 49' ' ' LEU . 19.0 pt -42.03 -43.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.357 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.472 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 95.0 m95 -54.28 -32.45 56.33 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.722 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.19 -39.2 96.82 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.1 m -69.62 -51.21 37.09 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.12 0.486 . . . . 0.0 111.04 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.8 mp -67.55 -31.77 72.09 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.431 0.634 . . . . 0.0 109.771 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.489 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -51.23 -55.87 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.633 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.6 m -64.03 -40.09 95.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.341 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.92 -44.5 89.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.993 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.52 -38.05 88.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.831 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -54.81 9.56 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.32 -37.6 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.13 -40.72 91.98 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.6 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -63.27 -31.71 72.93 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.188 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.33 -42.41 86.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.913 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 -41.22 84.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG13 HG11 ' A' ' 129' ' ' VAL . 46.7 t -58.7 -40.72 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.943 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.41 -51.16 70.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.464 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 71.4 mttt -53.36 -35.1 59.91 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.424 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.51 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 88.8 mt-10 -75.75 -43.82 44.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.767 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.29 -26.65 58.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.86 -5.42 42.9 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.681 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.58 -167.46 29.2 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.874 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 79' ' ' MET . 7.6 t80 -90.86 87.05 6.49 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' ALA . 11.2 p -124.04 167.64 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.205 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -42.88 -36.96 1.67 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.261 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 89.2 m-20 -62.54 -41.01 98.61 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.75 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -84.89 -40.27 17.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' GLY . 86.7 mtp -59.95 -35.17 74.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.27 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.9 -57.25 25.19 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.49 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.423 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 13.0 Cg_endo -61.95 -53.45 2.09 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.011 1.141 . . . . 0.0 112.01 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -63.52 -41.27 98.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.242 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.97 -39.76 97.99 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.41 -38.72 77.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.039 0.447 . . . . 0.0 110.241 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -59.79 -44.4 93.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.11 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.9 m -65.82 -45.4 82.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.472 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.83 5.97 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.42 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.72 -41.66 86.91 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.493 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.08 -36.96 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.82 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.59 66.74 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.63 -37.32 81.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.564 ' OD1' HD11 ' A' ' 113' ' ' LEU . 21.2 t-20 -60.04 -43.89 95.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.951 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.547 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 60.0 m95 -57.45 -30.47 65.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.041 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 -23.57 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 97' ' ' PRO . 55.9 t-105 -54.15 -67.56 0.61 Allowed Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 22.8 Cg_endo -43.35 80.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.832 1.688 . . . . 0.0 112.007 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.609 ' N ' ' O ' ' A' ' 95' ' ' TRP . 69.2 Cg_endo -57.54 -22.04 49.25 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.294 1.996 . . . . 0.0 113.293 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 107' ' ' TRP . 37.3 pt -57.11 -23.27 18.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 8.4 p90 -45.06 -41.59 7.77 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.718 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.532 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 75.7 t80 -66.51 -52.13 49.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.8 -68.89 0.5 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.791 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 63.79 3.21 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 0.0 110.749 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -53.8 -35.04 60.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -89.57 155.22 19.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.672 ' C ' ' H ' ' A' ' 107' ' ' TRP . 21.9 ttm -58.75 -15.17 10.88 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.039 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.59 15.06 0.01 OUTLIER Glycine 0 CA--C 1.544 1.846 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.351 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.672 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -56.15 -19.25 12.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.359 0.58 . . . . 0.0 112.257 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.662 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -43.09 -21.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 111.742 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.6 mt -61.08 -36.17 78.92 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.654 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.34 -39.29 93.6 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.731 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.642 ' OD2' ' ND2' ' A' ' 151' ' ' ASN . 47.0 t0 -62.95 -46.79 86.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.51 -49.11 76.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.904 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.5 tt -67.99 -42.54 80.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.544 0.688 . . . . 0.0 109.768 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 147' ' ' THR . 18.1 tp -50.67 -60.2 3.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.582 ' HA ' HD22 ' A' ' 144' ' ' LEU . 71.7 t -71.05 -63.58 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.495 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.8 t -68.91 -40.36 79.15 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.39 -51.01 60.71 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.795 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.83 -38.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.27 -47.88 22.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 116' ' ' SER . 56.7 m -57.89 -42.48 84.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.88 -57.58 3.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.675 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.636 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 16.9 m -62.3 -41.18 98.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.283 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 85.9 m -61.61 -45.47 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 124' ' ' LEU . 95.9 mt -63.11 -37.45 87.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.5 -63.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.636 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.7 m0 -65.98 -41.02 91.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.451 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.3 t-80 -57.4 -47.14 82.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.079 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.28 -43.74 90.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.73 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.63 HG11 HG13 ' A' ' 67' ' ' VAL . 86.4 t -78.6 -48.7 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.5 p -127.9 85.34 60.89 Favored Pre-proline 0 N--CA 1.465 0.297 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.726 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.463 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.05 -44.95 42.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.628 1.552 . . . . 0.0 112.258 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 17.0 Cg_exo -58.44 -31.76 94.85 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.361 0.708 . . . . 0.0 111.913 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.68 72.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.538 . . . . 0.0 110.078 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.3 84.75 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.704 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.57 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 73.7 ttt180 -60.51 -41.03 93.52 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 110.109 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.2 tp -53.29 -35.68 60.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.23 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.531 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 43.3 mt -69.64 12.42 0.19 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.331 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -44.88 -41.96 14.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.531 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 10.3 Cg_endo -64.24 -22.59 66.71 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.95 1.375 . . . . 0.0 112.5 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.24 -39.61 90.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.024 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.769 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.0 tm? -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.318 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.89 -43.59 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 111.593 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.714 ' CE2' HD12 ' A' ' 52' ' ' ILE . 1.4 t-105 -66.0 -51.35 59.16 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.467 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 115' ' ' VAL . 54.0 mt -64.12 -34.09 77.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.179 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.89 95.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.241 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.738 ' CE2' HD22 ' A' ' 150' ' ' LEU . 22.0 t80 -62.31 -40.76 97.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.405 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.758 HG21 HD21 ' A' ' 114' ' ' LEU . 66.9 p -58.28 -38.32 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.259 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.5 m -63.56 -51.15 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.346 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.48 -41.67 80.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.749 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.738 HD22 ' CE2' ' A' ' 146' ' ' PHE . 64.9 tp -57.89 -40.8 81.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.406 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.642 ' ND2' ' OD2' ' A' ' 111' ' ' ASP . 24.8 m-20 -65.53 -41.12 93.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.49 -40.21 96.47 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.85 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -60.42 -45.85 92.14 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.866 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.56 -48.22 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.662 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.2 m0 -63.85 -48.68 75.8 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.887 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.684 ' NH2' HH22 ' A' ' 166' ' ' ARG . 90.0 mtt-85 -56.35 -32.38 64.67 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.198 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -56.73 -40.0 74.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -99.61 -61.12 1.41 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.825 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 155' ' ' TRP . 22.9 t -127.87 135.64 50.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.22 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -154.27 177.66 31.54 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.554 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -129.44 150.62 50.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.372 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 166' ' ' ARG . 98.2 mtt180 -121.3 145.73 47.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.188 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.23 158.52 23.65 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -59.47 -34.33 80.58 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 168' ' ' ALA . 86.9 p -60.9 -28.69 69.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.57 0.224 . . . . 0.0 111.215 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.684 HH22 ' NH2' ' A' ' 156' ' ' ARG . 92.5 mtt-85 -57.47 -36.88 72.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.63 -36.62 84.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.276 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -151.36 147.1 26.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.005 0.431 . . . . 0.0 110.927 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.469 179.613 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.506 ' C23' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 mmt . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -54.93 142.89 74.63 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.55 1.5 . . . . 0.0 112.318 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.35 -34.12 77.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.055 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -62.53 -42.28 99.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.418 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -76.0 -32.51 59.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 0.0 111.817 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.0 t -40.58 -41.66 2.82 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.337 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 37.2 Cg_exo -53.74 -23.34 26.18 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 CA-C-N 119.232 0.761 . . . . 0.0 112.236 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.42 47.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 12' ' ' THR . 88.5 t -60.99 -41.71 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.12 -36.32 92.77 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.443 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mp -58.32 -40.9 83.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.013 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.1 t -77.78 -34.5 52.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.676 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.2 mt -66.78 -34.95 78.96 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 t -50.99 -58.06 11.61 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.3 Cg_endo -58.33 -31.51 93.99 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 120.577 0.852 . . . . 0.0 112.556 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -59.31 -38.12 79.47 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt -64.36 -37.99 89.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.262 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -66.39 -53.27 29.83 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.052 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.14 94.41 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -59.63 -48.95 79.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.018 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.16 -39.42 92.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.064 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.7 90.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -69.94 -28.91 65.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.099 0.476 . . . . 0.0 110.279 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -56.6 -34.11 66.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.483 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 81.3 t80 -60.27 -47.85 84.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.1 m -74.15 -32.51 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.784 0.802 . . . . 0.0 109.936 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' O ' HD11 ' A' ' 31' ' ' LEU . 14.4 ttt85 -61.32 -41.46 97.05 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.939 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.23 -124.84 2.53 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.133 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.562 ' OE1' ' NE ' ' A' ' 32' ' ' ARG . 78.1 mm-40 -56.88 -28.24 61.56 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.964 0.412 . . . . 0.0 110.857 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.13 -32.74 13.27 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.5 mt -51.33 -42.19 61.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' OE1' ' A' ' 29' ' ' GLU . 72.7 mtm180 -61.53 -42.71 99.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.401 0.62 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.76 -41.76 98.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.59 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 46.8 m-85 -66.32 -22.98 66.29 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.518 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.15 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.169 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.69 84.65 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 34' ' ' TYR . 69.5 mt -90.13 151.07 21.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.744 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.424 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 90.2 mt-30 -97.32 128.27 44.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.058 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.719 ' HZ2' HH21 ' A' ' 46' ' ' ARG . 55.7 mttt -103.04 143.94 27.62 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 20.9 Cg_endo -57.03 140.25 92.1 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 120.677 0.918 . . . . 0.0 111.829 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.8 p -64.2 -30.31 71.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.346 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.409 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 20.7 p90 -78.53 -1.58 34.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.462 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.2 t-80 -60.37 126.4 84.3 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.316 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 74.1 Cg_endo -79.73 164.24 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.347 1.365 . . . . 0.0 111.28 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 16.1 Cg_exo -50.78 139.85 39.11 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.341 1.361 . . . . 0.0 111.322 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.719 HH21 ' HZ2' ' A' ' 39' ' ' LYS . 50.2 mtt85 -58.86 -36.13 74.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.981 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.448 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 5.0 p90 -66.98 -24.0 66.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.413 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 52.7 m -67.88 -63.35 1.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.965 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.007 ' O ' HG23 ' A' ' 52' ' ' ILE . 71.6 mt -72.19 -34.24 68.26 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.31 -49.56 3.42 Favored Pre-proline 0 C--N 1.321 -0.635 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.671 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 12.1 Cg_endo -71.43 6.11 2.05 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.034 1.823 . . . . 0.0 114.117 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.007 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.9 pt -50.09 -25.39 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.158 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 5.0 m-90 -55.03 -34.41 63.49 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.421 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -44.47 97.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.0 m -65.21 -47.57 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.129 0.49 . . . . 0.0 110.557 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 143' ' ' TRP . 6.1 mt -67.71 -34.21 76.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.587 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' TRP . 15.2 t80 -58.88 -50.87 72.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.762 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.1 p -71.03 -33.06 69.96 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.83 -43.14 97.09 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.696 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -64.28 -37.12 86.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.194 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.18 -64.19 3.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -59.94 -39.26 84.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.707 0.289 . . . . 0.0 111.312 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.48 -43.19 85.34 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.8 p -63.95 -27.98 69.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.908 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -57.59 -43.51 84.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.84 -43.41 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.44 -38.63 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.957 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.05 -36.57 79.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.17 -45.68 83.93 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.048 0.452 . . . . 0.0 110.82 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.83 -39.52 76.41 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.07 -2.6 57.59 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.94 7.08 66.45 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.269 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.21 -163.55 29.1 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.14 80.0 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.918 0.866 . . . . 0.0 110.365 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.3 m -119.82 147.4 44.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.556 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -41.11 -37.45 0.87 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.163 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.1 -42.77 96.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.833 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -71.33 -29.41 64.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.6 mmm -57.21 -34.4 68.49 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.784 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.87 -54.35 57.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.828 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -65.21 -55.65 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 120.439 0.759 . . . . 0.0 112.713 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -61.57 -42.49 98.93 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.684 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.07 95.65 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.7 tp -58.1 -40.28 80.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 110.166 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -61.13 -43.45 98.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.424 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 m -64.84 -41.38 95.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -53.56 5.81 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.261 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.02 -41.87 84.09 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.227 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 15' ' ' PRO . 25.2 tp -62.59 -37.64 87.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.117 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -46.25 80.81 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.75 -39.06 87.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.441 ' O ' HD12 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -63.52 -37.1 86.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.355 178.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.415 ' CZ2' ' CA ' ' A' ' 18' ' ' GLY . 1.7 m95 -56.24 -32.4 64.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.359 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.1 75.0 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.563 ' NE1' HD23 ' A' ' 112' ' ' LEU . 21.0 t-105 -54.78 -56.31 28.88 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 19.9 Cg_endo -57.95 128.61 29.58 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.469 1.446 . . . . 0.0 113.209 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 109' ' ' LEU . 98.5 Cg_endo -108.04 -28.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.112 1.875 . . . . 0.0 110.745 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.84 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 22.7 pt -54.21 -30.31 20.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.23 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 21.3 p90 -54.61 -44.64 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.512 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.574 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 78.6 t80 -64.17 -48.35 76.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.13 -58.07 0.42 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.84 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 57.97 -0.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 101' ' ' GLY . 14.7 tpt180 -53.56 -33.27 54.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.081 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -84.5 152.95 23.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.288 0.566 . . . . 0.0 111.603 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.65 ' O ' ' N ' ' A' ' 107' ' ' TRP . 2.8 ttp -62.06 -14.7 38.73 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.098 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.39 33.71 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.826 -0.226 . . . . 0.0 113.27 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.65 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.7 -20.89 62.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.575 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.06 -23.97 15.61 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.441 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 109' ' ' LEU . 5.8 mp -59.66 -33.86 72.1 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.898 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.0 -37.01 83.24 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 30.0 t0 -61.53 -41.11 96.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.015 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.563 HD23 ' NE1' ' A' ' 95' ' ' TRP . 45.3 tp -60.51 -57.09 14.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 113' ' ' LEU . 2.7 tt -61.85 -41.2 97.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.523 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.601 HD21 ' CZ2' ' A' ' 143' ' ' TRP . 13.7 tp -53.03 -64.91 0.67 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.744 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.635 ' HA ' HD13 ' A' ' 144' ' ' LEU . 95.5 t -69.04 -56.61 11.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.598 -176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.7 t -69.38 -44.01 72.37 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.61 -49.41 70.0 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -45.4 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.658 0.266 . . . . 0.0 111.297 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.475 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.68 -56.12 5.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.7 m -58.59 -43.57 89.57 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.99 -58.0 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.054 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.654 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.3 m -63.87 -41.87 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.6 m -61.47 -45.51 93.93 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.74 -36.03 82.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.72 -63.2 1.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.654 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 37.0 m0 -65.75 -42.06 91.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.0 t-80 -59.2 -48.33 82.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.684 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -64.66 -45.21 87.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.865 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.4 t -76.18 -45.43 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.2 p -133.65 86.76 38.47 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.193 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 40.2 Cg_exo -52.7 -42.25 63.94 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.755 1.637 . . . . 0.0 112.873 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -57.09 -31.27 89.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.359 0.706 . . . . 0.0 112.344 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.48 71.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.72 80.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.888 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -59.27 -39.35 82.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.17 -39.43 75.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.2 mt -58.79 -29.79 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.423 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.524 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER 1.83 -63.77 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.7 Cg_endo -51.09 -31.01 33.72 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 120.798 0.999 . . . . 0.0 112.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -59.43 -40.97 88.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.938 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.705 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -68.55 -41.98 79.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.649 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.8 34.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.023 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.695 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 1.3 t-105 -63.02 -51.79 65.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 115' ' ' VAL . 55.5 mt -62.47 -32.78 73.73 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.52 -39.34 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.684 ' CE2' HD22 ' A' ' 150' ' ' LEU . 23.0 t80 -61.87 -42.77 99.45 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.695 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 71.3 p -60.06 -37.26 79.34 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.402 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 55.3 m -60.79 -50.86 71.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.385 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.99 -43.47 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.214 0.53 . . . . 0.0 110.432 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.684 HD22 ' CE2' ' A' ' 146' ' ' PHE . 60.9 tp -58.82 -40.58 84.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.378 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.483 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.5 m120 -62.6 -41.39 98.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 148' ' ' THR . 54.5 m-85 -65.08 -39.52 93.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.435 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -58.94 -47.14 86.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.59 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.14 -46.17 67.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.539 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.3 m0 -62.15 -42.66 99.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -60.08 -29.85 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.582 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 84.2 m-20 -51.7 -40.6 60.43 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.895 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -104.46 -61.84 1.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p -65.81 -29.37 69.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.094 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -55.67 -33.59 59.66 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.275 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -58.29 -34.25 70.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.23 146.08 52.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.682 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.78 -177.3 37.26 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.47 8.8 70.29 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.3 m -57.23 -34.05 68.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.668 0.27 . . . . 0.0 110.682 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -56.0 -37.29 68.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.197 0.522 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.83 150.97 22.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.306 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 169' ' ' GLU . . . -137.33 149.21 46.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.005 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 168' ' ' ALA . 77.2 mm-40 . . . . . 0 C--N 1.322 -0.596 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.524 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.496 ' C1 ' ' HZ1' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.659 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.305 0.098 . . . . 0.0 111.039 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 1' ' ' MET . 35.0 Cg_exo -55.37 -19.29 21.67 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.355 1.37 . . . . 0.0 111.632 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.78 -31.89 50.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 m -60.53 -42.08 95.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.189 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -77.02 -30.68 55.89 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.836 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 15.1 t -40.56 -48.68 6.99 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 7.6 Cg_endo -57.27 -20.59 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.105 0.716 . . . . 0.0 112.037 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.53 59.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.95 -39.95 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.148 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -63.17 -36.54 93.57 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 11' ' ' LEU . 11.1 mp -60.19 -42.63 95.47 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 57' ' ' TYR . 3.9 t -79.64 -46.12 17.79 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 12' ' ' THR . 93.1 mt -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 t -50.18 -41.97 69.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.776 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.26 -33.0 89.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.172 . . . . 0.0 113.246 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.53 -39.06 86.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.48 -37.91 89.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.15 -55.63 17.92 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.802 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.42 91.39 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.094 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.11 -47.84 80.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.348 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.1 mtm -64.33 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.798 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.31 -45.19 88.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.654 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.22 64.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.203 0.525 . . . . 0.0 110.929 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -30.99 65.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.036 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 102' ' ' ALA . 85.4 t80 -63.46 -47.7 80.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.2 m -69.45 -32.1 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.87 0.843 . . . . 0.0 109.256 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -64.38 -40.79 96.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.191 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.51 -116.94 2.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.791 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.23 -30.23 62.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 111.123 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.51 -33.13 24.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.5 mt -50.94 -44.44 60.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.365 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -63.35 -41.98 98.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 0.0 111.048 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -59.26 -38.69 80.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.96 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.552 ' O ' ' O ' ' A' ' 37' ' ' LEU . 66.5 m-85 -63.61 -22.73 67.05 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.733 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.85 17.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.677 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.89 -34.23 65.74 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.552 ' O ' ' O ' ' A' ' 34' ' ' TYR . 66.2 mt -92.31 152.35 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 89.8 mt-30 -92.65 128.38 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -106.47 144.22 28.56 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.62 0.248 . . . . 0.0 110.766 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.522 ' CG ' ' CE1' ' A' ' 43' ' ' HIS . 96.2 Cg_endo -62.68 138.64 70.74 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.299 1.999 . . . . 0.0 111.949 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.0 m -84.19 0.54 48.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.417 ' CZ3' ' HB3' ' A' ' 40' ' ' PRO . 13.0 p90 -101.18 12.04 38.3 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.102 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.863 ' NE2' HD13 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -85.3 137.66 36.85 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.759 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.4 171.48 18.0 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.63 1.554 . . . . 0.0 110.796 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HB2' ' CE2' ' A' ' 47' ' ' TRP . 3.0 Cg_exo -49.46 145.19 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 120.289 0.659 . . . . 0.0 110.659 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.565 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 36.7 mtt180 -58.62 -33.69 70.32 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.311 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.43 ' CE2' ' HB2' ' A' ' 45' ' ' PRO . 11.9 p90 -71.83 -11.94 61.04 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -74.77 -68.06 0.58 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.021 ' O ' HG23 ' A' ' 52' ' ' ILE . 94.2 mt -67.76 -35.68 79.15 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.322 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.24 -39.65 2.17 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 38.4 Cg_exo -71.03 1.29 5.43 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.892 2.395 . . . . 0.0 113.562 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.021 HG23 ' O ' ' A' ' 49' ' ' LEU . 15.9 pt -46.21 -37.23 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.726 0.298 . . . . 0.0 111.568 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.605 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.0 m-90 -53.8 -29.52 40.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.921 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 57' ' ' TYR . . . -53.44 -40.87 62.48 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -81.25 -39.61 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 143' ' ' TRP . 4.7 mt -64.73 -38.94 92.68 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 58' ' ' SER . 2.0 p90 -67.68 -44.02 78.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.293 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.525 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 49.6 m -60.67 -42.39 96.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.633 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.57 -43.72 88.91 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.886 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.7 mtt -63.08 -37.51 87.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.779 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.57 -59.14 9.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 47.9 t80 -64.65 -36.96 85.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.863 0.363 . . . . 0.0 110.792 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.81 -42.44 68.91 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.6 p -68.72 -26.26 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.637 0.256 . . . . 0.0 110.669 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 42.7 t80 -55.34 -49.27 72.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.229 0.538 . . . . 0.0 110.225 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.94 -40.92 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.507 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.37 -45.9 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 69' ' ' LYS . 1.2 p90 -69.48 -31.95 70.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.279 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 73.9 mttt -59.66 -37.66 79.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.047 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 83.9 mt-10 -67.12 -35.17 79.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.44 2.3 48.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.41 37.44 10.87 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.013 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.08 -161.09 27.68 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -87.45 109.52 19.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -133.35 168.78 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.176 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.85 -38.68 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.093 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 75' ' ' THR . 85.0 m-20 -63.11 -39.75 95.62 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.626 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.99 66.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.851 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 83' ' ' GLY . 8.8 mtt -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.806 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -58.25 -51.78 79.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.721 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.11 -56.91 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 120.701 0.934 . . . . 0.0 112.428 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.9 mp -63.46 -41.62 98.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.634 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.51 -38.24 95.47 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.1 tp -56.8 -40.24 75.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 110.186 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.6 -44.19 96.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -66.12 -41.59 90.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.152 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.5 -55.04 5.73 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.089 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -59.06 -41.31 87.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.404 ' HG ' ' NE1' ' A' ' 93' ' ' TRP . 37.8 tp -61.8 -38.89 89.8 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.238 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -46.25 90.53 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.293 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.11 -36.2 83.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.113 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -58.6 -43.18 89.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.948 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.404 ' NE1' ' HG ' ' A' ' 89' ' ' LEU . 74.5 m95 -64.42 -32.9 74.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.01 -31.62 72.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.53 ' C ' ' CD1' ' A' ' 95' ' ' TRP . 8.3 t-105 -54.82 -54.86 44.82 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.15 87.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.034 0 CA-C-N 119.304 0.787 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.58 -18.75 41.51 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.176 1.251 . . . . 0.0 111.843 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.752 HG21 ' HA ' ' A' ' 107' ' ' TRP . 47.2 pt -58.62 -23.98 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 5.4 p90 -45.94 -41.31 11.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.555 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 52.7 t80 -67.37 -57.45 6.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.932 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -114.67 -68.77 0.47 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.84 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 101' ' ' GLY . . . 72.73 11.89 5.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.256 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -52.2 -35.56 49.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.333 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -87.17 149.63 24.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.659 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.615 ' O ' ' N ' ' A' ' 107' ' ' TRP . 13.5 ptm -62.56 -16.01 53.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.557 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -44.79 -4.01 0.01 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.565 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.752 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.7 p90 -44.49 -18.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.791 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.29 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.803 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 107' ' ' TRP . 70.8 mt -61.93 -35.6 78.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.09 -40.68 96.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.596 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 62.3 t0 -61.46 -49.82 75.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.295 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 tp -66.06 -44.11 85.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.02 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 113' ' ' LEU . 1.2 mm? -72.16 -38.78 69.08 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.869 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.58 HD21 HG21 ' A' ' 147' ' ' THR . 17.8 tp -53.02 -62.12 1.86 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.388 0.613 . . . . 0.0 110.816 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.555 ' HA ' HD13 ' A' ' 144' ' ' LEU . 97.0 t -66.61 -62.87 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.814 -1.084 . . . . 0.0 113.252 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 120' ' ' THR . 44.1 t -69.49 -39.04 77.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.73 -55.86 27.49 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.942 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 114' ' ' LEU . 6.1 p -65.75 -37.22 79.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.634 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.5 -49.19 15.27 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 116' ' ' SER . 37.0 m -56.67 -41.83 77.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -58.14 3.8 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.733 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.532 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 31.8 m -64.72 -40.76 95.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 77.4 m -59.93 -45.62 92.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.452 HD22 HH21 ' A' ' 128' ' ' ARG . 99.0 mt -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.88 -63.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.532 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 45.7 m0 -65.41 -41.3 93.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.1 t-80 -58.02 -48.0 81.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.003 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.452 HH21 HD22 ' A' ' 124' ' ' LEU . 85.0 mtt180 -64.9 -42.99 94.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 70.7 t -78.19 -53.11 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.6 p -127.31 90.81 47.91 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.3 Cg_exo -52.69 -42.22 64.07 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.866 1.711 . . . . 0.0 113.0 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 26.5 Cg_exo -56.78 -30.45 84.75 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 120.269 0.646 . . . . 0.0 112.258 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.8 70.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.5 91.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.668 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -59.82 -38.26 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 0.0 110.432 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.6 -35.34 70.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 138' ' ' TYR . 82.9 mt -64.95 -5.05 5.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.204 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -24.55 -53.57 0.15 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.5 -27.8 77.98 Favored 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 121.513 1.475 . . . . 0.0 113.523 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -58.21 -43.34 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.514 -178.295 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.5 tp -72.01 -41.58 67.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.24 73.54 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.527 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.557 ' CE2' HD12 ' A' ' 52' ' ' ILE . 2.5 t-105 -64.92 -49.92 68.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.945 0.402 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.555 HD13 ' HA ' ' A' ' 115' ' ' VAL . 78.9 mt -66.47 -34.38 77.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.849 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -59.51 -37.93 79.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.297 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.41 -45.04 81.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.654 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 68.9 p -58.23 -40.21 81.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.607 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.9 m -60.53 -46.88 88.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.204 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.9 t -68.59 -43.81 83.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 111.721 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.978 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -65.06 -41.9 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.834 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.654 ' ND2' ' O ' ' A' ' 147' ' ' THR . 79.4 m-20 -60.47 -39.84 89.1 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.046 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -64.69 -39.19 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.75 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.18 -46.09 83.12 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.431 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.0 t -72.25 -46.21 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.791 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.5 m95 -61.4 -37.19 82.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 159' ' ' SER . 24.1 mmt85 -56.32 -26.16 51.38 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.889 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.478 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 92.6 m-20 -53.48 -41.86 66.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.754 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.546 ' ND2' HD21 ' A' ' 37' ' ' LEU . 86.0 m-20 -111.01 4.13 19.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.029 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 156' ' ' ARG . 48.2 t -128.65 149.61 50.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.564 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 167.61 -175.75 42.5 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -57.57 -36.74 72.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 110.244 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -56.32 -35.67 67.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.771 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -51.68 -31.14 29.65 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -54.53 -30.72 51.0 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.9 p -59.57 -25.9 64.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.687 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -56.75 -30.92 64.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.746 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.3 mm? -90.52 146.13 24.34 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -67.03 132.0 46.99 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.146 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 88.9 mt-10 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.512 ' C12' HD11 ' A' ' 52' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.877 0.37 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -55.92 -16.92 17.3 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.801 2.334 . . . . 0.0 112.075 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -51.19 -36.22 40.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.63 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.0 m -64.44 -38.71 91.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.302 0.572 . . . . 0.0 110.288 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.615 ' NE1' ' CE3' ' A' ' 68' ' ' TRP . 1.3 t90 -67.72 -37.16 81.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.739 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 t -44.12 -42.28 11.97 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.415 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.53 ' O ' HD13 ' A' ' 11' ' ' LEU . 87.4 Cg_exo -54.54 -23.74 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.311 1.341 . . . . 0.0 112.497 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.98 60.37 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.624 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.41 -42.45 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.9 -34.52 88.81 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.147 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.6 mp -54.9 -44.43 74.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.886 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 t -78.7 -35.71 44.57 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.885 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.16 -37.7 88.22 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -51.57 -41.93 80.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.679 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -57.58 -27.59 77.53 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.411 1.407 . . . . 0.0 113.674 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.2 p -61.17 -32.75 72.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.59 -38.32 87.14 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.522 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.76 92.37 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.169 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.3 -59.29 3.94 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.775 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -58.79 -46.15 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.3 mmm -62.88 -40.0 96.18 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 -43.2 10.9 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.182 -0.533 . . . . 0.0 111.997 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.485 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -66.72 -21.66 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -53.35 -32.89 51.32 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.279 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 52.3 t80 -59.53 -47.49 85.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -72.94 -34.08 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.647 0.737 . . . . 0.0 109.713 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -61.09 -40.58 94.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.886 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.38 -132.57 2.02 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.987 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.61 -26.34 55.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.168 0.508 . . . . 0.0 110.669 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.41 8.84 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -52.45 -43.96 65.22 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.963 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -60.77 -40.65 93.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.022 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -59.32 -40.49 86.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.216 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' LEU . 57.3 m-85 -63.83 -22.93 67.15 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.974 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.19 10.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.852 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.55 81.59 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 34' ' ' TYR . 32.2 mt -91.23 151.15 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.853 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -98.85 130.76 45.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.032 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.623 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 61.0 mttt -102.93 140.57 21.19 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 31.1 Cg_endo -59.81 132.72 46.77 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.144 1.229 . . . . 0.0 112.414 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.1 m -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.117 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.486 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 5.8 p90 -76.1 -11.96 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.99 147.95 98.42 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.289 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.96 171.63 7.97 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.916 1.744 . . . . 0.0 111.521 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 24.0 Cg_exo -53.23 143.64 51.7 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.976 1.784 . . . . 0.0 111.793 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.623 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 38.8 mtt85 -58.9 -37.91 77.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.446 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 10.6 p90 -69.2 -26.89 65.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.497 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.2 m -64.75 -55.12 21.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.973 ' O ' HG23 ' A' ' 52' ' ' ILE . 87.0 mt -75.19 -32.49 61.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -38.79 -48.28 3.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.517 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 15.6 Cg_endo -71.85 1.78 5.44 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.299 2.0 . . . . 0.0 114.063 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.973 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.7 pt -44.85 -40.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.82 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' TYR . 98.4 m95 -53.25 -33.39 52.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.607 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.39 -41.6 98.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 m -67.09 -49.52 64.71 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.797 0.332 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -67.73 -33.08 74.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' TRP . 4.4 t80 -52.38 -49.72 63.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.823 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.7 p -69.57 -36.63 76.47 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.18 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.4 -44.99 77.49 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.2 mtt -61.98 -37.5 85.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.105 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.11 25.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -62.52 -38.38 89.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.931 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.55 -43.38 78.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.449 ' CB ' HD21 ' A' ' 82' ' ' LEU . 86.9 p -62.83 -30.4 71.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -56.76 -46.9 81.14 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.911 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.08 -42.95 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.45 HG22 ' OG ' ' A' ' 130' ' ' SER . 71.0 t -61.9 -40.51 87.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.715 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.615 ' CE3' ' NE1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -62.63 -37.38 86.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -61.06 -41.55 96.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -63.94 -40.38 96.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.978 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.163 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 10.53 61.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.21 -162.14 27.88 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.08 111.32 23.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 78' ' ' ALA . 14.5 t -135.27 166.63 22.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -46.78 -33.73 4.65 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -36.57 72.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -63.06 -27.36 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.38 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.1 mmt -55.5 -35.95 66.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.87 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.66 -42.34 91.04 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.589 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 14.5 Cg_endo -89.64 -71.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 120.826 1.017 . . . . 0.0 112.594 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.449 HD21 ' CB ' ' A' ' 64' ' ' SER . 19.0 mt -62.05 -43.41 98.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.604 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.77 -43.03 98.24 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.16 -39.13 88.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.232 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.6 -43.24 89.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.1 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.2 m -68.03 -42.9 79.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.139 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.15 -58.8 3.29 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -56.13 -40.91 74.51 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.323 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 13.3 tp -64.18 -40.34 95.91 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.011 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.6 -48.1 76.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.534 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.9 mt -61.21 -39.21 89.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.335 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' HD11 ' A' ' 113' ' ' LEU . 41.6 t-20 -61.76 -41.45 97.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.479 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 52.9 m95 -58.96 -29.26 67.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.249 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.5 64.39 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.543 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.9 t-105 -61.59 -66.15 1.72 Allowed Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 85.0 Cg_endo -45.21 85.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.957 1.771 . . . . 0.0 112.543 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' TRP . 83.9 Cg_endo -59.52 -16.54 36.46 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.542 1.495 . . . . 0.0 112.31 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.792 HG21 ' HA ' ' A' ' 107' ' ' TRP . 33.5 pt -58.57 -26.56 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.581 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.97 -41.89 16.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.022 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.52 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.9 t80 -69.28 -51.99 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.201 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.87 -68.52 0.49 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.185 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 65.43 8.77 5.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 110.447 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -52.43 -35.17 51.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -94.17 154.41 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.259 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.645 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.7 ttm -58.44 -19.03 33.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.255 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -40.98 -8.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.263 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.67 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.792 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.7 p90 -45.31 -16.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.818 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.46 -23.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.098 -178.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.4 mp -60.74 -35.52 76.57 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.738 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.47 -41.15 96.79 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.459 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 56.3 t0 -63.27 -55.27 26.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.561 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 tp -64.93 -40.21 94.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.847 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.7 tt -69.56 -46.83 65.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.74 -36.66 67.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.632 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.443 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 42.5 t -70.58 -62.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.532 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -69.55 -39.85 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.12 -52.52 52.88 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.512 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 114' ' ' LEU . 6.8 p -64.7 -36.34 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.689 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.95 -53.52 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -56.91 -41.56 78.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.52 8.92 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.778 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.595 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.8 m -66.07 -41.93 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.551 HG23 ' CD2' ' A' ' 127' ' ' HIS . 47.2 m -58.9 -46.31 88.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.58 -33.37 71.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 81' ' ' PRO . . . -78.46 -63.91 1.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.595 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 33.9 m0 -64.57 -43.71 93.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.564 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -58.2 -41.73 84.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.391 -177.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -60.64 -43.75 97.18 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.2 t -79.97 -46.79 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.416 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 67' ' ' VAL . 22.9 p -135.64 93.55 15.92 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.483 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 53.2 Cg_exo -54.7 -39.13 90.69 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.84 1.694 . . . . 0.0 113.101 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 44.7 Cg_exo -55.67 -27.97 63.66 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.536 0.824 . . . . 0.0 112.652 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.66 71.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.81 -40.14 87.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.123 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.436 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 75.1 ttt180 -60.76 -39.68 89.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.5 -37.41 65.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.506 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 76.0 mt -65.06 13.25 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -46.09 -42.53 27.42 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.506 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 17.9 Cg_endo -67.14 -19.84 50.58 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.985 1.388 . . . . 0.0 112.885 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.45 -38.46 87.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 24.9 tp -65.94 -38.85 89.69 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.668 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.73 76.28 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.764 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.604 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -68.45 -52.02 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.366 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' A' ' 140' ' ' TYR . 34.1 mt -64.35 -33.85 76.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -60.72 -46.56 89.95 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.608 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.775 ' CE2' HD22 ' A' ' 150' ' ' LEU . 24.0 t80 -64.07 -40.09 95.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.522 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.7 m -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.375 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.9 m -63.95 -48.21 77.4 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.392 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.84 -40.48 78.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.172 0.511 . . . . 0.0 110.564 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.775 HD22 ' CE2' ' A' ' 146' ' ' PHE . 58.6 tp -55.04 -54.32 44.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.558 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.459 ' OD1' ' CG ' ' A' ' 111' ' ' ASP . 9.4 m120 -63.36 -36.65 84.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.602 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.487 ' CE2' ' NH1' ' A' ' 156' ' ' ARG . 20.8 t80 -58.4 -42.27 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.592 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.427 ' HA ' HH12 ' A' ' 156' ' ' ARG . 61.5 t80 -63.36 -47.0 83.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.03 -48.5 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.818 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 2.2 m95 -63.5 -39.35 94.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.662 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.487 ' NH1' ' CE2' ' A' ' 152' ' ' TYR . 29.8 ttp-105 -57.88 -37.79 74.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.358 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.97 -43.06 95.31 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.3 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -89.9 -49.48 6.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 155' ' ' TRP . 70.0 p -63.31 -24.53 67.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -53.16 -29.29 36.21 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -54.8 -33.88 62.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.753 0.311 . . . . 0.0 110.328 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -57.9 -33.38 68.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.55 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -84.12 -175.2 50.75 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.23 -179.57 17.28 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.6 m -117.58 148.85 41.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.55 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -57.42 -33.02 67.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.176 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.4 mm? -93.53 143.48 26.26 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.689 -0.404 . . . . 0.0 109.922 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -87.87 119.2 27.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.98 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.512 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.525 ' C10' ' CH2' ' A' ' 143' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.788 0.328 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -56.87 -20.35 35.63 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.28 1.986 . . . . 0.0 112.386 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.31 -31.34 32.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.465 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.0 t -61.0 -41.56 96.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.396 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -73.65 -33.92 64.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.934 0.397 . . . . 0.0 111.955 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t -41.03 -49.85 7.9 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.0 Cg_endo -57.05 -20.17 36.2 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 CA-C-N 119.231 0.761 . . . . 0.0 112.513 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -33.78 54.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.124 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.509 ' O ' HG22 ' A' ' 12' ' ' THR . 74.4 t -60.42 -40.74 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.03 92.83 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.36 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.85 -41.67 82.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.863 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.1 t -78.83 -35.97 43.21 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.105 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.34 -37.03 84.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.5 t -52.35 -55.93 27.14 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 14.9 Cg_endo -58.98 -34.5 99.18 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 120.697 0.931 . . . . 0.0 113.124 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.14 -37.16 79.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.146 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.0 -39.5 94.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.48 -48.35 69.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.784 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.76 96.8 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.248 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -58.65 -45.63 88.92 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.607 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -61.78 -38.77 89.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.135 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.93 93.85 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.22 -26.61 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.975 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -35.52 69.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.081 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 65.0 t80 -61.34 -46.0 92.06 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.271 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG11 'CL ' ' A' ' 201' ' ' PKA . 1.0 OUTLIER -73.38 -33.14 39.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.0 109.568 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -62.5 -40.67 97.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.531 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.87 -128.92 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.915 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.98 -27.72 61.7 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.698 0.285 . . . . 0.0 110.934 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.24 -32.27 6.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.624 ' CD2' ' HE ' ' A' ' 46' ' ' ARG . 94.9 mt -51.55 -45.06 62.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -65.39 -40.9 94.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 111.563 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -57.83 -37.48 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.23 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 78.6 m-85 -63.89 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.979 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -43.97 -41.91 5.62 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.353 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.5 -32.19 71.36 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 34' ' ' TYR . 34.4 mt -92.52 154.55 18.38 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.311 -0.444 . . . . 0.0 111.069 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 93.5 mm-40 -103.19 129.13 50.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mttp -103.23 145.15 30.05 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -57.08 136.1 74.59 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 120.881 1.054 . . . . 0.0 111.122 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.8 p -64.54 -25.92 68.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.005 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -79.45 -4.86 53.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.574 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.607 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.8 t-80 -53.85 130.06 56.65 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.637 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.607 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.8 Cg_endo -87.12 170.94 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.073 1.849 . . . . 0.0 111.219 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 28.6 Cg_exo -49.92 138.39 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 120.42 0.746 . . . . 0.0 110.911 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.624 ' HE ' ' CD2' ' A' ' 31' ' ' LEU . 38.1 mtt-85 -59.61 -36.49 76.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 8.0 p90 -72.6 -19.55 61.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.742 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -66.46 -63.35 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.871 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.997 ' O ' HG23 ' A' ' 52' ' ' ILE . 85.4 mt -71.9 -33.07 68.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.63 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.38 -50.11 2.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.814 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 10.2 Cg_endo -70.77 2.19 4.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.342 2.028 . . . . 0.0 114.286 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' O ' ' A' ' 49' ' ' LEU . 23.8 pt -45.22 -38.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.199 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.406 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.8 m95 -52.18 -29.11 20.8 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.718 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.01 -44.33 92.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.567 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -74.04 -44.76 53.18 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.199 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.74 -33.07 75.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.179 0.514 . . . . 0.0 109.664 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.41 -57.55 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.841 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -66.0 -38.72 89.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.812 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.44 90.76 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.6 mtt -61.14 -37.86 84.34 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.33 -54.0 22.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 88.8 t80 -63.11 -39.32 94.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.962 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.7 -41.36 74.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 90.8 p -66.28 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.431 ' HA ' ' CE2' ' A' ' 68' ' ' TRP . 56.0 t80 -56.44 -48.69 76.49 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.46 -39.71 86.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.201 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG22 ' OG ' ' A' ' 130' ' ' SER . 52.5 t -57.4 -49.02 81.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.3 p90 -73.64 -26.13 60.62 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.084 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CE ' ' CZ ' ' A' ' 65' ' ' TYR . 70.2 mmtt -59.87 -37.64 79.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.324 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 77.2 mt-10 -67.67 -41.03 84.39 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.374 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.3 mt -72.83 -25.81 61.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.754 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 103.42 45.9 1.5 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.98 -168.03 35.17 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.627 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.54 109.98 17.23 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.709 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.1 t -128.74 164.55 22.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.611 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -52.43 -37.88 57.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.414 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' H ' HG23 ' A' ' 75' ' ' THR . 85.2 m-20 -63.65 -38.96 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.714 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.45 71.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.627 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 82.0 mmm -59.22 -33.01 70.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.476 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.36 -56.96 26.11 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.957 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -65.14 -52.78 1.03 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.654 0.903 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.6 mp -63.29 -42.37 99.08 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.411 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.45 -38.33 95.58 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.7 tp -57.86 -40.0 79.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.727 0.299 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -60.67 -45.99 92.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.549 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.5 m -67.74 -41.57 83.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.076 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.52 -55.15 5.66 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.431 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -57.9 -41.37 82.49 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.23 -37.97 84.95 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.061 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.95 86.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.472 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.26 -39.14 85.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.456 ' ND2' ' CA ' ' A' ' 117' ' ' GLY . 39.3 t-20 -64.44 -37.79 88.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.325 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -53.99 -32.18 53.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.19 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.22 70.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -55.84 -56.81 26.24 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.37 130.26 39.65 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 120.721 0.947 . . . . 0.0 112.969 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -107.63 -24.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.568 1.512 . . . . 0.0 110.372 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.861 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 34.7 pt -60.54 -28.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.884 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 24.3 p90 -55.8 -44.34 77.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.2 t80 -65.42 -50.29 66.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.677 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.75 -57.11 0.4 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.861 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 61.19 -1.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.566 0.222 . . . . 0.0 110.908 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 101' ' ' GLY . 61.6 ttt180 -54.58 -34.5 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.061 0.458 . . . . 0.0 110.376 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -86.15 157.9 19.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.222 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.1 tpp -57.4 -13.74 3.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.471 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.07 -1.58 0.01 OUTLIER Glycine 0 CA--C 1.539 1.539 0 C-N-CA 121.703 -0.284 . . . . 0.0 112.418 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.702 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.83 -22.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.411 -0.464 . . . . 0.0 111.079 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.591 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.8 -28.13 68.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.202 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.58 -30.34 68.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.59 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -59.42 -37.46 78.1 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.474 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 t0 -63.01 -44.21 96.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.0 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.01 -53.32 55.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.1 -40.37 96.07 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.77 ' CD2' HG21 ' A' ' 147' ' ' THR . 19.9 tp -51.03 -63.8 1.01 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.938 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.613 ' HA ' HD13 ' A' ' 144' ' ' LEU . 88.1 t -69.53 -55.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.942 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 t -67.63 -44.9 76.87 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.456 ' CA ' ' ND2' ' A' ' 92' ' ' ASN . . . -56.72 -48.35 78.4 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.499 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -74.21 -46.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.392 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -54.23 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.2 m -59.91 -44.18 94.42 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.32 -58.27 3.94 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.149 -0.621 . . . . 0.0 112.183 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.613 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.2 m -64.79 -40.95 96.07 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 76.7 m -60.01 -45.92 91.17 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.49 -37.32 87.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.83 -63.52 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.613 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.94 -42.3 97.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.419 ' CB ' ' O ' ' A' ' 123' ' ' THR . 29.0 t-80 -59.61 -48.21 82.54 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.322 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.72 -43.4 93.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.894 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.483 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 93.4 t -78.51 -47.8 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 67' ' ' VAL . 51.1 p -133.42 90.42 29.48 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.5 Cg_exo -55.32 -42.65 66.3 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.712 1.608 . . . . 0.0 112.541 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 21.7 Cg_exo -57.23 -28.48 79.72 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 120.323 0.682 . . . . 0.0 111.987 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -31.41 71.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.101 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.17 81.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.277 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -58.03 -39.24 77.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 110.206 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.05 -36.76 78.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.897 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 71.7 mt -67.47 -5.19 13.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.086 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -25.3 -58.75 0.16 Allowed Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.27 -28.99 79.49 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 120.643 0.895 . . . . 0.0 113.273 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -57.43 -45.09 85.05 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.473 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 22.8 tp -65.39 -39.75 92.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.01 82.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.133 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.659 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.7 t-105 -64.06 -45.6 88.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.571 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.613 HD13 ' HA ' ' A' ' 115' ' ' VAL . 40.4 mt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.33 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.28 97.01 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.321 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 67.6 t80 -63.64 -44.53 93.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.116 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.77 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.1 m -62.74 -42.4 99.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.737 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.1 m -57.37 -49.83 74.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.399 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.19 -41.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.325 0.583 . . . . 0.0 110.75 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.604 HD12 ' CZ ' ' A' ' 146' ' ' PHE . 9.6 tt -60.33 -44.12 95.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.322 -0.853 . . . . 0.0 112.028 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.71 ' OD1' HG22 ' A' ' 147' ' ' THR . 18.0 m120 -64.28 -41.0 97.1 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.38 -36.82 85.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.041 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -57.03 -44.8 83.25 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.546 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.76 -47.12 80.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.667 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.566 ' NE1' ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -64.32 -45.43 87.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.521 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 160' ' ' GLY . 70.7 mtm180 -61.04 -32.53 72.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.079 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 92.6 m-20 -52.95 -40.12 63.43 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -97.46 -56.75 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.288 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.456 ' HG ' ' HA ' ' A' ' 156' ' ' ARG . 88.7 p -63.08 -22.71 67.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.904 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -49.33 -27.88 8.44 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -56.11 -30.77 62.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.937 0.399 . . . . 0.0 110.268 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -117.08 146.71 42.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -130.74 58.0 0.71 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -79.61 -176.33 48.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.2 p -68.97 162.35 26.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -56.78 -34.18 67.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.068 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.65 146.42 23.84 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 110.075 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -137.31 147.46 45.65 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 168' ' ' ALA . 96.2 mt-10 . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.533 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.508 'CL ' ' HA ' ' A' ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.63 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.3 mmm . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -56.37 -23.85 48.85 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.546 1.497 . . . . 0.0 111.676 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.26 -32.34 72.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.201 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -61.5 -42.92 99.53 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.456 ' CD1' ' CE3' ' A' ' 68' ' ' TRP . 7.4 m0 -72.9 -33.14 65.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 111.964 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.406 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.2 t -42.73 -44.25 9.81 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 29.6 Cg_exo -54.35 -22.46 26.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 120.72 0.946 . . . . 0.0 112.153 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.18 -32.01 45.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.695 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' THR . 72.1 t -59.93 -41.84 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.68 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -62.56 -35.92 92.47 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.8 mp -58.44 -42.02 86.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.682 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.7 t -76.71 -34.35 58.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.845 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' OG ' ' A' ' 16' ' ' SER . 95.7 mt -67.47 -34.69 77.67 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 10' ' ' GLY . 13.0 t -46.95 -56.2 12.67 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.85 -29.19 87.66 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 120.826 1.017 . . . . 0.0 113.347 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 79.7 p -61.17 -36.74 80.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.612 -0.435 . . . . 0.0 112.061 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.7 -39.22 93.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.288 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.12 -40.14 98.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.55 99.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.236 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE1' ' CZ3' ' A' ' 53' ' ' TRP . 57.9 m-85 -61.86 -49.09 77.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.916 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.6 mtm -64.88 -40.35 94.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.438 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.55 60.9 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.837 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.537 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -75.05 -22.45 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.158 0.504 . . . . 0.0 111.015 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -35.35 69.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.764 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 58.8 t80 -60.7 -48.15 83.09 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.1 -31.48 29.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' HD11 ' A' ' 31' ' ' LEU . 28.3 ttt-85 -60.6 -42.55 97.02 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.323 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -129.35 5.41 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.996 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.56 -29.65 3.0 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.588 0.233 . . . . 0.0 110.442 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.39 -35.24 27.89 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.5 mt -50.5 -45.19 56.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -62.71 -38.55 90.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -58.62 -38.02 77.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.298 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' LEU . 86.9 m-85 -62.05 -22.36 65.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.742 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.83 -32.36 1.54 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.079 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.18 -32.3 20.61 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 34' ' ' TYR . 56.0 mt -93.35 150.52 20.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.992 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -98.3 132.61 43.64 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.865 ' HZ1' HH21 ' A' ' 46' ' ' ARG . 42.1 mttt -105.82 145.54 31.08 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 38.7 Cg_endo -60.91 143.36 99.34 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.454 1.436 . . . . 0.0 112.212 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.1 p -64.27 -29.93 71.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.526 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 41.6 p90 -78.32 3.24 16.06 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.106 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.031 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.75 167.7 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.181 1.254 . . . . 0.0 111.842 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 34.9 Cg_exo -52.44 140.87 52.94 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.65 1.567 . . . . 0.0 111.533 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.865 HH21 ' HZ1' ' A' ' 39' ' ' LYS . 39.4 mtt85 -61.77 -35.63 78.7 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.611 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 8.0 p90 -72.25 -14.58 61.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -76.94 -67.18 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.002 0.429 . . . . 0.0 110.663 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.028 ' O ' HG23 ' A' ' 52' ' ' ILE . 81.2 mt -67.52 -33.07 74.34 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.744 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.72 -41.12 5.49 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.789 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 71.0 Cg_exo -64.21 -9.53 20.09 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 123.239 2.626 . . . . 0.0 113.953 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.028 HG23 ' O ' ' A' ' 49' ' ' LEU . 32.1 pt -45.11 -32.5 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.773 0.32 . . . . 0.0 111.252 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.599 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 6.2 m0 -53.61 -31.27 46.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.34 -43.81 95.46 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.9 p -71.75 -44.87 63.32 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.611 -0.347 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.94 -33.69 76.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.865 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -61.18 -50.98 70.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.376 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -73.36 -33.71 65.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.82 89.13 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.845 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtt -64.25 -36.94 85.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.567 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.41 -64.5 3.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.53 -37.32 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.125 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.89 -42.7 60.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 86.9 p -67.14 -26.75 66.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.59 0.233 . . . . 0.0 110.544 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.75 -49.69 72.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 110.356 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.31 -35.02 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.641 HG22 ' OG ' ' A' ' 130' ' ' SER . 74.2 t -55.77 -46.75 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.001 -177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.456 ' CE3' ' CD1' ' A' ' 5' ' ' TRP . 1.6 p90 -74.22 -31.54 62.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.145 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 68.3 mmtt -59.76 -39.08 83.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.215 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.82 -38.4 88.83 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.85 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.14 -13.18 56.11 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.945 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 98.07 1.6 58.31 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.61 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 136.09 -166.5 24.65 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.716 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.92 102.09 11.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.369 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.508 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 1.4 p -124.33 164.92 18.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.21 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.43 -37.03 10.79 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.341 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.31 -45.0 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.245 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.508 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -74.64 -35.14 62.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 111.392 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.716 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.3 mmm -58.7 -34.03 70.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -60.21 -60.73 9.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.65 -50.29 11.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.997 1.131 . . . . 0.0 112.151 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.8 mp -65.89 -40.85 91.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.852 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.92 96.73 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.53 -40.01 85.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 68.5 t80 -60.93 -45.58 94.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.742 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 m -65.23 -42.93 92.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.0 -57.55 3.69 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.37 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -57.19 -41.98 80.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.419 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 41.4 tp -62.93 -39.22 93.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.91 65.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.153 0.502 . . . . 0.0 110.338 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.45 -38.61 84.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 113' ' ' LEU . 50.3 t-20 -61.49 -40.67 95.43 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.272 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.546 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 33.0 m95 -58.11 -27.93 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.77 -23.0 65.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.019 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.497 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 20.0 t-105 -54.13 -64.43 1.88 Allowed Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.546 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 86.2 Cg_endo -55.46 130.36 40.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.992 1.795 . . . . 0.0 112.584 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -100.81 -15.55 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.34 1.36 . . . . 0.0 111.105 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.858 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.7 pt -59.37 -30.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.29 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.548 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 30.7 p90 -55.63 -44.76 77.42 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.913 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.548 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 71.6 t80 -64.86 -48.94 72.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.08 -59.62 0.42 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.09 -1.92 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.691 0.281 . . . . 0.0 110.836 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.4 ttt180 -52.91 -35.71 58.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.957 0.408 . . . . 0.0 110.44 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -87.83 157.46 19.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.365 0.602 . . . . 0.0 111.797 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.716 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.0 ttm -56.32 -13.56 2.26 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.684 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.08 -2.59 0.01 OUTLIER Glycine 0 CA--C 1.541 1.673 0 C-N-CA 121.493 -0.384 . . . . 0.0 112.637 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.716 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.36 -20.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.475 -0.427 . . . . 0.0 111.273 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.02 -28.51 67.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.89 -30.92 70.45 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.269 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.571 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.11 -35.89 76.23 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.485 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.5 t0 -64.65 -46.09 83.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 tp -63.99 -48.39 76.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.8 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.5 tt -64.95 -40.3 94.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.493 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.764 ' CD2' HG21 ' A' ' 147' ' ' THR . 21.2 tp -55.02 -63.75 1.05 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.311 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.579 ' HA ' HD13 ' A' ' 144' ' ' LEU . 96.9 t -67.04 -53.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -75.32 -41.74 56.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.87 85.64 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.675 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 t -71.44 -45.46 68.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.039 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.83 -57.35 4.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 m -57.23 -44.67 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -55.35 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.96 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.647 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.3 m -65.18 -41.5 94.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.832 HG23 ' CE1' ' A' ' 127' ' ' HIS . 83.8 m -59.67 -46.8 87.94 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.16 -35.64 80.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.79 -63.01 1.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.647 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.96 -43.98 94.14 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.832 ' CE1' HG23 ' A' ' 123' ' ' THR . 25.2 m170 -59.67 -45.61 91.53 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.621 -0.831 . . . . 0.0 111.616 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.35 -41.37 96.94 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.339 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.8 t -80.78 -49.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.641 ' OG ' HG22 ' A' ' 67' ' ' VAL . 3.8 p -132.01 89.64 37.7 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.255 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.9 Cg_exo -53.85 -41.89 70.99 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.943 1.762 . . . . 0.0 113.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.9 Cg_exo -55.72 -31.52 80.43 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.613 0.875 . . . . 0.0 112.721 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.32 67.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.462 . . . . 0.0 110.652 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.6 87.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.871 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.529 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 71.5 mtm180 -63.61 -37.98 89.39 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.913 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -51.63 -38.55 55.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.498 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 70.6 mt -57.65 -31.3 66.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.171 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER 4.42 -65.43 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.9 Cg_endo -51.56 -28.5 28.91 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 120.867 1.044 . . . . 0.0 112.847 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -61.9 -35.38 78.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.002 0.43 . . . . 0.0 110.319 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.701 ' O ' HD13 ' A' ' 141' ' ' LEU . 3.2 tm? -67.12 -45.49 77.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.064 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.46 41.04 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.604 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 3.6 t-105 -61.4 -50.81 71.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.453 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 115' ' ' VAL . 52.6 mt -64.3 -31.83 73.18 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.03 -45.36 93.9 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.711 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.732 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 19.0 t80 -66.99 -44.74 79.65 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.483 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.764 HG21 ' CD2' ' A' ' 114' ' ' LEU . 4.1 m -56.91 -42.07 79.26 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.427 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.6 m -60.65 -50.48 73.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.935 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.4 -40.98 85.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.345 0.593 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.732 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 17.6 tp -55.61 -46.07 77.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.739 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.713 HD21 HG22 ' A' ' 147' ' ' THR . 69.1 m-80 -62.65 -38.89 92.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -64.11 -39.94 95.13 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.422 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -60.09 -45.89 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.939 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.49 -47.14 78.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.576 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -67.93 -41.45 82.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.349 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -57.67 -41.88 82.46 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.885 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -63.49 -49.57 73.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.112 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.55 -43.04 67.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.324 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.5 p -66.87 -26.84 67.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.435 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -55.21 -33.26 57.78 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -56.87 -31.95 65.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.72 0.295 . . . . 0.0 111.26 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -53.76 -35.32 61.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.088 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -52.6 -34.85 44.07 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.438 ' O ' HD22 ' A' ' 167' ' ' LEU . . . -56.11 -31.39 58.92 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 88.3 p -60.27 -26.42 66.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.555 0.217 . . . . 0.0 110.862 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -53.49 -37.59 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.732 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.438 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -63.52 -33.33 75.35 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.427 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -76.01 126.68 31.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.536 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 92.4 mt-10 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.546 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.537 'CL ' ' HA ' ' A' ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.657 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 1' ' ' MET . 40.1 Cg_endo -55.8 -19.55 25.35 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.426 2.084 . . . . 0.0 112.066 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.91 -33.28 68.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.997 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.6 p -63.4 -38.62 91.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.397 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.611 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 11.2 m0 -75.13 -32.42 61.35 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.698 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.6 t -40.79 -54.57 5.19 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.184 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 14.3 Cg_endo -59.62 -23.61 71.98 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 120.316 0.678 . . . . 0.0 111.443 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 5' ' ' TRP . . . -56.2 -34.62 66.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.197 0.522 . . . . 0.0 110.384 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.43 -41.07 86.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.86 -35.68 91.68 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.1 -44.87 87.9 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 t -79.11 -37.19 39.29 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.21 -31.83 73.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.5 t -47.14 -56.47 12.1 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.68 ' HB3' HD21 ' A' ' 89' ' ' LEU . 7.7 Cg_endo -60.45 -28.79 87.38 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.073 1.182 . . . . 0.0 113.25 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.0 m -57.29 -39.26 75.38 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.249 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.79 -40.17 91.69 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.006 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.25 -49.27 47.22 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.98 93.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.39 -43.51 88.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.92 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.9 mtt -60.75 -40.05 91.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.263 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.64 83.32 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.19 -29.16 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.295 0.569 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -36.15 73.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.468 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 62.0 t80 -61.15 -47.55 85.72 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.2 m -71.26 -31.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.839 0.828 . . . . 0.0 109.337 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -67.47 -41.03 85.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.781 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.91 -120.37 0.66 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.343 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.77 -28.51 61.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.899 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.93 -32.81 19.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.6 mt -49.93 -46.98 52.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.326 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -62.98 -39.89 96.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.55 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -59.64 -39.92 85.95 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.108 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 37' ' ' LEU . 76.2 m-85 -63.93 -23.07 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.08 -42.76 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.6 75.15 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 34' ' ' TYR . 38.8 mt -91.55 152.19 20.41 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.064 0.459 . . . . 0.0 111.454 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.545 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.9 mt-30 -101.16 129.09 47.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.657 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 31.7 mttt -100.14 142.86 25.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 56.1 Cg_endo -59.38 135.59 66.2 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.206 1.271 . . . . 0.0 111.702 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.3 p -68.59 -23.32 64.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.307 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 10.4 p90 -78.55 -10.19 59.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.579 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.596 ' NE2' ' O ' ' A' ' 44' ' ' PRO . 1.5 t-80 -69.99 133.49 88.0 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.46 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.596 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 18.2 Cg_endo -75.97 163.2 33.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.243 1.295 . . . . 0.0 110.675 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.0 Cg_endo -50.13 146.7 17.05 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 120.48 0.786 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.657 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 62.8 mtt180 -57.52 -37.08 72.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 48' ' ' THR . 4.5 p90 -63.34 -31.05 72.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.654 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 16.1 m -63.18 -55.67 23.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 96.4 mt -73.24 -35.6 66.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.41 -50.18 3.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.441 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 17.9 Cg_endo -71.01 6.54 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.979 1.786 . . . . 0.0 113.822 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.996 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.8 pt -44.21 -33.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.257 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.611 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.1 m-90 -53.54 -28.24 30.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.875 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 57' ' ' TYR . . . -52.52 -38.59 51.78 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.7 t -87.1 -41.74 13.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.684 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.634 HD11 ' CD1' ' A' ' 143' ' ' TRP . 9.8 mt -61.25 -38.97 88.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 58' ' ' SER . 1.4 p90 -64.6 -43.64 93.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.906 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 26.9 m -61.2 -39.75 91.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.34 99.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.492 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mtt -63.08 -36.15 82.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.67 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.08 -65.22 2.95 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.36 -38.46 87.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.84 -43.12 81.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.5 p -64.88 -27.54 68.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.851 0.358 . . . . 0.0 110.041 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' CE2' ' CZ2' ' A' ' 5' ' ' TRP . 30.6 t80 -57.98 -44.49 87.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.48 -42.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.9 -37.94 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.592 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.7 -37.8 85.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.931 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -64.59 -45.23 87.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -68.92 -39.56 79.56 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . 49.4 mt -91.48 -0.51 57.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.39 5.99 66.7 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.24 -165.79 30.42 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.466 -0.397 . . . . 0.0 112.301 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.08 80.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.292 0.568 . . . . 0.0 111.511 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.485 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 6.9 p -125.59 162.04 25.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.764 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -44.32 -38.87 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.99 -46.33 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.738 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 73' ' ' GLY . . . -76.33 -32.79 58.88 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.3 mtp -56.53 -32.8 65.46 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.235 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.28 -47.2 94.83 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.725 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -66.16 -56.72 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.617 0.878 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.7 mp -60.04 -41.35 92.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.94 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.86 93.52 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.0 -39.58 78.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.877 0.37 . . . . 0.0 110.049 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.462 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 81.0 t80 -60.07 -44.8 94.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 48.8 m -68.51 -41.35 80.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.56 -64.21 2.54 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.653 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -57.16 -40.61 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.853 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 15' ' ' PRO . 30.2 tp -63.01 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -49.92 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.57 -38.71 85.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 63.7 t30 -62.14 -41.15 97.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.351 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.473 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 35.5 m95 -56.75 -30.58 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.747 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.94 -24.38 66.06 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' PRO . 14.5 t-105 -54.99 -70.92 0.26 Allowed Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 53.0 Cg_endo -43.32 82.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.949 1.766 . . . . 0.0 112.641 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' N ' ' O ' ' A' ' 95' ' ' TRP . 90.3 Cg_endo -58.91 -16.84 33.96 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.108 1.872 . . . . 0.0 112.57 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.721 HG21 ' HA ' ' A' ' 107' ' ' TRP . 33.6 pt -59.01 -25.03 28.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.049 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.36 -44.63 17.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.492 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 67.3 t80 -66.95 -50.39 62.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.76 -68.99 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.271 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 62.12 7.22 2.07 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -50.5 -35.94 31.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.251 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -90.36 153.43 20.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.678 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.647 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ttp -59.02 -16.45 18.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.03 13.84 0.01 OUTLIER Glycine 0 CA--C 1.539 1.568 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.194 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.721 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.8 p90 -60.5 -18.7 53.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.923 0.862 . . . . 0.0 112.02 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.39 -19.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.3 mp -62.46 -35.13 78.34 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.814 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.63 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.9 -38.69 89.31 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.2 t0 -62.24 -45.13 94.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.409 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 tp -63.29 -47.64 81.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.625 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.4 tt -68.92 -40.96 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.518 0.675 . . . . 0.0 109.965 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.7 HD21 HG21 ' A' ' 147' ' ' THR . 18.2 tp -52.21 -60.31 3.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.095 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 144' ' ' LEU . 67.4 t -69.83 -57.11 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.737 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 120' ' ' THR . 25.4 t -67.92 -41.74 82.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -56.55 -48.12 79.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.457 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 119' ' ' ALA . 1.2 t -71.09 -46.61 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.511 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -74.46 -54.96 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' SER . 26.6 m -57.41 -44.3 84.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.96 3.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.825 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.652 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 26.8 m -62.13 -40.28 95.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.51 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 82.2 m -61.65 -44.74 96.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.98 -36.69 84.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.26 -63.6 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.652 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.5 m0 -66.92 -42.33 85.58 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 52.0 t-80 -58.03 -47.28 83.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.241 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.53 -44.4 94.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.61 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.63 -49.96 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -132.49 89.94 34.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.464 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 41.1 Cg_exo -52.54 -41.21 69.5 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.447 1.431 . . . . 0.0 112.786 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.1 Cg_exo -57.45 -28.27 79.81 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 120.348 0.699 . . . . 0.0 112.713 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.58 71.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.142 0.496 . . . . 0.0 110.281 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.16 90.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.3 ttt-85 -59.11 -39.85 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.5 tp -57.33 -38.07 73.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.088 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.617 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.7 mt -57.91 -31.28 66.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.385 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 8.56 -68.74 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' A' ' 137' ' ' LEU . 4.8 Cg_endo -49.74 -27.37 15.18 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 120.727 0.951 . . . . 0.0 113.072 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -61.77 -40.72 96.13 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.103 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -66.57 -41.98 87.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.734 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.58 -51.74 26.31 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.634 ' CD1' HD11 ' A' ' 56' ' ' LEU . 2.7 t-105 -61.54 -49.61 75.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.05 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 115' ' ' VAL . 52.2 mt -64.44 -34.16 77.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.66 -40.06 95.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.883 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.76 ' CE2' HD22 ' A' ' 150' ' ' LEU . 24.3 t80 -60.86 -42.06 97.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.568 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.7 HG21 HD21 ' A' ' 114' ' ' LEU . 79.7 p -61.49 -35.59 78.09 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.537 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.3 m -63.95 -52.38 59.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.042 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.0 -42.64 82.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.113 0.483 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.76 HD22 ' CE2' ' A' ' 146' ' ' PHE . 61.6 tp -56.26 -41.48 75.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.234 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.43 -42.32 96.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -64.56 -40.5 95.68 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.472 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -59.97 -46.93 87.83 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.632 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.9 -45.5 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.693 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.5 m95 -59.82 -40.36 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HA ' ' H ' ' A' ' 160' ' ' GLY . 94.4 mtt-85 -60.07 -30.04 68.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.578 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 95.1 m-20 -50.37 -39.97 48.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.15 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -102.13 -60.5 1.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.278 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.518 ' OG ' ' NH2' ' A' ' 162' ' ' ARG . 22.8 t -60.45 -36.13 77.49 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.848 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 156' ' ' ARG . . . -52.78 -31.92 39.39 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -54.75 -34.81 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.38 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.518 ' NH2' ' OG ' ' A' ' 159' ' ' SER . 78.4 mtm180 -55.56 -34.52 64.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.482 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.87 -177.81 50.14 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.47 -159.58 38.86 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.0 t -85.13 145.23 27.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.901 0.381 . . . . 0.0 110.71 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -57.21 -32.03 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.935 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.541 ' H ' HD22 ' A' ' 167' ' ' LEU . 1.0 OUTLIER -86.3 145.6 26.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.966 0.412 . . . . 0.0 110.0 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -83.4 124.79 31.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.672 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 91.4 mt-10 . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.558 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.448 ' C6 ' ' NE2' ' A' ' 43' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 mmt . . . . . 0 C--O 1.232 0.163 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -56.11 -24.57 50.22 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.394 1.396 . . . . 0.0 111.426 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -59.87 -31.07 69.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.199 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -61.49 -40.64 95.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.373 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -73.57 -34.88 65.35 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t -41.15 -41.14 3.02 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.562 ' O ' HD13 ' A' ' 11' ' ' LEU . 87.2 Cg_exo -53.62 -22.33 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.137 1.224 . . . . 0.0 112.346 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.48 62.86 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.932 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 12' ' ' THR . 73.3 t -62.64 -44.02 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.5 89.93 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.334 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.7 mp -56.53 -40.9 75.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 111.265 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.5 t -79.0 -32.9 45.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 13' ' ' LEU . 96.7 mt -61.72 -37.45 84.24 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 t -53.75 -42.78 94.33 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.416 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.46 -37.44 71.16 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.392 1.395 . . . . 0.0 113.348 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.9 m -60.05 -38.58 83.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.92 -38.94 87.53 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.417 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.36 99.88 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.106 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.79 -42.18 97.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.963 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -61.89 -39.66 92.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -60.76 -39.34 88.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.675 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.54 -46.48 25.12 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.529 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.53 -22.85 62.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.231 0.538 . . . . 0.0 110.209 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -55.68 -33.47 64.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 29.8 t80 -64.6 -49.88 69.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.394 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.49 -37.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.791 0.805 . . . . 0.0 109.65 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -59.27 -39.83 84.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.351 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -129.12 2.23 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.695 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.87 -27.03 62.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 110.981 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -32.39 10.07 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -50.76 -45.25 58.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.835 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -60.57 -41.91 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.23 -41.46 98.42 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 23.0 m-85 -64.02 -22.89 67.12 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.689 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.44 -41.46 52.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.003 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.36 -29.86 74.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 34' ' ' TYR . 50.2 mt -91.14 150.11 21.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.544 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -100.9 128.63 46.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 18.8 mtpp -109.9 139.22 21.09 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 39.2 Cg_endo -60.41 130.71 34.93 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.172 1.248 . . . . 0.0 112.515 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.4 m -66.67 -23.1 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.206 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.51 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.7 p90 -75.91 -15.5 60.18 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.606 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 1.2 p80 -72.62 143.29 84.75 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.429 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -69.42 161.97 43.78 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.808 1.005 . . . . 0.0 110.849 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.27 152.76 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.144 1.23 . . . . 0.0 110.931 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -55.57 -36.24 66.63 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 9.2 p90 -71.88 -14.67 62.01 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.886 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -80.06 -68.4 0.68 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.29 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.8 mt -62.11 -34.61 76.65 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.556 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.655 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -44.97 -41.8 13.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.724 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 85.4 Cg_exo -63.62 -8.64 15.79 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 123.217 2.611 . . . . 0.0 113.958 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.996 HG23 ' O ' ' A' ' 49' ' ' LEU . 25.3 pt -40.99 -40.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.369 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.455 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.9 m95 -53.21 -33.7 53.93 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.172 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.0 -38.88 96.24 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.0 m -68.52 -51.74 39.76 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.067 0.46 . . . . 0.0 110.616 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -66.25 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.923 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' TRP . 20.9 t80 -50.86 -53.32 33.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.022 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.8 p -67.9 -34.99 77.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.981 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.58 93.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.521 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.57 -38.14 90.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.56 -57.86 9.44 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.46 -0.876 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -62.43 -36.5 82.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.639 0.257 . . . . 0.0 111.287 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -42.8 84.31 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.427 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -65.36 -30.12 70.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.394 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -58.92 -43.84 91.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.416 . . . . 0.0 110.006 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.07 -40.11 82.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 109.967 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.534 HG13 HG11 ' A' ' 129' ' ' VAL . 55.1 t -61.02 -40.48 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.963 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -62.42 -49.56 74.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.517 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.595 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 75.2 mttt -54.44 -37.15 64.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.421 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -71.54 -43.61 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.495 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -77.89 -26.11 48.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.54 -3.6 46.54 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.76 -169.3 26.12 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.05 95.74 8.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.56 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 16.8 p -122.99 174.29 7.28 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.968 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.45 -35.37 39.3 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 87.7 m-20 -63.97 -39.88 95.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.411 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -84.73 -40.33 17.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.785 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.68 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.2 mmm -59.1 -36.17 74.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.531 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.94 -56.82 25.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.409 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 18.2 Cg_endo -62.94 -53.69 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.071 1.181 . . . . 0.0 112.234 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -63.53 -41.37 98.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.802 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.9 96.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.29 -38.97 78.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -59.56 -44.88 93.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.484 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.8 m -69.67 -41.33 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.71 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.96 -61.93 2.76 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.982 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -55.92 -41.77 75.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.544 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.44 -39.14 93.69 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.332 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.015 0.436 . . . . 0.0 110.646 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.51 -38.42 84.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.554 ' O ' HD11 ' A' ' 113' ' ' LEU . 60.8 t30 -61.86 -41.66 98.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.562 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.534 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 30.5 m95 -57.41 -31.16 65.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.632 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.87 -23.53 66.02 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 97' ' ' PRO . 45.6 t-105 -58.46 -67.95 0.82 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 29.5 Cg_endo -38.68 81.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.25 1.967 . . . . 0.0 113.046 -177.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.585 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.4 Cg_endo -62.84 -21.84 73.4 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.141 1.894 . . . . 0.0 112.544 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.692 HG21 ' HA ' ' A' ' 107' ' ' TRP . 46.0 pt -59.83 -25.89 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.488 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.51 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.3 p90 -44.86 -41.81 7.42 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.279 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 72.5 t80 -66.76 -51.83 51.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.73 -69.05 0.5 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.813 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 63.12 8.01 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.589 0.233 . . . . 0.0 110.722 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.5 ttp85 -53.59 -33.9 56.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -88.45 149.08 23.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.598 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.668 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.1 ttm -60.43 -18.97 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -49.73 8.96 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.217 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.692 ' HA ' HG21 ' A' ' 98' ' ' ILE . 23.1 p-90 -49.36 -15.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.418 0.609 . . . . 0.0 112.018 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.728 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -36.39 -17.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.9 mp -66.34 -32.5 73.93 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.104 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.495 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.73 -56.68 15.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.472 ' OD1' HG22 ' A' ' 147' ' ' THR . 21.2 t70 -58.16 -44.48 87.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.53 -40.19 93.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.599 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 92' ' ' ASN . 5.5 tt -73.37 -45.76 53.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 113' ' ' LEU . 1.9 pp -74.08 -38.35 63.93 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.087 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.524 ' HA ' HD22 ' A' ' 144' ' ' LEU . 65.5 t -67.83 -44.6 85.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.58 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 120' ' ' THR . 42.3 t -84.72 -41.19 16.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 121' ' ' ALA . . . -55.15 -43.58 83.68 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.172 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 119' ' ' ALA . 0.9 OUTLIER -74.11 -48.65 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.655 0.264 . . . . 0.0 110.923 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -72.64 -57.25 4.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 116' ' ' SER . 37.4 m -59.82 -43.61 94.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 117' ' ' GLY . . . -71.87 -56.64 5.35 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.095 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.642 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.5 m -63.3 -41.99 99.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 87.7 m -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.55 -38.12 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.186 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.68 -63.91 1.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.642 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 43.0 m0 -65.74 -41.33 92.33 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.9 t-80 -59.51 -48.7 80.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.914 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -65.7 -45.21 83.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.798 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.534 HG11 HG13 ' A' ' 67' ' ' VAL . 86.3 t -76.6 -46.76 30.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.6 p -130.9 83.76 60.29 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.288 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.455 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.2 Cg_exo -51.3 -43.94 46.17 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.497 1.465 . . . . 0.0 112.433 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 20.8 Cg_exo -59.15 -32.19 96.75 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.565 0.843 . . . . 0.0 112.364 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.65 -29.02 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.54 91.4 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 79.6 mtt180 -62.57 -38.87 91.8 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.437 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.7 tp -52.53 -37.31 57.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.091 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 138' ' ' TYR . 54.0 mt -58.93 -27.55 65.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.291 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -2.92 -69.9 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.811 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 138' ' ' TYR . 11.8 Cg_endo -50.97 -26.51 18.61 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 120.653 0.902 . . . . 0.0 112.951 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -57.61 -43.71 84.95 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 31.2 tp -59.45 -39.91 85.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.352 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.91 92.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.059 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.586 ' NE1' HD12 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -67.36 -50.73 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.434 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 115' ' ' VAL . 28.6 mt -65.26 -32.34 73.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.029 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.49 -49.02 78.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.724 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.749 ' CZ ' HD13 ' A' ' 150' ' ' LEU . 30.7 t80 -64.43 -40.48 95.83 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.613 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 1.4 m -55.12 -43.79 74.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.503 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 60.8 p -67.98 -44.47 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.974 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.42 -42.05 92.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.52 0.676 . . . . 0.0 109.797 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.749 HD13 ' CZ ' ' A' ' 146' ' ' PHE . 53.2 tp -59.91 -38.23 81.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 147' ' ' THR . 3.2 m120 -61.67 -41.91 98.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 73.2 m-85 -65.82 -39.52 90.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.0 t80 -61.68 -45.08 95.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.761 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.96 -52.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.728 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 5.1 m0 -63.56 -42.32 98.37 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CG ' ' O ' ' A' ' 152' ' ' TYR . 24.5 mmt85 -60.81 -35.85 77.56 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.117 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 88.0 m-20 -59.33 -40.94 87.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.577 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -92.34 -55.89 3.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.717 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 155' ' ' TRP . 85.3 p -59.88 -25.26 64.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.313 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.13 -34.03 38.84 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -69.49 150.65 46.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -55.97 -34.14 65.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.799 0.333 . . . . 0.0 110.604 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.79 8.28 70.0 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.477 ' O ' HD22 ' A' ' 167' ' ' LEU . . . -53.67 -32.44 46.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.1 p -62.33 -25.75 68.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.541 0.21 . . . . 0.0 111.016 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -55.16 -36.49 65.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.016 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -61.18 -36.86 80.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.5 -32.23 73.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.816 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.604 -179.821 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.6 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.022 0.439 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 75.7 Cg_exo -55.84 145.92 70.11 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.514 2.143 . . . . 0.0 112.013 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.45 -36.39 80.27 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.181 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.2 m -64.91 -41.16 95.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.439 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.08 -31.56 61.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.821 0.343 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 2' ' ' PRO . 3.7 t -41.98 -41.7 4.96 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.535 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' O ' HD13 ' A' ' 11' ' ' LEU . 77.5 Cg_exo -54.31 -20.79 20.9 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 120.764 0.976 . . . . 0.0 111.806 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.36 -36.28 53.26 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 12' ' ' THR . 89.9 t -62.9 -42.01 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.19 -34.81 90.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.261 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.6 mp -57.52 -41.33 80.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.036 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 9' ' ' VAL . 6.9 t -76.8 -31.77 57.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.212 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.44 -32.83 73.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.823 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -44.44 -57.42 6.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 89' ' ' LEU . 17.9 Cg_endo -58.68 -32.77 97.55 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 121.013 1.142 . . . . 0.0 113.029 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -58.46 -39.14 79.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.422 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.07 -36.35 82.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.539 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.7 -58.16 7.26 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.006 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -36.29 82.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -57.71 -47.04 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.67 0.271 . . . . 0.0 110.979 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -64.48 -38.49 91.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.572 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.53 -42.24 97.56 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.627 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -68.45 -26.07 65.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.917 0.389 . . . . 0.0 111.701 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -32.6 65.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 51.4 t80 -60.51 -48.71 80.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -72.81 -31.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -63.21 -41.86 99.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.076 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.36 -126.26 4.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.91 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.22 -30.18 11.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.683 0.278 . . . . 0.0 111.037 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.77 -31.58 23.89 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.2 mt -51.74 -46.1 63.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.907 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -63.55 -37.6 87.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.83 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -56.22 -37.91 70.34 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.942 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CZ3' ' A' ' 107' ' ' TRP . 84.9 m-85 -63.31 -21.92 66.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.23 -35.05 2.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.659 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.69 -30.17 27.49 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 49.8 mt -95.69 151.45 19.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.499 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.1 mt-30 -97.76 133.18 42.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -111.34 142.15 25.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.304 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 58.2 Cg_endo -61.31 134.42 51.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.382 1.388 . . . . 0.0 111.341 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 p -78.94 -12.13 60.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.51 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.8 p90 -81.12 -15.17 56.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.6 148.96 95.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.814 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -83.29 175.66 8.06 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.878 1.719 . . . . 0.0 111.82 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CB ' ' NE1' ' A' ' 47' ' ' TRP . 39.7 Cg_exo -51.44 144.77 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.115 1.877 . . . . 0.0 112.057 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 49.9 mtt85 -59.84 -36.32 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.495 ' NE1' ' CB ' ' A' ' 45' ' ' PRO . 61.6 p-90 -70.95 -26.92 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.073 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -62.92 -57.86 9.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.923 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.982 ' O ' HG23 ' A' ' 52' ' ' ILE . 86.2 mt -73.91 -34.21 64.28 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -36.89 -51.21 2.08 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.012 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.7 Cg_endo -68.81 0.61 4.72 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.455 2.103 . . . . 0.0 114.17 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 49' ' ' LEU . 14.1 pt -43.81 -42.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 96.9 m95 -51.69 -32.82 31.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.96 96.18 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.8 m -68.54 -50.99 47.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.065 0.46 . . . . 0.0 111.206 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.3 mp -67.33 -34.27 76.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.94 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.446 ' CD1' HG23 ' A' ' 12' ' ' THR . 5.5 t80 -48.76 -60.62 2.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -63.47 -38.21 90.26 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.536 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.199 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.0 mtt -64.61 -38.55 91.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.29 -48.06 85.23 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.259 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -61.18 -38.68 87.38 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.48 -43.0 66.54 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.235 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -61.25 -31.67 71.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -58.61 -47.65 83.64 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.196 -0.601 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.07 -41.53 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 109.558 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG22 ' OG ' ' A' ' 130' ' ' SER . 97.3 t -61.0 -38.46 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -65.16 -36.56 84.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.907 178.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -63.81 -43.25 96.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.683 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.79 -44.38 85.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.492 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 78' ' ' ALA . 65.1 mt -76.68 -26.4 54.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.24 -4.15 62.25 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 156.64 -167.41 33.6 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.389 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.582 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 1.2 t80 -85.57 99.17 11.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 77' ' ' ASP . 5.7 t -133.48 165.71 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.62 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -41.69 -35.5 0.79 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.598 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.722 ' H ' HG23 ' A' ' 75' ' ' THR . 88.0 m-20 -60.69 -40.89 93.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.959 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.464 ' HB2' HD12 ' A' ' 71' ' ' LEU . . . -74.86 -32.22 61.83 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.012 0.434 . . . . 0.0 111.94 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.582 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 55.7 mmm -62.29 -35.12 78.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -59.66 -40.69 81.29 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.538 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.493 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 13.1 Cg_endo -85.56 -65.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.056 1.171 . . . . 0.0 112.231 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.78 -44.16 94.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.27 96.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.23 -36.62 78.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.469 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 89.6 t80 -56.58 -43.48 80.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.1 m -63.82 -43.65 95.61 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.16 -57.43 3.68 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.744 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.91 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.469 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 42.3 tp -62.93 -39.67 95.29 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.37 75.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.043 0.449 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.35 -39.72 88.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.007 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.451 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 58.5 t30 -62.29 -40.75 97.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -57.44 -29.99 64.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.925 0.393 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.93 67.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.544 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.634 ' O ' ' N ' ' A' ' 97' ' ' PRO . 36.7 t-105 -59.71 -68.51 0.73 Allowed Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 113' ' ' LEU . 10.4 Cg_endo -40.2 78.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.263 0 C-N-CA 121.699 1.599 . . . . 0.0 112.662 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' TRP . 97.1 Cg_endo -57.28 -19.78 36.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.947 1.765 . . . . 0.0 112.076 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.909 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 33.3 pt -58.7 -23.36 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.042 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.1 p90 -56.54 -47.07 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.606 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.7 t80 -64.81 -49.59 70.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.51 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.6 0.42 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.626 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.94 -2.24 0.2 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.636 0.255 . . . . 0.0 110.705 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.515 ' H ' ' C ' ' A' ' 101' ' ' GLY . 60.8 ttt85 -54.34 -35.44 62.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.63 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -85.8 158.65 19.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.522 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 107' ' ' TRP . 15.4 ttm -56.46 -13.9 2.64 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.255 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.95 -3.33 0.01 OUTLIER Glycine 0 CA--C 1.538 1.503 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.503 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.715 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.12 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.252 -0.558 . . . . 0.0 110.995 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.32 -27.93 67.72 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.832 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 109' ' ' LEU . 82.6 mt -59.09 -31.3 68.78 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.131 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.68 -38.72 88.84 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.94 -45.95 86.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.8 tp -64.71 -49.54 70.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.051 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.462 HD13 ' HD3' ' A' ' 96' ' ' PRO . 3.7 tt -67.17 -40.96 86.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.414 0.626 . . . . 0.0 110.078 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.785 ' CD2' HG21 ' A' ' 147' ' ' THR . 18.9 tp -50.82 -59.01 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.711 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 144' ' ' LEU . 61.0 t -69.98 -60.74 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.647 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.497 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -66.98 -42.74 84.57 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -60.38 -56.04 26.72 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.446 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.09 -38.62 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.671 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.32 -48.06 18.36 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.5 m -59.29 -41.68 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.55 -54.96 10.07 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.97 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.57 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 17.7 m -66.1 -42.3 89.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.443 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 53.4 m -59.4 -46.63 88.16 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.67 -34.7 78.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.055 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -82.23 -64.5 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.5 m0 -70.09 -42.0 73.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 40.8 t-80 -56.41 -45.59 80.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.277 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -63.1 -44.23 96.24 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.849 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.52 -47.47 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.587 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.578 ' OG ' HG22 ' A' ' 67' ' ' VAL . 59.4 p -133.79 87.28 36.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.472 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.7 Cg_exo -52.03 -40.86 67.03 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.767 1.645 . . . . 0.0 112.932 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.0 Cg_exo -58.27 -27.62 81.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 120.49 0.794 . . . . 0.0 112.81 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.18 -33.48 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.187 0.518 . . . . 0.0 110.783 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 137' ' ' LEU . . . -60.18 -36.42 77.56 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.989 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -60.59 -34.84 74.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.151 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -62.07 -40.06 94.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.902 0.858 . . . . 0.0 110.013 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 134' ' ' ALA . 38.4 mt -62.6 -26.72 68.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.964 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -1.74 -67.86 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 19.4 Cg_endo -51.27 -24.38 15.36 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 CA-C-N 119.711 0.933 . . . . 0.0 112.91 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -59.34 -39.37 82.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.818 0.342 . . . . 0.0 110.446 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.624 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -62.77 -41.39 99.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.897 0.38 . . . . 0.0 110.244 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.98 73.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.628 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.691 ' CE2' HD12 ' A' ' 52' ' ' ILE . 2.5 t-105 -61.27 -44.63 96.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 115' ' ' VAL . 50.0 mt -69.67 -36.66 76.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.634 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.273 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.644 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 64.7 t80 -62.85 -46.92 85.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.094 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.785 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.4 m -62.48 -41.75 99.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.09 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.1 m -58.93 -50.41 74.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.807 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 -40.35 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 110.491 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.644 HD12 ' CZ ' ' A' ' 146' ' ' PHE . 9.5 tt -56.81 -46.36 81.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.692 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.68 HD22 ' C21' ' A' ' 201' ' ' PKA . 32.5 m120 -65.37 -41.55 93.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -64.58 -38.99 92.91 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.772 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -58.26 -43.66 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.104 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.76 -42.96 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.374 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 1.6 m95 -60.87 -25.1 66.43 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -50.38 -36.57 33.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.562 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 91.2 m-20 -59.76 -43.77 94.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.085 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -87.62 -51.23 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 162' ' ' ARG . 62.5 p -62.67 -23.75 67.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.568 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.54 -31.93 37.61 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -57.16 -33.97 67.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.74 0.305 . . . . 0.0 110.711 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 159' ' ' SER . 80.4 mtm180 -118.7 148.36 42.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.428 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 82.66 18.97 64.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.02 -177.08 51.63 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.3 m -57.59 -36.44 71.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.722 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 -57.32 -37.25 72.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 0.7 OUTLIER -94.72 145.39 24.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.272 179.292 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -138.36 149.05 45.19 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.066 0.46 . . . . 0.0 110.417 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 168' ' ' ALA . 95.9 mt-10 . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.79 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.68 ' C21' HD22 ' A' ' 151' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.976 0.417 . . . . 0.0 110.569 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 1' ' ' MET . 18.5 Cg_endo -55.72 -18.7 21.86 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.799 2.333 . . . . 0.0 112.062 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.3 -35.54 60.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.355 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 t -61.62 -41.57 97.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.928 0.394 . . . . 0.0 110.691 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.86 -30.45 62.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.139 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t -40.16 -39.28 1.33 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.862 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.529 ' O ' HD13 ' A' ' 11' ' ' LEU . 86.0 Cg_exo -55.29 -22.93 35.16 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 120.738 0.959 . . . . 0.0 112.769 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.65 63.99 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -44.07 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.77 90.79 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.533 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.7 mp -56.6 -41.53 77.2 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.293 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.409 HG23 ' CD1' ' A' ' 57' ' ' TYR . 3.2 t -79.4 -32.28 42.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.854 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 13' ' ' LEU . 96.3 mt -64.44 -37.09 86.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.8 t -50.85 -43.57 83.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.026 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.66 -36.8 91.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.357 1.372 . . . . 0.0 112.835 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.4 m -60.6 -39.16 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.812 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.44 -37.98 87.99 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.225 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.33 -55.0 17.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.576 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -62.67 -37.3 94.55 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.268 -0.491 . . . . 0.0 111.954 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.0 -46.97 86.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.8 mtm -63.47 -39.85 95.57 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.44 97.44 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.466 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -72.11 -28.37 63.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 0.0 110.648 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -35.88 74.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.05 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.62 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 69.5 t80 -60.75 -48.67 80.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.58 -36.01 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.933 0.873 . . . . 0.0 109.627 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -60.2 -41.08 92.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.097 -1.41 . . . . 0.0 112.357 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.72 -129.88 1.4 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.714 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.403 ' HB3' HH21 ' A' ' 32' ' ' ARG . 96.9 mt-10 -57.05 -26.67 60.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.91 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.08 -33.52 10.61 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.53 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.6 mt -50.87 -41.31 57.96 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.403 HH21 ' HB3' ' A' ' 29' ' ' GLU . 49.5 mtm180 -61.63 -43.53 98.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.506 0.669 . . . . 0.0 109.594 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -62.72 -40.1 96.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.146 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.6 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.9 m-85 -63.87 -22.94 67.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.328 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.59 -40.81 28.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.123 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -31.98 78.87 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.0 mt -91.1 148.81 22.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.977 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.32 127.92 46.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 12.1 mtpt -100.67 136.06 19.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 59.2 Cg_endo -56.06 143.79 82.17 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.139 1.226 . . . . 0.0 112.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 t -60.84 -31.22 70.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.998 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.425 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 18.4 p90 -76.99 0.39 21.36 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.309 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.6 t-80 -61.86 124.38 81.41 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.587 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.2 Cg_endo -80.86 166.01 19.42 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.462 1.442 . . . . 0.0 111.295 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 31.5 Cg_exo -49.25 140.75 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.133 1.222 . . . . 0.0 111.364 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.616 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 36.8 mtt-85 -58.74 -37.38 76.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.006 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.437 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 8.5 p90 -74.8 -21.5 59.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.928 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -65.25 -59.91 3.56 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.008 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.977 ' O ' HG23 ' A' ' 52' ' ' ILE . 71.2 mt -72.85 -33.31 66.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.4 -50.69 2.54 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.951 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 16.6 Cg_endo -69.59 0.8 5.0 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.433 2.088 . . . . 0.0 114.05 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.977 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.3 pt -42.34 -41.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.228 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 57' ' ' TYR . 99.4 m95 -53.86 -33.15 55.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.322 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.15 -40.11 98.09 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -67.83 -51.84 43.82 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.235 0.541 . . . . 0.0 110.82 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.7 mp -66.55 -32.85 74.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.934 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' TRP . 22.8 t80 -51.63 -53.53 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.374 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 p -68.04 -36.85 80.59 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.326 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.09 88.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.3 mtt -62.86 -37.47 87.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.68 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.16 -57.94 7.14 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.524 -0.846 . . . . 0.0 110.987 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.64 -39.35 87.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.595 0.236 . . . . 0.0 110.825 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.78 -42.02 84.57 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.0 p -62.35 -29.4 70.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.85 -44.47 91.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.807 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.13 -42.49 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.533 HG22 ' OG ' ' A' ' 130' ' ' SER . 90.5 t -60.89 -40.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.522 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.65 -33.27 75.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.153 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 31.5 mtpt -65.49 -44.89 85.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.151 0.5 . . . . 0.0 111.091 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.95 -37.94 85.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.774 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.6 mt -91.36 -3.75 56.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.44 35.9 40.49 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.518 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.37 -161.71 24.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.4 OUTLIER -78.64 109.91 13.29 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 121.56 0.695 . . . . 0.0 110.741 -178.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.9 t -133.94 164.45 27.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -43.93 -38.24 3.32 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.023 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.626 ' H ' HG23 ' A' ' 75' ' ' THR . 86.7 m-20 -65.5 -41.94 92.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.912 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -71.97 -33.24 68.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.632 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.1 mmm -59.06 -35.17 72.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.561 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.48 -59.68 12.77 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.2 -54.09 2.03 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.415 1.41 . . . . 0.0 113.051 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -62.57 -41.61 99.03 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.127 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.51 98.27 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp -58.29 -39.28 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -59.0 -44.42 91.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 65.4 m -68.22 -39.92 82.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.42 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.18 -58.98 3.5 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.894 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -56.96 -42.04 79.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.331 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.826 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.76 78.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.04 -40.4 89.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.826 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.515 ' O ' HD11 ' A' ' 113' ' ' LEU . 43.0 t-20 -62.66 -39.78 94.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.512 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.554 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.0 m95 -57.97 -27.46 63.46 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.12 62.63 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 26.4 t-105 -71.51 -56.36 5.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 76.4 Cg_endo -44.08 86.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.099 1.199 . . . . 0.0 112.549 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.3 Cg_endo -57.05 -26.71 70.16 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 120.845 1.03 . . . . 0.0 111.321 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.628 HD11 ' HB2' ' A' ' 110' ' ' ALA . 39.5 pt -62.44 -28.19 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.702 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.35 -44.47 65.22 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.895 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 70.5 t80 -64.43 -49.35 71.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.876 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -113.38 -68.6 0.51 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.308 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 101' ' ' GLY . . . 80.15 -5.26 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -54.4 -36.56 64.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -80.72 146.43 31.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.125 0.488 . . . . 0.0 111.257 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.629 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.3 ttp -64.22 -15.69 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.214 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.13 33.95 0.02 OUTLIER Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.629 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -61.41 -19.74 62.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -46.88 -24.47 0.6 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 111.594 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.1 -31.16 69.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.365 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.91 -52.74 58.46 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.662 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.0 t0 -62.2 -45.71 92.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.64 -38.52 85.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 110.379 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.792 HD23 ' C ' ' A' ' 113' ' ' LEU . 6.4 tt -71.15 -48.99 48.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 113' ' ' LEU . 2.8 pp -74.22 -31.46 62.62 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.49 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 111' ' ' ASP . 48.3 t -67.18 -61.58 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.722 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.9 t -72.54 -42.13 65.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 92' ' ' ASN . . . -59.18 -51.25 60.3 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.339 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 114' ' ' LEU . 2.4 p -67.38 -35.93 75.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.649 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.33 -57.4 3.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -60.08 -42.7 95.16 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.81 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.94 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.438 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 27.2 m -63.62 -39.39 94.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.935 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.432 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 77.7 m -59.34 -48.79 80.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 128' ' ' ARG . 74.3 mt -63.87 -32.31 73.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.68 -63.39 1.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.7 m0 -76.12 -45.28 34.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 123' ' ' THR . 2.0 t60 -57.67 -43.42 85.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.949 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.481 ' CG ' ' O ' ' A' ' 124' ' ' LEU . 37.0 mmm-85 -64.63 -46.08 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.273 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.24 -48.65 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.533 ' OG ' HG22 ' A' ' 67' ' ' VAL . 37.4 p -128.64 84.77 62.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.138 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.7 Cg_exo -53.41 -41.81 70.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.178 1.919 . . . . 0.0 112.925 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 24.3 Cg_exo -57.36 -30.15 86.78 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 120.323 0.682 . . . . 0.0 112.378 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.46 71.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.074 0.464 . . . . 0.0 110.316 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.77 -37.74 76.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.811 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 50.4 ttt85 -59.59 -40.9 88.98 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.433 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.55 -36.04 63.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.305 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.516 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 55.6 mt -70.73 16.87 0.08 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.423 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -48.04 -41.06 38.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.231 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.516 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 18.2 Cg_endo -67.9 -18.67 46.84 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 CA-C-N 120.633 1.262 . . . . 0.0 112.876 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -58.98 -41.33 87.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.915 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 36.4 tp -63.79 -38.39 90.91 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.424 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.92 -43.95 91.11 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.596 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.59 ' CE2' HD12 ' A' ' 52' ' ' ILE . 1.3 t-105 -69.86 -50.46 42.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.449 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 115' ' ' VAL . 30.2 mt -65.83 -32.87 74.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.404 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -50.2 74.15 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.733 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.843 ' CE2' HD22 ' A' ' 150' ' ' LEU . 29.7 t80 -64.15 -42.28 96.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.905 0.383 . . . . 0.0 111.605 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.582 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.8 m -55.73 -43.66 76.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.1 m -64.36 -49.63 70.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.512 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.51 -40.23 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.193 0.521 . . . . 0.0 110.667 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.843 HD22 ' CE2' ' A' ' 146' ' ' PHE . 63.9 tp -56.06 -42.4 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.249 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.535 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.4 m120 -64.55 -41.0 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -62.69 -40.89 98.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.415 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -61.03 -46.41 90.85 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.227 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.87 -45.18 81.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.037 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.449 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -59.72 -39.21 83.89 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.647 -178.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 159' ' ' SER . 66.5 mtp180 -58.66 -25.96 63.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.65 -39.4 58.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.702 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -113.77 -2.39 13.71 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.145 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 156' ' ' ARG . 69.8 m -121.99 155.91 34.56 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.641 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.73 2.23 63.17 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -55.46 -35.18 65.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.874 0.368 . . . . 0.0 110.606 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -54.5 -32.92 58.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.859 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -51.91 -33.76 36.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.498 ' O ' HD22 ' A' ' 167' ' ' LEU . . . 86.86 12.05 69.37 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.7 p -60.6 -27.42 67.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.939 0.4 . . . . 0.0 110.516 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -55.01 -36.93 65.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.014 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -61.16 -33.56 73.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.07 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.52 158.06 36.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.304 0.573 . . . . 0.0 110.509 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 C--N 1.318 -0.784 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.473 -179.675 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.564 ' C22' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.881 0.372 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.484 ' O ' HG23 ' A' ' 6' ' ' VAL . 87.1 Cg_exo -54.66 148.26 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.554 2.17 . . . . 0.0 112.611 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.84 -31.93 70.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.493 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m -62.14 -47.98 82.14 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -77.45 -29.97 53.06 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 111.503 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 2' ' ' PRO . 2.7 t -40.04 -50.41 6.0 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.947 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.8 Cg_endo -58.01 -20.53 45.68 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.554 0.836 . . . . 0.0 112.222 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.589 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 13' ' ' LEU . 68.0 t -60.24 -40.5 83.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.017 0.437 . . . . 0.0 109.863 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.65 -36.86 93.3 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.33 -42.19 90.87 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 t -78.15 -41.4 34.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.514 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 HG12 ' A' ' 9' ' ' VAL . 85.8 mt -65.25 -35.33 80.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 10' ' ' GLY . 13.7 t -50.07 -43.9 78.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.354 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.07 -34.58 98.92 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.3 1.333 . . . . 0.0 112.895 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 m -59.61 -39.56 84.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 0.0 112.009 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.03 -37.72 83.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.365 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.46 -40.88 99.28 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.925 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -44.59 97.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.489 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -61.92 -40.87 96.98 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.65 -39.85 92.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.717 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -43.99 9.56 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.041 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.475 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -68.01 -24.57 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.432 . . . . 0.0 110.89 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.26 -35.42 64.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.55 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 64.1 t80 -60.92 -48.02 83.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.34 -32.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.721 0.772 . . . . 0.0 109.451 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -63.6 -41.26 98.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.523 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.41 -129.63 2.21 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.855 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.19 -27.93 62.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.853 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.21 -31.5 6.24 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.7 mt -51.9 -45.89 64.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.814 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -62.48 -39.0 92.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -57.34 -39.91 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.891 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.541 ' O ' ' O ' ' A' ' 37' ' ' LEU . 74.9 m-85 -64.76 -22.43 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.41 -40.23 5.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.74 -34.61 72.51 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 34' ' ' TYR . 31.6 mt -93.29 152.87 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.496 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.6 mt-30 -98.55 132.48 43.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 48.6 mttt -99.39 148.57 34.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 9.8 Cg_endo -57.49 140.02 91.95 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.62 1.546 . . . . 0.0 111.908 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 m -61.53 -33.22 73.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.762 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.434 ' NE1' ' CE1' ' A' ' 146' ' ' PHE . 13.3 p90 -85.79 6.43 28.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.496 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -54.86 124.55 51.85 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.136 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.93 168.45 6.75 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.172 1.248 . . . . 0.0 111.581 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 48.7 Cg_exo -51.21 139.28 44.14 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.427 1.418 . . . . 0.0 111.924 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.518 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 39.7 mtt85 -61.9 -37.09 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.2 p90 -73.88 -13.38 60.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.622 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -77.5 -65.92 0.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.967 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.994 ' O ' HG23 ' A' ' 52' ' ' ILE . 77.7 mt -65.79 -35.63 81.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.498 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.652 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.12 -40.42 3.87 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.033 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 63.6 Cg_exo -66.81 -8.95 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.913 2.409 . . . . 0.0 113.746 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' O ' ' A' ' 49' ' ' LEU . 26.3 pt -41.84 -42.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.412 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.45 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.3 m95 -53.54 -32.05 48.99 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.264 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -52.6 -37.08 49.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.5 p -87.54 -45.85 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.97 -40.32 96.13 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CE1' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -62.62 -44.65 95.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.639 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 57' ' ' TYR . 28.4 m -60.15 -40.79 91.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.61 91.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.42 -37.88 87.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.6 -55.53 19.83 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -61.78 -33.76 74.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.118 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.35 -44.18 58.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.48 ' CB ' HD21 ' A' ' 82' ' ' LEU . 95.4 p -64.13 -31.52 72.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -56.61 -46.04 81.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.412 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.6 mt -61.59 -39.4 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 129' ' ' VAL . 75.7 t -63.18 -38.78 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.91 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.13 -51.41 69.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.943 0.401 . . . . 0.0 111.2 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 73.5 mttt -54.96 -36.57 65.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.367 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -72.77 -41.17 65.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.89 -8.22 40.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.82 -6.28 58.58 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.515 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 124.8 -168.19 16.97 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.431 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -59.5 79.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.789 0.804 . . . . 0.0 108.873 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.1 m -116.09 152.77 32.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.595 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' THR . 97.0 mt-10 -42.59 -36.52 1.4 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.184 -0.607 . . . . 0.0 109.894 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.58 -41.33 98.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.114 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -74.97 -33.03 61.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.46 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.452 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 89.3 mmm -61.2 -35.76 78.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.652 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -56.42 -45.06 99.97 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.585 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 9.5 Cg_endo -78.18 -61.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 120.929 1.086 . . . . 0.0 111.985 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.48 HD21 ' CB ' ' A' ' 64' ' ' SER . 27.9 mt -57.81 -43.75 85.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.91 0.386 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.83 -43.85 98.66 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -59.07 -38.45 79.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.269 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.85 -42.98 80.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 m -65.66 -42.35 91.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.33 3.08 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.897 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -55.78 -41.59 74.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.522 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.21 -37.91 89.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.03 -49.84 73.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 111.004 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.8 -37.01 82.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.461 HD21 HD22 ' A' ' 113' ' ' LEU . 19.8 t-20 -59.51 -41.34 89.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.559 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.483 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 62.0 m95 -62.1 -30.42 70.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.652 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.24 -28.95 66.79 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.685 ' CD1' HD11 ' A' ' 113' ' ' LEU . 18.9 t-105 -55.74 -64.52 2.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_endo -46.2 82.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.457 1.438 . . . . 0.0 112.148 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.557 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.5 Cg_endo -57.82 -19.21 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.351 1.368 . . . . 0.0 111.477 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.746 HG21 ' HA ' ' A' ' 107' ' ' TRP . 39.6 pt -60.23 -26.18 35.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.032 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.7 p90 -46.82 -44.64 19.48 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.386 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 73.6 t80 -70.05 -49.4 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.99 -66.24 0.48 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.947 -0.645 . . . . 0.0 113.131 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 66.16 8.57 5.63 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.608 0.242 . . . . 0.0 111.015 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -55.07 -36.31 65.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -88.66 149.77 23.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.286 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 107' ' ' TRP . 1.7 ttp -59.98 -19.41 52.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.298 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.02 -8.06 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.88 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.746 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.5 p90 -44.67 -18.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.19 -20.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.0 mt -60.87 -35.76 77.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.82 -39.8 93.04 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.479 0.657 . . . . 0.0 109.345 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 111' ' ' ASP . 56.7 t0 -66.73 -43.38 84.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.785 -1.098 . . . . 0.0 113.57 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.21 -49.26 65.19 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.685 HD11 ' CD1' ' A' ' 95' ' ' TRP . 21.8 mt -67.87 -38.85 83.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.02 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.765 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.0 tp -51.6 -55.81 17.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.286 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' HD22 ' A' ' 144' ' ' LEU . 57.3 t -73.1 -63.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.662 -178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -67.82 -41.86 82.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -63.48 -52.9 42.81 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.965 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 114' ' ' LEU . 1.8 p -65.93 -36.83 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.582 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.9 -56.0 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.3 m -56.34 -42.34 77.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.97 -53.96 15.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.397 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.499 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.8 m -65.03 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.874 HG23 ' CD2' ' A' ' 127' ' ' HIS . 86.9 m -59.16 -48.2 82.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.508 HD22 HH21 ' A' ' 128' ' ' ARG . 78.9 mt -65.96 -35.1 79.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.319 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -73.66 -55.25 6.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.499 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 38.6 m0 -84.86 -49.96 7.96 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.874 ' CD2' HG23 ' A' ' 123' ' ' THR . 0.2 OUTLIER -52.25 -41.87 63.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.206 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.508 HH21 HD22 ' A' ' 124' ' ' LEU . 96.9 mtt-85 -61.44 -43.57 98.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.316 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.408 HG11 HG13 ' A' ' 67' ' ' VAL . 79.3 t -78.6 -48.98 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.589 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 87.8 p -132.47 88.06 40.41 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.786 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.8 Cg_exo -53.31 -39.58 80.7 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.931 1.754 . . . . 0.0 113.147 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 34.1 Cg_exo -56.27 -29.74 77.49 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.35 0.7 . . . . 0.0 112.76 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -32.65 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.63 . . . . 0.0 110.392 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.542 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.48 -38.4 80.74 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 45.5 ttp180 -61.28 -38.65 87.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.625 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.58 -39.74 71.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.8 mt -56.85 -28.82 62.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.314 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.51 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 5.86 -69.45 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 9.6 Cg_endo -52.1 -31.36 44.6 Favored 'Trans proline' 0 N--CA 1.505 2.158 0 C-N-CA 120.435 0.756 . . . . 0.0 113.275 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -59.07 -38.3 79.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.809 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.754 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.1 tm? -59.58 -44.24 93.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.303 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.42 72.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.8 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.6 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 1.8 t-105 -61.26 -44.04 97.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 115' ' ' VAL . 43.3 mt -65.8 -34.25 77.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.823 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.42 89.39 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.727 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.675 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 15.7 t80 -65.27 -43.21 91.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.765 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.6 m -57.31 -42.73 82.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.612 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -61.26 -47.29 86.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.163 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.81 -42.7 82.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.688 0.756 . . . . 0.0 109.995 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.675 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 14.1 tp -53.44 -60.86 2.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.118 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.584 HD22 ' C21' ' A' ' 201' ' ' PKA . 31.7 m120 -63.02 -38.81 92.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.272 0.558 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.35 -43.09 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.19 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.88 -44.46 96.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.47 -42.7 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 111.209 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 4.9 m95 -57.65 -36.23 71.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.37 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -57.35 -30.41 64.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 89.5 m-20 -53.13 -40.31 64.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.564 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -109.06 -60.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.4 m -60.56 -32.57 71.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.793 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.38 -32.99 38.69 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -121.87 149.47 43.34 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 110.976 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -118.5 149.08 41.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.95 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.59 -179.33 50.39 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -85.26 -174.9 50.36 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 53.8 p -67.92 160.31 28.8 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.19 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -58.36 -35.1 71.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.759 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -62.47 -33.45 74.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.747 179.546 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.7 34.32 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.994 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.563 179.834 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.584 ' C21' HD22 ' A' ' 151' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 mmt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.946 0.403 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -56.64 -19.19 29.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.883 2.389 . . . . 0.0 112.144 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.07 -33.39 70.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.095 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.1 m -61.16 -40.86 95.46 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.22 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -31.18 57.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.864 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.3 t -41.17 -40.89 2.86 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.252 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.5 ' O ' HD13 ' A' ' 11' ' ' LEU . 79.5 Cg_exo -54.52 -21.22 23.41 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 120.916 1.077 . . . . 0.0 112.177 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.29 -36.81 53.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.04 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 12' ' ' THR . 96.8 t -62.38 -42.81 96.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.47 -34.79 90.17 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.482 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.1 mp -55.82 -43.75 77.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.105 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.451 HG23 ' CD1' ' A' ' 57' ' ' TYR . 7.5 t -75.99 -27.01 57.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.19 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.97 -32.42 67.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 40.9 t -45.51 -57.69 7.22 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB3' HD21 ' A' ' 89' ' ' LEU . 6.6 Cg_endo -57.88 -31.52 92.76 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.086 1.191 . . . . 0.0 112.902 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.422 ' H ' ' HD2' ' A' ' 15' ' ' PRO . 23.2 t -60.2 -39.47 86.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.56 -39.27 87.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.275 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.56 15.37 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.2 94.05 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.08 -45.37 87.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.907 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.88 -39.42 94.41 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.51 -42.84 97.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.569 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -71.07 -26.28 62.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.386 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -62.94 -34.9 78.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.913 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 74.8 t80 -61.25 -49.45 77.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.64 -35.79 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.477 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -34.16 74.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.654 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.9 -136.88 2.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.505 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.1 -24.73 59.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.121 0.486 . . . . 0.0 110.759 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.86 -32.69 4.64 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.468 HD22 ' CZ ' ' A' ' 46' ' ' ARG . 92.1 mt -52.18 -43.42 64.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.074 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.23 -42.84 99.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 110.238 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -60.05 -39.15 84.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 45.1 m-85 -64.89 -23.06 67.11 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.751 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.15 -41.62 27.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.543 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.04 84.48 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 73.3 mt -91.0 149.18 21.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.789 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -98.0 122.56 41.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.791 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.696 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 54.7 mttt -91.35 140.94 25.67 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 30.4 Cg_endo -56.44 140.73 89.6 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.122 1.215 . . . . 0.0 112.398 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.4 m -61.17 -34.04 74.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.207 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 39.0 p90 -77.43 4.45 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.619 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.586 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.3 t-80 -64.5 132.0 95.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 57.6 Cg_endo -89.81 169.65 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.697 1.598 . . . . 0.0 111.284 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 41.0 Cg_exo -50.92 138.73 42.32 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.84 1.027 . . . . 0.0 111.501 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.696 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 43.0 mtt85 -60.43 -38.69 84.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.9 p90 -72.21 -25.66 61.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.901 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -64.24 -57.45 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.983 ' O ' HG23 ' A' ' 52' ' ' ILE . 50.1 mt -73.28 -33.78 65.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.36 -48.64 2.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.882 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.2 Cg_endo -72.34 3.77 3.88 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.364 2.043 . . . . 0.0 114.189 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 49' ' ' LEU . 19.4 pt -47.21 -38.24 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.263 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -51.76 -33.59 35.76 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.079 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.23 97.86 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.7 m -66.39 -51.17 59.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 110.834 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.28 -33.09 74.58 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.205 0.526 . . . . 0.0 109.966 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.451 ' CD1' HG23 ' A' ' 12' ' ' THR . 31.1 t80 -53.12 -52.8 57.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.618 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.5 p -69.42 -35.39 75.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.618 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.74 90.13 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.455 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.2 mtt -62.29 -37.41 85.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.269 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.29 -56.25 14.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.95 -40.13 96.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 111.102 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.85 -43.41 92.37 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.482 ' HB2' HD21 ' A' ' 82' ' ' LEU . 92.7 p -63.5 -28.14 69.76 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.954 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -58.3 -44.85 88.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.95 -44.71 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.914 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 HG11 ' A' ' 129' ' ' VAL . 55.4 t -59.32 -41.64 84.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.21 -37.17 86.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.511 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -62.46 -40.94 98.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.064 0.459 . . . . 0.0 111.113 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.63 -37.59 88.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.07 -5.31 56.7 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.47 17.19 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.972 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.451 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 104.24 -166.35 15.33 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.96 110.11 21.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.461 0.648 . . . . 0.0 109.332 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 77' ' ' ASP . 5.7 t -131.32 163.47 27.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.981 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -43.51 -37.85 2.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.309 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' H ' HG23 ' A' ' 75' ' ' THR . 83.9 m-20 -63.45 -41.02 98.64 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.879 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.4 -29.18 65.74 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.689 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 86.1 mmm -60.15 -33.64 72.45 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.781 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.3 t -60.33 -50.22 86.84 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.22 -61.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.935 1.09 . . . . 0.0 113.038 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 64' ' ' SER . 7.3 mp -61.87 -39.26 91.3 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.077 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.18 96.26 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.82 -39.27 80.72 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 84.0 t80 -60.62 -45.71 93.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.034 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.0 m -67.95 -40.28 83.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.856 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.93 -60.33 3.17 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.022 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -56.96 -40.63 76.83 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.17 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 15' ' ' PRO . 44.9 tp -61.96 -40.23 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.174 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.0 79.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.98 0.419 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.02 85.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t30 -61.64 -42.44 98.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.679 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -58.42 -29.62 66.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.831 0.348 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -31.12 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.279 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.0 t-105 -56.94 -44.25 99.71 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -53.05 127.37 24.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.521 1.48 . . . . 0.0 113.125 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.454 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 37.5 Cg_endo -108.67 -27.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.194 1.263 . . . . 0.0 110.793 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 26.5 pt -59.59 -27.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.953 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 20.8 p90 -56.7 -44.51 81.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.608 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.568 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 60.5 t80 -64.95 -49.08 71.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.908 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.32 -59.16 0.41 Allowed Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.52 -1.27 0.22 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.649 0.262 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 101' ' ' GLY . 71.0 ttp85 -52.89 -33.28 49.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 110.34 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -86.62 151.82 23.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.784 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.683 ' C ' ' H ' ' A' ' 107' ' ' TRP . 2.7 ttp -62.16 -13.41 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.109 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.07 27.43 0.01 OUTLIER Glycine 0 CA--C 1.541 1.683 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.869 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.683 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.47 -19.17 34.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.559 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -55.07 -24.22 24.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.33 -33.1 65.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.431 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.537 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.76 -38.01 89.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -65.21 -48.43 73.39 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.29 -47.39 86.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.872 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.3 tt -69.11 -40.43 78.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.379 0.609 . . . . 0.0 110.356 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.737 ' CD2' HG21 ' A' ' 147' ' ' THR . 14.4 tp -54.07 -57.47 10.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.309 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.554 ' HA ' HD13 ' A' ' 144' ' ' LEU . 98.9 t -69.7 -56.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.883 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -68.7 -42.35 77.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -58.04 -45.2 94.14 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.661 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.38 -45.53 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.677 0.275 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.48 -55.59 9.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.1 m -59.72 -42.81 93.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.38 -60.37 2.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.459 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.6 m -62.48 -41.05 98.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.859 HG23 ' CE1' ' A' ' 127' ' ' HIS . 76.3 m -59.3 -46.47 88.49 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.5 -35.01 79.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.41 -63.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.8 m0 -64.47 -43.76 93.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.859 ' CE1' HG23 ' A' ' 123' ' ' THR . 24.9 m170 -56.87 -43.38 81.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.634 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.12 -44.32 96.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.587 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.509 HG11 HG13 ' A' ' 67' ' ' VAL . 98.5 t -75.9 -42.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.815 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.55 103.65 3.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.262 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.529 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.3 Cg_exo -60.76 -38.98 66.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.699 1.599 . . . . 0.0 113.236 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 28.1 Cg_exo -56.45 -29.59 78.5 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.93 1.086 . . . . 0.0 112.96 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 -33.53 73.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.018 0.437 . . . . 0.0 110.765 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.55 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.44 -37.29 77.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.902 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 44.1 ttt180 -59.45 -40.77 87.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.396 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.6 -36.84 67.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.307 0.575 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.524 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 60.8 mt -70.66 15.39 0.1 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.543 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -46.27 -40.64 19.01 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.072 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 9.2 Cg_endo -66.92 -22.9 47.94 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.809 1.325 . . . . 0.0 112.417 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.56 -34.02 74.86 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.751 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.0 tm? -67.93 -41.55 82.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.927 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.71 -52.15 33.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 0.661 ' CD1' HD12 ' A' ' 52' ' ' ILE . 1.1 t-105 -61.31 -46.34 90.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.756 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 115' ' ' VAL . 34.8 mt -67.6 -33.83 75.79 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.843 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.93 -46.03 89.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.993 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.694 ' CE2' HD22 ' A' ' 150' ' ' LEU . 16.1 t80 -64.69 -43.33 93.88 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.426 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.737 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.6 m -57.66 -43.48 85.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.39 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 54.4 m -60.29 -49.73 76.45 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.557 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.39 -41.81 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.366 0.603 . . . . 0.0 110.331 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 146' ' ' PHE . 23.9 tp -56.76 -47.88 79.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.139 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.656 HD22 ' C21' ' A' ' 201' ' ' PKA . 32.5 m120 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -65.28 -40.52 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.342 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.74 -45.98 88.43 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.304 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.68 -45.62 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -62.66 -44.08 97.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.669 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -60.44 -32.12 71.07 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.306 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -54.71 -40.85 69.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.948 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -99.73 -59.97 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.5 m -58.78 -33.24 70.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.108 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.55 -178.91 52.48 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -116.55 149.81 39.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -108.54 149.23 29.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.288 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.6 -177.8 52.0 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.55 -176.88 51.38 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 56.2 p -69.03 163.66 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 110.573 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -56.36 -33.0 65.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.455 ' H ' HD22 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -61.85 -34.53 76.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.288 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -75.23 157.55 34.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.305 0.574 . . . . 0.0 110.741 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 168' ' ' ALA . 94.6 mt-10 . . . . . 0 C--N 1.319 -0.756 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.276 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.656 ' C21' HD22 ' A' ' 151' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtp . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.53 -16.81 19.8 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.501 1.468 . . . . 0.0 112.013 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.47 -33.15 53.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.309 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.9 m -60.19 -40.64 90.74 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.522 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.467 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 8.1 m0 -76.23 -31.55 58.43 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.3 t -41.44 -51.69 8.41 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.0 Cg_endo -55.31 -19.4 21.71 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 CA-C-N 119.147 0.731 . . . . 0.0 111.451 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 5' ' ' TRP . . . -54.12 -32.01 53.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 12' ' ' THR . 79.2 t -61.17 -41.15 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.25 -36.86 93.07 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.312 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.27 -41.69 84.86 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 9' ' ' VAL . 9.2 t -75.81 -34.52 60.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.652 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.15 -34.74 78.21 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 10' ' ' GLY . 26.8 t -49.26 -55.84 19.32 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.2 Cg_endo -58.92 -32.6 97.7 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 120.539 0.826 . . . . 0.0 112.963 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.8 m -59.97 -40.04 87.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.746 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.98 -38.09 87.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.42 -59.04 8.24 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.191 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -60.1 -36.34 90.21 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.284 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.15 -46.48 85.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.497 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.08 -38.21 87.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.554 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.83 -39.51 97.48 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.646 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.441 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -67.66 -28.42 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.337 . . . . 0.0 111.763 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.72 -34.82 67.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.724 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 88.6 t80 -60.89 -47.59 85.71 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.435 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.1 m -71.79 -33.9 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.702 0.763 . . . . 0.0 109.333 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -61.75 -40.77 96.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.028 -1.442 . . . . 0.0 112.674 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.14 -126.08 1.83 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.047 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.39 -28.11 62.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.777 0.322 . . . . 0.0 111.317 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.96 -32.88 12.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.25 -41.23 62.64 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.025 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.2 mtp85 -61.48 -45.86 92.45 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.677 0.751 . . . . 0.0 109.334 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -62.46 -40.67 97.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.595 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 21.4 m-85 -65.16 -23.0 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.647 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.86 -39.72 54.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.56 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -33.21 85.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 60.5 mt -91.47 149.42 21.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.59 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -99.62 130.71 45.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.639 -0.425 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' NZ ' ' C1 ' ' A' ' 201' ' ' PKA . 1.3 mtpt -111.67 141.35 24.49 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.852 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 62.3 Cg_endo -58.61 133.29 53.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.972 1.114 . . . . 0.0 111.971 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.3 p -82.47 -9.19 59.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.05 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.3 p90 -77.79 -15.4 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.818 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -74.2 151.97 88.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.407 -178.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.68 173.13 14.07 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 112.455 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 19.5 Cg_exo -51.72 151.38 15.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.984 2.456 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -58.09 -35.69 71.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 14.7 p90 -74.51 -12.3 60.44 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.672 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -76.96 -66.91 0.76 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 110.956 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 19.5 mt -66.52 -35.82 81.2 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.581 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.656 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -40.76 -42.49 3.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 51.3 Cg_exo -65.51 -5.39 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.87 2.38 . . . . 0.0 112.98 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.035 HD12 ' HE1' ' A' ' 143' ' ' TRP . 5.9 pt -41.22 -42.54 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 120.658 0.266 . . . . 0.0 111.709 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.449 ' O ' ' N ' ' A' ' 57' ' ' TYR . 95.0 m95 -56.31 -34.06 66.17 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.105 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.49 -39.09 95.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -66.73 -52.28 46.25 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.19 0.519 . . . . 0.0 111.049 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.722 HD21 ' CE3' ' A' ' 143' ' ' TRP . 6.8 mp -68.22 -31.47 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.076 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' TRP . 19.8 t80 -52.2 -49.12 64.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.131 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -74.09 -34.79 64.09 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.651 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.94 -45.02 87.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.858 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.78 -37.18 85.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.75 -60.84 6.46 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.152 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -62.15 -36.48 81.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.637 0.256 . . . . 0.0 111.02 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.81 85.0 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.115 -1.04 . . . . 0.0 110.738 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.2 p -65.07 -30.11 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.566 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -58.49 -44.01 89.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.43 -38.48 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.949 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 129' ' ' VAL . 63.1 t -62.15 -41.6 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.636 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.33 -50.03 75.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.308 -178.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 74.9 mttt -54.4 -36.24 63.75 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.978 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -72.94 -44.73 60.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.658 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 78' ' ' ALA . 70.6 mt -77.41 -26.06 51.36 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.07 -6.85 40.42 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.269 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.85 -161.61 25.49 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.113 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.686 ' CD2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -89.23 82.68 6.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.35 0.595 . . . . 0.0 110.083 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 13.4 p -123.16 166.0 15.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.46 -36.87 3.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.82 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.76 -42.82 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.952 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -82.27 -36.64 26.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.983 0.42 . . . . 0.0 111.657 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.686 ' SD ' ' CD2' ' A' ' 74' ' ' PHE . 98.7 mmm -59.08 -34.47 72.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.052 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.3 t -60.14 -52.39 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.929 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -68.88 -58.78 0.1 Allowed 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.155 1.237 . . . . 0.0 112.775 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 82' ' ' LEU . 11.0 mp -60.84 -42.0 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.194 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.19 95.38 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.34 -39.79 76.66 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.449 ' CE2' HD22 ' A' ' 89' ' ' LEU . 75.0 t80 -59.13 -43.99 92.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.1 m -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.134 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.89 -60.07 3.26 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.595 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -56.97 -41.17 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.329 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 15' ' ' PRO . 33.0 tp -61.94 -38.86 90.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.632 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.78 76.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.981 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.4 -39.09 86.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.555 ' O ' HD11 ' A' ' 113' ' ' LEU . 57.5 t30 -61.46 -41.07 96.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.666 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.572 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 48.3 m95 -60.42 -28.76 68.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.71 -17.86 62.82 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.587 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.3 t-105 -72.43 -55.92 4.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 71.8 Cg_endo -42.62 87.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.182 1.255 . . . . 0.0 112.508 -177.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.6 Cg_endo -59.53 -27.1 84.13 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 120.606 0.871 . . . . 0.0 111.762 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.655 HD11 ' HB2' ' A' ' 110' ' ' ALA . 40.0 pt -61.71 -33.99 60.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.5 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -46.68 -43.78 18.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.534 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -67.53 -52.16 42.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.68 -55.11 0.39 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.847 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 61.04 10.81 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 0.0 110.356 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -55.66 -35.6 66.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.546 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -87.22 149.38 24.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.501 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.633 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.4 ttp -62.62 -14.93 48.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.28 35.44 0.02 OUTLIER Glycine 0 CA--C 1.54 1.598 0 C-N-CA 121.679 -0.296 . . . . 0.0 112.743 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.633 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -64.03 -19.67 65.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.605 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -47.46 -22.7 0.49 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.91 0.386 . . . . 0.0 111.258 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt -57.77 -31.48 66.57 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.563 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.02 -53.72 45.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.678 ' OD1' HG22 ' A' ' 147' ' ' THR . 31.1 t70 -63.13 -46.7 86.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.61 -38.09 83.57 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.781 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.6 tt -67.26 -48.78 66.71 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.616 ' N ' HD23 ' A' ' 113' ' ' LEU . 1.6 pp -76.15 -32.99 59.37 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.977 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 111' ' ' ASP . 70.6 t -64.82 -45.91 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.89 -38.75 17.72 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.55 -42.22 89.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.213 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 119' ' ' ALA . 0.9 OUTLIER -75.86 -48.38 29.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.776 0.322 . . . . 0.0 111.033 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.24 -56.79 10.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.7 m -61.9 -45.17 94.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.79 -59.11 3.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.423 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 28.3 m -63.11 -41.71 99.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 88.8 m -58.84 -45.22 90.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.393 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 124' ' ' LEU . 96.4 mt -63.45 -37.48 87.44 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.215 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.28 -64.3 1.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.423 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.6 m0 -66.1 -43.01 88.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -59.29 -50.12 75.2 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.691 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.11 -43.53 95.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.798 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 67' ' ' VAL . 97.7 t -76.02 -48.04 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 p -134.1 87.87 32.97 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.446 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.46 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.53 -42.41 61.91 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.391 1.394 . . . . 0.0 112.433 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.5 Cg_exo -56.79 -30.46 84.91 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 120.328 0.685 . . . . 0.0 111.994 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -30.79 70.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.094 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.91 97.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.114 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -59.98 -38.4 82.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.07 0.462 . . . . 0.0 110.352 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.53 -37.71 73.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.198 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.3 mt -57.86 -31.54 66.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.499 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 5.88 -72.37 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.4 Cg_endo -50.8 -22.32 9.67 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 CA-C-N 119.23 0.761 . . . . 0.0 112.79 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 p90 -57.73 -41.95 82.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.696 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -61.34 -44.39 97.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.053 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.21 83.57 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.234 0.54 . . . . 0.0 110.344 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TRP . . . . . 1.035 ' HE1' HD12 ' A' ' 52' ' ' ILE . 26.7 t90 -60.47 -50.59 72.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.486 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.736 HD21 ' CZ3' ' A' ' 143' ' ' TRP . 57.8 mt -74.78 -29.69 61.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.32 -54.92 39.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.841 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 150' ' ' LEU . 40.8 t80 -65.36 -44.93 86.1 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.786 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.678 HG22 ' OD1' ' A' ' 111' ' ' ASP . 9.6 m -56.56 -42.33 78.42 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.672 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.5 m -68.18 -50.17 56.08 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 111.604 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.06 -39.57 86.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.258 0.551 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 146' ' ' PHE . 66.1 tp -55.45 -41.73 73.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 6.2 m120 -63.18 -42.62 99.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -63.58 -35.9 82.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.664 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -58.57 -47.02 85.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.549 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.42 -47.44 52.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.756 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 3.1 m0 -61.58 -43.91 97.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -60.86 -33.66 73.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.269 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.6 -41.08 76.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.126 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -96.75 -59.97 1.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 111.482 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p -62.09 -25.94 68.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.069 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.5 155.58 53.3 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.149 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -122.52 156.39 34.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.747 0.308 . . . . 0.0 110.569 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -53.8 -37.03 63.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.433 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -55.9 -30.6 57.26 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -52.93 -33.06 42.96 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.4 m -56.53 -33.41 66.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.895 0.379 . . . . 0.0 110.397 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -55.41 -35.09 64.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.33 144.88 24.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.85 0.357 . . . . 0.0 110.283 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -85.02 124.62 31.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.494 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 92.4 mt-10 . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.53 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PKA . . . . . 0.586 ' C22' ' HB3' ' A' ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.5 t . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.56 ' O ' HD13 ' A' ' 11' ' ' LEU . 88.6 Cg_exo -55.28 -22.91 34.96 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.218 1.279 . . . . 0.0 112.794 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.31 62.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.4 t -64.31 -42.69 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.15 -34.61 90.4 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.012 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.1 mp -55.57 -44.23 76.66 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.795 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 t -78.83 -33.43 46.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.241 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.408 HD21 ' CE1' ' A' ' 57' ' ' TYR . 87.1 mt -65.39 -35.44 80.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.794 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 t -54.35 -57.27 19.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.54 -33.21 97.04 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 120.843 1.029 . . . . 0.0 112.767 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -59.31 -38.05 79.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.941 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.04 -38.52 91.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.579 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.97 -53.88 27.87 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.882 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.92 90.68 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CZ ' ' NH1' ' A' ' 27' ' ' ARG . 54.3 t80 -59.13 -43.47 91.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.296 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtt -61.06 -40.78 94.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.072 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.15 -42.46 91.48 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.64 -27.74 65.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.22 0.533 . . . . 0.0 110.302 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -35.39 76.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.669 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 40.7 t80 -61.05 -49.94 75.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.91 -34.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.693 0.759 . . . . 0.0 109.645 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.48 ' NH1' ' CZ ' ' A' ' 20' ' ' PHE . 7.9 ttt180 -61.81 -40.91 96.9 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.779 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.14 -123.47 3.16 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.149 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.1 -29.54 60.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.204 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -33.43 17.93 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD21 ' NE ' ' A' ' 46' ' ' ARG . 96.1 mt -50.37 -43.18 54.25 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -61.41 -43.07 99.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.58 . . . . 0.0 109.834 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.94 -39.17 93.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.85 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.617 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 16.5 m-85 -63.88 -23.26 67.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.29 -40.19 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.796 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.98 -31.96 72.92 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 34' ' ' TYR . 51.1 mt -90.62 148.55 22.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.869 0.366 . . . . 0.0 110.976 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -98.43 127.04 44.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.598 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.773 ' HZ1' ' NH1' ' A' ' 46' ' ' ARG . 11.0 mtpt -105.21 138.3 19.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 37.2 Cg_endo -55.65 141.47 83.78 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.669 0.913 . . . . 0.0 111.888 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.8 p -62.76 -30.04 71.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.335 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.42 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 24.8 p90 -78.39 0.18 26.7 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.884 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 19.7 t-80 -59.61 127.64 85.16 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 98.4 Cg_endo -81.68 167.06 17.1 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.181 1.254 . . . . 0.0 111.803 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 33.0 Cg_exo -52.01 140.66 49.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.731 1.621 . . . . 0.0 111.482 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.773 ' NH1' ' HZ1' ' A' ' 39' ' ' LYS . 62.5 mtt-85 -59.74 -36.37 76.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.519 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.412 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 7.7 p90 -73.94 -13.54 60.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.948 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 m -75.91 -69.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.421 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.008 ' O ' HG23 ' A' ' 52' ' ' ILE . 63.4 mt -66.01 -34.78 78.87 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.476 -0.49 . . . . 0.0 112.031 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.03 -41.03 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.324 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 51.0 Cg_exo -67.2 -7.11 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 123.123 2.549 . . . . 0.0 113.983 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.008 HG23 ' O ' ' A' ' 49' ' ' LEU . 24.4 pt -42.8 -40.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.465 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 99.3 m95 -53.44 -32.95 52.16 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.578 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.75 97.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -68.39 -51.04 48.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.924 0.393 . . . . 0.0 111.403 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.2 mp -67.95 -33.39 74.58 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.248 0.547 . . . . 0.0 110.111 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 17.1 t80 -51.15 -57.16 9.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.125 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -64.97 -38.74 91.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.871 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.24 99.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.214 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.5 mtt -61.34 -37.89 84.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.43 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -55.81 16.12 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -62.15 -38.46 89.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.503 0.192 . . . . 0.0 111.257 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.46 -42.62 93.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.822 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 82' ' ' LEU . 99.2 p -62.58 -30.74 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.27 -43.27 92.52 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.48 -43.87 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.873 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.446 HG13 HG11 ' A' ' 129' ' ' VAL . 77.8 t -61.04 -40.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.287 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.72 -33.23 75.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 29.0 mtpt -62.17 -44.04 97.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.44 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 80.1 mt-10 -70.89 -45.75 63.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.734 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.41 -27.81 60.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.792 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.7 67.96 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.663 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.414 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 149.55 -161.29 28.76 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.94 108.51 20.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.641 0.734 . . . . 0.0 109.904 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . 11.8 t -133.53 167.6 20.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.209 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' THR . 77.6 mm-40 -43.98 -35.57 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.321 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.95 -41.99 97.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.613 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.7 69.52 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.678 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 78.9 mmm -61.21 -34.78 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.534 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.56 -48.36 95.75 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -73.35 -62.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.272 1.315 . . . . 0.0 113.387 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 64' ' ' SER . 8.3 mp -61.82 -41.32 97.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.034 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.55 97.92 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.28 -40.32 90.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.666 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -59.82 -44.54 93.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.769 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.7 m -65.69 -42.41 91.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.98 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.84 -55.91 6.21 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -57.87 -41.27 82.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.412 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.22 -38.87 84.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.113 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.29 84.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.107 0.48 . . . . 0.0 111.414 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.65 -41.8 82.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.039 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.504 HD22 ' CA ' ' A' ' 117' ' ' GLY . 50.4 t-20 -65.93 -36.0 82.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.758 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.572 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m95 -53.06 -30.84 38.27 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.38 62.9 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.198 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.55 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 40.0 t-105 -64.03 -56.75 22.05 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.572 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 46.1 Cg_endo -54.83 131.83 48.37 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.742 1.628 . . . . 0.0 113.035 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.418 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 42.5 Cg_endo -107.56 -26.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.435 1.423 . . . . 0.0 110.556 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 110' ' ' ALA . 27.1 pt -60.69 -25.59 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.069 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 35.3 p90 -51.69 -42.74 62.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.29 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.499 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.8 t80 -64.53 -49.55 70.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.874 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -113.49 -68.65 0.51 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.369 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 75.53 -3.66 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -54.74 -34.07 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -86.4 155.88 20.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 111.194 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.704 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.8 ttm -57.39 -14.26 4.52 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.811 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -44.69 2.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.155 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.704 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -47.42 -21.84 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.472 0.636 . . . . 0.0 111.374 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 155' ' ' TRP . . . -55.14 -27.86 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.61 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.23 -33.18 73.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.009 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.86 -36.73 79.89 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.543 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 56.1 t0 -61.75 -45.02 95.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.347 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.53 -47.77 71.84 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.715 -0.394 . . . . 0.0 112.005 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.796 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.0 tt -67.0 -41.18 87.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.381 0.61 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.696 ' CD2' HG21 ' A' ' 147' ' ' THR . 17.0 tp -53.22 -60.88 2.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.404 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.505 ' HA ' HD13 ' A' ' 144' ' ' LEU . 65.3 t -70.82 -63.21 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.452 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.0 t -65.39 -38.8 91.08 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.504 ' CA ' HD22 ' A' ' 92' ' ' ASN . . . -61.61 -56.55 22.46 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.714 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.1 -38.26 77.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.972 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.88 -47.47 25.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 32.0 m -58.98 -43.39 91.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.02 -50.99 43.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.558 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.403 HG23 ' CD2' ' A' ' 126' ' ' TRP . 34.2 m -65.08 -40.99 95.41 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 71.1 m -60.56 -46.55 89.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 124' ' ' LEU . 83.2 mt -66.25 -35.99 81.84 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.67 -64.14 1.23 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.403 ' CD2' HG23 ' A' ' 122' ' ' THR . 38.6 m0 -66.4 -41.17 89.72 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 33.5 t-80 -58.49 -49.03 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.922 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -65.61 -46.07 80.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.486 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 99.0 t -78.27 -46.5 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.414 ' OG ' HG22 ' A' ' 67' ' ' VAL . 20.1 p -129.4 82.42 67.84 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.591 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.474 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 36.5 Cg_exo -53.14 -43.34 57.95 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.795 1.663 . . . . 0.0 112.257 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 23.7 Cg_exo -58.02 -32.47 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.474 0.783 . . . . 0.0 112.208 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.46 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.522 . . . . 0.0 110.379 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.72 77.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.098 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.501 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 42.7 mtm105 -62.95 -38.59 91.69 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.296 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.15 -38.53 62.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.16 0.505 . . . . 0.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 140' ' ' TYR . 83.7 mt -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -2.81 -67.33 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.794 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.475 ' N ' ' O ' ' A' ' 137' ' ' LEU . 10.9 Cg_endo -54.31 -30.06 60.66 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 120.799 0.999 . . . . 0.0 112.992 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -56.77 -40.69 76.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.733 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.2 tm? -63.61 -42.85 98.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.84 75.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.269 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.639 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -61.7 -50.34 72.83 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.483 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 115' ' ' VAL . 41.1 mt -63.84 -33.73 76.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.839 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.58 96.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.201 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.709 ' CE2' HD22 ' A' ' 150' ' ' LEU . 21.3 t80 -61.47 -41.65 97.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.345 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.696 HG21 ' CD2' ' A' ' 114' ' ' LEU . 53.8 p -60.81 -38.64 86.08 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.1 m -59.49 -50.59 73.34 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.948 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 91.8 t -71.32 -43.88 73.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.864 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.709 HD22 ' CE2' ' A' ' 146' ' ' PHE . 62.2 tp -57.97 -41.59 83.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.184 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 147' ' ' THR . 47.3 m-80 -63.04 -40.14 96.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.492 ' O ' ' CB ' ' A' ' 156' ' ' ARG . 37.1 m-85 -62.19 -39.57 93.15 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.697 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.441 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 47.4 t80 -59.9 -46.59 88.84 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.175 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -71.4 -51.32 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.9 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.595 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.771 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 152' ' ' TYR . 28.4 ttp180 -59.57 -38.32 80.81 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.162 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 92.6 m-20 -59.37 -42.46 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.905 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -87.44 -54.64 4.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.345 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 79.7 p . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.913 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.447 ' O ' HD13 ' A' ' 11' ' ' LEU . 75.5 Cg_exo -53.58 -22.66 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 120.656 0.904 . . . . 0.0 111.8 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.34 -33.92 55.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.36 -42.22 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -64.83 -35.25 91.68 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.8 mp -56.46 -41.62 76.82 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 122.728 -0.277 . . . . 0.0 110.962 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 t -79.71 -34.89 39.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.511 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.08 -36.22 79.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.1 t -48.0 -56.41 13.82 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HB3' HD21 ' A' ' 89' ' ' LEU . 20.6 Cg_endo -59.22 -34.16 98.18 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.719 0.946 . . . . 0.0 112.933 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.4 m -59.04 -40.47 85.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.271 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.09 -37.89 88.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.001 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.29 -40.22 98.3 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.89 -44.22 98.36 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.881 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.4 m-85 -63.88 -43.38 96.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.3 mtt -61.83 -40.91 96.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.81 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.44 -45.82 10.72 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB1' ' NH2' ' A' ' 46' ' ' ARG . . . -69.15 -25.15 64.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.33 0.586 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -52.95 -36.55 60.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.358 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 89.7 t80 -60.24 -47.12 87.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.61 -32.81 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' CA ' ' HE ' ' A' ' 46' ' ' ARG . 20.5 ttt-85 -62.42 -42.77 99.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.029 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.94 -132.07 1.18 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.687 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.0 -26.05 59.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.796 0.331 . . . . 0.0 110.69 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.49 8.94 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.25 -41.64 62.97 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.67 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -62.87 -42.17 99.66 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.365 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -61.27 -39.89 92.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.592 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 29.3 m-85 -64.55 -22.82 67.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.021 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.7 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.338 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.86 82.25 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 72.8 mt -91.54 150.02 21.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.408 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.72 126.91 41.32 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.222 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -102.47 141.69 23.03 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 69.3 Cg_endo -57.99 144.15 94.96 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.112 1.208 . . . . 0.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.7 p -64.08 -30.24 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.039 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 35.6 p90 -78.66 3.76 15.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.927 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 32.8 t-80 -60.1 139.52 91.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.598 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 79.7 Cg_endo -95.67 169.3 1.32 Allowed 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.035 1.157 . . . . 0.0 112.759 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.36 148.46 41.9 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.876 2.384 . . . . 0.0 112.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' NH2' ' HB1' ' A' ' 23' ' ' ALA . 22.7 tpt85 -57.21 -39.39 75.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -79.89 -5.94 56.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.4 m -76.79 -76.4 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.9 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.004 ' O ' HG23 ' A' ' 52' ' ' ILE . 69.9 mt -66.38 -32.29 73.58 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.889 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.52 -42.73 5.11 Favored Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.374 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 61.7 Cg_exo -64.31 -6.94 12.68 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.083 2.522 . . . . 0.0 113.789 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.004 HG23 ' O ' ' A' ' 49' ' ' LEU . 18.4 pt -42.32 -44.03 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.731 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.3 m95 -54.8 -31.99 59.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.606 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.68 -39.89 98.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -68.77 -51.79 37.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.092 0.472 . . . . 0.0 111.036 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.1 mp -66.81 -32.63 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.87 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 8.8 t80 -51.79 -49.39 62.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.734 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.0 p -70.88 -36.04 72.6 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.456 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.76 89.07 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.06 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.5 mtt -62.25 -38.77 90.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.427 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.52 -56.68 10.78 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.92 -38.41 88.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.93 92.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 94.1 p -63.5 -28.89 70.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -58.88 -43.81 91.0 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.22 -46.43 88.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.411 HG22 ' OG ' ' A' ' 130' ' ' SER . 78.1 t -60.26 -41.05 85.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.522 0.677 . . . . 0.0 109.198 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.505 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.35 -34.19 77.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.206 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -63.23 -43.18 98.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 82.7 mt-10 -67.49 -37.06 82.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.25 -4.39 58.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.18 46.67 15.18 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.721 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.463 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.39 -159.53 23.34 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.677 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -85.18 111.62 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.719 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.473 HG23 ' H ' ' A' ' 77' ' ' ASP . 3.6 t -130.27 161.21 31.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -47.07 -39.75 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.482 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.473 ' H ' HG23 ' A' ' 75' ' ' THR . 86.2 m-20 -63.33 -39.62 95.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.719 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.8 71.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.212 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 87.4 mmm -58.72 -34.54 71.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.112 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.15 -59.23 13.97 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.22 -53.84 1.33 Allowed 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 120.828 1.019 . . . . 0.0 112.767 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.2 mp -64.0 -43.01 96.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.448 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.55 -41.99 97.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.84 -39.33 77.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.921 0.391 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 73.2 t80 -60.42 -44.17 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.561 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.0 m -64.85 -43.1 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 112.072 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.23 -58.25 4.39 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.76 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -57.8 -40.91 81.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.681 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 15' ' ' PRO . 25.4 tp -62.77 -41.21 99.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.633 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 111.416 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.36 -37.76 78.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.734 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 45.3 t-20 -61.73 -42.46 98.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.169 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -57.57 -31.42 66.13 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.775 0.322 . . . . 0.0 111.193 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.1 -28.81 69.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.666 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -55.05 -55.45 38.89 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.406 ' CD ' HD13 ' A' ' 113' ' ' LEU . 73.4 Cg_exo -38.49 81.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.814 1.676 . . . . 0.0 113.18 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' A' ' 95' ' ' TRP . 65.1 Cg_endo -63.71 -23.69 69.44 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 120.498 0.799 . . . . 0.0 111.704 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 38.1 pt -62.21 -30.0 47.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.65 -48.26 66.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.779 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.489 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 68.5 t80 -64.95 -46.78 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.633 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -109.38 -65.04 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 59.79 -1.32 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 110.838 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 101' ' ' GLY . 24.0 ttp-105 -52.59 -33.55 46.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -91.52 151.77 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.263 0.554 . . . . 0.0 111.688 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.648 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.0 ttp -62.93 -14.63 49.34 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.193 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.75 32.65 0.01 OUTLIER Glycine 0 CA--C 1.543 1.824 0 C-N-CA 121.821 -0.228 . . . . 0.0 113.018 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -63.58 -19.61 64.97 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -179.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.681 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.97 -21.89 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.859 0.361 . . . . 0.0 111.924 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 107' ' ' TRP . 75.3 mt -58.73 -34.79 71.76 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.9 t0 -63.84 -48.06 78.28 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.5 tp -61.54 -49.39 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.399 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.6 tt -67.16 -41.27 86.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.289 0.566 . . . . 0.0 110.11 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.629 ' CD2' HG21 ' A' ' 147' ' ' THR . 13.3 tp -51.42 -59.89 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.678 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.529 ' HA ' HD13 ' A' ' 144' ' ' LEU . 59.8 t -71.13 -63.07 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.588 -1.187 . . . . 0.0 113.2 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.486 ' O ' ' OG1' ' A' ' 120' ' ' THR . 43.7 t -66.93 -39.29 87.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.22 -56.12 23.88 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.355 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 114' ' ' LEU . 4.1 p -65.25 -37.3 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.317 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.03 -52.81 8.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.9 m -54.58 -42.58 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -60.37 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.913 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.608 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 21.6 m -66.02 -41.19 91.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.765 HG23 ' CD2' ' A' ' 127' ' ' HIS . 47.6 m -58.27 -47.22 84.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.165 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.1 -34.17 77.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.11 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.608 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 39.0 m0 -65.06 -45.3 85.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.765 ' CD2' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -59.84 -43.89 94.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.148 -177.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.56 -43.45 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.221 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.492 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 84.7 t -81.02 -50.83 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 67' ' ' VAL . 76.1 p -128.58 88.88 51.0 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.046 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.5 Cg_exo -52.06 -40.14 68.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 121.651 1.567 . . . . 0.0 113.019 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.7 Cg_exo -57.42 -27.0 74.03 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.532 0.821 . . . . 0.0 112.905 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.77 74.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.639 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.62 -38.83 86.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.202 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 59.8 ttt180 -60.39 -38.76 84.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.14 -39.13 74.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.176 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.0 mt -56.79 -33.14 66.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.852 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.522 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER 9.91 -72.62 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -53.4 -26.43 35.48 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 120.617 0.878 . . . . 0.0 113.675 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -57.5 -41.33 80.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.357 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.678 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -64.96 -41.15 95.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.09 0.472 . . . . 0.0 109.943 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.74 -42.4 95.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.647 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -67.2 -53.11 33.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.398 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 115' ' ' VAL . 43.7 mt -61.39 -33.41 73.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.674 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.36 96.96 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.555 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 21.5 t80 -60.55 -41.11 93.87 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.633 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 69.4 p -61.82 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.452 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.438 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 59.3 m -61.21 -53.06 61.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.445 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.4 -42.84 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 54.9 tp -57.39 -41.92 81.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.03 -41.8 97.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 148' ' ' THR . 50.1 m-85 -64.85 -36.75 85.36 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.659 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 62.2 t80 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.426 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.43 -49.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.135 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.681 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.0 m0 -61.72 -43.91 97.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.555 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.411 ' CG ' ' O ' ' A' ' 152' ' ' TYR . 82.2 mmt-85 -62.87 -34.77 78.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.381 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 91.0 m-20 -56.56 -41.27 76.58 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.795 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -94.22 -48.13 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.443 . . . . 0.0 110.573 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 80.6 p . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.788 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.457 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.19 -19.83 35.75 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 119.368 0.81 . . . . 0.0 112.514 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.35 -34.73 61.7 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' THR . 70.1 t -59.85 -39.97 81.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -36.47 92.74 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.7 -41.99 87.55 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 122.824 -0.221 . . . . 0.0 111.565 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 9' ' ' VAL . 3.8 t -75.41 -37.33 60.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.189 -0.604 . . . . 0.0 112.072 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.56 -36.71 81.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 t -51.6 -43.07 86.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.48 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -58.39 -36.45 97.55 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.15 1.233 . . . . 0.0 112.902 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -63.46 -37.52 87.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.602 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.68 -40.03 80.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.455 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.99 76.34 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.7 -40.85 97.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.59 -48.65 80.85 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.171 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 65.0 mtt -63.93 -39.47 94.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.409 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.84 -45.47 74.25 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.799 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.31 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 111.64 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -57.61 -30.94 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 90.6 t80 -61.0 -48.6 81.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.73 -32.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.747 0.785 . . . . 0.0 109.631 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -63.06 -41.18 99.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.575 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.86 -128.58 4.78 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.025 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CG ' HH21 ' A' ' 32' ' ' ARG . 84.2 tt0 -49.97 -30.51 10.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.253 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.97 -33.12 20.48 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.8 mt -50.59 -44.63 56.97 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.543 HH21 ' CG ' ' A' ' 29' ' ' GLU . 67.9 mtm180 -62.18 -43.45 98.8 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.0 110.071 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.06 -39.74 91.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.954 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' LEU . 17.8 m-85 -65.27 -23.14 66.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.2 -41.11 49.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.155 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.18 -32.62 84.53 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' TYR . 67.5 mt -92.51 150.63 20.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -101.54 127.83 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.917 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.792 ' HZ2' ' HE ' ' A' ' 46' ' ' ARG . 14.0 mtpt -107.42 140.69 21.75 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.595 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 37.1 Cg_endo -58.03 130.23 37.12 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 120.713 0.942 . . . . 0.0 111.431 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.6 p -75.64 -13.44 60.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.884 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.508 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 2.7 p90 -77.29 -15.49 59.41 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.488 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -76.04 147.35 80.14 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.49 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HG2' HD21 ' A' ' 49' ' ' LEU . 1.3 Cg_endo -72.83 162.05 42.15 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.803 1.002 . . . . 0.0 111.297 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.9 Cg_endo -50.73 150.6 12.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.217 1.945 . . . . 0.0 111.848 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.792 ' HE ' ' HZ2' ' A' ' 39' ' ' LYS . 51.7 mtt85 -57.11 -36.85 71.13 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.447 ' C ' ' CD1' ' A' ' 47' ' ' TRP . 5.1 p90 -65.02 -22.09 66.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.864 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.7 m -78.45 -63.07 1.49 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.431 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.007 ' O ' HG23 ' A' ' 52' ' ' ILE . 85.8 mt -63.24 -36.98 85.46 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -45.49 -41.38 16.72 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.742 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 75.3 Cg_exo -64.92 -7.56 15.48 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 123.376 2.718 . . . . 0.0 114.081 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.007 HG23 ' O ' ' A' ' 49' ' ' LEU . 27.9 pt -41.99 -41.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.291 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' TYR . 97.2 m95 -51.2 -34.09 30.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.946 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.19 -39.99 96.66 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.0 m -68.68 -51.44 41.83 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.99 0.424 . . . . 0.0 110.936 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -65.98 -32.42 73.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 53' ' ' TRP . 3.5 t80 -52.28 -48.97 65.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.463 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -68.37 -36.92 79.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.23 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.91 76.54 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.672 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.503 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 62.9 mtt -61.84 -37.23 83.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.93 -61.75 5.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 39.4 t80 -61.61 -36.05 79.62 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.753 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.61 -42.91 58.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.1 p -66.65 -27.29 67.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 49.9 t80 -55.5 -49.86 71.45 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.445 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.7 mt -66.25 -37.33 79.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.668 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.7 t -53.88 -48.03 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.448 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.6 p90 -73.23 -30.74 63.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.235 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 65.6 mmtt -58.36 -38.56 77.48 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.204 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.26 -40.91 94.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.27 -25.77 60.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.772 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 104.77 39.12 2.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.15 -166.55 28.52 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.662 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.13 112.05 19.47 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.16 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.2 t -129.94 165.77 21.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.589 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.85 -37.87 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.471 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 75' ' ' THR . 85.3 m-20 -64.28 -38.92 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.868 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.29 73.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.662 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 81.6 mmm -59.74 -33.74 72.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.974 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.4 -57.6 23.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.66 -50.85 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 120.61 0.874 . . . . 0.0 112.335 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.0 mp -65.06 -41.16 95.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.109 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.66 -39.23 97.65 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.94 -38.38 78.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.112 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' OH ' ' SD ' ' A' ' 60' ' ' MET . 86.8 t80 -59.36 -45.17 92.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.144 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.7 m -69.15 -41.89 76.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.45 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.19 -54.41 6.96 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.548 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -57.98 -41.41 82.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.299 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.54 -37.29 85.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.835 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.79 81.72 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.711 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.36 -36.53 84.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -57.85 -40.96 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -66.01 -32.68 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.76 78.17 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.594 ' CD1' HD11 ' A' ' 113' ' ' LEU . 3.8 t-105 -57.84 -50.68 86.73 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 47.9 Cg_exo -42.79 82.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.403 1.402 . . . . 0.0 112.549 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 95' ' ' TRP . 72.3 Cg_endo -62.35 -25.45 76.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 120.574 0.849 . . . . 0.0 111.601 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.801 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.0 pt -59.91 -33.73 53.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -46.61 64.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.89 -50.48 66.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.826 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.33 -53.1 0.47 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.801 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 57.14 3.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 0.0 110.797 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 101' ' ' GLY . 12.6 tpt180 -53.12 -34.96 59.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -92.0 145.33 24.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.329 0.585 . . . . 0.0 111.503 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.637 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.3 ttp -65.31 -14.36 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.343 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.03 38.56 0.01 OUTLIER Glycine 0 CA--C 1.54 1.628 0 O-C-N 123.077 0.236 . . . . 0.0 112.952 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.694 ' HA ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.16 -18.94 65.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.672 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -41.5 -21.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.756 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 107' ' ' TRP . 89.2 mt -57.2 -39.47 75.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.503 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -67.81 -39.04 84.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 109.942 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 49.6 t0 -60.92 -45.18 95.67 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.71 -48.99 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.46 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.594 HD11 ' CD1' ' A' ' 95' ' ' TRP . 85.0 mt -69.08 -40.34 78.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.417 0.627 . . . . 0.0 110.459 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.793 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.1 tp -51.75 -60.25 3.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.154 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.514 ' HA ' HD13 ' A' ' 144' ' ' LEU . 97.5 t -69.11 -63.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.754 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -71.63 -40.32 69.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -61.36 -51.29 58.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.534 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 114' ' ' LEU . 3.7 p -65.83 -37.04 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.174 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.78 -51.43 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.8 m -59.49 -45.28 92.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.28 68.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.37 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.476 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.3 m -64.33 -39.07 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.156 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 89.9 m -59.62 -52.96 63.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 0.0 112.296 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.597 ' O ' ' NE ' ' A' ' 128' ' ' ARG . 65.9 mt -59.34 -31.2 68.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.991 0.425 . . . . 0.0 110.362 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.87 -63.17 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.493 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 33.8 m0 -86.5 -52.21 5.71 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.603 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 0.5 OUTLIER -52.63 -47.15 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.597 ' NE ' ' O ' ' A' ' 124' ' ' LEU . 68.2 mtm180 -63.5 -40.83 98.1 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.3 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.36 -43.41 49.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.8 p -140.33 94.87 8.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.875 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.457 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.3 Cg_exo -54.08 -39.94 83.59 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.948 1.765 . . . . 0.0 113.775 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.5 Cg_exo -55.7 -26.21 54.98 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.338 0.692 . . . . 0.0 112.87 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.54 -31.24 71.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.668 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.603 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -61.38 -40.15 93.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.441 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.537 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 51.9 ttp180 -59.77 -38.16 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.3 tp -58.7 -38.83 79.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.203 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 139' ' ' PRO . 22.0 mt -56.04 -29.62 60.7 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.065 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.9 OUTLIER 9.28 -74.41 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.6 Cg_endo -52.32 -29.12 37.37 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 120.436 0.758 . . . . 0.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -57.92 -42.34 84.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.987 0.423 . . . . 0.0 109.977 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 42.7 tp -63.34 -39.56 94.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.63 96.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.006 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.663 ' CD1' HD12 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -67.09 -47.93 69.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.234 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 115' ' ' VAL . 44.5 mt -65.25 -33.74 76.71 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.801 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.89 77.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.795 ' CE2' HD22 ' A' ' 150' ' ' LEU . 16.0 t80 -63.32 -42.02 98.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.646 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.793 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.0 m -57.6 -43.74 84.89 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.516 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.7 m -60.18 -49.61 76.94 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.705 0.288 . . . . 0.0 111.604 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.44 -40.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.54 0.686 . . . . 0.0 109.757 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.795 HD22 ' CE2' ' A' ' 146' ' ' PHE . 63.8 tp -57.79 -42.98 85.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.729 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 147' ' ' THR . 17.1 m120 -63.48 -41.24 98.58 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -66.04 -40.32 90.9 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -61.52 -40.9 96.32 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.811 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.6 -47.66 79.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 5.3 m0 -62.15 -39.23 91.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -54.81 -31.1 58.75 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.215 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.49 -40.86 68.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.651 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -103.8 -60.91 1.5 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.675 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 155' ' ' TRP . 49.2 m . . . . . 0 N--CA 1.461 0.111 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.875 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.486 ' O ' HD13 ' A' ' 11' ' ' LEU . 76.6 Cg_exo -54.87 -21.35 25.77 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.445 1.43 . . . . 0.0 112.617 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.09 -40.94 59.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.797 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 12' ' ' THR . 93.9 t -63.37 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.74 -34.44 89.91 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.277 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.1 mp -56.55 -42.63 78.85 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.871 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 9' ' ' VAL . 4.0 t -76.03 -36.55 59.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.822 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.98 -38.17 90.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -53.87 -42.23 91.85 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -56.47 -36.36 97.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 120.953 1.102 . . . . 0.0 112.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -61.25 -37.88 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 mt -62.35 -39.11 92.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.252 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.82 -52.58 28.22 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.76 -38.27 95.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -57.33 -44.78 84.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.279 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.08 -38.92 90.66 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.375 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.72 -46.27 76.93 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.99 -24.08 62.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 110.826 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -34.92 70.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 54.3 t80 -60.71 -49.05 79.06 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.62 -33.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.156 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -61.01 -40.79 94.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.817 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.06 -125.83 2.67 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.032 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.87 -28.8 62.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 111.209 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.4 -33.97 12.58 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 94.1 mt -48.78 -44.33 38.82 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.663 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.09 -42.45 99.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.976 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -62.31 -38.14 88.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.843 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.607 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.1 m-85 -63.78 -22.75 67.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.224 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.19 -41.41 27.06 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.973 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.99 -32.25 76.73 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.8 mt -88.93 149.51 23.28 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.451 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.0 mt-30 -101.96 130.17 48.41 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.079 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HZ1' ' HE ' ' A' ' 46' ' ' ARG . 16.1 mtpt -108.99 141.5 23.51 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 27.6 Cg_endo -58.98 135.93 69.95 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.387 1.391 . . . . 0.0 111.944 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.9 p -71.94 -21.29 61.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.312 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.525 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 4.5 p90 -77.95 -14.8 59.41 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.66 148.49 92.74 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.948 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -80.14 162.34 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.202 1.935 . . . . 0.0 111.424 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.2 Cg_endo -52.47 149.49 23.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.768 1.645 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HE ' ' HZ1' ' A' ' 39' ' ' LYS . 39.2 mtt85 -57.19 -37.96 72.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 48' ' ' THR . 5.0 p90 -63.98 -28.21 69.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.941 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 25.0 m -66.12 -61.21 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.993 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.2 mt -72.22 -34.78 68.61 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -38.33 -49.35 3.44 Favored Pre-proline 0 C--N 1.321 -0.634 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.938 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.4 Cg_endo -73.19 4.67 3.61 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 122.113 1.875 . . . . 0.0 114.134 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.993 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.5 pt -42.07 -40.17 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.637 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.6 m95 -50.7 -32.32 19.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.333 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.1 -40.69 95.95 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 m -67.98 -50.97 52.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 111.352 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -67.61 -33.12 74.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.238 0.542 . . . . 0.0 109.897 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.3 t80 -52.67 -49.43 65.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.2 p -70.41 -36.55 74.1 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.684 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.403 ' C ' HD11 ' A' ' 136' ' ' LEU . . . -67.33 -40.88 85.96 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.48 -39.37 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.095 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.99 -49.3 76.81 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -64.05 -39.16 93.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -55.82 -42.09 85.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.472 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.9 p -64.27 -29.27 70.37 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.76 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 50.6 t80 -58.78 -40.13 83.05 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.218 0.532 . . . . 0.0 110.169 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.38 -39.55 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.539 0.685 . . . . 0.0 109.865 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.567 HG22 ' OG ' ' A' ' 130' ' ' SER . 61.4 t -65.42 -54.08 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.55 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.46 ' NE1' ' HG2' ' A' ' 69' ' ' LYS . 0.7 OUTLIER -66.37 -35.75 81.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG2' ' NE1' ' A' ' 68' ' ' TRP . 22.0 mmtp -61.4 -39.49 90.92 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.495 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -63.32 -40.07 96.3 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.334 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 71' ' ' LEU . 77.3 mt -74.73 -25.49 59.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.74 49.26 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.449 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.39 -158.64 24.64 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.633 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -92.18 109.13 20.49 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.482 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.548 ' CG2' ' OD1' ' A' ' 77' ' ' ASP . 6.3 t -131.68 167.37 19.58 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -49.91 -38.36 35.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 35.6 p30 -66.45 -32.87 74.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.974 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.664 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -76.61 -30.69 57.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.633 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 88.1 mmm -59.04 -34.9 72.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.23 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -64.08 -58.13 15.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.406 ' CA ' ' HB1' ' A' ' 125' ' ' ALA . 13.3 Cg_endo -59.37 -56.5 1.28 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 121.461 1.441 . . . . 0.0 113.117 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.3 mp -64.14 -43.07 96.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.947 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.85 97.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.868 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -57.33 -39.8 76.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.083 0.468 . . . . 0.0 110.203 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -61.12 -43.98 98.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.042 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.3 m -68.42 -42.93 78.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -61.2 2.97 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -55.6 -41.09 72.93 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.22 -38.82 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.43 69.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.1 -38.54 86.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.918 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.436 ' OD1' HD12 ' A' ' 113' ' ' LEU . 42.8 t-20 -60.65 -42.13 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -58.14 -31.71 67.46 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.619 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.5 70.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.374 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -54.3 -54.3 49.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.401 ' CD ' HD13 ' A' ' 113' ' ' LEU . 86.8 Cg_exo -40.37 79.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.678 1.586 . . . . 0.0 113.28 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.601 ' N ' ' O ' ' A' ' 95' ' ' TRP . 57.3 Cg_endo -61.0 -21.3 71.06 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 120.818 1.012 . . . . 0.0 110.525 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.871 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.0 pt -62.41 -23.96 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.175 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -54.49 -46.88 73.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.027 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 69.3 t80 -64.33 -50.2 68.72 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.17 0.42 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.676 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.98 -2.3 0.2 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.567 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.0 ttt180 -53.92 -35.08 61.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.58 157.02 19.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.244 0.545 . . . . 0.0 111.455 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.696 ' O ' ' N ' ' A' ' 107' ' ' TRP . 21.7 ttm -56.26 -14.07 2.58 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.584 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.31 -1.37 0.01 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.368 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.696 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.92 -20.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.081 -0.658 . . . . 0.0 111.08 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.555 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.49 -27.45 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.739 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.98 -33.88 73.92 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.546 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.18 -37.14 84.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.544 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.9 t0 -63.11 -50.43 70.53 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.59 -46.38 86.08 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.498 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.764 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -67.6 -42.16 82.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.359 0.599 . . . . 0.0 110.35 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.684 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.6 tp -50.02 -59.51 3.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.489 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 144' ' ' LEU . 60.3 t -70.69 -63.19 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.04 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.411 ' O ' ' OG1' ' A' ' 120' ' ' THR . 42.3 t -66.1 -38.97 89.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.4 -55.87 26.63 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.963 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -65.21 -39.07 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.741 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.72 -45.18 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 116' ' ' SER . 62.3 m -60.56 -42.27 96.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.7 -53.82 16.76 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.155 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.457 HG23 ' CE3' ' A' ' 126' ' ' TRP . 49.0 m -64.36 -41.18 96.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 65.5 m -59.2 -45.68 90.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.7 -37.22 85.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB1' ' CA ' ' A' ' 81' ' ' PRO . . . -83.01 -64.22 1.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.457 ' CE3' HG23 ' A' ' 122' ' ' THR . 41.1 m0 -66.54 -42.16 87.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 50.6 t-80 -58.33 -48.08 81.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.698 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -62.43 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.33 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -72.57 -43.57 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 0.0 111.448 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 67' ' ' VAL . 1.3 p -145.84 106.23 4.25 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.666 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.493 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.0 Cg_exo -56.58 -38.2 95.98 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.371 1.38 . . . . 0.0 112.985 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.8 Cg_exo -55.16 -27.46 56.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 120.484 0.789 . . . . 0.0 112.446 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' LEU . . . -60.84 -24.48 65.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.516 0.674 . . . . 0.0 109.296 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.49 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -64.67 -43.64 92.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.37 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.439 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.6 mtt85 -66.28 -37.44 85.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.548 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.834 ' C ' HD13 ' A' ' 136' ' ' LEU . 1.1 tm? -49.23 -43.16 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.401 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.503 ' O ' ' C ' ' A' ' 138' ' ' TYR . 60.2 mt -60.84 -29.02 69.25 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.503 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 2.82 -76.2 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -53.08 -25.57 29.42 Favored 'Trans proline' 0 N--CA 1.509 2.423 0 CA-C-N 119.384 0.816 . . . . 0.0 113.278 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -56.61 -38.41 72.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -178.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 34.0 tp -65.17 -40.36 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.79 94.09 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.647 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -65.3 -50.81 64.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.114 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.519 HD13 ' HA ' ' A' ' 115' ' ' VAL . 43.8 mt -64.51 -34.1 77.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.079 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.723 ' CE2' HD22 ' A' ' 150' ' ' LEU . 21.4 t80 -62.72 -42.2 99.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.624 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.684 HG21 ' CD2' ' A' ' 114' ' ' LEU . 53.2 p -60.28 -38.0 82.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.5 m -59.6 -50.99 71.75 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.1 t -69.94 -44.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.215 0.531 . . . . 0.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.723 HD22 ' CE2' ' A' ' 146' ' ' PHE . 62.2 tp -58.09 -40.68 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 147' ' ' THR . 43.2 m-80 -63.96 -40.03 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -61.94 -44.29 97.08 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.325 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -64.22 -40.04 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.076 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.82 -48.99 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.516 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -62.59 -40.23 96.26 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.65 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 159' ' ' SER . 39.1 mtm180 -60.03 -23.58 63.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.291 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 88.1 m-20 -53.63 -42.38 67.71 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.142 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -102.41 -41.4 6.33 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 156' ' ' ARG . 50.4 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.112 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.41 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -58.05 -28.06 81.96 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 CA-C-N 119.01 0.682 . . . . 0.0 111.052 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 -30.92 63.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.11 -42.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.25 -36.26 93.18 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.685 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mp -56.27 -44.21 79.54 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.609 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -79.33 -30.51 42.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.107 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.07 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 t -52.32 -56.6 20.8 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.2 Cg_endo -58.95 -33.36 98.68 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 CA-C-N 119.076 0.706 . . . . 0.0 112.72 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -60.23 -39.41 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.303 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.3 -37.66 88.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.232 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -64.49 -53.37 35.99 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.94 95.23 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.0 -45.9 89.52 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.567 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.3 mtm -62.91 -37.22 86.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.281 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.94 98.77 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.124 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.24 -28.07 64.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.93 -34.22 69.64 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.98 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 86.8 t80 -62.53 -46.75 86.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.216 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -74.09 -33.2 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.83 0.824 . . . . 0.0 109.766 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -59.35 -40.39 86.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.019 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.8 -130.6 4.64 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.808 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -51.55 -28.05 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.071 0.462 . . . . 0.0 110.85 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.99 15.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD21 ' HE ' ' A' ' 46' ' ' ARG . 95.3 mt -51.35 -43.21 61.74 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.848 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.391 0.615 . . . . 0.0 110.618 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -59.79 -40.44 88.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.662 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' NZ ' ' A' ' 39' ' ' LYS . 44.3 m-85 -66.08 -22.64 66.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.745 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.95 -41.65 16.47 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.443 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.74 -32.2 83.36 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.4 mt -93.63 149.16 21.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.286 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.585 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.8 mt-30 -99.21 122.21 42.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.87 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.699 ' NZ ' ' CD1' ' A' ' 34' ' ' TYR . 22.4 mttp -94.5 141.0 22.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HG3' HD12 ' A' ' 150' ' ' LEU . 55.2 Cg_endo -57.25 144.85 89.71 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.557 1.504 . . . . 0.0 113.069 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 m -61.58 -32.42 72.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.918 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 20.2 p90 -76.87 2.08 15.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.583 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.699 ' CE1' ' NH1' ' A' ' 46' ' ' ARG . 8.4 t-80 -62.7 140.16 97.06 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 71.7 Cg_endo -101.14 169.86 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.111 1.207 . . . . 0.0 112.461 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 50.4 Cg_exo -52.3 147.97 26.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.653 2.235 . . . . 0.0 112.209 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.699 ' NH1' ' CE1' ' A' ' 43' ' ' HIS . 80.0 mmt-85 -58.33 -37.58 75.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.402 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 25.7 p90 -81.21 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 49' ' ' LEU . 16.1 m -74.3 -76.18 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.599 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.99 ' O ' HG23 ' A' ' 52' ' ' ILE . 77.6 mt -66.09 -32.73 74.36 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.653 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.0 -43.45 4.57 Favored Pre-proline 0 C--N 1.324 -0.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.63 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 53.8 Cg_exo -63.61 -7.2 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.929 2.419 . . . . 0.0 113.714 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.99 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.5 pt -42.44 -41.46 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.444 ' N ' HG13 ' A' ' 52' ' ' ILE . 97.9 m95 -53.91 -33.79 57.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.442 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.64 94.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -69.38 -52.8 23.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.754 0.311 . . . . 0.0 111.44 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.1 mp -66.48 -33.68 76.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.179 0.514 . . . . 0.0 110.423 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 23.8 t80 -49.37 -59.55 3.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.287 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 m -65.01 -38.05 89.66 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.81 95.38 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.701 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -63.16 -37.73 88.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.687 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.24 -58.66 8.39 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -61.67 -37.44 84.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.491 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.86 -41.45 67.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 85.3 p -66.64 -27.95 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.37 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -55.82 -45.92 78.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.14 -44.19 97.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.75 -37.04 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.739 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.612 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 58.4 mttt -65.2 -41.71 94.27 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.465 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 87.3 mt-10 -70.15 -37.93 75.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . 58.7 mt -92.2 -0.54 57.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.6 5.21 67.07 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 90.52 -167.18 32.24 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -59.3 82.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.212 0.53 . . . . 0.0 111.065 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.0 t -133.12 160.84 36.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.664 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -41.95 -40.48 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.323 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 75' ' ' THR . 87.1 m-20 -66.88 -44.12 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.539 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 73' ' ' GLY . . . -77.67 -33.24 53.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 83' ' ' GLY . 87.8 mtp -57.87 -33.7 68.96 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.156 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.01 -50.17 89.56 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.305 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.7 -52.31 1.05 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 120.495 0.797 . . . . 0.0 111.948 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.4 mp -62.44 -42.48 99.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.319 0.581 . . . . 0.0 109.507 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.86 -38.66 96.91 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -58.38 -38.03 76.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.149 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 88.5 t80 -60.4 -44.45 95.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.1 m -65.88 -41.29 91.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.507 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.86 -54.22 19.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.819 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -59.79 -39.88 86.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.635 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' A' ' 15' ' ' PRO . 22.7 tp -58.79 -37.99 77.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.178 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.42 88.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 0.0 111.199 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -58.66 -39.95 82.1 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.507 HD22 ' CA ' ' A' ' 117' ' ' GLY . 50.8 t-20 -64.48 -35.96 82.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.693 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.557 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.7 m95 -56.17 -31.86 63.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.316 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.01 -16.39 62.06 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.6 t-105 -70.32 -52.81 11.29 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 27.4 Cg_endo -55.86 131.11 44.05 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.864 1.709 . . . . 0.0 113.309 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.412 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 41.3 Cg_endo -107.97 -28.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 120.841 1.028 . . . . 0.0 111.382 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.754 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 28.8 pt -56.58 -30.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.367 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 15.6 p90 -54.12 -42.29 69.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.526 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.9 t80 -63.53 -51.29 66.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.315 . . . . 0.0 111.532 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -114.11 -54.53 0.42 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.86 -1.0 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 101' ' ' GLY . 25.7 tpt180 -54.36 -33.72 59.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.847 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.77 151.36 27.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.318 0.58 . . . . 0.0 111.958 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.598 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ppp? -65.58 -14.41 61.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.741 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.37 32.74 0.02 OUTLIER Glycine 0 CA--C 1.538 1.496 0 O-C-N 123.131 0.269 . . . . 0.0 112.924 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.598 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.49 -21.26 62.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.596 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -50.1 -23.73 2.29 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.773 0.32 . . . . 0.0 111.813 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.11 -32.14 70.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.379 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.669 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.61 -45.52 93.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.495 . . . . 0.0 109.948 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.565 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 37.3 t0 -63.44 -44.03 95.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.903 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -60.73 -40.05 90.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.148 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.756 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -66.63 -48.25 70.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 113' ' ' LEU . 2.6 pp -75.31 -34.05 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.796 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 111' ' ' ASP . 45.3 t -63.63 -45.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.777 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 t -85.8 -41.45 15.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.507 ' CA ' HD22 ' A' ' 92' ' ' ASN . . . -56.56 -47.1 86.66 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.573 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.2 -46.22 45.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.568 0.223 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -71.71 -57.97 3.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 38.1 m -58.04 -43.12 86.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -59.42 2.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.011 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 34.4 m -64.64 -41.59 96.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.796 HG23 ' ND1' ' A' ' 127' ' ' HIS . 55.8 m -59.46 -47.73 84.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.412 HD22 HH21 ' A' ' 128' ' ' ARG . 88.9 mt -66.09 -34.55 78.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.44 -63.7 1.36 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.477 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.2 m0 -66.78 -43.95 82.59 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -177.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.796 ' ND1' HG23 ' A' ' 123' ' ' THR . 22.3 m170 -59.87 -45.32 92.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.931 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.412 HH21 HD22 ' A' ' 124' ' ' LEU . 96.7 mtt-85 -61.96 -44.4 96.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.354 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.497 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 77.1 t -76.85 -47.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.418 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.0 p -134.58 91.26 21.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.073 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.461 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.7 Cg_exo -52.4 -40.53 70.86 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.607 1.538 . . . . 0.0 112.975 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.6 Cg_exo -57.63 -29.18 84.38 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.591 0.861 . . . . 0.0 112.857 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.44 -32.3 71.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.202 0.525 . . . . 0.0 110.5 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.15 -36.55 77.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.64 -39.23 83.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.366 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 tp -57.7 -39.76 77.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.007 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 140' ' ' TYR . 82.7 mt -59.52 -27.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.973 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -6.2 -64.32 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.453 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -54.05 -30.2 58.64 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 CA-C-N 119.523 0.865 . . . . 0.0 112.898 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.45 -47.02 80.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 41.2 tp -60.58 -39.76 89.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.21 96.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.581 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -70.0 -50.22 43.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.893 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 115' ' ' VAL . 24.0 mt -65.38 -34.06 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.523 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.11 -47.54 84.14 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CE2' HD22 ' A' ' 150' ' ' LEU . 32.1 t80 -64.18 -43.69 94.34 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.345 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.568 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.2 m -56.14 -43.99 78.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.951 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 48.9 m -64.79 -48.37 74.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.775 0.322 . . . . 0.0 111.564 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.26 -41.74 86.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.836 HD22 ' CE2' ' A' ' 146' ' ' PHE . 56.6 tp -57.9 -41.15 81.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.974 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.565 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.5 m120 -62.09 -41.35 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -64.14 -42.37 96.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.818 0.674 . . . . 0.0 112.818 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -58.63 -45.21 89.75 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.062 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.97 -46.01 82.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.6 m0 -61.78 -40.03 93.73 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.78 -29.98 65.29 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.229 -0.589 . . . . 0.0 111.471 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 86.9 m-20 -50.71 -39.8 52.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -103.11 -58.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.228 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.224 -179.189 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 11' ' ' LEU . 86.0 Cg_exo -53.91 -21.7 21.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 120.841 1.027 . . . . 0.0 111.921 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.17 -35.96 62.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.933 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.8 t -62.48 -43.32 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.64 -33.37 85.96 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.378 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.8 mp -56.13 -43.2 77.98 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.136 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -37.95 35.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.836 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 57' ' ' TYR . 83.1 mt -62.3 -37.61 86.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -52.67 -43.43 92.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.819 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -57.17 -33.26 95.58 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.167 1.245 . . . . 0.0 113.176 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.6 p -62.19 -35.46 78.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.93 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.078 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -42.1 97.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.1 97.63 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.91 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 55.5 m-85 -61.99 -41.21 97.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.539 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.68 -40.29 96.62 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.765 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.42 -47.87 11.81 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.586 ' HB1' ' NH2' ' A' ' 46' ' ' ARG . . . -69.31 -23.37 63.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.209 0.528 . . . . 0.0 110.441 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -51.62 -38.95 57.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.032 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.558 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 58.1 t80 -62.69 -48.79 77.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -32.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.55 0.69 . . . . 0.0 109.967 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.494 ' CB ' ' HE ' ' A' ' 46' ' ' ARG . 13.9 ttt-85 -62.4 -41.44 98.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.023 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -131.22 2.64 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.132 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -26.99 48.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.618 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.6 -35.49 11.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -49.14 -44.64 42.75 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.962 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -61.0 -39.34 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.938 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -58.68 -37.07 75.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.349 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 37' ' ' LEU . 55.8 m-85 -61.02 -22.8 64.9 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.7 -40.57 6.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.059 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.47 -31.8 71.28 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 34' ' ' TYR . 56.9 mt -92.79 148.16 22.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 110.887 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -96.49 123.79 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.85 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -94.85 139.61 22.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 74.4 Cg_endo -58.84 147.06 90.73 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.501 1.467 . . . . 0.0 112.601 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -64.45 -29.42 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.09 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 39.4 p90 -78.32 2.7 17.66 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.492 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 57.8 t-80 -62.16 142.71 95.59 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.58 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 87.1 Cg_endo -107.74 172.55 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.336 1.357 . . . . 0.0 112.282 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 27.6 Cg_exo -54.41 148.14 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.87 2.38 . . . . 0.0 112.335 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.586 ' NH2' ' HB1' ' A' ' 23' ' ' ALA . 28.6 tpt85 -56.61 -39.28 73.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.406 ' CZ2' ' HB3' ' A' ' 45' ' ' PRO . 26.4 p90 -77.15 -9.12 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -75.57 -73.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.573 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.994 ' O ' HG23 ' A' ' 52' ' ' ILE . 92.1 mt -66.94 -32.72 74.16 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.694 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.38 -42.71 4.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.156 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 76.1 Cg_exo -63.79 -6.27 10.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.914 2.409 . . . . 0.0 113.387 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.1 pt -41.24 -44.84 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.084 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.492 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.1 m95 -58.08 -34.0 69.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.089 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.26 -40.35 98.48 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -66.99 -53.26 33.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 0.0 111.325 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.8 mp -67.82 -32.16 72.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.0 t80 -52.34 -50.14 62.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.875 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -69.89 -36.62 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.29 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' HD21 ' A' ' 136' ' ' LEU . . . -67.57 -43.46 80.58 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.046 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.5 mtt -60.63 -38.9 86.31 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.87 -52.64 40.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -61.4 -35.48 77.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.572 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.64 -46.02 59.54 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.435 ' CB ' HD21 ' A' ' 82' ' ' LEU . 97.4 p -63.26 -30.13 71.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.456 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 46.7 t80 -55.01 -40.3 70.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 109.797 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.0 mt -69.51 -44.39 79.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG13 HG11 ' A' ' 129' ' ' VAL . 53.8 t -63.68 -51.89 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.456 ' CD1' ' O ' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -64.27 -33.07 74.97 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.838 -178.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 67.0 mmtt -60.64 -40.79 93.27 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.783 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -67.68 -34.05 76.14 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.143 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 78' ' ' ALA . 54.6 mt -85.5 -0.54 55.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.092 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.76 44.08 8.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 90.43 -154.43 23.43 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -87.25 110.71 20.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.517 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.1 t -133.95 168.63 18.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.893 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -52.27 -37.96 56.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.385 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.472 ' H ' HG23 ' A' ' 75' ' ' THR . 84.8 m-20 -62.22 -40.02 94.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.339 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 71' ' ' LEU . . . -67.49 -28.28 67.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.851 0.358 . . . . 0.0 111.377 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 mtt -58.82 -35.25 72.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.306 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.18 -47.65 98.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.457 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 16.2 Cg_endo -77.75 -63.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 120.735 0.957 . . . . 0.0 112.538 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' A' ' 64' ' ' SER . 20.7 mt -59.49 -41.71 90.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.19 98.78 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.773 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.55 -38.11 74.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 109.916 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -57.92 -43.94 86.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.588 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.98 -60.72 3.76 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.396 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.59 -40.06 74.63 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.56 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.63 -40.39 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.224 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.96 78.52 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.48 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.11 87.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.226 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.546 ' O ' HD11 ' A' ' 113' ' ' LEU . 41.3 t-20 -62.23 -39.91 94.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.568 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.8 m95 -59.46 -28.45 67.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.07 63.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 97' ' ' PRO . 8.7 t-105 -71.12 -55.7 6.14 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.5 Cg_endo -40.96 82.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.034 1.156 . . . . 0.0 112.317 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -59.33 -23.82 71.7 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.739 1.626 . . . . 0.0 112.459 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.645 HD11 ' HB2' ' A' ' 110' ' ' ALA . 35.5 pt -59.62 -30.02 43.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.402 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.3 p90 -44.85 -42.27 7.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.493 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 57.7 t80 -66.62 -52.01 49.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.79 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.27 -68.69 0.48 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.737 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.558 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 65.58 5.07 3.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -54.92 -35.55 64.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 109.913 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -85.74 152.86 22.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.245 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.634 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.4 ttm -61.14 -14.97 28.55 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.975 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.7 21.59 0.01 OUTLIER Glycine 0 CA--C 1.543 1.79 0 C-N-CA 121.724 -0.274 . . . . 0.0 113.239 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.634 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.6 -19.82 41.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.409 0.605 . . . . 0.0 112.248 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.58 -22.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.446 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 107' ' ' TRP . 77.8 mt -59.63 -36.45 76.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.645 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -66.6 -40.25 88.77 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.33 0.586 . . . . 0.0 109.858 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.489 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 48.6 t0 -60.57 -57.15 13.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.664 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.97 -37.9 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.673 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.1 tt -64.46 -49.94 69.45 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 113' ' ' LEU . 3.2 pp -75.58 -35.21 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.065 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.516 ' HA ' HD22 ' A' ' 144' ' ' LEU . 55.7 t -66.6 -59.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 111.595 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -72.47 -40.48 66.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.474 ' HA3' HD22 ' A' ' 92' ' ' ASN . . . -58.54 -54.43 37.84 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.598 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.71 -35.69 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.504 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -75.46 -52.96 9.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.0 m -57.45 -43.04 83.65 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.66 -54.62 13.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.545 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.2 m -66.79 -40.01 87.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 91.2 m -59.36 -47.09 86.76 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 HH21 ' A' ' 128' ' ' ARG . 70.2 mt -72.83 -34.25 66.7 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.457 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -78.68 -64.16 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -64.56 -43.61 93.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.685 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 51.2 m170 -59.38 -44.7 92.72 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.022 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.489 HH21 HD22 ' A' ' 124' ' ' LEU . 98.5 mtt180 -61.58 -43.61 98.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.586 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.54 HG11 HG13 ' A' ' 67' ' ' VAL . 95.6 t -79.95 -46.68 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.557 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 96.0 p -133.58 88.53 33.76 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.48 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 34.7 Cg_exo -53.94 -41.01 78.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.766 1.644 . . . . 0.0 112.858 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 33.4 Cg_exo -56.44 -30.59 82.48 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 120.597 0.864 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.79 68.81 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.261 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.685 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -57.74 -39.25 76.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.421 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.508 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 93.2 mtt180 -63.28 -37.4 87.12 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.001 0.429 . . . . 0.0 110.533 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 59' ' ' ALA . 17.0 tp -54.28 -37.69 65.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 138' ' ' TYR . 85.1 mt -67.56 -3.16 7.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.147 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -26.97 -59.99 0.2 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.89 -23.96 78.18 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.079 1.186 . . . . 0.0 113.802 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -55.47 -41.21 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.179 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 37.2 tp -63.47 -39.51 94.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.17 93.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.669 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.708 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -66.44 -53.97 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.614 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 115' ' ' VAL . 50.1 mt -63.85 -33.51 75.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -41.02 95.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.799 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 28.2 t80 -61.69 -40.27 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.59 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 81.4 p -59.93 -37.94 80.94 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.404 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.6 p -68.33 -47.2 68.14 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.087 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.84 -41.16 79.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.373 0.606 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.799 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 36.9 tp -60.3 -42.95 96.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.489 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.3 m120 -66.51 -36.65 83.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.23 0.538 . . . . 0.0 110.947 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.553 ' CE1' ' NE ' ' A' ' 156' ' ' ARG . 1.4 t80 -56.42 -48.17 77.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.104 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -67.28 -45.01 77.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.82 -47.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.2 m0 -61.1 -40.73 94.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.553 ' NE ' ' CE1' ' A' ' 152' ' ' TYR . 86.2 mtt-85 -59.39 -28.07 66.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.526 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -51.71 -40.63 60.49 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.202 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -105.28 -60.34 1.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.449 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.767 -179.402 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 17.1 t . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.29 -18.25 29.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 120.44 0.76 . . . . 0.0 112.288 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.26 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.3 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 12' ' ' THR . 60.8 t -59.93 -40.31 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.64 -36.9 93.36 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.8 mp -58.52 -42.22 87.25 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 9' ' ' VAL . 6.6 t -74.95 -35.46 62.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.581 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.48 -34.9 78.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 10' ' ' GLY . 16.9 t -47.91 -56.6 12.9 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.0 Cg_endo -58.58 -34.44 98.84 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 120.797 0.998 . . . . 0.0 112.958 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p -62.14 -37.56 85.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.403 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.17 -38.71 85.9 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.479 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' C ' ' CZ3' ' A' ' 93' ' ' TRP . . . -67.76 -54.23 19.66 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.815 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.671 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -59.86 -36.17 89.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.814 -0.515 . . . . 0.0 111.814 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.48 -45.03 89.52 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.435 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.5 mtt -63.45 -39.23 93.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.8 0.333 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.95 -43.52 91.1 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.66 -26.07 64.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 110.816 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.78 -36.61 72.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.711 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 69.5 t80 -59.94 -49.67 76.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.4 m -73.6 -34.15 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.725 0.774 . . . . 0.0 109.929 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -61.79 -42.0 98.45 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.783 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.45 -127.51 1.57 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.854 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.93 -27.61 61.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.708 0.29 . . . . 0.0 110.682 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.24 -34.81 13.37 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -50.79 -41.48 57.17 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.488 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -61.06 -43.46 98.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.366 0.603 . . . . 0.0 109.458 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.17 -40.2 95.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.518 ' O ' ' O ' ' A' ' 37' ' ' LEU . 15.4 m-85 -62.4 -22.74 66.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.11 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.6 -41.5 31.04 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.209 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.0 79.02 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.1 mt -90.87 148.57 22.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.587 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -100.82 128.88 46.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.887 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.5 145.56 31.27 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.946 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 24.0 Cg_endo -58.41 137.13 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.135 1.223 . . . . 0.0 111.691 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -66.03 -26.73 67.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.089 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.411 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 13.0 p90 -78.32 -4.19 46.75 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.685 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 3.4 t-80 -60.09 134.09 90.31 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.362 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 51.4 Cg_exo -75.03 167.23 27.48 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.092 1.195 . . . . 0.0 111.678 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 26.9 Cg_exo -53.88 149.22 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.948 1.765 . . . . 0.0 111.242 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -57.24 -36.08 70.48 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.208 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CZ2' ' HB3' ' A' ' 45' ' ' PRO . 22.5 p90 -76.81 -11.54 59.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -77.02 -72.43 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.799 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.03 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.9 mt -62.77 -35.59 80.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.158 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.58 -41.28 5.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.002 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 66.1 Cg_exo -67.06 -2.21 7.55 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.917 2.411 . . . . 0.0 113.73 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.03 HG23 ' O ' ' A' ' 49' ' ' LEU . 20.1 pt -46.51 -34.57 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.732 0.301 . . . . 0.0 111.512 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.619 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 4.7 m-90 -54.07 -27.36 32.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.7 94.83 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -72.99 -45.85 55.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.853 0.358 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.682 HD11 ' CD1' ' A' ' 143' ' ' TRP . 6.8 mt -66.03 -33.61 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.228 0.537 . . . . 0.0 109.877 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 25.2 t80 -60.14 -50.05 75.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.913 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.7 p -74.79 -33.32 62.22 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.971 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.69 -46.18 83.48 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.638 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.8 mtt -63.93 -38.2 90.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.657 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.85 -61.41 5.58 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.13 -37.3 86.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.603 0.239 . . . . 0.0 111.256 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.22 -43.33 74.54 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.8 p -67.44 -26.0 66.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.475 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 43.7 t80 -56.45 -50.16 72.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.163 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.58 -41.72 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.583 HG22 ' OG ' ' A' ' 130' ' ' SER . 62.8 t -53.64 -48.32 59.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 65' ' ' TYR . 1.4 p90 -70.58 -31.52 68.56 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.966 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 67.8 mmtt -59.71 -37.92 80.21 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.761 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 81.0 mt-10 -68.15 -35.66 78.43 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.87 3.68 47.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.931 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 36.0 11.62 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.32 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 89.21 -174.85 42.42 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.61 84.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.6 m -93.42 146.69 23.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.212 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -50.88 -37.96 46.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.596 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.25 -39.52 92.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.17 0.51 . . . . 0.0 109.671 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.5 71.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.601 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.4 mtp -58.49 -33.05 69.37 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.612 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -55.98 -57.9 19.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.791 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.7 -47.9 10.21 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 119.023 0.687 . . . . 0.0 112.428 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.221 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.0 -37.44 94.96 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.6 tp -57.03 -41.65 78.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 77.6 t80 -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.3 m -65.42 -42.72 92.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.674 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.51 -58.41 3.88 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.635 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -57.15 -41.67 79.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.577 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 15' ' ' PRO . 36.2 tp -63.25 -38.1 89.84 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.135 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.76 75.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.9 -39.13 88.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.589 ' OD1' HD13 ' A' ' 113' ' ' LEU . 43.6 t-20 -60.78 -38.3 84.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.475 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.671 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 50.2 m95 -62.07 -31.33 71.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.632 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -31.8 73.14 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.686 ' CD1' HD11 ' A' ' 113' ' ' LEU . 4.0 t-105 -55.38 -50.69 85.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -41.05 80.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.684 1.589 . . . . 0.0 113.107 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.597 ' N ' ' O ' ' A' ' 95' ' ' TRP . 67.5 Cg_endo -63.04 -26.25 73.65 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 120.616 0.878 . . . . 0.0 111.143 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 107' ' ' TRP . 42.4 pt -63.82 -33.96 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -44.88 -41.09 6.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.808 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 64.8 t80 -67.18 -51.76 49.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.323 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.38 -65.83 0.44 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.572 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.512 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 64.84 5.19 2.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.441 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -54.24 -34.26 60.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.953 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -90.12 153.61 20.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.477 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.662 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.8 ttm -61.95 -15.16 41.4 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.18 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.7 20.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.638 0 C-N-CA 121.526 -0.369 . . . . 0.0 113.345 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.662 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -60.05 -19.38 52.59 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.74 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.82 -20.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' TRP . 83.8 mt -59.23 -38.91 81.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.03 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -66.12 -38.44 88.21 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.372 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.456 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 59.4 t0 -60.66 -45.88 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.96 -47.49 65.51 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.732 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 95' ' ' TRP . 76.8 mt -67.78 -38.9 83.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.421 0.629 . . . . 0.0 109.909 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.707 HD21 HG21 ' A' ' 147' ' ' THR . 19.7 tp -52.93 -61.51 2.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.282 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 144' ' ' LEU . 74.0 t -69.78 -63.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.765 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' ' 120' ' ' THR . 36.4 t -69.71 -40.78 76.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.02 -51.52 56.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.702 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 114' ' ' LEU . 3.6 p -66.2 -37.36 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.386 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.504 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -78.47 -49.71 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 116' ' ' SER . 38.1 m -55.44 -42.23 73.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.58 -54.37 12.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.623 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.5 m -65.78 -39.22 90.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.17 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.745 HG23 ' ND1' ' A' ' 127' ' ' HIS . 85.9 m -58.96 -47.47 84.99 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.91 -34.63 77.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.37 1.43 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.623 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.2 m0 -67.65 -44.01 78.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.745 ' ND1' HG23 ' A' ' 123' ' ' THR . 30.5 m170 -57.72 -45.46 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.534 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -63.07 -43.04 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.454 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.513 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 76.5 t -79.21 -53.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.936 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.583 ' OG ' HG22 ' A' ' 67' ' ' VAL . 43.8 p -128.39 91.38 44.13 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.319 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.441 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 45.2 Cg_exo -51.39 -42.28 55.61 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.915 1.743 . . . . 0.0 113.158 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.4 Cg_exo -56.47 -28.02 71.36 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.211 0.607 . . . . 0.0 112.311 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.38 71.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.77 -41.44 95.5 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.768 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -61.45 -36.06 79.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.49 . . . . 0.0 110.744 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.38 -38.19 76.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.6 mt -59.22 -30.76 68.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.521 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 0.17 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.3 Cg_endo -50.73 -29.96 27.63 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.513 0.809 . . . . 0.0 112.331 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -60.65 -36.49 78.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.633 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -67.8 -44.35 77.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.025 0.441 . . . . 0.0 110.104 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.58 -49.8 37.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.094 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.682 ' CD1' HD11 ' A' ' 56' ' ' LEU . 1.7 t-105 -59.94 -49.01 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 115' ' ' VAL . 74.7 mt -66.07 -32.4 73.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.301 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.39 90.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.825 ' CE2' HD22 ' A' ' 150' ' ' LEU . 23.1 t80 -63.25 -42.03 99.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.264 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.707 HG21 HD21 ' A' ' 114' ' ' LEU . 74.3 p -60.84 -38.36 85.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.604 -0.438 . . . . 0.0 112.049 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.8 m -62.34 -49.31 76.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.695 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.22 -40.68 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.45 0.643 . . . . 0.0 111.01 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 146' ' ' PHE . 53.5 tp -55.91 -47.02 78.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.54 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 147' ' ' THR . 14.9 m120 -66.95 -37.59 84.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.389 0.614 . . . . 0.0 110.449 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -58.88 -44.31 91.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.903 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.97 -46.12 86.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.999 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.06 -47.74 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.7 m95 -61.27 -43.65 98.52 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.493 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.4 mmt-85 -59.7 -35.65 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.842 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -59.46 -41.05 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -96.63 -59.62 1.78 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TRP . 34.4 m . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.524 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 111.46 0.17 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.31 -24.49 51.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.002 1.135 . . . . 0.0 111.733 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.22 -34.12 21.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.141 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.52 -41.93 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.29 92.6 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.447 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.38 -39.56 83.73 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.375 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -81.23 -36.57 29.83 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' CZ ' ' A' ' 57' ' ' TYR . 96.4 mt -61.93 -36.63 81.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 t -54.9 -43.73 99.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.601 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.41 -32.61 94.48 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.397 1.398 . . . . 0.0 113.49 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.9 m -59.34 -38.0 79.23 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.716 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.5 mt -60.67 -38.08 83.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.165 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.91 99.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.599 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.61 -42.4 99.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.128 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.404 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.0 m-85 -62.98 -45.37 92.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.0 mtm -62.57 -40.31 96.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 -48.26 23.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.21 -18.68 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.478 . . . . 0.0 110.969 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -54.25 -36.98 64.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.26 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 48.5 t80 -61.05 -50.75 72.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.04 -35.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.63 0.729 . . . . 0.0 110.216 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -60.95 -41.12 95.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.786 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.17 -125.21 2.27 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.031 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -56.99 -27.98 62.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.473 -0.364 . . . . 0.0 111.052 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.71 -32.78 17.87 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -51.33 -41.54 60.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.344 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -63.15 -42.87 99.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -62.12 -37.27 84.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.652 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' LEU . 6.0 m-85 -61.29 -23.2 65.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.955 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.86 -43.44 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.456 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.9 -32.21 81.99 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 34' ' ' TYR . 45.5 mt -93.07 149.23 21.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.831 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -100.94 129.92 46.86 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.004 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.579 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 11.9 mtpt -107.74 139.42 20.59 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.424 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 60.6 Cg_endo -61.47 134.05 49.32 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 120.668 0.912 . . . . 0.0 111.6 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.9 p -81.78 -9.81 59.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.781 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.478 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.8 p90 -77.88 -15.34 59.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.661 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' ND1' ' A' ' 43' ' ' HIS . 0.7 OUTLIER -76.69 149.81 81.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.915 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -76.38 163.99 31.48 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.573 1.515 . . . . 0.0 111.136 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.7 Cg_endo -51.38 149.45 17.25 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.803 1.669 . . . . 0.0 111.951 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.579 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 42.0 mtt85 -57.0 -35.51 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.426 ' CD2' ' HB2' ' A' ' 45' ' ' PRO . 4.5 p90 -64.19 -20.27 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.118 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.87 -62.77 1.48 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.426 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.979 ' O ' HG23 ' A' ' 52' ' ' ILE . 88.4 mt -67.46 -36.14 80.58 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.652 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -43.09 -41.0 6.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.983 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 53.0 Cg_exo -66.33 -7.39 17.4 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.181 2.587 . . . . 0.0 113.745 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.979 HG23 ' O ' ' A' ' 49' ' ' LEU . 19.0 pt -42.03 -43.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.357 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.472 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 95.0 m95 -54.28 -32.45 56.33 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.722 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.19 -39.2 96.82 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.1 m -69.62 -51.21 37.09 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.12 0.486 . . . . 0.0 111.04 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.8 mp -67.55 -31.77 72.09 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.431 0.634 . . . . 0.0 109.771 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.489 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -51.23 -55.87 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.633 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.6 m -64.03 -40.09 95.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.341 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.92 -44.5 89.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.993 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.52 -38.05 88.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.831 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -54.81 9.56 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.32 -37.6 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.13 -40.72 91.98 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.6 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -63.27 -31.71 72.93 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.188 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.33 -42.41 86.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.913 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 -41.22 84.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG13 HG11 ' A' ' 129' ' ' VAL . 46.7 t -58.7 -40.72 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.943 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.41 -51.16 70.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.464 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 71.4 mttt -53.36 -35.1 59.91 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.424 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.51 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 88.8 mt-10 -75.75 -43.82 44.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.767 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.29 -26.65 58.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.86 -5.42 42.9 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.681 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.58 -167.46 29.2 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.874 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 79' ' ' MET . 7.6 t80 -90.86 87.05 6.49 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' ALA . 11.2 p -124.04 167.64 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.205 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -42.88 -36.96 1.67 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.261 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.423 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 89.2 m-20 -62.54 -41.01 98.61 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.75 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -84.89 -40.27 17.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' GLY . 86.7 mtp -59.95 -35.17 74.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.27 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.9 -57.25 25.19 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.49 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.423 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 13.0 Cg_endo -61.95 -53.45 2.09 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.011 1.141 . . . . 0.0 112.01 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -63.52 -41.27 98.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.242 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.97 -39.76 97.99 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.41 -38.72 77.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.039 0.447 . . . . 0.0 110.241 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -59.79 -44.4 93.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.11 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.9 m -65.82 -45.4 82.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.472 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.83 5.97 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.42 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.72 -41.66 86.91 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.493 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.08 -36.96 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.82 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.59 66.74 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.63 -37.32 81.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.564 ' OD1' HD11 ' A' ' 113' ' ' LEU . 21.2 t-20 -60.04 -43.89 95.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.951 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.547 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 60.0 m95 -57.45 -30.47 65.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.041 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 -23.57 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 97' ' ' PRO . 55.9 t-105 -54.15 -67.56 0.61 Allowed Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 22.8 Cg_endo -43.35 80.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.832 1.688 . . . . 0.0 112.007 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.609 ' N ' ' O ' ' A' ' 95' ' ' TRP . 69.2 Cg_endo -57.54 -22.04 49.25 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.294 1.996 . . . . 0.0 113.293 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 107' ' ' TRP . 37.3 pt -57.11 -23.27 18.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 8.4 p90 -45.06 -41.59 7.77 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.718 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.532 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 75.7 t80 -66.51 -52.13 49.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.8 -68.89 0.5 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.791 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 63.79 3.21 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 0.0 110.749 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -53.8 -35.04 60.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -89.57 155.22 19.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.672 ' C ' ' H ' ' A' ' 107' ' ' TRP . 21.9 ttm -58.75 -15.17 10.88 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.039 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.59 15.06 0.01 OUTLIER Glycine 0 CA--C 1.544 1.846 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.351 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.672 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -56.15 -19.25 12.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.359 0.58 . . . . 0.0 112.257 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.662 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -43.09 -21.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 111.742 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.6 mt -61.08 -36.17 78.92 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.654 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.34 -39.29 93.6 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.731 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.492 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.0 t0 -62.95 -46.79 86.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.51 -49.11 76.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.904 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.5 tt -67.99 -42.54 80.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.544 0.688 . . . . 0.0 109.768 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 147' ' ' THR . 18.1 tp -50.67 -60.2 3.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.582 ' HA ' HD22 ' A' ' 144' ' ' LEU . 71.7 t -71.05 -63.58 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.495 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.8 t -68.91 -40.36 79.15 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.39 -51.01 60.71 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.795 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.83 -38.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.27 -47.88 22.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 116' ' ' SER . 56.7 m -57.89 -42.48 84.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.88 -57.58 3.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.675 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.636 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 16.9 m -62.3 -41.18 98.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.283 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 85.9 m -61.61 -45.47 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 124' ' ' LEU . 95.9 mt -63.11 -37.45 87.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.5 -63.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.636 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.7 m0 -65.98 -41.02 91.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.451 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.3 t-80 -57.4 -47.14 82.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.079 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.28 -43.74 90.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.73 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.63 HG11 HG13 ' A' ' 67' ' ' VAL . 86.4 t -78.6 -48.7 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.5 p -127.9 85.34 60.89 Favored Pre-proline 0 N--CA 1.465 0.297 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.726 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.463 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.05 -44.95 42.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.628 1.552 . . . . 0.0 112.258 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 17.0 Cg_exo -58.44 -31.76 94.85 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.361 0.708 . . . . 0.0 111.913 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.68 72.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.538 . . . . 0.0 110.078 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.3 84.75 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.704 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.57 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 73.7 ttt180 -60.51 -41.03 93.52 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 110.109 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.2 tp -53.29 -35.68 60.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.23 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.531 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 43.3 mt -69.64 12.42 0.19 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.331 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -44.88 -41.96 14.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.531 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 10.3 Cg_endo -64.24 -22.59 66.71 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.95 1.375 . . . . 0.0 112.5 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.24 -39.61 90.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.024 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.769 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.0 tm? -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.318 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.89 -43.59 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 111.593 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.714 ' CE2' HD12 ' A' ' 52' ' ' ILE . 1.4 t-105 -66.0 -51.35 59.16 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.467 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 115' ' ' VAL . 54.0 mt -64.12 -34.09 77.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.179 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.89 95.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.241 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.738 ' CE2' HD22 ' A' ' 150' ' ' LEU . 22.0 t80 -62.31 -40.76 97.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.405 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.758 HG21 HD21 ' A' ' 114' ' ' LEU . 66.9 p -58.28 -38.32 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.259 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.5 m -63.56 -51.15 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.346 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.48 -41.67 80.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.749 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.738 HD22 ' CE2' ' A' ' 146' ' ' PHE . 64.9 tp -57.89 -40.8 81.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.406 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 151' ' ' ASN . 2.2 m120 -65.53 -41.12 93.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.49 -40.21 96.47 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.85 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -60.42 -45.85 92.14 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.866 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.56 -48.22 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.662 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.2 m0 -63.85 -48.68 75.8 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.887 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -56.35 -32.38 64.67 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.198 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -56.73 -40.0 74.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -99.61 -61.12 1.41 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.825 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 155' ' ' TRP . 22.9 t . . . . . 0 CA--C 1.529 0.143 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.22 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.0 t . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 37.2 Cg_exo -53.74 -23.34 26.18 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 CA-C-N 119.232 0.761 . . . . 0.0 112.236 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.42 47.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 12' ' ' THR . 88.5 t -60.99 -41.71 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.12 -36.32 92.77 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.443 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mp -58.32 -40.9 83.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.013 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.1 t -77.78 -34.5 52.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.676 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.2 mt -66.78 -34.95 78.96 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 t -50.99 -58.06 11.61 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.3 Cg_endo -58.33 -31.51 93.99 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 120.577 0.852 . . . . 0.0 112.556 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -59.31 -38.12 79.47 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt -64.36 -37.99 89.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.262 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -66.39 -53.27 29.83 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.052 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.14 94.41 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -59.63 -48.95 79.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.018 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.16 -39.42 92.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.064 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.7 90.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.91 65.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.099 0.476 . . . . 0.0 110.279 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -56.6 -34.11 66.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.483 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 81.3 t80 -60.27 -47.85 84.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.1 m -74.15 -32.51 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.784 0.802 . . . . 0.0 109.936 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' O ' HD11 ' A' ' 31' ' ' LEU . 14.4 ttt85 -61.32 -41.46 97.05 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.939 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.23 -124.84 2.53 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.133 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.562 ' OE1' ' NE ' ' A' ' 32' ' ' ARG . 78.1 mm-40 -56.88 -28.24 61.56 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.964 0.412 . . . . 0.0 110.857 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.13 -32.74 13.27 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.5 mt -51.33 -42.19 61.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' OE1' ' A' ' 29' ' ' GLU . 72.7 mtm180 -61.53 -42.71 99.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.401 0.62 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.76 -41.76 98.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.59 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 46.8 m-85 -66.32 -22.98 66.29 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.518 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.15 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.169 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.69 84.65 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 34' ' ' TYR . 69.5 mt -90.13 151.07 21.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.744 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.424 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 90.2 mt-30 -97.32 128.27 44.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.058 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.602 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 55.7 mttt -103.04 143.94 27.62 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 20.9 Cg_endo -57.03 140.25 92.1 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 120.677 0.918 . . . . 0.0 111.829 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.8 p -64.2 -30.31 71.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.346 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.409 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 20.7 p90 -78.53 -1.58 34.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.462 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.2 t-80 -60.37 126.4 84.3 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.316 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 74.1 Cg_endo -79.73 164.24 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.347 1.365 . . . . 0.0 111.28 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.448 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 16.1 Cg_exo -50.78 139.85 39.11 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.341 1.361 . . . . 0.0 111.322 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.602 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 50.2 mtt85 -58.86 -36.13 74.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.981 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.448 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 5.0 p90 -66.98 -24.0 66.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.413 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 52.7 m -67.88 -63.35 1.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.965 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.007 ' O ' HG23 ' A' ' 52' ' ' ILE . 71.6 mt -72.19 -34.24 68.26 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.31 -49.56 3.42 Favored Pre-proline 0 C--N 1.321 -0.635 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.671 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 12.1 Cg_endo -71.43 6.11 2.05 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.034 1.823 . . . . 0.0 114.117 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.007 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.9 pt -50.09 -25.39 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.158 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 5.0 m-90 -55.03 -34.41 63.49 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.421 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -44.47 97.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.0 m -65.21 -47.57 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.129 0.49 . . . . 0.0 110.557 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 143' ' ' TRP . 6.1 mt -67.71 -34.21 76.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.587 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' TRP . 15.2 t80 -58.88 -50.87 72.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.762 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.1 p -71.03 -33.06 69.96 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.83 -43.14 97.09 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.696 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -64.28 -37.12 86.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.194 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.18 -64.19 3.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -59.94 -39.26 84.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.707 0.289 . . . . 0.0 111.312 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.48 -43.19 85.34 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.8 p -63.95 -27.98 69.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.908 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -57.59 -43.51 84.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.84 -43.41 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.44 -38.63 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.957 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.05 -36.57 79.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.17 -45.68 83.93 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.048 0.452 . . . . 0.0 110.82 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.83 -39.52 76.41 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.07 -2.6 57.59 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.94 7.08 66.45 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.269 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.21 -163.55 29.1 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.14 80.0 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.918 0.866 . . . . 0.0 110.365 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.3 m -119.82 147.4 44.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.556 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -41.11 -37.45 0.87 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.163 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.1 -42.77 96.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.833 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -71.33 -29.41 64.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.6 mmm -57.21 -34.4 68.49 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.784 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.87 -54.35 57.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.828 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -65.21 -55.65 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 120.439 0.759 . . . . 0.0 112.713 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -61.57 -42.49 98.93 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.684 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.07 95.65 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.7 tp -58.1 -40.28 80.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 110.166 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -61.13 -43.45 98.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.424 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 m -64.84 -41.38 95.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -53.56 5.81 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.261 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.02 -41.87 84.09 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.227 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 15' ' ' PRO . 25.2 tp -62.59 -37.64 87.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.117 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -46.25 80.81 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.75 -39.06 87.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.476 HD22 ' CA ' ' A' ' 117' ' ' GLY . 49.0 t-20 -63.52 -37.1 86.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.355 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.415 ' CZ2' ' CA ' ' A' ' 18' ' ' GLY . 1.7 m95 -56.24 -32.4 64.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.359 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.1 75.0 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.563 ' NE1' HD23 ' A' ' 112' ' ' LEU . 21.0 t-105 -54.78 -56.31 28.88 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 19.9 Cg_endo -57.95 128.61 29.58 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.469 1.446 . . . . 0.0 113.209 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 109' ' ' LEU . 98.5 Cg_endo -108.04 -28.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.112 1.875 . . . . 0.0 110.745 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.84 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 22.7 pt -54.21 -30.31 20.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.23 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 21.3 p90 -54.61 -44.64 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.512 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.574 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 78.6 t80 -64.17 -48.35 76.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.13 -58.07 0.42 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.84 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 57.97 -0.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 101' ' ' GLY . 14.7 tpt180 -53.56 -33.27 54.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.081 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -84.5 152.95 23.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.288 0.566 . . . . 0.0 111.603 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.65 ' O ' ' N ' ' A' ' 107' ' ' TRP . 2.8 ttp -62.06 -14.7 38.73 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.098 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.39 33.71 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.826 -0.226 . . . . 0.0 113.27 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.65 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.7 -20.89 62.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.575 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.06 -23.97 15.61 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.441 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 109' ' ' LEU . 5.8 mp -59.66 -33.86 72.1 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.898 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.0 -37.01 83.24 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 30.0 t0 -61.53 -41.11 96.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.015 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.563 HD23 ' NE1' ' A' ' 95' ' ' TRP . 45.3 tp -60.51 -57.09 14.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 113' ' ' LEU . 2.7 tt -61.85 -41.2 97.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.523 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.601 HD21 ' CZ2' ' A' ' 143' ' ' TRP . 13.7 tp -53.03 -64.91 0.67 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.744 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.635 ' HA ' HD13 ' A' ' 144' ' ' LEU . 95.5 t -69.04 -56.61 11.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.598 -176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.7 t -69.38 -44.01 72.37 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.476 ' CA ' HD22 ' A' ' 92' ' ' ASN . . . -56.61 -49.41 70.0 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -45.4 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.658 0.266 . . . . 0.0 111.297 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.475 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.68 -56.12 5.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.7 m -58.59 -43.57 89.57 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.99 -58.0 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.054 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.654 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.3 m -63.87 -41.87 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.6 m -61.47 -45.51 93.93 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.74 -36.03 82.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.72 -63.2 1.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.654 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 37.0 m0 -65.75 -42.06 91.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.0 t-80 -59.2 -48.33 82.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.684 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -64.66 -45.21 87.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.865 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.4 t -76.18 -45.43 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.2 p -133.65 86.76 38.47 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.193 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 40.2 Cg_exo -52.7 -42.25 63.94 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.755 1.637 . . . . 0.0 112.873 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -57.09 -31.27 89.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.359 0.706 . . . . 0.0 112.344 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.48 71.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.72 80.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.888 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -59.27 -39.35 82.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.17 -39.43 75.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.2 mt -58.79 -29.79 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.423 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.524 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER 1.83 -63.77 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.7 Cg_endo -51.09 -31.01 33.72 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 120.798 0.999 . . . . 0.0 112.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -59.43 -40.97 88.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.938 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.705 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -68.55 -41.98 79.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.649 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.8 34.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.023 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.695 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 1.3 t-105 -63.02 -51.79 65.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 115' ' ' VAL . 55.5 mt -62.47 -32.78 73.73 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.52 -39.34 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.684 ' CE2' HD22 ' A' ' 150' ' ' LEU . 23.0 t80 -61.87 -42.77 99.45 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.695 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 71.3 p -60.06 -37.26 79.34 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.402 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 55.3 m -60.79 -50.86 71.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.385 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.99 -43.47 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.214 0.53 . . . . 0.0 110.432 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.684 HD22 ' CE2' ' A' ' 146' ' ' PHE . 60.9 tp -58.82 -40.58 84.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.378 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.483 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.5 m120 -62.6 -41.39 98.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 148' ' ' THR . 54.5 m-85 -65.08 -39.52 93.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.435 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -58.94 -47.14 86.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.59 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.14 -46.17 67.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.539 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.3 m0 -62.15 -42.66 99.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -60.08 -29.85 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.582 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 84.2 m-20 -51.7 -40.6 60.43 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.895 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -104.46 -61.84 1.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.094 -178.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 15.1 t . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 7.6 Cg_endo -57.27 -20.59 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.105 0.716 . . . . 0.0 112.037 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.53 59.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.95 -39.95 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.148 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -63.17 -36.54 93.57 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 11' ' ' LEU . 11.1 mp -60.19 -42.63 95.47 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 57' ' ' TYR . 3.9 t -79.64 -46.12 17.79 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 12' ' ' THR . 93.1 mt -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 t -50.18 -41.97 69.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.776 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.26 -33.0 89.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.172 . . . . 0.0 113.246 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.53 -39.06 86.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.48 -37.91 89.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.15 -55.63 17.92 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.802 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.42 91.39 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.094 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.11 -47.84 80.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.348 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.1 mtm -64.33 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.798 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.31 -45.19 88.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.654 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.22 64.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.203 0.525 . . . . 0.0 110.929 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -30.99 65.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.036 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 102' ' ' ALA . 85.4 t80 -63.46 -47.7 80.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.2 m -69.45 -32.1 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.87 0.843 . . . . 0.0 109.256 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -64.38 -40.79 96.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.191 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.51 -116.94 2.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.791 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.23 -30.23 62.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 111.123 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.51 -33.13 24.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.5 mt -50.94 -44.44 60.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.365 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -63.35 -41.98 98.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 0.0 111.048 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -59.26 -38.69 80.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.96 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.552 ' O ' ' O ' ' A' ' 37' ' ' LEU . 66.5 m-85 -63.61 -22.73 67.05 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.733 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.85 17.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.677 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.89 -34.23 65.74 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.552 ' O ' ' O ' ' A' ' 34' ' ' TYR . 66.2 mt -92.31 152.35 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 89.8 mt-30 -92.65 128.38 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -106.47 144.22 28.56 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.62 0.248 . . . . 0.0 110.766 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.522 ' CG ' ' CE1' ' A' ' 43' ' ' HIS . 96.2 Cg_endo -62.68 138.64 70.74 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.299 1.999 . . . . 0.0 111.949 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.0 m -84.19 0.54 48.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.417 ' CZ3' ' HB3' ' A' ' 40' ' ' PRO . 13.0 p90 -101.18 12.04 38.3 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.102 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.863 ' NE2' HD13 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -85.3 137.66 36.85 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.759 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.4 171.48 18.0 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.63 1.554 . . . . 0.0 110.796 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HB2' ' CE2' ' A' ' 47' ' ' TRP . 3.0 Cg_exo -49.46 145.19 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 120.289 0.659 . . . . 0.0 110.659 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.565 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 36.7 mtt180 -58.62 -33.69 70.32 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.311 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.43 ' CE2' ' HB2' ' A' ' 45' ' ' PRO . 11.9 p90 -71.83 -11.94 61.04 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -74.77 -68.06 0.58 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.021 ' O ' HG23 ' A' ' 52' ' ' ILE . 94.2 mt -67.76 -35.68 79.15 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.322 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.24 -39.65 2.17 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 38.4 Cg_exo -71.03 1.29 5.43 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.892 2.395 . . . . 0.0 113.562 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.021 HG23 ' O ' ' A' ' 49' ' ' LEU . 15.9 pt -46.21 -37.23 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.726 0.298 . . . . 0.0 111.568 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.605 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.0 m-90 -53.8 -29.52 40.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.921 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 57' ' ' TYR . . . -53.44 -40.87 62.48 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -81.25 -39.61 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 143' ' ' TRP . 4.7 mt -64.73 -38.94 92.68 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 58' ' ' SER . 2.0 p90 -67.68 -44.02 78.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.293 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.525 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 49.6 m -60.67 -42.39 96.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.633 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.57 -43.72 88.91 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.886 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.7 mtt -63.08 -37.51 87.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.779 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.57 -59.14 9.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 47.9 t80 -64.65 -36.96 85.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.863 0.363 . . . . 0.0 110.792 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.81 -42.44 68.91 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.6 p -68.72 -26.26 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.637 0.256 . . . . 0.0 110.669 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 42.7 t80 -55.34 -49.27 72.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.229 0.538 . . . . 0.0 110.225 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.94 -40.92 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.507 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.37 -45.9 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 69' ' ' LYS . 1.2 p90 -69.48 -31.95 70.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.279 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 73.9 mttt -59.66 -37.66 79.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.047 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 83.9 mt-10 -67.12 -35.17 79.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.44 2.3 48.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.41 37.44 10.87 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.013 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.08 -161.09 27.68 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -87.45 109.52 19.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -133.35 168.78 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.176 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.85 -38.68 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.093 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 75' ' ' THR . 85.0 m-20 -63.11 -39.75 95.62 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.626 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.99 66.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.851 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 83' ' ' GLY . 8.8 mtt -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.806 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -58.25 -51.78 79.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.721 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.11 -56.91 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 120.701 0.934 . . . . 0.0 112.428 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.9 mp -63.46 -41.62 98.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.634 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.51 -38.24 95.47 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.1 tp -56.8 -40.24 75.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 110.186 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.6 -44.19 96.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -66.12 -41.59 90.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.152 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.5 -55.04 5.73 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.089 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -59.06 -41.31 87.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.404 ' HG ' ' NE1' ' A' ' 93' ' ' TRP . 37.8 tp -61.8 -38.89 89.8 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.238 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -46.25 90.53 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.293 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.11 -36.2 83.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.113 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.427 HD21 ' HA3' ' A' ' 117' ' ' GLY . 18.6 t-20 -58.6 -43.18 89.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.948 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.404 ' NE1' ' HG ' ' A' ' 89' ' ' LEU . 74.5 m95 -64.42 -32.9 74.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.01 -31.62 72.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.53 ' C ' ' CD1' ' A' ' 95' ' ' TRP . 8.3 t-105 -54.82 -54.86 44.82 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.15 87.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.034 0 CA-C-N 119.304 0.787 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.58 -18.75 41.51 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.176 1.251 . . . . 0.0 111.843 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.752 HG21 ' HA ' ' A' ' 107' ' ' TRP . 47.2 pt -58.62 -23.98 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 5.4 p90 -45.94 -41.31 11.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.555 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 52.7 t80 -67.37 -57.45 6.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.932 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -114.67 -68.77 0.47 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.84 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 101' ' ' GLY . . . 72.73 11.89 5.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.256 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -52.2 -35.56 49.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.333 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -87.17 149.63 24.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.659 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.615 ' O ' ' N ' ' A' ' 107' ' ' TRP . 13.5 ptm -62.56 -16.01 53.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.557 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -44.79 -4.01 0.01 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.565 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.752 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.7 p90 -44.49 -18.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.791 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.29 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.803 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 107' ' ' TRP . 70.8 mt -61.93 -35.6 78.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.09 -40.68 96.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 62.3 t0 -61.46 -49.82 75.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.295 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 tp -66.06 -44.11 85.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.02 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 113' ' ' LEU . 1.2 mm? -72.16 -38.78 69.08 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.869 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.58 HD21 HG21 ' A' ' 147' ' ' THR . 17.8 tp -53.02 -62.12 1.86 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.388 0.613 . . . . 0.0 110.816 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.555 ' HA ' HD13 ' A' ' 144' ' ' LEU . 97.0 t -66.61 -62.87 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.814 -1.084 . . . . 0.0 113.252 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 120' ' ' THR . 44.1 t -69.49 -39.04 77.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' A' ' 92' ' ' ASN . . . -60.73 -55.86 27.49 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.942 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 114' ' ' LEU . 6.1 p -65.75 -37.22 79.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.634 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.5 -49.19 15.27 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 116' ' ' SER . 37.0 m -56.67 -41.83 77.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -58.14 3.8 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.733 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.532 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 31.8 m -64.72 -40.76 95.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 77.4 m -59.93 -45.62 92.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.452 HD22 HH21 ' A' ' 128' ' ' ARG . 99.0 mt -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.88 -63.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.532 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 45.7 m0 -65.41 -41.3 93.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.1 t-80 -58.02 -48.0 81.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.003 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.452 HH21 HD22 ' A' ' 124' ' ' LEU . 85.0 mtt180 -64.9 -42.99 94.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 70.7 t -78.19 -53.11 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.6 p -127.31 90.81 47.91 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.3 Cg_exo -52.69 -42.22 64.07 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.866 1.711 . . . . 0.0 113.0 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 26.5 Cg_exo -56.78 -30.45 84.75 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 120.269 0.646 . . . . 0.0 112.258 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.8 70.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.5 91.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.668 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -59.82 -38.26 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 0.0 110.432 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.6 -35.34 70.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 138' ' ' TYR . 82.9 mt -64.95 -5.05 5.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.204 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -24.55 -53.57 0.15 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.5 -27.8 77.98 Favored 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 121.513 1.475 . . . . 0.0 113.523 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -58.21 -43.34 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.514 -178.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.5 tp -72.01 -41.58 67.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.24 73.54 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.527 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.557 ' CE2' HD12 ' A' ' 52' ' ' ILE . 2.5 t-105 -64.92 -49.92 68.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.945 0.402 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.555 HD13 ' HA ' ' A' ' 115' ' ' VAL . 78.9 mt -66.47 -34.38 77.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.849 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -59.51 -37.93 79.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.297 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.41 -45.04 81.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.58 HG21 HD21 ' A' ' 114' ' ' LEU . 68.9 p -58.23 -40.21 81.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.607 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.9 m -60.53 -46.88 88.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.204 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.9 t -68.59 -43.81 83.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 111.721 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.978 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -65.06 -41.9 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.834 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 147' ' ' THR . 19.4 m120 -60.47 -39.84 89.1 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.046 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -64.69 -39.19 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.75 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.18 -46.09 83.12 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.431 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.0 t -72.25 -46.21 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.791 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.5 m95 -61.4 -37.19 82.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 159' ' ' SER . 24.1 mmt85 -56.32 -26.16 51.38 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.889 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.478 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 92.6 m-20 -53.48 -41.86 66.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.754 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.546 ' ND2' HD21 ' A' ' 37' ' ' LEU . 86.0 m-20 -111.01 4.13 19.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.029 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 156' ' ' ARG . 48.2 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.564 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.53 ' O ' HD13 ' A' ' 11' ' ' LEU . 87.4 Cg_exo -54.54 -23.74 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.311 1.341 . . . . 0.0 112.497 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.98 60.37 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.624 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.41 -42.45 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.9 -34.52 88.81 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.147 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.6 mp -54.9 -44.43 74.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.886 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 t -78.7 -35.71 44.57 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.885 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.16 -37.7 88.22 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -51.57 -41.93 80.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.679 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -57.58 -27.59 77.53 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.411 1.407 . . . . 0.0 113.674 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.2 p -61.17 -32.75 72.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.59 -38.32 87.14 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.522 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.76 92.37 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.169 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.3 -59.29 3.94 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.775 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -58.79 -46.15 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.3 mmm -62.88 -40.0 96.18 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 -43.2 10.9 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.182 -0.533 . . . . 0.0 111.997 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.72 -21.66 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -53.35 -32.89 51.32 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.279 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 52.3 t80 -59.53 -47.49 85.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -72.94 -34.08 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.647 0.737 . . . . 0.0 109.713 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -61.09 -40.58 94.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.886 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.38 -132.57 2.02 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.987 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.61 -26.34 55.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.168 0.508 . . . . 0.0 110.669 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.41 8.84 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -52.45 -43.96 65.22 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.963 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -60.77 -40.65 93.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.022 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -59.32 -40.49 86.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.216 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' LEU . 57.3 m-85 -63.83 -22.93 67.15 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.974 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.19 10.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.852 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.55 81.59 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 34' ' ' TYR . 32.2 mt -91.23 151.15 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.853 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -98.85 130.76 45.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.032 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.623 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 61.0 mttt -102.93 140.57 21.19 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 31.1 Cg_endo -59.81 132.72 46.77 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.144 1.229 . . . . 0.0 112.414 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.1 m -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.117 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.486 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 5.8 p90 -76.1 -11.96 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.99 147.95 98.42 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.289 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.96 171.63 7.97 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.916 1.744 . . . . 0.0 111.521 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 24.0 Cg_exo -53.23 143.64 51.7 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.976 1.784 . . . . 0.0 111.793 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.623 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 38.8 mtt85 -58.9 -37.91 77.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.446 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 10.6 p90 -69.2 -26.89 65.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.497 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.2 m -64.75 -55.12 21.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.973 ' O ' HG23 ' A' ' 52' ' ' ILE . 87.0 mt -75.19 -32.49 61.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -38.79 -48.28 3.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.517 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 15.6 Cg_endo -71.85 1.78 5.44 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.299 2.0 . . . . 0.0 114.063 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.973 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.7 pt -44.85 -40.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.82 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' TYR . 98.4 m95 -53.25 -33.39 52.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.607 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.39 -41.6 98.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 m -67.09 -49.52 64.71 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.797 0.332 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -67.73 -33.08 74.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' TRP . 4.4 t80 -52.38 -49.72 63.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.823 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.7 p -69.57 -36.63 76.47 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.18 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.4 -44.99 77.49 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.2 mtt -61.98 -37.5 85.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.105 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.11 25.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -62.52 -38.38 89.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.931 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.55 -43.38 78.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.449 ' CB ' HD21 ' A' ' 82' ' ' LEU . 86.9 p -62.83 -30.4 71.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -56.76 -46.9 81.14 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.911 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.08 -42.95 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.45 HG22 ' OG ' ' A' ' 130' ' ' SER . 71.0 t -61.9 -40.51 87.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.715 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.528 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -62.63 -37.38 86.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -61.06 -41.55 96.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -63.94 -40.38 96.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.978 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.163 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 10.53 61.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.21 -162.14 27.88 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.08 111.32 23.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 78' ' ' ALA . 14.5 t -135.27 166.63 22.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -46.78 -33.73 4.65 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -36.57 72.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -63.06 -27.36 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.38 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.1 mmt -55.5 -35.95 66.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.87 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.66 -42.34 91.04 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.589 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 14.5 Cg_endo -89.64 -71.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 120.826 1.017 . . . . 0.0 112.594 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.449 HD21 ' CB ' ' A' ' 64' ' ' SER . 19.0 mt -62.05 -43.41 98.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.604 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.77 -43.03 98.24 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.16 -39.13 88.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.232 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.6 -43.24 89.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.1 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.2 m -68.03 -42.9 79.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.139 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.15 -58.8 3.29 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -56.13 -40.91 74.51 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.323 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 13.3 tp -64.18 -40.34 95.91 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.011 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.6 -48.1 76.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.534 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.9 mt -61.21 -39.21 89.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.335 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' HD11 ' A' ' 113' ' ' LEU . 41.6 t-20 -61.76 -41.45 97.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.479 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 52.9 m95 -58.96 -29.26 67.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.249 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.5 64.39 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.543 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.9 t-105 -61.59 -66.15 1.72 Allowed Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 85.0 Cg_endo -45.21 85.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.957 1.771 . . . . 0.0 112.543 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' TRP . 83.9 Cg_endo -59.52 -16.54 36.46 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.542 1.495 . . . . 0.0 112.31 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.792 HG21 ' HA ' ' A' ' 107' ' ' TRP . 33.5 pt -58.57 -26.56 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.581 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.97 -41.89 16.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.022 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.52 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.9 t80 -69.28 -51.99 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.201 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.87 -68.52 0.49 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.185 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 65.43 8.77 5.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 110.447 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -52.43 -35.17 51.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -94.17 154.41 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.259 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.645 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.7 ttm -58.44 -19.03 33.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.255 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -40.98 -8.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.263 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.67 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.792 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.7 p90 -45.31 -16.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.818 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.46 -23.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.098 -178.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.4 mp -60.74 -35.52 76.57 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.738 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.47 -41.15 96.79 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.459 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 56.3 t0 -63.27 -55.27 26.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.561 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 tp -64.93 -40.21 94.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.847 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.7 tt -69.56 -46.83 65.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.74 -36.66 67.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.632 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.443 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 42.5 t -70.58 -62.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.532 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -69.55 -39.85 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.12 -52.52 52.88 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.512 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 114' ' ' LEU . 6.8 p -64.7 -36.34 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.689 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.95 -53.52 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -56.91 -41.56 78.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.52 8.92 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.778 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.595 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.8 m -66.07 -41.93 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.551 HG23 ' CD2' ' A' ' 127' ' ' HIS . 47.2 m -58.9 -46.31 88.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.58 -33.37 71.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 81' ' ' PRO . . . -78.46 -63.91 1.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.595 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 33.9 m0 -64.57 -43.71 93.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.564 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -58.2 -41.73 84.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.391 -177.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -60.64 -43.75 97.18 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.2 t -79.97 -46.79 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.416 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 67' ' ' VAL . 22.9 p -135.64 93.55 15.92 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.483 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 53.2 Cg_exo -54.7 -39.13 90.69 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.84 1.694 . . . . 0.0 113.101 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 44.7 Cg_exo -55.67 -27.97 63.66 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.536 0.824 . . . . 0.0 112.652 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.66 71.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.81 -40.14 87.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.123 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.436 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 75.1 ttt180 -60.76 -39.68 89.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.5 -37.41 65.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.506 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 76.0 mt -65.06 13.25 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -46.09 -42.53 27.42 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.506 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 17.9 Cg_endo -67.14 -19.84 50.58 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.985 1.388 . . . . 0.0 112.885 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.45 -38.46 87.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 24.9 tp -65.94 -38.85 89.69 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.668 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.73 76.28 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.764 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.604 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -68.45 -52.02 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.366 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' A' ' 140' ' ' TYR . 34.1 mt -64.35 -33.85 76.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -60.72 -46.56 89.95 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.608 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.775 ' CE2' HD22 ' A' ' 150' ' ' LEU . 24.0 t80 -64.07 -40.09 95.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.522 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.7 m -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.375 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.9 m -63.95 -48.21 77.4 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.392 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.84 -40.48 78.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.172 0.511 . . . . 0.0 110.564 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.775 HD22 ' CE2' ' A' ' 146' ' ' PHE . 58.6 tp -55.04 -54.32 44.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.558 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.459 ' OD1' ' CG ' ' A' ' 111' ' ' ASP . 9.4 m120 -63.36 -36.65 84.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.602 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.487 ' CE2' ' NH1' ' A' ' 156' ' ' ARG . 20.8 t80 -58.4 -42.27 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.592 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.427 ' HA ' HH12 ' A' ' 156' ' ' ARG . 61.5 t80 -63.36 -47.0 83.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.03 -48.5 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.818 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 2.2 m95 -63.5 -39.35 94.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.662 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.487 ' NH1' ' CE2' ' A' ' 152' ' ' TYR . 29.8 ttp-105 -57.88 -37.79 74.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.358 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.97 -43.06 95.31 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.3 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -89.9 -49.48 6.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 155' ' ' TRP . 70.0 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.0 Cg_endo -57.05 -20.17 36.2 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 CA-C-N 119.231 0.761 . . . . 0.0 112.513 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -33.78 54.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.124 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.509 ' O ' HG22 ' A' ' 12' ' ' THR . 74.4 t -60.42 -40.74 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.03 92.83 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.36 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.85 -41.67 82.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.863 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.1 t -78.83 -35.97 43.21 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.105 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.34 -37.03 84.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.401 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.5 t -52.35 -55.93 27.14 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 14.9 Cg_endo -58.98 -34.5 99.18 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 120.697 0.931 . . . . 0.0 113.124 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.14 -37.16 79.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.146 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.0 -39.5 94.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.48 -48.35 69.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.784 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.76 96.8 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.248 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -58.65 -45.63 88.92 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.607 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -61.78 -38.77 89.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.135 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.93 93.85 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.22 -26.61 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.975 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -35.52 69.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.081 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 65.0 t80 -61.34 -46.0 92.06 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.271 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.408 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -73.38 -33.14 39.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.0 109.568 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -62.5 -40.67 97.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.531 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.87 -128.92 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.915 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.98 -27.72 61.7 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.698 0.285 . . . . 0.0 110.934 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.24 -32.27 6.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.624 ' CD2' ' HE ' ' A' ' 46' ' ' ARG . 94.9 mt -51.55 -45.06 62.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -65.39 -40.9 94.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 111.563 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -57.83 -37.48 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.23 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 78.6 m-85 -63.89 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.979 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -43.97 -41.91 5.62 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.353 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.5 -32.19 71.36 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 34' ' ' TYR . 34.4 mt -92.52 154.55 18.38 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.311 -0.444 . . . . 0.0 111.069 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 93.5 mm-40 -103.19 129.13 50.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mttp -103.23 145.15 30.05 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -57.08 136.1 74.59 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 120.881 1.054 . . . . 0.0 111.122 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.8 p -64.54 -25.92 68.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.005 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -79.45 -4.86 53.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.574 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.607 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.8 t-80 -53.85 130.06 56.65 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.637 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.607 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.8 Cg_endo -87.12 170.94 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.073 1.849 . . . . 0.0 111.219 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 28.6 Cg_exo -49.92 138.39 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 120.42 0.746 . . . . 0.0 110.911 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.624 ' HE ' ' CD2' ' A' ' 31' ' ' LEU . 38.1 mtt-85 -59.61 -36.49 76.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 8.0 p90 -72.6 -19.55 61.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.742 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -66.46 -63.35 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.871 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.997 ' O ' HG23 ' A' ' 52' ' ' ILE . 85.4 mt -71.9 -33.07 68.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.63 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.38 -50.11 2.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.814 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 10.2 Cg_endo -70.77 2.19 4.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.342 2.028 . . . . 0.0 114.286 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' O ' ' A' ' 49' ' ' LEU . 23.8 pt -45.22 -38.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.199 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.406 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.8 m95 -52.18 -29.11 20.8 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.718 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.01 -44.33 92.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.567 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -74.04 -44.76 53.18 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.199 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.74 -33.07 75.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.179 0.514 . . . . 0.0 109.664 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.41 -57.55 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.841 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -66.0 -38.72 89.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.812 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.44 90.76 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.6 mtt -61.14 -37.86 84.34 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.33 -54.0 22.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 88.8 t80 -63.11 -39.32 94.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.962 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.7 -41.36 74.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 90.8 p -66.28 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.431 ' HA ' ' CE2' ' A' ' 68' ' ' TRP . 56.0 t80 -56.44 -48.69 76.49 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.46 -39.71 86.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.201 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG22 ' OG ' ' A' ' 130' ' ' SER . 52.5 t -57.4 -49.02 81.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.3 p90 -73.64 -26.13 60.62 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.084 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CE ' ' CZ ' ' A' ' 65' ' ' TYR . 70.2 mmtt -59.87 -37.64 79.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.324 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 77.2 mt-10 -67.67 -41.03 84.39 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.374 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.3 mt -72.83 -25.81 61.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.754 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 103.42 45.9 1.5 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.98 -168.03 35.17 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.627 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.54 109.98 17.23 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.709 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.1 t -128.74 164.55 22.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.611 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -52.43 -37.88 57.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.414 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' H ' HG23 ' A' ' 75' ' ' THR . 85.2 m-20 -63.65 -38.96 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.714 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.45 71.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.627 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 82.0 mmm -59.22 -33.01 70.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.476 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.36 -56.96 26.11 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.957 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -65.14 -52.78 1.03 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.654 0.903 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.6 mp -63.29 -42.37 99.08 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.411 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.45 -38.33 95.58 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.7 tp -57.86 -40.0 79.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.727 0.299 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -60.67 -45.99 92.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.549 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.5 m -67.74 -41.57 83.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.076 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.52 -55.15 5.66 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.431 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -57.9 -41.37 82.49 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.23 -37.97 84.95 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.061 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.95 86.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.472 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.26 -39.14 85.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.456 ' ND2' ' CA ' ' A' ' 117' ' ' GLY . 39.3 t-20 -64.44 -37.79 88.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.325 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -53.99 -32.18 53.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.19 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.22 70.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -55.84 -56.81 26.24 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.37 130.26 39.65 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 120.721 0.947 . . . . 0.0 112.969 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -107.63 -24.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.568 1.512 . . . . 0.0 110.372 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.861 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 34.7 pt -60.54 -28.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.884 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 24.3 p90 -55.8 -44.34 77.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.2 t80 -65.42 -50.29 66.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.677 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.75 -57.11 0.4 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.861 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 61.19 -1.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.566 0.222 . . . . 0.0 110.908 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 101' ' ' GLY . 61.6 ttt180 -54.58 -34.5 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.061 0.458 . . . . 0.0 110.376 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -86.15 157.9 19.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.222 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.1 tpp -57.4 -13.74 3.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.471 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.07 -1.58 0.01 OUTLIER Glycine 0 CA--C 1.539 1.539 0 C-N-CA 121.703 -0.284 . . . . 0.0 112.418 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.702 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.83 -22.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.411 -0.464 . . . . 0.0 111.079 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.591 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.8 -28.13 68.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.202 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.58 -30.34 68.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.59 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -59.42 -37.46 78.1 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.474 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 t0 -63.01 -44.21 96.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.0 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.01 -53.32 55.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.1 -40.37 96.07 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.77 ' CD2' HG21 ' A' ' 147' ' ' THR . 19.9 tp -51.03 -63.8 1.01 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.938 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.613 ' HA ' HD13 ' A' ' 144' ' ' LEU . 88.1 t -69.53 -55.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.942 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 t -67.63 -44.9 76.87 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.456 ' CA ' ' ND2' ' A' ' 92' ' ' ASN . . . -56.72 -48.35 78.4 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.499 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -74.21 -46.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.392 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -54.23 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.2 m -59.91 -44.18 94.42 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.32 -58.27 3.94 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.149 -0.621 . . . . 0.0 112.183 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.613 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.2 m -64.79 -40.95 96.07 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 76.7 m -60.01 -45.92 91.17 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.49 -37.32 87.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.83 -63.52 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.613 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.94 -42.3 97.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.419 ' CB ' ' O ' ' A' ' 123' ' ' THR . 29.0 t-80 -59.61 -48.21 82.54 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.322 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.72 -43.4 93.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.894 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.483 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 93.4 t -78.51 -47.8 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 67' ' ' VAL . 51.1 p -133.42 90.42 29.48 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.5 Cg_exo -55.32 -42.65 66.3 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.712 1.608 . . . . 0.0 112.541 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 21.7 Cg_exo -57.23 -28.48 79.72 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 120.323 0.682 . . . . 0.0 111.987 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -31.41 71.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.101 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.17 81.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.277 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -58.03 -39.24 77.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 110.206 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.05 -36.76 78.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.897 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 71.7 mt -67.47 -5.19 13.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.086 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -25.3 -58.75 0.16 Allowed Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.27 -28.99 79.49 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 120.643 0.895 . . . . 0.0 113.273 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -57.43 -45.09 85.05 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.473 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 22.8 tp -65.39 -39.75 92.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.01 82.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.133 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.659 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.7 t-105 -64.06 -45.6 88.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.571 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.613 HD13 ' HA ' ' A' ' 115' ' ' VAL . 40.4 mt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.33 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.28 97.01 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.321 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 67.6 t80 -63.64 -44.53 93.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.116 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.77 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.1 m -62.74 -42.4 99.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.737 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.1 m -57.37 -49.83 74.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.399 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.19 -41.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.325 0.583 . . . . 0.0 110.75 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.604 HD12 ' CZ ' ' A' ' 146' ' ' PHE . 9.6 tt -60.33 -44.12 95.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.322 -0.853 . . . . 0.0 112.028 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.71 ' OD1' HG22 ' A' ' 147' ' ' THR . 18.0 m120 -64.28 -41.0 97.1 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.38 -36.82 85.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.041 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -57.03 -44.8 83.25 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.546 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.76 -47.12 80.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.667 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.566 ' NE1' ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -64.32 -45.43 87.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.521 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.456 ' HA ' ' HG ' ' A' ' 159' ' ' SER . 70.7 mtm180 -61.04 -32.53 72.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.079 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 92.6 m-20 -52.95 -40.12 63.43 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -97.46 -56.75 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.288 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.456 ' HG ' ' HA ' ' A' ' 156' ' ' ARG . 88.7 p . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.904 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.406 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.2 t . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 29.6 Cg_exo -54.35 -22.46 26.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 120.72 0.946 . . . . 0.0 112.153 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.18 -32.01 45.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.695 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' THR . 72.1 t -59.93 -41.84 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.68 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -62.56 -35.92 92.47 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.8 mp -58.44 -42.02 86.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.682 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.7 t -76.71 -34.35 58.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.845 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' OG ' ' A' ' 16' ' ' SER . 95.7 mt -67.47 -34.69 77.67 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 10' ' ' GLY . 13.0 t -46.95 -56.2 12.67 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.85 -29.19 87.66 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 120.826 1.017 . . . . 0.0 113.347 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 79.7 p -61.17 -36.74 80.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.612 -0.435 . . . . 0.0 112.061 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.7 -39.22 93.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.288 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.12 -40.14 98.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.55 99.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.236 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE1' ' CZ3' ' A' ' 53' ' ' TRP . 57.9 m-85 -61.86 -49.09 77.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.916 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.6 mtm -64.88 -40.35 94.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.438 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.55 60.9 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.837 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.45 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.158 0.504 . . . . 0.0 111.015 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -35.35 69.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.764 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 58.8 t80 -60.7 -48.15 83.09 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.1 -31.48 29.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' HD11 ' A' ' 31' ' ' LEU . 28.3 ttt-85 -60.6 -42.55 97.02 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.323 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -129.35 5.41 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.996 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.56 -29.65 3.0 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.588 0.233 . . . . 0.0 110.442 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.39 -35.24 27.89 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.5 mt -50.5 -45.19 56.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -62.71 -38.55 90.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -58.62 -38.02 77.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.298 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' LEU . 86.9 m-85 -62.05 -22.36 65.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.742 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.83 -32.36 1.54 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.079 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.18 -32.3 20.61 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 34' ' ' TYR . 56.0 mt -93.35 150.52 20.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.992 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -98.3 132.61 43.64 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.865 ' HZ1' HH21 ' A' ' 46' ' ' ARG . 42.1 mttt -105.82 145.54 31.08 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 38.7 Cg_endo -60.91 143.36 99.34 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.454 1.436 . . . . 0.0 112.212 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.1 p -64.27 -29.93 71.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.526 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 41.6 p90 -78.32 3.24 16.06 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.106 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.031 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.75 167.7 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.181 1.254 . . . . 0.0 111.842 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 34.9 Cg_exo -52.44 140.87 52.94 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.65 1.567 . . . . 0.0 111.533 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.865 HH21 ' HZ1' ' A' ' 39' ' ' LYS . 39.4 mtt85 -61.77 -35.63 78.7 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.611 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 8.0 p90 -72.25 -14.58 61.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -76.94 -67.18 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.002 0.429 . . . . 0.0 110.663 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.028 ' O ' HG23 ' A' ' 52' ' ' ILE . 81.2 mt -67.52 -33.07 74.34 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.744 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.72 -41.12 5.49 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.789 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 71.0 Cg_exo -64.21 -9.53 20.09 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 123.239 2.626 . . . . 0.0 113.953 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.028 HG23 ' O ' ' A' ' 49' ' ' LEU . 32.1 pt -45.11 -32.5 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.773 0.32 . . . . 0.0 111.252 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.599 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 6.2 m0 -53.61 -31.27 46.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.34 -43.81 95.46 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.9 p -71.75 -44.87 63.32 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.611 -0.347 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.94 -33.69 76.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.865 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -61.18 -50.98 70.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.376 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -73.36 -33.71 65.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.82 89.13 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.845 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtt -64.25 -36.94 85.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.567 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.41 -64.5 3.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.53 -37.32 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.125 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.89 -42.7 60.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 86.9 p -67.14 -26.75 66.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.59 0.233 . . . . 0.0 110.544 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.75 -49.69 72.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 110.356 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.31 -35.02 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.641 HG22 ' OG ' ' A' ' 130' ' ' SER . 74.2 t -55.77 -46.75 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.001 -177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.441 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.6 p90 -74.22 -31.54 62.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.145 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 68.3 mmtt -59.76 -39.08 83.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.215 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.82 -38.4 88.83 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.85 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.14 -13.18 56.11 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.945 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 98.07 1.6 58.31 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.61 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 136.09 -166.5 24.65 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.716 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.92 102.09 11.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.369 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.508 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 1.4 p -124.33 164.92 18.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.21 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.43 -37.03 10.79 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.341 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.31 -45.0 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.245 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.508 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -74.64 -35.14 62.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 111.392 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.716 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.3 mmm -58.7 -34.03 70.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -60.21 -60.73 9.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.65 -50.29 11.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.997 1.131 . . . . 0.0 112.151 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.8 mp -65.89 -40.85 91.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.852 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.92 96.73 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.53 -40.01 85.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 68.5 t80 -60.93 -45.58 94.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.742 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 m -65.23 -42.93 92.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.0 -57.55 3.69 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.37 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -57.19 -41.98 80.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.419 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 41.4 tp -62.93 -39.22 93.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.91 65.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.153 0.502 . . . . 0.0 110.338 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.45 -38.61 84.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 113' ' ' LEU . 50.3 t-20 -61.49 -40.67 95.43 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.272 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.546 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 33.0 m95 -58.11 -27.93 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.77 -23.0 65.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.019 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.497 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 20.0 t-105 -54.13 -64.43 1.88 Allowed Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.546 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 86.2 Cg_endo -55.46 130.36 40.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.992 1.795 . . . . 0.0 112.584 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -100.81 -15.55 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.34 1.36 . . . . 0.0 111.105 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.858 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.7 pt -59.37 -30.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.29 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.548 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 30.7 p90 -55.63 -44.76 77.42 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.913 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.548 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 71.6 t80 -64.86 -48.94 72.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.08 -59.62 0.42 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.09 -1.92 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.691 0.281 . . . . 0.0 110.836 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.4 ttt180 -52.91 -35.71 58.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.957 0.408 . . . . 0.0 110.44 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -87.83 157.46 19.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.365 0.602 . . . . 0.0 111.797 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.716 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.0 ttm -56.32 -13.56 2.26 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.684 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.08 -2.59 0.01 OUTLIER Glycine 0 CA--C 1.541 1.673 0 C-N-CA 121.493 -0.384 . . . . 0.0 112.637 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.716 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.36 -20.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.475 -0.427 . . . . 0.0 111.273 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.02 -28.51 67.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.89 -30.92 70.45 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.269 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.571 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.11 -35.89 76.23 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.485 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.5 t0 -64.65 -46.09 83.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 tp -63.99 -48.39 76.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.8 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.5 tt -64.95 -40.3 94.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.493 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.764 ' CD2' HG21 ' A' ' 147' ' ' THR . 21.2 tp -55.02 -63.75 1.05 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.311 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.579 ' HA ' HD13 ' A' ' 144' ' ' LEU . 96.9 t -67.04 -53.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -75.32 -41.74 56.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.87 85.64 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.675 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 t -71.44 -45.46 68.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.039 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.83 -57.35 4.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 m -57.23 -44.67 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -55.35 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.96 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.647 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.3 m -65.18 -41.5 94.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.832 HG23 ' CE1' ' A' ' 127' ' ' HIS . 83.8 m -59.67 -46.8 87.94 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.16 -35.64 80.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.79 -63.01 1.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.647 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.96 -43.98 94.14 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.832 ' CE1' HG23 ' A' ' 123' ' ' THR . 25.2 m170 -59.67 -45.61 91.53 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.621 -0.831 . . . . 0.0 111.616 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.35 -41.37 96.94 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.339 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.8 t -80.78 -49.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.641 ' OG ' HG22 ' A' ' 67' ' ' VAL . 3.8 p -132.01 89.64 37.7 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.255 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.9 Cg_exo -53.85 -41.89 70.99 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.943 1.762 . . . . 0.0 113.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.9 Cg_exo -55.72 -31.52 80.43 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.613 0.875 . . . . 0.0 112.721 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.32 67.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.462 . . . . 0.0 110.652 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.6 87.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.871 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.529 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 71.5 mtm180 -63.61 -37.98 89.39 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.913 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -51.63 -38.55 55.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.498 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 70.6 mt -57.65 -31.3 66.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.171 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER 4.42 -65.43 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.9 Cg_endo -51.56 -28.5 28.91 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 120.867 1.044 . . . . 0.0 112.847 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -61.9 -35.38 78.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.002 0.43 . . . . 0.0 110.319 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.701 ' O ' HD13 ' A' ' 141' ' ' LEU . 3.2 tm? -67.12 -45.49 77.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.064 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.46 41.04 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.604 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 3.6 t-105 -61.4 -50.81 71.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.453 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 115' ' ' VAL . 52.6 mt -64.3 -31.83 73.18 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.03 -45.36 93.9 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.711 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.732 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 19.0 t80 -66.99 -44.74 79.65 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.483 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.764 HG21 ' CD2' ' A' ' 114' ' ' LEU . 4.1 m -56.91 -42.07 79.26 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.427 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.6 m -60.65 -50.48 73.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.935 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.4 -40.98 85.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.345 0.593 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.732 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 17.6 tp -55.61 -46.07 77.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.739 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.713 HD21 HG22 ' A' ' 147' ' ' THR . 69.1 m-80 -62.65 -38.89 92.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -64.11 -39.94 95.13 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.422 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -60.09 -45.89 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.939 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.49 -47.14 78.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.576 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -67.93 -41.45 82.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -57.67 -41.88 82.46 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.885 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -63.49 -49.57 73.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.112 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.55 -43.04 67.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.324 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.435 -179.05 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.6 t . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 111.184 0.068 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 14.3 Cg_endo -59.62 -23.61 71.98 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 120.316 0.678 . . . . 0.0 111.443 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.2 -34.62 66.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.197 0.522 . . . . 0.0 110.384 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.43 -41.07 86.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.86 -35.68 91.68 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.1 -44.87 87.9 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 t -79.11 -37.19 39.29 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.21 -31.83 73.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.5 t -47.14 -56.47 12.1 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.68 ' HB3' HD21 ' A' ' 89' ' ' LEU . 7.7 Cg_endo -60.45 -28.79 87.38 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.073 1.182 . . . . 0.0 113.25 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.0 m -57.29 -39.26 75.38 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.249 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.79 -40.17 91.69 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.006 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.25 -49.27 47.22 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.98 93.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.39 -43.51 88.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.92 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.9 mtt -60.75 -40.05 91.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.263 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.64 83.32 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.19 -29.16 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.295 0.569 . . . . 0.0 109.935 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -36.15 73.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.468 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 62.0 t80 -61.15 -47.55 85.72 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.2 m -71.26 -31.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.839 0.828 . . . . 0.0 109.337 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -67.47 -41.03 85.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.781 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.91 -120.37 0.66 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.343 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.77 -28.51 61.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.899 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.93 -32.81 19.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.6 mt -49.93 -46.98 52.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.326 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -62.98 -39.89 96.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.55 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -59.64 -39.92 85.95 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.108 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 37' ' ' LEU . 76.2 m-85 -63.93 -23.07 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.08 -42.76 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.6 75.15 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 34' ' ' TYR . 38.8 mt -91.55 152.19 20.41 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.064 0.459 . . . . 0.0 111.454 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.545 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.9 mt-30 -101.16 129.09 47.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.657 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 31.7 mttt -100.14 142.86 25.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 56.1 Cg_endo -59.38 135.59 66.2 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.206 1.271 . . . . 0.0 111.702 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.3 p -68.59 -23.32 64.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.307 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 10.4 p90 -78.55 -10.19 59.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.579 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.596 ' NE2' ' O ' ' A' ' 44' ' ' PRO . 1.5 t-80 -69.99 133.49 88.0 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.46 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.596 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 18.2 Cg_endo -75.97 163.2 33.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.243 1.295 . . . . 0.0 110.675 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.0 Cg_endo -50.13 146.7 17.05 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 120.48 0.786 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.657 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 62.8 mtt180 -57.52 -37.08 72.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 48' ' ' THR . 4.5 p90 -63.34 -31.05 72.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.654 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 16.1 m -63.18 -55.67 23.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 96.4 mt -73.24 -35.6 66.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.41 -50.18 3.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.441 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 17.9 Cg_endo -71.01 6.54 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.979 1.786 . . . . 0.0 113.822 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.996 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.8 pt -44.21 -33.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.257 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.611 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.1 m-90 -53.54 -28.24 30.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.875 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 57' ' ' TYR . . . -52.52 -38.59 51.78 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.7 t -87.1 -41.74 13.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.684 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.634 HD11 ' CD1' ' A' ' 143' ' ' TRP . 9.8 mt -61.25 -38.97 88.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 58' ' ' SER . 1.4 p90 -64.6 -43.64 93.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.906 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 26.9 m -61.2 -39.75 91.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.34 99.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.492 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mtt -63.08 -36.15 82.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.67 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.08 -65.22 2.95 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.36 -38.46 87.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.84 -43.12 81.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.5 p -64.88 -27.54 68.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.851 0.358 . . . . 0.0 110.041 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -57.98 -44.49 87.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.48 -42.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.9 -37.94 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.592 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.7 -37.8 85.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.931 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -64.59 -45.23 87.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -68.92 -39.56 79.56 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . 49.4 mt -91.48 -0.51 57.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.39 5.99 66.7 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.24 -165.79 30.42 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.466 -0.397 . . . . 0.0 112.301 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.08 80.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.292 0.568 . . . . 0.0 111.511 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.485 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 6.9 p -125.59 162.04 25.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.764 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -44.32 -38.87 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.99 -46.33 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.738 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 73' ' ' GLY . . . -76.33 -32.79 58.88 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.3 mtp -56.53 -32.8 65.46 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.235 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.28 -47.2 94.83 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.725 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -66.16 -56.72 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.617 0.878 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.7 mp -60.04 -41.35 92.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.94 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.86 93.52 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.0 -39.58 78.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.877 0.37 . . . . 0.0 110.049 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.462 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 81.0 t80 -60.07 -44.8 94.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 48.8 m -68.51 -41.35 80.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.56 -64.21 2.54 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.653 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -57.16 -40.61 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.853 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 15' ' ' PRO . 30.2 tp -63.01 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -49.92 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.57 -38.71 85.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 63.7 t30 -62.14 -41.15 97.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.351 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.473 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 35.5 m95 -56.75 -30.58 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.747 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.94 -24.38 66.06 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' PRO . 14.5 t-105 -54.99 -70.92 0.26 Allowed Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 53.0 Cg_endo -43.32 82.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.949 1.766 . . . . 0.0 112.641 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.558 ' N ' ' O ' ' A' ' 95' ' ' TRP . 90.3 Cg_endo -58.91 -16.84 33.96 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.108 1.872 . . . . 0.0 112.57 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.721 HG21 ' HA ' ' A' ' 107' ' ' TRP . 33.6 pt -59.01 -25.03 28.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.049 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.36 -44.63 17.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.492 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 67.3 t80 -66.95 -50.39 62.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.76 -68.99 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.271 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 62.12 7.22 2.07 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -50.5 -35.94 31.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.251 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -90.36 153.43 20.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.678 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.647 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ttp -59.02 -16.45 18.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.03 13.84 0.01 OUTLIER Glycine 0 CA--C 1.539 1.568 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.194 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.721 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.8 p90 -60.5 -18.7 53.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.923 0.862 . . . . 0.0 112.02 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.39 -19.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.3 mp -62.46 -35.13 78.34 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.814 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.63 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.9 -38.69 89.31 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.2 t0 -62.24 -45.13 94.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.409 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 tp -63.29 -47.64 81.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.625 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.4 tt -68.92 -40.96 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.518 0.675 . . . . 0.0 109.965 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.7 HD21 HG21 ' A' ' 147' ' ' THR . 18.2 tp -52.21 -60.31 3.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.095 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 144' ' ' LEU . 67.4 t -69.83 -57.11 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.737 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 120' ' ' THR . 25.4 t -67.92 -41.74 82.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -56.55 -48.12 79.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.457 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 119' ' ' ALA . 1.2 t -71.09 -46.61 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.511 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -74.46 -54.96 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' SER . 26.6 m -57.41 -44.3 84.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.96 3.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.825 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.652 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 26.8 m -62.13 -40.28 95.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.51 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 82.2 m -61.65 -44.74 96.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.98 -36.69 84.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.26 -63.6 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.652 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.5 m0 -66.92 -42.33 85.58 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 52.0 t-80 -58.03 -47.28 83.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.241 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.53 -44.4 94.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.61 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.63 -49.96 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -132.49 89.94 34.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.464 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 41.1 Cg_exo -52.54 -41.21 69.5 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.447 1.431 . . . . 0.0 112.786 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.1 Cg_exo -57.45 -28.27 79.81 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 120.348 0.699 . . . . 0.0 112.713 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.58 71.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.142 0.496 . . . . 0.0 110.281 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.16 90.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.3 ttt-85 -59.11 -39.85 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.5 tp -57.33 -38.07 73.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.088 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.617 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.7 mt -57.91 -31.28 66.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.385 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.508 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 8.56 -68.74 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' A' ' 137' ' ' LEU . 4.8 Cg_endo -49.74 -27.37 15.18 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 120.727 0.951 . . . . 0.0 113.072 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -61.77 -40.72 96.13 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.103 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -66.57 -41.98 87.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.734 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.58 -51.74 26.31 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.634 ' CD1' HD11 ' A' ' 56' ' ' LEU . 2.7 t-105 -61.54 -49.61 75.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.05 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 115' ' ' VAL . 52.2 mt -64.44 -34.16 77.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.66 -40.06 95.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.883 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.76 ' CE2' HD22 ' A' ' 150' ' ' LEU . 24.3 t80 -60.86 -42.06 97.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.568 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.7 HG21 HD21 ' A' ' 114' ' ' LEU . 79.7 p -61.49 -35.59 78.09 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.537 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.3 m -63.95 -52.38 59.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.042 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.0 -42.64 82.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.113 0.483 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.76 HD22 ' CE2' ' A' ' 146' ' ' PHE . 61.6 tp -56.26 -41.48 75.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.234 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.43 -42.32 96.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -64.56 -40.5 95.68 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.472 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -59.97 -46.93 87.83 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.632 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.9 -45.5 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.693 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.5 m95 -59.82 -40.36 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -60.07 -30.04 68.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.578 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 95.1 m-20 -50.37 -39.97 48.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.15 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -102.13 -60.5 1.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.278 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.462 0.164 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.848 -179.447 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.409 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.562 ' O ' HD13 ' A' ' 11' ' ' LEU . 87.2 Cg_exo -53.62 -22.33 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.137 1.224 . . . . 0.0 112.346 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.48 62.86 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.932 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 12' ' ' THR . 73.3 t -62.64 -44.02 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.5 89.93 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.334 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.7 mp -56.53 -40.9 75.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 111.265 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.5 t -79.0 -32.9 45.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 13' ' ' LEU . 96.7 mt -61.72 -37.45 84.24 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 t -53.75 -42.78 94.33 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.416 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.46 -37.44 71.16 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.392 1.395 . . . . 0.0 113.348 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.9 m -60.05 -38.58 83.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.92 -38.94 87.53 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.417 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.36 99.88 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.106 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.79 -42.18 97.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.963 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -61.89 -39.66 92.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -60.76 -39.34 88.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.675 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.54 -46.48 25.12 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.53 -22.85 62.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.231 0.538 . . . . 0.0 110.209 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -55.68 -33.47 64.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 29.8 t80 -64.6 -49.88 69.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.394 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.49 -37.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.791 0.805 . . . . 0.0 109.65 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -59.27 -39.83 84.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.351 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -129.12 2.23 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.695 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.87 -27.03 62.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 110.981 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -32.39 10.07 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -50.76 -45.25 58.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.835 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -60.57 -41.91 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.23 -41.46 98.42 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 23.0 m-85 -64.02 -22.89 67.12 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.689 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.44 -41.46 52.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.003 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.36 -29.86 74.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 34' ' ' TYR . 50.2 mt -91.14 150.11 21.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.544 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -100.9 128.63 46.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 18.8 mtpp -109.9 139.22 21.09 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 39.2 Cg_endo -60.41 130.71 34.93 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.172 1.248 . . . . 0.0 112.515 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.4 m -66.67 -23.1 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.206 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.51 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.7 p90 -75.91 -15.5 60.18 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.606 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 1.2 p80 -72.62 143.29 84.75 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.429 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -69.42 161.97 43.78 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.808 1.005 . . . . 0.0 110.849 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.27 152.76 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.144 1.23 . . . . 0.0 110.931 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -55.57 -36.24 66.63 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 9.2 p90 -71.88 -14.67 62.01 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.886 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -80.06 -68.4 0.68 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.29 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.8 mt -62.11 -34.61 76.65 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.556 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.655 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -44.97 -41.8 13.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.724 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 85.4 Cg_exo -63.62 -8.64 15.79 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 123.217 2.611 . . . . 0.0 113.958 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.996 HG23 ' O ' ' A' ' 49' ' ' LEU . 25.3 pt -40.99 -40.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.369 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.455 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.9 m95 -53.21 -33.7 53.93 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.172 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.0 -38.88 96.24 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.0 m -68.52 -51.74 39.76 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.067 0.46 . . . . 0.0 110.616 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -66.25 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.923 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' TRP . 20.9 t80 -50.86 -53.32 33.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.022 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.8 p -67.9 -34.99 77.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.981 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.58 93.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.521 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.57 -38.14 90.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.56 -57.86 9.44 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.46 -0.876 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -62.43 -36.5 82.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.639 0.257 . . . . 0.0 111.287 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -42.8 84.31 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.427 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -65.36 -30.12 70.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.394 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -58.92 -43.84 91.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.416 . . . . 0.0 110.006 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.07 -40.11 82.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 109.967 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.534 HG13 HG11 ' A' ' 129' ' ' VAL . 55.1 t -61.02 -40.48 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.963 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -62.42 -49.56 74.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.517 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.595 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 75.2 mttt -54.44 -37.15 64.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.421 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -71.54 -43.61 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.495 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -77.89 -26.11 48.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.54 -3.6 46.54 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.76 -169.3 26.12 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.05 95.74 8.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.56 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 16.8 p -122.99 174.29 7.28 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.968 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.45 -35.37 39.3 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 87.7 m-20 -63.97 -39.88 95.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.411 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -84.73 -40.33 17.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.785 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.68 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.2 mmm -59.1 -36.17 74.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.531 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.94 -56.82 25.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.409 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 18.2 Cg_endo -62.94 -53.69 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.071 1.181 . . . . 0.0 112.234 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -63.53 -41.37 98.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.802 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.9 96.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.29 -38.97 78.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -59.56 -44.88 93.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.484 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.8 m -69.67 -41.33 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.71 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.96 -61.93 2.76 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.982 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -55.92 -41.77 75.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.544 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.44 -39.14 93.69 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.332 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.015 0.436 . . . . 0.0 110.646 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.51 -38.42 84.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.554 ' O ' HD11 ' A' ' 113' ' ' LEU . 60.8 t30 -61.86 -41.66 98.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.562 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.534 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 30.5 m95 -57.41 -31.16 65.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.632 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.87 -23.53 66.02 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 97' ' ' PRO . 45.6 t-105 -58.46 -67.95 0.82 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 29.5 Cg_endo -38.68 81.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.25 1.967 . . . . 0.0 113.046 -177.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.585 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.4 Cg_endo -62.84 -21.84 73.4 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.141 1.894 . . . . 0.0 112.544 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.692 HG21 ' HA ' ' A' ' 107' ' ' TRP . 46.0 pt -59.83 -25.89 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.488 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.51 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.3 p90 -44.86 -41.81 7.42 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.279 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 72.5 t80 -66.76 -51.83 51.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.73 -69.05 0.5 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.813 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 63.12 8.01 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.589 0.233 . . . . 0.0 110.722 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.505 ' CZ ' ' NE2' ' A' ' 104' ' ' GLN . 68.5 ttp85 -53.59 -33.9 56.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.505 ' NE2' ' CZ ' ' A' ' 103' ' ' ARG . 90.1 mm-40 -88.45 149.08 23.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.598 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.668 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.1 ttm -60.43 -18.97 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -49.73 8.96 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.217 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.692 ' HA ' HG21 ' A' ' 98' ' ' ILE . 23.1 p-90 -49.36 -15.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.418 0.609 . . . . 0.0 112.018 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.728 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -36.39 -17.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.9 mp -66.34 -32.5 73.93 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.104 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.495 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.73 -56.68 15.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.472 ' OD1' HG22 ' A' ' 147' ' ' THR . 21.2 t70 -58.16 -44.48 87.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.53 -40.19 93.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.599 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 92' ' ' ASN . 5.5 tt -73.37 -45.76 53.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 113' ' ' LEU . 1.9 pp -74.08 -38.35 63.93 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.087 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.524 ' HA ' HD22 ' A' ' 144' ' ' LEU . 65.5 t -67.83 -44.6 85.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.58 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 120' ' ' THR . 42.3 t -84.72 -41.19 16.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 121' ' ' ALA . . . -55.15 -43.58 83.68 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.172 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 119' ' ' ALA . 0.9 OUTLIER -74.11 -48.65 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.655 0.264 . . . . 0.0 110.923 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -72.64 -57.25 4.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 116' ' ' SER . 37.4 m -59.82 -43.61 94.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 117' ' ' GLY . . . -71.87 -56.64 5.35 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.095 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.642 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.5 m -63.3 -41.99 99.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 87.7 m -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.55 -38.12 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.186 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.68 -63.91 1.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.642 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 43.0 m0 -65.74 -41.33 92.33 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.9 t-80 -59.51 -48.7 80.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.914 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -65.7 -45.21 83.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.798 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.534 HG11 HG13 ' A' ' 67' ' ' VAL . 86.3 t -76.6 -46.76 30.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.6 p -130.9 83.76 60.29 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.288 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.455 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.2 Cg_exo -51.3 -43.94 46.17 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.497 1.465 . . . . 0.0 112.433 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 20.8 Cg_exo -59.15 -32.19 96.75 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.565 0.843 . . . . 0.0 112.364 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.65 -29.02 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.54 91.4 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 79.6 mtt180 -62.57 -38.87 91.8 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.437 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.7 tp -52.53 -37.31 57.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.091 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 138' ' ' TYR . 54.0 mt -58.93 -27.55 65.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.291 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -2.92 -69.9 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.811 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 138' ' ' TYR . 11.8 Cg_endo -50.97 -26.51 18.61 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 120.653 0.902 . . . . 0.0 112.951 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -57.61 -43.71 84.95 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 31.2 tp -59.45 -39.91 85.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.352 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.91 92.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.059 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.586 ' NE1' HD12 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -67.36 -50.73 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.434 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 115' ' ' VAL . 28.6 mt -65.26 -32.34 73.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.029 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.49 -49.02 78.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.724 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.749 ' CZ ' HD13 ' A' ' 150' ' ' LEU . 30.7 t80 -64.43 -40.48 95.83 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.613 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 1.4 m -55.12 -43.79 74.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.503 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 60.8 p -67.98 -44.47 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.974 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.42 -42.05 92.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.52 0.676 . . . . 0.0 109.797 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.749 HD13 ' CZ ' ' A' ' 146' ' ' PHE . 53.2 tp -59.91 -38.23 81.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 147' ' ' THR . 3.2 m120 -61.67 -41.91 98.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 73.2 m-85 -65.82 -39.52 90.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.0 t80 -61.68 -45.08 95.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.761 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.96 -52.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.728 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 5.1 m0 -63.56 -42.32 98.37 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CG ' ' O ' ' A' ' 152' ' ' TYR . 24.5 mmt85 -60.81 -35.85 77.56 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.117 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 88.0 m-20 -59.33 -40.94 87.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.577 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -92.34 -55.89 3.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.717 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 155' ' ' TRP . 85.3 p . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.313 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' O ' HD13 ' A' ' 11' ' ' LEU . 77.5 Cg_exo -54.31 -20.79 20.9 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 120.764 0.976 . . . . 0.0 111.806 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.36 -36.28 53.26 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 12' ' ' THR . 89.9 t -62.9 -42.01 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.19 -34.81 90.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.261 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.6 mp -57.52 -41.33 80.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.036 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 9' ' ' VAL . 6.9 t -76.8 -31.77 57.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.212 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.44 -32.83 73.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.823 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -44.44 -57.42 6.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 89' ' ' LEU . 17.9 Cg_endo -58.68 -32.77 97.55 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 121.013 1.142 . . . . 0.0 113.029 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -58.46 -39.14 79.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.422 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.07 -36.35 82.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.539 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.7 -58.16 7.26 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.006 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -36.29 82.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -57.71 -47.04 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.67 0.271 . . . . 0.0 110.979 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -64.48 -38.49 91.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.572 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.53 -42.24 97.56 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.627 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.45 -26.07 65.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.917 0.389 . . . . 0.0 111.701 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -32.6 65.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 51.4 t80 -60.51 -48.71 80.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -72.81 -31.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -63.21 -41.86 99.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.076 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.36 -126.26 4.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.91 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.22 -30.18 11.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.683 0.278 . . . . 0.0 111.037 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.77 -31.58 23.89 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.2 mt -51.74 -46.1 63.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.907 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -63.55 -37.6 87.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.83 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -56.22 -37.91 70.34 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.942 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CZ3' ' A' ' 107' ' ' TRP . 84.9 m-85 -63.31 -21.92 66.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.23 -35.05 2.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.659 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.69 -30.17 27.49 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 49.8 mt -95.69 151.45 19.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.499 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.1 mt-30 -97.76 133.18 42.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -111.34 142.15 25.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.304 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 58.2 Cg_endo -61.31 134.42 51.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.382 1.388 . . . . 0.0 111.341 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 p -78.94 -12.13 60.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.51 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.8 p90 -81.12 -15.17 56.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.6 148.96 95.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.814 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -83.29 175.66 8.06 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.878 1.719 . . . . 0.0 111.82 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CB ' ' NE1' ' A' ' 47' ' ' TRP . 39.7 Cg_exo -51.44 144.77 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.115 1.877 . . . . 0.0 112.057 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 49.9 mtt85 -59.84 -36.32 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.495 ' NE1' ' CB ' ' A' ' 45' ' ' PRO . 61.6 p-90 -70.95 -26.92 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.073 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -62.92 -57.86 9.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.923 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.982 ' O ' HG23 ' A' ' 52' ' ' ILE . 86.2 mt -73.91 -34.21 64.28 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -36.89 -51.21 2.08 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.012 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.7 Cg_endo -68.81 0.61 4.72 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.455 2.103 . . . . 0.0 114.17 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 49' ' ' LEU . 14.1 pt -43.81 -42.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 96.9 m95 -51.69 -32.82 31.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.96 96.18 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.8 m -68.54 -50.99 47.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.065 0.46 . . . . 0.0 111.206 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.3 mp -67.33 -34.27 76.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.94 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.446 ' CD1' HG23 ' A' ' 12' ' ' THR . 5.5 t80 -48.76 -60.62 2.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -63.47 -38.21 90.26 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.536 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.199 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.0 mtt -64.61 -38.55 91.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.29 -48.06 85.23 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.259 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -61.18 -38.68 87.38 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.48 -43.0 66.54 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.235 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -61.25 -31.67 71.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -58.61 -47.65 83.64 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.196 -0.601 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.07 -41.53 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 109.558 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG22 ' OG ' ' A' ' 130' ' ' SER . 97.3 t -61.0 -38.46 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -65.16 -36.56 84.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.907 178.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -63.81 -43.25 96.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.683 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.79 -44.38 85.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.492 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 78' ' ' ALA . 65.1 mt -76.68 -26.4 54.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.24 -4.15 62.25 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 156.64 -167.41 33.6 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.389 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.582 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 1.2 t80 -85.57 99.17 11.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 77' ' ' ASP . 5.7 t -133.48 165.71 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.62 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -41.69 -35.5 0.79 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.598 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.722 ' H ' HG23 ' A' ' 75' ' ' THR . 88.0 m-20 -60.69 -40.89 93.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.959 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.464 ' HB2' HD12 ' A' ' 71' ' ' LEU . . . -74.86 -32.22 61.83 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.012 0.434 . . . . 0.0 111.94 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.582 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 55.7 mmm -62.29 -35.12 78.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -59.66 -40.69 81.29 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.538 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.493 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 13.1 Cg_endo -85.56 -65.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.056 1.171 . . . . 0.0 112.231 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.78 -44.16 94.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.27 96.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.23 -36.62 78.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.469 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 89.6 t80 -56.58 -43.48 80.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.1 m -63.82 -43.65 95.61 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.16 -57.43 3.68 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.744 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.91 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.469 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 42.3 tp -62.93 -39.67 95.29 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.37 75.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.043 0.449 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.35 -39.72 88.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.007 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.451 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 58.5 t30 -62.29 -40.75 97.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -57.44 -29.99 64.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.925 0.393 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.93 67.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.544 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.634 ' O ' ' N ' ' A' ' 97' ' ' PRO . 36.7 t-105 -59.71 -68.51 0.73 Allowed Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 113' ' ' LEU . 10.4 Cg_endo -40.2 78.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.263 0 C-N-CA 121.699 1.599 . . . . 0.0 112.662 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' TRP . 97.1 Cg_endo -57.28 -19.78 36.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.947 1.765 . . . . 0.0 112.076 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.909 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 33.3 pt -58.7 -23.36 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.042 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.1 p90 -56.54 -47.07 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.606 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.7 t80 -64.81 -49.59 70.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.51 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.6 0.42 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.626 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.94 -2.24 0.2 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.636 0.255 . . . . 0.0 110.705 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.515 ' H ' ' C ' ' A' ' 101' ' ' GLY . 60.8 ttt85 -54.34 -35.44 62.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.63 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -85.8 158.65 19.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.522 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 107' ' ' TRP . 15.4 ttm -56.46 -13.9 2.64 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.255 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.95 -3.33 0.01 OUTLIER Glycine 0 CA--C 1.538 1.503 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.503 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.715 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.12 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.252 -0.558 . . . . 0.0 110.995 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.32 -27.93 67.72 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.832 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 109' ' ' LEU . 82.6 mt -59.09 -31.3 68.78 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.131 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.68 -38.72 88.84 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.595 ' CG ' HD22 ' A' ' 151' ' ' ASN . 54.7 t0 -63.94 -45.95 86.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.8 tp -64.71 -49.54 70.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.051 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.462 HD13 ' HD3' ' A' ' 96' ' ' PRO . 3.7 tt -67.17 -40.96 86.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.414 0.626 . . . . 0.0 110.078 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.785 ' CD2' HG21 ' A' ' 147' ' ' THR . 18.9 tp -50.82 -59.01 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.711 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 144' ' ' LEU . 61.0 t -69.98 -60.74 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.647 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.497 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -66.98 -42.74 84.57 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -60.38 -56.04 26.72 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.446 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.09 -38.62 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.671 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.32 -48.06 18.36 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.5 m -59.29 -41.68 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.55 -54.96 10.07 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.97 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.57 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 17.7 m -66.1 -42.3 89.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.443 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 53.4 m -59.4 -46.63 88.16 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.67 -34.7 78.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.055 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -82.23 -64.5 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.5 m0 -70.09 -42.0 73.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 40.8 t-80 -56.41 -45.59 80.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.277 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -63.1 -44.23 96.24 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.849 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.52 -47.47 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.587 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.578 ' OG ' HG22 ' A' ' 67' ' ' VAL . 59.4 p -133.79 87.28 36.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.472 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.7 Cg_exo -52.03 -40.86 67.03 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.767 1.645 . . . . 0.0 112.932 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.0 Cg_exo -58.27 -27.62 81.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 120.49 0.794 . . . . 0.0 112.81 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.18 -33.48 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.187 0.518 . . . . 0.0 110.783 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 137' ' ' LEU . . . -60.18 -36.42 77.56 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.989 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -60.59 -34.84 74.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.151 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -62.07 -40.06 94.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.902 0.858 . . . . 0.0 110.013 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 134' ' ' ALA . 38.4 mt -62.6 -26.72 68.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.964 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -1.74 -67.86 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 19.4 Cg_endo -51.27 -24.38 15.36 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 CA-C-N 119.711 0.933 . . . . 0.0 112.91 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -59.34 -39.37 82.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.818 0.342 . . . . 0.0 110.446 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.624 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -62.77 -41.39 99.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.897 0.38 . . . . 0.0 110.244 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.98 73.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.628 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.691 ' CE2' HD12 ' A' ' 52' ' ' ILE . 2.5 t-105 -61.27 -44.63 96.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 115' ' ' VAL . 50.0 mt -69.67 -36.66 76.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.634 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.273 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.644 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 64.7 t80 -62.85 -46.92 85.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.094 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.908 HG22 HD21 ' A' ' 151' ' ' ASN . 2.4 m -62.48 -41.75 99.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.09 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.1 m -58.93 -50.41 74.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.807 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 -40.35 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 110.491 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.644 HD12 ' CZ ' ' A' ' 146' ' ' PHE . 9.5 tt -56.81 -46.36 81.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.692 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.908 HD21 HG22 ' A' ' 147' ' ' THR . 79.7 m-20 -65.37 -41.55 93.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -64.58 -38.99 92.91 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.772 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -58.26 -43.66 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.104 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.76 -42.96 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.374 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 1.6 m95 -60.87 -25.1 66.43 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -50.38 -36.57 33.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.562 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 91.2 m-20 -59.76 -43.77 94.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.085 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -87.62 -51.23 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 p . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.568 -179.719 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.529 ' O ' HD13 ' A' ' 11' ' ' LEU . 86.0 Cg_exo -55.29 -22.93 35.16 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 120.738 0.959 . . . . 0.0 112.769 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.65 63.99 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -44.07 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.77 90.79 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.533 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.7 mp -56.6 -41.53 77.2 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.293 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.409 HG23 ' CD1' ' A' ' 57' ' ' TYR . 3.2 t -79.4 -32.28 42.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.854 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 13' ' ' LEU . 96.3 mt -64.44 -37.09 86.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.8 t -50.85 -43.57 83.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.026 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.66 -36.8 91.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.357 1.372 . . . . 0.0 112.835 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.4 m -60.6 -39.16 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.812 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.44 -37.98 87.99 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.225 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.33 -55.0 17.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.576 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -62.67 -37.3 94.55 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.268 -0.491 . . . . 0.0 111.954 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.0 -46.97 86.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.8 mtm -63.47 -39.85 95.57 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.44 97.44 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.11 -28.37 63.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 0.0 110.648 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -35.88 74.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.05 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.62 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 69.5 t80 -60.75 -48.67 80.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.58 -36.01 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.933 0.873 . . . . 0.0 109.627 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -60.2 -41.08 92.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.097 -1.41 . . . . 0.0 112.357 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.72 -129.88 1.4 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.714 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.403 ' HB3' HH21 ' A' ' 32' ' ' ARG . 96.9 mt-10 -57.05 -26.67 60.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.91 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.08 -33.52 10.61 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.53 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.6 mt -50.87 -41.31 57.96 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.403 HH21 ' HB3' ' A' ' 29' ' ' GLU . 49.5 mtm180 -61.63 -43.53 98.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.506 0.669 . . . . 0.0 109.594 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -62.72 -40.1 96.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.146 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.6 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.9 m-85 -63.87 -22.94 67.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.328 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.59 -40.81 28.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.123 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -31.98 78.87 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.0 mt -91.1 148.81 22.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.977 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.32 127.92 46.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 12.1 mtpt -100.67 136.06 19.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 59.2 Cg_endo -56.06 143.79 82.17 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.139 1.226 . . . . 0.0 112.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 t -60.84 -31.22 70.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.998 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.425 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 18.4 p90 -76.99 0.39 21.36 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.309 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.6 t-80 -61.86 124.38 81.41 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.587 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.2 Cg_endo -80.86 166.01 19.42 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.462 1.442 . . . . 0.0 111.295 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 31.5 Cg_exo -49.25 140.75 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.133 1.222 . . . . 0.0 111.364 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.616 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 36.8 mtt-85 -58.74 -37.38 76.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.006 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.437 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 8.5 p90 -74.8 -21.5 59.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.928 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -65.25 -59.91 3.56 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.008 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.977 ' O ' HG23 ' A' ' 52' ' ' ILE . 71.2 mt -72.85 -33.31 66.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.586 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.4 -50.69 2.54 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.951 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 16.6 Cg_endo -69.59 0.8 5.0 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.433 2.088 . . . . 0.0 114.05 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.977 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.3 pt -42.34 -41.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.228 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 57' ' ' TYR . 99.4 m95 -53.86 -33.15 55.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.322 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.15 -40.11 98.09 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -67.83 -51.84 43.82 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.235 0.541 . . . . 0.0 110.82 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.7 mp -66.55 -32.85 74.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.934 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' TRP . 22.8 t80 -51.63 -53.53 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.374 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 p -68.04 -36.85 80.59 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.326 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.09 88.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.3 mtt -62.86 -37.47 87.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.68 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.16 -57.94 7.14 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.524 -0.846 . . . . 0.0 110.987 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.64 -39.35 87.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.595 0.236 . . . . 0.0 110.825 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.78 -42.02 84.57 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.0 p -62.35 -29.4 70.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.85 -44.47 91.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.807 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.13 -42.49 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.533 HG22 ' OG ' ' A' ' 130' ' ' SER . 90.5 t -60.89 -40.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.522 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.65 -33.27 75.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.153 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 31.5 mtpt -65.49 -44.89 85.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.151 0.5 . . . . 0.0 111.091 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.95 -37.94 85.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.774 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.6 mt -91.36 -3.75 56.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.44 35.9 40.49 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.518 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.37 -161.71 24.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.4 OUTLIER -78.64 109.91 13.29 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 121.56 0.695 . . . . 0.0 110.741 -178.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.9 t -133.94 164.45 27.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -43.93 -38.24 3.32 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.023 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.626 ' H ' HG23 ' A' ' 75' ' ' THR . 86.7 m-20 -65.5 -41.94 92.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.912 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -71.97 -33.24 68.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.632 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.1 mmm -59.06 -35.17 72.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.561 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.48 -59.68 12.77 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.2 -54.09 2.03 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.415 1.41 . . . . 0.0 113.051 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -62.57 -41.61 99.03 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.127 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.51 98.27 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp -58.29 -39.28 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -59.0 -44.42 91.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 65.4 m -68.22 -39.92 82.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.42 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.18 -58.98 3.5 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.894 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -56.96 -42.04 79.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.331 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.826 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.76 78.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.04 -40.4 89.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.826 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.515 ' O ' HD11 ' A' ' 113' ' ' LEU . 43.0 t-20 -62.66 -39.78 94.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.512 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.554 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.0 m95 -57.97 -27.46 63.46 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.12 62.63 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.586 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 26.4 t-105 -71.51 -56.36 5.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 76.4 Cg_endo -44.08 86.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.099 1.199 . . . . 0.0 112.549 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.3 Cg_endo -57.05 -26.71 70.16 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 120.845 1.03 . . . . 0.0 111.321 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.628 HD11 ' HB2' ' A' ' 110' ' ' ALA . 39.5 pt -62.44 -28.19 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.702 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.35 -44.47 65.22 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.895 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 70.5 t80 -64.43 -49.35 71.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.876 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -113.38 -68.6 0.51 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.308 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 101' ' ' GLY . . . 80.15 -5.26 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -54.4 -36.56 64.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -80.72 146.43 31.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.125 0.488 . . . . 0.0 111.257 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.629 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.3 ttp -64.22 -15.69 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.214 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.13 33.95 0.02 OUTLIER Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.629 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -61.41 -19.74 62.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -46.88 -24.47 0.6 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 111.594 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.1 -31.16 69.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.365 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.91 -52.74 58.46 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.662 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.0 t0 -62.2 -45.71 92.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.64 -38.52 85.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 110.379 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.792 HD23 ' C ' ' A' ' 113' ' ' LEU . 6.4 tt -71.15 -48.99 48.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 113' ' ' LEU . 2.8 pp -74.22 -31.46 62.62 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.49 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 111' ' ' ASP . 48.3 t -67.18 -61.58 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.722 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.9 t -72.54 -42.13 65.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 92' ' ' ASN . . . -59.18 -51.25 60.3 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.339 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 114' ' ' LEU . 2.4 p -67.38 -35.93 75.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.649 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.33 -57.4 3.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -60.08 -42.7 95.16 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.81 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.94 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.438 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 27.2 m -63.62 -39.39 94.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.935 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.432 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 77.7 m -59.34 -48.79 80.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 128' ' ' ARG . 74.3 mt -63.87 -32.31 73.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.68 -63.39 1.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.7 m0 -76.12 -45.28 34.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 123' ' ' THR . 16.4 t-80 -57.67 -43.42 85.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.949 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.481 ' CG ' ' O ' ' A' ' 124' ' ' LEU . 37.0 mmm-85 -64.63 -46.08 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.273 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.24 -48.65 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.533 ' OG ' HG22 ' A' ' 67' ' ' VAL . 37.4 p -128.64 84.77 62.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.138 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.7 Cg_exo -53.41 -41.81 70.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.178 1.919 . . . . 0.0 112.925 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 24.3 Cg_exo -57.36 -30.15 86.78 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 120.323 0.682 . . . . 0.0 112.378 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.46 71.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.074 0.464 . . . . 0.0 110.316 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -58.77 -37.74 76.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.811 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 50.4 ttt85 -59.59 -40.9 88.98 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.433 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.55 -36.04 63.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.305 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.516 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 55.6 mt -70.73 16.87 0.08 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.423 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -48.04 -41.06 38.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.231 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.516 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 18.2 Cg_endo -67.9 -18.67 46.84 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 CA-C-N 120.633 1.262 . . . . 0.0 112.876 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -58.98 -41.33 87.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.915 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 36.4 tp -63.79 -38.39 90.91 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.424 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.92 -43.95 91.11 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.596 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.59 ' CE2' HD12 ' A' ' 52' ' ' ILE . 1.3 t-105 -69.86 -50.46 42.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.449 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 115' ' ' VAL . 30.2 mt -65.83 -32.87 74.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.404 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -50.2 74.15 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.733 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.843 ' CE2' HD22 ' A' ' 150' ' ' LEU . 29.7 t80 -64.15 -42.28 96.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.905 0.383 . . . . 0.0 111.605 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.582 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.8 m -55.73 -43.66 76.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.1 m -64.36 -49.63 70.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.512 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.51 -40.23 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.193 0.521 . . . . 0.0 110.667 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.843 HD22 ' CE2' ' A' ' 146' ' ' PHE . 63.9 tp -56.06 -42.4 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.249 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.535 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.4 m120 -64.55 -41.0 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -62.69 -40.89 98.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.415 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -61.03 -46.41 90.85 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.227 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.87 -45.18 81.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.037 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.449 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -59.72 -39.21 83.89 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.647 -178.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 159' ' ' SER . 66.5 mtp180 -58.66 -25.96 63.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.65 -39.4 58.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.702 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -113.77 -2.39 13.71 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.145 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 156' ' ' ARG . 69.8 m . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.641 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.7 t . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.8 Cg_endo -58.01 -20.53 45.68 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.554 0.836 . . . . 0.0 112.222 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.589 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 13' ' ' LEU . 68.0 t -60.24 -40.5 83.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.017 0.437 . . . . 0.0 109.863 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.65 -36.86 93.3 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.33 -42.19 90.87 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 t -78.15 -41.4 34.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.514 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 HG12 ' A' ' 9' ' ' VAL . 85.8 mt -65.25 -35.33 80.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 10' ' ' GLY . 13.7 t -50.07 -43.9 78.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.354 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.07 -34.58 98.92 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.3 1.333 . . . . 0.0 112.895 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 m -59.61 -39.56 84.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 0.0 112.009 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.03 -37.72 83.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.365 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.46 -40.88 99.28 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.925 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -44.59 97.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.489 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -61.92 -40.87 96.98 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.65 -39.85 92.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.717 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -43.99 9.56 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.041 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.01 -24.57 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.432 . . . . 0.0 110.89 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.26 -35.42 64.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.55 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 64.1 t80 -60.92 -48.02 83.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.34 -32.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.721 0.772 . . . . 0.0 109.451 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -63.6 -41.26 98.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.523 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.41 -129.63 2.21 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.855 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.19 -27.93 62.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.853 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.21 -31.5 6.24 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.7 mt -51.9 -45.89 64.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.814 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -62.48 -39.0 92.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -57.34 -39.91 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.891 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.541 ' O ' ' O ' ' A' ' 37' ' ' LEU . 74.9 m-85 -64.76 -22.43 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.41 -40.23 5.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.74 -34.61 72.51 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 34' ' ' TYR . 31.6 mt -93.29 152.87 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.496 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.6 mt-30 -98.55 132.48 43.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 48.6 mttt -99.39 148.57 34.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 9.8 Cg_endo -57.49 140.02 91.95 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.62 1.546 . . . . 0.0 111.908 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 m -61.53 -33.22 73.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.762 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.434 ' NE1' ' CE1' ' A' ' 146' ' ' PHE . 13.3 p90 -85.79 6.43 28.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.496 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -54.86 124.55 51.85 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.136 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.93 168.45 6.75 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.172 1.248 . . . . 0.0 111.581 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 48.7 Cg_exo -51.21 139.28 44.14 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.427 1.418 . . . . 0.0 111.924 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.518 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 39.7 mtt85 -61.9 -37.09 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.2 p90 -73.88 -13.38 60.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.622 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -77.5 -65.92 0.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.967 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.994 ' O ' HG23 ' A' ' 52' ' ' ILE . 77.7 mt -65.79 -35.63 81.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.498 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.652 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.12 -40.42 3.87 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.033 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 63.6 Cg_exo -66.81 -8.95 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.913 2.409 . . . . 0.0 113.746 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' O ' ' A' ' 49' ' ' LEU . 26.3 pt -41.84 -42.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.412 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.45 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.3 m95 -53.54 -32.05 48.99 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.264 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -52.6 -37.08 49.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.5 p -87.54 -45.85 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.97 -40.32 96.13 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CE1' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -62.62 -44.65 95.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.639 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 57' ' ' TYR . 28.4 m -60.15 -40.79 91.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.61 91.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.42 -37.88 87.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.6 -55.53 19.83 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -61.78 -33.76 74.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.118 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.35 -44.18 58.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.48 ' CB ' HD21 ' A' ' 82' ' ' LEU . 95.4 p -64.13 -31.52 72.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -56.61 -46.04 81.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.412 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.6 mt -61.59 -39.4 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 129' ' ' VAL . 75.7 t -63.18 -38.78 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.91 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.13 -51.41 69.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.943 0.401 . . . . 0.0 111.2 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 73.5 mttt -54.96 -36.57 65.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.367 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -72.77 -41.17 65.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.89 -8.22 40.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.82 -6.28 58.58 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.515 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 124.8 -168.19 16.97 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.431 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -59.5 79.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.789 0.804 . . . . 0.0 108.873 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.1 m -116.09 152.77 32.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.595 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' THR . 97.0 mt-10 -42.59 -36.52 1.4 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.184 -0.607 . . . . 0.0 109.894 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.58 -41.33 98.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.114 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -74.97 -33.03 61.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.46 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.452 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 89.3 mmm -61.2 -35.76 78.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.652 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -56.42 -45.06 99.97 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.585 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 9.5 Cg_endo -78.18 -61.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 120.929 1.086 . . . . 0.0 111.985 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.48 HD21 ' CB ' ' A' ' 64' ' ' SER . 27.9 mt -57.81 -43.75 85.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.91 0.386 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.83 -43.85 98.66 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -59.07 -38.45 79.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.269 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.85 -42.98 80.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 m -65.66 -42.35 91.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.33 3.08 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.897 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -55.78 -41.59 74.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.522 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.21 -37.91 89.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.03 -49.84 73.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 111.004 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.8 -37.01 82.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.461 HD21 HD22 ' A' ' 113' ' ' LEU . 19.8 t-20 -59.51 -41.34 89.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.559 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.483 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 62.0 m95 -62.1 -30.42 70.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.652 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.24 -28.95 66.79 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.685 ' CD1' HD11 ' A' ' 113' ' ' LEU . 18.9 t-105 -55.74 -64.52 2.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_endo -46.2 82.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.457 1.438 . . . . 0.0 112.148 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.557 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.5 Cg_endo -57.82 -19.21 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.351 1.368 . . . . 0.0 111.477 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.746 HG21 ' HA ' ' A' ' 107' ' ' TRP . 39.6 pt -60.23 -26.18 35.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.032 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.7 p90 -46.82 -44.64 19.48 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.386 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 73.6 t80 -70.05 -49.4 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.99 -66.24 0.48 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.947 -0.645 . . . . 0.0 113.131 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 66.16 8.57 5.63 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.608 0.242 . . . . 0.0 111.015 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.504 HH11 ' NE2' ' A' ' 104' ' ' GLN . 79.7 ttt-85 -55.07 -36.31 65.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.504 ' NE2' HH11 ' A' ' 103' ' ' ARG . 96.5 mm-40 -88.66 149.77 23.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.286 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 107' ' ' TRP . 1.7 ttp -59.98 -19.41 52.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.298 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.02 -8.06 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.88 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.746 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.5 p90 -44.67 -18.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.19 -20.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.0 mt -60.87 -35.76 77.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.82 -39.8 93.04 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.479 0.657 . . . . 0.0 109.345 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 111' ' ' ASP . 56.7 t0 -66.73 -43.38 84.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.785 -1.098 . . . . 0.0 113.57 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.21 -49.26 65.19 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.685 HD11 ' CD1' ' A' ' 95' ' ' TRP . 21.8 mt -67.87 -38.85 83.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.02 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.765 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.0 tp -51.6 -55.81 17.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.286 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' HD22 ' A' ' 144' ' ' LEU . 57.3 t -73.1 -63.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.662 -178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -67.82 -41.86 82.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -63.48 -52.9 42.81 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.965 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 114' ' ' LEU . 1.8 p -65.93 -36.83 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.582 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.9 -56.0 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.3 m -56.34 -42.34 77.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.97 -53.96 15.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.397 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.499 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.8 m -65.03 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.874 HG23 ' CD2' ' A' ' 127' ' ' HIS . 86.9 m -59.16 -48.2 82.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.508 HD22 HH21 ' A' ' 128' ' ' ARG . 78.9 mt -65.96 -35.1 79.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.319 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -73.66 -55.25 6.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.499 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 38.6 m0 -84.86 -49.96 7.96 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.874 ' CD2' HG23 ' A' ' 123' ' ' THR . 0.2 OUTLIER -52.25 -41.87 63.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.206 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.508 HH21 HD22 ' A' ' 124' ' ' LEU . 96.9 mtt-85 -61.44 -43.57 98.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.316 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.408 HG11 HG13 ' A' ' 67' ' ' VAL . 79.3 t -78.6 -48.98 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.589 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 87.8 p -132.47 88.06 40.41 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.786 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.8 Cg_exo -53.31 -39.58 80.7 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.931 1.754 . . . . 0.0 113.147 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 34.1 Cg_exo -56.27 -29.74 77.49 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.35 0.7 . . . . 0.0 112.76 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -32.65 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.63 . . . . 0.0 110.392 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.542 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.48 -38.4 80.74 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 45.5 ttp180 -61.28 -38.65 87.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.625 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.58 -39.74 71.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.8 mt -56.85 -28.82 62.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.314 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.51 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 5.86 -69.45 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 9.6 Cg_endo -52.1 -31.36 44.6 Favored 'Trans proline' 0 N--CA 1.505 2.158 0 C-N-CA 120.435 0.756 . . . . 0.0 113.275 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -59.07 -38.3 79.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.809 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.754 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.1 tm? -59.58 -44.24 93.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.303 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.42 72.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.8 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.6 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 1.8 t-105 -61.26 -44.04 97.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 115' ' ' VAL . 43.3 mt -65.8 -34.25 77.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.823 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.42 89.39 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.727 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.675 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 15.7 t80 -65.27 -43.21 91.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.765 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.6 m -57.31 -42.73 82.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.612 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -61.26 -47.29 86.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.163 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.81 -42.7 82.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.688 0.756 . . . . 0.0 109.995 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.675 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 14.1 tp -53.44 -60.86 2.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.118 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.714 HD21 HG22 ' A' ' 147' ' ' THR . 78.1 m-20 -63.02 -38.81 92.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.272 0.558 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.35 -43.09 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.19 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.88 -44.46 96.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.47 -42.7 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 111.209 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 4.9 m95 -57.65 -36.23 71.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.37 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -57.35 -30.41 64.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 89.5 m-20 -53.13 -40.31 64.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.564 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -109.06 -60.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.4 m . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.793 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.3 t . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.5 ' O ' HD13 ' A' ' 11' ' ' LEU . 79.5 Cg_exo -54.52 -21.22 23.41 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 120.916 1.077 . . . . 0.0 112.177 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.29 -36.81 53.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.04 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 12' ' ' THR . 96.8 t -62.38 -42.81 96.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.47 -34.79 90.17 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.482 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.1 mp -55.82 -43.75 77.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.105 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.451 HG23 ' CD1' ' A' ' 57' ' ' TYR . 7.5 t -75.99 -27.01 57.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.19 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.97 -32.42 67.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 40.9 t -45.51 -57.69 7.22 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB3' HD21 ' A' ' 89' ' ' LEU . 6.6 Cg_endo -57.88 -31.52 92.76 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.086 1.191 . . . . 0.0 112.902 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.422 ' H ' ' HD2' ' A' ' 15' ' ' PRO . 23.2 t -60.2 -39.47 86.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.56 -39.27 87.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.275 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.56 15.37 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.2 94.05 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.08 -45.37 87.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.907 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.88 -39.42 94.41 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.51 -42.84 97.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.07 -26.28 62.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.386 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -62.94 -34.9 78.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.913 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 74.8 t80 -61.25 -49.45 77.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.64 -35.79 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.477 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -34.16 74.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.654 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.9 -136.88 2.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.505 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.1 -24.73 59.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.121 0.486 . . . . 0.0 110.759 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.86 -32.69 4.64 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.468 HD22 ' CZ ' ' A' ' 46' ' ' ARG . 92.1 mt -52.18 -43.42 64.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.074 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.23 -42.84 99.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 110.238 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -60.05 -39.15 84.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 45.1 m-85 -64.89 -23.06 67.11 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.751 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.15 -41.62 27.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.543 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.04 84.48 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 73.3 mt -91.0 149.18 21.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.789 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -98.0 122.56 41.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.791 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.696 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 54.7 mttt -91.35 140.94 25.67 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 30.4 Cg_endo -56.44 140.73 89.6 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.122 1.215 . . . . 0.0 112.398 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.4 m -61.17 -34.04 74.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.207 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 39.0 p90 -77.43 4.45 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.619 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.586 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.3 t-80 -64.5 132.0 95.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 57.6 Cg_endo -89.81 169.65 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.697 1.598 . . . . 0.0 111.284 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 41.0 Cg_exo -50.92 138.73 42.32 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.84 1.027 . . . . 0.0 111.501 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.696 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 43.0 mtt85 -60.43 -38.69 84.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.9 p90 -72.21 -25.66 61.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.901 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -64.24 -57.45 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.983 ' O ' HG23 ' A' ' 52' ' ' ILE . 50.1 mt -73.28 -33.78 65.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.36 -48.64 2.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.882 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.2 Cg_endo -72.34 3.77 3.88 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.364 2.043 . . . . 0.0 114.189 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 49' ' ' LEU . 19.4 pt -47.21 -38.24 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.263 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -51.76 -33.59 35.76 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.079 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.23 97.86 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.7 m -66.39 -51.17 59.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 110.834 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.28 -33.09 74.58 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.205 0.526 . . . . 0.0 109.966 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.451 ' CD1' HG23 ' A' ' 12' ' ' THR . 31.1 t80 -53.12 -52.8 57.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.618 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.5 p -69.42 -35.39 75.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.618 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.74 90.13 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.455 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.2 mtt -62.29 -37.41 85.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.269 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.29 -56.25 14.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.95 -40.13 96.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 111.102 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.85 -43.41 92.37 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.482 ' HB2' HD21 ' A' ' 82' ' ' LEU . 92.7 p -63.5 -28.14 69.76 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.954 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -58.3 -44.85 88.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.95 -44.71 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.914 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 HG11 ' A' ' 129' ' ' VAL . 55.4 t -59.32 -41.64 84.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.21 -37.17 86.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.511 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -62.46 -40.94 98.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.064 0.459 . . . . 0.0 111.113 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.63 -37.59 88.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.07 -5.31 56.7 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.47 17.19 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.972 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.451 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 104.24 -166.35 15.33 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.96 110.11 21.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.461 0.648 . . . . 0.0 109.332 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 77' ' ' ASP . 5.7 t -131.32 163.47 27.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.981 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -43.51 -37.85 2.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.309 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' H ' HG23 ' A' ' 75' ' ' THR . 83.9 m-20 -63.45 -41.02 98.64 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.879 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.4 -29.18 65.74 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.689 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 86.1 mmm -60.15 -33.64 72.45 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.781 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.3 t -60.33 -50.22 86.84 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.22 -61.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.935 1.09 . . . . 0.0 113.038 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 64' ' ' SER . 7.3 mp -61.87 -39.26 91.3 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.077 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.18 96.26 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.82 -39.27 80.72 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.407 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 84.0 t80 -60.62 -45.71 93.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.034 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.0 m -67.95 -40.28 83.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.856 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.93 -60.33 3.17 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.022 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -56.96 -40.63 76.83 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.17 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 15' ' ' PRO . 44.9 tp -61.96 -40.23 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.174 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.0 79.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.98 0.419 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.02 85.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t30 -61.64 -42.44 98.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.679 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -58.42 -29.62 66.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.831 0.348 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -31.12 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.279 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.0 t-105 -56.94 -44.25 99.71 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -53.05 127.37 24.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.521 1.48 . . . . 0.0 113.125 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.454 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 37.5 Cg_endo -108.67 -27.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.194 1.263 . . . . 0.0 110.793 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 26.5 pt -59.59 -27.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.953 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 20.8 p90 -56.7 -44.51 81.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.608 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.568 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 60.5 t80 -64.95 -49.08 71.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.908 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.32 -59.16 0.41 Allowed Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.52 -1.27 0.22 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.649 0.262 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.505 ' CZ ' ' NE2' ' A' ' 104' ' ' GLN . 71.0 ttp85 -52.89 -33.28 49.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 110.34 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.505 ' NE2' ' CZ ' ' A' ' 103' ' ' ARG . 97.2 mm-40 -86.62 151.82 23.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.784 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.683 ' C ' ' H ' ' A' ' 107' ' ' TRP . 2.7 ttp -62.16 -13.41 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.109 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.07 27.43 0.01 OUTLIER Glycine 0 CA--C 1.541 1.683 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.869 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.683 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.47 -19.17 34.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.559 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -55.07 -24.22 24.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.33 -33.1 65.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.431 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.537 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.76 -38.01 89.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.54 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 56.6 t0 -65.21 -48.43 73.39 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.29 -47.39 86.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.872 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.3 tt -69.11 -40.43 78.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.379 0.609 . . . . 0.0 110.356 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.737 ' CD2' HG21 ' A' ' 147' ' ' THR . 14.4 tp -54.07 -57.47 10.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.309 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.554 ' HA ' HD13 ' A' ' 144' ' ' LEU . 98.9 t -69.7 -56.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.883 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -68.7 -42.35 77.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -58.04 -45.2 94.14 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.661 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.38 -45.53 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.677 0.275 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.48 -55.59 9.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.1 m -59.72 -42.81 93.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.38 -60.37 2.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.459 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.6 m -62.48 -41.05 98.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.859 HG23 ' CE1' ' A' ' 127' ' ' HIS . 76.3 m -59.3 -46.47 88.49 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.5 -35.01 79.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.41 -63.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.8 m0 -64.47 -43.76 93.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.859 ' CE1' HG23 ' A' ' 123' ' ' THR . 24.9 m170 -56.87 -43.38 81.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.634 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.12 -44.32 96.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.587 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.509 HG11 HG13 ' A' ' 67' ' ' VAL . 98.5 t -75.9 -42.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.815 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.55 103.65 3.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.262 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.529 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.3 Cg_exo -60.76 -38.98 66.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.699 1.599 . . . . 0.0 113.236 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 28.1 Cg_exo -56.45 -29.59 78.5 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.93 1.086 . . . . 0.0 112.96 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 -33.53 73.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.018 0.437 . . . . 0.0 110.765 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.55 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.44 -37.29 77.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.902 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 44.1 ttt180 -59.45 -40.77 87.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.396 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.6 -36.84 67.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.307 0.575 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.524 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 60.8 mt -70.66 15.39 0.1 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.543 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -46.27 -40.64 19.01 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.072 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 9.2 Cg_endo -66.92 -22.9 47.94 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.809 1.325 . . . . 0.0 112.417 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.56 -34.02 74.86 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.751 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.0 tm? -67.93 -41.55 82.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.927 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.71 -52.15 33.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 0.661 ' CD1' HD12 ' A' ' 52' ' ' ILE . 1.1 t-105 -61.31 -46.34 90.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.756 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 115' ' ' VAL . 34.8 mt -67.6 -33.83 75.79 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.843 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.93 -46.03 89.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.993 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.694 ' CE2' HD22 ' A' ' 150' ' ' LEU . 16.1 t80 -64.69 -43.33 93.88 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.426 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.794 HG22 HD21 ' A' ' 151' ' ' ASN . 1.6 m -57.66 -43.48 85.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.39 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 54.4 m -60.29 -49.73 76.45 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.557 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.39 -41.81 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.366 0.603 . . . . 0.0 110.331 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 146' ' ' PHE . 23.9 tp -56.76 -47.88 79.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.139 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.794 HD21 HG22 ' A' ' 147' ' ' THR . 72.4 m-80 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -65.28 -40.52 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.342 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.74 -45.98 88.43 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.304 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.68 -45.62 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -62.66 -44.08 97.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.669 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -60.44 -32.12 71.07 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.306 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -54.71 -40.85 69.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.948 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -99.73 -59.97 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.5 m . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.108 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.3 t . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.0 Cg_endo -55.31 -19.4 21.71 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 CA-C-N 119.147 0.731 . . . . 0.0 111.451 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.12 -32.01 53.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 12' ' ' THR . 79.2 t -61.17 -41.15 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.25 -36.86 93.07 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.312 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.27 -41.69 84.86 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 9' ' ' VAL . 9.2 t -75.81 -34.52 60.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.652 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.15 -34.74 78.21 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 10' ' ' GLY . 26.8 t -49.26 -55.84 19.32 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.2 Cg_endo -58.92 -32.6 97.7 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 120.539 0.826 . . . . 0.0 112.963 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.8 m -59.97 -40.04 87.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.746 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.98 -38.09 87.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.42 -59.04 8.24 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.191 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -60.1 -36.34 90.21 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.284 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.15 -46.48 85.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.497 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.08 -38.21 87.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.554 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.83 -39.51 97.48 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.646 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.66 -28.42 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.337 . . . . 0.0 111.763 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.72 -34.82 67.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.724 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 88.6 t80 -60.89 -47.59 85.71 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.435 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.1 m -71.79 -33.9 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.702 0.763 . . . . 0.0 109.333 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -61.75 -40.77 96.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.028 -1.442 . . . . 0.0 112.674 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.14 -126.08 1.83 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.047 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.39 -28.11 62.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.777 0.322 . . . . 0.0 111.317 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.96 -32.88 12.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.25 -41.23 62.64 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.025 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.2 mtp85 -61.48 -45.86 92.45 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.677 0.751 . . . . 0.0 109.334 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -62.46 -40.67 97.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.595 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 21.4 m-85 -65.16 -23.0 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.647 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.86 -39.72 54.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.56 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -33.21 85.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 60.5 mt -91.47 149.42 21.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.59 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -99.62 130.71 45.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.639 -0.425 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -111.67 141.35 24.49 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.852 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 62.3 Cg_endo -58.61 133.29 53.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.972 1.114 . . . . 0.0 111.971 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.3 p -82.47 -9.19 59.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.05 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.3 p90 -77.79 -15.4 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.818 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -74.2 151.97 88.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.407 -178.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.68 173.13 14.07 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 112.455 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 19.5 Cg_exo -51.72 151.38 15.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.984 2.456 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -58.09 -35.69 71.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 14.7 p90 -74.51 -12.3 60.44 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.672 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -76.96 -66.91 0.76 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 110.956 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 19.5 mt -66.52 -35.82 81.2 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.581 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.656 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -40.76 -42.49 3.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 51.3 Cg_exo -65.51 -5.39 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.87 2.38 . . . . 0.0 112.98 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.035 HD12 ' HE1' ' A' ' 143' ' ' TRP . 5.9 pt -41.22 -42.54 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 120.658 0.266 . . . . 0.0 111.709 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.449 ' O ' ' N ' ' A' ' 57' ' ' TYR . 95.0 m95 -56.31 -34.06 66.17 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.105 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.49 -39.09 95.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -66.73 -52.28 46.25 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.19 0.519 . . . . 0.0 111.049 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.722 HD21 ' CE3' ' A' ' 143' ' ' TRP . 6.8 mp -68.22 -31.47 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.076 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' TRP . 19.8 t80 -52.2 -49.12 64.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.131 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -74.09 -34.79 64.09 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.651 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.94 -45.02 87.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.858 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.78 -37.18 85.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.75 -60.84 6.46 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.152 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -62.15 -36.48 81.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.637 0.256 . . . . 0.0 111.02 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.81 85.0 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.115 -1.04 . . . . 0.0 110.738 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.2 p -65.07 -30.11 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.566 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -58.49 -44.01 89.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.43 -38.48 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.949 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 129' ' ' VAL . 63.1 t -62.15 -41.6 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.636 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.33 -50.03 75.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.308 -178.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 74.9 mttt -54.4 -36.24 63.75 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.978 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -72.94 -44.73 60.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.658 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 78' ' ' ALA . 70.6 mt -77.41 -26.06 51.36 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.07 -6.85 40.42 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.269 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.85 -161.61 25.49 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.113 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.686 ' CD2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -89.23 82.68 6.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.35 0.595 . . . . 0.0 110.083 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 13.4 p -123.16 166.0 15.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.46 -36.87 3.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.82 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.76 -42.82 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.952 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -82.27 -36.64 26.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.983 0.42 . . . . 0.0 111.657 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.686 ' SD ' ' CD2' ' A' ' 74' ' ' PHE . 98.7 mmm -59.08 -34.47 72.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.052 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.3 t -60.14 -52.39 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.929 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -68.88 -58.78 0.1 Allowed 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.155 1.237 . . . . 0.0 112.775 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 82' ' ' LEU . 11.0 mp -60.84 -42.0 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.194 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.19 95.38 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.34 -39.79 76.66 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.449 ' CE2' HD22 ' A' ' 89' ' ' LEU . 75.0 t80 -59.13 -43.99 92.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.1 m -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.134 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.89 -60.07 3.26 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.595 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -56.97 -41.17 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.329 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 15' ' ' PRO . 33.0 tp -61.94 -38.86 90.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.632 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.78 76.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.981 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.4 -39.09 86.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.555 ' O ' HD11 ' A' ' 113' ' ' LEU . 57.5 t30 -61.46 -41.07 96.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.666 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.572 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 48.3 m95 -60.42 -28.76 68.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.71 -17.86 62.82 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.587 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.3 t-105 -72.43 -55.92 4.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 71.8 Cg_endo -42.62 87.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.182 1.255 . . . . 0.0 112.508 -177.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.6 Cg_endo -59.53 -27.1 84.13 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 120.606 0.871 . . . . 0.0 111.762 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.655 HD11 ' HB2' ' A' ' 110' ' ' ALA . 40.0 pt -61.71 -33.99 60.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.5 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -46.68 -43.78 18.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.534 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -67.53 -52.16 42.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.68 -55.11 0.39 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.847 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 61.04 10.81 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 0.0 110.356 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -55.66 -35.6 66.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.546 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -87.22 149.38 24.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.501 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.633 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.4 ttp -62.62 -14.93 48.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.28 35.44 0.02 OUTLIER Glycine 0 CA--C 1.54 1.598 0 C-N-CA 121.679 -0.296 . . . . 0.0 112.743 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.633 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -64.03 -19.67 65.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -47.46 -22.7 0.49 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.91 0.386 . . . . 0.0 111.258 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt -57.77 -31.48 66.57 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.563 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.02 -53.72 45.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.678 ' OD1' HG22 ' A' ' 147' ' ' THR . 31.1 t70 -63.13 -46.7 86.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.61 -38.09 83.57 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.781 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.6 tt -67.26 -48.78 66.71 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.616 ' N ' HD23 ' A' ' 113' ' ' LEU . 1.6 pp -76.15 -32.99 59.37 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.977 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 111' ' ' ASP . 70.6 t -64.82 -45.91 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.89 -38.75 17.72 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.55 -42.22 89.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.213 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 119' ' ' ALA . 0.9 OUTLIER -75.86 -48.38 29.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.776 0.322 . . . . 0.0 111.033 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.24 -56.79 10.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.7 m -61.9 -45.17 94.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.79 -59.11 3.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.423 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 28.3 m -63.11 -41.71 99.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 88.8 m -58.84 -45.22 90.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.393 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 124' ' ' LEU . 96.4 mt -63.45 -37.48 87.44 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.215 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.28 -64.3 1.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.423 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.6 m0 -66.1 -43.01 88.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -59.29 -50.12 75.2 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.691 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.11 -43.53 95.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.798 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 67' ' ' VAL . 97.7 t -76.02 -48.04 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 p -134.1 87.87 32.97 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.446 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.46 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.53 -42.41 61.91 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.391 1.394 . . . . 0.0 112.433 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.5 Cg_exo -56.79 -30.46 84.91 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 120.328 0.685 . . . . 0.0 111.994 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -30.79 70.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.094 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.91 97.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.114 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -59.98 -38.4 82.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.07 0.462 . . . . 0.0 110.352 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.53 -37.71 73.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.198 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.3 mt -57.86 -31.54 66.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.499 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 5.88 -72.37 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.4 Cg_endo -50.8 -22.32 9.67 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 CA-C-N 119.23 0.761 . . . . 0.0 112.79 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 p90 -57.73 -41.95 82.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.696 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -61.34 -44.39 97.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.053 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.21 83.57 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.234 0.54 . . . . 0.0 110.344 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TRP . . . . . 1.035 ' HE1' HD12 ' A' ' 52' ' ' ILE . 26.7 t90 -60.47 -50.59 72.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.486 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.736 HD21 ' CZ3' ' A' ' 143' ' ' TRP . 57.8 mt -74.78 -29.69 61.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.32 -54.92 39.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.841 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 150' ' ' LEU . 40.8 t80 -65.36 -44.93 86.1 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.786 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.678 HG22 ' OD1' ' A' ' 111' ' ' ASP . 9.6 m -56.56 -42.33 78.42 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.672 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.5 m -68.18 -50.17 56.08 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 111.604 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.06 -39.57 86.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.258 0.551 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 146' ' ' PHE . 66.1 tp -55.45 -41.73 73.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 6.2 m120 -63.18 -42.62 99.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -63.58 -35.9 82.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.664 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -58.57 -47.02 85.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.549 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.42 -47.44 52.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.756 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 3.1 m0 -61.58 -43.91 97.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -60.86 -33.66 73.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.269 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.6 -41.08 76.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.126 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -96.75 -59.97 1.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 111.482 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.069 -178.743 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 mtp . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -57.31 -22.23 48.27 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.695 1.597 . . . . 0.0 112.373 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.93 -27.83 61.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.178 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -56.33 -42.67 78.05 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.403 ' NE1' ' HB2' ' A' ' 74' ' ' PHE . 10.5 m-90 -79.24 -30.61 43.23 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 2.5 t -41.43 -39.45 2.26 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.577 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.56 ' O ' HD13 ' A' ' 11' ' ' LEU . 88.6 Cg_exo -55.28 -22.91 34.96 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.218 1.279 . . . . 0.0 112.794 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.31 62.99 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 80.4 t -64.31 -42.69 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.15 -34.61 90.4 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.012 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.1 mp -55.57 -44.23 76.66 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.795 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 t -78.83 -33.43 46.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.241 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.408 HD21 ' CE1' ' A' ' 57' ' ' TYR . 87.1 mt -65.39 -35.44 80.97 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.794 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 t -54.35 -57.27 19.27 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.54 -33.21 97.04 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 120.843 1.029 . . . . 0.0 112.767 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -59.31 -38.05 79.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.941 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.04 -38.52 91.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.579 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.97 -53.88 27.87 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.882 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.1 -36.92 90.68 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CZ ' ' NH1' ' A' ' 27' ' ' ARG . 54.3 t80 -59.13 -43.47 91.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.296 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.2 mtt -61.06 -40.78 94.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.072 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.15 -42.46 91.48 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -69.64 -27.74 65.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.22 0.533 . . . . 0.0 110.302 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -35.39 76.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.669 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 40.7 t80 -61.05 -49.94 75.35 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.91 -34.12 54.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.693 0.759 . . . . 0.0 109.645 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.48 ' NH1' ' CZ ' ' A' ' 20' ' ' PHE . 7.9 ttt180 -61.81 -40.91 96.9 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.779 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.14 -123.47 3.16 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.149 -176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -56.1 -29.54 60.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.797 0.332 . . . . 0.0 111.204 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -33.43 17.93 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD21 ' NE ' ' A' ' 46' ' ' ARG . 96.1 mt -50.37 -43.18 54.25 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -61.41 -43.07 99.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.319 0.58 . . . . 0.0 109.834 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -63.94 -39.17 93.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.85 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.617 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 16.5 m-85 -63.88 -23.26 67.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.854 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.29 -40.19 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.58 -0.848 . . . . 0.0 108.796 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.98 -31.96 72.92 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 34' ' ' TYR . 51.1 mt -90.62 148.55 22.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.869 0.366 . . . . 0.0 110.976 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -98.43 127.04 44.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.598 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.773 ' HZ1' ' NH1' ' A' ' 46' ' ' ARG . 11.0 mtpt -105.21 138.3 19.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 37.2 Cg_endo -55.65 141.47 83.78 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 120.669 0.913 . . . . 0.0 111.888 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 87.8 p -62.76 -30.04 71.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.335 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.42 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 24.8 p90 -78.39 0.18 26.7 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.884 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 19.7 t-80 -59.61 127.64 85.16 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 98.4 Cg_endo -81.68 167.06 17.1 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.181 1.254 . . . . 0.0 111.803 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 33.0 Cg_exo -52.01 140.66 49.11 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.731 1.621 . . . . 0.0 111.482 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.773 ' NH1' ' HZ1' ' A' ' 39' ' ' LYS . 62.5 mtt-85 -59.74 -36.37 76.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.519 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.412 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 7.7 p90 -73.94 -13.54 60.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.948 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 m -75.91 -69.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.421 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.008 ' O ' HG23 ' A' ' 52' ' ' ILE . 63.4 mt -66.01 -34.78 78.87 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.476 -0.49 . . . . 0.0 112.031 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.03 -41.03 4.29 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.324 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 51.0 Cg_exo -67.2 -7.11 17.91 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 123.123 2.549 . . . . 0.0 113.983 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.008 HG23 ' O ' ' A' ' 49' ' ' LEU . 24.4 pt -42.8 -40.08 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.465 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 99.3 m95 -53.44 -32.95 52.16 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.578 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.75 97.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.5 m -68.39 -51.04 48.52 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.924 0.393 . . . . 0.0 111.403 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.2 mp -67.95 -33.39 74.58 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.248 0.547 . . . . 0.0 110.111 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 17.1 t80 -51.15 -57.16 9.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.125 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -64.97 -38.74 91.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.871 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.24 99.14 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.214 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.5 mtt -61.34 -37.89 84.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.43 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -55.81 16.12 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.088 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -62.15 -38.46 89.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.503 0.192 . . . . 0.0 111.257 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.46 -42.62 93.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.275 -0.964 . . . . 0.0 110.822 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 82' ' ' LEU . 99.2 p -62.58 -30.74 71.55 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.049 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -59.27 -43.27 92.52 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.48 -43.87 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.873 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.446 HG13 HG11 ' A' ' 129' ' ' VAL . 77.8 t -61.04 -40.1 84.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.287 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.72 -33.23 75.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.276 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 29.0 mtpt -62.17 -44.04 97.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.921 0.391 . . . . 0.0 111.44 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 80.1 mt-10 -70.89 -45.75 63.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.734 -178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.41 -27.81 60.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.792 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.04 0.7 67.96 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.663 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.414 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 149.55 -161.29 28.76 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.678 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.94 108.51 20.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.641 0.734 . . . . 0.0 109.904 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . 11.8 t -133.53 167.6 20.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.209 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' THR . 77.6 mm-40 -43.98 -35.57 2.11 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.321 -178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.95 -41.99 97.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.613 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.99 -31.7 69.52 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.678 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 78.9 mmm -61.21 -34.78 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.534 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.56 -48.36 95.75 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -73.35 -62.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.272 1.315 . . . . 0.0 113.387 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 64' ' ' SER . 8.3 mp -61.82 -41.32 97.63 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.196 -0.602 . . . . 0.0 111.034 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.97 -41.55 97.92 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.28 -40.32 90.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.868 0.366 . . . . 0.0 110.666 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -59.82 -44.54 93.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.769 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.7 m -65.69 -42.41 91.24 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.98 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.84 -55.91 6.21 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -57.87 -41.27 82.11 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.412 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.22 -38.87 84.69 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.113 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.47 -45.29 84.27 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.107 0.48 . . . . 0.0 111.414 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 mt -57.65 -41.8 82.18 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.039 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.504 HD22 ' CA ' ' A' ' 117' ' ' GLY . 50.4 t-20 -65.93 -36.0 82.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.758 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.572 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m95 -53.06 -30.84 38.27 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.45 -20.38 62.9 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.198 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.55 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 40.0 t-105 -64.03 -56.75 22.05 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.572 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 46.1 Cg_endo -54.83 131.83 48.37 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.742 1.628 . . . . 0.0 113.035 -176.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.418 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 42.5 Cg_endo -107.56 -26.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.435 1.423 . . . . 0.0 110.556 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 110' ' ' ALA . 27.1 pt -60.69 -25.59 35.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.518 -1.219 . . . . 0.0 113.069 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.499 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 35.3 p90 -51.69 -42.74 62.42 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.29 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.499 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.8 t80 -64.53 -49.55 70.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.874 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -113.49 -68.65 0.51 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.369 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 75.53 -3.66 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -54.74 -34.07 62.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.469 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -86.4 155.88 20.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.298 0.57 . . . . 0.0 111.194 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.704 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.8 ttm -57.39 -14.26 4.52 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.811 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -44.69 2.87 0.01 OUTLIER Glycine 0 CA--C 1.541 1.688 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.155 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.704 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -47.42 -21.84 0.37 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.472 0.636 . . . . 0.0 111.374 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 155' ' ' TRP . . . -55.14 -27.86 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.61 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.23 -33.18 73.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.009 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.559 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.86 -36.73 79.89 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.543 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 56.1 t0 -61.75 -45.02 95.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.347 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.53 -47.77 71.84 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 120.715 -0.394 . . . . 0.0 112.005 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.796 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.0 tt -67.0 -41.18 87.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.381 0.61 . . . . 0.0 110.039 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.696 ' CD2' HG21 ' A' ' 147' ' ' THR . 17.0 tp -53.22 -60.88 2.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.404 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.505 ' HA ' HD13 ' A' ' 144' ' ' LEU . 65.3 t -70.82 -63.21 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.639 -1.164 . . . . 0.0 113.452 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.0 t -65.39 -38.8 91.08 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.504 ' CA ' HD22 ' A' ' 92' ' ' ASN . . . -61.61 -56.55 22.46 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.714 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.1 -38.26 77.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.972 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.88 -47.47 25.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 116' ' ' SER . 32.0 m -58.98 -43.39 91.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.02 -50.99 43.86 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.558 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.403 HG23 ' CD2' ' A' ' 126' ' ' TRP . 34.2 m -65.08 -40.99 95.41 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 71.1 m -60.56 -46.55 89.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 124' ' ' LEU . 83.2 mt -66.25 -35.99 81.84 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.67 -64.14 1.23 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.403 ' CD2' HG23 ' A' ' 122' ' ' THR . 38.6 m0 -66.4 -41.17 89.72 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 33.5 t-80 -58.49 -49.03 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.922 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -65.61 -46.07 80.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.486 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 99.0 t -78.27 -46.5 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.414 ' OG ' HG22 ' A' ' 67' ' ' VAL . 20.1 p -129.4 82.42 67.84 Favored Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.591 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.474 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 36.5 Cg_exo -53.14 -43.34 57.95 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 121.795 1.663 . . . . 0.0 112.257 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 23.7 Cg_exo -58.02 -32.47 95.44 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 120.474 0.783 . . . . 0.0 112.208 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.46 70.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.195 0.522 . . . . 0.0 110.379 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.72 77.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.098 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.501 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 42.7 mtm105 -62.95 -38.59 91.69 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.296 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.4 tp -53.15 -38.53 62.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.16 0.505 . . . . 0.0 109.947 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 140' ' ' TYR . 83.7 mt -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.455 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -2.81 -67.33 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.794 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.475 ' N ' ' O ' ' A' ' 137' ' ' LEU . 10.9 Cg_endo -54.31 -30.06 60.66 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 120.799 0.999 . . . . 0.0 112.992 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -56.77 -40.69 76.3 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.733 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.2 tm? -63.61 -42.85 98.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.84 75.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.269 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.639 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 0.8 OUTLIER -61.7 -50.34 72.83 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.483 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 115' ' ' VAL . 41.1 mt -63.84 -33.73 76.34 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.839 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.58 96.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.201 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.709 ' CE2' HD22 ' A' ' 150' ' ' LEU . 21.3 t80 -61.47 -41.65 97.56 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.345 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.696 HG21 ' CD2' ' A' ' 114' ' ' LEU . 53.8 p -60.81 -38.64 86.08 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.801 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.1 m -59.49 -50.59 73.34 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.948 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 91.8 t -71.32 -43.88 73.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.02 0.438 . . . . 0.0 110.864 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.709 HD22 ' CE2' ' A' ' 146' ' ' PHE . 62.2 tp -57.97 -41.59 83.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.184 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 147' ' ' THR . 47.3 m-80 -63.04 -40.14 96.82 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.492 ' O ' ' CB ' ' A' ' 156' ' ' ARG . 37.1 m-85 -62.19 -39.57 93.15 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.697 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.441 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 47.4 t80 -59.9 -46.59 88.84 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.175 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.5 t -71.4 -51.32 34.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.9 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.595 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -67.41 -44.08 79.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.771 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 152' ' ' TYR . 28.4 ttp180 -59.57 -38.32 80.81 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.162 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 92.6 m-20 -59.37 -42.46 91.69 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.905 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -87.44 -54.64 4.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.345 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 79.7 p -61.46 -24.69 66.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.913 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -52.94 -30.95 38.5 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -57.28 -31.9 66.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.802 0.334 . . . . 0.0 110.43 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -117.57 146.88 43.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.343 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.02 14.26 67.39 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -52.97 -35.18 47.74 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.3 p -61.64 -26.63 68.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 110.304 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -56.14 -32.79 64.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.274 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.501 ' H ' HD22 ' A' ' 167' ' ' LEU . 1.0 OUTLIER -88.22 146.75 25.19 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.311 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -102.32 150.19 23.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.638 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 168' ' ' ALA . 95.3 mt-10 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.936 -1.03 . . . . 0.0 111.498 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.523 ' C23' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.628 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.731 0.3 . . . . 0.0 110.504 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -56.54 -22.91 45.34 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.036 1.824 . . . . 0.0 112.192 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.1 -35.12 74.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.0 m -63.12 -39.8 95.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.95 0.405 . . . . 0.0 110.953 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.639 ' CD1' ' CE3' ' A' ' 68' ' ' TRP . 1.0 OUTLIER -71.66 -35.12 70.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.74 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -42.27 -42.18 6.04 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.29 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.447 ' O ' HD13 ' A' ' 11' ' ' LEU . 75.5 Cg_exo -53.58 -22.66 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 120.656 0.904 . . . . 0.0 111.8 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.34 -33.92 55.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.049 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.36 -42.22 92.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -64.83 -35.25 91.68 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.8 mp -56.46 -41.62 76.82 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 122.728 -0.277 . . . . 0.0 110.962 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 t -79.71 -34.89 39.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.511 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -68.08 -36.22 79.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 10' ' ' GLY . 12.1 t -48.0 -56.41 13.82 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HB3' HD21 ' A' ' 89' ' ' LEU . 20.6 Cg_endo -59.22 -34.16 98.18 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 120.719 0.946 . . . . 0.0 112.933 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.4 m -59.04 -40.47 85.18 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.271 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.3 mt -63.09 -37.89 88.99 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.001 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.29 -40.22 98.3 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.89 -44.22 98.36 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.881 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.4 m-85 -63.88 -43.38 96.21 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.3 mtt -61.83 -40.91 96.94 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.81 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.44 -45.82 10.72 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB1' ' NH2' ' A' ' 46' ' ' ARG . . . -69.15 -25.15 64.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.33 0.586 . . . . 0.0 110.014 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -52.95 -36.55 60.1 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.358 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 89.7 t80 -60.24 -47.12 87.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.61 -32.81 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.602 0.715 . . . . 0.0 109.51 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' CA ' ' HE ' ' A' ' 46' ' ' ARG . 20.5 ttt-85 -62.42 -42.77 99.69 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.029 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.94 -132.07 1.18 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.687 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -57.0 -26.05 59.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.796 0.331 . . . . 0.0 110.69 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.49 8.94 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.25 -41.64 62.97 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.466 -0.493 . . . . 0.0 109.67 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -62.87 -42.17 99.66 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.365 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -61.27 -39.89 92.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.592 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 29.3 m-85 -64.55 -22.82 67.08 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.021 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.7 40.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.338 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.2 -31.86 82.25 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 72.8 mt -91.54 150.02 21.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.408 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -95.72 126.91 41.32 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.222 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.4 mttt -102.47 141.69 23.03 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 69.3 Cg_endo -57.99 144.15 94.96 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.112 1.208 . . . . 0.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.7 p -64.08 -30.24 71.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.039 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 35.6 p90 -78.66 3.76 15.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.927 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 32.8 t-80 -60.1 139.52 91.09 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.598 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 79.7 Cg_endo -95.67 169.3 1.32 Allowed 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.035 1.157 . . . . 0.0 112.759 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.36 148.46 41.9 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.876 2.384 . . . . 0.0 112.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' NH2' ' HB1' ' A' ' 23' ' ' ALA . 22.7 tpt85 -57.21 -39.39 75.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -79.89 -5.94 56.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.4 m -76.79 -76.4 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.9 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.004 ' O ' HG23 ' A' ' 52' ' ' ILE . 69.9 mt -66.38 -32.29 73.58 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.889 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.52 -42.73 5.11 Favored Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.374 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 61.7 Cg_exo -64.31 -6.94 12.68 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.083 2.522 . . . . 0.0 113.789 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.004 HG23 ' O ' ' A' ' 49' ' ' LEU . 18.4 pt -42.32 -44.03 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.731 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.3 m95 -54.8 -31.99 59.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.606 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.68 -39.89 98.02 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -68.77 -51.79 37.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.092 0.472 . . . . 0.0 111.036 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 56' ' ' LEU . 8.1 mp -66.81 -32.63 74.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.87 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 8.8 t80 -51.79 -49.39 62.8 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.734 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.0 p -70.88 -36.04 72.6 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.456 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.35 -41.76 89.07 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.06 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.5 mtt -62.25 -38.77 90.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.427 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.52 -56.68 10.78 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -61.92 -38.41 88.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.584 0.23 . . . . 0.0 110.896 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.11 -41.93 92.89 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 94.1 p -63.5 -28.89 70.26 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.68 -0.408 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -58.88 -43.81 91.0 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.22 -46.43 88.71 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.83 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.411 HG22 ' OG ' ' A' ' 130' ' ' SER . 78.1 t -60.26 -41.05 85.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.522 0.677 . . . . 0.0 109.198 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.639 ' CE3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -63.35 -34.19 77.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.206 179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -63.23 -43.18 98.8 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 82.7 mt-10 -67.49 -37.06 82.3 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.25 -4.39 58.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.18 46.67 15.18 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.721 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.463 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.39 -159.53 23.34 Favored Glycine 0 CA--C 1.519 0.301 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.677 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -85.18 111.62 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.719 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.473 HG23 ' H ' ' A' ' 77' ' ' ASP . 3.6 t -130.27 161.21 31.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -47.07 -39.75 13.68 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.482 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.473 ' H ' HG23 ' A' ' 75' ' ' THR . 86.2 m-20 -63.33 -39.62 95.05 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.719 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.8 71.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.212 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 87.4 mmm -58.72 -34.54 71.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.112 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.15 -59.23 13.97 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.22 -53.84 1.33 Allowed 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 120.828 1.019 . . . . 0.0 112.767 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.2 mp -64.0 -43.01 96.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.448 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.55 -41.99 97.63 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.84 -39.33 77.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.921 0.391 . . . . 0.0 110.351 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 73.2 t80 -60.42 -44.17 96.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.561 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.0 m -64.85 -43.1 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.694 -0.402 . . . . 0.0 112.072 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.23 -58.25 4.39 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.76 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -57.8 -40.91 81.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.681 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 15' ' ' PRO . 25.4 tp -62.77 -41.21 99.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.633 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.951 0.405 . . . . 0.0 111.416 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -59.36 -37.76 78.69 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.734 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 45.3 t-20 -61.73 -42.46 98.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.169 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -57.57 -31.42 66.13 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.775 0.322 . . . . 0.0 111.193 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.1 -28.81 69.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.666 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -55.05 -55.45 38.89 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.406 ' CD ' HD13 ' A' ' 113' ' ' LEU . 73.4 Cg_exo -38.49 81.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.814 1.676 . . . . 0.0 113.18 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' A' ' 95' ' ' TRP . 65.1 Cg_endo -63.71 -23.69 69.44 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 120.498 0.799 . . . . 0.0 111.704 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.839 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 38.1 pt -62.21 -30.0 47.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.215 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.65 -48.26 66.54 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.779 -179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.489 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 68.5 t80 -64.95 -46.78 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.633 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -109.38 -65.04 0.55 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 59.79 -1.32 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 110.838 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 101' ' ' GLY . 24.0 ttp-105 -52.59 -33.55 46.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.412 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -91.52 151.77 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.263 0.554 . . . . 0.0 111.688 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.648 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.0 ttp -62.93 -14.63 49.34 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.193 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.75 32.65 0.01 OUTLIER Glycine 0 CA--C 1.543 1.824 0 C-N-CA 121.821 -0.228 . . . . 0.0 113.018 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.648 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -63.58 -19.61 64.97 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.774 1.028 . . . . 0.0 113.774 -179.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.681 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.97 -21.89 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.859 0.361 . . . . 0.0 111.924 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 107' ' ' TRP . 75.3 mt -58.73 -34.79 71.76 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.878 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.9 t0 -63.84 -48.06 78.28 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.5 tp -61.54 -49.39 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.399 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.6 tt -67.16 -41.27 86.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.289 0.566 . . . . 0.0 110.11 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.629 ' CD2' HG21 ' A' ' 147' ' ' THR . 13.3 tp -51.42 -59.89 3.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.678 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.529 ' HA ' HD13 ' A' ' 144' ' ' LEU . 59.8 t -71.13 -63.07 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.588 -1.187 . . . . 0.0 113.2 -177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.486 ' O ' ' OG1' ' A' ' 120' ' ' THR . 43.7 t -66.93 -39.29 87.29 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.22 -56.12 23.88 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.355 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 114' ' ' LEU . 4.1 p -65.25 -37.3 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.317 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.03 -52.81 8.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.9 m -54.58 -42.58 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -60.37 2.3 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.913 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.608 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 21.6 m -66.02 -41.19 91.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.765 HG23 ' CD2' ' A' ' 127' ' ' HIS . 47.6 m -58.27 -47.22 84.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.165 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.1 -34.17 77.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -78.69 -63.11 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.608 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 39.0 m0 -65.06 -45.3 85.9 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.765 ' CD2' HG23 ' A' ' 123' ' ' THR . 0.3 OUTLIER -59.84 -43.89 94.35 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.148 -177.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -61.56 -43.45 98.83 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.221 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.492 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 84.7 t -81.02 -50.83 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.942 0.401 . . . . 0.0 111.52 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 67' ' ' VAL . 76.1 p -128.58 88.88 51.0 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.046 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.5 Cg_exo -52.06 -40.14 68.76 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 121.651 1.567 . . . . 0.0 113.019 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.7 Cg_exo -57.42 -27.0 74.03 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 120.532 0.821 . . . . 0.0 112.905 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.35 -34.77 74.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.639 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.62 -38.83 86.05 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.202 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 59.8 ttt180 -60.39 -38.76 84.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 0.0 110.631 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.14 -39.13 74.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.176 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.0 mt -56.79 -33.14 66.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.852 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.522 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.8 OUTLIER 9.91 -72.62 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -179.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -53.4 -26.43 35.48 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 120.617 0.878 . . . . 0.0 113.675 -178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -57.5 -41.33 80.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.357 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.678 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -64.96 -41.15 95.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.09 0.472 . . . . 0.0 109.943 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.74 -42.4 95.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.974 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.647 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -67.2 -53.11 33.35 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.349 0.595 . . . . 0.0 110.398 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 115' ' ' VAL . 43.7 mt -61.39 -33.41 73.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.674 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.36 96.96 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.555 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.714 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 21.5 t80 -60.55 -41.11 93.87 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.129 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.633 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 69.4 p -61.82 -34.74 76.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.452 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.438 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 59.3 m -61.21 -53.06 61.72 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.445 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.4 -42.84 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 120.983 0.42 . . . . 0.0 111.069 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 54.9 tp -57.39 -41.92 81.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.03 -41.8 97.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 148' ' ' THR . 50.1 m-85 -64.85 -36.75 85.36 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.659 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 62.2 t80 -58.97 -47.3 85.61 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.426 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -73.43 -49.51 36.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.135 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.681 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.0 m0 -61.72 -43.91 97.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.555 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 160' ' ' GLY . 82.2 mmt-85 -62.87 -34.77 78.08 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.381 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 91.0 m-20 -56.56 -41.27 76.58 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.795 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -94.22 -48.13 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.029 0.443 . . . . 0.0 110.573 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 155' ' ' TRP . 80.6 p -69.12 -22.69 63.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.788 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -80.6 177.43 54.36 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.791 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -69.52 146.1 52.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.891 0.377 . . . . 0.0 110.833 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -59.36 -32.83 70.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.57 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -54.71 -32.91 54.81 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.454 ' O ' HD22 ' A' ' 167' ' ' LEU . . . -54.25 -32.84 51.61 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.4 p -60.99 -25.85 67.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.732 0.301 . . . . 0.0 110.724 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -53.68 -37.58 63.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.563 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -63.84 -33.62 76.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.421 . . . . 0.0 109.928 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.47 162.43 28.83 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.415 0.626 . . . . 0.0 111.136 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 C--N 1.322 -0.621 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.609 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.428 ' C10' ' CH2' ' A' ' 143' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.818 0.342 . . . . 0.0 110.543 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.37 -18.99 20.61 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.578 2.185 . . . . 0.0 112.136 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.25 -31.63 67.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.83 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -60.68 -43.22 97.95 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.744 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -75.67 -32.76 60.29 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.72 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 25.0 t -41.34 -49.51 8.94 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.19 -19.83 35.75 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 CA-C-N 119.368 0.81 . . . . 0.0 112.514 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.35 -34.73 61.7 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.571 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' THR . 70.1 t -59.85 -39.97 81.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -36.47 92.74 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.7 -41.99 87.55 Favored 'General case' 0 N--CA 1.461 0.1 0 O-C-N 122.824 -0.221 . . . . 0.0 111.565 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 9' ' ' VAL . 3.8 t -75.41 -37.33 60.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.189 -0.604 . . . . 0.0 112.072 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.56 -36.71 81.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 t -51.6 -43.07 86.52 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.48 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -58.39 -36.45 97.55 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.15 1.233 . . . . 0.0 112.902 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 82.7 p -63.46 -37.52 87.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.602 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.8 mt -68.68 -40.03 80.28 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.455 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.96 -47.99 76.34 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.7 -40.85 97.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -60.59 -48.65 80.85 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.171 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 65.0 mtt -63.93 -39.47 94.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.409 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.84 -45.47 74.25 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.799 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.31 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 111.64 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.683 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -57.61 -30.94 65.73 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -178.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 90.6 t80 -61.0 -48.6 81.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.73 -32.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.747 0.785 . . . . 0.0 109.631 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.6 ttt-85 -63.06 -41.18 99.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.273 -1.33 . . . . 0.0 112.575 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.86 -128.58 4.78 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.121 -0.561 . . . . 0.0 113.025 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CG ' HH21 ' A' ' 32' ' ' ARG . 84.2 tt0 -49.97 -30.51 10.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.337 -0.431 . . . . 0.0 111.253 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.97 -33.12 20.48 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.8 mt -50.59 -44.63 56.97 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.328 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.543 HH21 ' CG ' ' A' ' 29' ' ' GLU . 67.9 mtm180 -62.18 -43.45 98.8 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.345 0.593 . . . . 0.0 110.071 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.06 -39.74 91.01 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.954 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' O ' ' O ' ' A' ' 37' ' ' LEU . 17.8 m-85 -65.27 -23.14 66.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.2 -41.11 49.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.155 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.18 -32.62 84.53 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 34' ' ' TYR . 67.5 mt -92.51 150.63 20.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -101.54 127.83 48.07 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.917 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.792 ' HZ2' ' HE ' ' A' ' 46' ' ' ARG . 14.0 mtpt -107.42 140.69 21.75 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.595 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 37.1 Cg_endo -58.03 130.23 37.12 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 120.713 0.942 . . . . 0.0 111.431 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.6 p -75.64 -13.44 60.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.884 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.508 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 2.7 p90 -77.29 -15.49 59.41 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.488 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 40' ' ' PRO . 0.5 OUTLIER -76.04 147.35 80.14 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.49 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HG2' HD21 ' A' ' 49' ' ' LEU . 1.3 Cg_endo -72.83 162.05 42.15 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.803 1.002 . . . . 0.0 111.297 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.9 Cg_endo -50.73 150.6 12.13 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.217 1.945 . . . . 0.0 111.848 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.792 ' HE ' ' HZ2' ' A' ' 39' ' ' LYS . 51.7 mtt85 -57.11 -36.85 71.13 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.447 ' C ' ' CD1' ' A' ' 47' ' ' TRP . 5.1 p90 -65.02 -22.09 66.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.864 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.7 m -78.45 -63.07 1.49 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.431 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.007 ' O ' HG23 ' A' ' 52' ' ' ILE . 85.8 mt -63.24 -36.98 85.46 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.642 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -45.49 -41.38 16.72 Favored Pre-proline 0 C--N 1.322 -0.624 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.742 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 75.3 Cg_exo -64.92 -7.56 15.48 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 123.376 2.718 . . . . 0.0 114.081 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.007 HG23 ' O ' ' A' ' 49' ' ' LEU . 27.9 pt -41.99 -41.42 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.291 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' TYR . 97.2 m95 -51.2 -34.09 30.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.946 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.19 -39.99 96.66 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.0 m -68.68 -51.44 41.83 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.99 0.424 . . . . 0.0 110.936 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -65.98 -32.42 73.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 53' ' ' TRP . 3.5 t80 -52.28 -48.97 65.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.463 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.0 p -68.37 -36.92 79.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.23 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.91 76.54 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.672 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.503 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 62.9 mtt -61.84 -37.23 83.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.93 -61.75 5.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.41 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 39.4 t80 -61.61 -36.05 79.62 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.753 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.61 -42.91 58.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.1 p -66.65 -27.29 67.55 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.705 0.288 . . . . 0.0 110.409 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 49.9 t80 -55.5 -49.86 71.45 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.445 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.7 mt -66.25 -37.33 79.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.668 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.7 t -53.88 -48.03 63.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.448 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.6 p90 -73.23 -30.74 63.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.235 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 65.6 mmtt -58.36 -38.56 77.48 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.204 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.26 -40.91 94.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.8 mt -73.27 -25.77 60.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.772 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 104.77 39.12 2.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.15 -166.55 28.52 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.662 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.13 112.05 19.47 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.16 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.2 t -129.94 165.77 21.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.589 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -52.85 -37.87 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.471 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 75' ' ' THR . 85.3 m-20 -64.28 -38.92 92.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.868 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.4 -32.29 73.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.662 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 81.6 mmm -59.74 -33.74 72.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.974 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.4 -57.6 23.92 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.66 -50.85 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 120.61 0.874 . . . . 0.0 112.335 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.0 mp -65.06 -41.16 95.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.109 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.66 -39.23 97.65 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.94 -38.38 78.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 110.112 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' OH ' ' SD ' ' A' ' 60' ' ' MET . 86.8 t80 -59.36 -45.17 92.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.144 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.7 m -69.15 -41.89 76.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.45 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.19 -54.41 6.96 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.548 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -57.98 -41.41 82.93 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.299 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.54 -37.29 85.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.835 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.93 -47.79 81.72 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.711 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.7 mt -63.36 -36.53 84.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -57.85 -40.96 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.924 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -66.01 -32.68 74.29 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.95 -34.76 78.17 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.594 ' CD1' HD11 ' A' ' 113' ' ' LEU . 3.8 t-105 -57.84 -50.68 86.73 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 47.9 Cg_exo -42.79 82.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.403 1.402 . . . . 0.0 112.549 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 95' ' ' TRP . 72.3 Cg_endo -62.35 -25.45 76.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 120.574 0.849 . . . . 0.0 111.601 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.801 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.0 pt -59.91 -33.73 53.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -46.61 64.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.785 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.89 -50.48 66.37 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.826 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.33 -53.1 0.47 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.801 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 57.14 3.53 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 0.0 110.797 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 101' ' ' GLY . 12.6 tpt180 -53.12 -34.96 59.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -92.0 145.33 24.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.329 0.585 . . . . 0.0 111.503 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.637 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.3 ttp -65.31 -14.36 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.343 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.03 38.56 0.01 OUTLIER Glycine 0 CA--C 1.54 1.628 0 O-C-N 123.077 0.236 . . . . 0.0 112.952 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.694 ' HA ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.16 -18.94 65.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.672 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -41.5 -21.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.756 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 107' ' ' TRP . 89.2 mt -57.2 -39.47 75.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.503 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -67.81 -39.04 84.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.124 0.488 . . . . 0.0 109.942 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 49.6 t0 -60.92 -45.18 95.67 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.1 tp -65.71 -48.99 70.11 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.46 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.594 HD11 ' CD1' ' A' ' 95' ' ' TRP . 85.0 mt -69.08 -40.34 78.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.417 0.627 . . . . 0.0 110.459 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.793 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.1 tp -51.75 -60.25 3.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.154 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.514 ' HA ' HD13 ' A' ' 144' ' ' LEU . 97.5 t -69.11 -63.14 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.672 -1.149 . . . . 0.0 112.754 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -71.63 -40.32 69.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -61.36 -51.29 58.92 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.534 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 114' ' ' LEU . 3.7 p -65.83 -37.04 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.174 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.78 -51.43 9.78 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.8 m -59.49 -45.28 92.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.86 -46.28 68.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.37 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.476 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.3 m -64.33 -39.07 93.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.156 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 127' ' ' HIS . 89.9 m -59.62 -52.96 63.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 0.0 112.296 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.597 ' O ' ' NE ' ' A' ' 128' ' ' ARG . 65.9 mt -59.34 -31.2 68.97 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.991 0.425 . . . . 0.0 110.362 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.87 -63.17 1.47 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.493 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 33.8 m0 -86.5 -52.21 5.71 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.603 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 0.5 OUTLIER -52.63 -47.15 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.597 ' NE ' ' O ' ' A' ' 124' ' ' LEU . 68.2 mtm180 -63.5 -40.83 98.1 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.3 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.8 t -74.36 -43.41 49.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.372 . . . . 0.0 111.124 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.8 p -140.33 94.87 8.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.875 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.457 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 50.3 Cg_exo -54.08 -39.94 83.59 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.948 1.765 . . . . 0.0 113.775 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 31.5 Cg_exo -55.7 -26.21 54.98 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.338 0.692 . . . . 0.0 112.87 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.54 -31.24 71.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.668 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.603 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -61.38 -40.15 93.28 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.441 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.537 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 51.9 ttp180 -59.77 -38.16 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.3 tp -58.7 -38.83 79.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.203 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 139' ' ' PRO . 22.0 mt -56.04 -29.62 60.7 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.065 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.9 OUTLIER 9.28 -74.41 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.533 ' N ' ' O ' ' A' ' 137' ' ' LEU . 17.6 Cg_endo -52.32 -29.12 37.37 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 120.436 0.758 . . . . 0.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -57.92 -42.34 84.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.987 0.423 . . . . 0.0 109.977 -179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 42.7 tp -63.34 -39.56 94.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.962 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.54 -43.63 96.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.006 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.663 ' CD1' HD12 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -67.09 -47.93 69.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.234 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 115' ' ' VAL . 44.5 mt -65.25 -33.74 76.71 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.801 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.89 77.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.368 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.795 ' CE2' HD22 ' A' ' 150' ' ' LEU . 16.0 t80 -63.32 -42.02 98.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.646 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.793 HG21 ' CD2' ' A' ' 114' ' ' LEU . 3.0 m -57.6 -43.74 84.89 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.516 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.7 m -60.18 -49.61 76.94 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.705 0.288 . . . . 0.0 111.604 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.44 -40.58 84.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.54 0.686 . . . . 0.0 109.757 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.795 HD22 ' CE2' ' A' ' 146' ' ' PHE . 63.8 tp -57.79 -42.98 85.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.729 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 147' ' ' THR . 17.1 m120 -63.48 -41.24 98.58 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.475 ' CD1' ' NH1' ' A' ' 161' ' ' ARG . 57.5 m-85 -66.04 -40.32 90.9 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -61.52 -40.9 96.32 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.811 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -67.6 -47.66 79.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.672 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 5.3 m0 -62.15 -39.23 91.91 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -54.81 -31.1 58.75 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.446 -0.501 . . . . 0.0 111.215 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -54.49 -40.86 68.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.651 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -103.8 -60.91 1.5 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.675 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 155' ' ' TRP . 49.2 m -120.78 143.46 48.82 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.875 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.04 -174.31 50.29 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.475 ' NH1' ' CD1' ' A' ' 152' ' ' TYR . 95.4 mtt-85 -59.99 148.28 35.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 111.035 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -57.61 -33.85 68.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.571 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -54.95 -33.49 56.96 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.451 ' O ' HD22 ' A' ' 167' ' ' LEU . . . 77.65 28.94 56.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.7 p -60.5 -28.21 68.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.699 0.285 . . . . 0.0 110.671 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -54.92 -37.48 66.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.005 0.431 . . . . 0.0 110.64 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -61.19 -34.19 74.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.554 179.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.53 -49.17 74.55 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.155 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 . . . . . 0 N--CA 1.445 -0.72 0 CA-C-O 117.93 -1.034 . . . . 0.0 111.065 178.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.589 ' C22' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 120.56 0.219 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -56.82 -16.94 21.57 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.653 1.569 . . . . 0.0 111.863 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' O ' ' CD ' ' A' ' 7' ' ' PRO . 84.8 tt0 -51.23 -27.67 9.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.018 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.6 m -58.59 -39.47 80.45 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' HE1' ' N ' ' A' ' 74' ' ' PHE . 5.0 m-90 -74.54 -36.98 63.14 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -42.45 -41.97 6.14 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.486 ' O ' HD13 ' A' ' 11' ' ' LEU . 76.6 Cg_exo -54.87 -21.35 25.77 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.445 1.43 . . . . 0.0 112.617 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.09 -40.94 59.57 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.797 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 12' ' ' THR . 93.9 t -63.37 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.74 -34.44 89.91 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.277 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.1 mp -56.55 -42.63 78.85 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.941 -0.303 . . . . 0.0 110.871 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 9' ' ' VAL . 4.0 t -76.03 -36.55 59.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.822 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.98 -38.17 90.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -53.87 -42.23 91.85 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -56.47 -36.36 97.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 120.953 1.102 . . . . 0.0 112.846 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 t -61.25 -37.88 84.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.712 0.291 . . . . 0.0 111.149 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.6 mt -62.35 -39.11 92.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.252 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.82 -52.58 28.22 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.76 -38.27 95.66 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -57.33 -44.78 84.52 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.279 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.08 -38.92 90.66 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.375 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.72 -46.27 76.93 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.504 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.476 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.99 -24.08 62.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.006 0.431 . . . . 0.0 110.826 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.74 -34.92 70.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.54 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 54.3 t80 -60.71 -49.05 79.06 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -75.62 -33.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.625 0.726 . . . . 0.0 110.156 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -61.01 -40.79 94.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.817 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.06 -125.83 2.67 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.032 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.87 -28.8 62.26 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 111.209 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.4 -33.97 12.58 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 94.1 mt -48.78 -44.33 38.82 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.663 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.09 -42.45 99.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.341 -0.543 . . . . 0.0 109.976 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -62.31 -38.14 88.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.843 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.607 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.1 m-85 -63.78 -22.75 67.07 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.224 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.19 -41.41 27.06 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 119.732 -0.787 . . . . 0.0 108.973 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.99 -32.25 76.73 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.8 mt -88.93 149.51 23.28 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.451 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.439 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.0 mt-30 -101.96 130.17 48.41 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.079 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.59 ' HZ1' ' HE ' ' A' ' 46' ' ' ARG . 16.1 mtpt -108.99 141.5 23.51 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 27.6 Cg_endo -58.98 135.93 69.95 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.387 1.391 . . . . 0.0 111.944 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 84.9 p -71.94 -21.29 61.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.312 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.525 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 4.5 p90 -77.95 -14.8 59.41 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.608 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.66 148.49 92.74 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.948 -178.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -80.14 162.34 23.07 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.202 1.935 . . . . 0.0 111.424 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.2 Cg_endo -52.47 149.49 23.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.768 1.645 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HE ' ' HZ1' ' A' ' 39' ' ' LYS . 39.2 mtt85 -57.19 -37.96 72.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 48' ' ' THR . 5.0 p90 -63.98 -28.21 69.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.941 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 25.0 m -66.12 -61.21 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.117 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.993 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.2 mt -72.22 -34.78 68.61 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.588 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -38.33 -49.35 3.44 Favored Pre-proline 0 C--N 1.321 -0.634 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.938 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.4 Cg_endo -73.19 4.67 3.61 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 122.113 1.875 . . . . 0.0 114.134 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.993 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.5 pt -42.07 -40.17 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.637 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.6 m95 -50.7 -32.32 19.02 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.333 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.1 -40.69 95.95 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.0 m -67.98 -50.97 52.51 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 111.352 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -67.61 -33.12 74.35 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.238 0.542 . . . . 0.0 109.897 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.3 t80 -52.67 -49.43 65.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.809 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.2 p -70.41 -36.55 74.1 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.684 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.403 ' C ' HD11 ' A' ' 136' ' ' LEU . . . -67.33 -40.88 85.96 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.781 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 62.8 mtt -61.48 -39.37 90.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.095 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -61.99 -49.3 76.81 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -64.05 -39.16 93.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -55.82 -42.09 85.01 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 119.81 -1.186 . . . . 0.0 110.472 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.9 p -64.27 -29.27 70.37 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.76 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.401 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 50.6 t80 -58.78 -40.13 83.05 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.218 0.532 . . . . 0.0 110.169 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.38 -39.55 71.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.539 0.685 . . . . 0.0 109.865 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.567 HG22 ' OG ' ' A' ' 130' ' ' SER . 61.4 t -65.42 -54.08 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.55 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.46 ' NE1' ' HG2' ' A' ' 69' ' ' LYS . 0.7 OUTLIER -66.37 -35.75 81.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG2' ' NE1' ' A' ' 68' ' ' TRP . 22.0 mmtp -61.4 -39.49 90.92 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.495 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -63.32 -40.07 96.3 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.334 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 71' ' ' LEU . 77.3 mt -74.73 -25.49 59.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.736 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.74 49.26 2.35 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.449 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.39 -158.64 24.64 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.633 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -92.18 109.13 20.49 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.482 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.548 ' CG2' ' OD1' ' A' ' 77' ' ' ASP . 6.3 t -131.68 167.37 19.58 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -49.91 -38.36 35.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.664 ' OD1' ' N ' ' A' ' 78' ' ' ALA . 35.6 p30 -66.45 -32.87 74.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.974 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.664 ' N ' ' OD1' ' A' ' 77' ' ' ASP . . . -76.61 -30.69 57.03 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.633 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 88.1 mmm -59.04 -34.9 72.46 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.23 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.0 t -64.08 -58.13 15.59 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.406 ' CA ' ' HB1' ' A' ' 125' ' ' ALA . 13.3 Cg_endo -59.37 -56.5 1.28 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 121.461 1.441 . . . . 0.0 113.117 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.3 mp -64.14 -43.07 96.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.947 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.78 -39.85 97.86 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.868 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -57.33 -39.8 76.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.083 0.468 . . . . 0.0 110.203 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -61.12 -43.98 98.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.042 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.3 m -68.42 -42.93 78.21 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -61.2 2.97 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.005 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -55.6 -41.09 72.93 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.398 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.22 -38.82 92.67 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.841 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.43 69.38 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.094 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -61.1 -38.54 86.66 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.918 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.436 ' OD1' HD12 ' A' ' 113' ' ' LEU . 42.8 t-20 -60.65 -42.13 96.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.76 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -58.14 -31.71 67.46 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.619 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.5 70.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.374 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 97' ' ' PRO . 21.2 t-105 -54.3 -54.3 49.54 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' CD ' HD13 ' A' ' 113' ' ' LEU . 86.8 Cg_exo -40.37 79.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.678 1.586 . . . . 0.0 113.28 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.601 ' N ' ' O ' ' A' ' 95' ' ' TRP . 57.3 Cg_endo -61.0 -21.3 71.06 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 120.818 1.012 . . . . 0.0 110.525 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.871 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.0 pt -62.41 -23.96 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.175 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 0.7 OUTLIER -54.49 -46.88 73.51 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.027 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 69.3 t80 -64.33 -50.2 68.72 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.17 0.42 Allowed Glycine 0 N--CA 1.466 0.677 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.676 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.98 -2.3 0.2 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.567 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.0 ttt180 -53.92 -35.08 61.3 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -86.58 157.02 19.82 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.244 0.545 . . . . 0.0 111.455 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.696 ' O ' ' N ' ' A' ' 107' ' ' TRP . 21.7 ttm -56.26 -14.07 2.58 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.584 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.31 -1.37 0.01 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 121.569 -0.348 . . . . 0.0 113.368 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.696 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.92 -20.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.081 -0.658 . . . . 0.0 111.08 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.555 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.49 -27.45 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.739 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.98 -33.88 73.92 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.463 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.546 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.18 -37.14 84.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.544 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.9 t0 -63.11 -50.43 70.53 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 30.6 tp -63.59 -46.38 86.08 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.498 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.764 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -67.6 -42.16 82.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.359 0.599 . . . . 0.0 110.35 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.684 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.6 tp -50.02 -59.51 3.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.489 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.519 ' HA ' HD13 ' A' ' 144' ' ' LEU . 60.3 t -70.69 -63.19 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.04 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.411 ' O ' ' OG1' ' A' ' 120' ' ' THR . 42.3 t -66.1 -38.97 89.55 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 -178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.4 -55.87 26.63 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.963 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -65.21 -39.07 84.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.741 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.72 -45.18 53.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 116' ' ' SER . 62.3 m -60.56 -42.27 96.24 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.7 -53.82 16.76 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.155 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.457 HG23 ' CE3' ' A' ' 126' ' ' TRP . 49.0 m -64.36 -41.18 96.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 65.5 m -59.2 -45.68 90.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.7 -37.22 85.86 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB1' ' CA ' ' A' ' 81' ' ' PRO . . . -83.01 -64.22 1.21 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.457 ' CE3' HG23 ' A' ' 122' ' ' THR . 41.1 m0 -66.54 -42.16 87.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 50.6 t-80 -58.33 -48.08 81.68 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.698 -177.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -62.43 -43.18 99.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.33 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -72.57 -43.57 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 0.0 111.448 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.567 ' OG ' HG22 ' A' ' 67' ' ' VAL . 1.3 p -145.84 106.23 4.25 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.666 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.493 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.0 Cg_exo -56.58 -38.2 95.98 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.371 1.38 . . . . 0.0 112.985 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 52.8 Cg_exo -55.16 -27.46 56.26 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 120.484 0.789 . . . . 0.0 112.446 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 136' ' ' LEU . . . -60.84 -24.48 65.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.516 0.674 . . . . 0.0 109.296 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.49 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -64.67 -43.64 92.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.37 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.439 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.6 mtt85 -66.28 -37.44 85.45 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.548 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.834 ' C ' HD13 ' A' ' 136' ' ' LEU . 1.1 tm? -49.23 -43.16 42.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.401 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.503 ' O ' ' C ' ' A' ' 138' ' ' TYR . 60.2 mt -60.84 -29.02 69.25 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.503 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 2.82 -76.2 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -53.08 -25.57 29.42 Favored 'Trans proline' 0 N--CA 1.509 2.423 0 CA-C-N 119.384 0.816 . . . . 0.0 113.278 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -56.61 -38.41 72.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -178.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 34.0 tp -65.17 -40.36 94.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.16 -43.79 94.09 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.647 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -65.3 -50.81 64.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.114 179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.519 HD13 ' HA ' ' A' ' 115' ' ' VAL . 43.8 mt -64.51 -34.1 77.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.44 -41.32 93.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.079 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.723 ' CE2' HD22 ' A' ' 150' ' ' LEU . 21.4 t80 -62.72 -42.2 99.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.624 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.684 HG21 ' CD2' ' A' ' 114' ' ' LEU . 53.2 p -60.28 -38.0 82.25 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.585 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 46.5 m -59.6 -50.99 71.75 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.1 t -69.94 -44.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.215 0.531 . . . . 0.0 110.85 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.723 HD22 ' CE2' ' A' ' 146' ' ' PHE . 62.2 tp -58.09 -40.68 81.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.321 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 147' ' ' THR . 43.2 m-80 -63.96 -40.03 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -61.94 -44.29 97.08 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.325 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -64.22 -40.04 95.22 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.076 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.82 -48.99 61.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.516 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -62.59 -40.23 96.26 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.65 -178.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 159' ' ' SER . 39.1 mtm180 -60.03 -23.58 63.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.291 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 88.1 m-20 -53.63 -42.38 67.71 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.142 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -102.41 -41.4 6.33 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.535 ' O ' ' O ' ' A' ' 156' ' ' ARG . 50.4 p -84.59 172.63 11.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.112 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.02 2.87 62.22 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -55.69 -32.98 63.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.366 . . . . 0.0 110.358 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -55.01 -33.38 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.187 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.43 -31.81 44.05 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' O ' HD22 ' A' ' 167' ' ' LEU . . . -54.11 -28.97 43.25 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.2 p -58.94 -25.29 63.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.754 0.311 . . . . 0.0 110.407 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -54.02 -38.35 65.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -64.07 -33.43 75.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.994 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' O ' ' OXT' ' A' ' 169' ' ' GLU . . . -74.33 157.91 34.92 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.194 0.521 . . . . 0.0 110.635 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' OXT' ' O ' ' A' ' 168' ' ' ALA . 95.4 mt-10 . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.606 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.588 ' C23' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 mtp . . . . . 0 C--O 1.233 0.188 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -55.61 -16.88 15.74 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.982 1.788 . . . . 0.0 111.915 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.22 -34.21 31.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.61 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.2 m -61.89 -40.41 95.33 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.609 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.588 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 14.5 m0 -73.64 -31.14 63.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.739 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.41 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t -40.64 -52.52 6.27 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.543 -178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -58.05 -28.06 81.96 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 CA-C-N 119.01 0.682 . . . . 0.0 111.052 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 5' ' ' TRP . . . -56.44 -30.92 63.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.636 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.11 -42.4 86.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.25 -36.26 93.18 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.685 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mp -56.27 -44.21 79.54 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.609 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -79.33 -30.51 42.77 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.258 -0.577 . . . . 0.0 112.107 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.85 -37.02 85.07 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 t -52.32 -56.6 20.8 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.2 Cg_endo -58.95 -33.36 98.68 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 CA-C-N 119.076 0.706 . . . . 0.0 112.72 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -60.23 -39.41 86.55 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.303 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.3 -37.66 88.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.232 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -64.49 -53.37 35.99 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.21 -37.94 95.23 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.0 -45.9 89.52 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.567 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.3 mtm -62.91 -37.22 86.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.281 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.94 -40.94 98.77 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.124 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.24 -28.07 64.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.924 0.392 . . . . 0.0 110.752 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.93 -34.22 69.64 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.601 -0.44 . . . . 0.0 109.98 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.47 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 86.8 t80 -62.53 -46.75 86.96 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.216 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -74.09 -33.2 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.83 0.824 . . . . 0.0 109.766 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -59.35 -40.39 86.24 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.052 -1.431 . . . . 0.0 113.019 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.8 -130.6 4.64 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.808 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -51.55 -28.05 12.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.071 0.462 . . . . 0.0 110.85 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.33 -32.99 15.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD21 ' HE ' ' A' ' 46' ' ' ARG . 95.3 mt -51.35 -43.21 61.74 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.848 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -62.64 -42.19 99.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.391 0.615 . . . . 0.0 110.618 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.8 t-105 -59.79 -40.44 88.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.662 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' NZ ' ' A' ' 39' ' ' LYS . 44.3 m-85 -66.08 -22.64 66.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.745 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.95 -41.65 16.47 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.443 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.74 -32.2 83.36 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.4 mt -93.63 149.16 21.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.286 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.585 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.8 mt-30 -99.21 122.21 42.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.87 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.699 ' NZ ' ' CD1' ' A' ' 34' ' ' TYR . 22.4 mttp -94.5 141.0 22.89 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HG3' HD12 ' A' ' 150' ' ' LEU . 55.2 Cg_endo -57.25 144.85 89.71 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.557 1.504 . . . . 0.0 113.069 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.5 m -61.58 -32.42 72.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.918 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.421 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 20.2 p90 -76.87 2.08 15.63 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.583 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.699 ' CE1' ' NH1' ' A' ' 46' ' ' ARG . 8.4 t-80 -62.7 140.16 97.06 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 71.7 Cg_endo -101.14 169.86 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.111 1.207 . . . . 0.0 112.461 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 50.4 Cg_exo -52.3 147.97 26.85 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.653 2.235 . . . . 0.0 112.209 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.699 ' NH1' ' CE1' ' A' ' 43' ' ' HIS . 80.0 mmt-85 -58.33 -37.58 75.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.402 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 25.7 p90 -81.21 -7.77 59.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 49' ' ' LEU . 16.1 m -74.3 -76.18 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.599 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.99 ' O ' HG23 ' A' ' 52' ' ' ILE . 77.6 mt -66.09 -32.73 74.36 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.653 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.0 -43.45 4.57 Favored Pre-proline 0 C--N 1.324 -0.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.63 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 53.8 Cg_exo -63.61 -7.2 12.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.929 2.419 . . . . 0.0 113.714 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.99 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.5 pt -42.44 -41.46 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.444 ' N ' HG13 ' A' ' 52' ' ' ILE . 97.9 m95 -53.91 -33.79 57.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.442 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.17 -39.64 94.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -69.38 -52.8 23.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.754 0.311 . . . . 0.0 111.44 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.1 mp -66.48 -33.68 76.22 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.179 0.514 . . . . 0.0 110.423 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 23.8 t80 -49.37 -59.55 3.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.287 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 m -65.01 -38.05 89.66 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.21 -40.81 95.38 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.701 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -63.16 -37.73 88.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.687 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.24 -58.66 8.39 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -61.67 -37.44 84.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.837 0.351 . . . . 0.0 110.491 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.86 -41.45 67.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 85.3 p -66.64 -27.95 68.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.37 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -55.82 -45.92 78.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.668 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 91.9 mt -61.14 -44.19 97.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.6 t -64.75 -37.04 79.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.739 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.612 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.96 -40.81 96.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 58.4 mttt -65.2 -41.71 94.27 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.335 -0.546 . . . . 0.0 112.465 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 87.3 mt-10 -70.15 -37.93 75.34 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . 58.7 mt -92.2 -0.54 57.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.6 5.21 67.07 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 90.52 -167.18 32.24 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -59.3 82.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.212 0.53 . . . . 0.0 111.065 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.0 t -133.12 160.84 36.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.664 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -41.95 -40.48 2.19 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.323 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 75' ' ' THR . 87.1 m-20 -66.88 -44.12 81.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.539 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 73' ' ' GLY . . . -77.67 -33.24 53.42 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 83' ' ' GLY . 87.8 mtp -57.87 -33.7 68.96 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.156 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.01 -50.17 89.56 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.305 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.7 -52.31 1.05 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 120.495 0.797 . . . . 0.0 111.948 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.4 mp -62.44 -42.48 99.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.319 0.581 . . . . 0.0 109.507 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -62.86 -38.66 96.91 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.6 tt -58.38 -38.03 76.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.149 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CE1' ' OG1' ' A' ' 122' ' ' THR . 88.5 t80 -60.4 -44.45 95.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.1 m -65.88 -41.29 91.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.507 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -67.86 -54.22 19.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.819 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -59.79 -39.88 86.42 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.635 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' A' ' 15' ' ' PRO . 22.7 tp -58.79 -37.99 77.56 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.178 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.08 -44.42 88.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 0.0 111.199 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -58.66 -39.95 82.1 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.507 HD22 ' CA ' ' A' ' 117' ' ' GLY . 50.8 t-20 -64.48 -35.96 82.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.693 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.557 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 1.7 m95 -56.17 -31.86 63.78 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.316 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.01 -16.39 62.06 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.567 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 10.6 t-105 -70.32 -52.81 11.29 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 27.4 Cg_endo -55.86 131.11 44.05 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.864 1.709 . . . . 0.0 113.309 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 41.3 Cg_endo -107.97 -28.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 120.841 1.028 . . . . 0.0 111.382 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.754 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 28.8 pt -56.58 -30.33 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.367 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 15.6 p90 -54.12 -42.29 69.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.014 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.526 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.9 t80 -63.53 -51.29 66.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.763 0.315 . . . . 0.0 111.532 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -114.11 -54.53 0.42 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.86 -1.0 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 101' ' ' GLY . 25.7 tpt180 -54.36 -33.72 59.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.847 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -81.77 151.36 27.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.318 0.58 . . . . 0.0 111.958 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.598 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ppp? -65.58 -14.41 61.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.741 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.37 32.74 0.02 OUTLIER Glycine 0 CA--C 1.538 1.496 0 O-C-N 123.131 0.269 . . . . 0.0 112.924 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.598 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.49 -21.26 62.21 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.596 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -50.1 -23.73 2.29 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.773 0.32 . . . . 0.0 111.813 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.11 -32.14 70.71 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.379 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.669 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.61 -45.52 93.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.141 0.495 . . . . 0.0 109.948 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.565 ' CB ' ' OD1' ' A' ' 151' ' ' ASN . 37.3 t0 -63.44 -44.03 95.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.903 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.7 tp -60.73 -40.05 90.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.148 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.756 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.4 tt -66.63 -48.25 70.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 113' ' ' LEU . 2.6 pp -75.31 -34.05 61.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.796 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 111' ' ' ASP . 45.3 t -63.63 -45.98 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.777 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.6 t -85.8 -41.45 15.03 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.507 ' CA ' HD22 ' A' ' 92' ' ' ASN . . . -56.56 -47.1 86.66 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.573 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.2 -46.22 45.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.568 0.223 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -71.71 -57.97 3.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 38.1 m -58.04 -43.12 86.64 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.5 -59.42 2.86 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.011 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 34.4 m -64.64 -41.59 96.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.796 HG23 ' ND1' ' A' ' 127' ' ' HIS . 55.8 m -59.46 -47.73 84.38 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.412 HD22 HH21 ' A' ' 128' ' ' ARG . 88.9 mt -66.09 -34.55 78.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.44 -63.7 1.36 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.477 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.2 m0 -66.78 -43.95 82.59 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -177.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.796 ' ND1' HG23 ' A' ' 123' ' ' THR . 22.3 m170 -59.87 -45.32 92.84 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.931 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.412 HH21 HD22 ' A' ' 124' ' ' LEU . 96.7 mtt-85 -61.96 -44.4 96.83 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.354 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.497 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 77.1 t -76.85 -47.35 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.418 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.0 p -134.58 91.26 21.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.073 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.461 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.7 Cg_exo -52.4 -40.53 70.86 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.607 1.538 . . . . 0.0 112.975 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 37.6 Cg_exo -57.63 -29.18 84.38 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 120.591 0.861 . . . . 0.0 112.857 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.44 -32.3 71.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.202 0.525 . . . . 0.0 110.5 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.15 -36.55 77.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -59.64 -39.23 83.67 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.366 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 tp -57.7 -39.76 77.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.007 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 140' ' ' TYR . 82.7 mt -59.52 -27.09 65.88 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.973 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -6.2 -64.32 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.453 ' N ' ' O ' ' A' ' 137' ' ' LEU . 11.9 Cg_endo -54.05 -30.2 58.64 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 CA-C-N 119.523 0.865 . . . . 0.0 112.898 -178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.601 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -56.45 -47.02 80.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 41.2 tp -60.58 -39.76 89.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.293 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.08 -40.21 96.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.581 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -70.0 -50.22 43.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.893 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.459 HD22 ' HA ' ' A' ' 115' ' ' VAL . 24.0 mt -65.38 -34.06 77.42 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.523 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.11 -47.54 84.14 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.907 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.836 ' CE2' HD22 ' A' ' 150' ' ' LEU . 32.1 t80 -64.18 -43.69 94.34 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.345 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.568 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.2 m -56.14 -43.99 78.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.951 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 48.9 m -64.79 -48.37 74.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.775 0.322 . . . . 0.0 111.564 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.26 -41.74 86.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.836 HD22 ' CE2' ' A' ' 146' ' ' PHE . 56.6 tp -57.9 -41.15 81.99 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.974 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.565 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.5 m120 -62.09 -41.35 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -64.14 -42.37 96.82 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.818 0.674 . . . . 0.0 112.818 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -58.63 -45.21 89.75 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.683 -0.807 . . . . 0.0 111.062 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.97 -46.01 82.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.6 m0 -61.78 -40.03 93.73 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.78 -29.98 65.29 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.229 -0.589 . . . . 0.0 111.471 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 86.9 m-20 -50.71 -39.8 52.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -103.11 -58.31 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.228 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 87.0 p -62.66 -27.92 69.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.224 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.83 -30.26 36.0 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -55.51 -34.84 64.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.813 0.339 . . . . 0.0 110.397 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -57.29 -31.79 65.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.668 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.01 -32.41 42.18 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -84.65 -177.44 51.14 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 48.3 m -118.81 147.77 43.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 110.627 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 168' ' ' ALA . 91.8 mtt180 -124.45 137.37 54.45 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.196 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 166' ' ' ARG . 13.3 mt 33.02 -81.5 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.91 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 166' ' ' ARG . . . -143.09 149.63 38.42 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 110.142 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.645 179.91 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.548 ' C22' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.52 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 110.647 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 1' ' ' MET . 48.2 Cg_endo -55.61 -22.84 37.37 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.366 2.044 . . . . 0.0 111.962 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.22 -33.94 71.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.606 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.2 m -62.82 -40.31 97.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.039 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.66 ' CD1' ' CE3' ' A' ' 68' ' ' TRP . 1.4 t90 -72.59 -33.96 67.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.69 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 t -41.5 -41.54 3.95 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.692 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.543 ' O ' HD13 ' A' ' 11' ' ' LEU . 86.0 Cg_exo -53.91 -21.7 21.73 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 120.841 1.027 . . . . 0.0 111.921 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.17 -35.96 62.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.933 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.8 t -62.48 -43.32 98.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.64 -33.37 85.96 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.378 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.8 mp -56.13 -43.2 77.98 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.136 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -37.95 35.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.836 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 57' ' ' TYR . 83.1 mt -62.3 -37.61 86.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -52.67 -43.43 92.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.819 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -57.17 -33.26 95.58 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.167 1.245 . . . . 0.0 113.176 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 83.6 p -62.19 -35.46 78.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.93 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.12 -39.64 93.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.078 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.55 -42.1 97.58 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.36 -43.1 97.63 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.91 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 55.5 m-85 -61.99 -41.21 97.78 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.539 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.6 mtt -62.68 -40.29 96.62 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.765 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.42 -47.87 11.81 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.586 ' HB1' ' NH2' ' A' ' 46' ' ' ARG . . . -69.31 -23.37 63.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.209 0.528 . . . . 0.0 110.441 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -51.62 -38.95 57.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.032 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.558 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 58.1 t80 -62.69 -48.79 77.75 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -32.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.55 0.69 . . . . 0.0 109.967 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.494 ' CB ' ' HE ' ' A' ' 46' ' ' ARG . 13.9 ttt-85 -62.4 -41.44 98.67 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.023 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -131.22 2.64 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.132 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.8 -26.99 48.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.618 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.6 -35.49 11.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.4 mt -49.14 -44.64 42.75 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.962 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -61.0 -39.34 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.938 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -58.68 -37.07 75.24 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.349 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.589 ' O ' ' N ' ' A' ' 37' ' ' LEU . 55.8 m-85 -61.02 -22.8 64.9 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.7 -40.57 6.05 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.059 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.47 -31.8 71.28 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 34' ' ' TYR . 56.9 mt -92.79 148.16 22.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.903 0.382 . . . . 0.0 110.887 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -96.49 123.79 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.85 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -94.85 139.61 22.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 74.4 Cg_endo -58.84 147.06 90.73 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.501 1.467 . . . . 0.0 112.601 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -64.45 -29.42 70.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.09 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 39.4 p90 -78.32 2.7 17.66 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.492 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 57.8 t-80 -62.16 142.71 95.59 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.288 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.58 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 87.1 Cg_endo -107.74 172.55 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.336 1.357 . . . . 0.0 112.282 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.406 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 27.6 Cg_exo -54.41 148.14 43.79 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.87 2.38 . . . . 0.0 112.335 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.586 ' NH2' ' HB1' ' A' ' 23' ' ' ALA . 28.6 tpt85 -56.61 -39.28 73.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.406 ' CZ2' ' HB3' ' A' ' 45' ' ' PRO . 26.4 p90 -77.15 -9.12 58.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 m -75.57 -73.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.573 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.994 ' O ' HG23 ' A' ' 52' ' ' ILE . 92.1 mt -66.94 -32.72 74.16 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.694 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.38 -42.71 4.8 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.156 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 76.1 Cg_exo -63.79 -6.27 10.51 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.914 2.409 . . . . 0.0 113.387 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' O ' ' A' ' 49' ' ' LEU . 11.1 pt -41.24 -44.84 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.084 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.492 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 98.1 m95 -58.08 -34.0 69.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.089 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.26 -40.35 98.48 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 m -66.99 -53.26 33.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.101 0.477 . . . . 0.0 111.325 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.8 mp -67.82 -32.16 72.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.143 0.497 . . . . 0.0 110.076 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 3.0 t80 -52.34 -50.14 62.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.875 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -69.89 -36.62 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.29 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' O ' HD21 ' A' ' 136' ' ' LEU . . . -67.57 -43.46 80.58 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.046 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.5 mtt -60.63 -38.9 86.31 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.87 -52.64 40.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -61.4 -35.48 77.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.572 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.64 -46.02 59.54 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.435 ' CB ' HD21 ' A' ' 82' ' ' LEU . 97.4 p -63.26 -30.13 71.33 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.456 ' O ' ' CD1' ' A' ' 68' ' ' TRP . 46.7 t80 -55.01 -40.3 70.0 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 109.797 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.0 mt -69.51 -44.39 79.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG13 HG11 ' A' ' 129' ' ' VAL . 53.8 t -63.68 -51.89 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.66 ' CE3' ' CD1' ' A' ' 5' ' ' TRP . 0.6 OUTLIER -64.27 -33.07 74.97 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.838 -178.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.401 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 67.0 mmtt -60.64 -40.79 93.27 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.783 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -67.68 -34.05 76.14 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.143 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 78' ' ' ALA . 54.6 mt -85.5 -0.54 55.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.092 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.76 44.08 8.63 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 90.43 -154.43 23.43 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -87.25 110.71 20.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.517 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.1 t -133.95 168.63 18.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.893 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -52.27 -37.96 56.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.385 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.472 ' H ' HG23 ' A' ' 75' ' ' THR . 84.8 m-20 -62.22 -40.02 94.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.339 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 71' ' ' LEU . . . -67.49 -28.28 67.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.851 0.358 . . . . 0.0 111.377 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 mtt -58.82 -35.25 72.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.306 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.18 -47.65 98.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.457 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 16.2 Cg_endo -77.75 -63.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 120.735 0.957 . . . . 0.0 112.538 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' A' ' 64' ' ' SER . 20.7 mt -59.49 -41.71 90.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.431 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.32 -43.19 98.78 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.773 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.55 -38.11 74.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.156 0.503 . . . . 0.0 109.916 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -57.92 -43.94 86.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.588 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.98 -60.72 3.76 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.201 -0.523 . . . . 0.0 113.396 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.59 -40.06 74.63 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.56 -178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.6 tp -61.63 -40.39 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.224 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.96 78.52 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.48 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.14 -41.11 87.5 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.226 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.546 ' O ' HD11 ' A' ' 113' ' ' LEU . 41.3 t-20 -62.23 -39.91 94.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.568 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.8 m95 -59.46 -28.45 67.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.362 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.07 63.19 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 97' ' ' PRO . 8.7 t-105 -71.12 -55.7 6.14 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 51.5 Cg_endo -40.96 82.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.034 1.156 . . . . 0.0 112.317 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -59.33 -23.82 71.7 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.739 1.626 . . . . 0.0 112.459 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.645 HD11 ' HB2' ' A' ' 110' ' ' ALA . 35.5 pt -59.62 -30.02 43.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.402 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.3 p90 -44.85 -42.27 7.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.061 -0.655 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.493 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 57.7 t80 -66.62 -52.01 49.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.79 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.27 -68.69 0.48 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.737 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.558 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 65.58 5.07 3.07 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.807 0.337 . . . . 0.0 110.917 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -54.92 -35.55 64.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.13 0.49 . . . . 0.0 109.913 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -85.74 152.86 22.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.245 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.634 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.4 ttm -61.14 -14.97 28.55 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.975 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.7 21.59 0.01 OUTLIER Glycine 0 CA--C 1.543 1.79 0 C-N-CA 121.724 -0.274 . . . . 0.0 113.239 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.634 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.6 -19.82 41.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.409 0.605 . . . . 0.0 112.248 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.58 -22.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.446 -178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 107' ' ' TRP . 77.8 mt -59.63 -36.45 76.37 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.645 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -66.6 -40.25 88.77 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.33 0.586 . . . . 0.0 109.858 178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.489 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 48.6 t0 -60.57 -57.15 13.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.664 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 29.2 tp -64.97 -37.9 89.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.673 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.763 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.1 tt -64.46 -49.94 69.45 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 113' ' ' LEU . 3.2 pp -75.58 -35.21 60.66 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.065 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.516 ' HA ' HD22 ' A' ' 144' ' ' LEU . 55.7 t -66.6 -59.32 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 111.595 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -72.47 -40.48 66.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.474 ' HA3' HD22 ' A' ' 92' ' ' ASN . . . -58.54 -54.43 37.84 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.598 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.71 -35.69 75.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.504 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.509 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -75.46 -52.96 9.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.0 m -57.45 -43.04 83.65 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.66 -54.62 13.03 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.545 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.2 m -66.79 -40.01 87.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 91.2 m -59.36 -47.09 86.76 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 HH21 ' A' ' 128' ' ' ARG . 70.2 mt -72.83 -34.25 66.7 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.457 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -78.68 -64.16 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -64.56 -43.61 93.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.685 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 51.2 m170 -59.38 -44.7 92.72 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.022 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.489 HH21 HD22 ' A' ' 124' ' ' LEU . 98.5 mtt180 -61.58 -43.61 98.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.586 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.54 HG11 HG13 ' A' ' 67' ' ' VAL . 95.6 t -79.95 -46.68 22.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.557 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 96.0 p -133.58 88.53 33.76 Favored Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.48 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 34.7 Cg_exo -53.94 -41.01 78.55 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 121.766 1.644 . . . . 0.0 112.858 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 33.4 Cg_exo -56.44 -30.59 82.48 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 120.597 0.864 . . . . 0.0 112.786 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.79 68.81 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.409 0.623 . . . . 0.0 110.261 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.685 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -57.74 -39.25 76.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.421 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.508 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 93.2 mtt180 -63.28 -37.4 87.12 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.001 0.429 . . . . 0.0 110.533 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 59' ' ' ALA . 17.0 tp -54.28 -37.69 65.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.391 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 138' ' ' TYR . 85.1 mt -67.56 -3.16 7.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.147 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -26.97 -59.99 0.2 Allowed Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.89 -23.96 78.18 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.079 1.186 . . . . 0.0 113.802 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -55.47 -41.21 72.63 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.179 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 37.2 tp -63.47 -39.51 94.66 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.09 -43.17 93.02 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.669 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.708 ' CE2' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -66.44 -53.97 29.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.079 0.466 . . . . 0.0 110.614 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 115' ' ' VAL . 50.1 mt -63.85 -33.51 75.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -41.02 95.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.862 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.799 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 28.2 t80 -61.69 -40.27 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.29 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.59 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 81.4 p -59.93 -37.94 80.94 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.404 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.6 p -68.33 -47.2 68.14 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.087 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.84 -41.16 79.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.373 0.606 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.799 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 36.9 tp -60.3 -42.95 96.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.353 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.489 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.3 m120 -66.51 -36.65 83.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.23 0.538 . . . . 0.0 110.947 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.553 ' CE1' ' NE ' ' A' ' 156' ' ' ARG . 1.4 t80 -56.42 -48.17 77.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.104 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -67.28 -45.01 77.86 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.7 t -67.82 -47.76 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.2 m0 -61.1 -40.73 94.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.553 ' NE ' ' CE1' ' A' ' 152' ' ' TYR . 86.2 mtt-85 -59.39 -28.07 66.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.526 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -51.71 -40.63 60.49 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.202 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.47 ' OD1' ' NH2' ' A' ' 161' ' ' ARG . 41.0 t30 -105.28 -60.34 1.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.449 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.7 m -59.44 -35.05 73.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.767 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' A' ' 156' ' ' ARG . . . -52.69 -29.6 33.3 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.47 ' NH2' ' OD1' ' A' ' 158' ' ' ASN . 74.4 mtm180 -55.28 -34.18 63.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.296 . . . . 0.0 110.793 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 62.3 ttm-85 -56.11 -36.91 68.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.52 -127.14 19.74 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.17 -164.08 38.24 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.527 ' O ' ' O ' ' A' ' 168' ' ' ALA . 92.5 p -118.9 154.9 32.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.956 0.407 . . . . 0.0 110.661 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -58.28 -33.98 70.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.401 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.611 ' H ' HD22 ' A' ' 167' ' ' LEU . 1.0 OUTLIER -61.44 -36.51 80.56 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.481 -179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -149.36 145.69 27.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.917 0.389 . . . . 0.0 110.834 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.544 179.636 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.552 ' C23' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.592 ' SD ' ' N ' ' A' ' 1' ' ' MET . 7.0 mmm . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -56.28 -21.17 35.06 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.606 1.538 . . . . 0.0 111.616 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.51 -31.14 69.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.869 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 t -60.87 -43.21 98.73 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.351 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -75.08 -32.15 61.4 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 17.1 t -41.35 -50.34 8.78 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.3 Cg_endo -57.29 -18.25 29.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 120.44 0.76 . . . . 0.0 112.288 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.88 -34.26 58.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.3 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 12' ' ' THR . 60.8 t -59.93 -40.31 82.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.64 -36.9 93.36 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 11' ' ' LEU . 10.8 mp -58.52 -42.22 87.25 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.944 -0.303 . . . . 0.0 111.17 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 9' ' ' VAL . 6.6 t -74.95 -35.46 62.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.581 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.48 -34.9 78.1 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 10' ' ' GLY . 16.9 t -47.91 -56.6 12.9 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.0 Cg_endo -58.58 -34.44 98.84 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 120.797 0.998 . . . . 0.0 112.958 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 84.5 p -62.14 -37.56 85.62 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.403 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.17 -38.71 85.9 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.479 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' C ' ' CZ3' ' A' ' 93' ' ' TRP . . . -67.76 -54.23 19.66 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.815 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.671 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -59.86 -36.17 89.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.814 -0.515 . . . . 0.0 111.814 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -58.48 -45.03 89.52 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.435 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.5 mtt -63.45 -39.23 93.91 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-O 120.8 0.333 . . . . 0.0 111.189 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.95 -43.52 91.1 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -69.66 -26.07 64.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 110.816 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -57.78 -36.61 72.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.711 -179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 69.5 t80 -59.94 -49.67 76.78 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.4 m -73.6 -34.15 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.725 0.774 . . . . 0.0 109.929 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt85 -61.79 -42.0 98.45 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.783 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.45 -127.51 1.57 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.854 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.93 -27.61 61.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.708 0.29 . . . . 0.0 110.682 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.24 -34.81 13.37 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -50.79 -41.48 57.17 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.488 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -61.06 -43.46 98.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.366 0.603 . . . . 0.0 109.458 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -64.17 -40.2 95.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.518 ' O ' ' O ' ' A' ' 37' ' ' LEU . 15.4 m-85 -62.4 -22.74 66.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.11 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.6 -41.5 31.04 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.209 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.0 79.02 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 57.1 mt -90.87 148.57 22.4 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.587 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -100.82 128.88 46.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.887 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -106.5 145.56 31.27 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.946 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 24.0 Cg_endo -58.41 137.13 78.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.135 1.223 . . . . 0.0 111.691 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.3 p -66.03 -26.73 67.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.089 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.411 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 13.0 p90 -78.32 -4.19 46.75 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.685 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 3.4 t-80 -60.09 134.09 90.31 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.362 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 51.4 Cg_exo -75.03 167.23 27.48 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 121.092 1.195 . . . . 0.0 111.678 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 26.9 Cg_exo -53.88 149.22 34.66 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 121.948 1.765 . . . . 0.0 111.242 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -57.24 -36.08 70.48 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.208 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CZ2' ' HB3' ' A' ' 45' ' ' PRO . 22.5 p90 -76.81 -11.54 59.84 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -77.02 -72.43 0.35 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.799 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.03 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.9 mt -62.77 -35.59 80.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.158 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.646 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.58 -41.28 5.47 Favored Pre-proline 0 C--N 1.32 -0.689 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.002 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 66.1 Cg_exo -67.06 -2.21 7.55 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.917 2.411 . . . . 0.0 113.73 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.03 HG23 ' O ' ' A' ' 49' ' ' LEU . 20.1 pt -46.51 -34.57 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.732 0.301 . . . . 0.0 111.512 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.619 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 4.7 m-90 -54.07 -27.36 32.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.96 -43.7 94.83 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -72.99 -45.85 55.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.853 0.358 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.682 HD11 ' CD1' ' A' ' 143' ' ' TRP . 6.8 mt -66.03 -33.61 76.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.228 0.537 . . . . 0.0 109.877 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' TRP . 25.2 t80 -60.14 -50.05 75.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.913 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.7 p -74.79 -33.32 62.22 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.971 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.69 -46.18 83.48 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.638 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.8 mtt -63.93 -38.2 90.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.657 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.85 -61.41 5.58 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.13 -37.3 86.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.603 0.239 . . . . 0.0 111.256 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.22 -43.33 74.54 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.8 p -67.44 -26.0 66.18 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.475 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 68' ' ' TRP . 43.7 t80 -56.45 -50.16 72.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.163 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.3 mt -63.58 -41.72 93.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.841 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.583 HG22 ' OG ' ' A' ' 130' ' ' SER . 62.8 t -53.64 -48.32 59.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 65' ' ' TYR . 1.4 p90 -70.58 -31.52 68.56 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.966 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 67.8 mmtt -59.71 -37.92 80.21 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.761 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.513 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 81.0 mt-10 -68.15 -35.66 78.43 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.629 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.87 3.68 47.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.931 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.16 36.0 11.62 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.32 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 89.21 -174.85 42.42 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.61 84.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 73' ' ' GLY . 6.6 m -93.42 146.69 23.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.212 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -50.88 -37.96 46.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.596 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -65.25 -39.52 92.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.17 0.51 . . . . 0.0 109.671 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -30.5 71.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.601 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 73.4 mtp -58.49 -33.05 69.37 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.612 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 t -55.98 -57.9 19.3 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.791 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -61.7 -47.9 10.21 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 CA-C-N 119.023 0.687 . . . . 0.0 112.428 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -64.43 -42.89 95.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.221 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.0 -37.44 94.96 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.6 tp -57.03 -41.65 78.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.0 110.203 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 77.6 t80 -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.911 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.3 m -65.42 -42.72 92.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.674 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.51 -58.41 3.88 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.635 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -57.15 -41.67 79.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.577 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' A' ' 15' ' ' PRO . 36.2 tp -63.25 -38.1 89.84 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.135 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.88 -48.76 75.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.573 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.9 -39.13 88.13 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.589 ' OD1' HD13 ' A' ' 113' ' ' LEU . 43.6 t-20 -60.78 -38.3 84.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.475 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.671 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 50.2 m95 -62.07 -31.33 71.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.632 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.27 -31.8 73.14 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.686 ' CD1' HD11 ' A' ' 113' ' ' LEU . 4.0 t-105 -55.38 -50.69 85.31 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -41.05 80.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.684 1.589 . . . . 0.0 113.107 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.597 ' N ' ' O ' ' A' ' 95' ' ' TRP . 67.5 Cg_endo -63.04 -26.25 73.65 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 120.616 0.878 . . . . 0.0 111.143 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 107' ' ' TRP . 42.4 pt -63.82 -33.96 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.31 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -44.88 -41.09 6.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.808 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 64.8 t80 -67.18 -51.76 49.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.323 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.38 -65.83 0.44 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.307 -0.473 . . . . 0.0 112.572 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.512 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 64.84 5.19 2.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.879 0.371 . . . . 0.0 110.441 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -54.24 -34.26 60.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.953 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -90.12 153.61 20.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.477 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.662 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.8 ttm -61.95 -15.16 41.4 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.18 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -53.7 20.61 0.01 OUTLIER Glycine 0 CA--C 1.54 1.638 0 C-N-CA 121.526 -0.369 . . . . 0.0 113.345 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.662 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -60.05 -19.38 52.59 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.74 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -42.82 -20.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.937 0.398 . . . . 0.0 111.249 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' TRP . 83.8 mt -59.23 -38.91 81.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.03 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 114' ' ' LEU . . . -66.12 -38.44 88.21 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.372 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.456 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 59.4 t0 -60.66 -45.88 92.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.8 tp -68.96 -47.49 65.51 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.732 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.686 HD11 ' CD1' ' A' ' 95' ' ' TRP . 76.8 mt -67.78 -38.9 83.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.421 0.629 . . . . 0.0 109.909 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.707 HD21 HG21 ' A' ' 147' ' ' THR . 19.7 tp -52.93 -61.51 2.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.282 179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 144' ' ' LEU . 74.0 t -69.78 -63.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.765 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' ' 120' ' ' THR . 36.4 t -69.71 -40.78 76.08 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.02 -51.52 56.36 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.702 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 114' ' ' LEU . 3.6 p -66.2 -37.36 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.386 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.504 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -78.47 -49.71 12.94 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 116' ' ' SER . 38.1 m -55.44 -42.23 73.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.58 -54.37 12.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.623 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.5 m -65.78 -39.22 90.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.17 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.745 HG23 ' ND1' ' A' ' 127' ' ' HIS . 85.9 m -58.96 -47.47 84.99 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.91 -34.63 77.0 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.17 -63.37 1.43 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.623 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.2 m0 -67.65 -44.01 78.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.745 ' ND1' HG23 ' A' ' 123' ' ' THR . 30.5 m170 -57.72 -45.46 85.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.534 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -63.07 -43.04 99.68 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.689 -0.405 . . . . 0.0 111.454 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.513 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 76.5 t -79.21 -53.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.936 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.583 ' OG ' HG22 ' A' ' 67' ' ' VAL . 43.8 p -128.39 91.38 44.13 Favored Pre-proline 0 N--CA 1.465 0.304 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.319 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.441 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 45.2 Cg_exo -51.39 -42.28 55.61 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.915 1.743 . . . . 0.0 113.158 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.4 Cg_exo -56.47 -28.02 71.36 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 120.211 0.607 . . . . 0.0 112.311 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.66 -31.38 71.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.622 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -60.77 -41.44 95.5 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.768 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -61.45 -36.06 79.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.128 0.49 . . . . 0.0 110.744 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.38 -38.19 76.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.6 mt -59.22 -30.76 68.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.27 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.521 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 0.17 -62.58 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.3 Cg_endo -50.73 -29.96 27.63 Favored 'Trans proline' 0 N--CA 1.5 1.87 0 C-N-CA 120.513 0.809 . . . . 0.0 112.331 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -60.65 -36.49 78.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.119 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.633 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -67.8 -44.35 77.56 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.025 0.441 . . . . 0.0 110.104 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.58 -49.8 37.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.094 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.682 ' CD1' HD11 ' A' ' 56' ' ' LEU . 1.7 t-105 -59.94 -49.01 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 115' ' ' VAL . 74.7 mt -66.07 -32.4 73.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.301 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.39 90.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.45 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.825 ' CE2' HD22 ' A' ' 150' ' ' LEU . 23.1 t80 -63.25 -42.03 99.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.264 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.707 HG21 HD21 ' A' ' 114' ' ' LEU . 74.3 p -60.84 -38.36 85.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.604 -0.438 . . . . 0.0 112.049 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.8 m -62.34 -49.31 76.09 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.695 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.4 t -73.22 -40.68 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.45 0.643 . . . . 0.0 111.01 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.825 HD22 ' CE2' ' A' ' 146' ' ' PHE . 53.5 tp -55.91 -47.02 78.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.54 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.608 HD21 ' C21' ' A' ' 201' ' ' PKA . 14.9 m120 -66.95 -37.59 84.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.389 0.614 . . . . 0.0 110.449 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -58.88 -44.31 91.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.903 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -63.97 -46.12 86.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.999 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.06 -47.74 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.74 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.7 m95 -61.27 -43.65 98.52 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.493 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 69.4 mmt-85 -59.7 -35.65 74.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.842 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -59.46 -41.05 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.365 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -96.63 -59.62 1.78 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.034 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TRP . 34.4 m -57.13 -32.3 66.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.524 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -66.11 161.09 44.93 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -56.85 -36.5 70.09 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.955 0.407 . . . . 0.0 110.45 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -56.38 -35.4 67.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.291 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.52 -31.17 43.65 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -80.32 174.09 54.94 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.4 p -78.79 160.58 27.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 0.0 111.065 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.0 ttp85 -57.97 -32.71 68.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.555 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.51 ' H ' HD22 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -87.14 146.14 26.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.904 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.438 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -84.07 126.3 32.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.001 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 92.5 mt-10 . . . . . 0 C--O 1.218 -0.56 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.371 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.608 ' C21' HD21 ' A' ' 151' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.82 ' H2 ' ' CD ' ' A' ' 2' ' ' PRO . 1.3 mpp? . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.954 0.407 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.82 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 18.5 Cg_endo -55.71 -22.47 36.58 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.389 2.059 . . . . 0.0 111.572 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.15 -31.83 70.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.938 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -62.19 -41.84 98.73 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.298 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.401 ' CZ2' ' CD2' ' A' ' 68' ' ' TRP . 10.9 m0 -73.83 -31.48 63.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.833 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -42.28 -43.07 7.13 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.46 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.31 -24.49 51.65 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.002 1.135 . . . . 0.0 111.733 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.22 -34.12 21.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.141 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.52 -41.93 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.91 -36.29 92.6 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.447 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -59.38 -39.56 83.73 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.375 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -81.23 -36.57 29.83 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' CZ ' ' A' ' 57' ' ' TYR . 96.4 mt -61.93 -36.63 81.95 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 t -54.9 -43.73 99.01 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.601 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.41 -32.61 94.48 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.397 1.398 . . . . 0.0 113.49 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.9 m -59.34 -38.0 79.23 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.716 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.5 mt -60.67 -38.08 83.73 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.165 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.17 -40.91 99.22 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.599 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.61 -42.4 99.22 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.128 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' O ' ' CB ' ' A' ' 24' ' ' TYR . 65.0 m-85 -62.98 -45.37 92.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 76.0 mtm -62.57 -40.31 96.45 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.62 -48.26 23.58 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.193 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.21 -18.68 61.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.478 . . . . 0.0 110.969 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -54.25 -36.98 64.17 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.26 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 48.5 t80 -61.05 -50.75 72.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -75.04 -35.15 34.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.63 0.729 . . . . 0.0 110.216 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -60.95 -41.12 95.7 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.786 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -88.17 -125.21 2.27 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.031 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -56.99 -27.98 62.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.473 -0.364 . . . . 0.0 111.052 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.71 -32.78 17.87 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.8 mt -51.33 -41.54 60.64 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.344 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -63.15 -42.87 99.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.208 0.527 . . . . 0.0 109.76 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -62.12 -37.27 84.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.652 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' O ' ' N ' ' A' ' 37' ' ' LEU . 6.0 m-85 -61.29 -23.2 65.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.955 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.86 -43.44 8.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.456 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.9 -32.21 81.99 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 34' ' ' TYR . 45.5 mt -93.07 149.23 21.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.831 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -100.94 129.92 46.86 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.004 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.579 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 11.9 mtpt -107.74 139.42 20.59 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.424 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.558 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 60.6 Cg_endo -61.47 134.05 49.32 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 120.668 0.912 . . . . 0.0 111.6 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.9 p -81.78 -9.81 59.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.781 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.478 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.8 p90 -77.88 -15.34 59.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.661 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' C ' ' ND1' ' A' ' 43' ' ' HIS . 0.7 OUTLIER -76.69 149.81 81.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.915 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -76.38 163.99 31.48 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.573 1.515 . . . . 0.0 111.136 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 11.7 Cg_endo -51.38 149.45 17.25 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.803 1.669 . . . . 0.0 111.951 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.579 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 42.0 mtt85 -57.0 -35.51 69.3 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.426 ' CD2' ' HB2' ' A' ' 45' ' ' PRO . 4.5 p90 -64.19 -20.27 65.9 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.118 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.87 -62.77 1.48 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.426 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.979 ' O ' HG23 ' A' ' 52' ' ' ILE . 88.4 mt -67.46 -36.14 80.58 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.652 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -43.09 -41.0 6.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.414 -0.914 . . . . 0.0 109.983 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 53.0 Cg_exo -66.33 -7.39 17.4 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 123.181 2.587 . . . . 0.0 113.745 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.979 HG23 ' O ' ' A' ' 49' ' ' LEU . 19.0 pt -42.03 -43.76 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.357 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.472 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 95.0 m95 -54.28 -32.45 56.33 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.722 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.19 -39.2 96.82 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.1 m -69.62 -51.21 37.09 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.12 0.486 . . . . 0.0 111.04 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.8 mp -67.55 -31.77 72.09 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.431 0.634 . . . . 0.0 109.771 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.489 ' C ' ' CD1' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -51.23 -55.87 15.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.633 -179.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.6 m -64.03 -40.09 95.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.341 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.92 -44.5 89.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.993 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.4 mtt -62.52 -38.05 88.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.831 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -54.81 9.56 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.32 -37.6 81.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.13 -40.72 91.98 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.6 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -63.27 -31.71 72.93 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.188 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -58.33 -42.41 86.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.913 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 -41.22 84.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.309 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG13 HG11 ' A' ' 129' ' ' VAL . 46.7 t -58.7 -40.72 80.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.943 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.61 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.41 -51.16 70.68 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.464 -179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 71.4 mttt -53.36 -35.1 59.91 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.424 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.51 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 88.8 mt-10 -75.75 -43.82 44.84 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.767 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.29 -26.65 58.89 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.86 -5.42 42.9 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.681 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.58 -167.46 29.2 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.874 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.4 ' CE2' ' HG2' ' A' ' 79' ' ' MET . 7.6 t80 -90.86 87.05 6.49 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' ALA . 11.2 p -124.04 167.64 13.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.205 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -42.88 -36.96 1.67 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.261 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.423 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 89.2 m-20 -62.54 -41.01 98.61 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.75 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -84.89 -40.27 17.26 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.503 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 83' ' ' GLY . 86.7 mtp -59.95 -35.17 74.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.27 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.5 t -61.9 -57.25 25.19 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.49 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.423 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 13.0 Cg_endo -61.95 -53.45 2.09 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.011 1.141 . . . . 0.0 112.01 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -63.52 -41.27 98.51 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.242 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.97 -39.76 97.99 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.41 -38.72 77.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.039 0.447 . . . . 0.0 110.241 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -59.79 -44.4 93.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.11 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 36.9 m -65.82 -45.4 82.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.472 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.17 -53.83 5.97 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.188 -0.53 . . . . 0.0 112.42 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -58.72 -41.66 86.91 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.493 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.5 tp -63.08 -36.96 85.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.82 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.59 66.74 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.63 -37.32 81.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.564 ' OD1' HD11 ' A' ' 113' ' ' LEU . 21.2 t-20 -60.04 -43.89 95.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.951 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.547 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 60.0 m95 -57.45 -30.47 65.05 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.041 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.24 -23.57 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.609 ' O ' ' N ' ' A' ' 97' ' ' PRO . 55.9 t-105 -54.15 -67.56 0.61 Allowed Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 22.8 Cg_endo -43.35 80.47 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.832 1.688 . . . . 0.0 112.007 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.609 ' N ' ' O ' ' A' ' 95' ' ' TRP . 69.2 Cg_endo -57.54 -22.04 49.25 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 122.294 1.996 . . . . 0.0 113.293 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 107' ' ' TRP . 37.3 pt -57.11 -23.27 18.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.532 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 8.4 p90 -45.06 -41.59 7.77 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.718 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.532 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 75.7 t80 -66.51 -52.13 49.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.8 -68.89 0.5 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.791 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 63.79 3.21 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.734 0.302 . . . . 0.0 110.749 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -53.8 -35.04 60.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.564 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -89.57 155.22 19.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.672 ' C ' ' H ' ' A' ' 107' ' ' TRP . 21.9 ttm -58.75 -15.17 10.88 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.039 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.59 15.06 0.01 OUTLIER Glycine 0 CA--C 1.544 1.846 0 C-N-CA 121.653 -0.308 . . . . 0.0 113.351 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.672 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -56.15 -19.25 12.68 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.359 0.58 . . . . 0.0 112.257 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.662 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -43.09 -21.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.695 0.283 . . . . 0.0 111.742 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.6 mt -61.08 -36.17 78.92 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.654 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.34 -39.29 93.6 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.731 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.492 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.0 t0 -62.95 -46.79 86.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.51 -49.11 76.65 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.904 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.5 tt -67.99 -42.54 80.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.544 0.688 . . . . 0.0 109.768 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 147' ' ' THR . 18.1 tp -50.67 -60.2 3.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.668 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.582 ' HA ' HD22 ' A' ' 144' ' ' LEU . 71.7 t -71.05 -63.58 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.495 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 120' ' ' THR . 45.8 t -68.91 -40.36 79.15 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.39 -51.01 60.71 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.795 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.83 -38.05 81.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.096 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.27 -47.88 22.18 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 116' ' ' SER . 56.7 m -57.89 -42.48 84.72 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.88 -57.58 3.96 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.675 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.636 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 16.9 m -62.3 -41.18 98.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.283 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 85.9 m -61.61 -45.47 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 124' ' ' LEU . 95.9 mt -63.11 -37.45 87.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.5 -63.55 1.35 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.636 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.7 m0 -65.98 -41.02 91.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.451 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.3 t-80 -57.4 -47.14 82.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.079 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.28 -43.74 90.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.73 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.63 HG11 HG13 ' A' ' 67' ' ' VAL . 86.4 t -78.6 -48.7 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.5 p -127.9 85.34 60.89 Favored Pre-proline 0 N--CA 1.465 0.297 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.726 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.463 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.05 -44.95 42.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 121.628 1.552 . . . . 0.0 112.258 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 17.0 Cg_exo -58.44 -31.76 94.85 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.361 0.708 . . . . 0.0 111.913 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.23 -32.68 72.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.229 0.538 . . . . 0.0 110.078 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.3 84.75 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.704 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.57 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 73.7 ttt180 -60.51 -41.03 93.52 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 110.109 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 15.2 tp -53.29 -35.68 60.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.23 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.531 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 43.3 mt -69.64 12.42 0.19 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.331 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -44.88 -41.96 14.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.531 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 10.3 Cg_endo -64.24 -22.59 66.71 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 CA-C-N 120.95 1.375 . . . . 0.0 112.5 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.24 -39.61 90.96 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.024 -178.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.769 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.0 tm? -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.318 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.89 -43.59 78.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 0.0 111.593 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.714 ' CE2' HD12 ' A' ' 52' ' ' ILE . 1.4 t-105 -66.0 -51.35 59.16 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.467 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 115' ' ' VAL . 54.0 mt -64.12 -34.09 77.26 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.179 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.89 95.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.241 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.738 ' CE2' HD22 ' A' ' 150' ' ' LEU . 22.0 t80 -62.31 -40.76 97.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.405 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.758 HG21 HD21 ' A' ' 114' ' ' LEU . 66.9 p -58.28 -38.32 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.259 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.5 m -63.56 -51.15 66.64 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.346 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -69.48 -41.67 80.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.189 0.519 . . . . 0.0 110.749 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.738 HD22 ' CE2' ' A' ' 146' ' ' PHE . 64.9 tp -57.89 -40.8 81.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.406 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 151' ' ' ASN . 2.2 m120 -65.53 -41.12 93.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -63.49 -40.21 96.47 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.85 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -60.42 -45.85 92.14 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.866 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.56 -48.22 47.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.662 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 1.2 m0 -63.85 -48.68 75.8 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.887 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.684 ' NH2' HH22 ' A' ' 166' ' ' ARG . 90.0 mtt-85 -56.35 -32.38 64.67 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.198 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -56.73 -40.0 74.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -99.61 -61.12 1.41 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.825 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 155' ' ' TRP . 22.9 t -127.87 135.64 50.3 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.22 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -154.27 177.66 31.54 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.554 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -129.44 150.62 50.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.372 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 166' ' ' ARG . 98.2 mtt180 -121.3 145.73 47.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.188 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.23 158.52 23.65 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -59.47 -34.33 80.58 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.508 ' O ' ' O ' ' A' ' 168' ' ' ALA . 86.9 p -60.9 -28.69 69.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.57 0.224 . . . . 0.0 111.215 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.684 HH22 ' NH2' ' A' ' 156' ' ' ARG . 92.5 mtt-85 -57.47 -36.88 72.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.63 -36.62 84.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.276 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' A' ' 165' ' ' SER . . . -151.36 147.1 26.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.005 0.431 . . . . 0.0 110.927 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.469 179.613 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.506 ' C23' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 mmt . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 110.426 -0.212 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -54.93 142.89 74.63 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.55 1.5 . . . . 0.0 112.318 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.35 -34.12 77.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.055 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -62.53 -42.28 99.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.418 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -76.0 -32.51 59.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 0.0 111.817 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.421 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.0 t -40.58 -41.66 2.82 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.337 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 37.2 Cg_exo -53.74 -23.34 26.18 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 CA-C-N 119.232 0.761 . . . . 0.0 112.236 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.67 -33.42 47.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' HG22 ' A' ' 12' ' ' THR . 88.5 t -60.99 -41.71 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.12 -36.32 92.77 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.443 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mp -58.32 -40.9 83.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.013 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.1 t -77.78 -34.5 52.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.676 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.2 mt -66.78 -34.95 78.96 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 t -50.99 -58.06 11.61 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.418 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.3 Cg_endo -58.33 -31.51 93.99 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 120.577 0.852 . . . . 0.0 112.556 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -59.31 -38.12 79.47 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.1 mt -64.36 -37.99 89.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.262 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' CA ' ' CZ2' ' A' ' 93' ' ' TRP . . . -66.39 -53.27 29.83 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.052 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.14 94.41 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -59.63 -48.95 79.65 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.018 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.5 mtm -65.16 -39.42 92.94 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.064 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.34 -44.7 90.02 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.465 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -69.94 -28.91 65.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.099 0.476 . . . . 0.0 110.279 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -56.6 -34.11 66.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.483 179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 81.3 t80 -60.27 -47.85 84.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.1 m -74.15 -32.51 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.784 0.802 . . . . 0.0 109.936 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' O ' HD11 ' A' ' 31' ' ' LEU . 14.4 ttt85 -61.32 -41.46 97.05 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.939 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.23 -124.84 2.53 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.133 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.562 ' OE1' ' NE ' ' A' ' 32' ' ' ARG . 78.1 mm-40 -56.88 -28.24 61.56 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.964 0.412 . . . . 0.0 110.857 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.13 -32.74 13.27 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.5 mt -51.33 -42.19 61.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.562 ' NE ' ' OE1' ' A' ' 29' ' ' GLU . 72.7 mtm180 -61.53 -42.71 99.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.401 0.62 . . . . 0.0 109.991 178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.76 -41.76 98.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.59 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 46.8 m-85 -66.32 -22.98 66.29 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.518 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.15 59.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.169 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.69 84.65 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 34' ' ' TYR . 69.5 mt -90.13 151.07 21.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.744 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.424 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 90.2 mt-30 -97.32 128.27 44.01 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.058 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.719 ' HZ2' HH21 ' A' ' 46' ' ' ARG . 55.7 mttt -103.04 143.94 27.62 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 20.9 Cg_endo -57.03 140.25 92.1 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 120.677 0.918 . . . . 0.0 111.829 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.8 p -64.2 -30.31 71.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.346 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.409 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 20.7 p90 -78.53 -1.58 34.6 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.462 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.593 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.2 t-80 -60.37 126.4 84.3 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.316 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.593 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 74.1 Cg_endo -79.73 164.24 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.347 1.365 . . . . 0.0 111.28 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.448 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 16.1 Cg_exo -50.78 139.85 39.11 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.341 1.361 . . . . 0.0 111.322 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.719 HH21 ' HZ2' ' A' ' 39' ' ' LYS . 50.2 mtt85 -58.86 -36.13 74.09 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.981 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.448 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 5.0 p90 -66.98 -24.0 66.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.522 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.413 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 52.7 m -67.88 -63.35 1.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.965 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.007 ' O ' HG23 ' A' ' 52' ' ' ILE . 71.6 mt -72.19 -34.24 68.26 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.601 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.31 -49.56 3.42 Favored Pre-proline 0 C--N 1.321 -0.635 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.671 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 12.1 Cg_endo -71.43 6.11 2.05 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.034 1.823 . . . . 0.0 114.117 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.007 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.9 pt -50.09 -25.39 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.158 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 5.0 m-90 -55.03 -34.41 63.49 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.421 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.78 -44.47 97.95 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.0 m -65.21 -47.57 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.129 0.49 . . . . 0.0 110.557 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 143' ' ' TRP . 6.1 mt -67.71 -34.21 76.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.587 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' TRP . 15.2 t80 -58.88 -50.87 72.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.762 -179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 55.1 p -71.03 -33.06 69.96 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.83 -43.14 97.09 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.696 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -64.28 -37.12 86.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.194 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.18 -64.19 3.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.231 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -59.94 -39.26 84.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.707 0.289 . . . . 0.0 111.312 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.48 -43.19 85.34 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.8 p -63.95 -27.98 69.51 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.599 -0.44 . . . . 0.0 109.908 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -57.59 -43.51 84.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.84 -43.41 88.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.44 -38.63 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.957 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.613 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.05 -36.57 79.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.17 -45.68 83.93 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.048 0.452 . . . . 0.0 110.82 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -69.83 -39.52 76.41 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.07 -2.6 57.59 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.94 7.08 66.45 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.269 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.21 -163.55 29.1 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.14 80.0 0.01 OUTLIER 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.918 0.866 . . . . 0.0 110.365 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.3 m -119.82 147.4 44.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.203 -1.362 . . . . 0.0 107.556 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 75' ' ' THR . 84.3 tt0 -41.11 -37.45 0.87 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.163 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.1 -42.77 96.78 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.833 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -71.33 -29.41 64.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.6 mmm -57.21 -34.4 68.49 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.784 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 t -58.87 -54.35 57.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.828 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -65.21 -55.65 0.45 Allowed 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 120.439 0.759 . . . . 0.0 112.713 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -61.57 -42.49 98.93 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.684 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.07 95.65 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.7 tp -58.1 -40.28 80.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.807 0.337 . . . . 0.0 110.166 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -61.13 -43.45 98.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.424 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.7 m -64.84 -41.38 95.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.917 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.76 -53.56 5.81 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.261 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -58.02 -41.87 84.09 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.227 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 15' ' ' PRO . 25.2 tp -62.59 -37.64 87.03 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.117 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -46.25 80.81 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.7 mt -60.75 -39.06 87.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.476 HD22 ' CA ' ' A' ' 117' ' ' GLY . 49.0 t-20 -63.52 -37.1 86.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.355 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.415 ' CZ2' ' CA ' ' A' ' 18' ' ' GLY . 1.7 m95 -56.24 -32.4 64.44 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.359 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.1 75.0 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.563 ' NE1' HD23 ' A' ' 112' ' ' LEU . 21.0 t-105 -54.78 -56.31 28.88 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 95' ' ' TRP . 19.9 Cg_endo -57.95 128.61 29.58 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.469 1.446 . . . . 0.0 113.209 -178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 109' ' ' LEU . 98.5 Cg_endo -108.04 -28.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.112 1.875 . . . . 0.0 110.745 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.84 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 22.7 pt -54.21 -30.31 20.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.23 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 21.3 p90 -54.61 -44.64 73.27 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.512 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.574 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 78.6 t80 -64.17 -48.35 76.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.13 -58.07 0.42 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.84 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 57.97 -0.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.553 ' H ' ' C ' ' A' ' 101' ' ' GLY . 14.7 tpt180 -53.56 -33.27 54.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.081 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -84.5 152.95 23.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.288 0.566 . . . . 0.0 111.603 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.65 ' O ' ' N ' ' A' ' 107' ' ' TRP . 2.8 ttp -62.06 -14.7 38.73 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.098 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.39 33.71 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 121.826 -0.226 . . . . 0.0 113.27 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.65 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -60.7 -20.89 62.16 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.575 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -54.06 -23.97 15.61 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.829 0.347 . . . . 0.0 111.441 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 109' ' ' LEU . 5.8 mp -59.66 -33.86 72.1 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.59 -0.444 . . . . 0.0 109.898 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.0 -37.01 83.24 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 30.0 t0 -61.53 -41.11 96.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.015 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.563 HD23 ' NE1' ' A' ' 95' ' ' TRP . 45.3 tp -60.51 -57.09 14.2 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 113' ' ' LEU . 2.7 tt -61.85 -41.2 97.53 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.523 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.601 HD21 ' CZ2' ' A' ' 143' ' ' TRP . 13.7 tp -53.03 -64.91 0.67 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.744 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.635 ' HA ' HD13 ' A' ' 144' ' ' LEU . 95.5 t -69.04 -56.61 11.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.748 -1.115 . . . . 0.0 113.598 -176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.7 t -69.38 -44.01 72.37 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.476 ' CA ' HD22 ' A' ' 92' ' ' ASN . . . -56.61 -49.41 70.0 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.33 -45.4 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.658 0.266 . . . . 0.0 111.297 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.475 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.68 -56.12 5.41 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.7 m -58.59 -43.57 89.57 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.99 -58.0 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.054 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.654 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.3 m -63.87 -41.87 97.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 47.6 m -61.47 -45.51 93.93 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.3 mt -63.74 -36.03 82.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.72 -63.2 1.44 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.654 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 37.0 m0 -65.75 -42.06 91.36 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.0 t-80 -59.2 -48.33 82.01 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.684 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -64.66 -45.21 87.7 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.865 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.4 t -76.18 -45.43 35.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.2 p -133.65 86.76 38.47 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.193 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 40.2 Cg_exo -52.7 -42.25 63.94 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 121.755 1.637 . . . . 0.0 112.873 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 27.5 Cg_exo -57.09 -31.27 89.8 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 120.359 0.706 . . . . 0.0 112.344 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -30.48 71.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.473 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.72 80.11 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.888 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -59.27 -39.35 82.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.17 -39.43 75.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.954 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 139' ' ' PRO . 77.2 mt -58.79 -29.79 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.423 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.524 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER 1.83 -63.77 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.939 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' A' ' 137' ' ' LEU . 3.7 Cg_endo -51.09 -31.01 33.72 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 120.798 0.999 . . . . 0.0 112.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -59.43 -40.97 88.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.938 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.705 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.4 OUTLIER -68.55 -41.98 79.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.905 0.383 . . . . 0.0 110.649 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.8 34.96 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.023 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.695 ' CH2' ' CG2' ' A' ' 147' ' ' THR . 1.3 t-105 -63.02 -51.79 65.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 115' ' ' VAL . 55.5 mt -62.47 -32.78 73.73 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.704 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.52 -39.34 93.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.684 ' CE2' HD22 ' A' ' 150' ' ' LEU . 23.0 t80 -61.87 -42.77 99.45 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.695 ' CG2' ' CH2' ' A' ' 143' ' ' TRP . 71.3 p -60.06 -37.26 79.34 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.537 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.402 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 55.3 m -60.79 -50.86 71.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.385 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.3 t -69.99 -43.47 79.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.214 0.53 . . . . 0.0 110.432 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.684 HD22 ' CE2' ' A' ' 146' ' ' PHE . 60.9 tp -58.82 -40.58 84.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.378 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.483 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.5 m120 -62.6 -41.39 98.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 148' ' ' THR . 54.5 m-85 -65.08 -39.52 93.33 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.435 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -58.94 -47.14 86.11 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.59 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.14 -46.17 67.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.539 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.3 m0 -62.15 -42.66 99.46 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -60.08 -29.85 68.84 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.582 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 84.2 m-20 -51.7 -40.6 60.43 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.895 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -104.46 -61.84 1.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.944 0.402 . . . . 0.0 111.243 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p -65.81 -29.37 69.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.094 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -55.67 -33.59 59.66 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.275 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -58.29 -34.25 70.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.23 146.08 52.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.682 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -164.78 -177.3 37.26 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 88.47 8.8 70.29 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.3 m -57.23 -34.05 68.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.668 0.27 . . . . 0.0 110.682 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -56.0 -37.29 68.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.197 0.522 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.83 150.97 22.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.306 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 169' ' ' GLU . . . -137.33 149.21 46.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.005 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 168' ' ' ALA . 77.2 mm-40 . . . . . 0 C--N 1.322 -0.596 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.524 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.496 ' C1 ' ' HZ1' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.659 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.305 0.098 . . . . 0.0 111.039 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 1' ' ' MET . 35.0 Cg_exo -55.37 -19.29 21.67 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.355 1.37 . . . . 0.0 111.632 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.78 -31.89 50.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.702 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 m -60.53 -42.08 95.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.189 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -77.02 -30.68 55.89 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.836 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 15.1 t -40.56 -48.68 6.99 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 7.6 Cg_endo -57.27 -20.59 39.85 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 119.105 0.716 . . . . 0.0 112.037 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.53 59.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.95 -39.95 83.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.148 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -63.17 -36.54 93.57 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 11' ' ' LEU . 11.1 mp -60.19 -42.63 95.47 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 57' ' ' TYR . 3.9 t -79.64 -46.12 17.79 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 12' ' ' THR . 93.1 mt -65.97 -35.24 80.04 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 10' ' ' GLY . 6.1 t -50.18 -41.97 69.06 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.776 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.26 -33.0 89.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.172 . . . . 0.0 113.246 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.53 -39.06 86.48 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.48 -37.91 89.11 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.15 -55.63 17.92 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.802 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.42 91.39 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.371 -0.442 . . . . 0.0 112.094 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -57.11 -47.84 80.1 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.348 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.1 mtm -64.33 -38.63 91.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.798 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.31 -45.19 88.02 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.654 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.94 -26.22 64.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.203 0.525 . . . . 0.0 110.929 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -30.99 65.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.036 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 102' ' ' ALA . 85.4 t80 -63.46 -47.7 80.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.2 m -69.45 -32.1 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.87 0.843 . . . . 0.0 109.256 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -64.38 -40.79 96.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.191 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -92.51 -116.94 2.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.791 -176.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.23 -30.23 62.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 111.123 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.51 -33.13 24.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.565 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.5 mt -50.94 -44.44 60.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.365 . . . . 0.0 110.368 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -63.35 -41.98 98.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.199 0.523 . . . . 0.0 111.048 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -59.26 -38.69 80.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.96 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.552 ' O ' ' O ' ' A' ' 37' ' ' LEU . 66.5 m-85 -63.61 -22.73 67.05 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.733 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.85 17.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.677 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.89 -34.23 65.74 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.552 ' O ' ' O ' ' A' ' 34' ' ' TYR . 66.2 mt -92.31 152.35 19.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 89.8 mt-30 -92.65 128.38 38.48 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -106.47 144.22 28.56 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.62 0.248 . . . . 0.0 110.766 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.522 ' CG ' ' CE1' ' A' ' 43' ' ' HIS . 96.2 Cg_endo -62.68 138.64 70.74 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.299 1.999 . . . . 0.0 111.949 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.0 m -84.19 0.54 48.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.417 ' CZ3' ' HB3' ' A' ' 40' ' ' PRO . 13.0 p90 -101.18 12.04 38.3 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.102 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.863 ' NE2' HD13 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -85.3 137.66 36.85 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.759 179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.4 171.48 18.0 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.63 1.554 . . . . 0.0 110.796 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' HB2' ' CE2' ' A' ' 47' ' ' TRP . 3.0 Cg_exo -49.46 145.19 16.8 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 120.289 0.659 . . . . 0.0 110.659 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.565 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 36.7 mtt180 -58.62 -33.69 70.32 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.311 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.43 ' CE2' ' HB2' ' A' ' 45' ' ' PRO . 11.9 p90 -71.83 -11.94 61.04 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -74.77 -68.06 0.58 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.005 0.431 . . . . 0.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.021 ' O ' HG23 ' A' ' 52' ' ' ILE . 94.2 mt -67.76 -35.68 79.15 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.322 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.621 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -41.24 -39.65 2.17 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 119.512 -0.875 . . . . 0.0 109.931 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.621 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 38.4 Cg_exo -71.03 1.29 5.43 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.892 2.395 . . . . 0.0 113.562 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.021 HG23 ' O ' ' A' ' 49' ' ' LEU . 15.9 pt -46.21 -37.23 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.726 0.298 . . . . 0.0 111.568 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.605 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.0 m-90 -53.8 -29.52 40.88 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.921 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' O ' ' CD2' ' A' ' 57' ' ' TYR . . . -53.44 -40.87 62.48 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -81.25 -39.61 25.05 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 143' ' ' TRP . 4.7 mt -64.73 -38.94 92.68 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' CG ' ' N ' ' A' ' 58' ' ' SER . 2.0 p90 -67.68 -44.02 78.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.293 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.525 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 49.6 m -60.67 -42.39 96.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.633 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.57 -43.72 88.91 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.886 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.7 mtt -63.08 -37.51 87.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.779 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.57 -59.14 9.75 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 47.9 t80 -64.65 -36.96 85.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.863 0.363 . . . . 0.0 110.792 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.81 -42.44 68.91 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.6 p -68.72 -26.26 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.637 0.256 . . . . 0.0 110.669 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 62' ' ' TYR . 42.7 t80 -55.34 -49.27 72.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.229 0.538 . . . . 0.0 110.225 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 68.9 mt -65.94 -40.92 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.507 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -56.37 -45.9 81.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 69' ' ' LYS . 1.2 p90 -69.48 -31.95 70.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.279 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 73.9 mttt -59.66 -37.66 79.36 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 119.086 -1.045 . . . . 0.0 111.047 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 83.9 mt-10 -67.12 -35.17 79.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.62 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.4 mt -86.44 2.3 48.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.099 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.41 37.44 10.87 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.013 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.08 -161.09 27.68 Favored Glycine 0 CA--C 1.517 0.212 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -87.45 109.52 19.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 77' ' ' ASP . 6.6 t -133.35 168.78 17.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.176 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.85 -38.68 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.093 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 75' ' ' THR . 85.0 m-20 -63.11 -39.75 95.62 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.626 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.99 66.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.851 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 83' ' ' GLY . 8.8 mtt -57.83 -34.29 69.54 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.806 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.8 t -58.25 -51.78 79.32 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.721 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -69.11 -56.91 0.14 Allowed 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 120.701 0.934 . . . . 0.0 112.428 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.9 mp -63.46 -41.62 98.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.634 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 79' ' ' MET . . . -61.51 -38.24 95.47 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.1 tp -56.8 -40.24 75.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 110.186 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.6 -44.19 96.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 m -66.12 -41.59 90.33 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.152 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.5 -55.04 5.73 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.089 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -59.06 -41.31 87.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.342 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.404 ' HG ' ' NE1' ' A' ' 93' ' ' TRP . 37.8 tp -61.8 -38.89 89.8 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.238 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -46.25 90.53 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.293 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.11 -36.2 83.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.113 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.427 HD21 ' HA3' ' A' ' 117' ' ' GLY . 18.6 t-20 -58.6 -43.18 89.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.948 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.404 ' NE1' ' HG ' ' A' ' 89' ' ' LEU . 74.5 m95 -64.42 -32.9 74.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.01 -31.62 72.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.53 ' C ' ' CD1' ' A' ' 95' ' ' TRP . 8.3 t-105 -54.82 -54.86 44.82 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.15 87.5 0.09 OUTLIER 'Trans proline' 0 N--CA 1.503 2.034 0 CA-C-N 119.304 0.787 . . . . 0.0 111.941 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.58 -18.75 41.51 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.176 1.251 . . . . 0.0 111.843 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.752 HG21 ' HA ' ' A' ' 107' ' ' TRP . 47.2 pt -58.62 -23.98 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.845 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 5.4 p90 -45.94 -41.31 11.42 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.555 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 52.7 t80 -67.37 -57.45 6.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.932 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -114.67 -68.77 0.47 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.84 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 101' ' ' GLY . . . 72.73 11.89 5.39 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.256 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -52.2 -35.56 49.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.333 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -87.17 149.63 24.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.659 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.615 ' O ' ' N ' ' A' ' 107' ' ' TRP . 13.5 ptm -62.56 -16.01 53.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.557 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -44.79 -4.01 0.01 OUTLIER Glycine 0 CA--C 1.533 1.176 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.565 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.752 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.7 p90 -44.49 -18.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.791 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.29 -20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.803 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 107' ' ' TRP . 70.8 mt -61.93 -35.6 78.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.09 -40.68 96.67 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.449 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 62.3 t0 -61.46 -49.82 75.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.295 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.5 tp -66.06 -44.11 85.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.606 -0.438 . . . . 0.0 112.02 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 113' ' ' LEU . 1.2 mm? -72.16 -38.78 69.08 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.869 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.58 HD21 HG21 ' A' ' 147' ' ' THR . 17.8 tp -53.02 -62.12 1.86 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.388 0.613 . . . . 0.0 110.816 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.555 ' HA ' HD13 ' A' ' 144' ' ' LEU . 97.0 t -66.61 -62.87 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.814 -1.084 . . . . 0.0 113.252 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 120' ' ' THR . 44.1 t -69.49 -39.04 77.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.427 ' HA3' HD21 ' A' ' 92' ' ' ASN . . . -60.73 -55.86 27.49 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.942 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 114' ' ' LEU . 6.1 p -65.75 -37.22 79.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.634 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.484 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.5 -49.19 15.27 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 116' ' ' SER . 37.0 m -56.67 -41.83 77.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -58.14 3.8 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.733 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.532 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 31.8 m -64.72 -40.76 95.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 77.4 m -59.93 -45.62 92.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.452 HD22 HH21 ' A' ' 128' ' ' ARG . 99.0 mt -66.35 -36.32 82.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -76.88 -63.56 1.33 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.532 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 45.7 m0 -65.41 -41.3 93.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 123' ' ' THR . 59.1 t-80 -58.02 -48.0 81.39 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.003 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.452 HH21 HD22 ' A' ' 124' ' ' LEU . 85.0 mtt180 -64.9 -42.99 94.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.777 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.511 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 70.7 t -78.19 -53.11 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.6 p -127.31 90.81 47.91 Favored Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.459 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 48.3 Cg_exo -52.69 -42.22 64.07 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.866 1.711 . . . . 0.0 113.0 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 26.5 Cg_exo -56.78 -30.45 84.75 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 120.269 0.646 . . . . 0.0 112.258 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.77 -28.8 70.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.585 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.5 91.21 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.668 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -59.82 -38.26 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 0.0 110.432 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.6 -35.34 70.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.042 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.482 ' O ' ' C ' ' A' ' 138' ' ' TYR . 82.9 mt -64.95 -5.05 5.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.204 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -24.55 -53.57 0.15 Allowed Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.5 -27.8 77.98 Favored 'Trans proline' 0 N--CA 1.506 2.245 0 C-N-CA 121.513 1.475 . . . . 0.0 113.523 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.556 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -58.21 -43.34 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.514 -178.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 32.5 tp -72.01 -41.58 67.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.24 73.54 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.527 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.557 ' CE2' HD12 ' A' ' 52' ' ' ILE . 2.5 t-105 -64.92 -49.92 68.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.945 0.402 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.555 HD13 ' HA ' ' A' ' 115' ' ' VAL . 78.9 mt -66.47 -34.38 77.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.849 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -59.51 -37.93 79.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.297 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.41 -45.04 81.26 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.58 HG21 HD21 ' A' ' 114' ' ' LEU . 68.9 p -58.23 -40.21 81.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.607 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.9 m -60.53 -46.88 88.55 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.204 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.9 t -68.59 -43.81 83.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.083 0.468 . . . . 0.0 111.721 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.978 ' O ' HD12 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -65.06 -41.9 94.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.834 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.708 HD21 ' C21' ' A' ' 201' ' ' PKA . 19.4 m120 -60.47 -39.84 89.1 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.519 -0.473 . . . . 0.0 112.046 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -64.69 -39.19 93.23 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.75 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -57.18 -46.09 83.12 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.431 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.0 t -72.25 -46.21 58.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.791 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.5 m95 -61.4 -37.19 82.54 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 159' ' ' SER . 24.1 mmt85 -56.32 -26.16 51.38 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.889 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.478 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 92.6 m-20 -53.48 -41.86 66.67 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.754 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.546 ' ND2' HD21 ' A' ' 37' ' ' LEU . 86.0 m-20 -111.01 4.13 19.25 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.029 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 156' ' ' ARG . 48.2 t -128.65 149.61 50.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.564 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 167.61 -175.75 42.5 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -57.57 -36.74 72.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 110.244 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -56.32 -35.67 67.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.771 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -51.68 -31.14 29.65 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -54.53 -30.72 51.0 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 85.9 p -59.57 -25.9 64.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 110.687 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -56.75 -30.92 64.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.746 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.3 mm? -90.52 146.13 24.34 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -67.03 132.0 46.99 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.146 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.411 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 88.9 mt-10 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.708 ' C21' HD21 ' A' ' 151' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.877 0.37 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -55.92 -16.92 17.3 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.801 2.334 . . . . 0.0 112.075 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -51.19 -36.22 40.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.63 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.0 m -64.44 -38.71 91.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.302 0.572 . . . . 0.0 110.288 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.615 ' NE1' ' CE3' ' A' ' 68' ' ' TRP . 1.3 t90 -67.72 -37.16 81.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.739 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 t -44.12 -42.28 11.97 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.415 -177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.53 ' O ' HD13 ' A' ' 11' ' ' LEU . 87.4 Cg_exo -54.54 -23.74 33.28 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.311 1.341 . . . . 0.0 112.497 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.41 -38.98 60.37 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.426 -0.51 . . . . 0.0 109.624 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.41 -42.45 96.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.9 -34.52 88.81 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.147 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.6 mp -54.9 -44.43 74.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.886 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 t -78.7 -35.71 44.57 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.885 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.16 -37.7 88.22 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -51.57 -41.93 80.04 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.679 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -57.58 -27.59 77.53 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.411 1.407 . . . . 0.0 113.674 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.2 p -61.17 -32.75 72.49 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.59 -38.32 87.14 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.522 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.31 -37.76 92.37 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.169 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.3 -59.29 3.94 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.775 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -58.79 -46.15 88.22 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 97.3 mmm -62.88 -40.0 96.18 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.2 -43.2 10.9 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.182 -0.533 . . . . 0.0 111.997 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.485 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -66.72 -21.66 66.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.545 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -53.35 -32.89 51.32 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.279 179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 52.3 t80 -59.53 -47.49 85.33 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -72.94 -34.08 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.647 0.737 . . . . 0.0 109.713 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ttt-85 -61.09 -40.58 94.26 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.886 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.38 -132.57 2.02 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.987 -177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -56.61 -26.34 55.38 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.168 0.508 . . . . 0.0 110.669 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.61 -33.41 8.84 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.1 mt -52.45 -43.96 65.22 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.963 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -60.77 -40.65 93.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.022 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -59.32 -40.49 86.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.216 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.547 ' O ' ' O ' ' A' ' 37' ' ' LEU . 57.3 m-85 -63.83 -22.93 67.15 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.974 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.58 -42.19 10.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.852 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.55 81.59 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.547 ' O ' ' O ' ' A' ' 34' ' ' TYR . 32.2 mt -91.23 151.15 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.425 -0.387 . . . . 0.0 110.853 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -98.85 130.76 45.28 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.032 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.623 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 61.0 mttt -102.93 140.57 21.19 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 31.1 Cg_endo -59.81 132.72 46.77 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.144 1.229 . . . . 0.0 112.414 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.1 m -65.19 -27.24 68.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.117 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.486 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 5.8 p90 -76.1 -11.96 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.99 147.95 98.42 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.289 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.96 171.63 7.97 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.916 1.744 . . . . 0.0 111.521 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 47' ' ' TRP . 24.0 Cg_exo -53.23 143.64 51.7 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 121.976 1.784 . . . . 0.0 111.793 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.623 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 38.8 mtt85 -58.9 -37.91 77.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.039 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.446 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 10.6 p90 -69.2 -26.89 65.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.497 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.2 m -64.75 -55.12 21.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.973 ' O ' HG23 ' A' ' 52' ' ' ILE . 87.0 mt -75.19 -32.49 61.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -38.79 -48.28 3.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.517 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 15.6 Cg_endo -71.85 1.78 5.44 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.299 2.0 . . . . 0.0 114.063 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.973 HG23 ' O ' ' A' ' 49' ' ' LEU . 22.7 pt -44.85 -40.17 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.82 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.431 ' O ' ' N ' ' A' ' 57' ' ' TYR . 98.4 m95 -53.25 -33.39 52.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.607 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.39 -41.6 98.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 m -67.09 -49.52 64.71 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.797 0.332 . . . . 0.0 110.848 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mp -67.73 -33.08 74.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.981 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' TRP . 4.4 t80 -52.38 -49.72 63.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.823 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.7 p -69.57 -36.63 76.47 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.18 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.4 -44.99 77.49 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.2 mtt -61.98 -37.5 85.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.105 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.68 -53.11 25.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -62.52 -38.38 89.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.729 -0.236 . . . . 0.0 110.931 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.55 -43.38 78.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.449 ' CB ' HD21 ' A' ' 82' ' ' LEU . 86.9 p -62.83 -30.4 71.46 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -56.76 -46.9 81.14 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.911 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.3 mt -62.08 -42.95 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.45 HG22 ' OG ' ' A' ' 130' ' ' SER . 71.0 t -61.9 -40.51 87.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.715 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.615 ' CE3' ' NE1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -62.63 -37.38 86.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.938 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -61.06 -41.55 96.82 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.244 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -63.94 -40.38 96.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.978 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.9 mt -74.53 -26.27 59.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.163 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.75 10.53 61.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.21 -162.14 27.88 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -99.08 111.32 23.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 78' ' ' ALA . 14.5 t -135.27 166.63 22.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.797 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -46.78 -33.73 4.65 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -36.57 72.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -63.06 -27.36 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.38 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.1 mmt -55.5 -35.95 66.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.87 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.66 -42.34 91.04 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.589 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.504 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 14.5 Cg_endo -89.64 -71.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 120.826 1.017 . . . . 0.0 112.594 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.449 HD21 ' CB ' ' A' ' 64' ' ' SER . 19.0 mt -62.05 -43.41 98.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.604 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.77 -43.03 98.24 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.6 tp -61.16 -39.13 88.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.151 0.5 . . . . 0.0 110.232 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -58.6 -43.24 89.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.1 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 28.2 m -68.03 -42.9 79.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.139 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.15 -58.8 3.29 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.087 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -56.13 -40.91 74.51 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.323 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.41 ' O ' ' CD1' ' A' ' 93' ' ' TRP . 13.3 tp -64.18 -40.34 95.91 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.011 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.6 -48.1 76.17 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.844 -0.343 . . . . 0.0 111.534 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.9 mt -61.21 -39.21 89.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.335 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' HD11 ' A' ' 113' ' ' LEU . 41.6 t-20 -61.76 -41.45 97.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.649 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.479 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 52.9 m95 -58.96 -29.26 67.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.249 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.5 64.39 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.543 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 19.9 t-105 -61.59 -66.15 1.72 Allowed Pre-proline 0 N--CA 1.473 0.705 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 85.0 Cg_endo -45.21 85.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.957 1.771 . . . . 0.0 112.543 -177.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.489 ' N ' ' O ' ' A' ' 95' ' ' TRP . 83.9 Cg_endo -59.52 -16.54 36.46 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.542 1.495 . . . . 0.0 112.31 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.792 HG21 ' HA ' ' A' ' 107' ' ' TRP . 33.5 pt -58.57 -26.56 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.581 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.97 -41.89 16.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.022 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.52 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.9 t80 -69.28 -51.99 31.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.201 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.87 -68.52 0.49 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.185 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 65.43 8.77 5.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 110.447 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -52.43 -35.17 51.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -94.17 154.41 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.259 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.645 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.7 ttm -58.44 -19.03 33.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.255 179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -40.98 -8.94 0.01 OUTLIER Glycine 0 CA--C 1.534 1.263 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.67 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.792 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.7 p90 -45.31 -16.74 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.818 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.46 -23.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.098 -178.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.4 mp -60.74 -35.52 76.57 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.738 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.582 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.47 -41.15 96.79 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.459 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 56.3 t0 -63.27 -55.27 26.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.561 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 tp -64.93 -40.21 94.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.847 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.7 tt -69.56 -46.83 65.5 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.74 -36.66 67.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.632 -178.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.443 ' N ' ' HG ' ' A' ' 114' ' ' LEU . 42.5 t -70.58 -62.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.532 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.2 t -69.55 -39.85 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -59.12 -52.52 52.88 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.512 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 114' ' ' LEU . 6.8 p -64.7 -36.34 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.689 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -76.95 -53.52 7.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -56.91 -41.56 78.37 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.52 8.92 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.778 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.595 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 24.8 m -66.07 -41.93 90.07 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.551 HG23 ' CD2' ' A' ' 127' ' ' HIS . 47.2 m -58.9 -46.31 88.2 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.58 -33.37 71.02 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 81' ' ' PRO . . . -78.46 -63.91 1.29 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.595 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 33.9 m0 -64.57 -43.71 93.03 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.564 ' CD2' ' HB2' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -58.2 -41.73 84.62 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.391 -177.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -60.64 -43.75 97.18 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.006 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.2 t -79.97 -46.79 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.416 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 67' ' ' VAL . 22.9 p -135.64 93.55 15.92 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.483 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 53.2 Cg_exo -54.7 -39.13 90.69 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 121.84 1.694 . . . . 0.0 113.101 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 44.7 Cg_exo -55.67 -27.97 63.66 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.536 0.824 . . . . 0.0 112.652 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -59.95 -32.66 71.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 110.187 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.564 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.81 -40.14 87.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.123 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.436 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 75.1 ttt180 -60.76 -39.68 89.69 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.693 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.5 -37.41 65.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.506 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 76.0 mt -65.06 13.25 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CD1' ' HD3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -46.09 -42.53 27.42 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.506 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 17.9 Cg_endo -67.14 -19.84 50.58 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.985 1.388 . . . . 0.0 112.885 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.45 -38.46 87.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.933 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 24.9 tp -65.94 -38.85 89.69 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.668 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.07 -47.73 76.28 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.764 -178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.604 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 0.9 OUTLIER -68.45 -52.02 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.366 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.445 HD12 ' CD2' ' A' ' 140' ' ' TYR . 34.1 mt -64.35 -33.85 76.8 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.417 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -60.72 -46.56 89.95 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.608 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.775 ' CE2' HD22 ' A' ' 150' ' ' LEU . 24.0 t80 -64.07 -40.09 95.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.522 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.7 m -57.27 -43.71 83.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.375 -178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.9 m -63.95 -48.21 77.4 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.392 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 96.0 t -69.84 -40.48 78.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.172 0.511 . . . . 0.0 110.564 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.775 HD22 ' CE2' ' A' ' 146' ' ' PHE . 58.6 tp -55.04 -54.32 44.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.558 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.459 ' OD1' ' CG ' ' A' ' 111' ' ' ASP . 9.4 m120 -63.36 -36.65 84.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.602 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.487 ' CE2' ' NH1' ' A' ' 156' ' ' ARG . 20.8 t80 -58.4 -42.27 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.592 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.427 ' HA ' HH12 ' A' ' 156' ' ' ARG . 61.5 t80 -63.36 -47.0 83.96 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.386 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.03 -48.5 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.818 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 2.2 m95 -63.5 -39.35 94.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.662 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.487 ' NH1' ' CE2' ' A' ' 152' ' ' TYR . 29.8 ttp-105 -57.88 -37.79 74.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.358 -179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -59.97 -43.06 95.31 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.3 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -89.9 -49.48 6.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.138 0.494 . . . . 0.0 110.321 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 155' ' ' TRP . 70.0 p -63.31 -24.53 67.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -53.16 -29.29 36.21 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -54.8 -33.88 62.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.753 0.311 . . . . 0.0 110.328 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -57.9 -33.38 68.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.55 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -84.12 -175.2 50.75 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -138.23 -179.57 17.28 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.6 m -117.58 148.85 41.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.55 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -57.42 -33.02 67.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.176 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.543 HD22 ' N ' ' A' ' 167' ' ' LEU . 1.4 mm? -93.53 143.48 26.26 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 120.689 -0.404 . . . . 0.0 109.922 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -87.87 119.2 27.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.98 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.512 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.525 ' C10' ' CH2' ' A' ' 143' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.629 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.788 0.328 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -56.87 -20.35 35.63 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.28 1.986 . . . . 0.0 112.386 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.31 -31.34 32.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.465 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.0 t -61.0 -41.56 96.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.396 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -73.65 -33.92 64.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.934 0.397 . . . . 0.0 111.955 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.6 t -41.03 -49.85 7.9 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.0 Cg_endo -57.05 -20.17 36.2 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 CA-C-N 119.231 0.761 . . . . 0.0 112.513 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -33.78 54.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.056 0.455 . . . . 0.0 110.124 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.509 ' O ' HG22 ' A' ' 12' ' ' THR . 74.4 t -60.42 -40.74 85.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.03 92.83 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.36 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.85 -41.67 82.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.863 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.1 t -78.83 -35.97 43.21 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.105 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.1 mt -66.34 -37.03 84.39 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 11.5 t -52.35 -55.93 27.14 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 14' ' ' VAL . 14.9 Cg_endo -58.98 -34.5 99.18 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 120.697 0.931 . . . . 0.0 113.124 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.1 m -60.14 -37.16 79.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.146 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.0 -39.5 94.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.48 -48.35 69.35 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.784 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.76 96.8 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.305 -0.474 . . . . 0.0 112.248 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -58.65 -45.63 88.92 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.607 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -61.78 -38.77 89.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.135 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.93 -44.93 93.85 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.508 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.22 -26.61 63.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 110.975 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -35.52 69.07 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.081 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 65.0 t80 -61.34 -46.0 92.06 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.271 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG11 'CL ' ' A' ' 201' ' ' PKA . 1.0 OUTLIER -73.38 -33.14 39.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.721 0.772 . . . . 0.0 109.568 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -62.5 -40.67 97.44 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.531 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.87 -128.92 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.915 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.98 -27.72 61.7 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.698 0.285 . . . . 0.0 110.934 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.24 -32.27 6.81 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.624 ' CD2' ' HE ' ' A' ' 46' ' ' ARG . 94.9 mt -51.55 -45.06 62.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.85 0.357 . . . . 0.0 110.283 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -65.39 -40.9 94.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 111.563 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -57.83 -37.48 73.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.23 -178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 78.6 m-85 -63.89 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.979 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -43.97 -41.91 5.62 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.353 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.5 -32.19 71.36 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 34' ' ' TYR . 34.4 mt -92.52 154.55 18.38 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.311 -0.444 . . . . 0.0 111.069 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' O ' ' OD2' ' A' ' 157' ' ' ASP . 93.5 mm-40 -103.19 129.13 50.01 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mttp -103.23 145.15 30.05 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -57.08 136.1 74.59 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 120.881 1.054 . . . . 0.0 111.122 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.8 p -64.54 -25.92 68.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.005 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -79.45 -4.86 53.16 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.574 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.607 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.8 t-80 -53.85 130.06 56.65 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.637 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.607 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.8 Cg_endo -87.12 170.94 6.86 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.073 1.849 . . . . 0.0 111.219 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 28.6 Cg_exo -49.92 138.39 34.73 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 120.42 0.746 . . . . 0.0 110.911 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.624 ' HE ' ' CD2' ' A' ' 31' ' ' LEU . 38.1 mtt-85 -59.61 -36.49 76.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.055 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 8.0 p90 -72.6 -19.55 61.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.742 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -66.46 -63.35 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.871 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.997 ' O ' HG23 ' A' ' 52' ' ' ILE . 85.4 mt -71.9 -33.07 68.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.63 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.38 -50.11 2.49 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.814 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 10.2 Cg_endo -70.77 2.19 4.35 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.342 2.028 . . . . 0.0 114.286 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.997 HG23 ' O ' ' A' ' 49' ' ' LEU . 23.8 pt -45.22 -38.05 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.199 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.406 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.8 m95 -52.18 -29.11 20.8 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.718 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.01 -44.33 92.95 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.567 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -74.04 -44.76 53.18 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.199 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.74 -33.07 75.1 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.179 0.514 . . . . 0.0 109.664 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -55.41 -57.55 11.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.841 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.6 m -66.0 -38.72 89.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.812 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.44 90.76 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.6 mtt -61.14 -37.86 84.34 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.549 -0.461 . . . . 0.0 111.281 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.33 -54.0 22.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 65' ' ' TYR . 88.8 t80 -63.11 -39.32 94.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.937 0.399 . . . . 0.0 110.962 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.7 -41.36 74.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 90.8 p -66.28 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.431 ' HA ' ' CE2' ' A' ' 68' ' ' TRP . 56.0 t80 -56.44 -48.69 76.49 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.46 -39.71 86.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.201 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG22 ' OG ' ' A' ' 130' ' ' SER . 52.5 t -57.4 -49.02 81.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 1.3 p90 -73.64 -26.13 60.62 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.084 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' CE ' ' CZ ' ' A' ' 65' ' ' TYR . 70.2 mmtt -59.87 -37.64 79.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.324 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' OE1' ' O ' ' A' ' 129' ' ' VAL . 77.2 mt-10 -67.67 -41.03 84.39 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.374 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.3 mt -72.83 -25.81 61.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.754 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 103.42 45.9 1.5 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.98 -168.03 35.17 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.627 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.54 109.98 17.23 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.709 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.1 t -128.74 164.55 22.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.611 179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -52.43 -37.88 57.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.414 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' H ' HG23 ' A' ' 75' ' ' THR . 85.2 m-20 -63.65 -38.96 93.09 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.714 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.98 -31.45 71.18 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.627 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 82.0 mmm -59.22 -33.01 70.48 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.476 -178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 t -56.36 -56.96 26.11 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.957 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -65.14 -52.78 1.03 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 120.654 0.903 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.6 mp -63.29 -42.37 99.08 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.411 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.45 -38.33 95.58 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.7 tp -57.86 -40.0 79.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.727 0.299 . . . . 0.0 110.404 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -60.67 -45.99 92.04 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.549 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.5 m -67.74 -41.57 83.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.076 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.52 -55.15 5.66 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.431 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -57.9 -41.37 82.49 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.111 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.2 tp -61.23 -37.97 84.95 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.061 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.99 -45.95 86.75 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.472 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.26 -39.14 85.73 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.456 ' ND2' ' CA ' ' A' ' 117' ' ' GLY . 39.3 t-20 -64.44 -37.79 88.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.325 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -53.99 -32.18 53.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.19 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.22 70.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 55.3 t-105 -55.84 -56.81 26.24 Favored Pre-proline 0 N--CA 1.472 0.667 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.37 130.26 39.65 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 120.721 0.947 . . . . 0.0 112.969 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -107.63 -24.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.568 1.512 . . . . 0.0 110.372 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.861 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 34.7 pt -60.54 -28.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.884 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 24.3 p90 -55.8 -44.34 77.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.81 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 63.2 t80 -65.42 -50.29 66.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.677 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.75 -57.11 0.4 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.689 -0.565 . . . . 0.0 111.689 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.861 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 61.19 -1.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.566 0.222 . . . . 0.0 110.908 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.5 ' H ' ' C ' ' A' ' 101' ' ' GLY . 61.6 ttt180 -54.58 -34.5 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.061 0.458 . . . . 0.0 110.376 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -86.15 157.9 19.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.222 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.702 ' O ' ' N ' ' A' ' 107' ' ' TRP . 4.1 tpp -57.4 -13.74 3.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.471 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -43.07 -1.58 0.01 OUTLIER Glycine 0 CA--C 1.539 1.539 0 C-N-CA 121.703 -0.284 . . . . 0.0 112.418 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.702 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.83 -22.34 0.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.411 -0.464 . . . . 0.0 111.079 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.591 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.8 -28.13 68.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.014 0.435 . . . . 0.0 111.202 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.58 -30.34 68.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.281 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.59 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -59.42 -37.46 78.1 Favored 'General case' 0 CA--C 1.527 0.084 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.474 ' CG ' ' OD1' ' A' ' 151' ' ' ASN . 51.3 t0 -63.01 -44.21 96.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.0 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.01 -53.32 55.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.1 -40.37 96.07 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.824 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.77 ' CD2' HG21 ' A' ' 147' ' ' THR . 19.9 tp -51.03 -63.8 1.01 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.938 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.613 ' HA ' HD13 ' A' ' 144' ' ' LEU . 88.1 t -69.53 -55.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.942 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.0 t -67.63 -44.9 76.87 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.456 ' CA ' ' ND2' ' A' ' 92' ' ' ASN . . . -56.72 -48.35 78.4 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.499 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -74.21 -46.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.392 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.76 -54.23 14.69 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.2 m -59.91 -44.18 94.42 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.32 -58.27 3.94 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.149 -0.621 . . . . 0.0 112.183 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.613 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.2 m -64.79 -40.95 96.07 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 76.7 m -60.01 -45.92 91.17 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.8 mt -64.49 -37.32 87.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.83 -63.52 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.613 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.94 -42.3 97.36 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.419 ' CB ' ' O ' ' A' ' 123' ' ' THR . 29.0 t-80 -59.61 -48.21 82.54 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.322 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -64.72 -43.4 93.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.894 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.483 ' O ' ' OE1' ' A' ' 70' ' ' GLU . 93.4 t -78.51 -47.8 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.519 ' OG ' HG22 ' A' ' 67' ' ' VAL . 51.1 p -133.42 90.42 29.48 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 52.5 Cg_exo -55.32 -42.65 66.3 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 121.712 1.608 . . . . 0.0 112.541 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 21.7 Cg_exo -57.23 -28.48 79.72 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 120.323 0.682 . . . . 0.0 111.987 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -31.41 71.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.156 0.503 . . . . 0.0 110.101 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -37.17 81.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.277 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -58.03 -39.24 77.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.213 0.53 . . . . 0.0 110.206 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.05 -36.76 78.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.897 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' TYR . 71.7 mt -67.47 -5.19 13.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.086 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.506 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -25.3 -58.75 0.16 Allowed Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.27 -28.99 79.49 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 120.643 0.895 . . . . 0.0 113.273 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -57.43 -45.09 85.05 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.473 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.589 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 22.8 tp -65.39 -39.75 92.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.856 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.21 -46.01 82.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.133 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.659 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 1.7 t-105 -64.06 -45.6 88.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.571 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.613 HD13 ' HA ' ' A' ' 115' ' ' VAL . 40.4 mt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.33 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.28 97.01 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.321 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.604 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 67.6 t80 -63.64 -44.53 93.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.116 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.77 HG21 ' CD2' ' A' ' 114' ' ' LEU . 2.1 m -62.74 -42.4 99.65 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.737 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 55.1 m -57.37 -49.83 74.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.399 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.19 -41.48 81.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.325 0.583 . . . . 0.0 110.75 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.604 HD12 ' CZ ' ' A' ' 146' ' ' PHE . 9.6 tt -60.33 -44.12 95.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.322 -0.853 . . . . 0.0 112.028 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.71 ' OD1' HG22 ' A' ' 147' ' ' THR . 18.0 m120 -64.28 -41.0 97.1 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.38 -36.82 85.13 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.041 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -57.03 -44.8 83.25 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.546 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.8 t -67.76 -47.12 80.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.667 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.566 ' NE1' ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -64.32 -45.43 87.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.521 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 160' ' ' GLY . 70.7 mtm180 -61.04 -32.53 72.15 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.079 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.453 ' OD2' ' O ' ' A' ' 38' ' ' GLN . 92.6 m-20 -52.95 -40.12 63.43 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.492 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -97.46 -56.75 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.288 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.456 ' HG ' ' HA ' ' A' ' 156' ' ' ARG . 88.7 p -63.08 -22.71 67.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.904 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 156' ' ' ARG . . . -49.33 -27.88 8.44 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -56.11 -30.77 62.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.937 0.399 . . . . 0.0 110.268 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -117.08 146.71 42.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -130.74 58.0 0.71 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -79.61 -176.33 48.96 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.2 p -68.97 162.35 26.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -56.78 -34.18 67.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.068 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.65 146.42 23.84 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 110.075 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -137.31 147.46 45.65 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.266 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 168' ' ' ALA . 96.2 mt-10 . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.533 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.508 'CL ' ' HA ' ' A' ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.63 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.3 mmm . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -56.37 -23.85 48.85 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.546 1.497 . . . . 0.0 111.676 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.26 -32.34 72.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.201 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.1 m -61.5 -42.92 99.53 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.456 ' CD1' ' CE3' ' A' ' 68' ' ' TRP . 7.4 m0 -72.9 -33.14 65.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 111.964 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.406 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 4.2 t -42.73 -44.25 9.81 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 29.6 Cg_exo -54.35 -22.46 26.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 120.72 0.946 . . . . 0.0 112.153 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.18 -32.01 45.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.695 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' THR . 72.1 t -59.93 -41.84 87.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.356 -0.537 . . . . 0.0 109.68 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.412 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -62.56 -35.92 92.47 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.8 mp -58.44 -42.02 86.39 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.682 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.7 t -76.71 -34.35 58.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.845 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' ' OG ' ' A' ' 16' ' ' SER . 95.7 mt -67.47 -34.69 77.67 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 10' ' ' GLY . 13.0 t -46.95 -56.2 12.67 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.85 -29.19 87.66 Favored 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 120.826 1.017 . . . . 0.0 113.347 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 13' ' ' LEU . 79.7 p -61.17 -36.74 80.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.612 -0.435 . . . . 0.0 112.061 -178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.7 -39.22 93.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.288 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.12 -40.14 98.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.04 -42.55 99.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.236 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' CE1' ' CZ3' ' A' ' 53' ' ' TRP . 57.9 m-85 -61.86 -49.09 77.63 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.916 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.6 mtm -64.88 -40.35 94.98 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.438 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.69 -46.55 60.9 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.837 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.537 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -75.05 -22.45 58.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.158 0.504 . . . . 0.0 111.015 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -35.35 69.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.764 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 58.8 t80 -60.7 -48.15 83.09 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.1 -31.48 29.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.716 0.769 . . . . 0.0 110.083 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' O ' HD11 ' A' ' 31' ' ' LEU . 28.3 ttt-85 -60.6 -42.55 97.02 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.323 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.02 -129.35 5.41 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.996 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.56 -29.65 3.0 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 120.588 0.233 . . . . 0.0 110.442 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.39 -35.24 27.89 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.61 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.5 mt -50.5 -45.19 56.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -62.71 -38.55 90.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.594 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -58.62 -38.02 77.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.298 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.521 ' O ' ' O ' ' A' ' 37' ' ' LEU . 86.9 m-85 -62.05 -22.36 65.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.742 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.83 -32.36 1.54 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.079 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.18 -32.3 20.61 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 34' ' ' TYR . 56.0 mt -93.35 150.52 20.41 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.992 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -98.3 132.61 43.64 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.865 ' HZ1' HH21 ' A' ' 46' ' ' ARG . 42.1 mttt -105.82 145.54 31.08 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 38.7 Cg_endo -60.91 143.36 99.34 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.454 1.436 . . . . 0.0 112.212 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.1 p -64.27 -29.93 71.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.526 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.414 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 41.6 p90 -78.32 3.24 16.06 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.106 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.031 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -94.75 167.7 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.181 1.254 . . . . 0.0 111.842 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 34.9 Cg_exo -52.44 140.87 52.94 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.65 1.567 . . . . 0.0 111.533 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.865 HH21 ' HZ1' ' A' ' 39' ' ' LYS . 39.4 mtt85 -61.77 -35.63 78.7 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.611 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.407 ' CE2' ' HB3' ' A' ' 45' ' ' PRO . 8.0 p90 -72.25 -14.58 61.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -76.94 -67.18 0.73 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.002 0.429 . . . . 0.0 110.663 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.028 ' O ' HG23 ' A' ' 52' ' ' ILE . 81.2 mt -67.52 -33.07 74.34 Favored 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.744 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.72 -41.12 5.49 Favored Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.789 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 71.0 Cg_exo -64.21 -9.53 20.09 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 123.239 2.626 . . . . 0.0 113.953 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.028 HG23 ' O ' ' A' ' 49' ' ' LEU . 32.1 pt -45.11 -32.5 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.773 0.32 . . . . 0.0 111.252 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.599 ' CE3' ' O ' ' A' ' 50' ' ' ALA . 6.2 m0 -53.61 -31.27 46.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.763 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.34 -43.81 95.46 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.9 p -71.75 -44.87 63.32 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.611 -0.347 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mt -65.94 -33.69 76.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.865 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -61.18 -50.98 70.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.376 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.8 p -73.36 -33.71 65.22 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.82 89.13 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.845 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.1 mtt -64.25 -36.94 85.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.567 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' O ' ' OG ' ' A' ' 64' ' ' SER . . . -67.41 -64.5 3.18 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -61.53 -37.32 83.31 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.125 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.89 -42.7 60.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 61' ' ' GLY . 86.9 p -67.14 -26.75 66.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.59 0.233 . . . . 0.0 110.544 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.75 -49.69 72.42 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.966 0.412 . . . . 0.0 110.356 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 75.5 mt -67.31 -35.02 72.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.82 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.641 HG22 ' OG ' ' A' ' 130' ' ' SER . 74.2 t -55.77 -46.75 79.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.001 -177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.456 ' CE3' ' CD1' ' A' ' 5' ' ' TRP . 1.6 p90 -74.22 -31.54 62.66 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.145 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 68.3 mmtt -59.76 -39.08 83.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.215 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.82 -38.4 88.83 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.85 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -83.14 -13.18 56.11 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.945 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 98.07 1.6 58.31 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.61 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 136.09 -166.5 24.65 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.716 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -82.92 102.09 11.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.369 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.508 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 1.4 p -124.33 164.92 18.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.21 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -47.43 -37.03 10.79 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.341 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -65.31 -45.0 86.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.245 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.508 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -74.64 -35.14 62.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 111.392 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.716 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.3 mmm -58.7 -34.03 70.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.258 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 t -60.21 -60.73 9.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.65 -50.29 11.0 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 120.997 1.131 . . . . 0.0 112.151 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.8 mp -65.89 -40.85 91.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.852 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.92 96.73 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -59.53 -40.01 85.79 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 68.5 t80 -60.93 -45.58 94.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.742 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 m -65.23 -42.93 92.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.253 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.0 -57.55 3.69 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.37 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -57.19 -41.98 80.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.419 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.434 ' CB ' ' O ' ' A' ' 85' ' ' TYR . 41.4 tp -62.93 -39.22 93.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.943 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.59 -50.91 65.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.153 0.502 . . . . 0.0 110.338 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.45 -38.61 84.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.474 ' O ' HD12 ' A' ' 113' ' ' LEU . 50.3 t-20 -61.49 -40.67 95.43 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.272 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.546 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 33.0 m95 -58.11 -27.93 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.734 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.77 -23.0 65.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.019 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.497 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 20.0 t-105 -54.13 -64.43 1.88 Allowed Pre-proline 0 N--CA 1.474 0.741 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.546 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 86.2 Cg_endo -55.46 130.36 40.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.992 1.795 . . . . 0.0 112.584 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -100.81 -15.55 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.34 1.36 . . . . 0.0 111.105 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.858 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 29.7 pt -59.37 -30.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.29 -178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.548 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 30.7 p90 -55.63 -44.76 77.42 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.913 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.548 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 71.6 t80 -64.86 -48.94 72.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.08 -59.62 0.42 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.09 -1.92 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.691 0.281 . . . . 0.0 110.836 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 101' ' ' GLY . 77.4 ttt180 -52.91 -35.71 58.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.957 0.408 . . . . 0.0 110.44 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -87.83 157.46 19.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.365 0.602 . . . . 0.0 111.797 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.716 ' O ' ' N ' ' A' ' 107' ' ' TRP . 20.0 ttm -56.32 -13.56 2.26 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.684 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -42.08 -2.59 0.01 OUTLIER Glycine 0 CA--C 1.541 1.673 0 C-N-CA 121.493 -0.384 . . . . 0.0 112.637 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.716 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.36 -20.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.475 -0.427 . . . . 0.0 111.273 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.578 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.02 -28.51 67.8 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.89 -30.92 70.45 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.269 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.571 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -60.11 -35.89 76.23 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.485 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 60.5 t0 -64.65 -46.09 83.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 56.3 tp -63.99 -48.39 76.59 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.8 HD23 ' C ' ' A' ' 113' ' ' LEU . 4.5 tt -64.95 -40.3 94.8 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.493 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.764 ' CD2' HG21 ' A' ' 147' ' ' THR . 21.2 tp -55.02 -63.75 1.05 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.464 -1.244 . . . . 0.0 112.311 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.579 ' HA ' HD13 ' A' ' 144' ' ' LEU . 96.9 t -67.04 -53.3 35.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -75.32 -41.74 56.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.87 85.64 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.675 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 t -71.44 -45.46 68.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.039 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -73.83 -57.35 4.04 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 m -57.23 -44.67 84.02 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.33 -55.35 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.96 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.647 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 22.3 m -65.18 -41.5 94.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.832 HG23 ' CE1' ' A' ' 127' ' ' HIS . 83.8 m -59.67 -46.8 87.94 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.8 mt -66.16 -35.64 80.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -79.79 -63.01 1.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.647 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.2 m0 -63.96 -43.98 94.14 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.832 ' CE1' HG23 ' A' ' 123' ' ' THR . 25.2 m170 -59.67 -45.61 91.53 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 119.621 -0.831 . . . . 0.0 111.616 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.35 -41.37 96.94 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.339 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.8 t -80.78 -49.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.641 ' OG ' HG22 ' A' ' 67' ' ' VAL . 3.8 p -132.01 89.64 37.7 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.255 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.452 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.9 Cg_exo -53.85 -41.89 70.99 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.943 1.762 . . . . 0.0 113.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 35.9 Cg_exo -55.72 -31.52 80.43 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.613 0.875 . . . . 0.0 112.721 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.2 -24.32 67.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.071 0.462 . . . . 0.0 110.652 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.6 87.36 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.871 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.529 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 71.5 mtm180 -63.61 -37.98 89.39 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.913 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -51.63 -38.55 55.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.498 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.614 ' O ' ' N ' ' A' ' 139' ' ' PRO . 70.6 mt -57.65 -31.3 66.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.171 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER 4.42 -65.43 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.308 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.614 ' N ' ' O ' ' A' ' 137' ' ' LEU . 2.9 Cg_endo -51.56 -28.5 28.91 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 120.867 1.044 . . . . 0.0 112.847 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.8 OUTLIER -61.9 -35.38 78.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.002 0.43 . . . . 0.0 110.319 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.701 ' O ' HD13 ' A' ' 141' ' ' LEU . 3.2 tm? -67.12 -45.49 77.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.064 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.04 -50.46 41.04 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.604 ' CZ3' ' OG1' ' A' ' 147' ' ' THR . 3.6 t-105 -61.4 -50.81 71.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.453 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 115' ' ' VAL . 52.6 mt -64.3 -31.83 73.18 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.03 -45.36 93.9 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.711 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.732 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 19.0 t80 -66.99 -44.74 79.65 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.483 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.764 HG21 ' CD2' ' A' ' 114' ' ' LEU . 4.1 m -56.91 -42.07 79.26 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.427 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 57.6 m -60.65 -50.48 73.33 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.935 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.4 -40.98 85.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.345 0.593 . . . . 0.0 110.18 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.732 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 17.6 tp -55.61 -46.07 77.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.739 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.713 HD21 HG22 ' A' ' 147' ' ' THR . 69.1 m-80 -62.65 -38.89 92.09 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -64.11 -39.94 95.13 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.422 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -60.09 -45.89 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.939 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.49 -47.14 78.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.086 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.576 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -67.93 -41.45 82.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -57.67 -41.88 82.46 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.885 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -63.49 -49.57 73.07 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.112 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.55 -43.04 67.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 111.324 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.5 p -66.87 -26.84 67.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.435 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -55.21 -33.26 57.78 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -56.87 -31.95 65.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.72 0.295 . . . . 0.0 111.26 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -53.76 -35.32 61.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.088 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -52.6 -34.85 44.07 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.438 ' O ' HD22 ' A' ' 167' ' ' LEU . . . -56.11 -31.39 58.92 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 88.3 p -60.27 -26.42 66.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.555 0.217 . . . . 0.0 110.862 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -53.49 -37.59 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.732 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.438 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -63.52 -33.33 75.35 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.427 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -76.01 126.68 31.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.536 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 92.4 mt-10 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.546 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.537 'CL ' ' HA ' ' A' ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.657 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 110.583 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 1' ' ' MET . 40.1 Cg_endo -55.8 -19.55 25.35 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.426 2.084 . . . . 0.0 112.066 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.91 -33.28 68.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.997 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.6 p -63.4 -38.62 91.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.397 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.611 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 11.2 m0 -75.13 -32.42 61.35 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.698 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.6 t -40.79 -54.57 5.19 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.184 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 14.3 Cg_endo -59.62 -23.61 71.98 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 120.316 0.678 . . . . 0.0 111.443 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 5' ' ' TRP . . . -56.2 -34.62 66.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.197 0.522 . . . . 0.0 110.384 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.43 -41.07 86.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.86 -35.68 91.68 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.1 -44.87 87.9 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 t -79.11 -37.19 39.29 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.21 -31.83 73.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 10' ' ' GLY . 11.5 t -47.14 -56.47 12.1 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.68 ' HB3' HD21 ' A' ' 89' ' ' LEU . 7.7 Cg_endo -60.45 -28.79 87.38 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.073 1.182 . . . . 0.0 113.25 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.0 m -57.29 -39.26 75.38 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.249 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 41.7 mt -65.79 -40.17 91.69 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.006 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.25 -49.27 47.22 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.98 93.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.356 -0.697 . . . . 0.0 111.356 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -58.39 -43.51 88.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.92 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.9 mtt -60.75 -40.05 91.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.263 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.78 -43.64 83.32 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.19 -29.16 65.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.295 0.569 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -36.15 73.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.468 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 62.0 t80 -61.15 -47.55 85.72 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.433 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.2 m -71.26 -31.52 44.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.839 0.828 . . . . 0.0 109.337 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -67.47 -41.03 85.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.121 -1.4 . . . . 0.0 112.781 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.91 -120.37 0.66 Allowed Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.343 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.77 -28.51 61.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.899 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.93 -32.81 19.67 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 86.6 mt -49.93 -46.98 52.61 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.326 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -62.98 -39.89 96.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.953 0.406 . . . . 0.0 110.55 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -59.64 -39.92 85.95 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.108 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.537 ' O ' ' O ' ' A' ' 37' ' ' LEU . 76.2 m-85 -63.93 -23.07 67.2 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -45.08 -42.76 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.856 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.6 75.15 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' O ' ' O ' ' A' ' 34' ' ' TYR . 38.8 mt -91.55 152.19 20.41 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.064 0.459 . . . . 0.0 111.454 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.545 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 87.9 mt-30 -101.16 129.09 47.01 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.657 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 31.7 mttt -100.14 142.86 25.4 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 56.1 Cg_endo -59.38 135.59 66.2 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.206 1.271 . . . . 0.0 111.702 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.3 p -68.59 -23.32 64.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.307 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.416 ' CH2' ' HB3' ' A' ' 40' ' ' PRO . 10.4 p90 -78.55 -10.19 59.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.579 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.596 ' NE2' ' O ' ' A' ' 44' ' ' PRO . 1.5 t-80 -69.99 133.49 88.0 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.46 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.596 ' O ' ' NE2' ' A' ' 43' ' ' HIS . 18.2 Cg_endo -75.97 163.2 33.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.243 1.295 . . . . 0.0 110.675 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 47' ' ' TRP . 10.0 Cg_endo -50.13 146.7 17.05 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 120.48 0.786 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.657 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 62.8 mtt180 -57.52 -37.08 72.45 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 48' ' ' THR . 4.5 p90 -63.34 -31.05 72.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.654 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.522 ' N ' ' CD1' ' A' ' 47' ' ' TRP . 16.1 m -63.18 -55.67 23.17 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 96.4 mt -73.24 -35.6 66.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' O ' ' CZ3' ' A' ' 53' ' ' TRP . . . -38.41 -50.18 3.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.441 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 17.9 Cg_endo -71.01 6.54 1.68 Allowed 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.979 1.786 . . . . 0.0 113.822 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.996 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.8 pt -44.21 -33.25 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.869 0.366 . . . . 0.0 111.257 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.611 ' CZ3' ' O ' ' A' ' 50' ' ' ALA . 4.1 m-90 -53.54 -28.24 30.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.875 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' O ' ' CE2' ' A' ' 57' ' ' TYR . . . -52.52 -38.59 51.78 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 56' ' ' LEU . 1.7 t -87.1 -41.74 13.57 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.684 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.634 HD11 ' CD1' ' A' ' 143' ' ' TRP . 9.8 mt -61.25 -38.97 88.59 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 58' ' ' SER . 1.4 p90 -64.6 -43.64 93.14 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.906 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 57' ' ' TYR . 26.9 m -61.2 -39.75 91.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.34 99.01 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.492 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.1 mtt -63.08 -36.15 82.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.67 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.08 -65.22 2.95 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -61.36 -38.46 87.05 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -54.84 -43.12 81.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.5 p -64.88 -27.54 68.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.851 0.358 . . . . 0.0 110.041 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' CE2' ' CZ2' ' A' ' 5' ' ' TRP . 30.6 t80 -57.98 -44.49 87.15 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 84.9 mt -60.48 -42.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.9 -37.94 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.138 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.592 ' O ' ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -61.7 -37.8 85.49 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.931 179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -64.59 -45.23 87.9 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.903 0.382 . . . . 0.0 111.789 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -68.92 -39.56 79.56 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . 49.4 mt -91.48 -0.51 57.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -177.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.39 5.99 66.7 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 68' ' ' TRP . . . 91.24 -165.79 30.42 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 121.466 -0.397 . . . . 0.0 112.301 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.08 80.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.292 0.568 . . . . 0.0 111.511 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.485 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 6.9 p -125.59 162.04 25.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.764 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -44.32 -38.87 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -68.99 -46.33 68.32 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.738 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 73' ' ' GLY . . . -76.33 -32.79 58.88 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.3 mtp -56.53 -32.8 65.46 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.235 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.28 -47.2 94.83 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.725 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -66.16 -56.72 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.617 0.878 . . . . 0.0 112.568 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 82' ' ' LEU . 8.7 mp -60.04 -41.35 92.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.266 -0.574 . . . . 0.0 109.94 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.13 -37.86 93.52 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.1 tp -58.0 -39.58 78.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.877 0.37 . . . . 0.0 110.049 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.462 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 81.0 t80 -60.07 -44.8 94.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.8 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 48.8 m -68.51 -41.35 80.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.56 -64.21 2.54 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.653 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -57.16 -40.61 77.6 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.853 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 15' ' ' PRO . 30.2 tp -63.01 -39.09 93.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.619 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.26 -49.92 72.21 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.57 -38.71 85.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 63.7 t30 -62.14 -41.15 97.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.351 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.473 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 35.5 m95 -56.75 -30.58 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.747 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.94 -24.38 66.06 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' PRO . 14.5 t-105 -54.99 -70.92 0.26 Allowed Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 53.0 Cg_endo -43.32 82.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.949 1.766 . . . . 0.0 112.641 -177.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' N ' ' O ' ' A' ' 95' ' ' TRP . 90.3 Cg_endo -58.91 -16.84 33.96 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.108 1.872 . . . . 0.0 112.57 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.721 HG21 ' HA ' ' A' ' 107' ' ' TRP . 33.6 pt -59.01 -25.03 28.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.049 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.581 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 6.8 p90 -46.36 -44.63 17.12 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.492 -178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.581 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 67.3 t80 -66.95 -50.39 62.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.76 -68.99 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.271 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.587 ' O ' ' CZ ' ' A' ' 25' ' ' PHE . . . 62.12 7.22 2.07 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -50.5 -35.94 31.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.251 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -90.36 153.43 20.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.678 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.647 ' C ' ' H ' ' A' ' 107' ' ' TRP . 1.9 ttp -59.02 -16.45 18.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.695 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -51.03 13.84 0.01 OUTLIER Glycine 0 CA--C 1.539 1.568 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.194 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.721 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.8 p90 -60.5 -18.7 53.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.923 0.862 . . . . 0.0 112.02 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -39.39 -19.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.3 mp -62.46 -35.13 78.34 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.814 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.63 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.9 -38.69 89.31 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' OD2' ' OD1' ' A' ' 151' ' ' ASN . 47.2 t0 -62.24 -45.13 94.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.409 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 tp -63.29 -47.64 81.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.625 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.4 tt -68.92 -40.96 78.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.518 0.675 . . . . 0.0 109.965 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.7 HD21 HG21 ' A' ' 147' ' ' THR . 18.2 tp -52.21 -60.31 3.36 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.095 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 144' ' ' LEU . 67.4 t -69.83 -57.11 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.737 -178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 120' ' ' THR . 25.4 t -67.92 -41.74 82.17 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -56.55 -48.12 79.02 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.457 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 119' ' ' ALA . 1.2 t -71.09 -46.61 65.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.511 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -74.46 -54.96 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 116' ' ' SER . 26.6 m -57.41 -44.3 84.46 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.96 3.79 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.825 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.652 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 26.8 m -62.13 -40.28 95.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.51 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 82.2 m -61.65 -44.74 96.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.98 -36.69 84.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.26 -63.6 1.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.652 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 32.5 m0 -66.92 -42.33 85.58 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -177.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 52.0 t-80 -58.03 -47.28 83.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.241 -177.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.53 -44.4 94.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.61 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -77.63 -49.96 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.1 p -132.49 89.94 34.86 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.225 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.464 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 41.1 Cg_exo -52.54 -41.21 69.5 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.447 1.431 . . . . 0.0 112.786 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.1 Cg_exo -57.45 -28.27 79.81 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 120.348 0.699 . . . . 0.0 112.713 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.0 -31.58 71.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.142 0.496 . . . . 0.0 110.281 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.16 90.91 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 77.3 ttt-85 -59.11 -39.85 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.227 0.537 . . . . 0.0 110.461 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 41.5 tp -57.33 -38.07 73.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.088 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.617 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.7 mt -57.91 -31.28 66.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.385 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.508 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 8.56 -68.74 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' A' ' 137' ' ' LEU . 4.8 Cg_endo -49.74 -27.37 15.18 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 120.727 0.951 . . . . 0.0 113.072 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.569 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.1 p90 -61.77 -40.72 96.13 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.103 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -66.57 -41.98 87.73 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.734 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.58 -51.74 26.31 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.634 ' CD1' HD11 ' A' ' 56' ' ' LEU . 2.7 t-105 -61.54 -49.61 75.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.05 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 115' ' ' VAL . 52.2 mt -64.44 -34.16 77.54 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.526 -0.469 . . . . 0.0 111.1 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.66 -40.06 95.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.883 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.76 ' CE2' HD22 ' A' ' 150' ' ' LEU . 24.3 t80 -60.86 -42.06 97.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.568 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.7 HG21 HD21 ' A' ' 114' ' ' LEU . 79.7 p -61.49 -35.59 78.09 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.537 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.3 m -63.95 -52.38 59.99 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.042 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.0 -42.64 82.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.113 0.483 . . . . 0.0 110.804 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.76 HD22 ' CE2' ' A' ' 146' ' ' PHE . 61.6 tp -56.26 -41.48 75.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.234 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.482 ' OD1' ' OD2' ' A' ' 111' ' ' ASP . 2.4 m120 -64.43 -42.32 96.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -64.56 -40.5 95.68 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.472 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -59.97 -46.93 87.83 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.632 -178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.9 -45.5 76.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.693 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 3.5 m95 -59.82 -40.36 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.442 ' HA ' ' H ' ' A' ' 160' ' ' GLY . 94.4 mtt-85 -60.07 -30.04 68.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.578 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.545 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 95.1 m-20 -50.37 -39.97 48.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.15 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -102.13 -60.5 1.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.278 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.518 ' OG ' ' NH2' ' A' ' 162' ' ' ARG . 22.8 t -60.45 -36.13 77.49 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.848 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 156' ' ' ARG . . . -52.78 -31.92 39.39 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -54.75 -34.81 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.38 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.518 ' NH2' ' OG ' ' A' ' 159' ' ' SER . 78.4 mtm180 -55.56 -34.52 64.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.482 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.87 -177.81 50.14 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.47 -159.58 38.86 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.0 t -85.13 145.23 27.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.901 0.381 . . . . 0.0 110.71 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -57.21 -32.03 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.935 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.541 ' H ' HD22 ' A' ' 167' ' ' LEU . 1.0 OUTLIER -86.3 145.6 26.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.966 0.412 . . . . 0.0 110.0 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -83.4 124.79 31.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.672 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 91.4 mt-10 . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.558 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.448 ' C6 ' ' NE2' ' A' ' 43' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 mmt . . . . . 0 C--O 1.232 0.163 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -56.11 -24.57 50.22 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 121.394 1.396 . . . . 0.0 111.426 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -59.87 -31.07 69.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.199 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -61.49 -40.64 95.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.373 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -73.57 -34.88 65.35 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.409 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.1 t -41.15 -41.14 3.02 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.562 ' O ' HD13 ' A' ' 11' ' ' LEU . 87.2 Cg_exo -53.62 -22.33 22.01 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 121.137 1.224 . . . . 0.0 112.346 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.38 -35.48 62.86 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.932 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.524 ' O ' HG22 ' A' ' 12' ' ' THR . 73.3 t -62.64 -44.02 99.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.1 -34.5 89.93 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.334 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.562 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.7 mp -56.53 -40.9 75.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.605 0.24 . . . . 0.0 111.265 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.5 t -79.0 -32.9 45.33 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 13' ' ' LEU . 96.7 mt -61.72 -37.45 84.24 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 t -53.75 -42.78 94.33 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.416 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.46 -37.44 71.16 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.392 1.395 . . . . 0.0 113.348 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.9 m -60.05 -38.58 83.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.92 -38.94 87.53 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.417 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.03 -41.36 99.88 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.106 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.79 -42.18 97.94 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.963 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -61.89 -39.66 92.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -60.76 -39.34 88.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.675 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.54 -46.48 25.12 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.529 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -70.53 -22.85 62.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.231 0.538 . . . . 0.0 110.209 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.509 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -55.68 -33.47 64.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 29.8 t80 -64.6 -49.88 69.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.394 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.49 -37.26 56.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.791 0.805 . . . . 0.0 109.65 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -59.27 -39.83 84.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.351 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.75 -129.12 2.23 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.695 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.87 -27.03 62.9 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.15 0.5 . . . . 0.0 110.981 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.39 -32.39 10.07 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.9 mt -50.76 -45.25 58.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.835 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -60.57 -41.91 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -62.23 -41.46 98.42 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.169 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.703 ' CE1' ' NZ ' ' A' ' 39' ' ' LYS . 23.0 m-85 -64.02 -22.89 67.12 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.689 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.44 -41.46 52.75 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.003 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.36 -29.86 74.68 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.508 ' O ' ' O ' ' A' ' 34' ' ' TYR . 50.2 mt -91.14 150.11 21.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.368 -0.416 . . . . 0.0 110.544 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -100.9 128.63 46.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.703 ' NZ ' ' CE1' ' A' ' 34' ' ' TYR . 18.8 mtpp -109.9 139.22 21.09 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 39.2 Cg_endo -60.41 130.71 34.93 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.172 1.248 . . . . 0.0 112.515 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.4 m -66.67 -23.1 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.206 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.51 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.7 p90 -75.91 -15.5 60.18 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.606 ' O ' ' ND1' ' A' ' 43' ' ' HIS . 1.2 p80 -72.62 143.29 84.75 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.429 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -69.42 161.97 43.78 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 120.808 1.005 . . . . 0.0 110.849 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.27 152.76 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.144 1.23 . . . . 0.0 110.931 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -55.57 -36.24 66.63 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 47' ' ' TRP . 9.2 p90 -71.88 -14.67 62.01 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.886 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -80.06 -68.4 0.68 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.29 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 91.8 mt -62.11 -34.61 76.65 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.556 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.655 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -44.97 -41.8 13.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.724 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 85.4 Cg_exo -63.62 -8.64 15.79 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 123.217 2.611 . . . . 0.0 113.958 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.996 HG23 ' O ' ' A' ' 49' ' ' LEU . 25.3 pt -40.99 -40.88 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.369 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.455 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.9 m95 -53.21 -33.7 53.93 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.172 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.0 -38.88 96.24 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.0 m -68.52 -51.74 39.76 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.067 0.46 . . . . 0.0 110.616 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.9 mp -66.25 -32.04 73.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.923 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' TRP . 20.9 t80 -50.86 -53.32 33.41 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.022 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.8 p -67.9 -34.99 77.7 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.981 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.58 93.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.521 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.1 mtt -63.57 -38.14 90.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.56 -57.86 9.44 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.46 -0.876 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -62.43 -36.5 82.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.639 0.257 . . . . 0.0 111.287 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -42.8 84.31 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.964 -1.112 . . . . 0.0 110.427 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.7 p -65.36 -30.12 70.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.394 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -58.92 -43.84 91.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.975 0.416 . . . . 0.0 110.006 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.07 -40.11 82.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.13 0.49 . . . . 0.0 109.967 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.534 HG13 HG11 ' A' ' 129' ' ' VAL . 55.1 t -61.02 -40.48 85.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.963 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.595 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -62.42 -49.56 74.97 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.517 -179.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.595 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 75.2 mttt -54.44 -37.15 64.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.421 -178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -71.54 -43.61 66.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.495 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.9 mt -77.89 -26.11 48.94 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.54 -3.6 46.54 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.229 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.76 -169.3 26.12 Favored Glycine 0 N--CA 1.468 0.796 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.68 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -83.05 95.74 8.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.56 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 16.8 p -122.99 174.29 7.28 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.968 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.45 -35.37 39.3 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' O ' ' CD ' ' A' ' 81' ' ' PRO . 87.7 m-20 -63.97 -39.88 95.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.695 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.411 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -84.73 -40.33 17.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.116 0.484 . . . . 0.0 111.785 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.68 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.2 mmm -59.1 -36.17 74.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.531 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.2 t -62.94 -56.82 25.17 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.409 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 77' ' ' ASP . 18.2 Cg_endo -62.94 -53.69 1.49 Allowed 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.071 1.181 . . . . 0.0 112.234 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -63.53 -41.37 98.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.409 -0.516 . . . . 0.0 109.802 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.9 96.3 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.29 -38.97 78.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -59.56 -44.88 93.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.484 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.8 m -69.67 -41.33 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.71 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.96 -61.93 2.76 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.982 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -55.92 -41.77 75.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.544 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.2 tp -63.44 -39.14 93.69 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.332 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.015 0.436 . . . . 0.0 110.646 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.51 -38.42 84.33 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.554 ' O ' HD11 ' A' ' 113' ' ' LEU . 60.8 t30 -61.86 -41.66 98.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.562 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.534 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 30.5 m95 -57.41 -31.16 65.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.632 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.87 -23.53 66.02 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.585 ' O ' ' N ' ' A' ' 97' ' ' PRO . 45.6 t-105 -58.46 -67.95 0.82 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 93' ' ' TRP . 29.5 Cg_endo -38.68 81.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.25 1.967 . . . . 0.0 113.046 -177.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.585 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.4 Cg_endo -62.84 -21.84 73.4 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.141 1.894 . . . . 0.0 112.544 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.692 HG21 ' HA ' ' A' ' 107' ' ' TRP . 46.0 pt -59.83 -25.89 33.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.488 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.51 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.3 p90 -44.86 -41.81 7.42 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.279 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.51 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 72.5 t80 -66.76 -51.83 51.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -113.73 -69.05 0.5 Allowed Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.813 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . 63.12 8.01 3.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.589 0.233 . . . . 0.0 110.722 -178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.505 ' CZ ' ' NE2' ' A' ' 104' ' ' GLN . 68.5 ttp85 -53.59 -33.9 56.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.505 ' NE2' ' CZ ' ' A' ' 103' ' ' ARG . 90.1 mm-40 -88.45 149.08 23.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.598 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.668 ' C ' ' H ' ' A' ' 107' ' ' TRP . 22.1 ttm -60.43 -18.97 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.18 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -49.73 8.96 0.01 OUTLIER Glycine 0 CA--C 1.536 1.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.217 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.692 ' HA ' HG21 ' A' ' 98' ' ' ILE . 23.1 p-90 -49.36 -15.65 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.418 0.609 . . . . 0.0 112.018 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.728 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -36.39 -17.86 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.664 ' N ' ' O ' ' A' ' 107' ' ' TRP . 5.9 mp -66.34 -32.5 73.93 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.104 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.495 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -62.73 -56.68 15.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.618 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.472 ' OD1' HG22 ' A' ' 147' ' ' THR . 21.2 t70 -58.16 -44.48 87.95 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.53 -40.19 93.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.599 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.554 HD11 ' O ' ' A' ' 92' ' ' ASN . 5.5 tt -73.37 -45.76 53.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 113' ' ' LEU . 1.9 pp -74.08 -38.35 63.93 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.294 -0.562 . . . . 0.0 112.087 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.524 ' HA ' HD22 ' A' ' 144' ' ' LEU . 65.5 t -67.83 -44.6 85.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.58 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 120' ' ' THR . 42.3 t -84.72 -41.19 16.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 121' ' ' ALA . . . -55.15 -43.58 83.68 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.172 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 119' ' ' ALA . 0.9 OUTLIER -74.11 -48.65 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.655 0.264 . . . . 0.0 110.923 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -72.64 -57.25 4.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 116' ' ' SER . 37.4 m -59.82 -43.61 94.43 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 117' ' ' GLY . . . -71.87 -56.64 5.35 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.095 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.642 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 18.5 m -63.3 -41.99 99.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 87.7 m -59.63 -44.79 93.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.55 -38.12 88.8 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.186 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.68 -63.91 1.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.642 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 43.0 m0 -65.74 -41.33 92.33 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.453 ' CB ' ' O ' ' A' ' 123' ' ' THR . 47.9 t-80 -59.51 -48.7 80.62 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.914 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -65.7 -45.21 83.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.798 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.534 HG11 HG13 ' A' ' 67' ' ' VAL . 86.3 t -76.6 -46.76 30.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.6 p -130.9 83.76 60.29 Favored Pre-proline 0 N--CA 1.464 0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.288 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.455 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.2 Cg_exo -51.3 -43.94 46.17 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.497 1.465 . . . . 0.0 112.433 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 20.8 Cg_exo -59.15 -32.19 96.75 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 120.565 0.843 . . . . 0.0 112.364 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.65 -29.02 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.215 0.531 . . . . 0.0 110.491 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.43 -40.54 91.4 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.481 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.531 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 79.6 mtt180 -62.57 -38.87 91.8 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.437 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.7 tp -52.53 -37.31 57.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.091 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 138' ' ' TYR . 54.0 mt -58.93 -27.55 65.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.291 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -2.92 -69.9 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.811 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 138' ' ' TYR . 11.8 Cg_endo -50.97 -26.51 18.61 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 120.653 0.902 . . . . 0.0 112.951 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -57.61 -43.71 84.95 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 31.2 tp -59.45 -39.91 85.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.352 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.91 92.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.059 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.586 ' NE1' HD12 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -67.36 -50.73 58.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.434 179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.524 HD22 ' HA ' ' A' ' 115' ' ' VAL . 28.6 mt -65.26 -32.34 73.95 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.029 178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.49 -49.02 78.43 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.724 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.749 ' CZ ' HD13 ' A' ' 150' ' ' LEU . 30.7 t80 -64.43 -40.48 95.83 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.063 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.613 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 1.4 m -55.12 -43.79 74.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.503 -178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 60.8 p -67.98 -44.47 76.56 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.974 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.42 -42.05 92.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.52 0.676 . . . . 0.0 109.797 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.749 HD13 ' CZ ' ' A' ' 146' ' ' PHE . 53.2 tp -59.91 -38.23 81.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 147' ' ' THR . 3.2 m120 -61.67 -41.91 98.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 156' ' ' ARG . 73.2 m-85 -65.82 -39.52 90.94 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 157' ' ' ASP . 55.0 t80 -61.68 -45.08 95.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.761 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.96 -52.86 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.728 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 5.1 m0 -63.56 -42.32 98.37 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.406 ' CG ' ' O ' ' A' ' 152' ' ' TYR . 24.5 mmt85 -60.81 -35.85 77.56 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.117 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 153' ' ' TYR . 88.0 m-20 -59.33 -40.94 87.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.577 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -92.34 -55.89 3.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.717 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 155' ' ' TRP . 85.3 p -59.88 -25.26 64.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.313 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.13 -34.03 38.84 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -69.49 150.65 46.95 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -55.97 -34.14 65.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.799 0.333 . . . . 0.0 110.604 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.79 8.28 70.0 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.477 ' O ' HD22 ' A' ' 167' ' ' LEU . . . -53.67 -32.44 46.94 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.1 p -62.33 -25.75 68.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.541 0.21 . . . . 0.0 111.016 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -55.16 -36.49 65.89 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.016 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -61.18 -36.86 80.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.5 -32.23 73.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.816 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.604 -179.821 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.6 'CL ' ' C15' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.022 0.439 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.438 ' O ' HG23 ' A' ' 6' ' ' VAL . 75.7 Cg_exo -55.84 145.92 70.11 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.514 2.143 . . . . 0.0 112.013 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.45 -36.39 80.27 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.181 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.2 m -64.91 -41.16 95.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.439 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -75.08 -31.56 61.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.821 0.343 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 2' ' ' PRO . 3.7 t -41.98 -41.7 4.96 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.535 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' O ' HD13 ' A' ' 11' ' ' LEU . 77.5 Cg_exo -54.31 -20.79 20.9 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 120.764 0.976 . . . . 0.0 111.806 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.36 -36.28 53.26 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 12' ' ' THR . 89.9 t -62.9 -42.01 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.19 -34.81 90.93 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.261 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.6 mp -57.52 -41.33 80.65 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.036 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 9' ' ' VAL . 6.9 t -76.8 -31.77 57.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.212 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.44 -32.83 73.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.823 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.8 t -44.44 -57.42 6.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 89' ' ' LEU . 17.9 Cg_endo -58.68 -32.77 97.55 Favored 'Trans proline' 0 N--CA 1.505 2.181 0 C-N-CA 121.013 1.142 . . . . 0.0 113.029 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.0 m -58.46 -39.14 79.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.422 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.07 -36.35 82.96 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.539 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.7 -58.16 7.26 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.006 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.24 -36.29 82.15 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -57.71 -47.04 83.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.67 0.271 . . . . 0.0 110.979 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.2 mtt -64.48 -38.49 91.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.572 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.53 -42.24 97.56 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.627 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -68.45 -26.07 65.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.917 0.389 . . . . 0.0 111.701 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -32.6 65.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 51.4 t80 -60.51 -48.71 80.58 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -72.81 -31.53 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.775 0.798 . . . . 0.0 110.073 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -63.21 -41.86 99.21 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.076 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.36 -126.26 4.22 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.91 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.22 -30.18 11.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.683 0.278 . . . . 0.0 111.037 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.77 -31.58 23.89 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.433 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 95.2 mt -51.74 -46.1 63.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.907 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.1 ttt-85 -63.55 -37.6 87.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.83 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -56.22 -37.91 70.34 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.942 -178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CZ3' ' A' ' 107' ' ' TRP . 84.9 m-85 -63.31 -21.92 66.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.23 -35.05 2.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.659 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.69 -30.17 27.49 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 49.8 mt -95.69 151.45 19.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 110.933 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.499 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.1 mt-30 -97.76 133.18 42.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -111.34 142.15 25.85 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.304 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 58.2 Cg_endo -61.31 134.42 51.93 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.382 1.388 . . . . 0.0 111.341 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 59.5 p -78.94 -12.13 60.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.51 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.493 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.8 p90 -81.12 -15.17 56.68 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.604 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.6 148.96 95.39 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.814 -179.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -83.29 175.66 8.06 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.878 1.719 . . . . 0.0 111.82 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' CB ' ' NE1' ' A' ' 47' ' ' TRP . 39.7 Cg_exo -51.44 144.77 30.67 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.115 1.877 . . . . 0.0 112.057 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' CZ ' ' CD2' ' A' ' 31' ' ' LEU . 49.9 mtt85 -59.84 -36.32 76.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.411 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.495 ' NE1' ' CB ' ' A' ' 45' ' ' PRO . 61.6 p-90 -70.95 -26.92 63.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.073 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 m -62.92 -57.86 9.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.923 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.982 ' O ' HG23 ' A' ' 52' ' ' ILE . 86.2 mt -73.91 -34.21 64.28 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -36.89 -51.21 2.08 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.642 -0.423 . . . . 0.0 112.012 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.7 Cg_endo -68.81 0.61 4.72 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.455 2.103 . . . . 0.0 114.17 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 49' ' ' LEU . 14.1 pt -43.81 -42.53 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.593 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' TYR . 96.9 m95 -51.69 -32.82 31.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.249 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -59.88 -39.96 96.18 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.8 m -68.54 -50.99 47.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.065 0.46 . . . . 0.0 111.206 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 56' ' ' LEU . 7.3 mp -67.33 -34.27 76.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.94 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.446 ' CD1' HG23 ' A' ' 12' ' ' THR . 5.5 t80 -48.76 -60.62 2.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.1 m -63.47 -38.21 90.26 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.536 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.199 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.0 mtt -64.61 -38.55 91.38 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.29 -48.06 85.23 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.259 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -61.18 -38.68 87.38 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.918 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.48 -43.0 66.54 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.235 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.2 p -61.25 -31.67 71.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -58.61 -47.65 83.64 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.196 -0.601 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.07 -41.53 89.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.251 0.548 . . . . 0.0 109.558 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG22 ' OG ' ' A' ' 130' ' ' SER . 97.3 t -61.0 -38.46 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.542 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -65.16 -36.56 84.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.907 178.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -63.81 -43.25 96.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.683 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -65.79 -44.38 85.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.492 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.464 HD12 ' HB2' ' A' ' 78' ' ' ALA . 65.1 mt -76.68 -26.4 54.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.115 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.24 -4.15 62.25 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.449 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 156.64 -167.41 33.6 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.389 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.582 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 1.2 t80 -85.57 99.17 11.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 77' ' ' ASP . 5.7 t -133.48 165.71 24.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.62 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -41.69 -35.5 0.79 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.598 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.722 ' H ' HG23 ' A' ' 75' ' ' THR . 88.0 m-20 -60.69 -40.89 93.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.959 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.464 ' HB2' HD12 ' A' ' 71' ' ' LEU . . . -74.86 -32.22 61.83 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.012 0.434 . . . . 0.0 111.94 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.582 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 55.7 mmm -62.29 -35.12 78.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.566 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.0 t -59.66 -40.69 81.29 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.538 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.493 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 13.1 Cg_endo -85.56 -65.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.056 1.171 . . . . 0.0 112.231 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.9 mt -59.78 -44.16 94.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.647 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.27 96.37 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.23 -36.62 78.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.022 0.439 . . . . 0.0 110.579 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.469 ' CZ ' HD22 ' A' ' 89' ' ' LEU . 89.6 t80 -56.58 -43.48 80.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.131 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.1 m -63.82 -43.65 95.61 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.492 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.16 -57.43 3.68 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.744 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.91 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.469 HD22 ' CZ ' ' A' ' 85' ' ' TYR . 42.3 tp -62.93 -39.67 95.29 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.68 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.61 -48.37 75.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.043 0.449 . . . . 0.0 111.052 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.35 -39.72 88.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.007 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.451 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 58.5 t30 -62.29 -40.75 97.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -57.44 -29.99 64.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.925 0.393 . . . . 0.0 110.762 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.93 67.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.544 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.634 ' O ' ' N ' ' A' ' 97' ' ' PRO . 36.7 t-105 -59.71 -68.51 0.73 Allowed Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 113' ' ' LEU . 10.4 Cg_endo -40.2 78.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.263 0 C-N-CA 121.699 1.599 . . . . 0.0 112.662 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' TRP . 97.1 Cg_endo -57.28 -19.78 36.24 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.947 1.765 . . . . 0.0 112.076 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.909 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 33.3 pt -58.7 -23.36 23.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.042 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 1.1 p90 -56.54 -47.07 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.561 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.606 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 64.7 t80 -64.81 -49.59 70.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.51 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -112.93 -60.6 0.42 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.626 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.909 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.94 -2.24 0.2 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.636 0.255 . . . . 0.0 110.705 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.515 ' H ' ' C ' ' A' ' 101' ' ' GLY . 60.8 ttt85 -54.34 -35.44 62.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.63 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -85.8 158.65 19.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.522 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.715 ' O ' ' N ' ' A' ' 107' ' ' TRP . 15.4 ttm -56.46 -13.9 2.64 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.255 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.95 -3.33 0.01 OUTLIER Glycine 0 CA--C 1.538 1.503 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.503 -178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.715 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -43.12 -20.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.252 -0.558 . . . . 0.0 110.995 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.552 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -60.32 -27.93 67.72 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.832 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 109' ' ' LEU . 82.6 mt -59.09 -31.3 68.78 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.131 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.68 -38.72 88.84 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.595 ' CG ' HD22 ' A' ' 151' ' ' ASN . 54.7 t0 -63.94 -45.95 86.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.8 tp -64.71 -49.54 70.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.051 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.462 HD13 ' HD3' ' A' ' 96' ' ' PRO . 3.7 tt -67.17 -40.96 86.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.414 0.626 . . . . 0.0 110.078 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.785 ' CD2' HG21 ' A' ' 147' ' ' THR . 18.9 tp -50.82 -59.01 4.55 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.711 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 144' ' ' LEU . 61.0 t -69.98 -60.74 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.647 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.497 ' O ' ' OG1' ' A' ' 120' ' ' THR . 39.0 t -66.98 -42.74 84.57 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -60.38 -56.04 26.72 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.446 -177.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -66.09 -38.62 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.671 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.32 -48.06 18.36 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 116' ' ' SER . 46.5 m -59.29 -41.68 89.53 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.55 -54.96 10.07 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.97 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.57 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 17.7 m -66.1 -42.3 89.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.443 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 53.4 m -59.4 -46.63 88.16 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.67 -34.7 78.9 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.055 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -82.23 -64.5 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 41.5 m0 -70.09 -42.0 73.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 123' ' ' THR . 40.8 t-80 -56.41 -45.59 80.59 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.277 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -63.1 -44.23 96.24 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.849 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 95.5 t -76.52 -47.47 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.587 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.578 ' OG ' HG22 ' A' ' 67' ' ' VAL . 59.4 p -133.79 87.28 36.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.472 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 38.7 Cg_exo -52.03 -40.86 67.03 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.767 1.645 . . . . 0.0 112.932 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 38.0 Cg_exo -58.27 -27.62 81.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 120.49 0.794 . . . . 0.0 112.81 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.18 -33.48 69.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.187 0.518 . . . . 0.0 110.783 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 137' ' ' LEU . . . -60.18 -36.42 77.56 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.989 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -60.59 -34.84 74.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.151 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 136' ' ' LEU . 1.0 OUTLIER -62.07 -40.06 94.5 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.902 0.858 . . . . 0.0 110.013 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 134' ' ' ALA . 38.4 mt -62.6 -26.72 68.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.964 -178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.487 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -1.74 -67.86 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.439 ' N ' ' O ' ' A' ' 137' ' ' LEU . 19.4 Cg_endo -51.27 -24.38 15.36 Favored 'Trans proline' 0 N--CA 1.506 2.247 0 CA-C-N 119.711 0.933 . . . . 0.0 112.91 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.9 OUTLIER -59.34 -39.37 82.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.818 0.342 . . . . 0.0 110.446 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.624 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -62.77 -41.39 99.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.897 0.38 . . . . 0.0 110.244 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.98 73.42 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.628 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.691 ' CE2' HD12 ' A' ' 52' ' ' ILE . 2.5 t-105 -61.27 -44.63 96.92 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.646 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 115' ' ' VAL . 50.0 mt -69.67 -36.66 76.22 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.634 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.64 98.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.273 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.644 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 64.7 t80 -62.85 -46.92 85.63 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.094 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.908 HG22 HD21 ' A' ' 151' ' ' ASN . 2.4 m -62.48 -41.75 99.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.09 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 45.1 m -58.93 -50.41 74.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.807 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.7 -40.35 81.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 110.491 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.644 HD12 ' CZ ' ' A' ' 146' ' ' PHE . 9.5 tt -56.81 -46.36 81.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.692 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.908 HD21 HG22 ' A' ' 147' ' ' THR . 79.7 m-20 -65.37 -41.55 93.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -64.58 -38.99 92.91 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.772 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -58.26 -43.66 88.0 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.104 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 91.1 t -63.76 -42.96 97.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.581 -0.447 . . . . 0.0 111.374 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 108' ' ' ALA . 1.6 m95 -60.87 -25.1 66.43 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -50.38 -36.57 33.16 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.562 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 91.2 m-20 -59.76 -43.77 94.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.085 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -87.62 -51.23 6.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.087 0.47 . . . . 0.0 110.638 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 162' ' ' ARG . 62.5 p -62.67 -23.75 67.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.568 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.54 -31.93 37.61 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -57.16 -33.97 67.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.74 0.305 . . . . 0.0 110.711 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 159' ' ' SER . 80.4 mtm180 -118.7 148.36 42.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.428 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 82.66 18.97 64.69 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.02 -177.08 51.63 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.3 m -57.59 -36.44 71.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.722 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 -57.32 -37.25 72.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 0.7 OUTLIER -94.72 145.39 24.89 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.272 179.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -138.36 149.05 45.19 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.066 0.46 . . . . 0.0 110.417 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 168' ' ' ALA . 95.9 mt-10 . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.79 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.471 'CL ' ' HA ' ' A' ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.976 0.417 . . . . 0.0 110.569 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 1' ' ' MET . 18.5 Cg_endo -55.72 -18.7 21.86 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.799 2.333 . . . . 0.0 112.062 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -53.3 -35.54 60.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.355 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 t -61.62 -41.57 97.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.928 0.394 . . . . 0.0 110.691 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -73.86 -30.45 62.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.139 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.0 t -40.16 -39.28 1.33 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.862 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.529 ' O ' HD13 ' A' ' 11' ' ' LEU . 86.0 Cg_exo -55.29 -22.93 35.16 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 120.738 0.959 . . . . 0.0 112.769 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.65 63.99 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.383 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.16 -44.07 97.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.77 90.79 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.533 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 7' ' ' PRO . 9.7 mp -56.6 -41.53 77.2 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.293 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.409 HG23 ' CD1' ' A' ' 57' ' ' TYR . 3.2 t -79.4 -32.28 42.95 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.854 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 13' ' ' LEU . 96.3 mt -64.44 -37.09 86.31 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.8 t -50.85 -43.57 83.43 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.026 -178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.66 -36.8 91.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 121.357 1.372 . . . . 0.0 112.835 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.4 m -60.6 -39.16 87.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.812 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.44 -37.98 87.99 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.225 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.33 -55.0 17.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.576 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -62.67 -37.3 94.55 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 121.268 -0.491 . . . . 0.0 111.954 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.0 -46.97 86.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 72.8 mtm -63.47 -39.85 95.57 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.663 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.71 -40.44 97.44 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.466 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -72.11 -28.37 63.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 0.0 110.648 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -35.88 74.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.05 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.62 ' CD2' ' HB1' ' A' ' 102' ' ' ALA . 69.5 t80 -60.75 -48.67 80.76 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.58 -36.01 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.933 0.873 . . . . 0.0 109.627 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -60.2 -41.08 92.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.097 -1.41 . . . . 0.0 112.357 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.72 -129.88 1.4 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.714 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.403 ' HB3' HH21 ' A' ' 32' ' ' ARG . 96.9 mt-10 -57.05 -26.67 60.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 110.91 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.08 -33.52 10.61 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.53 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 92.6 mt -50.87 -41.31 57.96 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.403 HH21 ' HB3' ' A' ' 29' ' ' GLU . 49.5 mtm180 -61.63 -43.53 98.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.506 0.669 . . . . 0.0 109.594 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -62.72 -40.1 96.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.146 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.6 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 17.9 m-85 -63.87 -22.94 67.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.328 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.59 -40.81 28.68 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.123 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -31.98 78.87 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 34' ' ' TYR . 61.0 mt -91.1 148.81 22.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 110.977 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -100.32 127.92 46.51 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' NZ ' ' CZ ' ' A' ' 46' ' ' ARG . 12.1 mtpt -100.67 136.06 19.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HB2' ' CD2' ' A' ' 42' ' ' TRP . 59.2 Cg_endo -56.06 143.79 82.17 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.139 1.226 . . . . 0.0 112.738 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.7 t -60.84 -31.22 70.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.998 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.425 ' CD2' ' HB2' ' A' ' 40' ' ' PRO . 18.4 p90 -76.99 0.39 21.36 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.309 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 8.6 t-80 -61.86 124.38 81.41 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.587 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 60.2 Cg_endo -80.86 166.01 19.42 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 121.462 1.442 . . . . 0.0 111.295 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 31.5 Cg_exo -49.25 140.75 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 121.133 1.222 . . . . 0.0 111.364 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.616 ' CZ ' ' NZ ' ' A' ' 39' ' ' LYS . 36.8 mtt-85 -58.74 -37.38 76.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.006 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.437 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 8.5 p90 -74.8 -21.5 59.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.928 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -65.25 -59.91 3.56 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.661 -0.416 . . . . 0.0 112.008 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.977 ' O ' HG23 ' A' ' 52' ' ' ILE . 71.2 mt -72.85 -33.31 66.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.586 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.4 -50.69 2.54 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.951 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 16.6 Cg_endo -69.59 0.8 5.0 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.433 2.088 . . . . 0.0 114.05 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.977 HG23 ' O ' ' A' ' 49' ' ' LEU . 13.3 pt -42.34 -41.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.228 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' O ' ' N ' ' A' ' 57' ' ' TYR . 99.4 m95 -53.86 -33.15 55.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.322 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -61.15 -40.11 98.09 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.3 m -67.83 -51.84 43.82 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.235 0.541 . . . . 0.0 110.82 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 56' ' ' LEU . 6.7 mp -66.55 -32.85 74.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.934 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' TRP . 22.8 t80 -51.63 -53.53 37.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.374 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.8 p -68.04 -36.85 80.59 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.326 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.09 88.4 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.091 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.3 mtt -62.86 -37.47 87.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.68 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.16 -57.94 7.14 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.524 -0.846 . . . . 0.0 110.987 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.64 -39.35 87.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.595 0.236 . . . . 0.0 110.825 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.78 -42.02 84.57 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 89.0 p -62.35 -29.4 70.43 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.85 -44.47 91.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.807 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 88.5 mt -57.13 -42.49 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.533 HG22 ' OG ' ' A' ' 130' ' ' SER . 90.5 t -60.89 -40.39 85.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.522 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.65 -33.27 75.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.153 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' N ' ' CD1' ' A' ' 68' ' ' TRP . 31.5 mtpt -65.49 -44.89 85.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.151 0.5 . . . . 0.0 111.091 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -66.95 -37.94 85.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.774 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.6 mt -91.36 -3.75 56.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.44 35.9 40.49 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.518 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 94.37 -161.71 24.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.632 ' CD1' ' SD ' ' A' ' 79' ' ' MET . 0.4 OUTLIER -78.64 109.91 13.29 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-O 121.56 0.695 . . . . 0.0 110.741 -178.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.626 HG23 ' H ' ' A' ' 77' ' ' ASP . 4.9 t -133.94 164.45 27.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -43.93 -38.24 3.32 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.023 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.626 ' H ' HG23 ' A' ' 75' ' ' THR . 86.7 m-20 -65.5 -41.94 92.66 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.912 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -71.97 -33.24 68.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.632 ' SD ' ' CD1' ' A' ' 74' ' ' PHE . 97.1 mmm -59.06 -35.17 72.88 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.121 -0.232 . . . . 0.0 111.561 -178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.0 t -61.48 -59.68 12.77 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.2 -54.09 2.03 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.415 1.41 . . . . 0.0 113.051 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.6 mp -62.57 -41.61 99.03 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.127 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.02 -40.51 98.27 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp -58.29 -39.28 78.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.855 0.359 . . . . 0.0 110.142 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -59.0 -44.42 91.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 65.4 m -68.22 -39.92 82.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.42 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.18 -58.98 3.5 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 121.159 -0.544 . . . . 0.0 112.894 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -56.96 -42.04 79.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.331 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.34 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.826 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.76 78.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.957 0.408 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.04 -40.4 89.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.826 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.515 ' O ' HD11 ' A' ' 113' ' ' LEU . 43.0 t-20 -62.66 -39.78 94.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.512 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.554 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 42.0 m95 -57.97 -27.46 63.46 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.91 -19.12 62.63 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.586 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 26.4 t-105 -71.51 -56.36 5.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 76.4 Cg_endo -44.08 86.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.099 1.199 . . . . 0.0 112.549 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.51 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.3 Cg_endo -57.05 -26.71 70.16 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 120.845 1.03 . . . . 0.0 111.321 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.628 HD11 ' HB2' ' A' ' 110' ' ' ALA . 39.5 pt -62.44 -28.19 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.702 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 0.1 OUTLIER -52.35 -44.47 65.22 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.895 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 99' ' ' PHE . 70.5 t80 -64.43 -49.35 71.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.876 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -113.38 -68.6 0.51 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.308 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 101' ' ' GLY . . . 80.15 -5.26 1.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.879 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -54.4 -36.56 64.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -80.72 146.43 31.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.125 0.488 . . . . 0.0 111.257 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.629 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.3 ttp -64.22 -15.69 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.214 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.13 33.95 0.02 OUTLIER Glycine 0 CA--C 1.537 1.463 0 C-N-CA 121.517 -0.373 . . . . 0.0 112.745 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.629 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -61.41 -19.74 62.28 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.54 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -46.88 -24.47 0.6 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 111.594 -178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.1 -31.16 69.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.365 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.91 -52.74 58.46 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.079 0.466 . . . . 0.0 110.662 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.0 t0 -62.2 -45.71 92.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.64 -38.52 85.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.11 0.481 . . . . 0.0 110.379 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.792 HD23 ' C ' ' A' ' 113' ' ' LEU . 6.4 tt -71.15 -48.99 48.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.563 ' N ' HD23 ' A' ' 113' ' ' LEU . 2.8 pp -74.22 -31.46 62.62 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.49 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 111' ' ' ASP . 48.3 t -67.18 -61.58 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.722 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.9 t -72.54 -42.13 65.05 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 92' ' ' ASN . . . -59.18 -51.25 60.3 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.339 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 114' ' ' LEU . 2.4 p -67.38 -35.93 75.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.649 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -77.33 -57.4 3.85 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -178.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 39.1 m -60.08 -42.7 95.16 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.29 -50.81 43.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.94 -178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.438 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 27.2 m -63.62 -39.39 94.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.935 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.432 ' O ' ' CB ' ' A' ' 127' ' ' HIS . 77.7 m -59.34 -48.79 80.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 128' ' ' ARG . 74.3 mt -63.87 -32.31 73.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.68 -63.39 1.4 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.453 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.7 m0 -76.12 -45.28 34.51 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.432 ' CB ' ' O ' ' A' ' 123' ' ' THR . 16.4 t-80 -57.67 -43.42 85.02 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.949 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.481 ' CG ' ' O ' ' A' ' 124' ' ' LEU . 37.0 mmm-85 -64.63 -46.08 84.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.273 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.4 t -79.24 -48.65 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.533 ' OG ' HG22 ' A' ' 67' ' ' VAL . 37.4 p -128.64 84.77 62.15 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.138 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.7 Cg_exo -53.41 -41.81 70.22 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.178 1.919 . . . . 0.0 112.925 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 24.3 Cg_exo -57.36 -30.15 86.78 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 120.323 0.682 . . . . 0.0 112.378 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.46 71.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.074 0.464 . . . . 0.0 110.316 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -58.77 -37.74 76.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.811 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 50.4 ttt85 -59.59 -40.9 88.98 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.433 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 16.0 tp -54.55 -36.04 63.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.305 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.516 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 55.6 mt -70.73 16.87 0.08 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.423 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -48.04 -41.06 38.76 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 119.545 -0.862 . . . . 0.0 113.231 -179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.516 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 18.2 Cg_endo -67.9 -18.67 46.84 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 CA-C-N 120.633 1.262 . . . . 0.0 112.876 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -58.98 -41.33 87.32 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.915 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 140' ' ' TYR . 36.4 tp -63.79 -38.39 90.91 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.664 -0.415 . . . . 0.0 111.424 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.92 -43.95 91.11 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.596 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.59 ' CE2' HD12 ' A' ' 52' ' ' ILE . 1.3 t-105 -69.86 -50.46 42.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.782 0.325 . . . . 0.0 111.449 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 115' ' ' VAL . 30.2 mt -65.83 -32.87 74.64 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.404 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -61.13 -50.2 74.15 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.733 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.843 ' CE2' HD22 ' A' ' 150' ' ' LEU . 29.7 t80 -64.15 -42.28 96.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.905 0.383 . . . . 0.0 111.605 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.582 ' OG1' ' CZ3' ' A' ' 143' ' ' TRP . 1.8 m -55.73 -43.66 76.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.022 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 61.1 m -64.36 -49.63 70.89 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.512 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.9 t -66.51 -40.23 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.193 0.521 . . . . 0.0 110.667 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.843 HD22 ' CE2' ' A' ' 146' ' ' PHE . 63.9 tp -56.06 -42.4 76.58 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.249 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.535 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 2.4 m120 -64.55 -41.0 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -62.69 -40.89 98.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.415 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -61.03 -46.41 90.85 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.726 -0.789 . . . . 0.0 111.227 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.87 -45.18 81.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.517 -0.473 . . . . 0.0 112.037 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.449 ' CZ2' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER -59.72 -39.21 83.89 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.647 -178.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 159' ' ' SER . 66.5 mtp180 -58.66 -25.96 63.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.625 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.65 -39.4 58.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.702 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -113.77 -2.39 13.71 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.145 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 156' ' ' ARG . 69.8 m -121.99 155.91 34.56 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.641 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.73 2.23 63.17 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -55.46 -35.18 65.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.874 0.368 . . . . 0.0 110.606 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -54.5 -32.92 58.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.859 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -51.91 -33.76 36.67 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.498 ' O ' HD22 ' A' ' 167' ' ' LEU . . . 86.86 12.05 69.37 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.7 p -60.6 -27.42 67.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.939 0.4 . . . . 0.0 110.516 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -55.01 -36.93 65.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.014 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.498 HD22 ' O ' ' A' ' 164' ' ' GLY . 0.3 OUTLIER -61.16 -33.56 73.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.07 179.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.52 158.06 36.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.304 0.573 . . . . 0.0 110.509 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 C--N 1.318 -0.784 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.473 -179.675 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.564 ' C22' ' CE3' ' A' ' 107' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.881 0.372 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.484 ' O ' HG23 ' A' ' 6' ' ' VAL . 87.1 Cg_exo -54.66 148.26 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.554 2.17 . . . . 0.0 112.611 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.84 -31.93 70.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.493 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m -62.14 -47.98 82.14 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -77.45 -29.97 53.06 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 111.503 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 2' ' ' PRO . 2.7 t -40.04 -50.41 6.0 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.947 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 8.8 Cg_endo -58.01 -20.53 45.68 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.554 0.836 . . . . 0.0 112.222 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.8 -35.03 68.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 0.0 110.589 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 13' ' ' LEU . 68.0 t -60.24 -40.5 83.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.017 0.437 . . . . 0.0 109.863 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.65 -36.86 93.3 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.33 -42.19 90.87 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 t -78.15 -41.4 34.93 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.514 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD12 HG12 ' A' ' 9' ' ' VAL . 85.8 mt -65.25 -35.33 80.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 10' ' ' GLY . 13.7 t -50.07 -43.9 78.02 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.354 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.07 -34.58 98.92 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.3 1.333 . . . . 0.0 112.895 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.3 m -59.61 -39.56 84.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 0.0 112.009 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.03 -37.72 83.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.365 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.46 -40.88 99.28 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.925 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.21 -44.59 97.5 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.489 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -61.92 -40.87 96.98 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.65 -39.85 92.83 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.717 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.82 -43.99 9.56 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.041 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.475 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -68.01 -24.57 65.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.006 0.432 . . . . 0.0 110.89 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.26 -35.42 64.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.55 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 64.1 t80 -60.92 -48.02 83.75 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 m -72.34 -32.63 43.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.721 0.772 . . . . 0.0 109.451 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -63.6 -41.26 98.35 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.206 -1.361 . . . . 0.0 112.523 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.41 -129.63 2.21 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.855 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.19 -27.93 62.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.867 0.365 . . . . 0.0 110.853 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.21 -31.5 6.24 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 46' ' ' ARG . 93.7 mt -51.9 -45.89 64.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.378 -0.529 . . . . 0.0 109.814 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -62.48 -39.0 92.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.605 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 72.8 t-105 -57.34 -39.91 76.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.891 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.541 ' O ' ' O ' ' A' ' 37' ' ' LEU . 74.9 m-85 -64.76 -22.43 66.98 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 34' ' ' TYR . . . -44.41 -40.23 5.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.412 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.74 -34.61 72.51 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 34' ' ' TYR . 31.6 mt -93.29 152.87 18.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.002 0.429 . . . . 0.0 111.274 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.496 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 88.6 mt-30 -98.55 132.48 43.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' NZ ' HH21 ' A' ' 46' ' ' ARG . 48.6 mttt -99.39 148.57 34.86 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 9.8 Cg_endo -57.49 140.02 91.95 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.62 1.546 . . . . 0.0 111.908 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.8 m -61.53 -33.22 73.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.762 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.434 ' NE1' ' CE1' ' A' ' 146' ' ' PHE . 13.3 p90 -85.79 6.43 28.06 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.496 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -54.86 124.55 51.85 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.136 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.93 168.45 6.75 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.172 1.248 . . . . 0.0 111.581 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 48.7 Cg_exo -51.21 139.28 44.14 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.427 1.418 . . . . 0.0 111.924 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.518 HH21 ' NZ ' ' A' ' 39' ' ' LYS . 39.7 mtt85 -61.9 -37.09 83.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.2 p90 -73.88 -13.38 60.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.622 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -77.5 -65.92 0.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.332 . . . . 0.0 110.967 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.994 ' O ' HG23 ' A' ' 52' ' ' ILE . 77.7 mt -65.79 -35.63 81.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.416 -0.513 . . . . 0.0 111.498 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.652 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -42.12 -40.42 3.87 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.033 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 63.6 Cg_exo -66.81 -8.95 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.913 2.409 . . . . 0.0 113.746 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.994 HG23 ' O ' ' A' ' 49' ' ' LEU . 26.3 pt -41.84 -42.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.412 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.45 ' N ' HG13 ' A' ' 52' ' ' ILE . 99.3 m95 -53.54 -32.05 48.99 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.264 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -52.6 -37.08 49.7 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.5 p -87.54 -45.85 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.97 -40.32 96.13 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CE1' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -62.62 -44.65 95.75 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.639 -178.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 57' ' ' TYR . 28.4 m -60.15 -40.79 91.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.968 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.71 -38.61 91.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.0 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.42 -37.88 87.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.6 -55.53 19.83 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -61.78 -33.76 74.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.118 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.35 -44.18 58.15 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.48 ' CB ' HD21 ' A' ' 82' ' ' LEU . 95.4 p -64.13 -31.52 72.75 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.722 0.296 . . . . 0.0 110.347 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -56.61 -46.04 81.11 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.412 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.6 mt -61.59 -39.4 82.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 129' ' ' VAL . 75.7 t -63.18 -38.78 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.91 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.13 -51.41 69.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.943 0.401 . . . . 0.0 111.2 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 73.5 mttt -54.96 -36.57 65.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.367 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -72.77 -41.17 65.32 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.89 -8.22 40.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.82 -6.28 58.58 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.515 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.57 ' O ' ' N ' ' A' ' 75' ' ' THR . . . 124.8 -168.19 16.97 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.431 178.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.452 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.2 OUTLIER -59.5 79.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.789 0.804 . . . . 0.0 108.873 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 73' ' ' GLY . 46.1 m -116.09 152.77 32.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.595 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' THR . 97.0 mt-10 -42.59 -36.52 1.4 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.184 -0.607 . . . . 0.0 109.894 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.58 -41.33 98.88 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.114 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 75' ' ' THR . . . -74.97 -33.03 61.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.46 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.452 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 89.3 mmm -61.2 -35.76 78.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.652 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.4 t -56.42 -45.06 99.97 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.585 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CB ' ' HB1' ' A' ' 125' ' ' ALA . 9.5 Cg_endo -78.18 -61.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 120.929 1.086 . . . . 0.0 111.985 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.48 HD21 ' CB ' ' A' ' 64' ' ' SER . 27.9 mt -57.81 -43.75 85.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.91 0.386 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.83 -43.85 98.66 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -59.07 -38.45 79.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.106 0.479 . . . . 0.0 110.269 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -56.85 -42.98 80.69 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.6 m -65.66 -42.35 91.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.33 -60.33 3.08 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.897 -178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -55.78 -41.59 74.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.522 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.21 -37.91 89.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.03 -49.84 73.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 111.004 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.8 -37.01 82.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.461 HD21 HD22 ' A' ' 113' ' ' LEU . 19.8 t-20 -59.51 -41.34 89.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.559 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.483 ' O ' ' CD ' ' A' ' 96' ' ' PRO . 62.0 m95 -62.1 -30.42 70.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.652 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.24 -28.95 66.79 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.685 ' CD1' HD11 ' A' ' 113' ' ' LEU . 18.9 t-105 -55.74 -64.52 2.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 31.8 Cg_endo -46.2 82.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.129 0 C-N-CA 121.457 1.438 . . . . 0.0 112.148 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.557 ' N ' ' O ' ' A' ' 95' ' ' TRP . 94.5 Cg_endo -57.82 -19.21 37.93 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.351 1.368 . . . . 0.0 111.477 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.746 HG21 ' HA ' ' A' ' 107' ' ' TRP . 39.6 pt -60.23 -26.18 35.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.032 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.543 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 3.7 p90 -46.82 -44.64 19.48 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.386 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.543 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 73.6 t80 -70.05 -49.4 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.99 -66.24 0.48 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.947 -0.645 . . . . 0.0 113.131 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 66.16 8.57 5.63 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.608 0.242 . . . . 0.0 111.015 -178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.504 HH11 ' NE2' ' A' ' 104' ' ' GLN . 79.7 ttt-85 -55.07 -36.31 65.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.504 ' NE2' HH11 ' A' ' 103' ' ' ARG . 96.5 mm-40 -88.66 149.77 23.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.286 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.643 ' O ' ' N ' ' A' ' 107' ' ' TRP . 1.7 ttp -59.98 -19.41 52.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.298 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 108' ' ' ALA . . . -41.02 -8.06 0.01 OUTLIER Glycine 0 CA--C 1.535 1.318 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.88 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.746 ' HA ' HG21 ' A' ' 98' ' ' ILE . 1.5 p90 -44.67 -18.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 155' ' ' TRP . . . -40.19 -20.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.967 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 107' ' ' TRP . 73.0 mt -60.87 -35.76 77.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -61.82 -39.8 93.04 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.479 0.657 . . . . 0.0 109.345 178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 111' ' ' ASP . 56.7 t0 -66.73 -43.38 84.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.785 -1.098 . . . . 0.0 113.57 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.21 -49.26 65.19 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.358 -177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.685 HD11 ' CD1' ' A' ' 95' ' ' TRP . 21.8 mt -67.87 -38.85 83.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.02 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.765 ' CD2' HG21 ' A' ' 147' ' ' THR . 15.0 tp -51.6 -55.81 17.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.286 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' HD22 ' A' ' 144' ' ' LEU . 57.3 t -73.1 -63.64 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.662 -178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -67.82 -41.86 82.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -63.48 -52.9 42.81 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.965 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 114' ' ' LEU . 1.8 p -65.93 -36.83 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.582 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.9 -56.0 4.42 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 30.3 m -56.34 -42.34 77.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.97 -53.96 15.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.397 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.499 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 32.8 m -65.03 -40.16 94.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.874 HG23 ' CD2' ' A' ' 127' ' ' HIS . 86.9 m -59.16 -48.2 82.47 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.508 HD22 HH21 ' A' ' 128' ' ' ARG . 78.9 mt -65.96 -35.1 79.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.297 -0.561 . . . . 0.0 112.319 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 81' ' ' PRO . . . -73.66 -55.25 6.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.499 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 38.6 m0 -84.86 -49.96 7.96 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -176.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.874 ' CD2' HG23 ' A' ' 123' ' ' THR . 0.2 OUTLIER -52.25 -41.87 63.16 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.206 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.508 HH21 HD22 ' A' ' 124' ' ' LEU . 96.9 mtt-85 -61.44 -43.57 98.64 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.316 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.408 HG11 HG13 ' A' ' 67' ' ' VAL . 79.3 t -78.6 -48.98 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.589 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 87.8 p -132.47 88.06 40.41 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.786 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 47.8 Cg_exo -53.31 -39.58 80.7 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.931 1.754 . . . . 0.0 113.147 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 34.1 Cg_exo -56.27 -29.74 77.49 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 120.35 0.7 . . . . 0.0 112.76 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -62.26 -32.65 73.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.422 0.63 . . . . 0.0 110.392 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.542 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.48 -38.4 80.74 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.429 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 45.5 ttp180 -61.28 -38.65 87.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.625 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.58 -39.74 71.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.386 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' A' ' 139' ' ' PRO . 80.8 mt -56.85 -28.82 62.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.314 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.51 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.4 OUTLIER 5.86 -69.45 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.586 ' N ' ' O ' ' A' ' 137' ' ' LEU . 9.6 Cg_endo -52.1 -31.36 44.6 Favored 'Trans proline' 0 N--CA 1.505 2.158 0 C-N-CA 120.435 0.756 . . . . 0.0 113.275 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -59.07 -38.3 79.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.809 -179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.754 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.1 tm? -59.58 -44.24 93.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.303 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.52 -45.42 72.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.8 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.6 ' O ' ' CE3' ' A' ' 143' ' ' TRP . 1.8 t-105 -61.26 -44.04 97.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 115' ' ' VAL . 43.3 mt -65.8 -34.25 77.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.823 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.42 89.39 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.727 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.675 ' CZ ' HD22 ' A' ' 150' ' ' LEU . 15.7 t80 -65.27 -43.21 91.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.765 HG21 ' CD2' ' A' ' 114' ' ' LEU . 1.6 m -57.31 -42.73 82.35 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.612 -177.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -61.26 -47.29 86.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.163 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.81 -42.7 82.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.688 0.756 . . . . 0.0 109.995 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.675 HD22 ' CZ ' ' A' ' 146' ' ' PHE . 14.1 tp -53.44 -60.86 2.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.118 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.714 HD21 HG22 ' A' ' 147' ' ' THR . 78.1 m-20 -63.02 -38.81 92.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.272 0.558 . . . . 0.0 110.518 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -62.35 -43.09 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.19 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -62.88 -44.46 96.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.47 -42.7 97.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 111.209 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.754 ' CZ2' ' HB2' ' A' ' 108' ' ' ALA . 4.9 m95 -57.65 -36.23 71.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.37 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -57.35 -30.41 64.8 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD2' ' N ' ' A' ' 38' ' ' GLN . 89.5 m-20 -53.13 -40.31 64.13 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.564 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -109.06 -60.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.4 m -60.56 -32.57 71.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.793 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -52.38 -32.99 38.69 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -121.87 149.47 43.34 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 110.976 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -118.5 149.08 41.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.95 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.59 -179.33 50.39 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -85.26 -174.9 50.36 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 53.8 p -67.92 160.31 28.8 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.19 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -58.36 -35.1 71.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.759 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -62.47 -33.45 74.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.747 179.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.7 34.32 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.994 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.563 179.834 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.49 ' N18' ' C3 ' ' A' ' 201' ' ' PKA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 mmt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.946 0.403 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -56.64 -19.19 29.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.883 2.389 . . . . 0.0 112.144 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.07 -33.39 70.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.095 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.1 m -61.16 -40.86 95.46 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.22 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -31.18 57.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.864 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 3.3 t -41.17 -40.89 2.86 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.252 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.5 ' O ' HD13 ' A' ' 11' ' ' LEU . 79.5 Cg_exo -54.52 -21.22 23.41 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 120.916 1.077 . . . . 0.0 112.177 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.29 -36.81 53.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.04 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 12' ' ' THR . 96.8 t -62.38 -42.81 96.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.47 -34.79 90.17 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.482 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 7' ' ' PRO . 10.1 mp -55.82 -43.75 77.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.105 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.451 HG23 ' CD1' ' A' ' 57' ' ' TYR . 7.5 t -75.99 -27.01 57.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.429 -0.509 . . . . 0.0 112.19 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.97 -32.42 67.25 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' N ' ' CD ' ' A' ' 15' ' ' PRO . 40.9 t -45.51 -57.69 7.22 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB3' HD21 ' A' ' 89' ' ' LEU . 6.6 Cg_endo -57.88 -31.52 92.76 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.086 1.191 . . . . 0.0 112.902 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.422 ' H ' ' HD2' ' A' ' 15' ' ' PRO . 23.2 t -60.2 -39.47 86.67 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 mt -60.56 -39.27 87.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.275 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.76 -53.56 15.37 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.03 -37.2 94.05 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -58.08 -45.37 87.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.907 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 65.7 mtt -62.88 -39.42 94.41 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.51 -42.84 97.32 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.569 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -71.07 -26.28 62.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.386 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.517 ' C ' ' CD1' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -62.94 -34.9 78.45 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.913 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 102' ' ' ALA . 74.8 t80 -61.25 -49.45 77.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.64 -35.79 51.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.477 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -34.16 74.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.654 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.9 -136.88 2.31 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.505 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.1 -24.73 59.75 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.121 0.486 . . . . 0.0 110.759 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -45.86 -32.69 4.64 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.468 HD22 ' CZ ' ' A' ' 46' ' ' ARG . 92.1 mt -52.18 -43.42 64.14 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.074 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.23 -42.84 99.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.291 0.567 . . . . 0.0 110.238 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -60.05 -39.15 84.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.946 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 45.1 m-85 -64.89 -23.06 67.11 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.751 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.15 -41.62 27.23 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.543 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.94 -33.04 84.48 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 34' ' ' TYR . 73.3 mt -91.0 149.18 21.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.166 -0.517 . . . . 0.0 110.789 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -98.0 122.56 41.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.791 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.696 ' NZ ' ' HE ' ' A' ' 46' ' ' ARG . 54.7 mttt -91.35 140.94 25.67 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HB2' ' CE2' ' A' ' 42' ' ' TRP . 30.4 Cg_endo -56.44 140.73 89.6 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.122 1.215 . . . . 0.0 112.398 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.4 m -61.17 -34.04 74.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.207 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 40' ' ' PRO . 39.0 p90 -77.43 4.45 10.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.619 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.586 ' CE1' ' O ' ' A' ' 44' ' ' PRO . 10.3 t-80 -64.5 132.0 95.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.321 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 57.6 Cg_endo -89.81 169.65 4.5 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.697 1.598 . . . . 0.0 111.284 178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 47' ' ' TRP . 41.0 Cg_exo -50.92 138.73 42.32 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 120.84 1.027 . . . . 0.0 111.501 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.696 ' HE ' ' NZ ' ' A' ' 39' ' ' LYS . 43.0 mtt85 -60.43 -38.69 84.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.537 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' CD ' ' A' ' 51' ' ' PRO . 7.9 p90 -72.21 -25.66 61.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.901 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 m -64.24 -57.45 9.42 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.983 ' O ' HG23 ' A' ' 52' ' ' ILE . 50.1 mt -73.28 -33.78 65.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -37.36 -48.64 2.36 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.882 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 18.2 Cg_endo -72.34 3.77 3.88 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.364 2.043 . . . . 0.0 114.189 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 49' ' ' LEU . 19.4 pt -47.21 -38.24 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.263 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -51.76 -33.59 35.76 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.079 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.02 -41.23 97.86 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.7 m -66.39 -51.17 59.83 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.918 0.39 . . . . 0.0 110.834 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.28 -33.09 74.58 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.205 0.526 . . . . 0.0 109.966 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.451 ' CD1' HG23 ' A' ' 12' ' ' THR . 31.1 t80 -53.12 -52.8 57.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.618 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.5 p -69.42 -35.39 75.66 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.618 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.74 90.13 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.455 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.2 mtt -62.29 -37.41 85.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.269 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.29 -56.25 14.67 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.95 -40.13 96.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 111.102 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.85 -43.41 92.37 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.482 ' HB2' HD21 ' A' ' 82' ' ' LEU . 92.7 p -63.5 -28.14 69.76 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.623 -0.431 . . . . 0.0 109.954 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -58.3 -44.85 88.75 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 94.7 mt -56.95 -44.71 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.914 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 HG11 ' A' ' 129' ' ' VAL . 55.4 t -59.32 -41.64 84.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.493 ' CD1' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -63.21 -37.17 86.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.511 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -62.46 -40.94 98.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.064 0.459 . . . . 0.0 111.113 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -64.63 -37.59 88.08 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.3 mt -90.07 -5.31 56.7 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.26 41.47 17.19 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.972 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.451 ' HA2' ' CE3' ' A' ' 68' ' ' TRP . . . 104.24 -166.35 15.33 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.689 ' CE2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -93.96 110.11 21.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.461 0.648 . . . . 0.0 109.332 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 77' ' ' ASP . 5.7 t -131.32 163.47 27.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.981 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -43.51 -37.85 2.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.309 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' H ' HG23 ' A' ' 75' ' ' THR . 83.9 m-20 -63.45 -41.02 98.64 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.879 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.4 -29.18 65.74 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.689 ' SD ' ' CE2' ' A' ' 74' ' ' PHE . 86.1 mmm -60.15 -33.64 72.45 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.781 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.3 t -60.33 -50.22 86.84 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -67.22 -61.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 120.935 1.09 . . . . 0.0 113.038 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 64' ' ' SER . 7.3 mp -61.87 -39.26 91.3 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.077 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.74 -40.18 96.26 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tp -58.82 -39.27 80.72 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.116 0.484 . . . . 0.0 109.95 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.407 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 84.0 t80 -60.62 -45.71 93.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.034 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.0 m -67.95 -40.28 83.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.856 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.93 -60.33 3.17 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.022 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -56.96 -40.63 76.83 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.17 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 15' ' ' PRO . 44.9 tp -61.96 -40.23 94.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.174 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.0 79.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.98 0.419 . . . . 0.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.32 -38.02 85.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t30 -61.64 -42.44 98.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.679 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -58.42 -29.62 66.24 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.831 0.348 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -31.12 69.27 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.279 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 20.0 t-105 -56.94 -44.25 99.71 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -53.05 127.37 24.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.521 1.48 . . . . 0.0 113.125 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.454 ' CD ' ' H ' ' A' ' 98' ' ' ILE . 37.5 Cg_endo -108.67 -27.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.194 1.263 . . . . 0.0 110.793 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 26.5 pt -59.59 -27.44 37.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.953 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.568 ' CG ' ' N ' ' A' ' 100' ' ' PHE . 20.8 p90 -56.7 -44.51 81.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.608 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.568 ' N ' ' CG ' ' A' ' 99' ' ' PHE . 60.5 t80 -64.95 -49.08 71.74 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.908 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 103' ' ' ARG . . . -113.32 -59.16 0.41 Allowed Glycine 0 N--CA 1.464 0.536 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 98' ' ' ILE . . . 60.52 -1.27 0.22 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.649 0.262 . . . . 0.0 110.984 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.505 ' CZ ' ' NE2' ' A' ' 104' ' ' GLN . 71.0 ttp85 -52.89 -33.28 49.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.894 0.378 . . . . 0.0 110.34 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.505 ' NE2' ' CZ ' ' A' ' 103' ' ' ARG . 97.2 mm-40 -86.62 151.82 23.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.784 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.683 ' C ' ' H ' ' A' ' 107' ' ' TRP . 2.7 ttp -62.16 -13.41 26.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.109 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -55.07 27.43 0.01 OUTLIER Glycine 0 CA--C 1.541 1.683 0 C-N-CA 121.639 -0.315 . . . . 0.0 112.869 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.683 ' H ' ' C ' ' A' ' 105' ' ' MET . 0.1 OUTLIER -58.47 -19.17 34.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.559 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -55.07 -24.22 24.12 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.33 -33.1 65.29 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.431 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.537 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -63.76 -38.01 89.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.54 ' CG ' ' ND2' ' A' ' 151' ' ' ASN . 56.6 t0 -65.21 -48.43 73.39 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.7 tp -61.29 -47.39 86.18 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.872 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 4.3 tt -69.11 -40.43 78.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.379 0.609 . . . . 0.0 110.356 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.737 ' CD2' HG21 ' A' ' 147' ' ' THR . 14.4 tp -54.07 -57.47 10.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.309 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.554 ' HA ' HD13 ' A' ' 144' ' ' LEU . 98.9 t -69.7 -56.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.883 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -68.7 -42.35 77.86 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 113' ' ' LEU . . . -58.04 -45.2 94.14 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.661 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.38 -45.53 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.677 0.275 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -69.48 -55.59 9.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.1 m -59.72 -42.81 93.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.38 -60.37 2.31 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.459 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.6 m -62.48 -41.05 98.52 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.859 HG23 ' CE1' ' A' ' 127' ' ' HIS . 76.3 m -59.3 -46.47 88.49 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -66.5 -35.01 79.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.41 -63.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 126' ' ' TRP . 39.8 m0 -64.47 -43.76 93.19 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.859 ' CE1' HG23 ' A' ' 123' ' ' THR . 24.9 m170 -56.87 -43.38 81.16 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.634 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -62.12 -44.32 96.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.587 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.509 HG11 HG13 ' A' ' 67' ' ' VAL . 98.5 t -75.9 -42.29 39.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.815 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.55 103.65 3.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.262 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.529 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 67.3 Cg_exo -60.76 -38.98 66.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.699 1.599 . . . . 0.0 113.236 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 28.1 Cg_exo -56.45 -29.59 78.5 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 120.93 1.086 . . . . 0.0 112.96 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 -33.53 73.58 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.018 0.437 . . . . 0.0 110.765 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.55 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . . . -59.44 -37.29 77.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.902 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 138' ' ' TYR . 44.1 ttt180 -59.45 -40.77 87.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.396 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.6 -36.84 67.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.307 0.575 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.524 ' C ' ' CD ' ' A' ' 139' ' ' PRO . 60.8 mt -70.66 15.39 0.1 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.543 -178.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 135' ' ' ARG . 0.7 OUTLIER -46.27 -40.64 19.01 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 119.555 -0.858 . . . . 0.0 113.072 -179.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' C ' ' A' ' 137' ' ' LEU . 9.2 Cg_endo -66.92 -22.9 47.94 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.809 1.325 . . . . 0.0 112.417 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.56 -34.02 74.86 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.751 ' C ' HD13 ' A' ' 141' ' ' LEU . 3.0 tm? -67.93 -41.55 82.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.927 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.71 -52.15 33.89 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 0.661 ' CD1' HD12 ' A' ' 52' ' ' ILE . 1.1 t-105 -61.31 -46.34 90.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.756 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 115' ' ' VAL . 34.8 mt -67.6 -33.83 75.79 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.843 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 141' ' ' LEU . . . -62.93 -46.03 89.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.993 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.694 ' CE2' HD22 ' A' ' 150' ' ' LEU . 16.1 t80 -64.69 -43.33 93.88 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.426 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.794 HG22 HD21 ' A' ' 151' ' ' ASN . 1.6 m -57.66 -43.48 85.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.239 -0.584 . . . . 0.0 111.39 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 54.4 m -60.29 -49.73 76.45 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.557 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.39 -41.81 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.366 0.603 . . . . 0.0 110.331 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.694 HD22 ' CE2' ' A' ' 146' ' ' PHE . 23.9 tp -56.76 -47.88 79.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.139 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.794 HD21 HG22 ' A' ' 147' ' ' THR . 72.4 m-80 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -65.28 -40.52 93.99 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.342 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -58.74 -45.98 88.43 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.304 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.68 -45.62 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.271 -0.572 . . . . 0.0 111.496 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.44 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -62.66 -44.08 97.18 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.669 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -60.44 -32.12 71.07 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.306 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -54.71 -40.85 69.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.948 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -99.73 -59.97 1.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 155' ' ' TRP . 23.5 m -58.78 -33.24 70.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.108 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.55 -178.91 52.48 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -116.55 149.81 39.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -108.54 149.23 29.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.288 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.6 -177.8 52.0 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.55 -176.88 51.38 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 56.2 p -69.03 163.66 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 110.573 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -56.36 -33.0 65.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.799 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.455 ' H ' HD22 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -61.85 -34.53 76.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.288 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 169' ' ' GLU . . . -75.23 157.55 34.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.305 0.574 . . . . 0.0 110.741 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 168' ' ' ALA . 94.6 mt-10 . . . . . 0 C--N 1.319 -0.756 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.276 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.569 'CL ' ' HA ' ' A' ' 23' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtp . . . . . 0 CA--C 1.53 0.191 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.53 -16.81 19.8 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.501 1.468 . . . . 0.0 112.013 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.47 -33.15 53.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.309 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.9 m -60.19 -40.64 90.74 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.522 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.467 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 8.1 m0 -76.23 -31.55 58.43 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 18.3 t -41.44 -51.69 8.41 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 6' ' ' VAL . 10.0 Cg_endo -55.31 -19.4 21.71 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 CA-C-N 119.147 0.731 . . . . 0.0 111.451 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 5' ' ' TRP . . . -54.12 -32.01 53.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 12' ' ' THR . 79.2 t -61.17 -41.15 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -61.25 -36.86 93.07 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.312 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.27 -41.69 84.86 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.043 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 9' ' ' VAL . 9.2 t -75.81 -34.52 60.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.652 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.15 -34.74 78.21 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 10' ' ' GLY . 26.8 t -49.26 -55.84 19.32 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HB3' HD21 ' A' ' 89' ' ' LEU . 18.2 Cg_endo -58.92 -32.6 97.7 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 120.539 0.826 . . . . 0.0 112.963 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.8 m -59.97 -40.04 87.72 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.746 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -65.98 -38.09 87.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.42 -59.04 8.24 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.191 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' CH2' ' A' ' 93' ' ' TRP . . . -60.1 -36.34 90.21 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.284 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -58.15 -46.48 85.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.497 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.08 -38.21 87.97 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.554 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.83 -39.51 97.48 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.646 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.441 ' HA ' 'CL ' ' A' ' 201' ' ' PKA . . . -67.66 -28.42 67.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.337 . . . . 0.0 111.763 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.72 -34.82 67.88 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.724 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' CE2' ' O ' ' A' ' 102' ' ' ALA . 88.6 t80 -60.89 -47.59 85.71 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.435 ' H ' HG13 ' A' ' 26' ' ' VAL . 1.1 m -71.79 -33.9 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.702 0.763 . . . . 0.0 109.333 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -61.75 -40.77 96.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.028 -1.442 . . . . 0.0 112.674 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.14 -126.08 1.83 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.047 -177.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.39 -28.11 62.92 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.777 0.322 . . . . 0.0 111.317 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.96 -32.88 12.28 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.25 -41.23 62.64 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.025 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.2 mtp85 -61.48 -45.86 92.45 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.677 0.751 . . . . 0.0 109.334 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -62.46 -40.67 97.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.97 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.595 ' OH ' ' CE3' ' A' ' 107' ' ' TRP . 21.4 m-85 -65.16 -23.0 66.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.647 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.86 -39.72 54.48 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.56 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -33.21 85.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 34' ' ' TYR . 60.5 mt -91.47 149.42 21.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.252 -0.474 . . . . 0.0 110.59 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -99.62 130.71 45.88 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.639 -0.425 . . . . 0.0 109.89 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' NZ ' ' C1 ' ' A' ' 201' ' ' PKA . 1.3 mtpt -111.67 141.35 24.49 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.852 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 62.3 Cg_endo -58.61 133.29 53.37 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.972 1.114 . . . . 0.0 111.971 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.3 p -82.47 -9.19 59.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.05 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 42' ' ' TRP . 3.3 p90 -77.79 -15.4 59.12 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.818 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -74.2 151.97 88.13 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.407 -178.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.68 173.13 14.07 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 112.455 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' CB ' ' CE2' ' A' ' 47' ' ' TRP . 19.5 Cg_exo -51.72 151.38 15.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.984 2.456 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -58.09 -35.69 71.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.152 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CE2' ' CB ' ' A' ' 45' ' ' PRO . 14.7 p90 -74.51 -12.3 60.44 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.672 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -76.96 -66.91 0.76 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.905 0.383 . . . . 0.0 110.956 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.996 ' O ' HG23 ' A' ' 52' ' ' ILE . 19.5 mt -66.52 -35.82 81.2 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.581 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.656 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . . . -40.76 -42.49 3.58 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.471 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 51.3 Cg_exo -65.51 -5.39 11.4 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.87 2.38 . . . . 0.0 112.98 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.035 HD12 ' HE1' ' A' ' 143' ' ' TRP . 5.9 pt -41.22 -42.54 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 120.658 0.266 . . . . 0.0 111.709 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.449 ' O ' ' N ' ' A' ' 57' ' ' TYR . 95.0 m95 -56.31 -34.06 66.17 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.105 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 51' ' ' PRO . . . -60.49 -39.09 95.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 83.5 m -66.73 -52.28 46.25 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.19 0.519 . . . . 0.0 111.049 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.722 HD21 ' CE3' ' A' ' 143' ' ' TRP . 6.8 mp -68.22 -31.47 71.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.076 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 53' ' ' TRP . 19.8 t80 -52.2 -49.12 64.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.131 -178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.2 p -74.09 -34.79 64.09 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.651 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.94 -45.02 87.51 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.858 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.78 -37.18 85.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.778 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.75 -60.84 6.46 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.152 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -62.15 -36.48 81.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.637 0.256 . . . . 0.0 111.02 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -55.4 -43.81 85.0 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.115 -1.04 . . . . 0.0 110.738 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.2 p -65.07 -30.11 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.566 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -58.49 -44.01 89.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.089 0.471 . . . . 0.0 109.947 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.43 -38.48 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.949 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 129' ' ' VAL . 63.1 t -62.15 -41.6 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.636 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.594 ' CG ' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.33 -50.03 75.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.308 -178.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.594 ' N ' ' CG ' ' A' ' 68' ' ' TRP . 74.9 mttt -54.4 -36.24 63.75 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.978 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -72.94 -44.73 60.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.658 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 78' ' ' ALA . 70.6 mt -77.41 -26.06 51.36 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.07 -6.85 40.42 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.269 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.85 -161.61 25.49 Favored Glycine 0 N--CA 1.47 0.959 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.113 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.686 ' CD2' ' SD ' ' A' ' 79' ' ' MET . 0.1 OUTLIER -89.23 82.68 6.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.35 0.595 . . . . 0.0 110.083 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 78' ' ' ALA . 13.4 p -123.16 166.0 15.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.484 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -44.46 -36.87 3.12 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.82 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -63.76 -42.82 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.952 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.414 ' HB3' ' H ' ' A' ' 75' ' ' THR . . . -82.27 -36.64 26.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.983 0.42 . . . . 0.0 111.657 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.686 ' SD ' ' CD2' ' A' ' 74' ' ' PHE . 98.7 mmm -59.08 -34.47 72.02 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.052 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.3 t -60.14 -52.39 73.65 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.929 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -68.88 -58.78 0.1 Allowed 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.155 1.237 . . . . 0.0 112.775 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 82' ' ' LEU . 11.0 mp -60.84 -42.0 96.92 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.194 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.19 95.38 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.4 tp -57.34 -39.79 76.66 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.449 ' CE2' HD22 ' A' ' 89' ' ' LEU . 75.0 t80 -59.13 -43.99 92.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.142 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.1 m -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.134 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -75.89 -60.07 3.26 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.595 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -56.97 -41.17 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.329 -178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 15' ' ' PRO . 33.0 tp -61.94 -38.86 90.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.632 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.86 -47.78 76.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.981 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.4 -39.09 86.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 0.0 109.72 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.555 ' O ' HD11 ' A' ' 113' ' ' LEU . 57.5 t30 -61.46 -41.07 96.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.666 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.572 ' CH2' ' N ' ' A' ' 19' ' ' GLY . 48.3 m95 -60.42 -28.76 68.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.71 -17.86 62.82 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.587 ' N ' ' CD ' ' A' ' 96' ' ' PRO . 11.3 t-105 -72.43 -55.92 4.37 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 -178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 95' ' ' TRP . 71.8 Cg_endo -42.62 87.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.182 1.255 . . . . 0.0 112.508 -177.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' N ' ' O ' ' A' ' 95' ' ' TRP . 84.6 Cg_endo -59.53 -27.1 84.13 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 120.606 0.871 . . . . 0.0 111.762 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.655 HD11 ' HB2' ' A' ' 110' ' ' ALA . 40.0 pt -61.71 -33.99 60.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.5 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -46.68 -43.78 18.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.534 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -67.53 -52.16 42.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.68 -55.11 0.39 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.847 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CE2' ' A' ' 25' ' ' PHE . . . 61.04 10.81 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.338 . . . . 0.0 110.356 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -55.66 -35.6 66.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.546 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -87.22 149.38 24.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.501 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.633 ' O ' ' N ' ' A' ' 107' ' ' TRP . 3.4 ttp -62.62 -14.93 48.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -58.28 35.44 0.02 OUTLIER Glycine 0 CA--C 1.54 1.598 0 C-N-CA 121.679 -0.296 . . . . 0.0 112.743 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.633 ' N ' ' O ' ' A' ' 105' ' ' MET . 0.2 OUTLIER -64.03 -19.67 65.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -179.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 107' ' ' TRP . . . -47.46 -22.7 0.49 Allowed 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.91 0.386 . . . . 0.0 111.258 -178.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.1 mt -57.77 -31.48 66.57 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.563 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 98' ' ' ILE . . . -64.02 -53.72 45.58 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.482 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.678 ' OD1' HG22 ' A' ' 147' ' ' THR . 31.1 t70 -63.13 -46.7 86.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.8 tp -60.61 -38.09 83.57 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.775 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.781 HD23 ' C ' ' A' ' 113' ' ' LEU . 5.6 tt -67.26 -48.78 66.71 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.616 ' N ' HD23 ' A' ' 113' ' ' LEU . 1.6 pp -76.15 -32.99 59.37 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.977 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 111' ' ' ASP . 70.6 t -64.82 -45.91 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.89 -38.75 17.72 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.55 -42.22 89.97 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.213 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 119' ' ' ALA . 0.9 OUTLIER -75.86 -48.38 29.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.776 0.322 . . . . 0.0 111.033 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 123' ' ' THR . . . -65.24 -56.79 10.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.7 m -61.9 -45.17 94.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.79 -59.11 3.14 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.423 ' CG2' ' CE3' ' A' ' 126' ' ' TRP . 28.3 m -63.11 -41.71 99.4 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 119' ' ' ALA . 88.8 m -58.84 -45.22 90.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.393 -178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 124' ' ' LEU . 96.4 mt -63.45 -37.48 87.44 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.176 -0.61 . . . . 0.0 112.215 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.28 -64.3 1.19 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.423 ' CE3' ' CG2' ' A' ' 122' ' ' THR . 42.6 m0 -66.1 -43.01 88.46 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -177.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -59.29 -50.12 75.2 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.691 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -64.11 -43.53 95.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.798 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 67' ' ' VAL . 97.7 t -76.02 -48.04 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 42.0 p -134.1 87.87 32.97 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.446 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.46 ' N ' ' CD ' ' A' ' 132' ' ' PRO . 31.4 Cg_exo -52.53 -42.41 61.91 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 121.391 1.394 . . . . 0.0 112.433 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 131' ' ' PRO . 36.5 Cg_exo -56.79 -30.46 84.91 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 120.328 0.685 . . . . 0.0 111.994 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.25 -30.79 70.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.094 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.91 97.83 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.526 -0.469 . . . . 0.0 110.114 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -59.98 -38.4 82.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.07 0.462 . . . . 0.0 110.352 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.6 tp -57.53 -37.71 73.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.198 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 139' ' ' PRO . 85.3 mt -57.86 -31.54 66.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.217 -178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.499 ' C ' ' O ' ' A' ' 137' ' ' LEU . 0.3 OUTLIER 5.88 -72.37 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.5 ' N ' ' O ' ' A' ' 137' ' ' LEU . 12.4 Cg_endo -50.8 -22.32 9.67 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 CA-C-N 119.23 0.761 . . . . 0.0 112.79 -178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 141' ' ' LEU . 1.7 p90 -57.73 -41.95 82.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.696 ' O ' HD13 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -61.34 -44.39 97.26 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.053 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.92 -39.21 83.57 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.234 0.54 . . . . 0.0 110.344 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TRP . . . . . 1.035 ' HE1' HD12 ' A' ' 52' ' ' ILE . 26.7 t90 -60.47 -50.59 72.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.486 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.736 HD21 ' CZ3' ' A' ' 143' ' ' TRP . 57.8 mt -74.78 -29.69 61.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.966 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.32 -54.92 39.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.841 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 150' ' ' LEU . 40.8 t80 -65.36 -44.93 86.1 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.786 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.678 HG22 ' OD1' ' A' ' 111' ' ' ASP . 9.6 m -56.56 -42.33 78.42 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.672 -178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 59.5 m -68.18 -50.17 56.08 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.922 0.391 . . . . 0.0 111.604 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.06 -39.57 86.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.258 0.551 . . . . 0.0 110.218 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 146' ' ' PHE . 66.1 tp -55.45 -41.73 73.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.119 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.576 ' OD1' ' CB ' ' A' ' 111' ' ' ASP . 6.2 m120 -63.18 -42.62 99.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.794 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -63.58 -35.9 82.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.664 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -58.57 -47.02 85.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.549 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.42 -47.44 52.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.756 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 108' ' ' ALA . 3.1 m0 -61.58 -43.91 97.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.419 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -60.86 -33.66 73.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.851 0.358 . . . . 0.0 111.269 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -56.6 -41.08 76.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.126 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -96.75 -59.97 1.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.053 0.454 . . . . 0.0 111.482 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 85.4 p -62.09 -25.94 68.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.069 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.5 155.58 53.3 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.149 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 75.2 mtp85 -122.52 156.39 34.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.747 0.308 . . . . 0.0 110.569 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -53.8 -37.03 63.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.433 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -55.9 -30.6 57.26 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -52.93 -33.06 42.96 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.4 m -56.53 -33.41 66.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.895 0.379 . . . . 0.0 110.397 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -55.41 -35.09 64.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.33 144.88 24.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.85 0.357 . . . . 0.0 110.283 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' O ' ' CG ' ' A' ' 169' ' ' GLU . . . -85.02 124.62 31.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.494 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.41 ' CG ' ' O ' ' A' ' 168' ' ' ALA . 92.4 mt-10 . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 117.926 -1.035 . . . . 0.0 110.53 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PKA . . . . . 0.586 ' C22' ' HB3' ' A' ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_